




Analysis Type:	PANTHER Overrepresentation Test (release 20170413)
Annotation Version and Release Date:	GO Ontology database  Released 2017-09-26
Analyzed List:	upload_1 (Homo sapiens)
Reference List:	Homo sapiens (all genes in database)
Bonferroni correction:	true
Bonferroni count:	8638
GO biological process complete	Homo sapiens - REFLIST (21002)	upload_1 (88)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (P-value)
Unclassified (UNCLASSIFIED)	3579	0	15.00	-	 < 0.2	0.00E00
regulation of cell proliferation (GO:0042127)	1594	53	6.68	+	7.94	1.09E-32
positive regulation of biological process (GO:0048518)	5600	78	23.46	+	3.32	3.07E-30
positive regulation of cellular process (GO:0048522)	4979	74	20.86	+	3.55	7.35E-29
intracellular signal transduction (GO:0035556)	1614	48	6.76	+	7.10	2.25E-26
response to organic substance (GO:0010033)	2780	58	11.65	+	4.98	4.55E-26
regulation of localization (GO:0032879)	2603	56	10.91	+	5.13	2.24E-25
positive regulation of metabolic process (GO:0009893)	3276	60	13.73	+	4.37	2.30E-24
positive regulation of macromolecule metabolic process (GO:0010604)	3032	58	12.70	+	4.57	4.64E-24
positive regulation of cellular metabolic process (GO:0031325)	3053	57	12.79	+	4.46	7.39E-23
response to oxygen-containing compound (GO:1901700)	1444	43	6.05	+	7.11	9.81E-23
cellular response to stimulus (GO:0051716)	6351	75	26.61	+	2.82	1.15E-22
developmental process (GO:0032502)	5506	71	23.07	+	3.08	1.72E-22
response to chemical (GO:0042221)	4097	63	17.17	+	3.67	4.86E-22
negative regulation of cellular process (GO:0048523)	4442	65	18.61	+	3.49	4.90E-22
negative regulation of biological process (GO:0048519)	4931	67	20.66	+	3.24	2.35E-21
response to stimulus (GO:0050896)	8009	80	33.56	+	2.38	4.06E-21
response to stress (GO:0006950)	3333	57	13.97	+	4.08	6.82E-21
cellular response to chemical stimulus (GO:0070887)	2588	51	10.84	+	4.70	2.71E-20
anatomical structure development (GO:0048856)	5141	67	21.54	+	3.11	2.94E-20
positive regulation of cell proliferation (GO:0008284)	876	34	3.67	+	9.26	3.09E-20
cellular developmental process (GO:0048869)	3596	58	15.07	+	3.85	3.61E-20
regulation of phosphorylation (GO:0042325)	1482	41	6.21	+	6.60	4.02E-20
regulation of apoptotic process (GO:0042981)	1495	41	6.26	+	6.55	5.58E-20
regulation of programmed cell death (GO:0043067)	1510	41	6.33	+	6.48	8.11E-20
regulation of cellular protein metabolic process (GO:0032268)	2537	50	10.63	+	4.70	1.07E-19
positive regulation of nitrogen compound metabolic process (GO:0051173)	2943	53	12.33	+	4.30	1.20E-19
regulation of cell death (GO:0010941)	1627	42	6.82	+	6.16	1.23E-19
regulation of protein phosphorylation (GO:0001932)	1355	39	5.68	+	6.87	2.03E-19
regulation of transport (GO:0051049)	1868	44	7.83	+	5.62	2.40E-19
regulation of intracellular signal transduction (GO:1902531)	1791	43	7.50	+	5.73	4.71E-19
response to organonitrogen compound (GO:0010243)	881	33	3.69	+	8.94	5.25E-19
cellular response to organic substance (GO:0071310)	2136	46	8.95	+	5.14	5.54E-19
regulation of protein metabolic process (GO:0051246)	2782	51	11.66	+	4.38	7.39E-19
regulation of phosphate metabolic process (GO:0019220)	1719	42	7.20	+	5.83	1.00E-18
response to wounding (GO:0009611)	558	28	2.34	+	11.98	1.01E-18
regulation of phosphorus metabolic process (GO:0051174)	1733	42	7.26	+	5.78	1.36E-18
response to nitrogen compound (GO:1901698)	995	34	4.17	+	8.16	1.72E-18
regulation of protein modification process (GO:0031399)	1744	42	7.31	+	5.75	1.73E-18
negative regulation of apoptotic process (GO:0043066)	851	32	3.57	+	8.97	2.54E-18
regulation of cell motility (GO:2000145)	778	31	3.26	+	9.51	2.56E-18
regulation of cellular component movement (GO:0051270)	852	32	3.57	+	8.96	2.63E-18
multicellular organism development (GO:0007275)	4786	63	20.05	+	3.14	3.14E-18
negative regulation of programmed cell death (GO:0043069)	865	32	3.62	+	8.83	4.12E-18
regulation of cell communication (GO:0010646)	3359	54	14.07	+	3.84	7.33E-18
regulation of response to stimulus (GO:0048583)	4032	58	16.89	+	3.43	1.31E-17
cellular response to oxygen-containing compound (GO:1901701)	903	32	3.78	+	8.46	1.47E-17
regulation of signaling (GO:0023051)	3409	54	14.28	+	3.78	1.48E-17
regulation of locomotion (GO:0040012)	848	31	3.55	+	8.72	3.06E-17
negative regulation of cell death (GO:0060548)	945	32	3.96	+	8.08	5.63E-17
response to abiotic stimulus (GO:0009628)	1114	34	4.67	+	7.28	5.88E-17
wound healing (GO:0042060)	467	25	1.96	+	12.78	6.35E-17
regulation of signal transduction (GO:0009966)	3072	51	12.87	+	3.96	6.51E-17
positive regulation of gene expression (GO:0010628)	1813	41	7.60	+	5.40	7.16E-17
positive regulation of cellular protein metabolic process (GO:0032270)	1512	38	6.34	+	6.00	1.01E-16
response to cytokine (GO:0034097)	964	32	4.04	+	7.92	1.01E-16
protein phosphorylation (GO:0006468)	974	32	4.08	+	7.84	1.37E-16
animal organ development (GO:0048513)	2990	50	12.53	+	3.99	1.57E-16
positive regulation of cell motility (GO:2000147)	443	24	1.86	+	12.93	3.31E-16
regulation of cellular process (GO:0050794)	10741	84	45.01	+	1.87	4.16E-16
multicellular organismal process (GO:0032501)	6697	70	28.06	+	2.49	4.22E-16
positive regulation of response to stimulus (GO:0048584)	2150	43	9.01	+	4.77	5.32E-16
cell differentiation (GO:0030154)	3522	53	14.76	+	3.59	5.37E-16
response to endogenous stimulus (GO:0009719)	1291	35	5.41	+	6.47	5.58E-16
phosphorylation (GO:0016310)	1293	35	5.42	+	6.46	5.86E-16
positive regulation of cellular component movement (GO:0051272)	455	24	1.91	+	12.59	6.07E-16
positive regulation of protein metabolic process (GO:0051247)	1603	38	6.72	+	5.66	7.40E-16
positive regulation of cellular biosynthetic process (GO:0031328)	1822	40	7.63	+	5.24	7.76E-16
regulation of protein localization (GO:0032880)	1036	32	4.34	+	7.37	8.34E-16
regulation of cell migration (GO:0030334)	724	28	3.03	+	9.23	9.31E-16
signal transduction (GO:0007165)	4925	61	20.64	+	2.96	9.32E-16
circulatory system development (GO:0072359)	807	29	3.38	+	8.58	1.26E-15
positive regulation of biosynthetic process (GO:0009891)	1852	40	7.76	+	5.15	1.39E-15
regulation of cellular component organization (GO:0051128)	2336	44	9.79	+	4.50	1.56E-15
positive regulation of locomotion (GO:0040017)	475	24	1.99	+	12.06	1.61E-15
regulation of cellular metabolic process (GO:0031323)	6181	67	25.90	+	2.59	1.68E-15
positive regulation of transport (GO:0051050)	977	31	4.09	+	7.57	1.73E-15
response to external stimulus (GO:0009605)	1868	40	7.83	+	5.11	1.88E-15
positive regulation of cell migration (GO:0030335)	425	23	1.78	+	12.92	2.32E-15
negative regulation of signal transduction (GO:0009968)	1164	33	4.88	+	6.77	2.43E-15
regulation of biological process (GO:0050789)	11390	85	47.72	+	1.78	2.45E-15
negative regulation of response to stimulus (GO:0048585)	1455	36	6.10	+	5.90	2.60E-15
negative regulation of cell communication (GO:0010648)	1264	34	5.30	+	6.42	2.90E-15
negative regulation of signaling (GO:0023057)	1268	34	5.31	+	6.40	3.20E-15
positive regulation of signal transduction (GO:0009967)	1480	36	6.20	+	5.81	4.51E-15
system development (GO:0048731)	4199	56	17.59	+	3.18	5.59E-15
cellular response to stress (GO:0033554)	1599	37	6.70	+	5.52	6.18E-15
regulation of primary metabolic process (GO:0080090)	6119	66	25.64	+	2.57	6.94E-15
positive regulation of cell communication (GO:0010647)	1611	37	6.75	+	5.48	7.90E-15
organonitrogen compound metabolic process (GO:1901564)	5523	63	23.14	+	2.72	8.38E-15
regulation of macromolecule metabolic process (GO:0060255)	6142	66	25.74	+	2.56	8.60E-15
cellular protein metabolic process (GO:0044267)	3745	53	15.69	+	3.38	8.97E-15
positive regulation of signaling (GO:0023056)	1618	37	6.78	+	5.46	9.11E-15
response to organic cyclic compound (GO:0014070)	882	29	3.70	+	7.85	1.35E-14
protein metabolic process (GO:0019538)	4456	57	18.67	+	3.05	1.44E-14
cell communication (GO:0007154)	5407	62	22.66	+	2.74	1.86E-14
regulation of metabolic process (GO:0019222)	6668	68	27.94	+	2.43	1.93E-14
positive regulation of phosphorylation (GO:0042327)	979	30	4.10	+	7.31	2.02E-14
tissue development (GO:0009888)	1658	37	6.95	+	5.33	2.03E-14
response to inorganic substance (GO:0010035)	478	23	2.00	+	11.48	2.94E-14
positive regulation of macromolecule biosynthetic process (GO:0010557)	1685	37	7.06	+	5.24	3.45E-14
signaling (GO:0023052)	5316	61	22.27	+	2.74	5.15E-14
positive regulation of phosphorus metabolic process (GO:0010562)	1106	31	4.63	+	6.69	5.68E-14
positive regulation of phosphate metabolic process (GO:0045937)	1106	31	4.63	+	6.69	5.68E-14
positive regulation of protein phosphorylation (GO:0001934)	933	29	3.91	+	7.42	5.95E-14
regulation of nitrogen compound metabolic process (GO:0051171)	5958	64	24.96	+	2.56	7.60E-14
response to hormone (GO:0009725)	782	27	3.28	+	8.24	8.14E-14
biological regulation (GO:0065007)	11993	85	50.25	+	1.69	1.63E-13
regulation of multicellular organismal process (GO:0051239)	2791	45	11.69	+	3.85	2.03E-13
cell surface receptor signaling pathway (GO:0007166)	2285	41	9.57	+	4.28	3.03E-13
regulation of establishment of protein localization (GO:0070201)	828	27	3.47	+	7.78	3.33E-13
regulation of cell adhesion (GO:0030155)	677	25	2.84	+	8.81	3.67E-13
regulation of kinase activity (GO:0043549)	843	27	3.53	+	7.64	5.18E-13
positive regulation of protein modification process (GO:0031401)	1198	31	5.02	+	6.18	5.24E-13
response to lipid (GO:0033993)	844	27	3.54	+	7.63	5.34E-13
cellular protein modification process (GO:0006464)	3156	47	13.22	+	3.55	5.65E-13
protein modification process (GO:0036211)	3156	47	13.22	+	3.55	5.65E-13
phosphorus metabolic process (GO:0006793)	2200	40	9.22	+	4.34	5.79E-13
regulation of transferase activity (GO:0051338)	1018	29	4.27	+	6.80	5.86E-13
aging (GO:0007568)	266	18	1.11	+	16.15	6.32E-13
response to reactive oxygen species (GO:0000302)	181	16	.76	+	21.10	6.45E-13
positive regulation of intracellular signal transduction (GO:1902533)	940	28	3.94	+	7.11	7.51E-13
positive regulation of molecular function (GO:0044093)	1975	38	8.28	+	4.59	8.05E-13
phosphate-containing compound metabolic process (GO:0006796)	2108	39	8.83	+	4.42	9.69E-13
regulation of response to stress (GO:0080134)	1435	33	6.01	+	5.49	1.17E-12
response to peptide (GO:1901652)	442	21	1.85	+	11.34	1.35E-12
regulation of biological quality (GO:0065008)	3554	49	14.89	+	3.29	1.74E-12
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	517	22	2.17	+	10.16	2.20E-12
peptidyl-amino acid modification (GO:0018193)	895	27	3.75	+	7.20	2.24E-12
macromolecule modification (GO:0043412)	3438	48	14.41	+	3.33	2.77E-12
response to extracellular stimulus (GO:0009991)	459	21	1.92	+	10.92	2.83E-12
apoptotic signaling pathway (GO:0097190)	296	18	1.24	+	14.51	3.93E-12
cellular response to organonitrogen compound (GO:0071417)	482	21	2.02	+	10.40	7.37E-12
regulation of developmental process (GO:0050793)	2372	40	9.94	+	4.02	7.67E-12
regulation of immune system process (GO:0002682)	1532	33	6.42	+	5.14	7.78E-12
regulation of catalytic activity (GO:0050790)	2512	41	10.53	+	3.90	8.44E-12
response to oxidative stress (GO:0006979)	364	19	1.53	+	12.46	8.46E-12
regulation of cell cycle (GO:0051726)	1132	29	4.74	+	6.11	9.20E-12
programmed cell death (GO:0012501)	1039	28	4.35	+	6.43	9.32E-12
regulation of protein kinase activity (GO:0045859)	780	25	3.27	+	7.65	9.32E-12
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1768	35	7.41	+	4.72	9.57E-12
regulation of protein transport (GO:0051223)	784	25	3.29	+	7.61	1.05E-11
positive regulation of catalytic activity (GO:0043085)	1659	34	6.95	+	4.89	1.05E-11
cellular response to nitrogen compound (GO:1901699)	570	22	2.39	+	9.21	1.60E-11
cellular response to endogenous stimulus (GO:0071495)	1064	28	4.46	+	6.28	1.69E-11
regulation of apoptotic signaling pathway (GO:2001233)	383	19	1.60	+	11.84	2.10E-11
cell death (GO:0008219)	1074	28	4.50	+	6.22	2.13E-11
regulation of cell activation (GO:0050865)	580	22	2.43	+	9.05	2.28E-11
regulation of peptide transport (GO:0090087)	813	25	3.41	+	7.34	2.38E-11
regulation of biosynthetic process (GO:0009889)	4494	53	18.83	+	2.81	3.11E-11
apoptotic process (GO:0006915)	911	26	3.82	+	6.81	3.34E-11
regulation of cellular localization (GO:0060341)	914	26	3.83	+	6.79	3.60E-11
regulation of molecular function (GO:0065009)	3380	46	14.16	+	3.25	5.05E-11
positive regulation of cellular protein localization (GO:1903829)	404	19	1.69	+	11.22	5.41E-11
interleukin-7-mediated signaling pathway (GO:0038111)	91	12	.38	+	31.47	5.73E-11
cellular component organization (GO:0016043)	5303	57	22.22	+	2.57	6.00E-11
cellular response to interleukin-7 (GO:0098761)	92	12	.39	+	31.13	6.51E-11
response to interleukin-7 (GO:0098760)	92	12	.39	+	31.13	6.51E-11
cell aging (GO:0007569)	66	11	.28	+	39.78	6.54E-11
anatomical structure morphogenesis (GO:0009653)	2013	36	8.43	+	4.27	7.22E-11
regulation of cellular protein localization (GO:1903827)	615	22	2.58	+	8.54	7.43E-11
positive regulation of immune system process (GO:0002684)	1040	27	4.36	+	6.20	8.46E-11
regulation of cellular biosynthetic process (GO:0031326)	4423	52	18.53	+	2.81	8.63E-11
cellular response to peptide (GO:1901653)	300	17	1.26	+	13.52	8.68E-11
regulation of MAPK cascade (GO:0043408)	697	23	2.92	+	7.88	8.86E-11
regulation of gene expression (GO:0010468)	4622	53	19.37	+	2.74	1.06E-10
peptidyl-serine phosphorylation (GO:0018105)	167	14	.70	+	20.01	1.29E-10
enzyme linked receptor protein signaling pathway (GO:0007167)	714	23	2.99	+	7.69	1.46E-10
response to nutrient levels (GO:0031667)	428	19	1.79	+	10.59	1.50E-10
positive regulation of cell cycle (GO:0045787)	372	18	1.56	+	11.55	1.89E-10
positive regulation of cell death (GO:0010942)	653	22	2.74	+	8.04	2.47E-10
positive regulation of multicellular organismal process (GO:0051240)	1505	31	6.31	+	4.92	2.62E-10
regulation of macromolecule biosynthetic process (GO:0010556)	4223	50	17.69	+	2.83	3.59E-10
response to hydrogen peroxide (GO:0042542)	107	12	.45	+	26.77	3.79E-10
cellular component organization or biogenesis (GO:0071840)	5525	57	23.15	+	2.46	4.05E-10
cellular response to oxidative stress (GO:0034599)	227	15	.95	+	15.77	4.19E-10
positive regulation of establishment of protein localization (GO:1904951)	522	20	2.19	+	9.14	4.23E-10
peptidyl-serine modification (GO:0018209)	186	14	.78	+	17.96	5.49E-10
positive regulation of programmed cell death (GO:0043068)	607	21	2.54	+	8.26	6.33E-10
gland development (GO:0048732)	408	18	1.71	+	10.53	8.86E-10
cellular response to hormone stimulus (GO:0032870)	548	20	2.30	+	8.71	1.03E-09
regulation of multicellular organismal development (GO:2000026)	1820	33	7.63	+	4.33	1.04E-09
epithelium development (GO:0060429)	1068	26	4.48	+	5.81	1.31E-09
regulation of epithelial cell proliferation (GO:0050678)	299	16	1.25	+	12.77	1.35E-09
regulation of protein serine/threonine kinase activity (GO:0071900)	492	19	2.06	+	9.22	1.73E-09
positive regulation of RNA metabolic process (GO:0051254)	1504	30	6.30	+	4.76	1.80E-09
regulation of intracellular transport (GO:0032386)	569	20	2.38	+	8.39	2.05E-09
cellular response to peptide hormone stimulus (GO:0071375)	256	15	1.07	+	13.98	2.31E-09
response to oxygen levels (GO:0070482)	371	17	1.55	+	10.94	2.55E-09
negative regulation of apoptotic signaling pathway (GO:2001234)	210	14	.88	+	15.91	2.78E-09
response to peptide hormone (GO:0043434)	373	17	1.56	+	10.88	2.78E-09
negative regulation of transferase activity (GO:0051348)	374	17	1.57	+	10.85	2.90E-09
regulation of cellular macromolecule biosynthetic process (GO:2000112)	4117	48	17.25	+	2.78	3.43E-09
positive regulation of nucleic acid-templated transcription (GO:1903508)	1433	29	6.00	+	4.83	3.61E-09
positive regulation of transcription, DNA-templated (GO:0045893)	1433	29	6.00	+	4.83	3.61E-09
positive regulation of RNA biosynthetic process (GO:1902680)	1434	29	6.01	+	4.83	3.68E-09
phosphatidylinositol-mediated signaling (GO:0048015)	131	12	.55	+	21.86	3.97E-09
positive regulation of cell activation (GO:0050867)	382	17	1.60	+	10.62	4.05E-09
cell activation (GO:0001775)	1026	25	4.30	+	5.82	4.23E-09
signal transduction in response to DNA damage (GO:0042770)	99	11	.41	+	26.52	5.06E-09
response to UV (GO:0009411)	134	12	.56	+	21.37	5.16E-09
inositol lipid-mediated signaling (GO:0048017)	134	12	.56	+	21.37	5.16E-09
positive regulation of apoptotic process (GO:0043065)	601	20	2.52	+	7.94	5.52E-09
response to metal ion (GO:0010038)	331	16	1.39	+	11.54	6.19E-09
multi-organism process (GO:0051704)	2334	36	9.78	+	3.68	6.31E-09
negative regulation of nitrogen compound metabolic process (GO:0051172)	2346	36	9.83	+	3.66	7.35E-09
cellular response to abiotic stimulus (GO:0071214)	279	15	1.17	+	12.83	7.79E-09
localization (GO:0051179)	5498	55	23.04	+	2.39	7.94E-09
cellular response to cytokine stimulus (GO:0071345)	868	23	3.64	+	6.32	8.16E-09
positive regulation of cell adhesion (GO:0045785)	404	17	1.69	+	10.04	9.77E-09
regulation of leukocyte activation (GO:0002694)	544	19	2.28	+	8.34	9.88E-09
cell development (GO:0048468)	1493	29	6.26	+	4.64	9.98E-09
positive regulation of smooth muscle cell proliferation (GO:0048661)	75	10	.31	+	31.82	1.02E-08
negative regulation of cellular metabolic process (GO:0031324)	2513	37	10.53	+	3.51	1.05E-08
negative regulation of protein phosphorylation (GO:0001933)	409	17	1.71	+	9.92	1.18E-08
positive regulation of intracellular transport (GO:0032388)	346	16	1.45	+	11.04	1.20E-08
response to ketone (GO:1901654)	187	13	.78	+	16.59	1.23E-08
positive regulation of cellular component organization (GO:0051130)	1182	26	4.95	+	5.25	1.30E-08
regulation of lymphocyte activation (GO:0051249)	481	18	2.02	+	8.93	1.36E-08
vasculature development (GO:0001944)	486	18	2.04	+	8.84	1.61E-08
positive regulation of protein transport (GO:0051222)	486	18	2.04	+	8.84	1.61E-08
regulation of cell-cell adhesion (GO:0022407)	425	17	1.78	+	9.55	2.16E-08
cardiovascular system development (GO:0072358)	496	18	2.08	+	8.66	2.25E-08
response to radiation (GO:0009314)	428	17	1.79	+	9.48	2.41E-08
locomotion (GO:0040011)	1215	26	5.09	+	5.11	2.41E-08
cellular response to DNA damage stimulus (GO:0006974)	736	21	3.08	+	6.81	2.42E-08
ERBB signaling pathway (GO:0038127)	82	10	.34	+	29.10	2.43E-08
response to growth factor (GO:0070848)	501	18	2.10	+	8.57	2.65E-08
negative regulation of phosphorus metabolic process (GO:0010563)	578	19	2.42	+	7.85	2.81E-08
negative regulation of protein metabolic process (GO:0051248)	1120	25	4.69	+	5.33	2.85E-08
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	157	12	.66	+	18.24	3.19E-08
anatomical structure formation involved in morphogenesis (GO:0048646)	836	22	3.50	+	6.28	3.21E-08
positive regulation of leukocyte activation (GO:0002696)	372	16	1.56	+	10.26	3.51E-08
nitrogen compound metabolic process (GO:0006807)	8609	68	36.07	+	1.89	3.99E-08
cellular process (GO:0009987)	15013	87	62.91	+	1.38	4.62E-08
cellular response to reactive oxygen species (GO:0034614)	122	11	.51	+	21.52	4.66E-08
negative regulation of phosphorylation (GO:0042326)	447	17	1.87	+	9.08	4.74E-08
negative regulation of metabolic process (GO:0009892)	2789	38	11.69	+	3.25	4.83E-08
regulation of reactive oxygen species metabolic process (GO:2000377)	166	12	.70	+	17.25	6.05E-08
cell proliferation (GO:0008283)	691	20	2.90	+	6.91	6.77E-08
response to mechanical stimulus (GO:0009612)	215	13	.90	+	14.43	6.88E-08
regulation of DNA metabolic process (GO:0051052)	391	16	1.64	+	9.77	7.32E-08
blood vessel development (GO:0001568)	462	17	1.94	+	8.78	7.92E-08
regulation of cellular response to stress (GO:0080135)	625	19	2.62	+	7.26	1.07E-07
cellular response to growth factor stimulus (GO:0071363)	472	17	1.98	+	8.60	1.10E-07
regulation of hydrolase activity (GO:0051336)	1416	27	5.93	+	4.55	1.16E-07
positive regulation of protein localization to nucleus (GO:1900182)	134	11	.56	+	19.59	1.26E-07
response to hypoxia (GO:0001666)	341	15	1.43	+	10.50	1.29E-07
positive regulation of lymphocyte activation (GO:0051251)	341	15	1.43	+	10.50	1.29E-07
cellular response to external stimulus (GO:0071496)	283	14	1.19	+	11.81	1.42E-07
replicative senescence (GO:0090399)	12	6	.05	+	 > 100	1.56E-07
response to drug (GO:0042493)	414	16	1.73	+	9.22	1.69E-07
signal transduction by protein phosphorylation (GO:0023014)	414	16	1.73	+	9.22	1.69E-07
regulation of cell differentiation (GO:0045595)	1680	29	7.04	+	4.12	1.77E-07
response to decreased oxygen levels (GO:0036293)	349	15	1.46	+	10.26	1.78E-07
negative regulation of intracellular signal transduction (GO:1902532)	490	17	2.05	+	8.28	1.97E-07
primary metabolic process (GO:0044238)	9129	69	38.25	+	1.80	2.06E-07
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	104	10	.44	+	22.95	2.43E-07
regulation of body fluid levels (GO:0050878)	498	17	2.09	+	8.15	2.52E-07
cellular response to organic cyclic compound (GO:0071407)	499	17	2.09	+	8.13	2.60E-07
negative regulation of phosphate metabolic process (GO:0045936)	577	18	2.42	+	7.45	2.64E-07
macromolecule metabolic process (GO:0043170)	7749	63	32.47	+	1.94	3.54E-07
negative regulation of macromolecule metabolic process (GO:0010605)	2537	35	10.63	+	3.29	3.68E-07
organic substance metabolic process (GO:0071704)	9489	70	39.76	+	1.76	3.70E-07
negative regulation of protein kinase activity (GO:0006469)	249	13	1.04	+	12.46	4.14E-07
cellular metabolic process (GO:0044237)	9003	68	37.72	+	1.80	4.48E-07
negative regulation of cellular protein metabolic process (GO:0032269)	1061	23	4.45	+	5.17	4.56E-07
positive regulation of transferase activity (GO:0051347)	687	19	2.88	+	6.60	5.28E-07
cell migration (GO:0016477)	874	21	3.66	+	5.73	5.79E-07
negative regulation of protein modification process (GO:0031400)	616	18	2.58	+	6.97	7.54E-07
regulation of smooth muscle cell proliferation (GO:0048660)	117	10	.49	+	20.40	7.56E-07
negative regulation of catalytic activity (GO:0043086)	891	21	3.73	+	5.62	8.23E-07
response to corticosteroid (GO:0031960)	161	11	.67	+	16.31	8.64E-07
metabolic process (GO:0008152)	9923	71	41.58	+	1.71	9.64E-07
negative regulation of kinase activity (GO:0033673)	267	13	1.12	+	11.62	9.66E-07
cellular macromolecule metabolic process (GO:0044260)	7006	59	29.36	+	2.01	9.82E-07
regulation of T cell activation (GO:0050863)	329	14	1.38	+	10.16	1.00E-06
response to insulin (GO:0032868)	213	12	.89	+	13.45	1.03E-06
response to acid chemical (GO:0001101)	330	14	1.38	+	10.12	1.04E-06
positive regulation of kinase activity (GO:0033674)	548	17	2.30	+	7.40	1.09E-06
response to steroid hormone (GO:0048545)	335	14	1.40	+	9.97	1.27E-06
cellular response to ketone (GO:1901655)	87	9	.36	+	24.69	1.32E-06
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	87	9	.36	+	24.69	1.32E-06
heart development (GO:0007507)	477	16	2.00	+	8.01	1.33E-06
positive regulation of epithelial cell proliferation (GO:0050679)	168	11	.70	+	15.63	1.35E-06
positive regulation of developmental process (GO:0051094)	1231	24	5.16	+	4.65	1.37E-06
regulation of growth (GO:0040008)	641	18	2.69	+	6.70	1.42E-06
positive regulation of smooth muscle cell migration (GO:0014911)	34	7	.14	+	49.14	1.42E-06
regulation of smooth muscle cell migration (GO:0014910)	58	8	.24	+	32.92	1.54E-06
positive regulation of T cell activation (GO:0050870)	222	12	.93	+	12.90	1.64E-06
regulation of leukocyte cell-cell adhesion (GO:1903037)	344	14	1.44	+	9.71	1.78E-06
regulation of mitotic cell cycle (GO:0007346)	651	18	2.73	+	6.60	1.82E-06
regulation of protein localization to nucleus (GO:1900180)	225	12	.94	+	12.73	1.91E-06
regulation of neuron death (GO:1901214)	284	13	1.19	+	10.92	2.04E-06
hematopoietic or lymphoid organ development (GO:0048534)	573	17	2.40	+	7.08	2.15E-06
regulation of response to DNA damage stimulus (GO:2001020)	176	11	.74	+	14.92	2.19E-06
extrinsic apoptotic signaling pathway (GO:0097191)	93	9	.39	+	23.10	2.36E-06
response to light stimulus (GO:0009416)	289	13	1.21	+	10.74	2.51E-06
negative regulation of cell proliferation (GO:0008285)	665	18	2.79	+	6.46	2.55E-06
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	231	12	.97	+	12.40	2.57E-06
positive regulation of protein kinase activity (GO:0045860)	510	16	2.14	+	7.49	3.48E-06
ERBB2 signaling pathway (GO:0038128)	39	7	.16	+	42.84	3.66E-06
regulation of RNA metabolic process (GO:0051252)	3893	42	16.31	+	2.57	3.95E-06
positive regulation of hydrolase activity (GO:0051345)	975	21	4.09	+	5.14	4.19E-06
localization of cell (GO:0051674)	977	21	4.09	+	5.13	4.34E-06
cell motility (GO:0048870)	977	21	4.09	+	5.13	4.34E-06
platelet activation (GO:0030168)	142	10	.59	+	16.81	4.82E-06
immune system development (GO:0002520)	605	17	2.53	+	6.71	4.87E-06
regulation of nucleobase-containing compound metabolic process (GO:0019219)	4272	44	17.90	+	2.46	5.02E-06
MAPK cascade (GO:0000165)	374	14	1.57	+	8.93	5.20E-06
DNA damage checkpoint (GO:0000077)	144	10	.60	+	16.57	5.50E-06
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	146	10	.61	+	16.35	6.27E-06
response to glucocorticoid (GO:0051384)	146	10	.61	+	16.35	6.27E-06
regulation of organelle organization (GO:0033043)	1214	23	5.09	+	4.52	6.28E-06
nervous system development (GO:0007399)	2228	31	9.34	+	3.32	6.35E-06
regulation of neuron apoptotic process (GO:0043523)	198	11	.83	+	13.26	7.42E-06
response to ionizing radiation (GO:0010212)	149	10	.62	+	16.02	7.61E-06
cellular response to radiation (GO:0071478)	149	10	.62	+	16.02	7.61E-06
regulation of intracellular protein transport (GO:0033157)	386	14	1.62	+	8.66	7.78E-06
cellular response to insulin stimulus (GO:0032869)	150	10	.63	+	15.91	8.11E-06
adherens junction organization (GO:0034332)	72	8	.30	+	26.52	8.30E-06
regulation of transcription from RNA polymerase II promoter (GO:0006357)	1985	29	8.32	+	3.49	9.12E-06
regulation of catabolic process (GO:0009894)	915	20	3.83	+	5.22	9.13E-06
immune system process (GO:0002376)	2552	33	10.69	+	3.09	9.30E-06
DNA integrity checkpoint (GO:0031570)	153	10	.64	+	15.60	9.79E-06
embryo development (GO:0009790)	923	20	3.87	+	5.17	1.06E-05
positive regulation of intracellular protein transport (GO:0090316)	263	12	1.10	+	10.89	1.09E-05
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	155	10	.65	+	15.40	1.11E-05
positive regulation of cell-cell adhesion (GO:0022409)	265	12	1.11	+	10.81	1.19E-05
regulation of ERK1 and ERK2 cascade (GO:0070372)	266	12	1.11	+	10.77	1.24E-05
intrinsic apoptotic signaling pathway (GO:0097193)	158	10	.66	+	15.11	1.33E-05
regulation of MAP kinase activity (GO:0043405)	336	13	1.41	+	9.23	1.52E-05
neurogenesis (GO:0022008)	1511	25	6.33	+	3.95	1.54E-05
regulation of cell cycle G1/S phase transition (GO:1902806)	162	10	.68	+	14.73	1.68E-05
regulation of insulin receptor signaling pathway (GO:0046626)	49	7	.21	+	34.09	1.75E-05
cellular response to lipid (GO:0071396)	489	15	2.05	+	7.32	1.76E-05
negative regulation of molecular function (GO:0044092)	1172	22	4.91	+	4.48	1.90E-05
regulation of nucleocytoplasmic transport (GO:0046822)	218	11	.91	+	12.04	2.00E-05
positive regulation of nucleocytoplasmic transport (GO:0046824)	120	9	.50	+	17.90	2.13E-05
regulation of protein secretion (GO:0050708)	421	14	1.76	+	7.94	2.33E-05
T cell costimulation (GO:0031295)	83	8	.35	+	23.00	2.49E-05
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	84	8	.35	+	22.73	2.74E-05
response to biotic stimulus (GO:0009607)	875	19	3.67	+	5.18	2.86E-05
regulation of cellular catabolic process (GO:0031329)	776	18	3.25	+	5.54	2.87E-05
establishment of localization (GO:0051234)	4517	44	18.93	+	2.32	3.13E-05
leukocyte activation (GO:0045321)	880	19	3.69	+	5.15	3.13E-05
mammary gland development (GO:0030879)	126	9	.53	+	17.05	3.24E-05
lymphocyte costimulation (GO:0031294)	86	8	.36	+	22.20	3.28E-05
cytokine-mediated signaling pathway (GO:0019221)	602	16	2.52	+	6.34	3.65E-05
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	232	11	.97	+	11.32	3.78E-05
angiogenesis (GO:0001525)	295	12	1.24	+	9.71	3.89E-05
blood coagulation (GO:0007596)	295	12	1.24	+	9.71	3.89E-05
regulation of transcription, DNA-templated (GO:0006355)	3666	39	15.36	+	2.54	3.91E-05
regulation of cyclin-dependent protein kinase activity (GO:1904029)	88	8	.37	+	21.70	3.92E-05
coagulation (GO:0050817)	297	12	1.24	+	9.64	4.19E-05
response to gamma radiation (GO:0010332)	56	7	.23	+	29.83	4.35E-05
positive regulation of transcription from RNA polymerase II promoter (GO:0045944)	1115	21	4.67	+	4.49	4.49E-05
movement of cell or subcellular component (GO:0006928)	1470	24	6.16	+	3.90	4.62E-05
hemopoiesis (GO:0030097)	526	15	2.20	+	6.81	4.66E-05
hemostasis (GO:0007599)	300	12	1.26	+	9.55	4.68E-05
regulation of nucleic acid-templated transcription (GO:1903506)	3690	39	15.46	+	2.52	4.72E-05
signal transduction by p53 class mediator (GO:0072331)	132	9	.55	+	16.27	4.83E-05
regulation of developmental growth (GO:0048638)	301	12	1.26	+	9.51	4.86E-05
regulation of RNA biosynthetic process (GO:2001141)	3699	39	15.50	+	2.52	5.07E-05
regulation of peptide secretion (GO:0002791)	448	14	1.88	+	7.46	5.09E-05
regulation of epithelial cell migration (GO:0010632)	183	10	.77	+	13.04	5.30E-05
response to X-ray (GO:0010165)	33	6	.14	+	43.39	6.31E-05
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	94	8	.39	+	20.31	6.50E-05
blood vessel morphogenesis (GO:0048514)	380	13	1.59	+	8.16	6.51E-05
negative regulation of cell cycle (GO:0045786)	542	15	2.27	+	6.60	6.93E-05
symbiosis, encompassing mutualism through parasitism (GO:0044403)	727	17	3.05	+	5.58	7.43E-05
regulation of secretion (GO:0051046)	727	17	3.05	+	5.58	7.43E-05
response to other organism (GO:0051707)	836	18	3.50	+	5.14	9.02E-05
positive regulation of proteolysis (GO:0045862)	391	13	1.64	+	7.93	9.09E-05
regulation of protein stability (GO:0031647)	253	11	1.06	+	10.38	9.14E-05
response to external biotic stimulus (GO:0043207)	839	18	3.52	+	5.12	9.53E-05
regulation of glucose import (GO:0046324)	63	7	.26	+	26.52	9.69E-05
negative regulation of multicellular organismal process (GO:0051241)	1053	20	4.41	+	4.53	9.74E-05
regulation of cellular component biogenesis (GO:0044087)	852	18	3.57	+	5.04	1.20E-04
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	147	9	.62	+	14.61	1.21E-04
cell junction organization (GO:0034330)	200	10	.84	+	11.93	1.22E-04
regulation of cellular response to insulin stimulus (GO:1900076)	66	7	.28	+	25.31	1.33E-04
epithelial cell differentiation (GO:0030855)	661	16	2.77	+	5.78	1.34E-04
cell cycle checkpoint (GO:0000075)	203	10	.85	+	11.76	1.40E-04
negative regulation of developmental process (GO:0051093)	863	18	3.62	+	4.98	1.46E-04
interspecies interaction between organisms (GO:0044419)	763	17	3.20	+	5.32	1.50E-04
regeneration (GO:0031099)	153	9	.64	+	14.04	1.70E-04
positive regulation of defense response (GO:0031349)	414	13	1.73	+	7.49	1.77E-04
cellular response to extracellular stimulus (GO:0031668)	209	10	.88	+	11.42	1.83E-04
regulation of cell cycle process (GO:0010564)	678	16	2.84	+	5.63	1.90E-04
positive regulation of MAPK cascade (GO:0043410)	499	14	2.09	+	6.70	1.94E-04
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	70	7	.29	+	23.87	1.98E-04
animal organ morphogenesis (GO:0009887)	882	18	3.70	+	4.87	2.04E-04
reproductive structure development (GO:0048608)	421	13	1.76	+	7.37	2.15E-04
regulation of protein localization to membrane (GO:1905475)	158	9	.66	+	13.59	2.23E-04
reproductive system development (GO:0061458)	425	13	1.78	+	7.30	2.40E-04
positive regulation of protein serine/threonine kinase activity (GO:0071902)	350	12	1.47	+	8.18	2.52E-04
positive regulation of DNA metabolic process (GO:0051054)	217	10	.91	+	11.00	2.60E-04
regulation of glucose transport (GO:0010827)	73	7	.31	+	22.89	2.63E-04
cellular response to UV (GO:0034644)	73	7	.31	+	22.89	2.63E-04
positive regulation of epithelial cell migration (GO:0010634)	115	8	.48	+	16.60	3.04E-04
regulation of cell cycle arrest (GO:0071156)	116	8	.49	+	16.46	3.25E-04
peptidyl-threonine phosphorylation (GO:0018107)	76	7	.32	+	21.98	3.45E-04
negative regulation of cellular component organization (GO:0051129)	617	15	2.59	+	5.80	3.77E-04
cell-cell junction organization (GO:0045216)	170	9	.71	+	12.63	4.14E-04
positive regulation of neuron death (GO:1901216)	79	7	.33	+	21.15	4.48E-04
head development (GO:0060322)	725	16	3.04	+	5.27	4.77E-04
cellular component morphogenesis (GO:0032989)	726	16	3.04	+	5.26	4.86E-04
cell morphogenesis (GO:0000902)	632	15	2.65	+	5.66	5.15E-04
generation of neurons (GO:0048699)	1417	22	5.94	+	3.71	5.70E-04
regulation of striated muscle tissue development (GO:0016202)	125	8	.52	+	15.27	5.73E-04
cellular response to biotic stimulus (GO:0071216)	177	9	.74	+	12.14	5.81E-04
developmental process involved in reproduction (GO:0003006)	638	15	2.67	+	5.61	5.81E-04
negative regulation of cell adhesion (GO:0007162)	237	10	.99	+	10.07	5.86E-04
protein localization to nucleus (GO:0034504)	178	9	.75	+	12.07	6.09E-04
peptidyl-threonine modification (GO:0018210)	83	7	.35	+	20.13	6.24E-04
biological_process (GO:0008150)	17423	88	73.00	+	1.21	6.26E-04
positive regulation of apoptotic signaling pathway (GO:2001235)	179	9	.75	+	12.00	6.39E-04
regulation of muscle tissue development (GO:1901861)	127	8	.53	+	15.03	6.46E-04
mitotic cell cycle process (GO:1903047)	647	15	2.71	+	5.53	6.96E-04
positive regulation of neuron apoptotic process (GO:0043525)	50	6	.21	+	28.64	7.21E-04
regulation of cell growth (GO:0001558)	387	12	1.62	+	7.40	7.42E-04
regulation of muscle organ development (GO:0048634)	130	8	.54	+	14.69	7.71E-04
tube development (GO:0035295)	559	14	2.34	+	5.98	7.80E-04
regulation of fibroblast proliferation (GO:0048145)	86	7	.36	+	19.43	7.92E-04
activation of protein kinase activity (GO:0032147)	314	11	1.32	+	8.36	8.00E-04
response to estradiol (GO:0032355)	132	8	.55	+	14.46	8.65E-04
cellular response to gamma radiation (GO:0071480)	26	5	.11	+	45.90	9.03E-04
cell adhesion (GO:0007155)	869	17	3.64	+	4.67	9.68E-04
response to bacterium (GO:0009617)	570	14	2.39	+	5.86	9.88E-04
regulation of secretion by cell (GO:1903530)	667	15	2.79	+	5.37	1.03E-03
biological adhesion (GO:0022610)	874	17	3.66	+	4.64	1.05E-03
regulation of protein complex assembly (GO:0043254)	400	12	1.68	+	7.16	1.06E-03
positive regulation of cell cycle arrest (GO:0071158)	90	7	.38	+	18.56	1.07E-03
homeostatic process (GO:0042592)	1470	22	6.16	+	3.57	1.08E-03
in utero embryonic development (GO:0001701)	325	11	1.36	+	8.08	1.13E-03
positive regulation of fibroblast proliferation (GO:0048146)	54	6	.23	+	26.52	1.13E-03
peptidyl-tyrosine phosphorylation (GO:0018108)	192	9	.80	+	11.19	1.15E-03
regulation of mitotic cell cycle phase transition (GO:1901990)	404	12	1.69	+	7.09	1.17E-03
positive regulation of cell differentiation (GO:0045597)	886	17	3.71	+	4.58	1.27E-03
histone phosphorylation (GO:0016572)	28	5	.12	+	42.62	1.30E-03
peptidyl-tyrosine modification (GO:0018212)	195	9	.82	+	11.02	1.31E-03
cellular response to light stimulus (GO:0071482)	94	7	.39	+	17.77	1.44E-03
positive regulation of reactive oxygen species metabolic process (GO:2000379)	94	7	.39	+	17.77	1.44E-03
regulation of defense response (GO:0031347)	789	16	3.31	+	4.84	1.49E-03
mitotic cell cycle phase transition (GO:0044772)	263	10	1.10	+	9.07	1.52E-03
positive regulation of MAP kinase activity (GO:0043406)	263	10	1.10	+	9.07	1.52E-03
chemotaxis (GO:0006935)	503	13	2.11	+	6.17	1.65E-03
taxis (GO:0042330)	503	13	2.11	+	6.17	1.65E-03
epidermal growth factor receptor signaling pathway (GO:0007173)	58	6	.24	+	24.69	1.71E-03
response to cadmium ion (GO:0046686)	58	6	.24	+	24.69	1.71E-03
regulation of peptidase activity (GO:0052547)	419	12	1.76	+	6.84	1.73E-03
growth (GO:0040007)	419	12	1.76	+	6.84	1.73E-03
negative regulation of insulin receptor signaling pathway (GO:0046627)	30	5	.13	+	39.78	1.82E-03
cell cycle phase transition (GO:0044770)	271	10	1.14	+	8.81	1.99E-03
mitotic cell cycle (GO:0000278)	703	15	2.95	+	5.09	2.01E-03
positive regulation of protein import into nucleus (GO:0042307)	99	7	.41	+	16.87	2.03E-03
cellular response to cadmium ion (GO:0071276)	31	5	.13	+	38.49	2.14E-03
cellular senescence (GO:0090398)	31	5	.13	+	38.49	2.14E-03
regulation of cell cycle phase transition (GO:1901987)	430	12	1.80	+	6.66	2.27E-03
apoptotic mitochondrial changes (GO:0008637)	61	6	.26	+	23.47	2.29E-03
regulation of endothelial cell proliferation (GO:0001936)	101	7	.42	+	16.54	2.32E-03
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	101	7	.42	+	16.54	2.32E-03
positive regulation of protein import (GO:1904591)	101	7	.42	+	16.54	2.32E-03
cellular response to oxygen levels (GO:0071453)	210	9	.88	+	10.23	2.42E-03
regulation of lymphocyte proliferation (GO:0050670)	210	9	.88	+	10.23	2.42E-03
negative regulation of cellular response to insulin stimulus (GO:1900077)	32	5	.13	+	37.29	2.50E-03
regulation of mononuclear cell proliferation (GO:0032944)	211	9	.88	+	10.18	2.52E-03
mitotic cell cycle checkpoint (GO:0007093)	153	8	.64	+	12.48	2.62E-03
entry into other organism involved in symbiotic interaction (GO:0051828)	103	7	.43	+	16.22	2.64E-03
entry into cell of other organism involved in symbiotic interaction (GO:0051806)	103	7	.43	+	16.22	2.64E-03
entry into host (GO:0044409)	103	7	.43	+	16.22	2.64E-03
entry into host cell (GO:0030260)	103	7	.43	+	16.22	2.64E-03
positive regulation of organelle organization (GO:0010638)	620	14	2.60	+	5.39	2.71E-03
regulation of immune response (GO:0050776)	1051	18	4.40	+	4.09	2.75E-03
cellular response to ionizing radiation (GO:0071479)	63	6	.26	+	22.73	2.76E-03
regulation of cytokine production (GO:0001817)	623	14	2.61	+	5.36	2.87E-03
cellular response to metal ion (GO:0071248)	155	8	.65	+	12.32	2.89E-03
signal transduction in absence of ligand (GO:0038034)	33	5	.14	+	36.16	2.91E-03
phosphatidylinositol 3-kinase signaling (GO:0014065)	33	5	.14	+	36.16	2.91E-03
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	33	5	.14	+	36.16	2.91E-03
negative regulation of cell cycle G1/S phase transition (GO:1902807)	105	7	.44	+	15.91	3.00E-03
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	64	6	.27	+	22.37	3.03E-03
negative regulation of mitotic cell cycle (GO:0045930)	286	10	1.20	+	8.34	3.25E-03
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)	65	6	.27	+	22.03	3.31E-03
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413)	65	6	.27	+	22.03	3.31E-03
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403)	65	6	.27	+	22.03	3.31E-03
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402)	65	6	.27	+	22.03	3.31E-03
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400)	65	6	.27	+	22.03	3.31E-03
regulation of leukocyte proliferation (GO:0070663)	219	9	.92	+	9.81	3.43E-03
rhythmic process (GO:0048511)	289	10	1.21	+	8.26	3.57E-03
positive regulation of muscle organ development (GO:0048636)	66	6	.28	+	21.70	3.62E-03
regulation of phospholipid metabolic process (GO:1903725)	66	6	.28	+	21.70	3.62E-03
positive regulation of striated muscle tissue development (GO:0045844)	66	6	.28	+	21.70	3.62E-03
insulin-like growth factor receptor signaling pathway (GO:0048009)	14	4	.06	+	68.19	3.80E-03
signal transduction involved in DNA damage checkpoint (GO:0072422)	67	6	.28	+	21.37	3.94E-03
signal transduction involved in DNA integrity checkpoint (GO:0072401)	67	6	.28	+	21.37	3.94E-03
positive regulation of muscle tissue development (GO:1901863)	67	6	.28	+	21.37	3.94E-03
signal transduction involved in cell cycle checkpoint (GO:0072395)	68	6	.28	+	21.06	4.30E-03
posttranscriptional regulation of gene expression (GO:0010608)	548	13	2.30	+	5.66	4.32E-03
positive regulation of immune response (GO:0050778)	750	15	3.14	+	4.77	4.53E-03
regulation of mitochondrion organization (GO:0010821)	228	9	.96	+	9.42	4.77E-03
negative regulation of cell differentiation (GO:0045596)	651	14	2.73	+	5.13	4.84E-03
viral process (GO:0016032)	654	14	2.74	+	5.11	5.11E-03
positive regulation of protein localization to membrane (GO:1905477)	114	7	.48	+	14.65	5.18E-03
response to lipopolysaccharide (GO:0032496)	303	10	1.27	+	7.88	5.46E-03
regulation of cardiac muscle tissue development (GO:0055024)	71	6	.30	+	20.17	5.51E-03
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	38	5	.16	+	31.40	5.79E-03
positive regulation of cytokine secretion (GO:0050715)	116	7	.49	+	14.40	5.82E-03
myeloid leukocyte activation (GO:0002274)	566	13	2.37	+	5.48	6.19E-03
regulation of cytokine secretion (GO:0050707)	173	8	.72	+	11.04	6.55E-03
response to starvation (GO:0042594)	173	8	.72	+	11.04	6.55E-03
regulation of protein import into nucleus (GO:0042306)	173	8	.72	+	11.04	6.55E-03
positive regulation of protein secretion (GO:0050714)	237	9	.99	+	9.06	6.56E-03
chordate embryonic development (GO:0043009)	569	13	2.38	+	5.45	6.57E-03
regulation of protein autophosphorylation (GO:0031952)	39	5	.16	+	30.60	6.57E-03
reproductive process (GO:0022414)	1368	20	5.73	+	3.49	6.61E-03
transport (GO:0006810)	4408	39	18.47	+	2.11	6.64E-03
negative regulation of gene expression (GO:0010629)	1636	22	6.85	+	3.21	6.69E-03
reproduction (GO:0000003)	1369	20	5.74	+	3.49	6.69E-03
negative regulation of cellular biosynthetic process (GO:0031327)	1502	21	6.29	+	3.34	6.79E-03
mitotic G1/S transition checkpoint (GO:0044819)	74	6	.31	+	19.35	6.99E-03
mitotic G1 DNA damage checkpoint (GO:0031571)	74	6	.31	+	19.35	6.99E-03
central nervous system development (GO:0007417)	888	16	3.72	+	4.30	7.13E-03
response to nutrient (GO:0007584)	175	8	.73	+	10.91	7.13E-03
embryo development ending in birth or egg hatching (GO:0009792)	574	13	2.41	+	5.41	7.24E-03
regulation of muscle cell differentiation (GO:0051147)	176	8	.74	+	10.85	7.44E-03
regulation of protein import (GO:1904589)	176	8	.74	+	10.85	7.44E-03
G1 DNA damage checkpoint (GO:0044783)	75	6	.31	+	19.09	7.56E-03
regulation of signal transduction by p53 class mediator (GO:1901796)	177	8	.74	+	10.79	7.76E-03
protein import into nucleus (GO:0006606)	122	7	.51	+	13.69	8.11E-03
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	17	4	.07	+	56.16	8.19E-03
negative regulation of anoikis (GO:2000811)	17	4	.07	+	56.16	8.19E-03
negative regulation of biosynthetic process (GO:0009890)	1522	21	6.38	+	3.29	8.40E-03
cellular response to inorganic substance (GO:0071241)	180	8	.75	+	10.61	8.79E-03
cellular response to nutrient levels (GO:0031669)	180	8	.75	+	10.61	8.79E-03
female gamete generation (GO:0007292)	124	7	.52	+	13.47	9.03E-03
response to molecule of bacterial origin (GO:0002237)	321	10	1.35	+	7.43	9.16E-03
Fc receptor signaling pathway (GO:0038093)	247	9	1.03	+	8.70	9.20E-03
brain development (GO:0007420)	688	14	2.88	+	4.86	9.27E-03
neuron apoptotic process (GO:0051402)	42	5	.18	+	28.41	9.43E-03
positive regulation of response to DNA damage stimulus (GO:2001022)	78	6	.33	+	18.36	9.47E-03
negative regulation of protein serine/threonine kinase activity (GO:0071901)	125	7	.52	+	13.36	9.52E-03
DNA damage response, signal transduction resulting in transcription (GO:0042772)	18	4	.08	+	53.04	1.03E-02
response to epidermal growth factor (GO:0070849)	43	5	.18	+	27.75	1.06E-02
protein destabilization (GO:0031648)	43	5	.18	+	27.75	1.06E-02
cell morphogenesis involved in differentiation (GO:0000904)	500	12	2.10	+	5.73	1.10E-02
cellular response to hypoxia (GO:0071456)	187	8	.78	+	10.21	1.16E-02
negative regulation of macromolecule biosynthetic process (GO:0010558)	1419	20	5.95	+	3.36	1.17E-02
positive regulation of phospholipid metabolic process (GO:1903727)	44	5	.18	+	27.12	1.18E-02
positive regulation of peptide secretion (GO:0002793)	256	9	1.07	+	8.39	1.23E-02
regulation of establishment of protein localization to mitochondrion (GO:1903747)	130	7	.54	+	12.85	1.23E-02
positive regulation of deoxyribonuclease activity (GO:0032077)	5	3	.02	+	 > 100	1.26E-02
regulation of protein kinase B signaling (GO:0051896)	131	7	.55	+	12.75	1.30E-02
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1430	20	5.99	+	3.34	1.31E-02
mesenchyme development (GO:0060485)	192	8	.80	+	9.94	1.41E-02
negative regulation of catabolic process (GO:0009895)	261	9	1.09	+	8.23	1.44E-02
response to dexamethasone (GO:0071548)	46	5	.19	+	25.94	1.47E-02
gliogenesis (GO:0042063)	193	8	.81	+	9.89	1.47E-02
regulation of peptidyl-serine phosphorylation (GO:0033135)	134	7	.56	+	12.47	1.50E-02
cellular response to decreased oxygen levels (GO:0036294)	194	8	.81	+	9.84	1.53E-02
regulation of wound healing (GO:0061041)	135	7	.57	+	12.37	1.58E-02
cellular response to starvation (GO:0009267)	136	7	.57	+	12.28	1.66E-02
tissue morphogenesis (GO:0048729)	521	12	2.18	+	5.50	1.67E-02
regulation of organ growth (GO:0046620)	87	6	.36	+	16.46	1.77E-02
positive regulation of mitotic cell cycle (GO:0045931)	138	7	.58	+	12.11	1.82E-02
regulation of proteolysis (GO:0030162)	840	15	3.52	+	4.26	1.84E-02
positive regulation of protein kinase B signaling (GO:0051897)	88	6	.37	+	16.27	1.89E-02
regulation of TOR signaling (GO:0032006)	88	6	.37	+	16.27	1.89E-02
developmental growth (GO:0048589)	353	10	1.48	+	6.76	2.12E-02
response to UV-A (GO:0070141)	6	3	.03	+	 > 100	2.17E-02
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	441	11	1.85	+	5.95	2.18E-02
nuclear import (GO:0051170)	142	7	.59	+	11.76	2.19E-02
negative regulation of mitotic cell cycle phase transition (GO:1901991)	204	8	.85	+	9.36	2.21E-02
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	1346	19	5.64	+	3.37	2.21E-02
cell cycle (GO:0007049)	1355	19	5.68	+	3.35	2.44E-02
negative regulation of cell cycle process (GO:0010948)	279	9	1.17	+	7.70	2.47E-02
regulation of cardiac muscle tissue growth (GO:0055021)	52	5	.22	+	22.95	2.65E-02
protein localization (GO:0008104)	1926	23	8.07	+	2.85	2.70E-02
positive regulation of catabolic process (GO:0009896)	452	11	1.89	+	5.81	2.76E-02
glial cell differentiation (GO:0010001)	148	7	.62	+	11.29	2.87E-02
glomerulus development (GO:0032835)	53	5	.22	+	22.52	2.91E-02
regulation of lipid metabolic process (GO:0019216)	366	10	1.53	+	6.52	2.92E-02
negative regulation of cell cycle phase transition (GO:1901988)	212	8	.89	+	9.01	2.92E-02
cellular response to lipopolysaccharide (GO:0071222)	149	7	.62	+	11.21	3.00E-02
response to toxic substance (GO:0009636)	213	8	.89	+	8.96	3.02E-02
regulation of striated muscle cell differentiation (GO:0051153)	96	6	.40	+	14.92	3.10E-02
phosphatidylinositol metabolic process (GO:0046488)	214	8	.90	+	8.92	3.13E-02
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	24	4	.10	+	39.78	3.18E-02
regulation of anoikis (GO:2000209)	24	4	.10	+	39.78	3.18E-02
TOR signaling (GO:0031929)	24	4	.10	+	39.78	3.18E-02
neuron death (GO:0070997)	54	5	.23	+	22.10	3.18E-02
muscle structure development (GO:0061061)	462	11	1.94	+	5.68	3.39E-02
glial cell apoptotic process (GO:0034349)	7	3	.03	+	 > 100	3.44E-02
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	56	5	.23	+	21.31	3.79E-02
negative regulation of MAPK cascade (GO:0043409)	155	7	.65	+	10.78	3.88E-02
regulation of heart growth (GO:0060420)	57	5	.24	+	20.94	4.13E-02
phosphatidylinositol phosphorylation (GO:0046854)	101	6	.42	+	14.18	4.13E-02
cellular response to molecule of bacterial origin (GO:0071219)	157	7	.66	+	10.64	4.21E-02
membrane organization (GO:0061024)	900	15	3.77	+	3.98	4.23E-02
regulation of autophagy (GO:0010506)	299	9	1.25	+	7.18	4.30E-02
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	26	4	.11	+	36.72	4.35E-02
mitotic DNA damage checkpoint (GO:0044773)	102	6	.43	+	14.04	4.37E-02
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	102	6	.43	+	14.04	4.37E-02
cell cycle process (GO:0022402)	1023	16	4.29	+	3.73	4.38E-02
regulation of response to wounding (GO:1903034)	158	7	.66	+	10.57	4.39E-02
Ras protein signal transduction (GO:0007265)	158	7	.66	+	10.57	4.39E-02
interaction with host (GO:0051701)	159	7	.67	+	10.51	4.57E-02
ovulation cycle (GO:0042698)	103	6	.43	+	13.90	4.62E-02
regulation of sequence-specific DNA binding transcription factor activity (GO:0051090)	390	10	1.63	+	6.12	5.08E-02
stress-induced premature senescence (GO:0090400)	8	3	.03	+	89.50	5.11E-02
regulation of DNA biosynthetic process (GO:2000278)	105	6	.44	+	13.64	5.15E-02
leukocyte differentiation (GO:0002521)	307	9	1.29	+	7.00	5.31E-02
multicellular organismal reproductive process (GO:0048609)	802	14	3.36	+	4.17	5.41E-02
regulation of chromosome organization (GO:0033044)	308	9	1.29	+	6.97	5.45E-02
cell-substrate adhesion (GO:0031589)	164	7	.69	+	10.19	5.59E-02
positive regulation of cellular catabolic process (GO:0031331)	395	10	1.66	+	6.04	5.67E-02
cardiocyte differentiation (GO:0035051)	107	6	.45	+	13.38	5.73E-02
positive regulation of developmental growth (GO:0048639)	165	7	.69	+	10.12	5.81E-02
cellular response to hydrogen peroxide (GO:0070301)	62	5	.26	+	19.25	6.19E-02
regulation of B cell proliferation (GO:0030888)	62	5	.26	+	19.25	6.19E-02
multicellular organism reproduction (GO:0032504)	813	14	3.41	+	4.11	6.31E-02
positive regulation of cytokine production (GO:0001819)	400	10	1.68	+	5.97	6.32E-02
mitotic DNA integrity checkpoint (GO:0044774)	109	6	.46	+	13.14	6.36E-02
response to amino acid (GO:0043200)	109	6	.46	+	13.14	6.36E-02
positive regulation of innate immune response (GO:0045089)	314	9	1.32	+	6.84	6.36E-02
granulocyte activation (GO:0036230)	495	11	2.07	+	5.30	6.48E-02
organelle organization (GO:0006996)	3167	30	13.27	+	2.26	6.53E-02
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	29	4	.12	+	32.92	6.67E-02
positive regulation of peptidase activity (GO:0010952)	169	7	.71	+	9.89	6.78E-02
positive regulation of hemopoiesis (GO:1903708)	169	7	.71	+	9.89	6.78E-02
negative regulation of immune system process (GO:0002683)	404	10	1.69	+	5.91	6.89E-02
cellular process involved in reproduction in multicellular organism (GO:0022412)	319	9	1.34	+	6.73	7.20E-02
secretion (GO:0046903)	1065	16	4.46	+	3.59	7.25E-02
protein import (GO:0017038)	171	7	.72	+	9.77	7.31E-02
regulation of protein catabolic process (GO:0042176)	407	10	1.71	+	5.86	7.34E-02
regulation of B cell activation (GO:0050864)	172	7	.72	+	9.71	7.59E-02
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	172	7	.72	+	9.71	7.59E-02
response to osmotic stress (GO:0006970)	65	5	.27	+	18.36	7.76E-02
lipid phosphorylation (GO:0046834)	113	6	.47	+	12.67	7.79E-02
neuron differentiation (GO:0030182)	948	15	3.97	+	3.78	7.85E-02
regulation of system process (GO:0044057)	507	11	2.12	+	5.18	8.10E-02
negative regulation of cell-matrix adhesion (GO:0001953)	31	4	.13	+	30.79	8.66E-02
positive regulation of blood vessel endothelial cell migration (GO:0043536)	31	4	.13	+	30.79	8.66E-02
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	31	4	.13	+	30.79	8.66E-02
cellular macromolecule localization (GO:0070727)	1345	18	5.64	+	3.19	8.86E-02
cellular component disassembly (GO:0022411)	416	10	1.74	+	5.74	8.86E-02
regulation of mitochondrial membrane potential (GO:0051881)	67	5	.28	+	17.81	8.97E-02
positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	116	6	.49	+	12.34	9.02E-02
positive regulation of growth (GO:0045927)	248	8	1.04	+	7.70	9.07E-02
response to growth hormone (GO:0060416)	32	4	.13	+	29.83	9.80E-02
macromolecule localization (GO:0033036)	2238	24	9.38	+	2.56	9.85E-02
regulation of deoxyribonuclease activity (GO:0032070)	10	3	.04	+	71.60	9.93E-02
Fc-epsilon receptor signaling pathway (GO:0038095)	181	7	.76	+	9.23	1.05E-01
regulation of innate immune response (GO:0045088)	426	10	1.78	+	5.60	1.09E-01
regulation of hemopoiesis (GO:1903706)	426	10	1.78	+	5.60	1.09E-01
epithelial cell development (GO:0002064)	182	7	.76	+	9.18	1.09E-01
muscle cell differentiation (GO:0042692)	256	8	1.07	+	7.46	1.14E-01
regulation of muscle adaptation (GO:0043502)	71	5	.30	+	16.81	1.18E-01
G1/S transition of mitotic cell cycle (GO:0000082)	122	6	.51	+	11.74	1.20E-01
response to iron ion (GO:0010039)	34	4	.14	+	28.08	1.24E-01
protein kinase B signaling (GO:0043491)	34	4	.14	+	28.08	1.24E-01
positive regulation of glucose metabolic process (GO:0010907)	34	4	.14	+	28.08	1.24E-01
cell-cell adhesion (GO:0098609)	433	10	1.81	+	5.51	1.25E-01
regulation of cell-substrate adhesion (GO:0010810)	186	7	.78	+	8.98	1.25E-01
stimulatory C-type lectin receptor signaling pathway (GO:0002223)	123	6	.52	+	11.64	1.25E-01
cell cycle G1/S phase transition (GO:0044843)	123	6	.52	+	11.64	1.25E-01
regulation of binding (GO:0051098)	343	9	1.44	+	6.26	1.28E-01
striated muscle cell differentiation (GO:0051146)	187	7	.78	+	8.93	1.30E-01
female pregnancy (GO:0007565)	187	7	.78	+	8.93	1.30E-01
negative regulation of protein autophosphorylation (GO:0031953)	11	3	.05	+	65.09	1.32E-01
mitochondrion organization (GO:0007005)	436	10	1.83	+	5.47	1.32E-01
positive regulation of endothelial cell proliferation (GO:0001938)	73	5	.31	+	16.35	1.35E-01
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	35	4	.15	+	27.28	1.39E-01
cellular response to dexamethasone stimulus (GO:0071549)	35	4	.15	+	27.28	1.39E-01
response to ischemia (GO:0002931)	35	4	.15	+	27.28	1.39E-01
response to fluid shear stress (GO:0034405)	35	4	.15	+	27.28	1.39E-01
cellular localization (GO:0051641)	2287	24	9.58	+	2.50	1.42E-01
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	126	6	.53	+	11.36	1.43E-01
positive regulation of lipid metabolic process (GO:0045834)	126	6	.53	+	11.36	1.43E-01
oogenesis (GO:0048477)	74	5	.31	+	16.13	1.44E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	74	5	.31	+	16.13	1.44E-01
immune response-regulating signaling pathway (GO:0002764)	541	11	2.27	+	4.85	1.47E-01
oocyte development (GO:0048599)	36	4	.15	+	26.52	1.55E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	193	7	.81	+	8.66	1.58E-01
liver development (GO:0001889)	129	6	.54	+	11.10	1.63E-01
response to estrogen (GO:0043627)	76	5	.32	+	15.70	1.64E-01
positive regulation of cell cycle process (GO:0090068)	270	8	1.13	+	7.07	1.66E-01
homeostasis of number of cells (GO:0048872)	195	7	.82	+	8.57	1.69E-01
lymphocyte activation (GO:0046649)	356	9	1.49	+	6.03	1.71E-01
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	37	4	.16	+	25.80	1.72E-01
negative regulation of signal transduction in absence of ligand (GO:1901099)	37	4	.16	+	25.80	1.72E-01
positive regulation of secretion by cell (GO:1903532)	357	9	1.50	+	6.02	1.74E-01
protein autophosphorylation (GO:0046777)	197	7	.83	+	8.48	1.80E-01
hepaticobiliary system development (GO:0061008)	132	6	.55	+	10.85	1.86E-01
regulation of protein binding (GO:0043393)	198	7	.83	+	8.44	1.86E-01
regulation of cellular amide metabolic process (GO:0034248)	454	10	1.90	+	5.26	1.87E-01
response to alcohol (GO:0097305)	199	7	.83	+	8.40	1.92E-01
regulation of response to external stimulus (GO:0032101)	780	13	3.27	+	3.98	1.95E-01
immune effector process (GO:0002252)	1026	15	4.30	+	3.49	1.98E-01
cellular component assembly (GO:0022607)	2338	24	9.80	+	2.45	2.04E-01
regulation of protein localization to plasma membrane (GO:1903076)	80	5	.34	+	14.92	2.09E-01
animal organ regeneration (GO:0031100)	80	5	.34	+	14.92	2.09E-01
establishment of protein localization (GO:0045184)	1434	18	6.01	+	3.00	2.09E-01
cellular response to epidermal growth factor stimulus (GO:0071364)	39	4	.16	+	24.48	2.11E-01
oocyte differentiation (GO:0009994)	39	4	.16	+	24.48	2.11E-01
endocardial cushion development (GO:0003197)	39	4	.16	+	24.48	2.11E-01
positive regulation of lymphocyte proliferation (GO:0050671)	136	6	.57	+	10.53	2.19E-01
positive regulation of mononuclear cell proliferation (GO:0032946)	137	6	.57	+	10.45	2.28E-01
regulation of histone modification (GO:0031056)	137	6	.57	+	10.45	2.28E-01
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	40	4	.17	+	23.87	2.33E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	82	5	.34	+	14.55	2.35E-01
regulation of stress-activated MAPK cascade (GO:0032872)	206	7	.86	+	8.11	2.39E-01
establishment of protein localization to organelle (GO:0072594)	373	9	1.56	+	5.76	2.45E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	207	7	.87	+	8.07	2.47E-01
insulin receptor signaling pathway (GO:0008286)	83	5	.35	+	14.38	2.48E-01
skin development (GO:0043588)	374	9	1.57	+	5.74	2.50E-01
regulation of homeostatic process (GO:0032844)	471	10	1.97	+	5.07	2.55E-01
regulation of vesicle-mediated transport (GO:0060627)	471	10	1.97	+	5.07	2.55E-01
nucleocytoplasmic transport (GO:0006913)	287	8	1.20	+	6.65	2.56E-01
negative regulation of TOR signaling (GO:0032007)	41	4	.17	+	23.28	2.57E-01
positive regulation of cardiac muscle tissue development (GO:0055025)	41	4	.17	+	23.28	2.57E-01
forebrain development (GO:0030900)	376	9	1.58	+	5.71	2.61E-01
negative regulation of cellular catabolic process (GO:0031330)	209	7	.88	+	7.99	2.62E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	209	7	.88	+	7.99	2.62E-01
positive regulation of histone modification (GO:0031058)	85	5	.36	+	14.04	2.78E-01
positive regulation of leukocyte proliferation (GO:0070665)	142	6	.59	+	10.08	2.78E-01
cell-substrate junction assembly (GO:0007044)	42	4	.18	+	22.73	2.82E-01
regulation of cardiocyte differentiation (GO:1905207)	42	4	.18	+	22.73	2.82E-01
positive regulation of glucose import (GO:0046326)	42	4	.18	+	22.73	2.82E-01
negative regulation of transport (GO:0051051)	479	10	2.01	+	4.98	2.93E-01
regulation of hemostasis (GO:1900046)	86	5	.36	+	13.88	2.94E-01
regulation of blood coagulation (GO:0030193)	86	5	.36	+	13.88	2.94E-01
regulation of muscle system process (GO:0090257)	213	7	.89	+	7.84	2.95E-01
nuclear transport (GO:0051169)	293	8	1.23	+	6.52	2.96E-01
angiotensin-activated signaling pathway involved in heart process (GO:0086098)	2	2	.01	+	 > 100	2.98E-01
regulation of cell projection organization (GO:0031344)	585	11	2.45	+	4.49	3.00E-01
cell maturation (GO:0048469)	144	6	.60	+	9.94	3.01E-01
cellular protein localization (GO:0034613)	1335	17	5.59	+	3.04	3.06E-01
positive regulation of cellular component biogenesis (GO:0044089)	485	10	2.03	+	4.92	3.25E-01
regulation of protein localization to cell periphery (GO:1904375)	88	5	.37	+	13.56	3.27E-01
positive regulation of nuclease activity (GO:0032075)	15	3	.06	+	47.73	3.30E-01
neurotrophin TRK receptor signaling pathway (GO:0048011)	15	3	.06	+	47.73	3.30E-01
multi-multicellular organism process (GO:0044706)	217	7	.91	+	7.70	3.32E-01
positive regulation of secretion (GO:0051047)	388	9	1.63	+	5.54	3.32E-01
activation of MAPK activity (GO:0000187)	147	6	.62	+	9.74	3.37E-01
regulation of protein oligomerization (GO:0032459)	44	4	.18	+	21.70	3.37E-01
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	44	4	.18	+	21.70	3.37E-01
regulation of cardiac muscle hypertrophy (GO:0010611)	44	4	.18	+	21.70	3.37E-01
regulation of endocytosis (GO:0030100)	218	7	.91	+	7.66	3.42E-01
positive regulation of homeostatic process (GO:0032846)	219	7	.92	+	7.63	3.51E-01
neutrophil activation (GO:0042119)	492	10	2.06	+	4.85	3.67E-01
multi-organism reproductive process (GO:0044703)	954	14	4.00	+	3.50	3.68E-01
placenta development (GO:0001890)	150	6	.63	+	9.55	3.77E-01
regulation of coagulation (GO:0050818)	91	5	.38	+	13.11	3.83E-01
viral entry into host cell (GO:0046718)	91	5	.38	+	13.11	3.83E-01
secretion by cell (GO:0032940)	959	14	4.02	+	3.48	3.90E-01
cellular component biogenesis (GO:0044085)	2599	25	10.89	+	2.30	3.91E-01
urogenital system development (GO:0001655)	305	8	1.28	+	6.26	3.91E-01
thymus development (GO:0048538)	46	4	.19	+	20.75	4.00E-01
positive regulation of glucose transport (GO:0010828)	46	4	.19	+	20.75	4.00E-01
positive regulation of organ growth (GO:0046622)	46	4	.19	+	20.75	4.00E-01
regulation of muscle hypertrophy (GO:0014743)	46	4	.19	+	20.75	4.00E-01
tissue remodeling (GO:0048771)	92	5	.39	+	12.97	4.03E-01
positive regulation of chromatin organization (GO:1905269)	92	5	.39	+	12.97	4.03E-01
protein localization to organelle (GO:0033365)	605	11	2.53	+	4.34	4.06E-01
lipid metabolic process (GO:0006629)	1227	16	5.14	+	3.11	4.06E-01
cellular response to nerve growth factor stimulus (GO:1990090)	47	4	.20	+	20.31	4.35E-01
regulation of membrane potential (GO:0042391)	402	9	1.68	+	5.34	4.36E-01
positive regulation of muscle cell differentiation (GO:0051149)	94	5	.39	+	12.69	4.46E-01
positive regulation of protein complex assembly (GO:0031334)	228	7	.96	+	7.33	4.52E-01
positive regulation of protein localization to plasma membrane (GO:1903078)	48	4	.20	+	19.89	4.72E-01
germ cell development (GO:0007281)	230	7	.96	+	7.26	4.77E-01
response to UV-B (GO:0010224)	17	3	.07	+	42.12	4.77E-01
negative regulation of cardiocyte differentiation (GO:1905208)	17	3	.07	+	42.12	4.77E-01
negative regulation of B cell proliferation (GO:0030889)	17	3	.07	+	42.12	4.77E-01
positive regulation of chromosome organization (GO:2001252)	157	6	.66	+	9.12	4.84E-01
regulation of ERBB signaling pathway (GO:1901184)	96	5	.40	+	12.43	4.93E-01
immune response-activating cell surface receptor signaling pathway (GO:0002429)	409	9	1.71	+	5.25	4.97E-01
regulation of T cell proliferation (GO:0042129)	158	6	.66	+	9.06	5.01E-01
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	49	4	.21	+	19.48	5.10E-01
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	49	4	.21	+	19.48	5.10E-01
myeloid cell activation involved in immune response (GO:0002275)	513	10	2.15	+	4.65	5.19E-01
organophosphate metabolic process (GO:0019637)	987	14	4.14	+	3.39	5.30E-01
regulation of translation (GO:0006417)	413	9	1.73	+	5.20	5.35E-01
gland morphogenesis (GO:0022612)	98	5	.41	+	12.18	5.43E-01
response to nerve growth factor (GO:1990089)	50	4	.21	+	19.09	5.52E-01
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	50	4	.21	+	19.09	5.52E-01
morphogenesis of an epithelium (GO:0002009)	415	9	1.74	+	5.18	5.55E-01
growth hormone receptor signaling pathway (GO:0060396)	18	3	.08	+	39.78	5.65E-01
regulation of superoxide anion generation (GO:0032928)	18	3	.08	+	39.78	5.65E-01
regulation of platelet aggregation (GO:0090330)	18	3	.08	+	39.78	5.65E-01
cellular response to angiotensin (GO:1904385)	18	3	.08	+	39.78	5.65E-01
glycerolipid metabolic process (GO:0046486)	416	9	1.74	+	5.16	5.66E-01
negative regulation of cell growth (GO:0030308)	162	6	.68	+	8.84	5.74E-01
regulation of cysteine-type endopeptidase activity (GO:2000116)	238	7	1.00	+	7.02	5.90E-01
positive regulation of phospholipase activity (GO:0010518)	51	4	.21	+	18.72	5.95E-01
regulation of cell-matrix adhesion (GO:0001952)	100	5	.42	+	11.93	5.96E-01
regulation of glucose metabolic process (GO:0010906)	101	5	.42	+	11.81	6.25E-01
negative regulation of RNA metabolic process (GO:0051253)	1273	16	5.33	+	3.00	6.28E-01
regulation of chromatin organization (GO:1902275)	165	6	.69	+	8.68	6.35E-01
positive regulation of proteasomal protein catabolic process (GO:1901800)	102	5	.43	+	11.70	6.54E-01
glomerulus vasculature development (GO:0072012)	19	3	.08	+	37.68	6.63E-01
cellular response to growth hormone stimulus (GO:0071378)	19	3	.08	+	37.68	6.63E-01
response to muscle stretch (GO:0035994)	19	3	.08	+	37.68	6.63E-01
negative regulation of cardiac muscle hypertrophy (GO:0010614)	19	3	.08	+	37.68	6.63E-01
response to insulin-like growth factor stimulus (GO:1990418)	3	2	.01	+	 > 100	6.69E-01
transcription factor import into nucleus (GO:0042991)	3	2	.01	+	 > 100	6.69E-01
diadenosine tetraphosphate biosynthetic process (GO:0015966)	3	2	.01	+	 > 100	6.69E-01
diadenosine tetraphosphate metabolic process (GO:0015965)	3	2	.01	+	 > 100	6.69E-01
diadenosine polyphosphate biosynthetic process (GO:0015960)	3	2	.01	+	 > 100	6.69E-01
cellular response to actinomycin D (GO:0072717)	3	2	.01	+	 > 100	6.69E-01
negative regulation of transcription, DNA-templated (GO:0045892)	1144	15	4.79	+	3.13	6.82E-01
lipid modification (GO:0030258)	244	7	1.02	+	6.85	6.89E-01
regulation of lipid kinase activity (GO:0043550)	53	4	.22	+	18.01	6.90E-01
negative regulation of cell-substrate adhesion (GO:0010812)	53	4	.22	+	18.01	6.90E-01
negative regulation of ERBB signaling pathway (GO:1901185)	54	4	.23	+	17.68	7.41E-01
positive regulation of protein localization to cell periphery (GO:1904377)	54	4	.23	+	17.68	7.41E-01
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	54	4	.23	+	17.68	7.41E-01
response to endoplasmic reticulum stress (GO:0034976)	247	7	1.03	+	6.76	7.43E-01
positive regulation of mitochondrion organization (GO:0010822)	170	6	.71	+	8.42	7.47E-01
cellular response to platelet-derived growth factor stimulus (GO:0036120)	20	3	.08	+	35.80	7.70E-01
response to hyperoxia (GO:0055093)	20	3	.08	+	35.80	7.70E-01
exocytosis (GO:0006887)	769	12	3.22	+	3.72	7.73E-01
gamete generation (GO:0007276)	651	11	2.73	+	4.03	7.77E-01
ossification (GO:0001503)	249	7	1.04	+	6.71	7.81E-01
regulation of monooxygenase activity (GO:0032768)	55	4	.23	+	17.36	7.95E-01
female sex differentiation (GO:0046660)	107	5	.45	+	11.15	8.17E-01
negative regulation of cell activation (GO:0050866)	173	6	.72	+	8.28	8.21E-01
kidney development (GO:0001822)	254	7	1.06	+	6.58	8.82E-01
chromosome organization (GO:0051276)	1036	14	4.34	+	3.23	8.86E-01
response to angiotensin (GO:1990776)	21	3	.09	+	34.09	8.89E-01
response to platelet-derived growth factor (GO:0036119)	21	3	.09	+	34.09	8.89E-01
kidney vasculature development (GO:0061440)	21	3	.09	+	34.09	8.89E-01
renal system vasculature development (GO:0061437)	21	3	.09	+	34.09	8.89E-01
negative regulation of muscle hypertrophy (GO:0014741)	21	3	.09	+	34.09	8.89E-01
positive regulation of immune effector process (GO:0002699)	176	6	.74	+	8.14	9.01E-01
mammary gland epithelium development (GO:0061180)	57	4	.24	+	16.75	9.11E-01
glycerophospholipid metabolic process (GO:0006650)	345	8	1.45	+	5.53	9.16E-01
chromatin organization (GO:0006325)	665	11	2.79	+	3.95	9.37E-01
regulation of leukocyte differentiation (GO:1902105)	258	7	1.08	+	6.48	9.71E-01
behavior (GO:0007610)	554	10	2.32	+	4.31	9.74E-01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	259	7	1.09	+	6.45	9.94E-01
ion transmembrane transport (GO:0034220)	885	4	3.71	+	1.08	1.00E00
respiratory burst involved in defense response (GO:0002679)	5	0	.02	-	 < 0.2	1.00E00
response to lead ion (GO:0010288)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of chronic inflammatory response (GO:0002678)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of chronic inflammatory response (GO:0002677)	6	0	.03	-	 < 0.2	1.00E00
heat acclimation (GO:0010286)	3	0	.01	-	 < 0.2	1.00E00
regulation of chronic inflammatory response (GO:0002676)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of acute inflammatory response (GO:0002675)	28	0	.12	-	 < 0.2	1.00E00
negative regulation of acute inflammatory response (GO:0002674)	14	0	.06	-	 < 0.2	1.00E00
regulation of acute inflammatory response (GO:0002673)	153	0	.64	-	 < 0.2	1.00E00
carbohydrate transmembrane transport (GO:0034219)	29	0	.12	-	 < 0.2	1.00E00
protein hexamerization (GO:0034214)	10	0	.04	-	 < 0.2	1.00E00
quinolinate catabolic process (GO:0034213)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of T cell anergy (GO:0002669)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of T cell anergy (GO:0002668)	1	0	.00	-	 < 0.2	1.00E00
regulation of T cell anergy (GO:0002667)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of T cell tolerance induction (GO:0002666)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of T cell tolerance induction (GO:0002665)	1	0	.00	-	 < 0.2	1.00E00
regulation of T cell tolerance induction (GO:0002664)	12	0	.05	-	 < 0.2	1.00E00
detoxification of copper ion (GO:0010273)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of B cell tolerance induction (GO:0002663)	2	0	.01	-	 < 0.2	1.00E00
regulation of B cell tolerance induction (GO:0002661)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of peripheral tolerance induction (GO:0002660)	1	0	.00	-	 < 0.2	1.00E00
amyloid-beta formation (GO:0034205)	4	0	.02	-	 < 0.2	1.00E00
lipid translocation (GO:0034204)	25	0	.10	-	 < 0.2	1.00E00
glycolipid translocation (GO:0034203)	2	0	.01	-	 < 0.2	1.00E00
response to oleic acid (GO:0034201)	5	0	.02	-	 < 0.2	1.00E00
response to selenium ion (GO:0010269)	8	0	.03	-	 < 0.2	1.00E00
regulation of peripheral tolerance induction (GO:0002658)	1	0	.00	-	 < 0.2	1.00E00
response to vitamin B1 (GO:0010266)	3	1	.01	+	79.55	1.00E00
SCF complex assembly (GO:0010265)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of tolerance induction dependent upon immune response (GO:0002654)	1	0	.00	-	 < 0.2	1.00E00
regulation of tolerance induction dependent upon immune response (GO:0002652)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of tolerance induction to self antigen (GO:0002651)	1	0	.00	-	 < 0.2	1.00E00
animal organ senescence (GO:0010260)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of chromatin assembly or disassembly (GO:0045799)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of intestinal cholesterol absorption (GO:0045796)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cell volume (GO:0045795)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell volume (GO:0045794)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of cell size (GO:0045793)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of cell size (GO:0045792)	10	1	.04	+	23.87	1.00E00
multicellular organism aging (GO:0010259)	29	2	.12	+	16.46	1.00E00
regulation of tolerance induction to self antigen (GO:0002649)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of central tolerance induction (GO:0002648)	1	0	.00	-	 < 0.2	1.00E00
NADH dehydrogenase complex assembly (GO:0010257)	65	0	.27	-	 < 0.2	1.00E00
endomembrane system organization (GO:0010256)	373	6	1.56	+	3.84	1.00E00
regulation of central tolerance induction (GO:0002646)	1	0	.00	-	 < 0.2	1.00E00
glucose mediated signaling pathway (GO:0010255)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of tolerance induction (GO:0002645)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of tolerance induction (GO:0002644)	2	0	.01	-	 < 0.2	1.00E00
regulation of tolerance induction (GO:0002643)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of immunoglobulin biosynthetic process (GO:0002642)	1	0	.00	-	 < 0.2	1.00E00
regulation of immunoglobulin biosynthetic process (GO:0002640)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of bone resorption (GO:0045780)	15	2	.06	+	31.82	1.00E00
positive regulation of immunoglobulin production (GO:0002639)	40	2	.17	+	11.93	1.00E00
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of immunoglobulin production (GO:0002638)	10	0	.04	-	 < 0.2	1.00E00
regulation of immunoglobulin production (GO:0002637)	58	2	.24	+	8.23	1.00E00
positive regulation of germinal center formation (GO:0002636)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of germinal center formation (GO:0002635)	2	0	.01	-	 < 0.2	1.00E00
regulation of germinal center formation (GO:0002634)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of bone resorption (GO:0045779)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of ossification (GO:0045778)	83	1	.35	+	2.88	1.00E00
positive regulation of blood pressure (GO:0045777)	40	0	.17	-	 < 0.2	1.00E00
negative regulation of blood pressure (GO:0045776)	47	0	.20	-	 < 0.2	1.00E00
positive regulation of axon extension (GO:0045773)	41	2	.17	+	11.64	1.00E00
negative regulation of T cell antigen processing and presentation (GO:0002626)	1	0	.00	-	 < 0.2	1.00E00
regulation of T cell antigen processing and presentation (GO:0002625)	2	0	.01	-	 < 0.2	1.00E00
vascular transport (GO:0010232)	1	0	.00	-	 < 0.2	1.00E00
regulation of B cell antigen processing and presentation (GO:0002622)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of asymmetric cell division (GO:0045769)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of angiogenesis (GO:0045766)	134	3	.56	+	5.34	1.00E00
regulation of angiogenesis (GO:0045765)	232	3	.97	+	3.09	1.00E00
positive regulation of cellular amino acid metabolic process (GO:0045764)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular amino acid metabolic process (GO:0045763)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of adenylate cyclase activity (GO:0045762)	48	2	.20	+	9.94	1.00E00
regulation of adenylate cyclase activity (GO:0045761)	81	2	.34	+	5.89	1.00E00
positive regulation of action potential (GO:0045760)	11	0	.05	-	 < 0.2	1.00E00
response to lithium ion (GO:0010226)	23	3	.10	+	31.13	1.00E00
response to UV-C (GO:0010225)	13	2	.05	+	36.72	1.00E00
negative regulation of action potential (GO:0045759)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of Toll signaling pathway (GO:0045751)	1	0	.00	-	 < 0.2	1.00E00
maintenance of DNA methylation (GO:0010216)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of dendritic cell antigen processing and presentation (GO:0002606)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	2	0	.01	-	 < 0.2	1.00E00
regulation of dendritic cell antigen processing and presentation (GO:0002604)	9	0	.04	-	 < 0.2	1.00E00
regulation of hexokinase activity (GO:1903299)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	5	0	.02	-	 < 0.2	1.00E00
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of Notch signaling pathway (GO:0045747)	34	1	.14	+	7.02	1.00E00
positive regulation of glutamate secretion, neurotransmission (GO:1903296)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of Notch signaling pathway (GO:0045746)	32	0	.13	-	 < 0.2	1.00E00
positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745)	27	1	.11	+	8.84	1.00E00
regulation of glutamate secretion, neurotransmission (GO:1903294)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of G-protein coupled receptor protein signaling pathway (GO:0045744)	38	0	.16	-	 < 0.2	1.00E00
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	7	0	.03	-	 < 0.2	1.00E00
protein localization to Golgi membrane (GO:1903292)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	37	1	.16	+	6.45	1.00E00
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of DNA replication (GO:0045740)	57	3	.24	+	12.56	1.00E00
positive regulation of DNA repair (GO:0045739)	47	3	.20	+	15.23	1.00E00
positive regulation of potassium ion import (GO:1903288)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of DNA repair (GO:0045738)	20	0	.08	-	 < 0.2	1.00E00
regulation of potassium ion import (GO:1903286)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of hydrogen peroxide catabolic process (GO:1903285)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of glutathione peroxidase activity (GO:1903284)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutathione peroxidase activity (GO:1903282)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein catabolic process (GO:0045732)	274	7	1.15	+	6.10	1.00E00
positive regulation of calcium:sodium antiporter activity (GO:1903281)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of calcium:sodium antiporter activity (GO:1903280)	1	0	.00	-	 < 0.2	1.00E00
respiratory burst (GO:0045730)	17	0	.07	-	 < 0.2	1.00E00
response to glucagon (GO:0033762)	49	1	.21	+	4.87	1.00E00
cerebral cortex radially oriented cell migration (GO:0021799)	31	0	.13	-	 < 0.2	1.00E00
forebrain dorsal/ventral pattern formation (GO:0021798)	7	0	.03	-	 < 0.2	1.00E00
forebrain anterior/posterior pattern specification (GO:0021797)	4	0	.02	-	 < 0.2	1.00E00
cerebral cortex regionalization (GO:0021796)	7	0	.03	-	 < 0.2	1.00E00
cerebral cortex cell migration (GO:0021795)	46	1	.19	+	5.19	1.00E00
thalamus development (GO:0021794)	15	0	.06	-	 < 0.2	1.00E00
chemorepulsion of branchiomotor axon (GO:0021793)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcium:sodium antiporter activity (GO:1903279)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of sodium ion export from cell (GO:1903278)	4	0	.02	-	 < 0.2	1.00E00
respiratory burst after phagocytosis (GO:0045728)	2	0	.01	-	 < 0.2	1.00E00
beta-alanine biosynthetic process (GO:0019483)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of translation (GO:0045727)	113	4	.47	+	8.45	1.00E00
regulation of sodium ion export from cell (GO:1903276)	4	0	.02	-	 < 0.2	1.00E00
beta-alanine metabolic process (GO:0019482)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of integrin biosynthetic process (GO:0045726)	3	1	.01	+	79.55	1.00E00
positive regulation of sodium ion export (GO:1903275)	4	0	.02	-	 < 0.2	1.00E00
L-alanine catabolic process, by transamination (GO:0019481)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of glycogen biosynthetic process (GO:0045725)	15	2	.06	+	31.82	1.00E00
positive regulation of cilium assembly (GO:0045724)	20	0	.08	-	 < 0.2	1.00E00
regulation of sodium ion export (GO:1903273)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of fatty acid biosynthetic process (GO:0045723)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of gluconeogenesis (GO:0045722)	11	1	.05	+	21.70	1.00E00
negative regulation of gluconeogenesis (GO:0045721)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of integrin biosynthetic process (GO:0045720)	2	1	.01	+	 > 100	1.00E00
ribosome localization (GO:0033750)	14	0	.06	-	 < 0.2	1.00E00
branchiomotor neuron axon guidance (GO:0021785)	7	0	.03	-	 < 0.2	1.00E00
postganglionic parasympathetic fiber development (GO:0021784)	2	0	.01	-	 < 0.2	1.00E00
preganglionic parasympathetic fiber development (GO:0021783)	17	0	.07	-	 < 0.2	1.00E00
glial cell development (GO:0021782)	87	3	.36	+	8.23	1.00E00
D-amino acid catabolic process (GO:0019478)	2	0	.01	-	 < 0.2	1.00E00
glial cell fate commitment (GO:0021781)	13	1	.05	+	18.36	1.00E00
L-lysine catabolic process (GO:0019477)	4	0	.02	-	 < 0.2	1.00E00
glial cell fate specification (GO:0021780)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of glycogen biosynthetic process (GO:0045719)	7	1	.03	+	34.09	1.00E00
L-lysine catabolic process to acetyl-CoA (GO:0019474)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of fatty acid biosynthetic process (GO:0045717)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045716)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	8	0	.03	-	 < 0.2	1.00E00
4-hydroxyproline metabolic process (GO:0019471)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045715)	3	0	.01	-	 < 0.2	1.00E00
4-hydroxyproline catabolic process (GO:0019470)	4	0	.02	-	 < 0.2	1.00E00
regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714)	9	0	.04	-	 < 0.2	1.00E00
low-density lipoprotein particle receptor biosynthetic process (GO:0045713)	1	0	.00	-	 < 0.2	1.00E00
oligodendrocyte cell fate commitment (GO:0021779)	5	0	.02	-	 < 0.2	1.00E00
oligodendrocyte cell fate specification (GO:0021778)	5	0	.02	-	 < 0.2	1.00E00
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	3	0	.01	-	 < 0.2	1.00E00
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	3	0	.01	-	 < 0.2	1.00E00
striatal medium spiny neuron differentiation (GO:0021773)	3	0	.01	-	 < 0.2	1.00E00
olfactory bulb development (GO:0021772)	32	0	.13	-	 < 0.2	1.00E00
lateral geniculate nucleus development (GO:0021771)	1	0	.00	-	 < 0.2	1.00E00
exon-exon junction complex disassembly (GO:1903259)	1	0	.00	-	 < 0.2	1.00E00
glycine decarboxylation via glycine cleavage system (GO:0019464)	3	0	.01	-	 < 0.2	1.00E00
ectoderm and mesoderm interaction (GO:0007499)	1	0	.00	-	 < 0.2	1.00E00
mesoderm development (GO:0007498)	123	2	.52	+	3.88	1.00E00
multi-ciliated epithelial cell differentiation (GO:1903251)	9	0	.04	-	 < 0.2	1.00E00
posterior midgut development (GO:0007497)	2	0	.01	-	 < 0.2	1.00E00
visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495)	1	0	.00	-	 < 0.2	1.00E00
midgut development (GO:0007494)	11	1	.05	+	21.70	1.00E00
endodermal cell fate determination (GO:0007493)	2	0	.01	-	 < 0.2	1.00E00
endoderm development (GO:0007492)	76	3	.32	+	9.42	1.00E00
orbitofrontal cortex development (GO:0021769)	4	0	.02	-	 < 0.2	1.00E00
nucleus accumbens development (GO:0021768)	1	0	.00	-	 < 0.2	1.00E00
mammillary body development (GO:0021767)	2	0	.01	-	 < 0.2	1.00E00
hippocampus development (GO:0021766)	79	1	.33	+	3.02	1.00E00
amygdala development (GO:0021764)	4	0	.02	-	 < 0.2	1.00E00
subthalamic nucleus development (GO:0021763)	1	0	.00	-	 < 0.2	1.00E00
substantia nigra development (GO:0021762)	43	1	.18	+	5.55	1.00E00
limbic system development (GO:0021761)	106	1	.44	+	2.25	1.00E00
negative regulation of citrulline biosynthetic process (GO:1903249)	1	0	.00	-	 < 0.2	1.00E00
regulation of citrulline biosynthetic process (GO:1903248)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	6	1	.03	+	39.78	1.00E00
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	9	1	.04	+	26.52	1.00E00
globus pallidus development (GO:0021759)	4	0	.02	-	 < 0.2	1.00E00
putamen development (GO:0021758)	1	0	.00	-	 < 0.2	1.00E00
caudate nucleus development (GO:0021757)	1	0	.00	-	 < 0.2	1.00E00
pronephric duct morphogenesis (GO:0039023)	1	0	.00	-	 < 0.2	1.00E00
striatum development (GO:0021756)	17	0	.07	-	 < 0.2	1.00E00
pronephric duct development (GO:0039022)	1	0	.00	-	 < 0.2	1.00E00
facial nucleus development (GO:0021754)	1	0	.00	-	 < 0.2	1.00E00
pronephric nephron tubule development (GO:0039020)	2	0	.01	-	 < 0.2	1.00E00
L-cysteine catabolic process (GO:0019448)	3	0	.01	-	 < 0.2	1.00E00
vestibular nucleus development (GO:0021750)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of leukocyte tethering or rolling (GO:1903238)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of leukocyte tethering or rolling (GO:1903237)	4	0	.02	-	 < 0.2	1.00E00
regulation of leukocyte tethering or rolling (GO:1903236)	7	0	.03	-	 < 0.2	1.00E00
tryptophan catabolic process to acetyl-CoA (GO:0019442)	2	0	.01	-	 < 0.2	1.00E00
tryptophan catabolic process to kynurenine (GO:0019441)	7	0	.03	-	 < 0.2	1.00E00
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	2	0	.01	-	 < 0.2	1.00E00
melanosome assembly (GO:1903232)	5	0	.02	-	 < 0.2	1.00E00
pronephric nephron development (GO:0039019)	3	0	.01	-	 < 0.2	1.00E00
pattern specification involved in pronephros development (GO:0039017)	2	0	.01	-	 < 0.2	1.00E00
cochlear nucleus development (GO:0021747)	3	1	.01	+	79.55	1.00E00
aromatic compound catabolic process (GO:0019439)	418	2	1.75	+	1.14	1.00E00
aromatic compound biosynthetic process (GO:0019438)	3019	22	12.65	+	1.74	1.00E00
embryonic skeletal joint development (GO:0072498)	15	0	.06	-	 < 0.2	1.00E00
principal sensory nucleus of trigeminal nerve development (GO:0021740)	2	0	.01	-	 < 0.2	1.00E00
mesenchymal stem cell differentiation (GO:0072497)	2	0	.01	-	 < 0.2	1.00E00
triglyceride catabolic process (GO:0019433)	25	0	.10	-	 < 0.2	1.00E00
triglyceride biosynthetic process (GO:0019432)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of endodermal cell differentiation (GO:1903225)	3	0	.01	-	 < 0.2	1.00E00
regulation of endodermal cell differentiation (GO:1903224)	6	0	.03	-	 < 0.2	1.00E00
removal of superoxide radicals (GO:0019430)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of oxidative stress-induced neuron death (GO:1903223)	5	1	.02	+	47.73	1.00E00
regulation of rhodopsin gene expression (GO:0007468)	3	0	.01	-	 < 0.2	1.00E00
DNA integration (GO:0015074)	19	0	.08	-	 < 0.2	1.00E00
pronephric nephron tubule morphogenesis (GO:0039008)	1	0	.00	-	 < 0.2	1.00E00
pronephric nephron morphogenesis (GO:0039007)	1	0	.00	-	 < 0.2	1.00E00
phospholipid efflux (GO:0033700)	12	0	.05	-	 < 0.2	1.00E00
pronephric field specification (GO:0039003)	2	0	.01	-	 < 0.2	1.00E00
midbrain-hindbrain boundary maturation (GO:0021732)	1	0	.00	-	 < 0.2	1.00E00
allantoin biosynthetic process (GO:0019428)	1	0	.00	-	 < 0.2	1.00E00
ammonium transmembrane transport (GO:0072488)	18	0	.08	-	 < 0.2	1.00E00
acetyl-CoA biosynthetic process from acetate (GO:0019427)	2	0	.01	-	 < 0.2	1.00E00
trigeminal sensory nucleus development (GO:0021730)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein targeting to mitochondrion (GO:1903215)	4	0	.02	-	 < 0.2	1.00E00
regulation of protein targeting to mitochondrion (GO:1903214)	97	4	.41	+	9.84	1.00E00
positive regulation of the force of heart contraction by chemical signal (GO:0003099)	3	0	.01	-	 < 0.2	1.00E00
renal water transport (GO:0003097)	5	0	.02	-	 < 0.2	1.00E00
renal sodium ion transport (GO:0003096)	5	0	.02	-	 < 0.2	1.00E00
pressure natriuresis (GO:0003095)	3	0	.01	-	 < 0.2	1.00E00
glomerular filtration (GO:0003094)	11	0	.05	-	 < 0.2	1.00E00
regulation of glomerular filtration (GO:0003093)	12	0	.05	-	 < 0.2	1.00E00
renal water homeostasis (GO:0003091)	35	1	.15	+	6.82	1.00E00
medullary reticular formation development (GO:0021723)	1	0	.00	-	 < 0.2	1.00E00
superior olivary nucleus maturation (GO:0021722)	2	0	.01	-	 < 0.2	1.00E00
sulfide oxidation (GO:0019418)	4	0	.02	-	 < 0.2	1.00E00
sulfur oxidation (GO:0019417)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of oxidative stress-induced cell death (GO:1903209)	17	1	.07	+	14.04	1.00E00
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208)	5	0	.02	-	 < 0.2	1.00E00
regulation of hydrogen peroxide-induced neuron death (GO:1903207)	5	0	.02	-	 < 0.2	1.00E00
acetate biosynthetic process (GO:0019413)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	18	0	.08	-	 < 0.2	1.00E00
regulation of hydrogen peroxide-induced cell death (GO:1903205)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of oxidative stress-induced neuron death (GO:1903204)	17	0	.07	-	 < 0.2	1.00E00
regulation of oxidative stress-induced neuron death (GO:1903203)	23	1	.10	+	10.38	1.00E00
negative regulation of oxidative stress-induced cell death (GO:1903202)	42	1	.18	+	5.68	1.00E00
regulation of oxidative stress-induced cell death (GO:1903201)	64	2	.27	+	7.46	1.00E00
positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.00	-	 < 0.2	1.00E00
hindgut morphogenesis (GO:0007442)	7	0	.03	-	 < 0.2	1.00E00
foregut morphogenesis (GO:0007440)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of systemic arterial blood pressure (GO:0003085)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of systemic arterial blood pressure (GO:0003084)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of renal output by angiotensin (GO:0003083)	1	0	.00	-	 < 0.2	1.00E00
superior olivary nucleus development (GO:0021718)	2	0	.01	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	21	1	.09	+	11.36	1.00E00
positive regulation of behavioral fear response (GO:2000987)	5	0	.02	-	 < 0.2	1.00E00
dolichol biosynthetic process (GO:0019408)	1	0	.00	-	 < 0.2	1.00E00
hexitol catabolic process (GO:0019407)	1	0	.00	-	 < 0.2	1.00E00
hexitol biosynthetic process (GO:0019406)	1	1	.00	+	 > 100	1.00E00
negative regulation of ATP citrate synthase activity (GO:2000984)	3	0	.01	-	 < 0.2	1.00E00
alditol catabolic process (GO:0019405)	7	0	.03	-	 < 0.2	1.00E00
regulation of ATP citrate synthase activity (GO:2000983)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of inner ear receptor cell differentiation (GO:2000982)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of inner ear receptor cell differentiation (GO:2000981)	4	0	.02	-	 < 0.2	1.00E00
galactitol metabolic process (GO:0019402)	1	0	.00	-	 < 0.2	1.00E00
regulation of inner ear receptor cell differentiation (GO:2000980)	8	0	.03	-	 < 0.2	1.00E00
alditol biosynthetic process (GO:0019401)	5	1	.02	+	47.73	1.00E00
alditol metabolic process (GO:0019400)	21	1	.09	+	11.36	1.00E00
ectodermal digestive tract development (GO:0007439)	2	0	.01	-	 < 0.2	1.00E00
mesenchymal-epithelial cell signaling involved in lung development (GO:0060496)	1	0	.00	-	 < 0.2	1.00E00
salivary gland morphogenesis (GO:0007435)	30	1	.13	+	7.96	1.00E00
cell-cell signaling involved in lung development (GO:0060495)	1	0	.00	-	 < 0.2	1.00E00
lung induction (GO:0060492)	3	0	.01	-	 < 0.2	1.00E00
salivary gland development (GO:0007431)	34	2	.14	+	14.04	1.00E00
regulation of cell projection assembly (GO:0060491)	156	3	.65	+	4.59	1.00E00
lateral sprouting involved in lung morphogenesis (GO:0060490)	2	0	.01	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure (GO:0003073)	92	3	.39	+	7.78	1.00E00
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	4	0	.02	-	 < 0.2	1.00E00
cerebellar granule cell differentiation (GO:0021707)	7	0	.03	-	 < 0.2	1.00E00
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	23	0	.10	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of forebrain neuron differentiation (GO:2000979)	1	0	.00	-	 < 0.2	1.00E00
locus ceruleus development (GO:0021703)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of forebrain neuron differentiation (GO:2000978)	2	0	.01	-	 < 0.2	1.00E00
cerebellar Purkinje cell differentiation (GO:0021702)	11	0	.05	-	 < 0.2	1.00E00
regulation of forebrain neuron differentiation (GO:2000977)	4	0	.02	-	 < 0.2	1.00E00
developmental maturation (GO:0021700)	216	6	.91	+	6.63	1.00E00
negative regulation of pro-B cell differentiation (GO:2000974)	3	0	.01	-	 < 0.2	1.00E00
regulation of pro-B cell differentiation (GO:2000973)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of detection of glucose (GO:2000971)	1	0	.00	-	 < 0.2	1.00E00
regulation of detection of glucose (GO:2000970)	1	0	.00	-	 < 0.2	1.00E00
planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489)	2	0	.01	-	 < 0.2	1.00E00
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488)	2	0	.01	-	 < 0.2	1.00E00
lung epithelial cell differentiation (GO:0060487)	23	0	.10	-	 < 0.2	1.00E00
Clara cell differentiation (GO:0060486)	4	0	.02	-	 < 0.2	1.00E00
open tracheal system development (GO:0007424)	1	0	.00	-	 < 0.2	1.00E00
lung-associated mesenchyme development (GO:0060484)	10	0	.04	-	 < 0.2	1.00E00
sensory organ development (GO:0007423)	521	6	2.18	+	2.75	1.00E00
peripheral nervous system development (GO:0007422)	71	4	.30	+	13.45	1.00E00
protein transport (GO:0015031)	1358	13	5.69	+	2.28	1.00E00
lobar bronchus development (GO:0060482)	5	0	.02	-	 < 0.2	1.00E00
lobar bronchus epithelium development (GO:0060481)	4	0	.02	-	 < 0.2	1.00E00
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.00	-	 < 0.2	1.00E00
lung goblet cell differentiation (GO:0060480)	3	0	.01	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of heart rate by epinephrine (GO:0003065)	1	0	.00	-	 < 0.2	1.00E00
regulation of heart rate by hormone (GO:0003064)	2	0	.01	-	 < 0.2	1.00E00
regulation of heart rate by chemical signal (GO:0003062)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of AMPA receptor activity (GO:2000969)	5	0	.02	-	 < 0.2	1.00E00
protein deglutathionylation (GO:0080058)	1	0	.00	-	 < 0.2	1.00E00
lung cell differentiation (GO:0060479)	24	0	.10	-	 < 0.2	1.00E00
ventral midline development (GO:0007418)	4	0	.02	-	 < 0.2	1.00E00
acrosomal vesicle exocytosis (GO:0060478)	3	0	.01	-	 < 0.2	1.00E00
synapse assembly (GO:0007416)	81	3	.34	+	8.84	1.00E00
positive regulation of flagellated sperm motility involved in capacitation (GO:0060474)	4	0	.02	-	 < 0.2	1.00E00
axonal fasciculation (GO:0007413)	20	0	.08	-	 < 0.2	1.00E00
axon target recognition (GO:0007412)	3	0	.01	-	 < 0.2	1.00E00
axon guidance (GO:0007411)	227	5	.95	+	5.26	1.00E00
hormonal regulation of the force of heart contraction (GO:0003058)	1	0	.00	-	 < 0.2	1.00E00
regulation of the force of heart contraction by chemical signal (GO:0003057)	6	1	.03	+	39.78	1.00E00
regulation of vascular smooth muscle contraction (GO:0003056)	7	0	.03	-	 < 0.2	1.00E00
angiotensin-mediated drinking behavior (GO:0003051)	3	0	.01	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	2	0	.01	-	 < 0.2	1.00E00
signal transduction involved in mitotic G2 DNA damage checkpoint (GO:0072434)	1	1	.00	+	 > 100	1.00E00
response to G1 DNA damage checkpoint signaling (GO:0072432)	1	0	.00	-	 < 0.2	1.00E00
axonogenesis (GO:0007409)	348	6	1.46	+	4.11	1.00E00
prevention of polyspermy (GO:0060468)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of fertilization (GO:0060467)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of neuroblast proliferation (GO:0007406)	5	0	.02	-	 < 0.2	1.00E00
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	5	0	.02	-	 < 0.2	1.00E00
activation of meiosis involved in egg activation (GO:0060466)	1	0	.00	-	 < 0.2	1.00E00
neuroblast proliferation (GO:0007405)	29	0	.12	-	 < 0.2	1.00E00
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	5	0	.02	-	 < 0.2	1.00E00
pharynx development (GO:0060465)	2	0	.01	-	 < 0.2	1.00E00
glial cell fate determination (GO:0007403)	1	0	.00	-	 < 0.2	1.00E00
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	21	0	.09	-	 < 0.2	1.00E00
lung lobe morphogenesis (GO:0060463)	7	0	.03	-	 < 0.2	1.00E00
ganglion mother cell fate determination (GO:0007402)	2	0	.01	-	 < 0.2	1.00E00
lung lobe development (GO:0060462)	7	0	.03	-	 < 0.2	1.00E00
right lung morphogenesis (GO:0060461)	1	0	.00	-	 < 0.2	1.00E00
neuroblast fate determination (GO:0007400)	1	0	.00	-	 < 0.2	1.00E00
left lung morphogenesis (GO:0060460)	2	0	.01	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	44	1	.18	+	5.42	1.00E00
phenol-containing compound biosynthetic process (GO:0046189)	33	0	.14	-	 < 0.2	1.00E00
aldehyde catabolic process (GO:0046185)	12	0	.05	-	 < 0.2	1.00E00
response to intra-S DNA damage checkpoint signaling (GO:0072429)	4	0	.02	-	 < 0.2	1.00E00
aldehyde biosynthetic process (GO:0046184)	9	0	.04	-	 < 0.2	1.00E00
signal transduction involved in intra-S DNA damage checkpoint (GO:0072428)	1	0	.00	-	 < 0.2	1.00E00
signal transduction involved in G2 DNA damage checkpoint (GO:0072425)	1	1	.00	+	 > 100	1.00E00
response to nitrite (GO:0080033)	1	0	.00	-	 < 0.2	1.00E00
response to DNA damage checkpoint signaling (GO:0072423)	6	0	.03	-	 < 0.2	1.00E00
left lung development (GO:0060459)	3	0	.01	-	 < 0.2	1.00E00
right lung development (GO:0060458)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of digestive system process (GO:0060457)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of digestive system process (GO:0060456)	13	0	.05	-	 < 0.2	1.00E00
somatic sex determination (GO:0018993)	2	1	.01	+	 > 100	1.00E00
negative regulation of gastric acid secretion (GO:0060455)	5	0	.02	-	 < 0.2	1.00E00
germ-line sex determination (GO:0018992)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of gastric acid secretion (GO:0060454)	2	0	.01	-	 < 0.2	1.00E00
regulation of gastric acid secretion (GO:0060453)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of cardiac muscle contraction (GO:0060452)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of hindgut contraction (GO:0060450)	1	0	.00	-	 < 0.2	1.00E00
detection of oxygen (GO:0003032)	5	0	.02	-	 < 0.2	1.00E00
D-gluconate catabolic process (GO:0046177)	1	0	.00	-	 < 0.2	1.00E00
aldonic acid catabolic process (GO:0046176)	1	0	.00	-	 < 0.2	1.00E00
polyol catabolic process (GO:0046174)	19	0	.08	-	 < 0.2	1.00E00
polyol biosynthetic process (GO:0046173)	36	1	.15	+	6.63	1.00E00
response to mitotic cell cycle checkpoint signaling (GO:0072414)	1	0	.00	-	 < 0.2	1.00E00
bud elongation involved in lung branching (GO:0060449)	6	0	.03	-	 < 0.2	1.00E00
dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	3	0	.01	-	 < 0.2	1.00E00
bud outgrowth involved in lung branching (GO:0060447)	3	0	.01	-	 < 0.2	1.00E00
branching involved in open tracheal system development (GO:0060446)	1	0	.00	-	 < 0.2	1.00E00
branching involved in salivary gland morphogenesis (GO:0060445)	17	0	.07	-	 < 0.2	1.00E00
branching involved in mammary gland duct morphogenesis (GO:0060444)	21	2	.09	+	22.73	1.00E00
mitochondrial large ribosomal subunit assembly (GO:1902775)	3	0	.01	-	 < 0.2	1.00E00
mammary gland morphogenesis (GO:0060443)	42	3	.18	+	17.05	1.00E00
late endosome to lysosome transport (GO:1902774)	3	0	.01	-	 < 0.2	1.00E00
branching involved in prostate gland morphogenesis (GO:0060442)	10	0	.04	-	 < 0.2	1.00E00
epithelial tube branching involved in lung morphogenesis (GO:0060441)	25	0	.10	-	 < 0.2	1.00E00
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029)	1	0	.00	-	 < 0.2	1.00E00
trachea formation (GO:0060440)	6	1	.03	+	39.78	1.00E00
positive regulation of choline O-acetyltransferase activity (GO:1902771)	1	0	.00	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027)	1	0	.00	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026)	1	0	.00	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	5	0	.02	-	 < 0.2	1.00E00
glycerol-3-phosphate catabolic process (GO:0046168)	2	0	.01	-	 < 0.2	1.00E00
glycerol-3-phosphate biosynthetic process (GO:0046167)	4	0	.02	-	 < 0.2	1.00E00
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	2	0	.01	-	 < 0.2	1.00E00
alcohol biosynthetic process (GO:0046165)	84	2	.35	+	5.68	1.00E00
alcohol catabolic process (GO:0046164)	47	0	.20	-	 < 0.2	1.00E00
heme a metabolic process (GO:0046160)	2	0	.01	-	 < 0.2	1.00E00
activation of protein kinase A activity (GO:0034199)	17	0	.07	-	 < 0.2	1.00E00
cellular response to amino acid starvation (GO:0034198)	43	2	.18	+	11.10	1.00E00
response to DNA integrity checkpoint signaling (GO:0072402)	6	0	.03	-	 < 0.2	1.00E00
trichloroethylene metabolic process (GO:0018979)	1	0	.00	-	 < 0.2	1.00E00
triglyceride transport (GO:0034197)	5	0	.02	-	 < 0.2	1.00E00
acylglycerol transport (GO:0034196)	5	0	.02	-	 < 0.2	1.00E00
trachea morphogenesis (GO:0060439)	11	1	.05	+	21.70	1.00E00
trachea development (GO:0060438)	19	1	.08	+	12.56	1.00E00
regulation of choline O-acetyltransferase activity (GO:1902769)	1	0	.00	-	 < 0.2	1.00E00
lung growth (GO:0060437)	5	1	.02	+	47.73	1.00E00
bronchiole morphogenesis (GO:0060436)	1	0	.00	-	 < 0.2	1.00E00
bronchiole development (GO:0060435)	3	0	.01	-	 < 0.2	1.00E00
skeletal muscle satellite cell migration (GO:1902766)	2	0	.01	-	 < 0.2	1.00E00
bronchus morphogenesis (GO:0060434)	2	0	.01	-	 < 0.2	1.00E00
bronchus development (GO:0060433)	10	0	.04	-	 < 0.2	1.00E00
lung pattern specification process (GO:0060432)	1	0	.00	-	 < 0.2	1.00E00
primary lung bud formation (GO:0060431)	2	0	.01	-	 < 0.2	1.00E00
lung saccule development (GO:0060430)	8	0	.03	-	 < 0.2	1.00E00
vascular process in circulatory system (GO:0003018)	162	4	.68	+	5.89	1.00E00
lymph circulation (GO:0003017)	1	0	.00	-	 < 0.2	1.00E00
respiratory system process (GO:0003016)	14	0	.06	-	 < 0.2	1.00E00
heart process (GO:0003015)	92	2	.39	+	5.19	1.00E00
renal system process (GO:0003014)	106	2	.44	+	4.50	1.00E00
circulatory system process (GO:0003013)	379	7	1.59	+	4.41	1.00E00
muscle system process (GO:0003012)	295	2	1.24	+	1.62	1.00E00
involuntary skeletal muscle contraction (GO:0003011)	3	0	.01	-	 < 0.2	1.00E00
voluntary skeletal muscle contraction (GO:0003010)	3	0	.01	-	 < 0.2	1.00E00
mRNA methylation (GO:0080009)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of sterol import (GO:2000911)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of sterol import (GO:2000910)	2	0	.01	-	 < 0.2	1.00E00
thiocyanate metabolic process (GO:0018969)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	5	0	.02	-	 < 0.2	1.00E00
lung epithelium development (GO:0060428)	32	1	.13	+	7.46	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	3	0	.01	-	 < 0.2	1.00E00
lung connective tissue development (GO:0060427)	1	0	.00	-	 < 0.2	1.00E00
propylene metabolic process (GO:0018964)	1	0	.00	-	 < 0.2	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	8	0	.03	-	 < 0.2	1.00E00
lung vasculature development (GO:0060426)	6	1	.03	+	39.78	1.00E00
phthalate metabolic process (GO:0018963)	3	0	.01	-	 < 0.2	1.00E00
lung morphogenesis (GO:0060425)	44	1	.18	+	5.42	1.00E00
nuclear pore organization (GO:0006999)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of heart growth (GO:0060421)	35	3	.15	+	20.46	1.00E00
skeletal muscle contraction (GO:0003009)	28	2	.12	+	17.05	1.00E00
nuclear envelope organization (GO:0006998)	87	3	.36	+	8.23	1.00E00
positive regulation of cell cycle G2/M phase transition (GO:1902751)	25	0	.10	-	 < 0.2	1.00E00
system process (GO:0003008)	1843	18	7.72	+	2.33	1.00E00
nucleus organization (GO:0006997)	147	4	.62	+	6.49	1.00E00
negative regulation of cell cycle G2/M phase transition (GO:1902750)	91	1	.38	+	2.62	1.00E00
heart morphogenesis (GO:0003007)	225	6	.94	+	6.36	1.00E00
cellular response to nitrogen starvation (GO:0006995)	12	0	.05	-	 < 0.2	1.00E00
regionalization (GO:0003002)	314	3	1.32	+	2.28	1.00E00
response to sterol depletion (GO:0006991)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	4	1	.02	+	59.66	1.00E00
pigment catabolic process (GO:0046149)	7	0	.03	-	 < 0.2	1.00E00
pigment biosynthetic process (GO:0046148)	48	0	.20	-	 < 0.2	1.00E00
regulation of sterol import (GO:2000909)	4	0	.02	-	 < 0.2	1.00E00
tetrahydrobiopterin metabolic process (GO:0046146)	7	0	.03	-	 < 0.2	1.00E00
D-alanine family amino acid metabolic process (GO:0046144)	1	0	.00	-	 < 0.2	1.00E00
phenol-containing compound metabolic process (GO:0018958)	80	2	.34	+	5.97	1.00E00
heart growth (GO:0060419)	28	0	.12	-	 < 0.2	1.00E00
regulation of cell cycle G2/M phase transition (GO:1902749)	204	5	.85	+	5.85	1.00E00
positive regulation of lens fiber cell differentiation (GO:1902748)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lens fiber cell differentiation (GO:1902747)	1	0	.00	-	 < 0.2	1.00E00
muscle tissue morphogenesis (GO:0060415)	74	1	.31	+	3.23	1.00E00
regulation of lens fiber cell differentiation (GO:1902746)	4	0	.02	-	 < 0.2	1.00E00
imidazole-containing compound catabolic process (GO:0052805)	8	0	.03	-	 < 0.2	1.00E00
aorta smooth muscle tissue morphogenesis (GO:0060414)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of lamellipodium organization (GO:1902745)	27	1	.11	+	8.84	1.00E00
atrial septum morphogenesis (GO:0060413)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of lamellipodium organization (GO:1902744)	5	0	.02	-	 < 0.2	1.00E00
imidazole-containing compound metabolic process (GO:0052803)	12	0	.05	-	 < 0.2	1.00E00
ventricular septum morphogenesis (GO:0060412)	36	0	.15	-	 < 0.2	1.00E00
regulation of lamellipodium organization (GO:1902743)	43	1	.18	+	5.55	1.00E00
cardiac septum morphogenesis (GO:0060411)	65	2	.27	+	7.34	1.00E00
apoptotic process involved in development (GO:1902742)	23	1	.10	+	10.38	1.00E00
positive regulation of interferon-alpha secretion (GO:1902741)	8	1	.03	+	29.83	1.00E00
activation of signaling protein activity involved in unfolded protein response (GO:0006987)	8	0	.03	-	 < 0.2	1.00E00
response to unfolded protein (GO:0006986)	161	2	.67	+	2.96	1.00E00
ER-nucleus signaling pathway (GO:0006984)	36	2	.15	+	13.26	1.00E00
ER overload response (GO:0006983)	11	1	.05	+	21.70	1.00E00
response to lipid hydroperoxide (GO:0006982)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of vitamin metabolic process (GO:0046137)	6	1	.03	+	39.78	1.00E00
positive regulation of vitamin metabolic process (GO:0046136)	3	0	.01	-	 < 0.2	1.00E00
pyrimidine nucleoside catabolic process (GO:0046135)	21	0	.09	-	 < 0.2	1.00E00
pyrimidine nucleoside biosynthetic process (GO:0046134)	29	0	.12	-	 < 0.2	1.00E00
pyrimidine ribonucleoside catabolic process (GO:0046133)	11	0	.05	-	 < 0.2	1.00E00
pyrimidine ribonucleoside biosynthetic process (GO:0046132)	22	0	.09	-	 < 0.2	1.00E00
pyrimidine ribonucleoside metabolic process (GO:0046131)	33	0	.14	-	 < 0.2	1.00E00
purine ribonucleoside catabolic process (GO:0046130)	8	0	.03	-	 < 0.2	1.00E00
toll-like receptor 10 signaling pathway (GO:0034166)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	3	0	.01	-	 < 0.2	1.00E00
regulation of acetylcholine metabolic process (GO:0060408)	1	0	.00	-	 < 0.2	1.00E00
regulation of interferon-alpha secretion (GO:1902739)	8	1	.03	+	29.83	1.00E00
regulation of toll-like receptor 9 signaling pathway (GO:0034163)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of penile erection (GO:0060407)	1	0	.00	-	 < 0.2	1.00E00
toll-like receptor 9 signaling pathway (GO:0034162)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of penile erection (GO:0060406)	4	0	.02	-	 < 0.2	1.00E00
regulation of penile erection (GO:0060405)	6	0	.03	-	 < 0.2	1.00E00
axonemal microtubule depolymerization (GO:0060404)	1	0	.00	-	 < 0.2	1.00E00
calcium ion transport into cytosol (GO:0060402)	65	0	.27	-	 < 0.2	1.00E00
cytosolic calcium ion transport (GO:0060401)	77	0	.32	-	 < 0.2	1.00E00
positive regulation of chondrocyte proliferation (GO:1902732)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of chondrocyte proliferation (GO:1902731)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of proteoglycan biosynthetic process (GO:1902730)	3	0	.01	-	 < 0.2	1.00E00
DNA damage induced protein phosphorylation (GO:0006975)	8	2	.03	+	59.66	1.00E00
hyperosmotic response (GO:0006972)	22	2	.09	+	21.70	1.00E00
hypotonic response (GO:0006971)	9	1	.04	+	26.52	1.00E00
purine ribonucleoside biosynthetic process (GO:0046129)	24	0	.10	-	 < 0.2	1.00E00
purine ribonucleoside metabolic process (GO:0046128)	73	0	.31	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	4	0	.02	-	 < 0.2	1.00E00
purine deoxyribonucleoside catabolic process (GO:0046124)	1	0	.00	-	 < 0.2	1.00E00
purine deoxyribonucleoside metabolic process (GO:0046122)	2	0	.01	-	 < 0.2	1.00E00
deoxyribonucleoside catabolic process (GO:0046121)	3	0	.01	-	 < 0.2	1.00E00
deoxyribonucleoside biosynthetic process (GO:0046120)	1	0	.00	-	 < 0.2	1.00E00
toll-like receptor 8 signaling pathway (GO:0034158)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of toll-like receptor 7 signaling pathway (GO:0034156)	1	0	.00	-	 < 0.2	1.00E00
regulation of toll-like receptor 7 signaling pathway (GO:0034155)	4	0	.02	-	 < 0.2	1.00E00
toll-like receptor 7 signaling pathway (GO:0034154)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	2	0	.01	-	 < 0.2	1.00E00
toll-like receptor 6 signaling pathway (GO:0034150)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of satellite cell differentiation (GO:1902725)	3	0	.01	-	 < 0.2	1.00E00
naphthalene metabolic process (GO:0018931)	2	1	.01	+	 > 100	1.00E00
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of prolactin secretion (GO:1902722)	2	1	.01	+	 > 100	1.00E00
cellular defense response (GO:0006968)	60	1	.25	+	3.98	1.00E00
queuosine metabolic process (GO:0046116)	5	0	.02	-	 < 0.2	1.00E00
nucleobase catabolic process (GO:0046113)	6	0	.03	-	 < 0.2	1.00E00
nucleobase biosynthetic process (GO:0046112)	18	0	.08	-	 < 0.2	1.00E00
xanthine biosynthetic process (GO:0046111)	1	0	.00	-	 < 0.2	1.00E00
xanthine metabolic process (GO:0046110)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	0	.00	-	 < 0.2	1.00E00
regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	0	.00	-	 < 0.2	1.00E00
toll-like receptor 5 signaling pathway (GO:0034146)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	9	0	.04	-	 < 0.2	1.00E00
regulation of toll-like receptor 4 signaling pathway (GO:0034143)	18	0	.08	-	 < 0.2	1.00E00
multivesicular body sorting pathway (GO:0071985)	23	0	.10	-	 < 0.2	1.00E00
toll-like receptor 4 signaling pathway (GO:0034142)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	7	1	.03	+	34.09	1.00E00
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of interferon-gamma secretion (GO:1902715)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of interferon-gamma secretion (GO:1902714)	4	0	.02	-	 < 0.2	1.00E00
regulation of interferon-gamma secretion (GO:1902713)	12	0	.05	-	 < 0.2	1.00E00
humoral immune response (GO:0006959)	308	2	1.29	+	1.55	1.00E00
complement activation, classical pathway (GO:0006958)	141	0	.59	-	 < 0.2	1.00E00
complement activation, alternative pathway (GO:0006957)	13	0	.05	-	 < 0.2	1.00E00
complement activation (GO:0006956)	156	0	.65	-	 < 0.2	1.00E00
immune response (GO:0006955)	1673	18	7.01	+	2.57	1.00E00
inflammatory response (GO:0006954)	465	4	1.95	+	2.05	1.00E00
acute-phase response (GO:0006953)	41	1	.17	+	5.82	1.00E00
defense response (GO:0006952)	1227	13	5.14	+	2.53	1.00E00
uridine metabolic process (GO:0046108)	2	0	.01	-	 < 0.2	1.00E00
thymidine biosynthetic process (GO:0046105)	1	0	.00	-	 < 0.2	1.00E00
thymidine metabolic process (GO:0046104)	4	0	.02	-	 < 0.2	1.00E00
inosine biosynthetic process (GO:0046103)	3	0	.01	-	 < 0.2	1.00E00
inosine metabolic process (GO:0046102)	4	0	.02	-	 < 0.2	1.00E00
hypoxanthine biosynthetic process (GO:0046101)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590)	2	0	.01	-	 < 0.2	1.00E00
hypoxanthine metabolic process (GO:0046100)	4	0	.02	-	 < 0.2	1.00E00
regulation of toll-like receptor 3 signaling pathway (GO:0034139)	9	1	.04	+	26.52	1.00E00
toll-like receptor 3 signaling pathway (GO:0034138)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	4	0	.02	-	 < 0.2	1.00E00
fluorene metabolic process (GO:0018917)	1	0	.00	-	 < 0.2	1.00E00
regulation of toll-like receptor 2 signaling pathway (GO:0034135)	9	0	.04	-	 < 0.2	1.00E00
nitrobenzene metabolic process (GO:0018916)	4	0	.02	-	 < 0.2	1.00E00
toll-like receptor 2 signaling pathway (GO:0034134)	5	0	.02	-	 < 0.2	1.00E00
cell gliding (GO:0071976)	1	0	.00	-	 < 0.2	1.00E00
toll-like receptor 1 signaling pathway (GO:0034130)	1	0	.00	-	 < 0.2	1.00E00
extracellular exosome assembly (GO:0071971)	1	0	.00	-	 < 0.2	1.00E00
benzene metabolic process (GO:0018910)	1	0	.00	-	 < 0.2	1.00E00
syncytium formation (GO:0006949)	29	0	.12	-	 < 0.2	1.00E00
induction by virus of host cell-cell fusion (GO:0006948)	1	0	.00	-	 < 0.2	1.00E00
regulation of striated muscle contraction (GO:0006942)	87	1	.36	+	2.74	1.00E00
striated muscle contraction (GO:0006941)	112	2	.47	+	4.26	1.00E00
regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589)	2	0	.01	-	 < 0.2	1.00E00
regulation of smooth muscle contraction (GO:0006940)	59	2	.25	+	8.09	1.00E00
positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587)	2	0	.01	-	 < 0.2	1.00E00
regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of antigen processing and presentation of peptide antigen (GO:0002585)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of antigen processing and presentation of peptide antigen (GO:0002584)	4	0	.02	-	 < 0.2	1.00E00
response to ozone (GO:0010193)	5	0	.02	-	 < 0.2	1.00E00
regulation of antigen processing and presentation of peptide antigen (GO:0002583)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	3	0	.01	-	 < 0.2	1.00E00
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	7	0	.03	-	 < 0.2	1.00E00
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125)	2	0	.01	-	 < 0.2	1.00E00
regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of toll-like receptor signaling pathway (GO:0034123)	20	1	.08	+	11.93	1.00E00
ether metabolic process (GO:0018904)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of toll-like receptor signaling pathway (GO:0034122)	35	1	.15	+	6.82	1.00E00
regulation of toll-like receptor signaling pathway (GO:0034121)	59	2	.25	+	8.09	1.00E00
establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of erythrocyte aggregation (GO:0034120)	1	0	.00	-	 < 0.2	1.00E00
mitotic sister chromatid cohesion, centromeric (GO:0071962)	2	0	.01	-	 < 0.2	1.00E00
smooth muscle contraction (GO:0006939)	50	0	.21	-	 < 0.2	1.00E00
regulation of muscle contraction (GO:0006937)	154	2	.65	+	3.10	1.00E00
muscle contraction (GO:0006936)	245	2	1.03	+	1.95	1.00E00
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	4	0	.02	-	 < 0.2	1.00E00
substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	3	0	.01	-	 < 0.2	1.00E00
vitamin E biosynthetic process (GO:0010189)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of antigen processing and presentation (GO:0002579)	9	0	.04	-	 < 0.2	1.00E00
substrate-dependent cell migration, cell extension (GO:0006930)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of antigen processing and presentation (GO:0002578)	7	0	.03	-	 < 0.2	1.00E00
regulation of antigen processing and presentation (GO:0002577)	17	0	.07	-	 < 0.2	1.00E00
platelet degranulation (GO:0002576)	127	4	.53	+	7.52	1.00E00
basophil chemotaxis (GO:0002575)	1	0	.00	-	 < 0.2	1.00E00
myeloid leukocyte differentiation (GO:0002573)	99	3	.41	+	7.23	1.00E00
sugar mediated signaling pathway (GO:0010182)	2	0	.01	-	 < 0.2	1.00E00
pro-T cell differentiation (GO:0002572)	1	0	.00	-	 < 0.2	1.00E00
regulation of erythrocyte aggregation (GO:0034118)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of heterotypic cell-cell adhesion (GO:0034115)	9	0	.04	-	 < 0.2	1.00E00
regulation of heterotypic cell-cell adhesion (GO:0034114)	20	0	.08	-	 < 0.2	1.00E00
heterotypic cell-cell adhesion (GO:0034113)	29	0	.12	-	 < 0.2	1.00E00
recycling endosome to Golgi transport (GO:0071955)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of homotypic cell-cell adhesion (GO:0034112)	6	0	.03	-	 < 0.2	1.00E00
chemokine (C-C motif) ligand 11 production (GO:0071954)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of homotypic cell-cell adhesion (GO:0034111)	14	1	.06	+	17.05	1.00E00
regulation of homotypic cell-cell adhesion (GO:0034110)	25	3	.10	+	28.64	1.00E00
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.00	-	 < 0.2	1.00E00
substrate-dependent cell migration (GO:0006929)	26	1	.11	+	9.18	1.00E00
inflammatory cell apoptotic process (GO:0006925)	7	0	.03	-	 < 0.2	1.00E00
activation-induced cell death of T cells (GO:0006924)	6	1	.03	+	39.78	1.00E00
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	26	1	.11	+	9.18	1.00E00
somatic diversification of T cell receptor genes (GO:0002568)	5	0	.02	-	 < 0.2	1.00E00
somatic diversification of immune receptors via somatic mutation (GO:0002566)	17	1	.07	+	14.04	1.00E00
embryonic body morphogenesis (GO:0010172)	6	0	.03	-	 < 0.2	1.00E00
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	33	1	.14	+	7.23	1.00E00
body morphogenesis (GO:0010171)	45	0	.19	-	 < 0.2	1.00E00
homotypic cell-cell adhesion (GO:0034109)	53	0	.22	-	 < 0.2	1.00E00
positive regulation of tissue remodeling (GO:0034105)	29	2	.12	+	16.46	1.00E00
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of tissue remodeling (GO:0034104)	20	0	.08	-	 < 0.2	1.00E00
regulation of tissue remodeling (GO:0034103)	70	3	.29	+	10.23	1.00E00
erythrocyte homeostasis (GO:0034101)	78	4	.33	+	12.24	1.00E00
nitrogen cycle metabolic process (GO:0071941)	14	0	.06	-	 < 0.2	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	87	3	.36	+	8.23	1.00E00
autophagy (GO:0006914)	250	4	1.05	+	3.82	1.00E00
phagocytosis, engulfment (GO:0006911)	86	0	.36	-	 < 0.2	1.00E00
phagocytosis, recognition (GO:0006910)	73	0	.31	-	 < 0.2	1.00E00
wax metabolic process (GO:0010166)	4	0	.02	-	 < 0.2	1.00E00
response to cesium ion (GO:0010164)	1	0	.00	-	 < 0.2	1.00E00
serotonin secretion by platelet (GO:0002554)	3	1	.01	+	79.55	1.00E00
histamine secretion by mast cell (GO:0002553)	3	0	.01	-	 < 0.2	1.00E00
mast cell chemotaxis (GO:0002551)	5	0	.02	-	 < 0.2	1.00E00
formation of animal organ boundary (GO:0010160)	1	0	.00	-	 < 0.2	1.00E00
thiamine transmembrane transport (GO:0071934)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	3	0	.01	-	 < 0.2	1.00E00
phagocytosis (GO:0006909)	291	7	1.22	+	5.74	1.00E00
pinocytosis (GO:0006907)	11	0	.05	-	 < 0.2	1.00E00
vesicle fusion (GO:0006906)	97	0	.41	-	 < 0.2	1.00E00
vesicle docking involved in exocytosis (GO:0006904)	39	0	.16	-	 < 0.2	1.00E00
vesicle targeting (GO:0006903)	82	0	.34	-	 < 0.2	1.00E00
vesicle coating (GO:0006901)	64	0	.27	-	 < 0.2	1.00E00
specification of animal organ position (GO:0010159)	3	0	.01	-	 < 0.2	1.00E00
vesicle budding from membrane (GO:0006900)	87	0	.36	-	 < 0.2	1.00E00
monocyte chemotaxis (GO:0002548)	40	0	.17	-	 < 0.2	1.00E00
response to chlorate (GO:0010157)	2	0	.01	-	 < 0.2	1.00E00
regulation of proton transport (GO:0010155)	17	0	.07	-	 < 0.2	1.00E00
chronic inflammatory response (GO:0002544)	13	0	.05	-	 < 0.2	1.00E00
activation of blood coagulation via clotting cascade (GO:0002543)	2	0	.01	-	 < 0.2	1.00E00
Factor XII activation (GO:0002542)	2	0	.01	-	 < 0.2	1.00E00
activation of plasma proteins involved in acute inflammatory response (GO:0002541)	1	0	.00	-	 < 0.2	1.00E00
leukotriene production involved in inflammatory response (GO:0002540)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of glial cell differentiation (GO:0045687)	33	0	.14	-	 < 0.2	1.00E00
negative regulation of glial cell differentiation (GO:0045686)	23	0	.10	-	 < 0.2	1.00E00
regulation of glial cell differentiation (GO:0045685)	59	0	.25	-	 < 0.2	1.00E00
alpha-tubulin acetylation (GO:0071929)	2	1	.01	+	 > 100	1.00E00
positive regulation of epidermis development (GO:0045684)	35	0	.15	-	 < 0.2	1.00E00
negative regulation of epidermis development (GO:0045683)	18	1	.08	+	13.26	1.00E00
regulation of epidermis development (GO:0045682)	78	2	.33	+	6.12	1.00E00
endocannabinoid signaling pathway (GO:0071926)	1	0	.00	-	 < 0.2	1.00E00
regulation of cohesin loading (GO:0071922)	4	0	.02	-	 < 0.2	1.00E00
arachidonic acid metabolite production involved in inflammatory response (GO:0002538)	2	0	.01	-	 < 0.2	1.00E00
nitric oxide production involved in inflammatory response (GO:0002537)	2	0	.01	-	 < 0.2	1.00E00
cytokine production involved in inflammatory response (GO:0002534)	3	0	.01	-	 < 0.2	1.00E00
production of molecular mediator involved in inflammatory response (GO:0002532)	15	1	.06	+	15.91	1.00E00
urea transmembrane transport (GO:0071918)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of osteoclast differentiation (GO:0045672)	24	0	.10	-	 < 0.2	1.00E00
negative regulation of osteoclast differentiation (GO:0045671)	27	1	.11	+	8.84	1.00E00
regulation of osteoclast differentiation (GO:0045670)	65	1	.27	+	3.67	1.00E00
determination of liver left/right asymmetry (GO:0071910)	6	0	.03	-	 < 0.2	1.00E00
pyrimidine ribonucleotide salvage (GO:0010138)	5	0	.02	-	 < 0.2	1.00E00
regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	2	0	.01	-	 < 0.2	1.00E00
acute inflammatory response (GO:0002526)	70	1	.29	+	3.41	1.00E00
hypersensitivity (GO:0002524)	2	0	.01	-	 < 0.2	1.00E00
proline catabolic process to glutamate (GO:0010133)	3	0	.01	-	 < 0.2	1.00E00
leukocyte migration involved in inflammatory response (GO:0002523)	14	0	.06	-	 < 0.2	1.00E00
leukocyte migration involved in immune response (GO:0002522)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of osteoblast differentiation (GO:0045669)	57	1	.24	+	4.19	1.00E00
negative regulation of osteoblast differentiation (GO:0045668)	41	0	.17	-	 < 0.2	1.00E00
regulation of osteoblast differentiation (GO:0045667)	109	1	.46	+	2.19	1.00E00
positive regulation of neuron differentiation (GO:0045666)	332	3	1.39	+	2.16	1.00E00
negative regulation of neuron differentiation (GO:0045665)	198	4	.83	+	4.82	1.00E00
determination of stomach left/right asymmetry (GO:0071909)	1	0	.00	-	 < 0.2	1.00E00
regulation of neuron differentiation (GO:0045664)	579	9	2.43	+	3.71	1.00E00
determination of intestine left/right asymmetry (GO:0071908)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of myoblast differentiation (GO:0045663)	22	1	.09	+	10.85	1.00E00
determination of digestive tract left/right asymmetry (GO:0071907)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of myoblast differentiation (GO:0045662)	26	0	.11	-	 < 0.2	1.00E00
regulation of myoblast differentiation (GO:0045661)	52	1	.22	+	4.59	1.00E00
positive regulation of neutrophil differentiation (GO:0045660)	1	0	.00	-	 < 0.2	1.00E00
neurofilament bundle assembly (GO:0033693)	3	0	.01	-	 < 0.2	1.00E00
cellular polysaccharide biosynthetic process (GO:0033692)	39	1	.16	+	6.12	1.00E00
positive regulation of osteoblast proliferation (GO:0033690)	11	0	.05	-	 < 0.2	1.00E00
natural killer cell tolerance induction (GO:0002519)	2	0	.01	-	 < 0.2	1.00E00
lymphocyte chemotaxis across high endothelial venule (GO:0002518)	1	0	.00	-	 < 0.2	1.00E00
T cell tolerance induction (GO:0002517)	2	0	.01	-	 < 0.2	1.00E00
phenylacetate catabolic process (GO:0010124)	1	0	.00	-	 < 0.2	1.00E00
tolerance induction to self antigen (GO:0002513)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of neutrophil differentiation (GO:0045659)	2	0	.01	-	 < 0.2	1.00E00
regulation of neutrophil differentiation (GO:0045658)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of monocyte differentiation (GO:0045657)	10	1	.04	+	23.87	1.00E00
negative regulation of monocyte differentiation (GO:0045656)	7	0	.03	-	 < 0.2	1.00E00
regulation of monocyte differentiation (GO:0045655)	19	1	.08	+	12.56	1.00E00
positive regulation of megakaryocyte differentiation (GO:0045654)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of megakaryocyte differentiation (GO:0045653)	5	0	.02	-	 < 0.2	1.00E00
regulation of megakaryocyte differentiation (GO:0045652)	51	1	.21	+	4.68	1.00E00
positive regulation of macrophage differentiation (GO:0045651)	13	1	.05	+	18.36	1.00E00
negative regulation of macrophage differentiation (GO:0045650)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of osteoblast proliferation (GO:0033689)	9	1	.04	+	26.52	1.00E00
regulation of osteoblast proliferation (GO:0033688)	23	1	.10	+	10.38	1.00E00
osteoblast proliferation (GO:0033687)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of luteinizing hormone secretion (GO:0033686)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of luteinizing hormone secretion (GO:0033685)	3	0	.01	-	 < 0.2	1.00E00
regulation of luteinizing hormone secretion (GO:0033684)	7	0	.03	-	 < 0.2	1.00E00
nucleotide-excision repair, DNA incision (GO:0033683)	40	1	.17	+	5.97	1.00E00
central tolerance induction to self antigen (GO:0002509)	1	0	.00	-	 < 0.2	1.00E00
central tolerance induction (GO:0002508)	2	0	.01	-	 < 0.2	1.00E00
tolerance induction (GO:0002507)	11	0	.05	-	 < 0.2	1.00E00
polysaccharide assembly with MHC class II protein complex (GO:0002506)	2	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of polysaccharide antigen via MHC class II (GO:0002505)	2	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	100	0	.42	-	 < 0.2	1.00E00
peptide antigen assembly with MHC class II protein complex (GO:0002503)	4	0	.02	-	 < 0.2	1.00E00
peptide antigen assembly with MHC class I protein complex (GO:0002502)	1	0	.00	-	 < 0.2	1.00E00
peptide antigen assembly with MHC protein complex (GO:0002501)	5	0	.02	-	 < 0.2	1.00E00
regulation of macrophage differentiation (GO:0045649)	20	1	.08	+	11.93	1.00E00
regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of erythrocyte differentiation (GO:0045648)	25	1	.10	+	9.55	1.00E00
positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of erythrocyte differentiation (GO:0045647)	9	0	.04	-	 < 0.2	1.00E00
regulation of erythrocyte differentiation (GO:0045646)	42	1	.18	+	5.68	1.00E00
regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of eosinophil differentiation (GO:0045645)	2	0	.01	-	 < 0.2	1.00E00
regulation of eosinophil differentiation (GO:0045643)	2	0	.01	-	 < 0.2	1.00E00
potassium ion import (GO:0010107)	25	0	.10	-	 < 0.2	1.00E00
cellular response to iron ion starvation (GO:0010106)	1	0	.00	-	 < 0.2	1.00E00
glyoxal metabolic process (GO:1903189)	1	0	.00	-	 < 0.2	1.00E00
fatty acid oxidation (GO:0019395)	77	1	.32	+	3.10	1.00E00
positive regulation of myeloid cell differentiation (GO:0045639)	86	4	.36	+	11.10	1.00E00
negative regulation of myeloid cell differentiation (GO:0045638)	79	1	.33	+	3.02	1.00E00
regulation of myeloid cell differentiation (GO:0045637)	221	6	.93	+	6.48	1.00E00
positive regulation of melanocyte differentiation (GO:0045636)	5	1	.02	+	47.73	1.00E00
glucuronoside catabolic process (GO:0019391)	1	0	.00	-	 < 0.2	1.00E00
regulation of melanocyte differentiation (GO:0045634)	7	1	.03	+	34.09	1.00E00
positive regulation of mechanoreceptor differentiation (GO:0045633)	1	0	.00	-	 < 0.2	1.00E00
regulation of SUMO transferase activity (GO:1903182)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mechanoreceptor differentiation (GO:0045632)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of dopamine biosynthetic process (GO:1903181)	2	0	.01	-	 < 0.2	1.00E00
regulation of mechanoreceptor differentiation (GO:0045631)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of T-helper 2 cell differentiation (GO:0045630)	8	0	.03	-	 < 0.2	1.00E00
negative regulation by symbiont of host apoptotic process (GO:0033668)	4	0	.02	-	 < 0.2	1.00E00
cerebellar cortex maturation (GO:0021699)	3	0	.01	-	 < 0.2	1.00E00
cerebellar cortex structural organization (GO:0021698)	2	0	.01	-	 < 0.2	1.00E00
cerebellar cortex formation (GO:0021697)	23	0	.10	-	 < 0.2	1.00E00
cerebellar cortex morphogenesis (GO:0021696)	33	0	.14	-	 < 0.2	1.00E00
cerebellar cortex development (GO:0021695)	50	0	.21	-	 < 0.2	1.00E00
cerebellar Purkinje cell layer formation (GO:0021694)	12	0	.05	-	 < 0.2	1.00E00
cerebellar Purkinje cell layer structural organization (GO:0021693)	2	0	.01	-	 < 0.2	1.00E00
glucuronoside metabolic process (GO:0019389)	1	0	.00	-	 < 0.2	1.00E00
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	16	0	.07	-	 < 0.2	1.00E00
galactose catabolic process (GO:0019388)	8	0	.03	-	 < 0.2	1.00E00
cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.01	-	 < 0.2	1.00E00
regulation of dopamine biosynthetic process (GO:1903179)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of T-helper 2 cell differentiation (GO:0045629)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.00	-	 < 0.2	1.00E00
regulation of T-helper 2 cell differentiation (GO:0045628)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of T-helper 1 cell differentiation (GO:0045627)	6	0	.03	-	 < 0.2	1.00E00
regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of T-helper 1 cell differentiation (GO:0045626)	3	0	.01	-	 < 0.2	1.00E00
regulation of T-helper 1 cell differentiation (GO:0045625)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of T-helper cell differentiation (GO:0045624)	20	0	.08	-	 < 0.2	1.00E00
fatty alcohol metabolic process (GO:1903173)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of T-helper cell differentiation (GO:0045623)	15	0	.06	-	 < 0.2	1.00E00
regulation of T-helper cell differentiation (GO:0045622)	32	0	.13	-	 < 0.2	1.00E00
positive regulation of lymphocyte differentiation (GO:0045621)	85	3	.36	+	8.42	1.00E00
negative regulation of calcium ion transmembrane transport (GO:1903170)	38	0	.16	-	 < 0.2	1.00E00
negative regulation of lymphocyte differentiation (GO:0045620)	44	1	.18	+	5.42	1.00E00
cerebellar molecular layer formation (GO:0021688)	1	0	.00	-	 < 0.2	1.00E00
cerebellar molecular layer morphogenesis (GO:0021687)	2	0	.01	-	 < 0.2	1.00E00
cerebellar granular layer maturation (GO:0021686)	1	0	.00	-	 < 0.2	1.00E00
cerebellar granular layer structural organization (GO:0021685)	1	0	.00	-	 < 0.2	1.00E00
cerebellar granular layer formation (GO:0021684)	7	0	.03	-	 < 0.2	1.00E00
cerebellar granular layer morphogenesis (GO:0021683)	9	0	.04	-	 < 0.2	1.00E00
nerve maturation (GO:0021682)	1	0	.00	-	 < 0.2	1.00E00
cerebellar granular layer development (GO:0021681)	12	0	.05	-	 < 0.2	1.00E00
glycolipid catabolic process (GO:0019377)	14	0	.06	-	 < 0.2	1.00E00
cerebellar Purkinje cell layer development (GO:0021680)	27	0	.11	-	 < 0.2	1.00E00
galactolipid catabolic process (GO:0019376)	2	0	.01	-	 < 0.2	1.00E00
regulation of calcium ion transmembrane transport (GO:1903169)	140	2	.59	+	3.41	1.00E00
galactolipid biosynthetic process (GO:0019375)	5	0	.02	-	 < 0.2	1.00E00
regulation of lymphocyte differentiation (GO:0045619)	154	4	.65	+	6.20	1.00E00
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.00	-	 < 0.2	1.00E00
galactolipid metabolic process (GO:0019374)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of keratinocyte differentiation (GO:0045618)	15	0	.06	-	 < 0.2	1.00E00
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.00	-	 < 0.2	1.00E00
epoxygenase P450 pathway (GO:0019373)	22	0	.09	-	 < 0.2	1.00E00
negative regulation of keratinocyte differentiation (GO:0045617)	9	0	.04	-	 < 0.2	1.00E00
lipoxygenase pathway (GO:0019372)	16	0	.07	-	 < 0.2	1.00E00
regulation of keratinocyte differentiation (GO:0045616)	39	1	.16	+	6.12	1.00E00
response to polycyclic arene (GO:1903165)	1	0	.00	-	 < 0.2	1.00E00
cyclooxygenase pathway (GO:0019371)	11	0	.05	-	 < 0.2	1.00E00
leukotriene biosynthetic process (GO:0019370)	21	1	.09	+	11.36	1.00E00
cerebellar molecular layer development (GO:0021679)	3	0	.01	-	 < 0.2	1.00E00
third ventricle development (GO:0021678)	3	0	.01	-	 < 0.2	1.00E00
nerve development (GO:0021675)	75	1	.31	+	3.18	1.00E00
lysobisphosphatidic acid metabolic process (GO:2001311)	1	0	.00	-	 < 0.2	1.00E00
arachidonic acid metabolic process (GO:0019369)	55	0	.23	-	 < 0.2	1.00E00
fatty acid elongation, unsaturated fatty acid (GO:0019368)	7	0	.03	-	 < 0.2	1.00E00
fatty acid elongation, saturated fatty acid (GO:0019367)	7	0	.03	-	 < 0.2	1.00E00
lateral ventricle development (GO:0021670)	11	0	.05	-	 < 0.2	1.00E00
pyridine nucleotide salvage (GO:0019365)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of auditory receptor cell differentiation (GO:0045609)	1	0	.00	-	 < 0.2	1.00E00
pyridine nucleotide catabolic process (GO:0019364)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of auditory receptor cell differentiation (GO:0045608)	3	0	.01	-	 < 0.2	1.00E00
pyridine nucleotide biosynthetic process (GO:0019363)	31	0	.13	-	 < 0.2	1.00E00
regulation of auditory receptor cell differentiation (GO:0045607)	8	0	.03	-	 < 0.2	1.00E00
pyridine nucleotide metabolic process (GO:0019362)	111	2	.47	+	4.30	1.00E00
positive regulation of epidermal cell differentiation (GO:0045606)	22	0	.09	-	 < 0.2	1.00E00
negative regulation of epidermal cell differentiation (GO:0045605)	14	0	.06	-	 < 0.2	1.00E00
regulation of epidermal cell differentiation (GO:0045604)	57	1	.24	+	4.19	1.00E00
positive regulation of endothelial cell differentiation (GO:0045603)	16	0	.07	-	 < 0.2	1.00E00
ectoderm development (GO:0007398)	20	0	.08	-	 < 0.2	1.00E00
negative regulation of endothelial cell differentiation (GO:0045602)	8	1	.03	+	29.83	1.00E00
regulation of endothelial cell differentiation (GO:0045601)	31	1	.13	+	7.70	1.00E00
positive regulation of fat cell differentiation (GO:0045600)	55	3	.23	+	13.02	1.00E00
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	8	1	.03	+	29.83	1.00E00
cell-cell adhesion mediated by integrin (GO:0033631)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of cell adhesion mediated by integrin (GO:0033630)	17	1	.07	+	14.04	1.00E00
lipoxin B4 biosynthetic process (GO:2001306)	1	0	.00	-	 < 0.2	1.00E00
lipoxin B4 metabolic process (GO:2001304)	1	0	.00	-	 < 0.2	1.00E00
rhombomere 5 formation (GO:0021666)	1	0	.00	-	 < 0.2	1.00E00
lipoxin A4 biosynthetic process (GO:2001303)	2	0	.01	-	 < 0.2	1.00E00
lipoxin A4 metabolic process (GO:2001302)	2	0	.01	-	 < 0.2	1.00E00
rhombomere 5 morphogenesis (GO:0021664)	1	0	.00	-	 < 0.2	1.00E00
lipoxin biosynthetic process (GO:2001301)	2	0	.01	-	 < 0.2	1.00E00
lipoxin metabolic process (GO:2001300)	6	0	.03	-	 < 0.2	1.00E00
nicotinamide nucleotide biosynthetic process (GO:0019359)	31	0	.13	-	 < 0.2	1.00E00
nicotinate nucleotide salvage (GO:0019358)	1	0	.00	-	 < 0.2	1.00E00
nicotinate nucleotide biosynthetic process (GO:0019357)	1	0	.00	-	 < 0.2	1.00E00
rhombomere 3 formation (GO:0021660)	1	0	.00	-	 < 0.2	1.00E00
nicotinamide nucleotide biosynthetic process from aspartate (GO:0019355)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of autophagy of mitochondrion (GO:1903147)	8	1	.03	+	29.83	1.00E00
regulation of autophagy of mitochondrion (GO:1903146)	52	3	.22	+	13.77	1.00E00
pattern specification process (GO:0007389)	407	3	1.71	+	1.76	1.00E00
positive regulation of establishment of endothelial barrier (GO:1903142)	5	0	.02	-	 < 0.2	1.00E00
posterior compartment specification (GO:0007388)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of establishment of endothelial barrier (GO:1903141)	1	0	.00	-	 < 0.2	1.00E00
anterior compartment pattern formation (GO:0007387)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment of endothelial barrier (GO:1903140)	12	0	.05	-	 < 0.2	1.00E00
compartment pattern specification (GO:0007386)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cell adhesion mediated by integrin (GO:0033629)	9	1	.04	+	26.52	1.00E00
regulation of cell adhesion mediated by integrin (GO:0033628)	39	3	.16	+	18.36	1.00E00
cell adhesion mediated by integrin (GO:0033627)	17	1	.07	+	14.04	1.00E00
positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of integrin activation (GO:0033625)	5	1	.02	+	47.73	1.00E00
negative regulation of integrin activation (GO:0033624)	2	0	.01	-	 < 0.2	1.00E00
regulation of integrin activation (GO:0033623)	10	1	.04	+	23.87	1.00E00
integrin activation (GO:0033622)	8	1	.03	+	29.83	1.00E00
rhombomere 3 morphogenesis (GO:0021658)	1	0	.00	-	 < 0.2	1.00E00
dolichol metabolic process (GO:0019348)	5	0	.02	-	 < 0.2	1.00E00
vestibulocochlear nerve formation (GO:0021650)	5	0	.02	-	 < 0.2	1.00E00
transsulfuration (GO:0019346)	4	0	.02	-	 < 0.2	1.00E00
cysteine biosynthetic process (GO:0019344)	4	0	.02	-	 < 0.2	1.00E00
cysteine biosynthetic process via cystathionine (GO:0019343)	3	0	.01	-	 < 0.2	1.00E00
dibenzo-p-dioxin catabolic process (GO:0019341)	1	0	.00	-	 < 0.2	1.00E00
segment specification (GO:0007379)	16	0	.07	-	 < 0.2	1.00E00
mononuclear cell differentiation (GO:1903131)	17	1	.07	+	14.04	1.00E00
membrane protein proteolysis (GO:0033619)	36	0	.15	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex IV assembly (GO:0033617)	16	0	.07	-	 < 0.2	1.00E00
ventral midline determination (GO:0007371)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	3	0	.01	-	 < 0.2	1.00E00
vestibulocochlear nerve structural organization (GO:0021649)	2	0	.01	-	 < 0.2	1.00E00
vestibulocochlear nerve morphogenesis (GO:0021648)	7	0	.03	-	 < 0.2	1.00E00
vagus nerve morphogenesis (GO:0021644)	2	0	.01	-	 < 0.2	1.00E00
trochlear nerve formation (GO:0021642)	1	0	.00	-	 < 0.2	1.00E00
phenol-containing compound catabolic process (GO:0019336)	11	0	.05	-	 < 0.2	1.00E00
response to cell cycle checkpoint signaling (GO:0072396)	6	0	.03	-	 < 0.2	1.00E00
microtubule anchoring at microtubule organizing center (GO:0072393)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of centriole-centriole cohesion (GO:1903126)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of thioredoxin peroxidase activity (GO:1903124)	1	0	.00	-	 < 0.2	1.00E00
regulation of thioredoxin peroxidase activity (GO:1903123)	1	0	.00	-	 < 0.2	1.00E00
gastrulation (GO:0007369)	160	5	.67	+	7.46	1.00E00
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.00	-	 < 0.2	1.00E00
determination of left/right symmetry (GO:0007368)	114	0	.48	-	 < 0.2	1.00E00
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	4	0	.02	-	 < 0.2	1.00E00
oxalate metabolic process (GO:0033609)	1	0	.00	-	 < 0.2	1.00E00
chemokine receptor transport within lipid bilayer (GO:0033606)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of catecholamine secretion (GO:0033605)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of catecholamine secretion (GO:0033604)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of dopamine secretion (GO:0033603)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of dopamine secretion (GO:0033602)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	4	1	.02	+	59.66	1.00E00
trochlear nerve morphogenesis (GO:0021639)	1	0	.00	-	 < 0.2	1.00E00
trigeminal nerve structural organization (GO:0021637)	5	0	.02	-	 < 0.2	1.00E00
trigeminal nerve morphogenesis (GO:0021636)	5	0	.02	-	 < 0.2	1.00E00
optic nerve structural organization (GO:0021633)	2	0	.01	-	 < 0.2	1.00E00
flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.00	-	 < 0.2	1.00E00
optic nerve morphogenesis (GO:0021631)	6	0	.03	-	 < 0.2	1.00E00
flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.00	-	 < 0.2	1.00E00
flavin adenine dinucleotide metabolic process (GO:0072387)	2	0	.01	-	 < 0.2	1.00E00
plus-end-directed organelle transport along microtubule (GO:0072386)	8	0	.03	-	 < 0.2	1.00E00
protein localization to actin cytoskeleton (GO:1903119)	1	0	.00	-	 < 0.2	1.00E00
minus-end-directed organelle transport along microtubule (GO:0072385)	4	0	.02	-	 < 0.2	1.00E00
urate homeostasis (GO:1903118)	1	0	.00	-	 < 0.2	1.00E00
organelle transport along microtubule (GO:0072384)	67	0	.28	-	 < 0.2	1.00E00
pentose catabolic process (GO:0019323)	6	0	.03	-	 < 0.2	1.00E00
plus-end-directed vesicle transport along microtubule (GO:0072383)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of actin filament-based movement (GO:1903116)	3	0	.01	-	 < 0.2	1.00E00
pentose biosynthetic process (GO:0019322)	4	1	.02	+	59.66	1.00E00
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.00	-	 < 0.2	1.00E00
regulation of actin filament-based movement (GO:1903115)	40	1	.17	+	5.97	1.00E00
pentose metabolic process (GO:0019321)	15	1	.06	+	15.91	1.00E00
hexose catabolic process (GO:0019320)	49	1	.21	+	4.87	1.00E00
thorax and anterior abdomen determination (GO:0007356)	5	0	.02	-	 < 0.2	1.00E00
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	6	0	.03	-	 < 0.2	1.00E00
zygotic specification of dorsal/ventral axis (GO:0007352)	3	0	.01	-	 < 0.2	1.00E00
tripartite regional subdivision (GO:0007351)	15	0	.06	-	 < 0.2	1.00E00
blastoderm segmentation (GO:0007350)	19	0	.08	-	 < 0.2	1.00E00
olfactory nerve structural organization (GO:0021629)	1	0	.00	-	 < 0.2	1.00E00
olfactory nerve morphogenesis (GO:0021627)	1	0	.00	-	 < 0.2	1.00E00
central nervous system maturation (GO:0021626)	7	0	.03	-	 < 0.2	1.00E00
oculomotor nerve formation (GO:0021623)	2	0	.01	-	 < 0.2	1.00E00
hexose biosynthetic process (GO:0019319)	49	1	.21	+	4.87	1.00E00
oculomotor nerve morphogenesis (GO:0021622)	2	0	.01	-	 < 0.2	1.00E00
hexose metabolic process (GO:0019318)	157	5	.66	+	7.60	1.00E00
blood coagulation, fibrin clot formation (GO:0072378)	26	0	.11	-	 < 0.2	1.00E00
amylopectin metabolic process (GO:2000896)	1	0	.00	-	 < 0.2	1.00E00
fucose catabolic process (GO:0019317)	9	0	.04	-	 < 0.2	1.00E00
blood coagulation, common pathway (GO:0072377)	1	0	.00	-	 < 0.2	1.00E00
protein activation cascade (GO:0072376)	180	0	.75	-	 < 0.2	1.00E00
inositol catabolic process (GO:0019310)	1	0	.00	-	 < 0.2	1.00E00
cellularization (GO:0007349)	1	0	.00	-	 < 0.2	1.00E00
pronuclear fusion (GO:0007344)	1	0	.00	-	 < 0.2	1.00E00
egg activation (GO:0007343)	5	0	.02	-	 < 0.2	1.00E00
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	14	0	.06	-	 < 0.2	1.00E00
penetration of zona pellucida (GO:0007341)	6	0	.03	-	 < 0.2	1.00E00
acrosome reaction (GO:0007340)	19	0	.08	-	 < 0.2	1.00E00
hypoglossal nerve morphogenesis (GO:0021618)	1	0	.00	-	 < 0.2	1.00E00
glossopharyngeal nerve morphogenesis (GO:0021615)	4	0	.02	-	 < 0.2	1.00E00
facial nerve structural organization (GO:0021612)	9	0	.04	-	 < 0.2	1.00E00
regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter (GO:0072369)	2	0	.01	-	 < 0.2	1.00E00
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter (GO:0072368)	2	0	.01	-	 < 0.2	1.00E00
facial nerve morphogenesis (GO:0021610)	11	0	.05	-	 < 0.2	1.00E00
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter (GO:0072367)	4	0	.02	-	 < 0.2	1.00E00
regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072366)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072365)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter (GO:0072364)	2	0	.01	-	 < 0.2	1.00E00
D-ribose catabolic process (GO:0019303)	2	0	.01	-	 < 0.2	1.00E00
regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter (GO:0072363)	1	0	.00	-	 < 0.2	1.00E00
regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter (GO:0072362)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dipeptide transport (GO:2000880)	2	0	.01	-	 < 0.2	1.00E00
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter (GO:0072361)	2	0	.01	-	 < 0.2	1.00E00
binding of sperm to zona pellucida (GO:0007339)	37	0	.16	-	 < 0.2	1.00E00
positive regulation of growth hormone receptor signaling pathway (GO:0060399)	3	0	.01	-	 < 0.2	1.00E00
single fertilization (GO:0007338)	128	1	.54	+	1.86	1.00E00
regulation of growth hormone receptor signaling pathway (GO:0060398)	5	0	.02	-	 < 0.2	1.00E00
JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397)	14	2	.06	+	34.09	1.00E00
SMAD protein signal transduction (GO:0060395)	60	1	.25	+	3.98	1.00E00
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	12	1	.05	+	19.89	1.00E00
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	61	1	.26	+	3.91	1.00E00
negative regulation of SMAD protein import into nucleus (GO:0060392)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of SMAD protein import into nucleus (GO:0060391)	13	0	.05	-	 < 0.2	1.00E00
regulation of SMAD protein import into nucleus (GO:0060390)	17	0	.07	-	 < 0.2	1.00E00
cranial nerve structural organization (GO:0021604)	12	0	.05	-	 < 0.2	1.00E00
cranial nerve formation (GO:0021603)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of oligopeptide transport (GO:2000878)	2	0	.01	-	 < 0.2	1.00E00
cranial nerve morphogenesis (GO:0021602)	31	0	.13	-	 < 0.2	1.00E00
chromosome passenger complex localization to kinetochore (GO:0072356)	2	0	.01	-	 < 0.2	1.00E00
histone H3-T3 phosphorylation (GO:0072355)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of progesterone secretion (GO:2000872)	1	0	.00	-	 < 0.2	1.00E00
regulation of progesterone secretion (GO:2000870)	2	0	.01	-	 < 0.2	1.00E00
tricarboxylic acid metabolic process (GO:0072350)	39	1	.16	+	6.12	1.00E00
pathway-restricted SMAD protein phosphorylation (GO:0060389)	13	0	.05	-	 < 0.2	1.00E00
synapse assembly involved in innervation (GO:0060386)	1	0	.00	-	 < 0.2	1.00E00
axonogenesis involved in innervation (GO:0060385)	5	0	.02	-	 < 0.2	1.00E00
innervation (GO:0060384)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of DNA strand elongation (GO:0060383)	1	0	.00	-	 < 0.2	1.00E00
regulation of DNA strand elongation (GO:0060382)	2	0	.01	-	 < 0.2	1.00E00
sperm displacement (GO:0007321)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.00	-	 < 0.2	1.00E00
insemination (GO:0007320)	13	0	.05	-	 < 0.2	1.00E00
regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.00	-	 < 0.2	1.00E00
sulfur compound transport (GO:0072348)	36	0	.15	-	 < 0.2	1.00E00
positive regulation of estradiol secretion (GO:2000866)	2	0	.01	-	 < 0.2	1.00E00
regulation of estradiol secretion (GO:2000864)	3	0	.01	-	 < 0.2	1.00E00
rescue of stalled ribosome (GO:0072344)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of aldosterone secretion (GO:2000860)	2	0	.01	-	 < 0.2	1.00E00
cellular lactam catabolic process (GO:0072340)	1	0	.00	-	 < 0.2	1.00E00
cardiac muscle cell myoblast differentiation (GO:0060379)	10	1	.04	+	23.87	1.00E00
regulation of brood size (GO:0060378)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mast cell differentiation (GO:0060377)	1	0	.00	-	 < 0.2	1.00E00
pole plasm assembly (GO:0007315)	2	0	.01	-	 < 0.2	1.00E00
regulation of mast cell differentiation (GO:0060375)	2	0	.01	-	 < 0.2	1.00E00
oocyte anterior/posterior axis specification (GO:0007314)	2	0	.01	-	 < 0.2	1.00E00
mast cell differentiation (GO:0060374)	3	0	.01	-	 < 0.2	1.00E00
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	6	0	.03	-	 < 0.2	1.00E00
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	7	0	.03	-	 < 0.2	1.00E00
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371)	7	0	.03	-	 < 0.2	1.00E00
susceptibility to T cell mediated cytotoxicity (GO:0060370)	3	0	.01	-	 < 0.2	1.00E00
guanine biosynthetic process (GO:0046099)	1	0	.00	-	 < 0.2	1.00E00
guanine metabolic process (GO:0046098)	3	0	.01	-	 < 0.2	1.00E00
regulation of aldosterone secretion (GO:2000858)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of mineralocorticoid secretion (GO:2000857)	2	0	.01	-	 < 0.2	1.00E00
cellular lactam metabolic process (GO:0072338)	6	2	.03	+	79.55	1.00E00
modified amino acid transport (GO:0072337)	18	0	.08	-	 < 0.2	1.00E00
regulation of mineralocorticoid secretion (GO:2000855)	6	0	.03	-	 < 0.2	1.00E00
deoxycytidine metabolic process (GO:0046092)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of corticosterone secretion (GO:2000854)	2	0	.01	-	 < 0.2	1.00E00
deoxyadenosine metabolic process (GO:0046090)	1	0	.00	-	 < 0.2	1.00E00
UDP-galactose transmembrane transport (GO:0072334)	2	0	.01	-	 < 0.2	1.00E00
regulation of corticosterone secretion (GO:2000852)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of glucocorticoid secretion (GO:2000851)	5	0	.02	-	 < 0.2	1.00E00
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	58	3	.24	+	12.34	1.00E00
negative regulation of glucocorticoid secretion (GO:2000850)	3	0	.01	-	 < 0.2	1.00E00
monocarboxylic acid biosynthetic process (GO:0072330)	159	3	.67	+	4.50	1.00E00
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	4	0	.02	-	 < 0.2	1.00E00
oocyte axis specification (GO:0007309)	2	0	.01	-	 < 0.2	1.00E00
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	6	0	.03	-	 < 0.2	1.00E00
oocyte construction (GO:0007308)	2	0	.01	-	 < 0.2	1.00E00
sagittal suture morphogenesis (GO:0060367)	1	0	.00	-	 < 0.2	1.00E00
lambdoid suture morphogenesis (GO:0060366)	1	0	.00	-	 < 0.2	1.00E00
frontal suture morphogenesis (GO:0060364)	4	0	.02	-	 < 0.2	1.00E00
cranial suture morphogenesis (GO:0060363)	9	0	.04	-	 < 0.2	1.00E00
regulation of neuroblast proliferation (GO:1902692)	28	0	.12	-	 < 0.2	1.00E00
respiratory basal cell differentiation (GO:1902691)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of NAD metabolic process (GO:1902690)	1	0	.00	-	 < 0.2	1.00E00
cytidine metabolic process (GO:0046087)	9	0	.04	-	 < 0.2	1.00E00
regulation of glucocorticoid secretion (GO:2000849)	10	0	.04	-	 < 0.2	1.00E00
adenosine biosynthetic process (GO:0046086)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of corticosteroid hormone secretion (GO:2000848)	7	0	.03	-	 < 0.2	1.00E00
adenosine metabolic process (GO:0046085)	10	0	.04	-	 < 0.2	1.00E00
monocarboxylic acid catabolic process (GO:0072329)	109	0	.46	-	 < 0.2	1.00E00
negative regulation of corticosteroid hormone secretion (GO:2000847)	3	0	.01	-	 < 0.2	1.00E00
adenine biosynthetic process (GO:0046084)	2	0	.01	-	 < 0.2	1.00E00
regulation of corticosteroid hormone secretion (GO:2000846)	16	0	.07	-	 < 0.2	1.00E00
adenine metabolic process (GO:0046083)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of testosterone secretion (GO:2000845)	2	0	.01	-	 < 0.2	1.00E00
dUTP catabolic process (GO:0046081)	2	0	.01	-	 < 0.2	1.00E00
regulation of testosterone secretion (GO:2000843)	2	0	.01	-	 < 0.2	1.00E00
dUTP metabolic process (GO:0046080)	2	0	.01	-	 < 0.2	1.00E00
chaperone-mediated protein transport (GO:0072321)	10	0	.04	-	 < 0.2	1.00E00
response to ammonium ion (GO:0060359)	127	4	.53	+	7.52	1.00E00
negative regulation of NAD metabolic process (GO:1902689)	1	0	.00	-	 < 0.2	1.00E00
regulation of NAD metabolic process (GO:1902688)	3	0	.01	-	 < 0.2	1.00E00
leucine import (GO:0060356)	1	0	.00	-	 < 0.2	1.00E00
dibenzo-p-dioxin metabolic process (GO:0018894)	4	0	.02	-	 < 0.2	1.00E00
inositol phosphorylation (GO:0052746)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cell adhesion molecule production (GO:0060355)	4	1	.02	+	59.66	1.00E00
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	17	1	.07	+	14.04	1.00E00
negative regulation of cell adhesion molecule production (GO:0060354)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of receptor localization to synapse (GO:1902685)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell adhesion molecule production (GO:0060353)	5	1	.02	+	47.73	1.00E00
negative regulation of receptor localization to synapse (GO:1902684)	1	0	.00	-	 < 0.2	1.00E00
cell adhesion molecule production (GO:0060352)	2	0	.01	-	 < 0.2	1.00E00
regulation of receptor localization to synapse (GO:1902683)	3	0	.01	-	 < 0.2	1.00E00
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	24	0	.10	-	 < 0.2	1.00E00
endochondral bone morphogenesis (GO:0060350)	51	0	.21	-	 < 0.2	1.00E00
dUMP catabolic process (GO:0046079)	1	0	.00	-	 < 0.2	1.00E00
dUMP metabolic process (GO:0046078)	5	0	.02	-	 < 0.2	1.00E00
dUDP metabolic process (GO:0046077)	2	0	.01	-	 < 0.2	1.00E00
dTTP metabolic process (GO:0046075)	4	0	.02	-	 < 0.2	1.00E00
vesicle uncoating (GO:0072319)	7	0	.03	-	 < 0.2	1.00E00
clathrin coat disassembly (GO:0072318)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of androgen secretion (GO:2000836)	1	0	.00	-	 < 0.2	1.00E00
dTMP metabolic process (GO:0046073)	3	0	.01	-	 < 0.2	1.00E00
dTDP metabolic process (GO:0046072)	2	0	.01	-	 < 0.2	1.00E00
regulation of androgen secretion (GO:2000834)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of steroid hormone secretion (GO:2000833)	9	0	.04	-	 < 0.2	1.00E00
dGTP metabolic process (GO:0046070)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of steroid hormone secretion (GO:2000832)	3	0	.01	-	 < 0.2	1.00E00
metanephric glomerular epithelial cell development (GO:0072313)	2	0	.01	-	 < 0.2	1.00E00
regulation of steroid hormone secretion (GO:2000831)	19	0	.08	-	 < 0.2	1.00E00
metanephric glomerular epithelial cell differentiation (GO:0072312)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of parathyroid hormone secretion (GO:2000830)	1	0	.00	-	 < 0.2	1.00E00
glomerular epithelial cell differentiation (GO:0072311)	18	1	.08	+	13.26	1.00E00
glomerular epithelial cell development (GO:0072310)	11	1	.05	+	21.70	1.00E00
bone morphogenesis (GO:0060349)	91	0	.38	-	 < 0.2	1.00E00
bone development (GO:0060348)	171	1	.72	+	1.40	1.00E00
negative regulation of RNA biosynthetic process (GO:1902679)	1191	15	4.99	+	3.01	1.00E00
heart trabecula formation (GO:0060347)	15	0	.06	-	 < 0.2	1.00E00
carbon tetrachloride metabolic process (GO:0018885)	1	0	.00	-	 < 0.2	1.00E00
bone trabecula formation (GO:0060346)	8	0	.03	-	 < 0.2	1.00E00
spleen trabecula formation (GO:0060345)	1	0	.00	-	 < 0.2	1.00E00
trabecula formation (GO:0060343)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	10	1	.04	+	23.87	1.00E00
cGMP catabolic process (GO:0046069)	6	0	.03	-	 < 0.2	1.00E00
cGMP metabolic process (GO:0046068)	32	0	.13	-	 < 0.2	1.00E00
dGDP catabolic process (GO:0046067)	1	0	.00	-	 < 0.2	1.00E00
dGDP metabolic process (GO:0046066)	3	0	.01	-	 < 0.2	1.00E00
regulation of parathyroid hormone secretion (GO:2000828)	2	0	.01	-	 < 0.2	1.00E00
dCTP metabolic process (GO:0046065)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial RNA surveillance (GO:2000827)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308)	1	0	.00	-	 < 0.2	1.00E00
regulation of heart morphogenesis (GO:2000826)	36	0	.15	-	 < 0.2	1.00E00
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of androgen receptor activity (GO:2000825)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of androgen receptor activity (GO:2000824)	2	0	.01	-	 < 0.2	1.00E00
dATP catabolic process (GO:0046061)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305)	2	0	.01	-	 < 0.2	1.00E00
regulation of androgen receptor activity (GO:2000823)	6	0	.03	-	 < 0.2	1.00E00
dATP metabolic process (GO:0046060)	5	0	.02	-	 < 0.2	1.00E00
regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304)	2	0	.01	-	 < 0.2	1.00E00
regulation of behavioral fear response (GO:2000822)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	0	.00	-	 < 0.2	1.00E00
regulation of grooming behavior (GO:2000821)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)	3	0	.01	-	 < 0.2	1.00E00
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	2	0	.01	-	 < 0.2	1.00E00
biphenyl metabolic process (GO:0018879)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of metanephric glomerulus development (GO:0072300)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	9	2	.04	+	53.04	1.00E00
regulation of type I interferon-mediated signaling pathway (GO:0060338)	44	2	.18	+	10.85	1.00E00
positive regulation of axon guidance (GO:1902669)	8	0	.03	-	 < 0.2	1.00E00
type I interferon signaling pathway (GO:0060337)	65	2	.27	+	7.34	1.00E00
negative regulation of axon guidance (GO:1902668)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	7	0	.03	-	 < 0.2	1.00E00
regulation of axon guidance (GO:1902667)	22	0	.09	-	 < 0.2	1.00E00
benzoate metabolic process (GO:0018874)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335)	6	0	.03	-	 < 0.2	1.00E00
regulation of maintenance of sister chromatid cohesion (GO:0034091)	8	0	.03	-	 < 0.2	1.00E00
regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	25	0	.10	-	 < 0.2	1.00E00
arsonoacetate metabolic process (GO:0018872)	1	0	.00	-	 < 0.2	1.00E00
interferon-gamma-mediated signaling pathway (GO:0060333)	71	2	.30	+	6.72	1.00E00
positive regulation of response to interferon-gamma (GO:0060332)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of response to interferon-gamma (GO:0060331)	7	0	.03	-	 < 0.2	1.00E00
regulation of response to interferon-gamma (GO:0060330)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of glucose mediated signaling pathway (GO:1902661)	3	0	.01	-	 < 0.2	1.00E00
cAMP metabolic process (GO:0046058)	34	0	.14	-	 < 0.2	1.00E00
dADP catabolic process (GO:0046057)	1	0	.00	-	 < 0.2	1.00E00
regulation of nucleotide-excision repair (GO:2000819)	3	0	.01	-	 < 0.2	1.00E00
dADP metabolic process (GO:0046056)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of myoblast proliferation (GO:2000818)	2	0	.01	-	 < 0.2	1.00E00
dGMP metabolic process (GO:0046054)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mitotic sister chromatid separation (GO:2000816)	24	2	.10	+	19.89	1.00E00
UTP metabolic process (GO:0046051)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of barbed-end actin filament capping (GO:2000813)	3	0	.01	-	 < 0.2	1.00E00
regulation of barbed-end actin filament capping (GO:2000812)	4	0	.02	-	 < 0.2	1.00E00
regulation of bicellular tight junction assembly (GO:2000810)	21	1	.09	+	11.36	1.00E00
maintenance of mitotic sister chromatid cohesion (GO:0034088)	4	0	.02	-	 < 0.2	1.00E00
establishment of mitotic sister chromatid cohesion (GO:0034087)	1	0	.00	-	 < 0.2	1.00E00
maintenance of sister chromatid cohesion (GO:0034086)	4	0	.02	-	 < 0.2	1.00E00
establishment of sister chromatid cohesion (GO:0034085)	1	0	.00	-	 < 0.2	1.00E00
regulation of glucose mediated signaling pathway (GO:1902659)	3	0	.01	-	 < 0.2	1.00E00
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	2	0	.01	-	 < 0.2	1.00E00
cell chemotaxis (GO:0060326)	184	4	.77	+	5.19	1.00E00
face morphogenesis (GO:0060325)	32	0	.13	-	 < 0.2	1.00E00
calcium ion import into cytosol (GO:1902656)	9	0	.04	-	 < 0.2	1.00E00
face development (GO:0060324)	50	2	.21	+	9.55	1.00E00
CENP-A containing nucleosome assembly (GO:0034080)	29	0	.12	-	 < 0.2	1.00E00
head morphogenesis (GO:0060323)	37	0	.16	-	 < 0.2	1.00E00
secondary alcohol biosynthetic process (GO:1902653)	42	1	.18	+	5.68	1.00E00
secondary alcohol metabolic process (GO:1902652)	116	1	.49	+	2.06	1.00E00
receptor-mediated endocytosis (GO:0006898)	284	3	1.19	+	2.52	1.00E00
endocytosis (GO:0006897)	619	10	2.59	+	3.86	1.00E00
Golgi to vacuole transport (GO:0006896)	14	0	.06	-	 < 0.2	1.00E00
Golgi to endosome transport (GO:0006895)	20	0	.08	-	 < 0.2	1.00E00
Golgi to plasma membrane transport (GO:0006893)	42	0	.18	-	 < 0.2	1.00E00
post-Golgi vesicle-mediated transport (GO:0006892)	87	0	.36	-	 < 0.2	1.00E00
intra-Golgi vesicle-mediated transport (GO:0006891)	39	0	.16	-	 < 0.2	1.00E00
retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)	81	0	.34	-	 < 0.2	1.00E00
UMP metabolic process (GO:0046049)	10	0	.04	-	 < 0.2	1.00E00
UDP metabolic process (GO:0046048)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of synaptic vesicle clustering (GO:2000809)	5	1	.02	+	47.73	1.00E00
negative regulation of synaptic vesicle clustering (GO:2000808)	1	0	.00	-	 < 0.2	1.00E00
regulation of synaptic vesicle clustering (GO:2000807)	7	1	.03	+	34.09	1.00E00
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.00	-	 < 0.2	1.00E00
regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	1	0	.00	-	 < 0.2	1.00E00
ITP metabolic process (GO:0046041)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802)	1	0	.00	-	 < 0.2	1.00E00
IMP metabolic process (GO:0046040)	13	0	.05	-	 < 0.2	1.00E00
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800)	1	0	.00	-	 < 0.2	1.00E00
primitive erythrocyte differentiation (GO:0060319)	2	0	.01	-	 < 0.2	1.00E00
definitive erythrocyte differentiation (GO:0060318)	2	0	.01	-	 < 0.2	1.00E00
cardiac epithelial to mesenchymal transition (GO:0060317)	27	1	.11	+	8.84	1.00E00
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	9	0	.04	-	 < 0.2	1.00E00
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of blood vessel remodeling (GO:0060313)	3	0	.01	-	 < 0.2	1.00E00
regulation of blood vessel remodeling (GO:0060312)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of elastin catabolic process (GO:0060311)	1	0	.00	-	 < 0.2	1.00E00
regulation of elastin catabolic process (GO:0060310)	1	0	.00	-	 < 0.2	1.00E00
ER to Golgi vesicle-mediated transport (GO:0006888)	177	0	.74	-	 < 0.2	1.00E00
intracellular protein transport (GO:0006886)	818	9	3.43	+	2.63	1.00E00
regulation of pH (GO:0006885)	103	2	.43	+	4.63	1.00E00
cell volume homeostasis (GO:0006884)	19	0	.08	-	 < 0.2	1.00E00
cellular sodium ion homeostasis (GO:0006883)	13	0	.05	-	 < 0.2	1.00E00
cellular zinc ion homeostasis (GO:0006882)	19	0	.08	-	 < 0.2	1.00E00
intracellular sequestering of iron ion (GO:0006880)	6	0	.03	-	 < 0.2	1.00E00
GTP metabolic process (GO:0046039)	31	0	.13	-	 < 0.2	1.00E00
GMP catabolic process (GO:0046038)	1	0	.00	-	 < 0.2	1.00E00
GMP metabolic process (GO:0046037)	20	0	.08	-	 < 0.2	1.00E00
CTP metabolic process (GO:0046036)	15	0	.06	-	 < 0.2	1.00E00
CMP metabolic process (GO:0046035)	1	0	.00	-	 < 0.2	1.00E00
ATP metabolic process (GO:0046034)	205	3	.86	+	3.49	1.00E00
AMP metabolic process (GO:0046033)	14	0	.06	-	 < 0.2	1.00E00
ADP catabolic process (GO:0046032)	1	0	.00	-	 < 0.2	1.00E00
ADP metabolic process (GO:0046031)	45	1	.19	+	5.30	1.00E00
protein localization to Golgi apparatus (GO:0034067)	23	0	.10	-	 < 0.2	1.00E00
elastin catabolic process (GO:0060309)	1	0	.00	-	 < 0.2	1.00E00
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	19	0	.08	-	 < 0.2	1.00E00
stress granule assembly (GO:0034063)	12	0	.05	-	 < 0.2	1.00E00
regulation of membrane repolarization (GO:0060306)	31	1	.13	+	7.70	1.00E00
regulation of cell diameter (GO:0060305)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphatidylinositol dephosphorylation (GO:0060304)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cytokine activity (GO:0060302)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cytokine activity (GO:0060301)	1	0	.00	-	 < 0.2	1.00E00
cellular iron ion homeostasis (GO:0006879)	66	0	.28	-	 < 0.2	1.00E00
regulation of cytokine activity (GO:0060300)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of membrane hyperpolarization (GO:1902631)	1	0	.00	-	 < 0.2	1.00E00
cellular copper ion homeostasis (GO:0006878)	13	0	.05	-	 < 0.2	1.00E00
regulation of membrane hyperpolarization (GO:1902630)	2	0	.01	-	 < 0.2	1.00E00
cellular cadmium ion homeostasis (GO:0006876)	1	0	.00	-	 < 0.2	1.00E00
cellular metal ion homeostasis (GO:0006875)	495	3	2.07	+	1.45	1.00E00
cellular calcium ion homeostasis (GO:0006874)	387	3	1.62	+	1.85	1.00E00
cellular ion homeostasis (GO:0006873)	592	4	2.48	+	1.61	1.00E00
positive regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046022)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0046021)	3	0	.01	-	 < 0.2	1.00E00
response to anoxia (GO:0034059)	3	0	.01	-	 < 0.2	1.00E00
endosomal vesicle fusion (GO:0034058)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of estrogen receptor binding (GO:0071899)	3	0	.01	-	 < 0.2	1.00E00
regulation of estrogen receptor binding (GO:0071898)	3	0	.01	-	 < 0.2	1.00E00
DNA biosynthetic process (GO:0071897)	130	3	.54	+	5.51	1.00E00
protein localization to adherens junction (GO:0071896)	4	0	.02	-	 < 0.2	1.00E00
odontoblast differentiation (GO:0071895)	3	0	.01	-	 < 0.2	1.00E00
histone H2B conserved C-terminal lysine ubiquitination (GO:0071894)	1	0	.00	-	 < 0.2	1.00E00
BMP signaling pathway involved in nephric duct formation (GO:0071893)	1	0	.00	-	 < 0.2	1.00E00
assembly of large subunit precursor of preribosome (GO:1902626)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of neutrophil migration (GO:1902624)	32	0	.13	-	 < 0.2	1.00E00
negative regulation of neutrophil migration (GO:1902623)	2	0	.01	-	 < 0.2	1.00E00
regulation of neutrophil migration (GO:1902622)	38	0	.16	-	 < 0.2	1.00E00
lipid transport (GO:0006869)	276	2	1.16	+	1.73	1.00E00
glutamine transport (GO:0006868)	5	0	.02	-	 < 0.2	1.00E00
asparagine transport (GO:0006867)	2	0	.01	-	 < 0.2	1.00E00
amino acid transport (GO:0006865)	115	0	.48	-	 < 0.2	1.00E00
pyrimidine nucleotide transport (GO:0006864)	2	0	.01	-	 < 0.2	1.00E00
purine nucleobase transport (GO:0006863)	7	0	.03	-	 < 0.2	1.00E00
nucleotide transport (GO:0006862)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of transcription by glucose (GO:0046016)	4	0	.02	-	 < 0.2	1.00E00
regulation of transcription by glucose (GO:0046015)	6	0	.03	-	 < 0.2	1.00E00
regulation of T cell homeostatic proliferation (GO:0046013)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	3	0	.01	-	 < 0.2	1.00E00
macrophage apoptotic process (GO:0071888)	2	0	.01	-	 < 0.2	1.00E00
leukocyte apoptotic process (GO:0071887)	24	1	.10	+	9.94	1.00E00
cellular response to fluoride (GO:1902618)	1	0	.00	-	 < 0.2	1.00E00
response to fluoride (GO:1902617)	5	0	.02	-	 < 0.2	1.00E00
acyl carnitine transmembrane transport (GO:1902616)	1	0	.00	-	 < 0.2	1.00E00
activation of MAPK activity by adrenergic receptor signaling pathway (GO:0071883)	4	0	.02	-	 < 0.2	1.00E00
phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882)	1	0	.00	-	 < 0.2	1.00E00
adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of anti-Mullerian hormone signaling pathway (GO:1902613)	2	0	.01	-	 < 0.2	1.00E00
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	15	0	.06	-	 < 0.2	1.00E00
regulation of anti-Mullerian hormone signaling pathway (GO:1902612)	2	0	.01	-	 < 0.2	1.00E00
extracellular transport (GO:0006858)	3	0	.01	-	 < 0.2	1.00E00
oligopeptide transport (GO:0006857)	7	0	.03	-	 < 0.2	1.00E00
drug transmembrane transport (GO:0006855)	22	0	.09	-	 < 0.2	1.00E00
carnitine shuttle (GO:0006853)	11	0	.05	-	 < 0.2	1.00E00
mitochondrial calcium ion transmembrane transport (GO:0006851)	24	0	.10	-	 < 0.2	1.00E00
mitochondrial pyruvate transport (GO:0006850)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of activated T cell proliferation (GO:0046007)	11	2	.05	+	43.39	1.00E00
regulation of activated T cell proliferation (GO:0046006)	40	3	.17	+	17.90	1.00E00
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	99	0	.41	-	 < 0.2	1.00E00
positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of adrenergic receptor signaling pathway (GO:0071879)	3	1	.01	+	79.55	1.00E00
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of adrenergic receptor signaling pathway (GO:0071878)	3	0	.01	-	 < 0.2	1.00E00
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	24	0	.10	-	 < 0.2	1.00E00
regulation of adrenergic receptor signaling pathway (GO:0071877)	6	1	.03	+	39.78	1.00E00
purine nucleoside bisphosphate catabolic process (GO:0034034)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608)	2	0	.01	-	 < 0.2	1.00E00
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	16	0	.07	-	 < 0.2	1.00E00
adrenergic receptor signaling pathway (GO:0071875)	17	0	.07	-	 < 0.2	1.00E00
purine nucleoside bisphosphate metabolic process (GO:0034032)	39	0	.16	-	 < 0.2	1.00E00
cellular response to norepinephrine stimulus (GO:0071874)	2	0	.01	-	 < 0.2	1.00E00
regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	2	0	.01	-	 < 0.2	1.00E00
ribonucleoside bisphosphate catabolic process (GO:0034031)	1	0	.00	-	 < 0.2	1.00E00
response to norepinephrine (GO:0071873)	3	0	.01	-	 < 0.2	1.00E00
heterotrimeric G-protein complex assembly (GO:1902605)	1	0	.00	-	 < 0.2	1.00E00
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	16	0	.07	-	 < 0.2	1.00E00
cellular response to epinephrine stimulus (GO:0071872)	13	0	.05	-	 < 0.2	1.00E00
response to epinephrine (GO:0071871)	16	0	.07	-	 < 0.2	1.00E00
carnitine transmembrane transport (GO:1902603)	4	0	.02	-	 < 0.2	1.00E00
cellular response to catecholamine stimulus (GO:0071870)	35	1	.15	+	6.82	1.00E00
pyruvate transport (GO:0006848)	5	0	.02	-	 < 0.2	1.00E00
hydrogen ion transmembrane transport (GO:1902600)	116	1	.49	+	2.06	1.00E00
acyl carnitine transport (GO:0006844)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial citrate transport (GO:0006843)	1	0	.00	-	 < 0.2	1.00E00
tricarboxylic acid transport (GO:0006842)	4	0	.02	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	3	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	3	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	11	1	.05	+	21.70	1.00E00
specification of animal organ identity (GO:0010092)	15	0	.06	-	 < 0.2	1.00E00
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)	9	1	.04	+	26.52	1.00E00
response to catecholamine (GO:0071869)	38	1	.16	+	6.28	1.00E00
cellular response to monoamine stimulus (GO:0071868)	35	1	.15	+	6.82	1.00E00
response to monoamine (GO:0071867)	38	1	.16	+	6.28	1.00E00
negative regulation of apoptotic process in bone marrow (GO:0071866)	4	0	.02	-	 < 0.2	1.00E00
regulation of apoptotic process in bone marrow (GO:0071865)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of cell proliferation in bone marrow (GO:0071864)	6	0	.03	-	 < 0.2	1.00E00
response to silicon dioxide (GO:0034021)	3	0	.01	-	 < 0.2	1.00E00
regulation of cell proliferation in bone marrow (GO:0071863)	6	0	.03	-	 < 0.2	1.00E00
mitochondrial transport (GO:0006839)	230	5	.96	+	5.19	1.00E00
serotonin transport (GO:0006837)	7	1	.03	+	34.09	1.00E00
neurotransmitter transport (GO:0006836)	143	0	.60	-	 < 0.2	1.00E00
dicarboxylic acid transport (GO:0006835)	71	0	.30	-	 < 0.2	1.00E00
water transport (GO:0006833)	19	0	.08	-	 < 0.2	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	76	1	.32	+	3.14	1.00E00
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	175	1	.73	+	1.36	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	2	1	.01	+	 > 100	1.00E00
polarity specification of proximal/distal axis (GO:0010085)	2	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation via MHC class Ib (GO:0002475)	10	1	.04	+	23.87	1.00E00
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	94	1	.39	+	2.54	1.00E00
response to triglyceride (GO:0034014)	1	0	.00	-	 < 0.2	1.00E00
mitotic cell cycle arrest (GO:0071850)	15	1	.06	+	15.91	1.00E00
zinc II ion transport (GO:0006829)	28	0	.12	-	 < 0.2	1.00E00
manganese ion transport (GO:0006828)	14	0	.06	-	 < 0.2	1.00E00
iron ion transport (GO:0006826)	58	0	.24	-	 < 0.2	1.00E00
copper ion transport (GO:0006825)	18	0	.08	-	 < 0.2	1.00E00
cobalt ion transport (GO:0006824)	5	0	.02	-	 < 0.2	1.00E00
chloride transport (GO:0006821)	101	0	.42	-	 < 0.2	1.00E00
anion transport (GO:0006820)	542	0	2.27	-	 < 0.2	1.00E00
dendritic cell antigen processing and presentation (GO:0002468)	1	0	.00	-	 < 0.2	1.00E00
germinal center formation (GO:0002467)	8	0	.03	-	 < 0.2	1.00E00
peripheral tolerance induction (GO:0002465)	1	0	.00	-	 < 0.2	1.00E00
tolerance induction dependent upon immune response (GO:0002461)	1	0	.00	-	 < 0.2	1.00E00
zygote asymmetric cell division (GO:0010070)	1	0	.00	-	 < 0.2	1.00E00
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	239	2	1.00	+	2.00	1.00E00
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848)	2	0	.01	-	 < 0.2	1.00E00
TNFSF11-mediated signaling pathway (GO:0071847)	4	0	.02	-	 < 0.2	1.00E00
actin filament debranching (GO:0071846)	1	0	.00	-	 < 0.2	1.00E00
corpus callosum development (GO:0022038)	15	0	.06	-	 < 0.2	1.00E00
metencephalon development (GO:0022037)	104	2	.44	+	4.59	1.00E00
hydrogen transport (GO:0006818)	151	1	.63	+	1.58	1.00E00
phosphate ion transport (GO:0006817)	21	0	.09	-	 < 0.2	1.00E00
calcium ion transport (GO:0006816)	242	1	1.01	-	.99	1.00E00
sodium ion transport (GO:0006814)	162	0	.68	-	 < 0.2	1.00E00
potassium ion transport (GO:0006813)	176	2	.74	+	2.71	1.00E00
cation transport (GO:0006812)	846	5	3.54	+	1.41	1.00E00
telencephalon glial cell migration (GO:0022030)	24	0	.10	-	 < 0.2	1.00E00
ion transport (GO:0006811)	1316	6	5.51	+	1.09	1.00E00
peripheral T cell tolerance induction (GO:0002458)	1	0	.00	-	 < 0.2	1.00E00
T cell antigen processing and presentation (GO:0002457)	3	0	.01	-	 < 0.2	1.00E00
T cell mediated immunity (GO:0002456)	34	1	.14	+	7.02	1.00E00
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	146	0	.61	-	 < 0.2	1.00E00
negative regulation of fat cell differentiation (GO:0045599)	47	1	.20	+	5.08	1.00E00
regulation of fat cell differentiation (GO:0045598)	117	4	.49	+	8.16	1.00E00
apoptotic process in bone marrow (GO:0071839)	1	0	.00	-	 < 0.2	1.00E00
cell proliferation in bone marrow (GO:0071838)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of regulatory T cell differentiation (GO:0045591)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of regulatory T cell differentiation (GO:0045590)	3	0	.01	-	 < 0.2	1.00E00
telencephalon cell migration (GO:0022029)	58	2	.24	+	8.23	1.00E00
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	6	0	.03	-	 < 0.2	1.00E00
triglyceride-rich lipoprotein particle clearance (GO:0071830)	8	0	.03	-	 < 0.2	1.00E00
nitric oxide biosynthetic process (GO:0006809)	13	1	.05	+	18.36	1.00E00
interkinetic nuclear migration (GO:0022027)	6	0	.03	-	 < 0.2	1.00E00
regulation of nitrogen utilization (GO:0006808)	3	1	.01	+	79.55	1.00E00
xenobiotic metabolic process (GO:0006805)	106	0	.44	-	 < 0.2	1.00E00
malonyl-CoA biosynthetic process (GO:2001295)	2	0	.01	-	 < 0.2	1.00E00
malonyl-CoA catabolic process (GO:2001294)	1	0	.00	-	 < 0.2	1.00E00
superoxide metabolic process (GO:0006801)	36	1	.15	+	6.63	1.00E00
malonyl-CoA metabolic process (GO:2001293)	3	0	.01	-	 < 0.2	1.00E00
lymphocyte mediated immunity (GO:0002449)	234	2	.98	+	2.04	1.00E00
mast cell mediated immunity (GO:0002448)	19	0	.08	-	 < 0.2	1.00E00
eosinophil mediated immunity (GO:0002447)	3	0	.01	-	 < 0.2	1.00E00
neutrophil mediated immunity (GO:0002446)	496	8	2.08	+	3.85	1.00E00
myeloid leukocyte mediated immunity (GO:0002444)	516	8	2.16	+	3.70	1.00E00
leukocyte mediated immunity (GO:0002443)	736	9	3.08	+	2.92	1.00E00
serotonin secretion involved in inflammatory response (GO:0002442)	3	1	.01	+	79.55	1.00E00
histamine secretion involved in inflammatory response (GO:0002441)	3	0	.01	-	 < 0.2	1.00E00
regulation of regulatory T cell differentiation (GO:0045589)	25	0	.10	-	 < 0.2	1.00E00
production of molecular mediator of immune response (GO:0002440)	140	1	.59	+	1.70	1.00E00
positive regulation of gamma-delta T cell differentiation (GO:0045588)	3	1	.01	+	79.55	1.00E00
regulation of gamma-delta T cell differentiation (GO:0045586)	4	1	.02	+	59.66	1.00E00
positive regulation of cytotoxic T cell differentiation (GO:0045585)	2	0	.01	-	 < 0.2	1.00E00
regulation of cytotoxic T cell differentiation (GO:0045583)	2	0	.01	-	 < 0.2	1.00E00
plasma lipoprotein particle organization (GO:0071827)	44	0	.18	-	 < 0.2	1.00E00
positive regulation of T cell differentiation (GO:0045582)	73	2	.31	+	6.54	1.00E00
ribonucleoprotein complex subunit organization (GO:0071826)	221	1	.93	+	1.08	1.00E00
negative regulation of T cell differentiation (GO:0045581)	36	1	.15	+	6.63	1.00E00
protein-lipid complex subunit organization (GO:0071825)	47	0	.20	-	 < 0.2	1.00E00
regulation of T cell differentiation (GO:0045580)	126	3	.53	+	5.68	1.00E00
protein-DNA complex subunit organization (GO:0071824)	227	1	.95	+	1.05	1.00E00
protein-carbohydrate complex subunit organization (GO:0071823)	2	0	.01	-	 < 0.2	1.00E00
protein complex subunit organization (GO:0071822)	1311	14	5.49	+	2.55	1.00E00
lateral ganglionic eminence cell proliferation (GO:0022018)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of caveolin-mediated endocytosis (GO:2001288)	2	0	.01	-	 < 0.2	1.00E00
pallium cell proliferation in forebrain (GO:0022013)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of caveolin-mediated endocytosis (GO:2001287)	2	0	.01	-	 < 0.2	1.00E00
subpallium cell proliferation in forebrain (GO:0022012)	1	0	.00	-	 < 0.2	1.00E00
regulation of caveolin-mediated endocytosis (GO:2001286)	5	1	.02	+	47.73	1.00E00
myelination in peripheral nervous system (GO:0022011)	23	2	.10	+	20.75	1.00E00
central nervous system myelination (GO:0022010)	17	0	.07	-	 < 0.2	1.00E00
chronic inflammatory response to antigenic stimulus (GO:0002439)	2	0	.01	-	 < 0.2	1.00E00
acute inflammatory response to antigenic stimulus (GO:0002438)	9	0	.04	-	 < 0.2	1.00E00
inflammatory response to antigenic stimulus (GO:0002437)	24	0	.10	-	 < 0.2	1.00E00
response to mycotoxin (GO:0010046)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	4	0	.02	-	 < 0.2	1.00E00
immune complex clearance by monocytes and macrophages (GO:0002436)	1	0	.00	-	 < 0.2	1.00E00
response to nickel cation (GO:0010045)	1	0	.00	-	 < 0.2	1.00E00
response to aluminum ion (GO:0010044)	5	0	.02	-	 < 0.2	1.00E00
immune complex clearance (GO:0002434)	1	0	.00	-	 < 0.2	1.00E00
response to zinc ion (GO:0010043)	54	0	.23	-	 < 0.2	1.00E00
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433)	132	5	.55	+	9.04	1.00E00
response to manganese ion (GO:0010042)	17	0	.07	-	 < 0.2	1.00E00
granuloma formation (GO:0002432)	2	0	.01	-	 < 0.2	1.00E00
response to iron(III) ion (GO:0010041)	5	2	.02	+	95.46	1.00E00
Fc receptor mediated stimulatory signaling pathway (GO:0002431)	134	5	.56	+	8.91	1.00E00
response to iron(II) ion (GO:0010040)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of B cell differentiation (GO:0045579)	13	2	.05	+	36.72	1.00E00
complement receptor mediated signaling pathway (GO:0002430)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of B cell differentiation (GO:0045578)	4	0	.02	-	 < 0.2	1.00E00
regulation of B cell differentiation (GO:0045577)	26	2	.11	+	18.36	1.00E00
mast cell activation (GO:0045576)	23	1	.10	+	10.38	1.00E00
basophil activation (GO:0045575)	2	1	.01	+	 > 100	1.00E00
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812)	2	0	.01	-	 < 0.2	1.00E00
central nervous system vasculogenesis (GO:0022009)	4	0	.02	-	 < 0.2	1.00E00
convergent extension involved in neural plate elongation (GO:0022007)	3	0	.01	-	 < 0.2	1.00E00
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	6	0	.03	-	 < 0.2	1.00E00
midbrain-hindbrain boundary maturation during brain development (GO:0022004)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of glucose import in response to insulin stimulus (GO:2001275)	15	2	.06	+	31.82	1.00E00
negative regulation of glucose import in response to insulin stimulus (GO:2001274)	3	0	.01	-	 < 0.2	1.00E00
regulation of glucose import in response to insulin stimulus (GO:2001273)	19	2	.08	+	25.12	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	3	1	.01	+	79.55	1.00E00
response to carbon dioxide (GO:0010037)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	3	0	.01	-	 < 0.2	1.00E00
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	4	0	.02	-	 < 0.2	1.00E00
immunoglobulin production in mucosal tissue (GO:0002426)	1	0	.00	-	 < 0.2	1.00E00
response to acetate (GO:0010034)	1	0	.00	-	 < 0.2	1.00E00
meiotic chromosome condensation (GO:0010032)	5	0	.02	-	 < 0.2	1.00E00
protein transmembrane transport (GO:0071806)	63	1	.26	+	3.79	1.00E00
potassium ion transmembrane transport (GO:0071805)	156	2	.65	+	3.06	1.00E00
cellular potassium ion transport (GO:0071804)	156	2	.65	+	3.06	1.00E00
regulation of mammary gland epithelial cell proliferation (GO:0033599)	18	1	.08	+	13.26	1.00E00
positive regulation of podosome assembly (GO:0071803)	10	2	.04	+	47.73	1.00E00
mammary gland epithelial cell proliferation (GO:0033598)	12	1	.05	+	19.89	1.00E00
negative regulation of podosome assembly (GO:0071802)	1	0	.00	-	 < 0.2	1.00E00
regulation of podosome assembly (GO:0071801)	14	2	.06	+	34.09	1.00E00
podosome assembly (GO:0071800)	8	0	.03	-	 < 0.2	1.00E00
response to genistein (GO:0033595)	2	0	.01	-	 < 0.2	1.00E00
response to hydroxyisoflavone (GO:0033594)	4	1	.02	+	59.66	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)	5	0	.02	-	 < 0.2	1.00E00
response to L-ascorbic acid (GO:0033591)	6	1	.03	+	39.78	1.00E00
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	23	0	.10	-	 < 0.2	1.00E00
response to cobalamin (GO:0033590)	3	1	.01	+	79.55	1.00E00
negative regulation of C-C chemokine binding (GO:2001264)	1	0	.00	-	 < 0.2	1.00E00
regulation of C-C chemokine binding (GO:2001263)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	0	.00	-	 < 0.2	1.00E00
immune response to tumor cell (GO:0002418)	2	0	.01	-	 < 0.2	1.00E00
regulation of semaphorin-plexin signaling pathway (GO:2001260)	1	0	.00	-	 < 0.2	1.00E00
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor (GO:0002416)	1	0	.00	-	 < 0.2	1.00E00
wax biosynthetic process (GO:0010025)	4	0	.02	-	 < 0.2	1.00E00
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415)	2	0	.01	-	 < 0.2	1.00E00
immunoglobulin transcytosis in epithelial cells (GO:0002414)	4	0	.02	-	 < 0.2	1.00E00
amylopectin biosynthetic process (GO:0010021)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of TRAIL biosynthetic process (GO:0045556)	1	0	.00	-	 < 0.2	1.00E00
regulation of TRAIL biosynthetic process (GO:0045554)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cation channel activity (GO:2001259)	52	0	.22	-	 < 0.2	1.00E00
negative regulation of cation channel activity (GO:2001258)	42	1	.18	+	5.68	1.00E00
regulation of cation channel activity (GO:2001257)	145	1	.61	+	1.65	1.00E00
protein galactosylation at cell surface (GO:0033580)	1	0	.00	-	 < 0.2	1.00E00
regulation of store-operated calcium entry (GO:2001256)	9	0	.04	-	 < 0.2	1.00E00
regulation of histone H3-K36 trimethylation (GO:2001253)	1	0	.00	-	 < 0.2	1.00E00
myeloid dendritic cell chemotaxis (GO:0002408)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of chromosome organization (GO:2001251)	115	3	.48	+	6.23	1.00E00
dendritic cell chemotaxis (GO:0002407)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of ammonia assimilation cycle (GO:2001250)	1	0	.00	-	 < 0.2	1.00E00
protein localization to meiotic spindle midzone (GO:1903096)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein K48-linked deubiquitination (GO:1903093)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cholesterol biosynthetic process (GO:0045542)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cholesterol biosynthetic process (GO:0045541)	5	0	.02	-	 < 0.2	1.00E00
regulation of cholesterol biosynthetic process (GO:0045540)	42	1	.18	+	5.68	1.00E00
protein glycosylation in Golgi (GO:0033578)	2	0	.01	-	 < 0.2	1.00E00
protein glycosylation in endoplasmic reticulum (GO:0033577)	2	0	.01	-	 < 0.2	1.00E00
protein glycosylation at cell surface (GO:0033575)	1	0	.00	-	 < 0.2	1.00E00
response to testosterone (GO:0033574)	44	3	.18	+	16.27	1.00E00
transferrin transport (GO:0033572)	36	0	.15	-	 < 0.2	1.00E00
regulation of ammonia assimilation cycle (GO:2001248)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	12	0	.05	-	 < 0.2	1.00E00
cardioblast differentiation (GO:0010002)	13	1	.05	+	18.36	1.00E00
siderophore biosynthetic process (GO:0019290)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082)	1	0	.00	-	 < 0.2	1.00E00
regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080)	1	0	.00	-	 < 0.2	1.00E00
DNA replication, Okazaki fragment processing (GO:0033567)	5	0	.02	-	 < 0.2	1.00E00
gamma-tubulin complex localization (GO:0033566)	3	0	.01	-	 < 0.2	1.00E00
anterior/posterior axon guidance (GO:0033564)	5	0	.02	-	 < 0.2	1.00E00
dorsal/ventral axon guidance (GO:0033563)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	51	3	.21	+	14.04	1.00E00
regulation of water loss via skin (GO:0033561)	22	0	.09	-	 < 0.2	1.00E00
abducens nerve formation (GO:0021599)	2	0	.01	-	 < 0.2	1.00E00
abducens nerve morphogenesis (GO:0021598)	2	0	.01	-	 < 0.2	1.00E00
rhombomere formation (GO:0021594)	1	0	.00	-	 < 0.2	1.00E00
rhombomere morphogenesis (GO:0021593)	1	0	.00	-	 < 0.2	1.00E00
fourth ventricle development (GO:0021592)	1	0	.00	-	 < 0.2	1.00E00
ventricular system development (GO:0021591)	25	0	.10	-	 < 0.2	1.00E00
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	3	0	.01	-	 < 0.2	1.00E00
cerebellum maturation (GO:0021590)	4	0	.02	-	 < 0.2	1.00E00
glycine betaine biosynthetic process from choline (GO:0019285)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein localization to plasma membrane (GO:1903077)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of death-inducing signaling complex assembly (GO:1903073)	1	0	.00	-	 < 0.2	1.00E00
regulation of death-inducing signaling complex assembly (GO:1903072)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)	8	2	.03	+	59.66	1.00E00
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070)	3	0	.01	-	 < 0.2	1.00E00
unsaturated fatty acid metabolic process (GO:0033559)	97	0	.41	-	 < 0.2	1.00E00
multicellular organismal response to stress (GO:0033555)	66	3	.28	+	10.85	1.00E00
negative regulation of response to gamma radiation (GO:2001229)	1	0	.00	-	 < 0.2	1.00E00
response to vitamin B3 (GO:0033552)	1	0	.00	-	 < 0.2	1.00E00
regulation of response to gamma radiation (GO:2001228)	2	1	.01	+	 > 100	1.00E00
negative regulation of chloride transport (GO:2001226)	3	0	.01	-	 < 0.2	1.00E00
cerebellum structural organization (GO:0021589)	2	0	.01	-	 < 0.2	1.00E00
regulation of chloride transport (GO:2001225)	10	0	.04	-	 < 0.2	1.00E00
cerebellum formation (GO:0021588)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neuron migration (GO:2001224)	14	0	.06	-	 < 0.2	1.00E00
cerebellum morphogenesis (GO:0021587)	39	0	.16	-	 < 0.2	1.00E00
negative regulation of neuron migration (GO:2001223)	9	1	.04	+	26.52	1.00E00
pons maturation (GO:0021586)	3	0	.01	-	 < 0.2	1.00E00
regulation of neuron migration (GO:2001222)	33	1	.14	+	7.23	1.00E00
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	10	2	.04	+	47.73	1.00E00
UDP-N-acetylgalactosamine metabolic process (GO:0019276)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of protein lipidation (GO:1903061)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of protein lipidation (GO:1903060)	1	0	.00	-	 < 0.2	1.00E00
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	15	0	.06	-	 < 0.2	1.00E00
hindbrain maturation (GO:0021578)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of vasculogenesis (GO:2001214)	10	0	.04	-	 < 0.2	1.00E00
hindbrain structural organization (GO:0021577)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of vasculogenesis (GO:2001213)	1	0	.00	-	 < 0.2	1.00E00
hindbrain formation (GO:0021576)	1	0	.00	-	 < 0.2	1.00E00
regulation of vasculogenesis (GO:2001212)	14	0	.06	-	 < 0.2	1.00E00
hindbrain morphogenesis (GO:0021575)	43	0	.18	-	 < 0.2	1.00E00
rhombomere 6 development (GO:0021572)	1	0	.00	-	 < 0.2	1.00E00
rhombomere 5 development (GO:0021571)	3	0	.01	-	 < 0.2	1.00E00
rhombomere 4 development (GO:0021570)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein lipidation (GO:1903059)	5	0	.02	-	 < 0.2	1.00E00
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999)	1	0	.00	-	 < 0.2	1.00E00
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.01	-	 < 0.2	1.00E00
glycine biosynthetic process from serine (GO:0019264)	2	0	.01	-	 < 0.2	1.00E00
regulation of melanosome organization (GO:1903056)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of extracellular matrix organization (GO:1903055)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996)	4	0	.02	-	 < 0.2	1.00E00
N-acetylneuraminate catabolic process (GO:0019262)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of extracellular matrix organization (GO:1903054)	6	1	.03	+	39.78	1.00E00
regulation of extracellular matrix organization (GO:1903053)	31	1	.13	+	7.70	1.00E00
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	186	6	.78	+	7.70	1.00E00
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	58	1	.24	+	4.11	1.00E00
regulation of systemic arterial blood pressure by vasopressin (GO:0001992)	5	0	.02	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	14	1	.06	+	17.05	1.00E00
regulation of systemic arterial blood pressure by hormone (GO:0001990)	34	1	.14	+	7.02	1.00E00
vitellogenesis (GO:0007296)	4	1	.02	+	59.66	1.00E00
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	15	0	.06	-	 < 0.2	1.00E00
sperm individualization (GO:0007291)	1	0	.00	-	 < 0.2	1.00E00
spermatid nucleus elongation (GO:0007290)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription elongation from RNA polymerase I promoter (GO:2001208)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription elongation from RNA polymerase I promoter (GO:2001207)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of osteoclast development (GO:2001206)	4	0	.02	-	 < 0.2	1.00E00
rhombomere 3 development (GO:0021569)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of osteoclast development (GO:2001205)	5	0	.02	-	 < 0.2	1.00E00
rhombomere 2 development (GO:0021568)	1	0	.00	-	 < 0.2	1.00E00
regulation of osteoclast development (GO:2001204)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of transforming growth factor-beta secretion (GO:2001203)	1	0	.00	-	 < 0.2	1.00E00
hypoglossal nerve development (GO:0021566)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transforming growth factor-beta secretion (GO:2001202)	3	1	.01	+	79.55	1.00E00
regulation of transforming growth factor-beta secretion (GO:2001201)	4	1	.02	+	59.66	1.00E00
vagus nerve development (GO:0021564)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of dendritic cell differentiation (GO:2001200)	4	0	.02	-	 < 0.2	1.00E00
glossopharyngeal nerve development (GO:0021563)	5	0	.02	-	 < 0.2	1.00E00
vestibulocochlear nerve development (GO:0021562)	10	0	.04	-	 < 0.2	1.00E00
facial nerve development (GO:0021561)	11	0	.05	-	 < 0.2	1.00E00
abducens nerve development (GO:0021560)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of acetylcholine-gated cation channel activity (GO:1903049)	1	0	.00	-	 < 0.2	1.00E00
regulation of acetylcholine-gated cation channel activity (GO:1903048)	1	0	.00	-	 < 0.2	1.00E00
glucose 1-phosphate metabolic process (GO:0019255)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure (GO:0001988)	1	0	.00	-	 < 0.2	1.00E00
carnitine metabolic process, CoA-linked (GO:0019254)	3	0	.01	-	 < 0.2	1.00E00
meiotic cell cycle process (GO:1903046)	164	3	.69	+	4.37	1.00E00
neural crest cell migration involved in sympathetic nervous system development (GO:1903045)	1	0	.00	-	 < 0.2	1.00E00
protein localization to membrane raft (GO:1903044)	9	1	.04	+	26.52	1.00E00
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985)	1	0	.00	-	 < 0.2	1.00E00
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984)	1	0	.00	-	 < 0.2	1.00E00
baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	2	0	.01	-	 < 0.2	1.00E00
spermatid nucleus differentiation (GO:0007289)	21	0	.09	-	 < 0.2	1.00E00
baroreceptor response to decreased systemic arterial blood pressure (GO:0001982)	1	0	.00	-	 < 0.2	1.00E00
sperm axoneme assembly (GO:0007288)	10	0	.04	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	1	0	.00	-	 < 0.2	1.00E00
spermatid development (GO:0007286)	136	0	.57	-	 < 0.2	1.00E00
spermatogonial cell division (GO:0007284)	1	0	.00	-	 < 0.2	1.00E00
spermatogenesis (GO:0007283)	510	4	2.14	+	1.87	1.00E00
histone H2B ubiquitination (GO:0033523)	10	0	.04	-	 < 0.2	1.00E00
histone H2A ubiquitination (GO:0033522)	22	0	.09	-	 < 0.2	1.00E00
trigeminal nerve development (GO:0021559)	12	0	.05	-	 < 0.2	1.00E00
trochlear nerve development (GO:0021558)	3	0	.01	-	 < 0.2	1.00E00
oculomotor nerve development (GO:0021557)	4	0	.02	-	 < 0.2	1.00E00
midbrain-hindbrain boundary morphogenesis (GO:0021555)	4	0	.02	-	 < 0.2	1.00E00
optic nerve development (GO:0021554)	12	0	.05	-	 < 0.2	1.00E00
olfactory nerve development (GO:0021553)	4	0	.02	-	 < 0.2	1.00E00
lactate biosynthetic process (GO:0019249)	3	0	.01	-	 < 0.2	1.00E00
central nervous system morphogenesis (GO:0021551)	2	0	.01	-	 < 0.2	1.00E00
medulla oblongata development (GO:0021550)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	107	3	.45	+	6.69	1.00E00
regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979)	1	0	.00	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	3	0	.01	-	 < 0.2	1.00E00
lactate biosynthetic process from pyruvate (GO:0019244)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of response to wounding (GO:1903036)	57	2	.24	+	8.37	1.00E00
renal system process involved in regulation of blood volume (GO:0001977)	17	0	.07	-	 < 0.2	1.00E00
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of response to wounding (GO:1903035)	76	3	.32	+	9.42	1.00E00
neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976)	15	0	.06	-	 < 0.2	1.00E00
methylglyoxal biosynthetic process (GO:0019242)	1	0	.00	-	 < 0.2	1.00E00
response to amphetamine (GO:0001975)	27	0	.11	-	 < 0.2	1.00E00
positive regulation of microtubule plus-end binding (GO:1903033)	2	0	.01	-	 < 0.2	1.00E00
blood vessel remodeling (GO:0001974)	32	3	.13	+	22.37	1.00E00
citrulline biosynthetic process (GO:0019240)	3	0	.01	-	 < 0.2	1.00E00
adenosine receptor signaling pathway (GO:0001973)	9	0	.04	-	 < 0.2	1.00E00
regulation of microtubule plus-end binding (GO:1903031)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of activation of membrane attack complex (GO:0001971)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of activation of membrane attack complex (GO:0001970)	2	0	.01	-	 < 0.2	1.00E00
neuromuscular synaptic transmission (GO:0007274)	28	0	.12	-	 < 0.2	1.00E00
ensheathment of neurons (GO:0007272)	97	3	.41	+	7.38	1.00E00
synaptic transmission, cholinergic (GO:0007271)	29	0	.12	-	 < 0.2	1.00E00
neuron-neuron synaptic transmission (GO:0007270)	9	0	.04	-	 < 0.2	1.00E00
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.00	-	 < 0.2	1.00E00
L-lysine catabolic process to acetyl-CoA via saccharopine (GO:0033512)	3	0	.01	-	 < 0.2	1.00E00
cerebellum development (GO:0021549)	95	0	.40	-	 < 0.2	1.00E00
pons development (GO:0021548)	11	1	.05	+	21.70	1.00E00
midbrain-hindbrain boundary initiation (GO:0021547)	1	0	.00	-	 < 0.2	1.00E00
rhombomere development (GO:0021546)	6	0	.03	-	 < 0.2	1.00E00
cranial nerve development (GO:0021545)	52	1	.22	+	4.59	1.00E00
subpallium development (GO:0021544)	23	0	.10	-	 < 0.2	1.00E00
pallium development (GO:0021543)	172	3	.72	+	4.16	1.00E00
dentate gyrus development (GO:0021542)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of metanephric glomerulus development (GO:0072299)	1	0	.00	-	 < 0.2	1.00E00
ammon gyrus development (GO:0021541)	1	0	.00	-	 < 0.2	1.00E00
regulation of metanephric glomerulus development (GO:0072298)	6	0	.03	-	 < 0.2	1.00E00
corpus callosum morphogenesis (GO:0021540)	5	0	.02	-	 < 0.2	1.00E00
response to pheromone (GO:0019236)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of opsonization (GO:1903028)	1	0	.00	-	 < 0.2	1.00E00
regulation of activation of membrane attack complex (GO:0001969)	3	0	.01	-	 < 0.2	1.00E00
regulation of opsonization (GO:1903027)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	6	0	.03	-	 < 0.2	1.00E00
suckling behavior (GO:0001967)	13	0	.05	-	 < 0.2	1.00E00
sensory perception of pain (GO:0019233)	73	3	.31	+	9.81	1.00E00
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	10	0	.04	-	 < 0.2	1.00E00
startle response (GO:0001964)	27	1	.11	+	8.84	1.00E00
proprioception (GO:0019230)	5	0	.02	-	 < 0.2	1.00E00
synaptic transmission, dopaminergic (GO:0001963)	20	0	.08	-	 < 0.2	1.00E00
neurotransmitter secretion (GO:0007269)	102	0	.43	-	 < 0.2	1.00E00
chemical synaptic transmission (GO:0007268)	406	3	1.70	+	1.76	1.00E00
positive regulation of glycoprotein metabolic process (GO:1903020)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	41	2	.17	+	11.64	1.00E00
cell-cell signaling (GO:0007267)	1132	7	4.74	+	1.48	1.00E00
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	52	3	.22	+	13.77	1.00E00
Rho protein signal transduction (GO:0007266)	63	1	.26	+	3.79	1.00E00
small GTPase mediated signal transduction (GO:0007264)	276	7	1.16	+	6.05	1.00E00
nitric oxide mediated signal transduction (GO:0007263)	19	0	.08	-	 < 0.2	1.00E00
STAT protein import into nucleus (GO:0007262)	5	0	.02	-	 < 0.2	1.00E00
floor plate morphogenesis (GO:0033505)	2	0	.01	-	 < 0.2	1.00E00
tyrosine phosphorylation of STAT protein (GO:0007260)	11	0	.05	-	 < 0.2	1.00E00
floor plate development (GO:0033504)	7	0	.03	-	 < 0.2	1.00E00
carbohydrate homeostasis (GO:0033500)	178	5	.75	+	6.70	1.00E00
subthalamus development (GO:0021539)	2	0	.01	-	 < 0.2	1.00E00
epithalamus development (GO:0021538)	3	0	.01	-	 < 0.2	1.00E00
telencephalon development (GO:0021537)	248	5	1.04	+	4.81	1.00E00
diencephalon development (GO:0021536)	78	1	.33	+	3.06	1.00E00
cell migration in hindbrain (GO:0021535)	14	0	.06	-	 < 0.2	1.00E00
cell proliferation in hindbrain (GO:0021534)	7	0	.03	-	 < 0.2	1.00E00
cell differentiation in hindbrain (GO:0021533)	21	0	.09	-	 < 0.2	1.00E00
regulation of vasoconstriction (GO:0019229)	60	3	.25	+	11.93	1.00E00
neural tube patterning (GO:0021532)	34	0	.14	-	 < 0.2	1.00E00
metanephric nephron tubule formation (GO:0072289)	4	0	.02	-	 < 0.2	1.00E00
neuronal action potential (GO:0019228)	30	0	.13	-	 < 0.2	1.00E00
neuronal action potential propagation (GO:0019227)	7	0	.03	-	 < 0.2	1.00E00
spinal cord oligodendrocyte cell fate specification (GO:0021530)	3	0	.01	-	 < 0.2	1.00E00
metanephric distal tubule morphogenesis (GO:0072287)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glycoprotein metabolic process (GO:1903019)	18	0	.08	-	 < 0.2	1.00E00
transmission of nerve impulse (GO:0019226)	54	0	.23	-	 < 0.2	1.00E00
metanephric connecting tubule development (GO:0072286)	1	0	.00	-	 < 0.2	1.00E00
regulation of glycoprotein metabolic process (GO:1903018)	50	1	.21	+	4.77	1.00E00
regulation of cytokine-mediated signaling pathway (GO:0001959)	165	5	.69	+	7.23	1.00E00
mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of exo-alpha-sialidase activity (GO:1903017)	1	0	.00	-	 < 0.2	1.00E00
endochondral ossification (GO:0001958)	27	0	.11	-	 < 0.2	1.00E00
metanephric S-shaped body morphogenesis (GO:0072284)	5	1	.02	+	47.73	1.00E00
negative regulation of exo-alpha-sialidase activity (GO:1903016)	2	0	.01	-	 < 0.2	1.00E00
intramembranous ossification (GO:0001957)	6	0	.03	-	 < 0.2	1.00E00
metanephric renal vesicle morphogenesis (GO:0072283)	11	0	.05	-	 < 0.2	1.00E00
regulation of exo-alpha-sialidase activity (GO:1903015)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of neurotransmitter secretion (GO:0001956)	13	0	.05	-	 < 0.2	1.00E00
metanephric nephron tubule morphogenesis (GO:0072282)	8	0	.03	-	 < 0.2	1.00E00
blood vessel maturation (GO:0001955)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of cell-matrix adhesion (GO:0001954)	47	0	.20	-	 < 0.2	1.00E00
positive regulation of bone development (GO:1903012)	9	0	.04	-	 < 0.2	1.00E00
JAK-STAT cascade (GO:0007259)	50	2	.21	+	9.55	1.00E00
negative regulation of bone development (GO:1903011)	9	0	.04	-	 < 0.2	1.00E00
JUN phosphorylation (GO:0007258)	4	1	.02	+	59.66	1.00E00
regulation of bone development (GO:1903010)	22	0	.09	-	 < 0.2	1.00E00
intestinal D-glucose absorption (GO:0001951)	4	0	.02	-	 < 0.2	1.00E00
activation of JUN kinase activity (GO:0007257)	36	1	.15	+	6.63	1.00E00
activation of JNKK activity (GO:0007256)	7	0	.03	-	 < 0.2	1.00E00
JNK cascade (GO:0007254)	84	2	.35	+	5.68	1.00E00
cytoplasmic sequestering of NF-kappaB (GO:0007253)	7	0	.03	-	 < 0.2	1.00E00
I-kappaB phosphorylation (GO:0007252)	12	0	.05	-	 < 0.2	1.00E00
activation of NF-kappaB-inducing kinase activity (GO:0007250)	18	0	.08	-	 < 0.2	1.00E00
spinal cord oligodendrocyte cell differentiation (GO:0021529)	3	0	.01	-	 < 0.2	1.00E00
commissural neuron differentiation in spinal cord (GO:0021528)	1	0	.00	-	 < 0.2	1.00E00
spinal cord association neuron differentiation (GO:0021527)	14	0	.06	-	 < 0.2	1.00E00
medial motor column neuron differentiation (GO:0021526)	2	0	.01	-	 < 0.2	1.00E00
visceral motor neuron differentiation (GO:0021524)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of amniotic stem cell differentiation (GO:2000798)	1	0	.00	-	 < 0.2	1.00E00
somatic motor neuron differentiation (GO:0021523)	5	0	.02	-	 < 0.2	1.00E00
regulation of amniotic stem cell differentiation (GO:2000797)	1	0	.00	-	 < 0.2	1.00E00
spinal cord motor neuron differentiation (GO:0021522)	33	0	.14	-	 < 0.2	1.00E00
regulation of steroid metabolic process (GO:0019218)	109	2	.46	+	4.38	1.00E00
ventral spinal cord interneuron specification (GO:0021521)	11	0	.05	-	 < 0.2	1.00E00
metanephric comma-shaped body morphogenesis (GO:0072278)	3	1	.01	+	79.55	1.00E00
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	0	.00	-	 < 0.2	1.00E00
regulation of fatty acid metabolic process (GO:0019217)	90	3	.38	+	7.96	1.00E00
spinal cord motor neuron cell fate specification (GO:0021520)	13	0	.05	-	 < 0.2	1.00E00
metanephric glomerular capillary formation (GO:0072277)	3	1	.01	+	79.55	1.00E00
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	8	0	.03	-	 < 0.2	1.00E00
metanephric glomerulus vasculature morphogenesis (GO:0072276)	3	1	.01	+	79.55	1.00E00
organelle disassembly (GO:1903008)	63	1	.26	+	3.79	1.00E00
cell proliferation involved in heart valve development (GO:2000793)	1	0	.00	-	 < 0.2	1.00E00
sebaceous gland cell differentiation (GO:0001949)	1	0	.00	-	 < 0.2	1.00E00
metanephric glomerulus morphogenesis (GO:0072275)	3	1	.01	+	79.55	1.00E00
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.00	-	 < 0.2	1.00E00
metanephric glomerular basement membrane development (GO:0072274)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein K63-linked deubiquitination (GO:1903006)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	0	.01	-	 < 0.2	1.00E00
heart looping (GO:0001947)	59	0	.25	-	 < 0.2	1.00E00
metanephric nephron morphogenesis (GO:0072273)	21	1	.09	+	11.36	1.00E00
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	0	.01	-	 < 0.2	1.00E00
lymphangiogenesis (GO:0001946)	12	0	.05	-	 < 0.2	1.00E00
proximal/distal pattern formation involved in metanephric nephron development (GO:0072272)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein K63-linked deubiquitination (GO:1903004)	2	0	.01	-	 < 0.2	1.00E00
lymph vessel development (GO:0001945)	22	1	.09	+	10.85	1.00E00
positive regulation of protein deubiquitination (GO:1903003)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of lipid transport across blood brain barrier (GO:1903002)	1	0	.00	-	 < 0.2	1.00E00
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	73	1	.31	+	3.27	1.00E00
hair follicle development (GO:0001942)	73	3	.31	+	9.81	1.00E00
regulation of lipid transport across blood brain barrier (GO:1903000)	1	0	.00	-	 < 0.2	1.00E00
postsynaptic membrane organization (GO:0001941)	27	1	.11	+	8.84	1.00E00
xenobiotic glucuronidation (GO:0052697)	9	0	.04	-	 < 0.2	1.00E00
flavonoid glucuronidation (GO:0052696)	9	0	.04	-	 < 0.2	1.00E00
cellular glucuronidation (GO:0052695)	16	0	.07	-	 < 0.2	1.00E00
spinal cord association neuron specification (GO:0021519)	1	0	.00	-	 < 0.2	1.00E00
ventral spinal cord development (GO:0021517)	46	0	.19	-	 < 0.2	1.00E00
dorsal spinal cord development (GO:0021516)	21	0	.09	-	 < 0.2	1.00E00
cell differentiation in spinal cord (GO:0021515)	53	0	.22	-	 < 0.2	1.00E00
ventral spinal cord interneuron differentiation (GO:0021514)	17	0	.07	-	 < 0.2	1.00E00
spinal cord dorsal/ventral patterning (GO:0021513)	22	0	.09	-	 < 0.2	1.00E00
spinal cord anterior/posterior patterning (GO:0021512)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of autophagosome assembly (GO:2000786)	11	0	.05	-	 < 0.2	1.00E00
spinal cord patterning (GO:0021511)	24	0	.10	-	 < 0.2	1.00E00
pattern specification involved in metanephros development (GO:0072268)	4	0	.02	-	 < 0.2	1.00E00
regulation of autophagosome assembly (GO:2000785)	37	0	.16	-	 < 0.2	1.00E00
spinal cord development (GO:0021510)	101	1	.42	+	2.36	1.00E00
metanephric capsule specification (GO:0072267)	1	0	.00	-	 < 0.2	1.00E00
metanephric capsule formation (GO:0072266)	1	0	.00	-	 < 0.2	1.00E00
metanephric capsule morphogenesis (GO:0072265)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of double-strand break repair (GO:2000781)	14	1	.06	+	17.05	1.00E00
negative regulation of endothelial cell proliferation (GO:0001937)	33	2	.14	+	14.46	1.00E00
negative regulation of double-strand break repair (GO:2000780)	18	0	.08	-	 < 0.2	1.00E00
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	1	1	.00	+	 > 100	1.00E00
endothelial cell proliferation (GO:0001935)	24	1	.10	+	9.94	1.00E00
negative regulation of sarcomere organization (GO:0060299)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of sarcomere organization (GO:0060298)	4	0	.02	-	 < 0.2	1.00E00
regulation of sarcomere organization (GO:0060297)	7	0	.03	-	 < 0.2	1.00E00
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	6	0	.03	-	 < 0.2	1.00E00
regulation of cilium movement involved in cell motility (GO:0060295)	6	0	.03	-	 < 0.2	1.00E00
cilium movement involved in cell motility (GO:0060294)	13	0	.05	-	 < 0.2	1.00E00
long term synaptic depression (GO:0060292)	17	0	.07	-	 < 0.2	1.00E00
osmosensory signaling pathway (GO:0007231)	2	0	.01	-	 < 0.2	1.00E00
long-term synaptic potentiation (GO:0060291)	42	1	.18	+	5.68	1.00E00
transdifferentiation (GO:0060290)	7	0	.03	-	 < 0.2	1.00E00
roof plate formation (GO:0021509)	1	0	.00	-	 < 0.2	1.00E00
floor plate formation (GO:0021508)	1	0	.00	-	 < 0.2	1.00E00
regulation of double-strand break repair (GO:2000779)	52	2	.22	+	9.18	1.00E00
positive regulation of interleukin-6 secretion (GO:2000778)	23	1	.10	+	10.38	1.00E00
neural fold bending (GO:0021503)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777)	2	0	.01	-	 < 0.2	1.00E00
neural fold elevation formation (GO:0021502)	3	0	.01	-	 < 0.2	1.00E00
metanephric interstitial fibroblast development (GO:0072259)	1	0	.00	-	 < 0.2	1.00E00
prechordal plate formation (GO:0021501)	1	0	.00	-	 < 0.2	1.00E00
metanephric interstitial fibroblast differentiation (GO:0072258)	1	0	.00	-	 < 0.2	1.00E00
histone H3-S10 phosphorylation involved in chromosome condensation (GO:2000775)	1	1	.00	+	 > 100	1.00E00
positive regulation of cellular senescence (GO:2000774)	10	1	.04	+	23.87	1.00E00
negative regulation of cellular senescence (GO:2000773)	12	0	.05	-	 < 0.2	1.00E00
metanephric glomerular mesangial cell development (GO:0072255)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular senescence (GO:2000772)	31	1	.13	+	7.70	1.00E00
regulation of exocyst assembly (GO:0001928)	1	0	.00	-	 < 0.2	1.00E00
metanephric glomerular mesangial cell differentiation (GO:0072254)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	1	0	.00	-	 < 0.2	1.00E00
exocyst assembly (GO:0001927)	2	0	.01	-	 < 0.2	1.00E00
B-1 B cell differentiation (GO:0001923)	3	0	.01	-	 < 0.2	1.00E00
integrin-mediated signaling pathway (GO:0007229)	90	3	.38	+	7.96	1.00E00
B-1 B cell homeostasis (GO:0001922)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of hh target transcription factor activity (GO:0007228)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of receptor recycling (GO:0001921)	14	0	.06	-	 < 0.2	1.00E00
signal transduction downstream of smoothened (GO:0007227)	4	0	.02	-	 < 0.2	1.00E00
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of receptor recycling (GO:0001920)	4	0	.02	-	 < 0.2	1.00E00
patched ligand maturation (GO:0007225)	1	0	.00	-	 < 0.2	1.00E00
cilium-dependent cell motility (GO:0060285)	23	0	.10	-	 < 0.2	1.00E00
smoothened signaling pathway (GO:0007224)	74	0	.31	-	 < 0.2	1.00E00
regulation of cell development (GO:0060284)	827	11	3.47	+	3.17	1.00E00
Wnt signaling pathway, calcium modulating pathway (GO:0007223)	36	0	.15	-	 < 0.2	1.00E00
negative regulation of oocyte development (GO:0060283)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of oocyte development (GO:0060282)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription of Notch receptor target (GO:0007221)	7	0	.03	-	 < 0.2	1.00E00
regulation of oocyte development (GO:0060281)	10	0	.04	-	 < 0.2	1.00E00
Notch receptor processing (GO:0007220)	17	2	.07	+	28.08	1.00E00
negative regulation of ovulation (GO:0060280)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of nephron tubule epithelial cell differentiation (GO:2000768)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cytoplasmic translation (GO:2000767)	7	1	.03	+	34.09	1.00E00
metanephric glomerular visceral epithelial cell development (GO:0072249)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cytoplasmic translation (GO:2000766)	8	0	.03	-	 < 0.2	1.00E00
metanephric glomerular visceral epithelial cell differentiation (GO:0072248)	2	0	.01	-	 < 0.2	1.00E00
regulation of cytoplasmic translation (GO:2000765)	23	1	.10	+	10.38	1.00E00
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763)	1	0	.00	-	 < 0.2	1.00E00
regulation of receptor recycling (GO:0001919)	23	0	.10	-	 < 0.2	1.00E00
metanephric glomerular epithelium development (GO:0072244)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761)	1	0	.00	-	 < 0.2	1.00E00
metanephric nephron epithelium development (GO:0072243)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of T cell mediated cytotoxicity (GO:0001916)	17	1	.07	+	14.04	1.00E00
negative regulation of T cell mediated cytotoxicity (GO:0001915)	6	0	.03	-	 < 0.2	1.00E00
regulation of T cell mediated cytotoxicity (GO:0001914)	25	1	.10	+	9.55	1.00E00
metanephric DCT cell differentiation (GO:0072240)	1	0	.00	-	 < 0.2	1.00E00
T cell mediated cytotoxicity (GO:0001913)	7	0	.03	-	 < 0.2	1.00E00
Notch signaling pathway (GO:0007219)	117	3	.49	+	6.12	1.00E00
positive regulation of ovulation (GO:0060279)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	36	1	.15	+	6.63	1.00E00
neuropeptide signaling pathway (GO:0007218)	103	0	.43	-	 < 0.2	1.00E00
regulation of ovulation (GO:0060278)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	17	1	.07	+	14.04	1.00E00
tachykinin receptor signaling pathway (GO:0007217)	8	0	.03	-	 < 0.2	1.00E00
regulation of leukocyte mediated cytotoxicity (GO:0001910)	56	1	.23	+	4.26	1.00E00
G-protein coupled glutamate receptor signaling pathway (GO:0007216)	15	0	.06	-	 < 0.2	1.00E00
glutamate receptor signaling pathway (GO:0007215)	45	0	.19	-	 < 0.2	1.00E00
gamma-aminobutyric acid signaling pathway (GO:0007214)	25	0	.10	-	 < 0.2	1.00E00
G-protein coupled acetylcholine receptor signaling pathway (GO:0007213)	16	0	.07	-	 < 0.2	1.00E00
dopamine receptor signaling pathway (GO:0007212)	39	1	.16	+	6.12	1.00E00
embryonic skeletal joint morphogenesis (GO:0060272)	12	0	.05	-	 < 0.2	1.00E00
cilium assembly (GO:0060271)	329	1	1.38	-	.73	1.00E00
serotonin receptor signaling pathway (GO:0007210)	24	0	.10	-	 < 0.2	1.00E00
regulation of N-terminal peptidyl-lysine acetylation (GO:2000759)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of peptidyl-lysine acetylation (GO:2000758)	30	1	.13	+	7.96	1.00E00
negative regulation of peptidyl-lysine acetylation (GO:2000757)	20	0	.08	-	 < 0.2	1.00E00
metanephric glomerulus vasculature development (GO:0072239)	7	1	.03	+	34.09	1.00E00
regulation of peptidyl-lysine acetylation (GO:2000756)	57	2	.24	+	8.37	1.00E00
positive regulation of sphingomyelin catabolic process (GO:2000755)	1	1	.00	+	 > 100	1.00E00
metanephric proximal tubule development (GO:0072237)	3	0	.01	-	 < 0.2	1.00E00
regulation of sphingomyelin catabolic process (GO:2000754)	1	1	.00	+	 > 100	1.00E00
metanephric loop of Henle development (GO:0072236)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of glucosylceramide catabolic process (GO:2000753)	1	1	.00	+	 > 100	1.00E00
leukocyte mediated cytotoxicity (GO:0001909)	35	0	.15	-	 < 0.2	1.00E00
metanephric distal tubule development (GO:0072235)	7	0	.03	-	 < 0.2	1.00E00
regulation of glucosylceramide catabolic process (GO:2000752)	1	1	.00	+	 > 100	1.00E00
metanephric nephron tubule development (GO:0072234)	16	0	.07	-	 < 0.2	1.00E00
histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore (GO:2000751)	1	0	.00	-	 < 0.2	1.00E00
killing by symbiont of host cells (GO:0001907)	5	0	.02	-	 < 0.2	1.00E00
metanephric thick ascending limb development (GO:0072233)	2	0	.01	-	 < 0.2	1.00E00
cell killing (GO:0001906)	79	0	.33	-	 < 0.2	1.00E00
metanephric proximal convoluted tubule segment 2 development (GO:0072232)	1	0	.00	-	 < 0.2	1.00E00
metanephric proximal straight tubule development (GO:0072230)	1	0	.00	-	 < 0.2	1.00E00
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of respiratory burst (GO:0060268)	4	0	.02	-	 < 0.2	1.00E00
creatine transmembrane transport (GO:1902598)	2	0	.01	-	 < 0.2	1.00E00
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway (GO:0007207)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of respiratory burst (GO:0060267)	8	0	.03	-	 < 0.2	1.00E00
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway (GO:0007206)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	3	0	.01	-	 < 0.2	1.00E00
protein kinase C-activating G-protein coupled receptor signaling pathway (GO:0007205)	29	0	.12	-	 < 0.2	1.00E00
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	0	.01	-	 < 0.2	1.00E00
regulation of DNA replication origin binding (GO:1902595)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cytosolic calcium ion concentration (GO:0007204)	248	2	1.04	+	1.92	1.00E00
regulation of respiratory burst involved in inflammatory response (GO:0060264)	4	0	.02	-	 < 0.2	1.00E00
multi-organism nuclear import (GO:1902594)	2	0	.01	-	 < 0.2	1.00E00
regulation of respiratory burst (GO:0060263)	14	0	.06	-	 < 0.2	1.00E00
activation of phospholipase C activity (GO:0007202)	27	2	.11	+	17.68	1.00E00
negative regulation of N-terminal protein palmitoylation (GO:0060262)	1	0	.00	-	 < 0.2	1.00E00
cyclic purine nucleotide metabolic process (GO:0052652)	33	0	.14	-	 < 0.2	1.00E00
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	19	0	.08	-	 < 0.2	1.00E00
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200)	109	0	.46	-	 < 0.2	1.00E00
monoacylglycerol catabolic process (GO:0052651)	2	0	.01	-	 < 0.2	1.00E00
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	26	0	.11	-	 < 0.2	1.00E00
metanephric proximal convoluted tubule development (GO:0072229)	2	0	.01	-	 < 0.2	1.00E00
metanephric macula densa development (GO:0072227)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of anterior head development (GO:2000744)	2	0	.01	-	 < 0.2	1.00E00
regulation of anterior head development (GO:2000742)	2	0	.01	-	 < 0.2	1.00E00
metanephric glomerulus development (GO:0072224)	11	1	.05	+	21.70	1.00E00
positive regulation of mesenchymal stem cell differentiation (GO:2000741)	4	0	.02	-	 < 0.2	1.00E00
metanephric glomerular mesangium development (GO:0072223)	3	1	.01	+	79.55	1.00E00
negative regulation of mesenchymal stem cell differentiation (GO:2000740)	1	0	.00	-	 < 0.2	1.00E00
metanephric distal convoluted tubule development (GO:0072221)	5	0	.02	-	 < 0.2	1.00E00
metanephric descending thin limb development (GO:0072220)	1	0	.00	-	 < 0.2	1.00E00
regulation of feeding behavior (GO:0060259)	24	0	.10	-	 < 0.2	1.00E00
alditol phosphate metabolic process (GO:0052646)	9	0	.04	-	 < 0.2	1.00E00
regulation of N-terminal protein palmitoylation (GO:0060254)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glial cell proliferation (GO:0060253)	15	0	.06	-	 < 0.2	1.00E00
multi-organism intracellular transport (GO:1902583)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of glial cell proliferation (GO:0060252)	11	0	.05	-	 < 0.2	1.00E00
regulation of glial cell proliferation (GO:0060251)	27	0	.11	-	 < 0.2	1.00E00
multi-organism cellular localization (GO:1902581)	5	0	.02	-	 < 0.2	1.00E00
regulation of mesenchymal stem cell differentiation (GO:2000739)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of stem cell differentiation (GO:2000738)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of stem cell differentiation (GO:2000737)	18	1	.08	+	13.26	1.00E00
metanephric cortical collecting duct development (GO:0072219)	1	0	.00	-	 < 0.2	1.00E00
regulation of stem cell differentiation (GO:2000736)	115	2	.48	+	4.15	1.00E00
metanephric ascending thin limb development (GO:0072218)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of metanephros development (GO:0072217)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of metanephros development (GO:0072216)	14	1	.06	+	17.05	1.00E00
regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733)	1	0	.00	-	 < 0.2	1.00E00
regulation of metanephros development (GO:0072215)	22	1	.09	+	10.85	1.00E00
metanephric cortex development (GO:0072214)	1	0	.00	-	 < 0.2	1.00E00
metanephric capsule development (GO:0072213)	1	0	.00	-	 < 0.2	1.00E00
metanephric nephron development (GO:0072210)	33	1	.14	+	7.23	1.00E00
anatomical structure homeostasis (GO:0060249)	292	7	1.22	+	5.72	1.00E00
multi-organism localization (GO:1902579)	71	1	.30	+	3.36	1.00E00
detection of cell density by contact stimulus involved in contact inhibition (GO:0060248)	1	0	.00	-	 < 0.2	1.00E00
detection of cell density by contact stimulus (GO:0060246)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of nuclear cell cycle DNA replication (GO:1902576)	4	0	.02	-	 < 0.2	1.00E00
detection of cell density (GO:0060245)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of cell growth involved in contact inhibition (GO:0060243)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of serine-type peptidase activity (GO:1902573)	3	0	.01	-	 < 0.2	1.00E00
contact inhibition (GO:0060242)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of serine-type peptidase activity (GO:1902572)	11	0	.05	-	 < 0.2	1.00E00
regulation of serine-type peptidase activity (GO:1902571)	13	0	.05	-	 < 0.2	1.00E00
protein localization to nucleolus (GO:1902570)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cardiac muscle cell differentiation (GO:2000727)	18	1	.08	+	13.26	1.00E00
metanephric mesangial cell differentiation (GO:0072209)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cardiac muscle cell differentiation (GO:2000726)	13	2	.05	+	36.72	1.00E00
metanephric smooth muscle tissue development (GO:0072208)	2	0	.01	-	 < 0.2	1.00E00
regulation of cardiac muscle cell differentiation (GO:2000725)	30	3	.13	+	23.87	1.00E00
metanephric epithelium development (GO:0072207)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724)	2	0	.01	-	 < 0.2	1.00E00
metanephric juxtaglomerular apparatus development (GO:0072206)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723)	1	0	.00	-	 < 0.2	1.00E00
metanephric collecting duct development (GO:0072205)	7	0	.03	-	 < 0.2	1.00E00
regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722)	3	0	.01	-	 < 0.2	1.00E00
cell-cell signaling involved in metanephros development (GO:0072204)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721)	3	0	.01	-	 < 0.2	1.00E00
cell proliferation involved in metanephros development (GO:0072203)	7	1	.03	+	34.09	1.00E00
cell differentiation involved in metanephros development (GO:0072202)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell proliferation (GO:0072201)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of activation of Janus kinase activity (GO:1902569)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of eosinophil activation (GO:1902568)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of eosinophil activation (GO:1902567)	2	0	.01	-	 < 0.2	1.00E00
regulation of mitotic spindle organization (GO:0060236)	36	1	.15	+	6.63	1.00E00
regulation of eosinophil activation (GO:1902566)	4	0	.02	-	 < 0.2	1.00E00
lens induction in camera-type eye (GO:0060235)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of neutrophil activation (GO:1902565)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of neutrophil activation (GO:1902564)	4	0	.02	-	 < 0.2	1.00E00
regulation of neutrophil activation (GO:1902563)	10	1	.04	+	23.87	1.00E00
delamination (GO:0060232)	2	0	.01	-	 < 0.2	1.00E00
mesenchymal to epithelial transition (GO:0060231)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000719)	1	0	.00	-	 < 0.2	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, centromeric (GO:2000718)	1	0	.00	-	 < 0.2	1.00E00
3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559)	2	0	.01	-	 < 0.2	1.00E00
retinal rod cell differentiation (GO:0060221)	3	0	.01	-	 < 0.2	1.00E00
camera-type eye photoreceptor cell fate commitment (GO:0060220)	1	0	.00	-	 < 0.2	1.00E00
polyphosphate metabolic process (GO:0006797)	1	0	.00	-	 < 0.2	1.00E00
sulfur compound metabolic process (GO:0006790)	367	3	1.54	+	1.95	1.00E00
positive regulation of dense core granule biogenesis (GO:2000707)	2	1	.01	+	 > 100	1.00E00
negative regulation of dense core granule biogenesis (GO:2000706)	1	0	.00	-	 < 0.2	1.00E00
regulation of dense core granule biogenesis (GO:2000705)	3	1	.01	+	79.55	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703)	1	0	.00	-	 < 0.2	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702)	1	0	.00	-	 < 0.2	1.00E00
camera-type eye photoreceptor cell differentiation (GO:0060219)	18	0	.08	-	 < 0.2	1.00E00
hematopoietic stem cell differentiation (GO:0060218)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	6	0	.03	-	 < 0.2	1.00E00
hemangioblast cell differentiation (GO:0060217)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	15	0	.06	-	 < 0.2	1.00E00
definitive hemopoiesis (GO:0060216)	17	1	.07	+	14.04	1.00E00
positive regulation of DNA N-glycosylase activity (GO:1902546)	1	0	.00	-	 < 0.2	1.00E00
primitive hemopoiesis (GO:0060215)	6	0	.03	-	 < 0.2	1.00E00
endocardium formation (GO:0060214)	4	0	.02	-	 < 0.2	1.00E00
regulation of DNA N-glycosylase activity (GO:1902544)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	1	0	.00	-	 < 0.2	1.00E00
bilirubin conjugation (GO:0006789)	2	0	.01	-	 < 0.2	1.00E00
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	11	0	.05	-	 < 0.2	1.00E00
heme oxidation (GO:0006788)	2	0	.01	-	 < 0.2	1.00E00
porphyrin-containing compound catabolic process (GO:0006787)	7	0	.03	-	 < 0.2	1.00E00
heme a biosynthetic process (GO:0006784)	2	0	.01	-	 < 0.2	1.00E00
heme biosynthetic process (GO:0006783)	22	0	.09	-	 < 0.2	1.00E00
protoporphyrinogen IX biosynthetic process (GO:0006782)	9	0	.04	-	 < 0.2	1.00E00
succinyl-CoA pathway (GO:0006781)	1	0	.00	-	 < 0.2	1.00E00
uroporphyrinogen III biosynthetic process (GO:0006780)	2	0	.01	-	 < 0.2	1.00E00
regulation of actin filament organization (GO:0110053)	240	4	1.01	+	3.98	1.00E00
porphyrin-containing compound biosynthetic process (GO:0006779)	26	0	.11	-	 < 0.2	1.00E00
porphyrin-containing compound metabolic process (GO:0006778)	38	0	.16	-	 < 0.2	1.00E00
positive regulation of protein linear polyubiquitination (GO:1902530)	2	0	.01	-	 < 0.2	1.00E00
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	6	0	.03	-	 < 0.2	1.00E00
vitamin A metabolic process (GO:0006776)	8	0	.03	-	 < 0.2	1.00E00
fat-soluble vitamin metabolic process (GO:0006775)	33	0	.14	-	 < 0.2	1.00E00
thiamine metabolic process (GO:0006772)	4	0	.02	-	 < 0.2	1.00E00
riboflavin metabolic process (GO:0006771)	7	0	.03	-	 < 0.2	1.00E00
cellular response to prostaglandin D stimulus (GO:0071799)	5	0	.02	-	 < 0.2	1.00E00
response to prostaglandin D (GO:0071798)	5	0	.02	-	 < 0.2	1.00E00
regulation of protein linear polyubiquitination (GO:1902528)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein monoubiquitination (GO:1902527)	4	0	.02	-	 < 0.2	1.00E00
regulation of protein monoubiquitination (GO:1902525)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of protein K48-linked ubiquitination (GO:1902524)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein K63-linked ubiquitination (GO:1902523)	3	0	.01	-	 < 0.2	1.00E00
biotin metabolic process (GO:0006768)	11	0	.05	-	 < 0.2	1.00E00
water-soluble vitamin metabolic process (GO:0006767)	85	1	.36	+	2.81	1.00E00
vitamin metabolic process (GO:0006766)	118	1	.49	+	2.02	1.00E00
folic acid-containing compound metabolic process (GO:0006760)	28	0	.12	-	 < 0.2	1.00E00
endoplasmic reticulum tubular network maintenance (GO:0071788)	1	0	.00	-	 < 0.2	1.00E00
endoplasmic reticulum tubular network formation (GO:0071787)	4	0	.02	-	 < 0.2	1.00E00
endoplasmic reticulum tubular network organization (GO:0071786)	10	0	.04	-	 < 0.2	1.00E00
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	9	1	.04	+	26.52	1.00E00
regulation of organelle transport along microtubule (GO:1902513)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of apoptotic DNA fragmentation (GO:1902512)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of apoptotic DNA fragmentation (GO:1902511)	1	0	.00	-	 < 0.2	1.00E00
regulation of apoptotic DNA fragmentation (GO:1902510)	8	1	.03	+	29.83	1.00E00
ATP generation from ADP (GO:0006757)	39	1	.16	+	6.12	1.00E00
AMP phosphorylation (GO:0006756)	1	0	.00	-	 < 0.2	1.00E00
ATP biosynthetic process (GO:0006754)	41	2	.17	+	11.64	1.00E00
nucleoside phosphate metabolic process (GO:0006753)	523	6	2.19	+	2.74	1.00E00
glutathione catabolic process (GO:0006751)	11	0	.05	-	 < 0.2	1.00E00
MHC class II protein complex assembly (GO:0002399)	4	0	.02	-	 < 0.2	1.00E00
glutathione biosynthetic process (GO:0006750)	16	0	.07	-	 < 0.2	1.00E00
MHC class I protein complex assembly (GO:0002397)	2	0	.01	-	 < 0.2	1.00E00
MHC protein complex assembly (GO:0002396)	6	0	.03	-	 < 0.2	1.00E00
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of meiosis I (GO:0110029)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mitotic spindle organization (GO:0110028)	1	0	.00	-	 < 0.2	1.00E00
regulation of DNA strand resection involved in replication fork processing (GO:0110026)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	3	0	.01	-	 < 0.2	1.00E00
response to fibroblast growth factor (GO:0071774)	120	2	.50	+	3.98	1.00E00
regulation of cardiac muscle myoblast proliferation (GO:0110022)	3	0	.01	-	 < 0.2	1.00E00
cellular response to BMP stimulus (GO:0071773)	106	0	.44	-	 < 0.2	1.00E00
response to BMP (GO:0071772)	106	0	.44	-	 < 0.2	1.00E00
regulation of actomyosin structure organization (GO:0110020)	86	1	.36	+	2.78	1.00E00
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504)	1	0	.00	-	 < 0.2	1.00E00
glutathione metabolic process (GO:0006749)	59	1	.25	+	4.05	1.00E00
FAD biosynthetic process (GO:0006747)	1	0	.00	-	 < 0.2	1.00E00
ubiquinone biosynthetic process (GO:0006744)	16	0	.07	-	 < 0.2	1.00E00
ubiquinone metabolic process (GO:0006743)	17	0	.07	-	 < 0.2	1.00E00
NADP catabolic process (GO:0006742)	2	0	.01	-	 < 0.2	1.00E00
NADP biosynthetic process (GO:0006741)	4	0	.02	-	 < 0.2	1.00E00
NADPH regeneration (GO:0006740)	3	1	.01	+	79.55	1.00E00
immune response in gut-associated lymphoid tissue (GO:0002387)	1	0	.00	-	 < 0.2	1.00E00
immune response in mucosal-associated lymphoid tissue (GO:0002386)	3	0	.01	-	 < 0.2	1.00E00
mucosal immune response (GO:0002385)	27	0	.11	-	 < 0.2	1.00E00
hepatic immune response (GO:0002384)	2	0	.01	-	 < 0.2	1.00E00
immunoglobulin production involved in immunoglobulin mediated immune response (GO:0002381)	23	0	.10	-	 < 0.2	1.00E00
immunoglobulin secretion involved in immune response (GO:0002380)	1	0	.00	-	 < 0.2	1.00E00
cap-independent translational initiation of linear mRNA (GO:0110017)	2	1	.01	+	 > 100	1.00E00
nuclear inner membrane organization (GO:0071765)	1	0	.00	-	 < 0.2	1.00E00
nuclear membrane organization (GO:0071763)	6	0	.03	-	 < 0.2	1.00E00
regulation of basement membrane organization (GO:0110011)	5	0	.02	-	 < 0.2	1.00E00
NADP metabolic process (GO:0006739)	32	1	.13	+	7.46	1.00E00
nicotinamide riboside catabolic process (GO:0006738)	1	0	.00	-	 < 0.2	1.00E00
NADH regeneration (GO:0006735)	25	1	.10	+	9.55	1.00E00
NADH metabolic process (GO:0006734)	36	1	.15	+	6.63	1.00E00
oxidoreduction coenzyme metabolic process (GO:0006733)	127	2	.53	+	3.76	1.00E00
coenzyme metabolic process (GO:0006732)	289	3	1.21	+	2.48	1.00E00
one-carbon metabolic process (GO:0006730)	35	0	.15	-	 < 0.2	1.00E00
immunoglobulin biosynthetic process (GO:0002378)	2	0	.01	-	 < 0.2	1.00E00
immunoglobulin production (GO:0002377)	117	1	.49	+	2.04	1.00E00
cytokine secretion involved in immune response (GO:0002374)	3	0	.01	-	 < 0.2	1.00E00
dendritic cell cytokine production (GO:0002371)	1	0	.00	-	 < 0.2	1.00E00
formin-nucleated actin cable organization (GO:0110009)	3	0	.01	-	 < 0.2	1.00E00
ncRNA deadenylation (GO:0110008)	1	0	.00	-	 < 0.2	1.00E00
tetrahydrobiopterin biosynthetic process (GO:0006729)	7	0	.03	-	 < 0.2	1.00E00
eye pigment biosynthetic process (GO:0006726)	4	0	.02	-	 < 0.2	1.00E00
cellular aromatic compound metabolic process (GO:0006725)	4751	30	19.91	+	1.51	1.00E00
triterpenoid metabolic process (GO:0006722)	1	0	.00	-	 < 0.2	1.00E00
terpenoid metabolic process (GO:0006721)	106	1	.44	+	2.25	1.00E00
T cell cytokine production (GO:0002369)	12	0	.05	-	 < 0.2	1.00E00
isoprenoid metabolic process (GO:0006720)	126	1	.53	+	1.89	1.00E00
B cell cytokine production (GO:0002368)	1	0	.00	-	 < 0.2	1.00E00
cytokine production involved in immune response (GO:0002367)	22	0	.09	-	 < 0.2	1.00E00
leukocyte activation involved in immune response (GO:0002366)	607	10	2.54	+	3.93	1.00E00
alpha-beta T cell lineage commitment (GO:0002363)	11	1	.05	+	21.70	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	1	0	.00	-	 < 0.2	1.00E00
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	3	0	.01	-	 < 0.2	1.00E00
T cell lineage commitment (GO:0002360)	18	1	.08	+	13.26	1.00E00
sesquiterpenoid metabolic process (GO:0006714)	3	0	.01	-	 < 0.2	1.00E00
glucocorticoid catabolic process (GO:0006713)	1	0	.00	-	 < 0.2	1.00E00
estrogen catabolic process (GO:0006711)	2	0	.01	-	 < 0.2	1.00E00
androgen catabolic process (GO:0006710)	4	0	.02	-	 < 0.2	1.00E00
B cell homeostatic proliferation (GO:0002358)	2	0	.01	-	 < 0.2	1.00E00
defense response to tumor cell (GO:0002357)	4	0	.02	-	 < 0.2	1.00E00
detection of tumor cell (GO:0002355)	1	0	.00	-	 < 0.2	1.00E00
plasma kallikrein-kinin cascade (GO:0002353)	3	0	.01	-	 < 0.2	1.00E00
B cell negative selection (GO:0002352)	2	0	.01	-	 < 0.2	1.00E00
serotonin production involved in inflammatory response (GO:0002351)	3	1	.01	+	79.55	1.00E00
photoreceptor cell maintenance (GO:0045494)	35	0	.15	-	 < 0.2	1.00E00
transcriptional activation by promoter-enhancer looping (GO:0071733)	3	0	.01	-	 < 0.2	1.00E00
cellular response to nitric oxide (GO:0071732)	16	0	.07	-	 < 0.2	1.00E00
response to nitric oxide (GO:0071731)	19	0	.08	-	 < 0.2	1.00E00
cholesterol catabolic process (GO:0006707)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of dendritic cell differentiation (GO:2001199)	6	0	.03	-	 < 0.2	1.00E00
steroid catabolic process (GO:0006706)	27	0	.11	-	 < 0.2	1.00E00
regulation of dendritic cell differentiation (GO:2001198)	11	0	.05	-	 < 0.2	1.00E00
mineralocorticoid biosynthetic process (GO:0006705)	6	0	.03	-	 < 0.2	1.00E00
glucocorticoid biosynthetic process (GO:0006704)	10	0	.04	-	 < 0.2	1.00E00
estrogen biosynthetic process (GO:0006703)	13	0	.05	-	 < 0.2	1.00E00
androgen biosynthetic process (GO:0006702)	11	0	.05	-	 < 0.2	1.00E00
progesterone biosynthetic process (GO:0006701)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of gamma-delta T cell activation involved in immune response (GO:2001193)	1	0	.00	-	 < 0.2	1.00E00
histamine production involved in inflammatory response (GO:0002349)	3	0	.01	-	 < 0.2	1.00E00
C21-steroid hormone biosynthetic process (GO:0006700)	17	1	.07	+	14.04	1.00E00
regulation of gamma-delta T cell activation involved in immune response (GO:2001191)	1	0	.00	-	 < 0.2	1.00E00
response to tumor cell (GO:0002347)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190)	2	0	.01	-	 < 0.2	1.00E00
B cell affinity maturation (GO:0002344)	1	0	.00	-	 < 0.2	1.00E00
peripheral B cell selection (GO:0002343)	1	0	.00	-	 < 0.2	1.00E00
cellular response to triacyl bacterial lipopeptide (GO:0071727)	3	0	.01	-	 < 0.2	1.00E00
cellular response to diacyl bacterial lipopeptide (GO:0071726)	4	0	.02	-	 < 0.2	1.00E00
response to triacyl bacterial lipopeptide (GO:0071725)	3	0	.01	-	 < 0.2	1.00E00
response to diacyl bacterial lipopeptide (GO:0071724)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189)	3	0	.01	-	 < 0.2	1.00E00
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	6	1	.03	+	39.78	1.00E00
negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)	2	0	.01	-	 < 0.2	1.00E00
regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	10	1	.04	+	23.87	1.00E00
positive regulation of interleukin-12 secretion (GO:2001184)	3	1	.01	+	79.55	1.00E00
negative regulation of interleukin-12 secretion (GO:2001183)	3	0	.01	-	 < 0.2	1.00E00
B cell selection (GO:0002339)	3	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-12 secretion (GO:2001182)	7	1	.03	+	34.09	1.00E00
positive regulation of interleukin-10 secretion (GO:2001181)	4	1	.02	+	59.66	1.00E00
B-1a B cell differentiation (GO:0002337)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of interleukin-10 secretion (GO:2001180)	3	0	.01	-	 < 0.2	1.00E00
mature B cell differentiation (GO:0002335)	21	0	.09	-	 < 0.2	1.00E00
transitional one stage B cell differentiation (GO:0002333)	1	0	.00	-	 < 0.2	1.00E00
transitional stage B cell differentiation (GO:0002332)	1	0	.00	-	 < 0.2	1.00E00
pre-B cell allelic exclusion (GO:0002331)	3	1	.01	+	79.55	1.00E00
locomotor rhythm (GO:0045475)	10	0	.04	-	 < 0.2	1.00E00
sodium-independent icosanoid transport (GO:0071718)	1	0	.00	-	 < 0.2	1.00E00
response to ether (GO:0045472)	13	1	.05	+	18.36	1.00E00
response to ethanol (GO:0045471)	138	5	.58	+	8.65	1.00E00
icosanoid transport (GO:0071715)	32	0	.13	-	 < 0.2	1.00E00
ER-associated misfolded protein catabolic process (GO:0071712)	13	0	.05	-	 < 0.2	1.00E00
basement membrane organization (GO:0071711)	17	0	.07	-	 < 0.2	1.00E00
regulation of interleukin-10 secretion (GO:2001179)	8	1	.03	+	29.83	1.00E00
positive regulation of mediator complex assembly (GO:2001178)	2	0	.01	-	 < 0.2	1.00E00
regulation of mediator complex assembly (GO:2001176)	2	0	.01	-	 < 0.2	1.00E00
pre-B cell differentiation (GO:0002329)	6	1	.03	+	39.78	1.00E00
pro-B cell differentiation (GO:0002328)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of ATP biosynthetic process (GO:2001171)	7	0	.03	-	 < 0.2	1.00E00
immature B cell differentiation (GO:0002327)	9	1	.04	+	26.52	1.00E00
negative regulation of ATP biosynthetic process (GO:2001170)	3	0	.01	-	 < 0.2	1.00E00
B cell lineage commitment (GO:0002326)	4	1	.02	+	59.66	1.00E00
natural killer cell activation involved in immune response (GO:0002323)	23	0	.10	-	 < 0.2	1.00E00
B cell proliferation involved in immune response (GO:0002322)	5	0	.02	-	 < 0.2	1.00E00
lymphoid progenitor cell differentiation (GO:0002320)	11	1	.05	+	21.70	1.00E00
membrane assembly (GO:0071709)	28	2	.12	+	17.05	1.00E00
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	1	0	.00	-	 < 0.2	1.00E00
tumor necrosis factor superfamily cytokine production (GO:0071706)	7	0	.03	-	 < 0.2	1.00E00
nitrogen compound transport (GO:0071705)	1669	13	6.99	+	1.86	1.00E00
galactose catabolic process via UDP-galactose (GO:0033499)	2	0	.01	-	 < 0.2	1.00E00
organic substance transport (GO:0071702)	2037	16	8.54	+	1.87	1.00E00
regulation of MAPK export from nucleus (GO:0071701)	1	0	.00	-	 < 0.2	1.00E00
regulation of ATP biosynthetic process (GO:2001169)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of histone H2B ubiquitination (GO:2001168)	4	0	.02	-	 < 0.2	1.00E00
cholesterol biosynthetic process via lathosterol (GO:0033490)	4	0	.02	-	 < 0.2	1.00E00
regulation of histone H2B ubiquitination (GO:2001166)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of histone H3-K79 methylation (GO:2001162)	2	0	.01	-	 < 0.2	1.00E00
myeloid progenitor cell differentiation (GO:0002318)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of histone H3-K79 methylation (GO:2001161)	1	0	.00	-	 < 0.2	1.00E00
plasma cell differentiation (GO:0002317)	3	0	.01	-	 < 0.2	1.00E00
regulation of histone H3-K79 methylation (GO:2001160)	3	0	.01	-	 < 0.2	1.00E00
follicular B cell differentiation (GO:0002316)	2	0	.01	-	 < 0.2	1.00E00
marginal zone B cell differentiation (GO:0002315)	9	0	.04	-	 < 0.2	1.00E00
germinal center B cell differentiation (GO:0002314)	3	0	.01	-	 < 0.2	1.00E00
mature B cell differentiation involved in immune response (GO:0002313)	17	0	.07	-	 < 0.2	1.00E00
B cell activation involved in immune response (GO:0002312)	40	0	.17	-	 < 0.2	1.00E00
cell redox homeostasis (GO:0045454)	73	0	.31	-	 < 0.2	1.00E00
bone resorption (GO:0045453)	23	1	.10	+	10.38	1.00E00
cholesterol biosynthetic process via desmosterol (GO:0033489)	4	0	.02	-	 < 0.2	1.00E00
cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)	1	0	.00	-	 < 0.2	1.00E00
nitric oxide homeostasis (GO:0033484)	3	1	.01	+	79.55	1.00E00
gas homeostasis (GO:0033483)	9	1	.04	+	26.52	1.00E00
positive regulation of renal water transport (GO:2001153)	1	0	.00	-	 < 0.2	1.00E00
T cell proliferation involved in immune response (GO:0002309)	5	0	.02	-	 < 0.2	1.00E00
regulation of renal water transport (GO:2001151)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dipeptide transmembrane transport (GO:2001150)	2	0	.01	-	 < 0.2	1.00E00
CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)	2	0	.01	-	 < 0.2	1.00E00
gamma-delta intraepithelial T cell differentiation (GO:0002304)	2	0	.01	-	 < 0.2	1.00E00
CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	2	0	.01	-	 < 0.2	1.00E00
CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)	1	0	.00	-	 < 0.2	1.00E00
endothelial cell differentiation (GO:0045446)	73	3	.31	+	9.81	1.00E00
myoblast differentiation (GO:0045445)	38	3	.16	+	18.84	1.00E00
fat cell differentiation (GO:0045444)	109	0	.46	-	 < 0.2	1.00E00
S-methylmethionine metabolic process (GO:0033477)	1	0	.00	-	 < 0.2	1.00E00
regulation of dipeptide transmembrane transport (GO:2001148)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	1	0	.00	-	 < 0.2	1.00E00
nicotinate transport (GO:2001142)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of phospholipid transport (GO:2001140)	8	1	.03	+	29.83	1.00E00
regulation of phospholipid transport (GO:2001138)	8	1	.03	+	29.83	1.00E00
positive regulation of endocytic recycling (GO:2001137)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of endocytic recycling (GO:2001136)	1	0	.00	-	 < 0.2	1.00E00
regulation of endocytic recycling (GO:2001135)	8	0	.03	-	 < 0.2	1.00E00
protein-carbohydrate complex assembly (GO:0065006)	2	0	.01	-	 < 0.2	1.00E00
protein-lipid complex assembly (GO:0065005)	29	0	.12	-	 < 0.2	1.00E00
protein-DNA complex assembly (GO:0065004)	195	1	.82	+	1.22	1.00E00
macromolecular complex assembly (GO:0065003)	1496	15	6.27	+	2.39	1.00E00
intracellular protein transmembrane transport (GO:0065002)	56	0	.23	-	 < 0.2	1.00E00
specification of axis polarity (GO:0065001)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of nitric oxide biosynthetic process (GO:0045429)	44	2	.18	+	10.85	1.00E00
nonribosomal peptide biosynthetic process (GO:0019184)	18	0	.08	-	 < 0.2	1.00E00
regulation of nitric oxide biosynthetic process (GO:0045428)	57	3	.24	+	12.56	1.00E00
positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045425)	3	1	.01	+	79.55	1.00E00
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045423)	4	1	.02	+	59.66	1.00E00
positive regulation of interleukin-8 biosynthetic process (GO:0045416)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of interleukin-8 biosynthetic process (GO:0045415)	4	0	.02	-	 < 0.2	1.00E00
regulation of interleukin-8 biosynthetic process (GO:0045414)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of interleukin-6 biosynthetic process (GO:0045410)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lens epithelial cell proliferation (GO:2001111)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cytolysis by symbiont of host cells (GO:0001899)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of interleukin-6 biosynthetic process (GO:0045409)	5	0	.02	-	 < 0.2	1.00E00
regulation of cytolysis by symbiont of host cells (GO:0001898)	1	0	.00	-	 < 0.2	1.00E00
regulation of interleukin-6 biosynthetic process (GO:0045408)	16	0	.07	-	 < 0.2	1.00E00
cytolysis by symbiont of host cells (GO:0001897)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-5 biosynthetic process (GO:0045407)	1	0	.00	-	 < 0.2	1.00E00
retina homeostasis (GO:0001895)	71	1	.30	+	3.36	1.00E00
regulation of interleukin-5 biosynthetic process (GO:0045405)	1	0	.00	-	 < 0.2	1.00E00
tissue homeostasis (GO:0001894)	176	4	.74	+	5.42	1.00E00
positive regulation of interleukin-4 biosynthetic process (GO:0045404)	2	0	.01	-	 < 0.2	1.00E00
maternal placenta development (GO:0001893)	34	1	.14	+	7.02	1.00E00
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of interleukin-4 biosynthetic process (GO:0045403)	1	0	.00	-	 < 0.2	1.00E00
embryonic placenta development (GO:0001892)	90	4	.38	+	10.61	1.00E00
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	4	0	.02	-	 < 0.2	1.00E00
regulation of interleukin-4 biosynthetic process (GO:0045402)	3	0	.01	-	 < 0.2	1.00E00
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway (GO:0007197)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of interleukin-3 biosynthetic process (GO:0045401)	2	1	.01	+	 > 100	1.00E00
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196)	9	0	.04	-	 < 0.2	1.00E00
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of adenylate cyclase activity (GO:0007194)	33	1	.14	+	7.23	1.00E00
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193)	75	0	.31	-	 < 0.2	1.00E00
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	10	0	.04	-	 < 0.2	1.00E00
activation of adenylate cyclase activity (GO:0007190)	37	2	.16	+	12.90	1.00E00
regulation of lens epithelial cell proliferation (GO:2001109)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	2	0	.01	-	 < 0.2	1.00E00
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	4	0	.02	-	 < 0.2	1.00E00
selenium compound metabolic process (GO:0001887)	5	0	.02	-	 < 0.2	1.00E00
endothelial cell morphogenesis (GO:0001886)	11	1	.05	+	21.70	1.00E00
endothelial cell development (GO:0001885)	45	1	.19	+	5.30	1.00E00
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189)	66	0	.28	-	 < 0.2	1.00E00
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188)	154	0	.65	-	 < 0.2	1.00E00
receptor recycling (GO:0001881)	10	0	.04	-	 < 0.2	1.00E00
G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	181	0	.76	-	 < 0.2	1.00E00
Mullerian duct regression (GO:0001880)	4	0	.02	-	 < 0.2	1.00E00
G-protein coupled receptor signaling pathway (GO:0007186)	1206	6	5.05	+	1.19	1.00E00
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	6	0	.03	-	 < 0.2	1.00E00
SMAD protein import into nucleus (GO:0007184)	8	1	.03	+	29.83	1.00E00
SMAD protein complex assembly (GO:0007183)	8	0	.03	-	 < 0.2	1.00E00
common-partner SMAD protein phosphorylation (GO:0007182)	6	0	.03	-	 < 0.2	1.00E00
transforming growth factor beta receptor complex assembly (GO:0007181)	3	0	.01	-	 < 0.2	1.00E00
response to yeast (GO:0001878)	6	0	.03	-	 < 0.2	1.00E00
transforming growth factor beta receptor signaling pathway (GO:0007179)	95	2	.40	+	5.02	1.00E00
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	193	3	.81	+	3.71	1.00E00
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	29	1	.12	+	8.23	1.00E00
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	14	1	.06	+	17.05	1.00E00
epidermal growth factor catabolic process (GO:0007174)	1	0	.00	-	 < 0.2	1.00E00
signal complex assembly (GO:0007172)	8	1	.03	+	29.83	1.00E00
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	13	1	.05	+	18.36	1.00E00
regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199)	3	0	.01	-	 < 0.2	1.00E00
mesenchymal cell proliferation involved in ureter development (GO:0072198)	1	0	.00	-	 < 0.2	1.00E00
ureter morphogenesis (GO:0072197)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of complement activation, lectin pathway (GO:0001869)	2	0	.01	-	 < 0.2	1.00E00
regulation of complement activation, lectin pathway (GO:0001868)	2	0	.01	-	 < 0.2	1.00E00
kidney smooth muscle tissue development (GO:0072194)	2	0	.01	-	 < 0.2	1.00E00
complement activation, lectin pathway (GO:0001867)	10	0	.04	-	 < 0.2	1.00E00
ureter smooth muscle cell differentiation (GO:0072193)	3	0	.01	-	 < 0.2	1.00E00
NK T cell proliferation (GO:0001866)	2	0	.01	-	 < 0.2	1.00E00
ureter epithelial cell differentiation (GO:0072192)	1	0	.00	-	 < 0.2	1.00E00
NK T cell differentiation (GO:0001865)	2	0	.01	-	 < 0.2	1.00E00
ureter smooth muscle development (GO:0072191)	3	0	.01	-	 < 0.2	1.00E00
ureter urothelium development (GO:0072190)	3	0	.01	-	 < 0.2	1.00E00
receptor guanylyl cyclase signaling pathway (GO:0007168)	10	0	.04	-	 < 0.2	1.00E00
establishment of tissue polarity (GO:0007164)	21	0	.09	-	 < 0.2	1.00E00
establishment or maintenance of cell polarity (GO:0007163)	162	1	.68	+	1.47	1.00E00
calcium-independent cell-matrix adhesion (GO:0007161)	4	1	.02	+	59.66	1.00E00
cell-matrix adhesion (GO:0007160)	120	5	.50	+	9.94	1.00E00
ureter development (GO:0072189)	12	0	.05	-	 < 0.2	1.00E00
metanephric cap morphogenesis (GO:0072186)	1	0	.00	-	 < 0.2	1.00E00
metanephric cap development (GO:0072185)	1	0	.00	-	 < 0.2	1.00E00
renal vesicle progenitor cell differentiation (GO:0072184)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	2	0	.01	-	 < 0.2	1.00E00
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	12	0	.05	-	 < 0.2	1.00E00
mesonephric duct formation (GO:0072181)	2	0	.01	-	 < 0.2	1.00E00
mesonephric duct morphogenesis (GO:0072180)	4	0	.02	-	 < 0.2	1.00E00
leukocyte cell-cell adhesion (GO:0007159)	45	2	.19	+	10.61	1.00E00
neuron cell-cell adhesion (GO:0007158)	15	0	.06	-	 < 0.2	1.00E00
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	50	1	.21	+	4.77	1.00E00
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	156	4	.65	+	6.12	1.00E00
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	4	0	.02	-	 < 0.2	1.00E00
nephric duct formation (GO:0072179)	5	0	.02	-	 < 0.2	1.00E00
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	17	0	.07	-	 < 0.2	1.00E00
nephric duct morphogenesis (GO:0072178)	12	0	.05	-	 < 0.2	1.00E00
mesonephric duct development (GO:0072177)	8	0	.03	-	 < 0.2	1.00E00
nephric duct development (GO:0072176)	15	0	.06	-	 < 0.2	1.00E00
epithelial tube formation (GO:0072175)	133	2	.56	+	3.59	1.00E00
metanephric tubule formation (GO:0072174)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.00	-	 < 0.2	1.00E00
metanephric tubule morphogenesis (GO:0072173)	10	0	.04	-	 < 0.2	1.00E00
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.00	-	 < 0.2	1.00E00
mesonephric tubule formation (GO:0072172)	8	0	.03	-	 < 0.2	1.00E00
phagolysosome assembly (GO:0001845)	11	0	.05	-	 < 0.2	1.00E00
mesonephric tubule morphogenesis (GO:0072171)	53	1	.22	+	4.50	1.00E00
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844)	7	0	.03	-	 < 0.2	1.00E00
metanephric tubule development (GO:0072170)	18	0	.08	-	 < 0.2	1.00E00
neural tube closure (GO:0001843)	90	2	.38	+	5.30	1.00E00
neural fold formation (GO:0001842)	8	0	.03	-	 < 0.2	1.00E00
neural tube formation (GO:0001841)	105	2	.44	+	4.55	1.00E00
female meiosis II (GO:0007147)	2	0	.01	-	 < 0.2	1.00E00
neural plate development (GO:0001840)	10	0	.04	-	 < 0.2	1.00E00
meiotic recombination nodule assembly (GO:0007146)	1	0	.00	-	 < 0.2	1.00E00
female meiosis I (GO:0007144)	7	0	.03	-	 < 0.2	1.00E00
female meiotic nuclear division (GO:0007143)	29	2	.12	+	16.46	1.00E00
male meiosis I (GO:0007141)	22	1	.09	+	10.85	1.00E00
male meiotic nuclear division (GO:0007140)	46	2	.19	+	10.38	1.00E00
positive regulation of rubidium ion transmembrane transporter activity (GO:2000688)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of rubidium ion transmembrane transporter activity (GO:2000687)	3	0	.01	-	 < 0.2	1.00E00
specification of posterior mesonephric tubule identity (GO:0072169)	1	0	.00	-	 < 0.2	1.00E00
regulation of rubidium ion transmembrane transporter activity (GO:2000686)	4	0	.02	-	 < 0.2	1.00E00
specification of anterior mesonephric tubule identity (GO:0072168)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cellular response to X-ray (GO:2000685)	1	0	.00	-	 < 0.2	1.00E00
specification of mesonephric tubule identity (GO:0072167)	1	0	.00	-	 < 0.2	1.00E00
posterior mesonephric tubule development (GO:0072166)	2	0	.01	-	 < 0.2	1.00E00
regulation of cellular response to X-ray (GO:2000683)	2	0	.01	-	 < 0.2	1.00E00
neural plate morphogenesis (GO:0001839)	7	0	.03	-	 < 0.2	1.00E00
anterior mesonephric tubule development (GO:0072165)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of rubidium ion transport (GO:2000682)	1	0	.00	-	 < 0.2	1.00E00
embryonic epithelial tube formation (GO:0001838)	125	2	.52	+	3.82	1.00E00
mesonephric tubule development (GO:0072164)	86	1	.36	+	2.78	1.00E00
negative regulation of rubidium ion transport (GO:2000681)	3	0	.01	-	 < 0.2	1.00E00
epithelial to mesenchymal transition (GO:0001837)	66	1	.28	+	3.62	1.00E00
mesonephric epithelium development (GO:0072163)	86	1	.36	+	2.78	1.00E00
regulation of rubidium ion transport (GO:2000680)	5	0	.02	-	 < 0.2	1.00E00
release of cytochrome c from mitochondria (GO:0001836)	22	3	.09	+	32.54	1.00E00
male somatic sex determination (GO:0019102)	1	1	.00	+	 > 100	1.00E00
metanephric mesenchymal cell differentiation (GO:0072162)	5	0	.02	-	 < 0.2	1.00E00
blastocyst hatching (GO:0001835)	2	0	.01	-	 < 0.2	1.00E00
female somatic sex determination (GO:0019101)	1	0	.00	-	 < 0.2	1.00E00
mesenchymal cell differentiation involved in kidney development (GO:0072161)	8	0	.03	-	 < 0.2	1.00E00
trophectodermal cell proliferation (GO:0001834)	1	0	.00	-	 < 0.2	1.00E00
male germ-line sex determination (GO:0019100)	2	0	.01	-	 < 0.2	1.00E00
nephron tubule epithelial cell differentiation (GO:0072160)	2	0	.01	-	 < 0.2	1.00E00
inner cell mass cell proliferation (GO:0001833)	12	2	.05	+	39.78	1.00E00
blastocyst growth (GO:0001832)	17	2	.07	+	28.08	1.00E00
trophectodermal cellular morphogenesis (GO:0001831)	2	0	.01	-	 < 0.2	1.00E00
cloacal septation (GO:0060197)	3	0	.01	-	 < 0.2	1.00E00
meiosis II (GO:0007135)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of lipase activity (GO:0060193)	64	4	.27	+	14.92	1.00E00
negative regulation of lipase activity (GO:0060192)	15	0	.06	-	 < 0.2	1.00E00
reciprocal meiotic recombination (GO:0007131)	47	1	.20	+	5.08	1.00E00
regulation of lipase activity (GO:0060191)	87	4	.36	+	10.97	1.00E00
synaptonemal complex assembly (GO:0007130)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of transcription regulatory region DNA binding (GO:2000679)	22	1	.09	+	10.85	1.00E00
negative regulation of transcription regulatory region DNA binding (GO:2000678)	21	0	.09	-	 < 0.2	1.00E00
regulation of transcription regulatory region DNA binding (GO:2000677)	47	1	.20	+	5.08	1.00E00
positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	6	0	.03	-	 < 0.2	1.00E00
regulation of type B pancreatic cell apoptotic process (GO:2000674)	10	0	.04	-	 < 0.2	1.00E00
distal tubule morphogenesis (GO:0072156)	3	0	.01	-	 < 0.2	1.00E00
trophectodermal cell differentiation (GO:0001829)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of motor neuron apoptotic process (GO:2000672)	4	0	.02	-	 < 0.2	1.00E00
inner cell mass cellular morphogenesis (GO:0001828)	2	0	.01	-	 < 0.2	1.00E00
regulation of motor neuron apoptotic process (GO:2000671)	5	0	.02	-	 < 0.2	1.00E00
inner cell mass cell fate commitment (GO:0001827)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of dendritic cell apoptotic process (GO:2000670)	3	0	.01	-	 < 0.2	1.00E00
inner cell mass cell differentiation (GO:0001826)	7	0	.03	-	 < 0.2	1.00E00
blastocyst formation (GO:0001825)	31	0	.13	-	 < 0.2	1.00E00
blastocyst development (GO:0001824)	66	2	.28	+	7.23	1.00E00
mesonephros development (GO:0001823)	90	1	.38	+	2.65	1.00E00
synapsis (GO:0007129)	47	0	.20	-	 < 0.2	1.00E00
histamine secretion (GO:0001821)	7	0	.03	-	 < 0.2	1.00E00
meiosis I (GO:0007127)	111	3	.47	+	6.45	1.00E00
serotonin secretion (GO:0001820)	4	1	.02	+	59.66	1.00E00
cell cycle switching (GO:0060184)	2	0	.01	-	 < 0.2	1.00E00
apelin receptor signaling pathway (GO:0060183)	2	0	.01	-	 < 0.2	1.00E00
response to host immune response (GO:0052572)	6	0	.03	-	 < 0.2	1.00E00
female mating behavior (GO:0060180)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of dendritic cell apoptotic process (GO:2000669)	3	1	.01	+	79.55	1.00E00
regulation of dendritic cell apoptotic process (GO:2000668)	6	1	.03	+	39.78	1.00E00
positive regulation of interleukin-13 secretion (GO:2000667)	6	0	.03	-	 < 0.2	1.00E00
cell part morphogenesis (GO:0032990)	483	7	2.02	+	3.46	1.00E00
negative regulation of interleukin-13 secretion (GO:2000666)	3	0	.01	-	 < 0.2	1.00E00
epithelial cell fate commitment (GO:0072148)	16	0	.07	-	 < 0.2	1.00E00
regulation of interleukin-13 secretion (GO:2000665)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of interleukin-5 secretion (GO:2000664)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of interleukin-5 secretion (GO:2000663)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-5 secretion (GO:2000662)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of cytokine production (GO:0001818)	244	5	1.02	+	4.89	1.00E00
glomerular mesangial cell development (GO:0072144)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of interleukin-1-mediated signaling pathway (GO:2000661)	1	0	.00	-	 < 0.2	1.00E00
mesangial cell development (GO:0072143)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	4	0	.02	-	 < 0.2	1.00E00
cytokine production (GO:0001816)	136	1	.57	+	1.75	1.00E00
renal interstitial fibroblast development (GO:0072141)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of antibody-dependent cellular cytotoxicity (GO:0001814)	1	0	.00	-	 < 0.2	1.00E00
regulation of antibody-dependent cellular cytotoxicity (GO:0001813)	1	0	.00	-	 < 0.2	1.00E00
male mating behavior (GO:0060179)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of type I hypersensitivity (GO:0001812)	3	0	.01	-	 < 0.2	1.00E00
regulation of exocyst localization (GO:0060178)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of type I hypersensitivity (GO:0001811)	1	0	.00	-	 < 0.2	1.00E00
regulation of angiotensin metabolic process (GO:0060177)	12	1	.05	+	19.89	1.00E00
regulation of type I hypersensitivity (GO:0001810)	4	0	.02	-	 < 0.2	1.00E00
response to defense-related host reactive oxygen species production (GO:0052567)	1	0	.00	-	 < 0.2	1.00E00
response to defense-related host nitric oxide production (GO:0052565)	1	0	.00	-	 < 0.2	1.00E00
limb bud formation (GO:0060174)	10	0	.04	-	 < 0.2	1.00E00
endomitotic cell cycle (GO:0007113)	3	0	.01	-	 < 0.2	1.00E00
response to immune response of other organism involved in symbiotic interaction (GO:0052564)	6	0	.03	-	 < 0.2	1.00E00
limb development (GO:0060173)	173	0	.72	-	 < 0.2	1.00E00
negative regulation by symbiont of host immune response (GO:0052562)	1	0	.00	-	 < 0.2	1.00E00
negative regulation by organism of immune response of other organism involved in symbiotic interaction (GO:0052561)	1	0	.00	-	 < 0.2	1.00E00
ribonucleoprotein complex disassembly (GO:0032988)	14	0	.06	-	 < 0.2	1.00E00
protein-DNA complex disassembly (GO:0032986)	20	0	.08	-	 < 0.2	1.00E00
macromolecular complex disassembly (GO:0032984)	218	2	.91	+	2.19	1.00E00
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	6	0	.03	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex I assembly (GO:0032981)	65	0	.27	-	 < 0.2	1.00E00
negative regulation of apolipoprotein binding (GO:2000657)	1	0	.00	-	 < 0.2	1.00E00
keratinocyte activation (GO:0032980)	1	0	.00	-	 < 0.2	1.00E00
glomerular parietal epithelial cell differentiation (GO:0072139)	3	0	.01	-	 < 0.2	1.00E00
regulation of apolipoprotein binding (GO:2000656)	1	0	.00	-	 < 0.2	1.00E00
mesenchymal cell proliferation involved in ureteric bud development (GO:0072138)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.00	-	 < 0.2	1.00E00
condensed mesenchymal cell proliferation (GO:0072137)	4	0	.02	-	 < 0.2	1.00E00
regulation of cellular response to testosterone stimulus (GO:2000654)	1	0	.00	-	 < 0.2	1.00E00
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	3	0	.01	-	 < 0.2	1.00E00
regulation of genetic imprinting (GO:2000653)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of type IV hypersensitivity (GO:0001809)	1	0	.00	-	 < 0.2	1.00E00
kidney mesenchymal cell proliferation (GO:0072135)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of type IV hypersensitivity (GO:0001808)	2	0	.01	-	 < 0.2	1.00E00
nephrogenic mesenchyme morphogenesis (GO:0072134)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	14	0	.06	-	 < 0.2	1.00E00
regulation of type IV hypersensitivity (GO:0001807)	3	0	.01	-	 < 0.2	1.00E00
metanephric mesenchyme morphogenesis (GO:0072133)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	10	0	.04	-	 < 0.2	1.00E00
type IV hypersensitivity (GO:0001806)	2	0	.01	-	 < 0.2	1.00E00
mesenchyme morphogenesis (GO:0072132)	44	2	.18	+	10.85	1.00E00
positive regulation of type III hypersensitivity (GO:0001805)	2	0	.01	-	 < 0.2	1.00E00
kidney mesenchyme morphogenesis (GO:0072131)	3	0	.01	-	 < 0.2	1.00E00
renal capsule specification (GO:0072130)	1	0	.00	-	 < 0.2	1.00E00
regulation of type III hypersensitivity (GO:0001803)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of adenosine receptor signaling pathway (GO:0060169)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein autoubiquitination (GO:1902499)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of adenosine receptor signaling pathway (GO:0060168)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein autoubiquitination (GO:1902498)	4	0	.02	-	 < 0.2	1.00E00
regulation of adenosine receptor signaling pathway (GO:0060167)	4	0	.02	-	 < 0.2	1.00E00
olfactory pit development (GO:0060166)	3	0	.01	-	 < 0.2	1.00E00
regulation of timing of subpallium neuron differentiation (GO:0060165)	1	0	.00	-	 < 0.2	1.00E00
regulation of timing of neuron differentiation (GO:0060164)	4	0	.02	-	 < 0.2	1.00E00
subpallium neuron fate commitment (GO:0060163)	2	0	.01	-	 < 0.2	1.00E00
modulation by symbiont of host immune response (GO:0052553)	3	0	.01	-	 < 0.2	1.00E00
modulation by organism of immune response of other organism involved in symbiotic interaction (GO:0052552)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of dopamine receptor signaling pathway (GO:0060161)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of sperm capacitation (GO:1902491)	1	0	.00	-	 < 0.2	1.00E00
mitotic centrosome separation (GO:0007100)	6	0	.03	-	 < 0.2	1.00E00
response to defense-related nitric oxide production by other organism involved in symbiotic interaction (GO:0052551)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of dopamine receptor signaling pathway (GO:0060160)	3	0	.01	-	 < 0.2	1.00E00
regulation of sperm capacitation (GO:1902490)	2	0	.01	-	 < 0.2	1.00E00
response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction (GO:0052550)	1	0	.00	-	 < 0.2	1.00E00
protein insertion into mitochondrial membrane from inner side (GO:0032979)	1	0	.00	-	 < 0.2	1.00E00
protein insertion into membrane from inner side (GO:0032978)	1	0	.00	-	 < 0.2	1.00E00
release of matrix enzymes from mitochondria (GO:0032976)	1	0	.00	-	 < 0.2	1.00E00
regulation of sodium ion transmembrane transporter activity (GO:2000649)	49	0	.21	-	 < 0.2	1.00E00
regulation of muscle filament sliding speed (GO:0032972)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of stem cell proliferation (GO:2000648)	39	0	.16	-	 < 0.2	1.00E00
regulation of muscle filament sliding (GO:0032971)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of stem cell proliferation (GO:2000647)	11	0	.05	-	 < 0.2	1.00E00
regulation of actin filament-based process (GO:0032970)	340	6	1.42	+	4.21	1.00E00
renal capsule formation (GO:0072129)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of receptor catabolic process (GO:2000646)	5	0	.02	-	 < 0.2	1.00E00
renal capsule morphogenesis (GO:0072128)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of receptor catabolic process (GO:2000645)	3	0	.01	-	 < 0.2	1.00E00
renal capsule development (GO:0072127)	1	0	.00	-	 < 0.2	1.00E00
regulation of receptor catabolic process (GO:2000644)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of glomerular mesangial cell proliferation (GO:0072126)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of early endosome to late endosome transport (GO:2000643)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of glomerular mesangial cell proliferation (GO:0072125)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.01	-	 < 0.2	1.00E00
regulation of glomerular mesangial cell proliferation (GO:0072124)	9	0	.04	-	 < 0.2	1.00E00
regulation of early endosome to late endosome transport (GO:2000641)	17	2	.07	+	28.08	1.00E00
regulation of dopamine receptor signaling pathway (GO:0060159)	10	0	.04	-	 < 0.2	1.00E00
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	13	0	.05	-	 < 0.2	1.00E00
regulation of endopeptidase activity (GO:0052548)	392	8	1.64	+	4.87	1.00E00
urinary bladder development (GO:0060157)	5	0	.02	-	 < 0.2	1.00E00
platelet dense granule organization (GO:0060155)	8	0	.03	-	 < 0.2	1.00E00
cellular process regulating host cell cycle in response to virus (GO:0060154)	3	0	.01	-	 < 0.2	1.00E00
microtubule-based peroxisome localization (GO:0060152)	2	0	.01	-	 < 0.2	1.00E00
peroxisome localization (GO:0060151)	2	0	.01	-	 < 0.2	1.00E00
protein localization to mitotic spindle (GO:1902480)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of collagen biosynthetic process (GO:0032967)	25	2	.10	+	19.09	1.00E00
negative regulation of collagen biosynthetic process (GO:0032966)	8	1	.03	+	29.83	1.00E00
regulation of collagen biosynthetic process (GO:0032965)	33	3	.14	+	21.70	1.00E00
collagen biosynthetic process (GO:0032964)	8	0	.03	-	 < 0.2	1.00E00
collagen metabolic process (GO:0032963)	80	2	.34	+	5.97	1.00E00
negative regulation of SREBP signaling pathway (GO:2000639)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	5	0	.02	-	 < 0.2	1.00E00
regulation of SREBP signaling pathway (GO:2000638)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of gene silencing by miRNA (GO:2000637)	21	1	.09	+	11.36	1.00E00
regulation of inositol trisphosphate biosynthetic process (GO:0032960)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of pre-miRNA processing (GO:2000632)	1	0	.00	-	 < 0.2	1.00E00
pronephros morphogenesis (GO:0072114)	2	0	.01	-	 < 0.2	1.00E00
regulation of pre-miRNA processing (GO:2000631)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of miRNA metabolic process (GO:2000630)	5	0	.02	-	 < 0.2	1.00E00
glomerular visceral epithelial cell differentiation (GO:0072112)	17	1	.07	+	14.04	1.00E00
cell proliferation involved in kidney development (GO:0072111)	10	1	.04	+	23.87	1.00E00
glomerular mesangial cell proliferation (GO:0072110)	2	1	.01	+	 > 100	1.00E00
negative regulation of posttranscriptional gene silencing (GO:0060149)	13	1	.05	+	18.36	1.00E00
positive regulation of posttranscriptional gene silencing (GO:0060148)	22	1	.09	+	10.85	1.00E00
regulation of posttranscriptional gene silencing (GO:0060147)	84	3	.35	+	8.52	1.00E00
chloride transmembrane transport (GO:1902476)	94	0	.39	-	 < 0.2	1.00E00
L-alpha-amino acid transmembrane transport (GO:1902475)	36	0	.15	-	 < 0.2	1.00E00
positive regulation of protein localization to synapse (GO:1902474)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	25	1	.10	+	9.55	1.00E00
regulation of protein localization to synapse (GO:1902473)	7	0	.03	-	 < 0.2	1.00E00
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	27	1	.11	+	8.84	1.00E00
inositol trisphosphate biosynthetic process (GO:0032959)	3	0	.01	-	 < 0.2	1.00E00
inositol phosphate biosynthetic process (GO:0032958)	8	0	.03	-	 < 0.2	1.00E00
inositol trisphosphate metabolic process (GO:0032957)	5	0	.02	-	 < 0.2	1.00E00
regulation of actin cytoskeleton organization (GO:0032956)	298	5	1.25	+	4.00	1.00E00
regulation of cytokinetic process (GO:0032954)	2	0	.01	-	 < 0.2	1.00E00
regulation of miRNA metabolic process (GO:2000628)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of miRNA catabolic process (GO:2000627)	2	0	.01	-	 < 0.2	1.00E00
glomerular mesangium development (GO:0072109)	8	1	.03	+	29.83	1.00E00
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)	4	0	.02	-	 < 0.2	1.00E00
regulation of miRNA catabolic process (GO:2000625)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ureteric bud formation (GO:0072107)	4	0	.02	-	 < 0.2	1.00E00
regulation of ureteric bud formation (GO:0072106)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	4	0	.02	-	 < 0.2	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	4	0	.02	-	 < 0.2	1.00E00
glomerular capillary formation (GO:0072104)	5	2	.02	+	95.46	1.00E00
glomerulus vasculature morphogenesis (GO:0072103)	5	2	.02	+	95.46	1.00E00
positive regulation of histone H4-K16 acetylation (GO:2000620)	2	0	.01	-	 < 0.2	1.00E00
glomerulus morphogenesis (GO:0072102)	8	2	.03	+	59.66	1.00E00
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101)	1	0	.00	-	 < 0.2	1.00E00
specification of ureteric bud anterior/posterior symmetry (GO:0072100)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of apoptotic process by virus (GO:0060139)	2	0	.01	-	 < 0.2	1.00E00
maternal process involved in parturition (GO:0060137)	9	0	.04	-	 < 0.2	1.00E00
embryonic process involved in female pregnancy (GO:0060136)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of histone H3-K27 trimethylation (GO:1902466)	1	0	.00	-	 < 0.2	1.00E00
maternal process involved in female pregnancy (GO:0060135)	62	3	.26	+	11.55	1.00E00
prepulse inhibition (GO:0060134)	13	0	.05	-	 < 0.2	1.00E00
regulation of histone H3-K27 trimethylation (GO:1902464)	1	0	.00	-	 < 0.2	1.00E00
somatotropin secreting cell development (GO:0060133)	2	0	.01	-	 < 0.2	1.00E00
protein localization to cell leading edge (GO:1902463)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mesenchymal stem cell proliferation (GO:1902462)	1	0	.00	-	 < 0.2	1.00E00
positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction (GO:0052522)	1	0	.00	-	 < 0.2	1.00E00
regulation of mesenchymal stem cell proliferation (GO:1902460)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mononuclear cell proliferation (GO:0032945)	73	4	.31	+	13.08	1.00E00
mononuclear cell proliferation (GO:0032943)	83	2	.35	+	5.75	1.00E00
negative regulation of histone H4-K16 acetylation (GO:2000619)	3	0	.01	-	 < 0.2	1.00E00
regulation of histone H4-K16 acetylation (GO:2000618)	5	0	.02	-	 < 0.2	1.00E00
secretion by tissue (GO:0032941)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of histone H3-K9 acetylation (GO:2000617)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of histone H3-K9 acetylation (GO:2000616)	2	0	.01	-	 < 0.2	1.00E00
regulation of histone H3-K9 acetylation (GO:2000615)	11	1	.05	+	21.70	1.00E00
regulation of thyroid-stimulating hormone secretion (GO:2000612)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of thyroid hormone generation (GO:2000611)	3	0	.01	-	 < 0.2	1.00E00
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of stem cell population maintenance (GO:1902459)	6	0	.03	-	 < 0.2	1.00E00
corticotropin hormone secreting cell differentiation (GO:0060128)	2	0	.01	-	 < 0.2	1.00E00
prolactin secreting cell differentiation (GO:0060127)	1	0	.00	-	 < 0.2	1.00E00
somatotropin secreting cell differentiation (GO:0060126)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of growth hormone secretion (GO:0060125)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of stem cell population maintenance (GO:1902455)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of growth hormone secretion (GO:0060124)	9	0	.04	-	 < 0.2	1.00E00
regulation of growth hormone secretion (GO:0060123)	13	0	.05	-	 < 0.2	1.00E00
inner ear receptor stereocilium organization (GO:0060122)	30	0	.13	-	 < 0.2	1.00E00
bile acid biosynthetic process (GO:0006699)	28	0	.12	-	 < 0.2	1.00E00
inner ear receptor cell fate commitment (GO:0060120)	6	0	.03	-	 < 0.2	1.00E00
positive regulation by organism of defense response of other organism involved in symbiotic interaction (GO:0052510)	2	0	.01	-	 < 0.2	1.00E00
ergosterol biosynthetic process (GO:0006696)	2	0	.01	-	 < 0.2	1.00E00
cholesterol biosynthetic process (GO:0006695)	41	1	.17	+	5.82	1.00E00
steroid biosynthetic process (GO:0006694)	127	2	.53	+	3.76	1.00E00
negative regulation of translation in response to oxidative stress (GO:0032938)	1	0	.00	-	 < 0.2	1.00E00
prostaglandin metabolic process (GO:0006693)	29	0	.12	-	 < 0.2	1.00E00
prostanoid metabolic process (GO:0006692)	29	0	.12	-	 < 0.2	1.00E00
leukotriene metabolic process (GO:0006691)	32	1	.13	+	7.46	1.00E00
icosanoid metabolic process (GO:0006690)	105	1	.44	+	2.27	1.00E00
SREBP signaling pathway (GO:0032933)	8	0	.03	-	 < 0.2	1.00E00
regulation of thyroid hormone generation (GO:2000609)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cell proliferation involved in mesonephros development (GO:2000607)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of superoxide anion generation (GO:0032930)	14	2	.06	+	34.09	1.00E00
regulation of cell proliferation involved in mesonephros development (GO:2000606)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	7	0	.03	-	 < 0.2	1.00E00
inner ear receptor cell development (GO:0060119)	44	0	.18	-	 < 0.2	1.00E00
positive regulation by symbiont of host defense response (GO:0052509)	2	0	.01	-	 < 0.2	1.00E00
vestibular receptor cell development (GO:0060118)	2	0	.01	-	 < 0.2	1.00E00
auditory receptor cell development (GO:0060117)	18	0	.08	-	 < 0.2	1.00E00
vestibular receptor cell morphogenesis (GO:0060116)	1	0	.00	-	 < 0.2	1.00E00
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	3	0	.01	-	 < 0.2	1.00E00
vestibular receptor cell differentiation (GO:0060114)	2	0	.01	-	 < 0.2	1.00E00
inner ear receptor cell differentiation (GO:0060113)	55	1	.23	+	4.34	1.00E00
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	1	0	.00	-	 < 0.2	1.00E00
generation of ovulation cycle rhythm (GO:0060112)	3	0	.01	-	 < 0.2	1.00E00
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	1	0	.00	-	 < 0.2	1.00E00
ganglioside catabolic process (GO:0006689)	6	0	.03	-	 < 0.2	1.00E00
glycosphingolipid biosynthetic process (GO:0006688)	22	0	.09	-	 < 0.2	1.00E00
positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052501)	3	0	.01	-	 < 0.2	1.00E00
glycosphingolipid metabolic process (GO:0006687)	71	0	.30	-	 < 0.2	1.00E00
sphingomyelin biosynthetic process (GO:0006686)	6	0	.03	-	 < 0.2	1.00E00
sphingomyelin catabolic process (GO:0006685)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of superoxide anion generation (GO:0032929)	3	0	.01	-	 < 0.2	1.00E00
sphingomyelin metabolic process (GO:0006684)	13	0	.05	-	 < 0.2	1.00E00
galactosylceramide catabolic process (GO:0006683)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of activin receptor signaling pathway (GO:0032927)	8	0	.03	-	 < 0.2	1.00E00
galactosylceramide biosynthetic process (GO:0006682)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of activin receptor signaling pathway (GO:0032926)	9	0	.04	-	 < 0.2	1.00E00
galactosylceramide metabolic process (GO:0006681)	8	0	.03	-	 < 0.2	1.00E00
regulation of activin receptor signaling pathway (GO:0032925)	23	0	.10	-	 < 0.2	1.00E00
glucosylceramide catabolic process (GO:0006680)	2	0	.01	-	 < 0.2	1.00E00
activin receptor signaling pathway (GO:0032924)	22	0	.09	-	 < 0.2	1.00E00
circadian regulation of gene expression (GO:0032922)	55	0	.23	-	 < 0.2	1.00E00
putrescine acetylation (GO:0032920)	1	0	.00	-	 < 0.2	1.00E00
glucosylceramide biosynthetic process (GO:0006679)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of phagocytosis, engulfment (GO:0060101)	1	0	.00	-	 < 0.2	1.00E00
glucosylceramide metabolic process (GO:0006678)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of phagocytosis, engulfment (GO:0060100)	9	1	.04	+	26.52	1.00E00
negative regulation of amyloid-beta formation (GO:1902430)	7	0	.03	-	 < 0.2	1.00E00
glycosylceramide metabolic process (GO:0006677)	16	0	.07	-	 < 0.2	1.00E00
spermine acetylation (GO:0032919)	1	0	.00	-	 < 0.2	1.00E00
spermidine acetylation (GO:0032918)	3	0	.01	-	 < 0.2	1.00E00
polyamine acetylation (GO:0032917)	3	0	.01	-	 < 0.2	1.00E00
ceramide metabolic process (GO:0006672)	79	0	.33	-	 < 0.2	1.00E00
positive regulation of transforming growth factor beta3 production (GO:0032916)	2	0	.01	-	 < 0.2	1.00E00
phytosphingosine metabolic process (GO:0006671)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transforming growth factor beta2 production (GO:0032915)	2	0	.01	-	 < 0.2	1.00E00
sphingosine metabolic process (GO:0006670)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of transforming growth factor beta1 production (GO:0032914)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of transforming growth factor beta3 production (GO:0032913)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transforming growth factor beta2 production (GO:0032912)	2	1	.01	+	 > 100	1.00E00
negative regulation of transforming growth factor beta1 production (GO:0032911)	4	0	.02	-	 < 0.2	1.00E00
regulation of transforming growth factor beta3 production (GO:0032910)	3	0	.01	-	 < 0.2	1.00E00
olfactory placode morphogenesis (GO:0071699)	4	0	.02	-	 < 0.2	1.00E00
olfactory placode development (GO:0071698)	4	0	.02	-	 < 0.2	1.00E00
ectodermal placode morphogenesis (GO:0071697)	14	0	.06	-	 < 0.2	1.00E00
ectodermal placode development (GO:0071696)	15	0	.06	-	 < 0.2	1.00E00
anatomical structure maturation (GO:0071695)	123	5	.52	+	9.70	1.00E00
maintenance of protein location in extracellular region (GO:0071694)	6	0	.03	-	 < 0.2	1.00E00
deactivation of mitotic spindle assembly checkpoint (GO:1902426)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	2	0	.01	-	 < 0.2	1.00E00
protein localization to extracellular region (GO:0071692)	6	0	.03	-	 < 0.2	1.00E00
cardiac muscle thin filament assembly (GO:0071691)	1	0	.00	-	 < 0.2	1.00E00
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	2	0	.01	-	 < 0.2	1.00E00
sphinganine-1-phosphate biosynthetic process (GO:0006669)	1	0	.00	-	 < 0.2	1.00E00
sphinganine-1-phosphate metabolic process (GO:0006668)	2	0	.01	-	 < 0.2	1.00E00
sphinganine metabolic process (GO:0006667)	3	0	.01	-	 < 0.2	1.00E00
3-keto-sphinganine metabolic process (GO:0006666)	1	0	.00	-	 < 0.2	1.00E00
sphingolipid metabolic process (GO:0006665)	157	0	.66	-	 < 0.2	1.00E00
regulation of transforming growth factor beta2 production (GO:0032909)	8	1	.03	+	29.83	1.00E00
glycolipid metabolic process (GO:0006664)	121	0	.51	-	 < 0.2	1.00E00
regulation of transforming growth factor beta1 production (GO:0032908)	9	0	.04	-	 < 0.2	1.00E00
platelet activating factor biosynthetic process (GO:0006663)	4	0	.02	-	 < 0.2	1.00E00
glycerol ether metabolic process (GO:0006662)	12	0	.05	-	 < 0.2	1.00E00
phosphatidylinositol biosynthetic process (GO:0006661)	138	4	.58	+	6.92	1.00E00
phosphatidylserine catabolic process (GO:0006660)	1	0	.00	-	 < 0.2	1.00E00
nerve growth factor production (GO:0032902)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neurotrophin production (GO:0032901)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of neurotrophin production (GO:0032900)	1	0	.00	-	 < 0.2	1.00E00
TORC2 signaling (GO:0038203)	5	0	.02	-	 < 0.2	1.00E00
TORC1 signaling (GO:0038202)	7	0	.03	-	 < 0.2	1.00E00
striated muscle myosin thick filament assembly (GO:0071688)	13	0	.05	-	 < 0.2	1.00E00
organism emergence from protective structure (GO:0071684)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mRNA binding (GO:1902416)	7	0	.03	-	 < 0.2	1.00E00
regulation of mRNA binding (GO:1902415)	9	0	.04	-	 < 0.2	1.00E00
protein localization to cell junction (GO:1902414)	11	1	.05	+	21.70	1.00E00
cellular response to indole-3-methanol (GO:0071681)	5	1	.02	+	47.73	1.00E00
response to indole-3-methanol (GO:0071680)	5	1	.02	+	47.73	1.00E00
regulation of mitotic cytokinesis (GO:1902412)	4	0	.02	-	 < 0.2	1.00E00
phosphatidylserine biosynthetic process (GO:0006659)	4	0	.02	-	 < 0.2	1.00E00
phosphatidylserine metabolic process (GO:0006658)	30	0	.13	-	 < 0.2	1.00E00
mitotic cytokinetic process (GO:1902410)	4	0	.02	-	 < 0.2	1.00E00
CDP-choline pathway (GO:0006657)	7	0	.03	-	 < 0.2	1.00E00
phosphatidylcholine biosynthetic process (GO:0006656)	34	0	.14	-	 < 0.2	1.00E00
phosphatidylglycerol biosynthetic process (GO:0006655)	9	0	.04	-	 < 0.2	1.00E00
phosphatidic acid biosynthetic process (GO:0006654)	41	0	.17	-	 < 0.2	1.00E00
diacylglycerol biosynthetic process (GO:0006651)	4	0	.02	-	 < 0.2	1.00E00
alpha-beta intraepithelial T cell differentiation (GO:0002299)	1	0	.00	-	 < 0.2	1.00E00
T-helper 1 cell lineage commitment (GO:0002296)	2	0	.01	-	 < 0.2	1.00E00
T-helper cell lineage commitment (GO:0002295)	9	0	.04	-	 < 0.2	1.00E00
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	25	0	.10	-	 < 0.2	1.00E00
alpha-beta T cell differentiation involved in immune response (GO:0002293)	27	0	.11	-	 < 0.2	1.00E00
T cell differentiation involved in immune response (GO:0002292)	31	0	.13	-	 < 0.2	1.00E00
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	3	0	.01	-	 < 0.2	1.00E00
commissural neuron axon guidance (GO:0071679)	8	0	.03	-	 < 0.2	1.00E00
olfactory bulb axon guidance (GO:0071678)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mononuclear cell migration (GO:0071677)	24	1	.10	+	9.94	1.00E00
negative regulation of mononuclear cell migration (GO:0071676)	6	0	.03	-	 < 0.2	1.00E00
regulation of mononuclear cell migration (GO:0071675)	42	3	.18	+	17.05	1.00E00
mononuclear cell migration (GO:0071674)	43	0	.18	-	 < 0.2	1.00E00
positive regulation of smooth muscle cell chemotaxis (GO:0071673)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of smooth muscle cell chemotaxis (GO:0071672)	4	0	.02	-	 < 0.2	1.00E00
regulation of smooth muscle cell chemotaxis (GO:0071671)	6	0	.03	-	 < 0.2	1.00E00
smooth muscle cell chemotaxis (GO:0071670)	2	1	.01	+	 > 100	1.00E00
phospholipid transfer to membrane (GO:0006649)	2	0	.01	-	 < 0.2	1.00E00
phosphatidylethanolamine biosynthetic process (GO:0006646)	14	0	.06	-	 < 0.2	1.00E00
phospholipid metabolic process (GO:0006644)	418	8	1.75	+	4.57	1.00E00
membrane lipid metabolic process (GO:0006643)	211	0	.88	-	 < 0.2	1.00E00
triglyceride mobilization (GO:0006642)	4	0	.02	-	 < 0.2	1.00E00
triglyceride metabolic process (GO:0006641)	74	1	.31	+	3.23	1.00E00
alpha-beta T cell activation involved in immune response (GO:0002287)	27	0	.11	-	 < 0.2	1.00E00
T cell activation involved in immune response (GO:0002286)	61	0	.26	-	 < 0.2	1.00E00
lymphocyte activation involved in immune response (GO:0002285)	102	0	.43	-	 < 0.2	1.00E00
neutrophil activation involved in immune response (GO:0002283)	484	9	2.03	+	4.44	1.00E00
microglial cell activation involved in immune response (GO:0002282)	3	0	.01	-	 < 0.2	1.00E00
macrophage activation involved in immune response (GO:0002281)	12	1	.05	+	19.89	1.00E00
positive regulation of granzyme B production (GO:0071663)	3	0	.01	-	 < 0.2	1.00E00
regulation of granzyme B production (GO:0071661)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of IP-10 production (GO:0071660)	1	0	.00	-	 < 0.2	1.00E00
acylglycerol metabolic process (GO:0006639)	91	1	.38	+	2.62	1.00E00
neutral lipid metabolic process (GO:0006638)	92	1	.39	+	2.59	1.00E00
acyl-CoA metabolic process (GO:0006637)	91	1	.38	+	2.62	1.00E00
unsaturated fatty acid biosynthetic process (GO:0006636)	34	0	.14	-	 < 0.2	1.00E00
fatty acid beta-oxidation (GO:0006635)	58	0	.24	-	 < 0.2	1.00E00
fatty acid biosynthetic process (GO:0006633)	96	2	.40	+	4.97	1.00E00
tRNA demethylation (GO:1990983)	1	0	.00	-	 < 0.2	1.00E00
fatty acid metabolic process (GO:0006631)	300	4	1.26	+	3.18	1.00E00
mast cell activation involved in immune response (GO:0002279)	17	0	.07	-	 < 0.2	1.00E00
eosinophil activation involved in immune response (GO:0002278)	3	0	.01	-	 < 0.2	1.00E00
myeloid dendritic cell activation involved in immune response (GO:0002277)	3	0	.01	-	 < 0.2	1.00E00
basophil activation involved in immune response (GO:0002276)	1	1	.00	+	 > 100	1.00E00
plasmacytoid dendritic cell activation (GO:0002270)	1	0	.00	-	 < 0.2	1.00E00
regulation of IP-10 production (GO:0071658)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of granulocyte colony-stimulating factor production (GO:0071656)	1	0	.00	-	 < 0.2	1.00E00
regulation of granulocyte colony-stimulating factor production (GO:0071655)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	4	0	.02	-	 < 0.2	1.00E00
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.02	-	 < 0.2	1.00E00
protein targeting to mitochondrion (GO:0006626)	55	1	.23	+	4.34	1.00E00
protein targeting to peroxisome (GO:0006625)	17	0	.07	-	 < 0.2	1.00E00
vacuolar protein processing (GO:0006624)	2	0	.01	-	 < 0.2	1.00E00
protein targeting to vacuole (GO:0006623)	28	0	.12	-	 < 0.2	1.00E00
protein targeting to lysosome (GO:0006622)	21	0	.09	-	 < 0.2	1.00E00
protein retention in ER lumen (GO:0006621)	9	0	.04	-	 < 0.2	1.00E00
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	6	0	.03	-	 < 0.2	1.00E00
follicular dendritic cell differentiation (GO:0002268)	2	0	.01	-	 < 0.2	1.00E00
follicular dendritic cell activation (GO:0002266)	3	0	.01	-	 < 0.2	1.00E00
astrocyte activation involved in immune response (GO:0002265)	3	0	.01	-	 < 0.2	1.00E00
endothelial cell activation involved in immune response (GO:0002264)	1	0	.00	-	 < 0.2	1.00E00
cell activation involved in immune response (GO:0002263)	611	10	2.56	+	3.91	1.00E00
myeloid cell homeostasis (GO:0002262)	97	4	.41	+	9.84	1.00E00
lymphocyte homeostasis (GO:0002260)	55	3	.23	+	13.02	1.00E00
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644)	1	0	.00	-	 < 0.2	1.00E00
regulation of chemokine (C-C motif) ligand 4 production (GO:0071643)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	2	0	.01	-	 < 0.2	1.00E00
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	4	0	.02	-	 < 0.2	1.00E00
modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.00	-	 < 0.2	1.00E00
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	3	0	.01	-	 < 0.2	1.00E00
modulation by host of RNA binding by virus (GO:1990968)	1	0	.00	-	 < 0.2	1.00E00
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	7	0	.03	-	 < 0.2	1.00E00
multi-organism toxin transport (GO:1990967)	2	0	.01	-	 < 0.2	1.00E00
ATP generation from poly-ADP-D-ribose (GO:1990966)	4	0	.02	-	 < 0.2	1.00E00
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	93	0	.39	-	 < 0.2	1.00E00
cotranslational protein targeting to membrane (GO:0006613)	99	0	.41	-	 < 0.2	1.00E00
protein targeting to membrane (GO:0006612)	133	0	.56	-	 < 0.2	1.00E00
establishment of blood-retinal barrier (GO:1990963)	1	0	.00	-	 < 0.2	1.00E00
protein export from nucleus (GO:0006611)	148	2	.62	+	3.23	1.00E00
drug transport across blood-brain barrier (GO:1990962)	1	0	.00	-	 < 0.2	1.00E00
ribosomal protein import into nucleus (GO:0006610)	8	0	.03	-	 < 0.2	1.00E00
kinin cascade (GO:0002254)	3	0	.01	-	 < 0.2	1.00E00
activation of immune response (GO:0002253)	568	9	2.38	+	3.78	1.00E00
organ or tissue specific immune response (GO:0002251)	29	0	.12	-	 < 0.2	1.00E00
regulation of interleukin-3 biosynthetic process (GO:0045399)	2	1	.01	+	 > 100	1.00E00
adaptive immune response (GO:0002250)	419	4	1.76	+	2.28	1.00E00
positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	6	0	.03	-	 < 0.2	1.00E00
regulation of monocyte chemotactic protein-1 production (GO:0071637)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of transforming growth factor beta production (GO:0071636)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of transforming growth factor beta production (GO:0071635)	8	1	.03	+	29.83	1.00E00
regulation of transforming growth factor beta production (GO:0071634)	27	1	.11	+	8.84	1.00E00
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	3	0	.01	-	 < 0.2	1.00E00
toxin transport (GO:1901998)	38	1	.16	+	6.28	1.00E00
NLS-bearing protein import into nucleus (GO:0006607)	23	0	.10	-	 < 0.2	1.00E00
protein targeting (GO:0006605)	276	1	1.16	-	.86	1.00E00
positive regulation of meiotic cell cycle phase transition (GO:1901995)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of meiotic cell cycle phase transition (GO:1901994)	3	0	.01	-	 < 0.2	1.00E00
phosphocreatine metabolic process (GO:0006603)	1	0	.00	-	 < 0.2	1.00E00
regulation of meiotic cell cycle phase transition (GO:1901993)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of mitotic cell cycle phase transition (GO:1901992)	62	1	.26	+	3.85	1.00E00
creatine biosynthetic process (GO:0006601)	2	0	.01	-	 < 0.2	1.00E00
creatine metabolic process (GO:0006600)	10	1	.04	+	23.87	1.00E00
connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	4	0	.02	-	 < 0.2	1.00E00
wound healing involved in inflammatory response (GO:0002246)	5	0	.02	-	 < 0.2	1.00E00
hematopoietic progenitor cell differentiation (GO:0002244)	89	3	.37	+	8.04	1.00E00
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	1	0	.00	-	 < 0.2	1.00E00
mastication (GO:0071626)	3	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-18 biosynthetic process (GO:0045381)	1	0	.00	-	 < 0.2	1.00E00
vocalization behavior (GO:0071625)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of granulocyte chemotaxis (GO:0071624)	32	0	.13	-	 < 0.2	1.00E00
negative regulation of granulocyte chemotaxis (GO:0071623)	2	0	.01	-	 < 0.2	1.00E00
regulation of granulocyte chemotaxis (GO:0071622)	50	2	.21	+	9.55	1.00E00
granulocyte chemotaxis (GO:0071621)	70	2	.29	+	6.82	1.00E00
positive regulation of cell cycle phase transition (GO:1901989)	77	1	.32	+	3.10	1.00E00
response to ketamine (GO:1901986)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein acetylation (GO:1901985)	35	2	.15	+	13.64	1.00E00
negative regulation of protein acetylation (GO:1901984)	22	0	.09	-	 < 0.2	1.00E00
regulation of protein acetylation (GO:1901983)	64	3	.27	+	11.19	1.00E00
positive regulation of inward rectifier potassium channel activity (GO:1901980)	1	0	.00	-	 < 0.2	1.00E00
response to molecule of fungal origin (GO:0002238)	3	1	.01	+	79.55	1.00E00
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of defense response to virus by host (GO:0002230)	28	0	.12	-	 < 0.2	1.00E00
acyl-CoA biosynthetic process (GO:0071616)	43	1	.18	+	5.55	1.00E00
oxidative deethylation (GO:0071615)	1	0	.00	-	 < 0.2	1.00E00
granulocyte colony-stimulating factor production (GO:0071611)	1	0	.00	-	 < 0.2	1.00E00
regulation of inward rectifier potassium channel activity (GO:1901979)	3	1	.01	+	79.55	1.00E00
positive regulation of cell cycle checkpoint (GO:1901978)	10	1	.04	+	23.87	1.00E00
negative regulation of cell cycle checkpoint (GO:1901977)	6	0	.03	-	 < 0.2	1.00E00
peptidyl-aspartic acid autophosphorylation (GO:1990938)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell cycle checkpoint (GO:1901976)	33	3	.14	+	21.70	1.00E00
positive regulation of metanephric ureteric bud development (GO:2001076)	2	0	.01	-	 < 0.2	1.00E00
regulation of metanephric ureteric bud development (GO:2001074)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mitotic sister chromatid separation (GO:1901970)	7	0	.03	-	 < 0.2	1.00E00
natural killer cell mediated immunity (GO:0002228)	27	0	.11	-	 < 0.2	1.00E00
innate immune response in mucosa (GO:0002227)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of antimicrobial peptide production (GO:0002225)	3	0	.01	-	 < 0.2	1.00E00
toll-like receptor signaling pathway (GO:0002224)	97	0	.41	-	 < 0.2	1.00E00
pattern recognition receptor signaling pathway (GO:0002221)	123	0	.52	-	 < 0.2	1.00E00
positive regulation of interleukin-13 biosynthetic process (GO:0045368)	1	0	.00	-	 < 0.2	1.00E00
regulation of interleukin-13 biosynthetic process (GO:0045366)	1	0	.00	-	 < 0.2	1.00E00
chemokine (C-C motif) ligand 5 production (GO:0071609)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interleukin-1 biosynthetic process (GO:0045362)	3	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-1 biosynthetic process (GO:0045360)	3	0	.01	-	 < 0.2	1.00E00
transforming growth factor beta production (GO:0071604)	1	0	.00	-	 < 0.2	1.00E00
endothelial cell-cell adhesion (GO:0071603)	4	0	.02	-	 < 0.2	1.00E00
phytosphingosine biosynthetic process (GO:0071602)	1	0	.00	-	 < 0.2	1.00E00
otic vesicle morphogenesis (GO:0071600)	9	0	.04	-	 < 0.2	1.00E00
response to amino acid starvation (GO:1990928)	3	1	.01	+	79.55	1.00E00
calcium ion regulated lysosome exocytosis (GO:1990927)	2	0	.01	-	 < 0.2	1.00E00
short-term synaptic potentiation (GO:1990926)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963)	2	0	.01	-	 < 0.2	1.00E00
S-adenosyl-L-methionine transmembrane transport (GO:1901962)	1	0	.00	-	 < 0.2	1.00E00
activation of innate immune response (GO:0002218)	246	6	1.03	+	5.82	1.00E00
defense response to nematode (GO:0002215)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of interferon-beta biosynthetic process (GO:0045359)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of interferon-beta biosynthetic process (GO:0045358)	1	0	.00	-	 < 0.2	1.00E00
regulation of interferon-beta biosynthetic process (GO:0045357)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of interferon-alpha biosynthetic process (GO:0045356)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of interferon-alpha biosynthetic process (GO:0045355)	2	0	.01	-	 < 0.2	1.00E00
regulation of interferon-alpha biosynthetic process (GO:0045354)	6	0	.03	-	 < 0.2	1.00E00
type I interferon biosynthetic process (GO:0045351)	4	0	.02	-	 < 0.2	1.00E00
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.00	-	 < 0.2	1.00E00
putrescine biosynthetic process from ornithine (GO:0033387)	3	0	.01	-	 < 0.2	1.00E00
geranylgeranyl diphosphate biosynthetic process (GO:0033386)	1	0	.00	-	 < 0.2	1.00E00
geranylgeranyl diphosphate metabolic process (GO:0033385)	1	0	.00	-	 < 0.2	1.00E00
geranyl diphosphate biosynthetic process (GO:0033384)	2	0	.01	-	 < 0.2	1.00E00
geranyl diphosphate metabolic process (GO:0033383)	2	0	.01	-	 < 0.2	1.00E00
double-strand break repair involved in meiotic recombination (GO:1990918)	3	0	.01	-	 < 0.2	1.00E00
maintenance of granzyme B location in T cell secretory granule (GO:0033382)	1	0	.00	-	 < 0.2	1.00E00
reactive nitrogen species metabolic process (GO:2001057)	21	1	.09	+	11.36	1.00E00
granzyme B localization to T cell secretory granule (GO:0033380)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	133	3	.56	+	5.38	1.00E00
positive regulation of mesenchymal cell apoptotic process (GO:2001055)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	10	0	.04	-	 < 0.2	1.00E00
regulation of mesenchymal cell apoptotic process (GO:2001053)	12	0	.05	-	 < 0.2	1.00E00
behavioral defense response (GO:0002209)	29	3	.12	+	24.69	1.00E00
dense core granule transport (GO:1901950)	1	0	.00	-	 < 0.2	1.00E00
response to psychosocial stress (GO:1990911)	2	0	.01	-	 < 0.2	1.00E00
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	17	0	.07	-	 < 0.2	1.00E00
response to hypobaric hypoxia (GO:1990910)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of tendon cell differentiation (GO:2001051)	1	0	.00	-	 < 0.2	1.00E00
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	17	0	.07	-	 < 0.2	1.00E00
somatic diversification of immune receptors (GO:0002200)	44	2	.18	+	10.85	1.00E00
positive regulation of MHC class II biosynthetic process (GO:0045348)	8	1	.03	+	29.83	1.00E00
negative regulation of MHC class II biosynthetic process (GO:0045347)	5	0	.02	-	 < 0.2	1.00E00
regulation of MHC class II biosynthetic process (GO:0045346)	12	1	.05	+	19.89	1.00E00
positive regulation of MHC class I biosynthetic process (GO:0045345)	6	0	.03	-	 < 0.2	1.00E00
regulation of MHC class I biosynthetic process (GO:0045343)	7	0	.03	-	 < 0.2	1.00E00
MHC class II biosynthetic process (GO:0045342)	1	0	.00	-	 < 0.2	1.00E00
maintenance of protease location in T cell secretory granule (GO:0033379)	1	0	.00	-	 < 0.2	1.00E00
maintenance of protein location in T cell secretory granule (GO:0033377)	1	0	.00	-	 < 0.2	1.00E00
protease localization to T cell secretory granule (GO:0033375)	1	0	.00	-	 < 0.2	1.00E00
protein localization to T cell secretory granule (GO:0033374)	1	0	.00	-	 < 0.2	1.00E00
maintenance of protease location in mast cell secretory granule (GO:0033373)	1	0	.00	-	 < 0.2	1.00E00
regulation of tendon cell differentiation (GO:2001049)	1	0	.00	-	 < 0.2	1.00E00
T cell secretory granule organization (GO:0033371)	1	0	.00	-	 < 0.2	1.00E00
maintenance of protein location in mast cell secretory granule (GO:0033370)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of integrin-mediated signaling pathway (GO:2001046)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of integrin-mediated signaling pathway (GO:2001045)	2	0	.01	-	 < 0.2	1.00E00
regulation of integrin-mediated signaling pathway (GO:2001044)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of cellular response to drug (GO:2001040)	1	0	.00	-	 < 0.2	1.00E00
reproductive behavior (GO:0019098)	31	0	.13	-	 < 0.2	1.00E00
farnesyl diphosphate metabolic process (GO:0045338)	3	0	.01	-	 < 0.2	1.00E00
farnesyl diphosphate biosynthetic process (GO:0045337)	2	0	.01	-	 < 0.2	1.00E00
cellular respiration (GO:0045333)	167	1	.70	+	1.43	1.00E00
phospholipid translocation (GO:0045332)	23	0	.10	-	 < 0.2	1.00E00
protease localization to mast cell secretory granule (GO:0033368)	1	0	.00	-	 < 0.2	1.00E00
protein localization to mast cell secretory granule (GO:0033367)	1	0	.00	-	 < 0.2	1.00E00
protein localization to secretory granule (GO:0033366)	1	0	.00	-	 < 0.2	1.00E00
mast cell secretory granule organization (GO:0033364)	2	0	.01	-	 < 0.2	1.00E00
secretory granule organization (GO:0033363)	32	0	.13	-	 < 0.2	1.00E00
regulation of cellular response to drug (GO:2001038)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of tongue muscle cell differentiation (GO:2001037)	2	0	.01	-	 < 0.2	1.00E00
regulation of tongue muscle cell differentiation (GO:2001035)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	4	0	.02	-	 < 0.2	1.00E00
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of cellular glucuronidation (GO:2001031)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cellular glucuronidation (GO:2001030)	8	0	.03	-	 < 0.2	1.00E00
transmission of virus (GO:0019089)	1	0	.00	-	 < 0.2	1.00E00
immortalization of host cell by virus (GO:0019088)	1	0	.00	-	 < 0.2	1.00E00
transformation of host cell by virus (GO:0019087)	3	0	.01	-	 < 0.2	1.00E00
late viral transcription (GO:0019086)	4	0	.02	-	 < 0.2	1.00E00
early viral transcription (GO:0019085)	2	0	.01	-	 < 0.2	1.00E00
carnitine biosynthetic process (GO:0045329)	5	0	.02	-	 < 0.2	1.00E00
viral transcription (GO:0019083)	114	0	.48	-	 < 0.2	1.00E00
viral protein processing (GO:0019082)	1	0	.00	-	 < 0.2	1.00E00
viral translation (GO:0019081)	13	0	.05	-	 < 0.2	1.00E00
viral gene expression (GO:0019080)	128	0	.54	-	 < 0.2	1.00E00
late endosome to vacuole transport (GO:0045324)	10	0	.04	-	 < 0.2	1.00E00
S-adenosylmethionine cycle (GO:0033353)	4	0	.02	-	 < 0.2	1.00E00
regulation of cellular glucuronidation (GO:2001029)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of endothelial cell chemotaxis (GO:2001028)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of endothelial cell chemotaxis (GO:2001027)	4	0	.02	-	 < 0.2	1.00E00
regulation of endothelial cell chemotaxis (GO:2001026)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of response to drug (GO:2001025)	2	0	.01	-	 < 0.2	1.00E00
regulation of response to drug (GO:2001023)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of response to DNA damage stimulus (GO:2001021)	62	3	.26	+	11.55	1.00E00
viral genome replication (GO:0019079)	28	0	.12	-	 < 0.2	1.00E00
viral release from host cell (GO:0019076)	6	0	.03	-	 < 0.2	1.00E00
virus maturation (GO:0019075)	2	0	.01	-	 < 0.2	1.00E00
viral RNA genome packaging (GO:0019074)	2	0	.01	-	 < 0.2	1.00E00
viral genome packaging (GO:0019072)	2	0	.01	-	 < 0.2	1.00E00
asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.00	-	 < 0.2	1.00E00
cholesterol efflux (GO:0033344)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of collagen binding (GO:0033343)	1	1	.00	+	 > 100	1.00E00
negative regulation of collagen binding (GO:0033342)	1	0	.00	-	 < 0.2	1.00E00
regulation of collagen binding (GO:0033341)	2	1	.01	+	 > 100	1.00E00
positive regulation of skeletal muscle cell differentiation (GO:2001016)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of skeletal muscle cell differentiation (GO:2001015)	6	0	.03	-	 < 0.2	1.00E00
regulation of skeletal muscle cell differentiation (GO:2001014)	19	0	.08	-	 < 0.2	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	4	0	.02	-	 < 0.2	1.00E00
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	4	0	.02	-	 < 0.2	1.00E00
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	4	0	.02	-	 < 0.2	1.00E00
mesenchymal cell differentiation involved in renal system development (GO:2001012)	8	0	.03	-	 < 0.2	1.00E00
virion assembly (GO:0019068)	36	0	.15	-	 < 0.2	1.00E00
receptor-mediated endocytosis of virus by host cell (GO:0019065)	3	1	.01	+	79.55	1.00E00
positive regulation of type IIa hypersensitivity (GO:0001798)	2	0	.01	-	 < 0.2	1.00E00
fusion of virus membrane with host plasma membrane (GO:0019064)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of type IIa hypersensitivity (GO:0001797)	1	0	.00	-	 < 0.2	1.00E00
regulation of type IIa hypersensitivity (GO:0001796)	3	0	.01	-	 < 0.2	1.00E00
virion attachment to host cell (GO:0019062)	9	0	.04	-	 < 0.2	1.00E00
uncoating of virus (GO:0019061)	1	0	.00	-	 < 0.2	1.00E00
intracellular transport of viral protein in host cell (GO:0019060)	2	0	.01	-	 < 0.2	1.00E00
centriole replication (GO:0007099)	16	0	.07	-	 < 0.2	1.00E00
centrosome cycle (GO:0007098)	81	2	.34	+	5.89	1.00E00
nuclear migration (GO:0007097)	18	0	.08	-	 < 0.2	1.00E00
regulation of exit from mitosis (GO:0007096)	20	0	.08	-	 < 0.2	1.00E00
mitotic G2 DNA damage checkpoint (GO:0007095)	16	1	.07	+	14.92	1.00E00
mitotic spindle assembly checkpoint (GO:0007094)	20	2	.08	+	23.87	1.00E00
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	4	0	.02	-	 < 0.2	1.00E00
diadenosine hexaphosphate catabolic process (GO:1901909)	4	0	.02	-	 < 0.2	1.00E00
diadenosine hexaphosphate metabolic process (GO:1901908)	4	0	.02	-	 < 0.2	1.00E00
diadenosine pentaphosphate catabolic process (GO:1901907)	4	0	.02	-	 < 0.2	1.00E00
diadenosine pentaphosphate metabolic process (GO:1901906)	4	0	.02	-	 < 0.2	1.00E00
viral life cycle (GO:0019058)	199	5	.83	+	6.00	1.00E00
modulation by virus of host transcription (GO:0019056)	1	0	.00	-	 < 0.2	1.00E00
modulation by virus of host process (GO:0019054)	25	0	.10	-	 < 0.2	1.00E00
natural killer cell proliferation (GO:0001787)	3	0	.01	-	 < 0.2	1.00E00
suppression by virus of host apoptotic process (GO:0019050)	3	0	.01	-	 < 0.2	1.00E00
B cell apoptotic process (GO:0001783)	7	0	.03	-	 < 0.2	1.00E00
traversing start control point of mitotic cell cycle (GO:0007089)	4	1	.02	+	59.66	1.00E00
B cell homeostasis (GO:0001782)	25	2	.10	+	19.09	1.00E00
regulation of mitotic nuclear division (GO:0007088)	160	5	.67	+	7.46	1.00E00
neutrophil apoptotic process (GO:0001781)	3	0	.01	-	 < 0.2	1.00E00
neutrophil homeostasis (GO:0001780)	11	1	.05	+	21.70	1.00E00
mitotic nuclear envelope reassembly (GO:0007084)	10	0	.04	-	 < 0.2	1.00E00
Leydig cell differentiation (GO:0033327)	11	1	.05	+	21.70	1.00E00
cerebrospinal fluid secretion (GO:0033326)	3	0	.01	-	 < 0.2	1.00E00
mitotic metaphase plate congression (GO:0007080)	41	1	.17	+	5.82	1.00E00
UDP-D-xylose biosynthetic process (GO:0033320)	1	0	.00	-	 < 0.2	1.00E00
evasion or tolerance of host defenses by virus (GO:0019049)	4	0	.02	-	 < 0.2	1.00E00
modulation by virus of host morphology or physiology (GO:0019048)	36	0	.15	-	 < 0.2	1.00E00
release from viral latency (GO:0019046)	3	0	.01	-	 < 0.2	1.00E00
natural killer cell differentiation (GO:0001779)	12	1	.05	+	19.89	1.00E00
latent virus replication (GO:0019045)	3	0	.01	-	 < 0.2	1.00E00
plasma membrane repair (GO:0001778)	7	0	.03	-	 < 0.2	1.00E00
T cell homeostatic proliferation (GO:0001777)	1	0	.00	-	 < 0.2	1.00E00
establishment of viral latency (GO:0019043)	10	0	.04	-	 < 0.2	1.00E00
leukocyte homeostasis (GO:0001776)	70	4	.29	+	13.64	1.00E00
viral latency (GO:0019042)	12	0	.05	-	 < 0.2	1.00E00
telomere maintenance via telomere trimming (GO:0090737)	11	0	.05	-	 < 0.2	1.00E00
microglial cell activation (GO:0001774)	17	1	.07	+	14.04	1.00E00
DNA repair complex assembly (GO:0090735)	10	0	.04	-	 < 0.2	1.00E00
myeloid dendritic cell activation (GO:0001773)	24	0	.10	-	 < 0.2	1.00E00
mitotic chromosome movement towards spindle pole (GO:0007079)	3	0	.01	-	 < 0.2	1.00E00
immunological synapse formation (GO:0001771)	11	0	.05	-	 < 0.2	1.00E00
mitotic nuclear envelope disassembly (GO:0007077)	44	3	.18	+	16.27	1.00E00
establishment of natural killer cell polarity (GO:0001770)	1	0	.00	-	 < 0.2	1.00E00
mitotic chromosome condensation (GO:0007076)	15	0	.06	-	 < 0.2	1.00E00
UDP-D-xylose metabolic process (GO:0033319)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcription involved in exit from mitosis (GO:0007072)	1	0	.00	-	 < 0.2	1.00E00
meiotic spindle assembly checkpoint (GO:0033316)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter during mitotic cell cycle (GO:0007070)	2	0	.01	-	 < 0.2	1.00E00
mitotic DNA replication checkpoint (GO:0033314)	9	0	.04	-	 < 0.2	1.00E00
meiotic cell cycle checkpoint (GO:0033313)	7	0	.03	-	 < 0.2	1.00E00
anterior/posterior pattern specification involved in ureteric bud development (GO:0072099)	1	0	.00	-	 < 0.2	1.00E00
anterior/posterior pattern specification involved in kidney development (GO:0072098)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of branch elongation involved in ureteric bud branching (GO:0072096)	1	0	.00	-	 < 0.2	1.00E00
regulation of branch elongation involved in ureteric bud branching (GO:0072095)	4	0	.02	-	 < 0.2	1.00E00
establishment of T cell polarity (GO:0001768)	6	0	.03	-	 < 0.2	1.00E00
establishment of lymphocyte polarity (GO:0001767)	7	0	.03	-	 < 0.2	1.00E00
metanephric renal vesicle formation (GO:0072093)	4	0	.02	-	 < 0.2	1.00E00
membrane raft polarization (GO:0001766)	8	0	.03	-	 < 0.2	1.00E00
ureteric bud invasion (GO:0072092)	3	0	.01	-	 < 0.2	1.00E00
membrane raft assembly (GO:0001765)	10	1	.04	+	23.87	1.00E00
regulation of stem cell proliferation (GO:0072091)	62	0	.26	-	 < 0.2	1.00E00
neuron migration (GO:0001764)	114	1	.48	+	2.09	1.00E00
morphogenesis of a branching structure (GO:0001763)	167	3	.70	+	4.29	1.00E00
negative regulation of transcription during mitotic cell cycle (GO:0007068)	2	0	.01	-	 < 0.2	1.00E00
female meiosis sister chromatid cohesion (GO:0007066)	1	0	.00	-	 < 0.2	1.00E00
mitotic sister chromatid cohesion (GO:0007064)	15	0	.06	-	 < 0.2	1.00E00
regulation of sister chromatid cohesion (GO:0007063)	21	0	.09	-	 < 0.2	1.00E00
sister chromatid cohesion (GO:0007062)	120	1	.50	+	1.99	1.00E00
phytol metabolic process (GO:0033306)	2	0	.01	-	 < 0.2	1.00E00
male meiosis chromosome segregation (GO:0007060)	4	0	.02	-	 < 0.2	1.00E00
cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	0	.00	-	 < 0.2	1.00E00
stem cell proliferation (GO:0072089)	53	0	.22	-	 < 0.2	1.00E00
nephron epithelium morphogenesis (GO:0072088)	65	1	.27	+	3.67	1.00E00
renal vesicle development (GO:0072087)	14	0	.06	-	 < 0.2	1.00E00
specification of loop of Henle identity (GO:0072086)	4	0	.02	-	 < 0.2	1.00E00
organ induction (GO:0001759)	16	0	.07	-	 < 0.2	1.00E00
somite specification (GO:0001757)	5	0	.02	-	 < 0.2	1.00E00
somitogenesis (GO:0001756)	62	2	.26	+	7.70	1.00E00
neural crest cell migration (GO:0001755)	37	0	.16	-	 < 0.2	1.00E00
specification of nephron tubule identity (GO:0072081)	5	0	.02	-	 < 0.2	1.00E00
eye photoreceptor cell differentiation (GO:0001754)	46	0	.19	-	 < 0.2	1.00E00
nephron tubule development (GO:0072080)	77	2	.32	+	6.20	1.00E00
immunological memory formation process (GO:0090715)	1	0	.00	-	 < 0.2	1.00E00
chromosome segregation (GO:0007059)	302	3	1.27	+	2.37	1.00E00
immunological memory process (GO:0090713)	1	0	.00	-	 < 0.2	1.00E00
spindle assembly involved in female meiosis I (GO:0007057)	2	0	.01	-	 < 0.2	1.00E00
spindle assembly involved in female meiosis (GO:0007056)	4	0	.02	-	 < 0.2	1.00E00
mitotic spindle organization (GO:0007052)	70	1	.29	+	3.41	1.00E00
spindle organization (GO:0007051)	126	1	.53	+	1.89	1.00E00
cell cycle arrest (GO:0007050)	153	5	.64	+	7.80	1.00E00
positive regulation of optic nerve formation (GO:2000597)	1	0	.00	-	 < 0.2	1.00E00
nephron tubule formation (GO:0072079)	18	0	.08	-	 < 0.2	1.00E00
nephron tubule morphogenesis (GO:0072078)	63	1	.26	+	3.79	1.00E00
regulation of optic nerve formation (GO:2000595)	1	0	.00	-	 < 0.2	1.00E00
renal vesicle morphogenesis (GO:0072077)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of metanephric DCT cell differentiation (GO:2000594)	2	0	.01	-	 < 0.2	1.00E00
nephrogenic mesenchyme development (GO:0072076)	3	0	.01	-	 < 0.2	1.00E00
metanephric mesenchyme development (GO:0072075)	14	1	.06	+	17.05	1.00E00
regulation of metanephric DCT cell differentiation (GO:2000592)	2	0	.01	-	 < 0.2	1.00E00
kidney mesenchyme development (GO:0072074)	18	1	.08	+	13.26	1.00E00
positive regulation of metanephric mesenchymal cell migration (GO:2000591)	3	1	.01	+	79.55	1.00E00
kidney epithelium development (GO:0072073)	128	3	.54	+	5.59	1.00E00
negative regulation of metanephric mesenchymal cell migration (GO:2000590)	1	0	.00	-	 < 0.2	1.00E00
kidney interstitial fibroblast differentiation (GO:0072071)	2	0	.01	-	 < 0.2	1.00E00
loop of Henle development (GO:0072070)	12	1	.05	+	19.89	1.00E00
optic placode formation (GO:0001743)	3	0	.01	-	 < 0.2	1.00E00
cell-substrate adherens junction assembly (GO:0007045)	24	3	.10	+	29.83	1.00E00
cell-cell junction assembly (GO:0007043)	78	1	.33	+	3.06	1.00E00
lysosomal lumen acidification (GO:0007042)	8	0	.03	-	 < 0.2	1.00E00
negative regulation by organism of signal transduction in other organism involved in symbiotic interaction (GO:0052493)	1	0	.00	-	 < 0.2	1.00E00
lysosomal transport (GO:0007041)	89	0	.37	-	 < 0.2	1.00E00
lysosome organization (GO:0007040)	55	0	.23	-	 < 0.2	1.00E00
negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052490)	4	0	.02	-	 < 0.2	1.00E00
regulation of metanephric mesenchymal cell migration (GO:2000589)	4	1	.02	+	59.66	1.00E00
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	8	1	.03	+	29.83	1.00E00
DCT cell differentiation (GO:0072069)	1	0	.00	-	 < 0.2	1.00E00
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	10	1	.04	+	23.87	1.00E00
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	2	0	.01	-	 < 0.2	1.00E00
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)	5	0	.02	-	 < 0.2	1.00E00
morphogenesis of a polarized epithelium (GO:0001738)	36	0	.15	-	 < 0.2	1.00E00
regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)	5	0	.02	-	 < 0.2	1.00E00
establishment of planar polarity (GO:0001736)	21	0	.09	-	 < 0.2	1.00E00
inner medullary collecting duct development (GO:0072061)	3	1	.01	+	79.55	1.00E00
outer medullary collecting duct development (GO:0072060)	1	0	.00	-	 < 0.2	1.00E00
protein catabolic process in the vacuole (GO:0007039)	5	0	.02	-	 < 0.2	1.00E00
regulation of phagocytosis, engulfment (GO:0060099)	11	1	.05	+	21.70	1.00E00
formation of cytoplasmic translation initiation complex (GO:0001732)	2	0	.01	-	 < 0.2	1.00E00
formation of translation preinitiation complex (GO:0001731)	11	0	.05	-	 < 0.2	1.00E00
vacuolar phosphate transport (GO:0007037)	1	0	.00	-	 < 0.2	1.00E00
mitotic cytokinesis checkpoint (GO:0044878)	4	0	.02	-	 < 0.2	1.00E00
vacuolar acidification (GO:0007035)	22	0	.09	-	 < 0.2	1.00E00
vacuolar transport (GO:0007034)	119	0	.50	-	 < 0.2	1.00E00
vacuole organization (GO:0007033)	117	0	.49	-	 < 0.2	1.00E00
endosome organization (GO:0007032)	73	0	.31	-	 < 0.2	1.00E00
peroxisome organization (GO:0007031)	31	0	.13	-	 < 0.2	1.00E00
Golgi organization (GO:0007030)	96	0	.40	-	 < 0.2	1.00E00
lipoprotein localization (GO:0044872)	16	0	.07	-	 < 0.2	1.00E00
negative regulation by host of viral glycoprotein metabolic process (GO:0044871)	2	0	.01	-	 < 0.2	1.00E00
modulation by host of viral glycoprotein metabolic process (GO:0044870)	2	0	.01	-	 < 0.2	1.00E00
cortical collecting duct development (GO:0072059)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of microtubule motor activity (GO:2000576)	6	0	.03	-	 < 0.2	1.00E00
regulation of microtubule motor activity (GO:2000574)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of DNA biosynthetic process (GO:2000573)	65	4	.27	+	14.69	1.00E00
renal cortex development (GO:0072055)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572)	1	0	.00	-	 < 0.2	1.00E00
renal outer medulla development (GO:0072054)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571)	1	0	.00	-	 < 0.2	1.00E00
renal inner medulla development (GO:0072053)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of T-helper 2 cell activation (GO:2000570)	2	0	.01	-	 < 0.2	1.00E00
juxtaglomerular apparatus development (GO:0072051)	1	0	.00	-	 < 0.2	1.00E00
S-shaped body morphogenesis (GO:0072050)	7	1	.03	+	34.09	1.00E00
endoplasmic reticulum organization (GO:0007029)	43	0	.18	-	 < 0.2	1.00E00
cytoplasm organization (GO:0007028)	10	1	.04	+	23.87	1.00E00
auditory receptor cell stereocilium organization (GO:0060088)	11	0	.05	-	 < 0.2	1.00E00
negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869)	2	0	.01	-	 < 0.2	1.00E00
relaxation of vascular smooth muscle (GO:0060087)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of microtubule depolymerization (GO:0007026)	20	0	.08	-	 < 0.2	1.00E00
modulation by host of viral molecular function (GO:0044868)	3	0	.01	-	 < 0.2	1.00E00
circadian temperature homeostasis (GO:0060086)	2	0	.01	-	 < 0.2	1.00E00
modulation by host of viral catalytic activity (GO:0044867)	2	0	.01	-	 < 0.2	1.00E00
modulation by host of viral exo-alpha-sialidase activity (GO:0044866)	2	0	.01	-	 < 0.2	1.00E00
synaptic transmission involved in micturition (GO:0060084)	3	0	.01	-	 < 0.2	1.00E00
post-chaperonin tubulin folding pathway (GO:0007023)	4	0	.02	-	 < 0.2	1.00E00
smooth muscle contraction involved in micturition (GO:0060083)	3	0	.01	-	 < 0.2	1.00E00
tubulin complex assembly (GO:0007021)	7	0	.03	-	 < 0.2	1.00E00
modulation by host of symbiont transcription (GO:0052472)	26	1	.11	+	9.18	1.00E00
membrane hyperpolarization (GO:0060081)	10	0	.04	-	 < 0.2	1.00E00
microtubule nucleation (GO:0007020)	20	0	.08	-	 < 0.2	1.00E00
inhibitory postsynaptic potential (GO:0060080)	8	0	.03	-	 < 0.2	1.00E00
protein transport into plasma membrane raft (GO:0044861)	2	0	.01	-	 < 0.2	1.00E00
protein localization to plasma membrane raft (GO:0044860)	4	1	.02	+	59.66	1.00E00
regulation of neurotrophin production (GO:0032899)	2	0	.01	-	 < 0.2	1.00E00
neurotrophin production (GO:0032898)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of viral transcription (GO:0032897)	25	1	.10	+	9.55	1.00E00
regulation of T-helper 2 cell activation (GO:2000569)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of organic acid transport (GO:0032892)	31	0	.13	-	 < 0.2	1.00E00
positive regulation of memory T cell activation (GO:2000568)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of organic acid transport (GO:0032891)	18	1	.08	+	13.26	1.00E00
regulation of memory T cell activation (GO:2000567)	3	0	.01	-	 < 0.2	1.00E00
regulation of organic acid transport (GO:0032890)	52	2	.22	+	9.18	1.00E00
comma-shaped body morphogenesis (GO:0072049)	5	1	.02	+	47.73	1.00E00
positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)	5	1	.02	+	47.73	1.00E00
urokinase plasminogen activator signaling pathway (GO:0038195)	2	0	.01	-	 < 0.2	1.00E00
renal system pattern specification (GO:0072048)	9	0	.04	-	 < 0.2	1.00E00
thyroid-stimulating hormone signaling pathway (GO:0038194)	2	0	.01	-	 < 0.2	1.00E00
proximal/distal pattern formation involved in nephron development (GO:0072047)	5	0	.02	-	 < 0.2	1.00E00
regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	6	1	.03	+	39.78	1.00E00
thromboxane A2 signaling pathway (GO:0038193)	1	0	.00	-	 < 0.2	1.00E00
establishment of planar polarity involved in nephron morphogenesis (GO:0072046)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	4	0	.02	-	 < 0.2	1.00E00
gastric inhibitory peptide signaling pathway (GO:0038192)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	5	0	.02	-	 < 0.2	1.00E00
collecting duct development (GO:0072044)	12	1	.05	+	19.89	1.00E00
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	7	0	.03	-	 < 0.2	1.00E00
VEGF-activated neuropilin signaling pathway (GO:0038190)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of CD24 biosynthetic process (GO:2000560)	1	0	.00	-	 < 0.2	1.00E00
endodermal cell fate specification (GO:0001714)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040)	4	0	.02	-	 < 0.2	1.00E00
microtubule depolymerization (GO:0007019)	11	0	.05	-	 < 0.2	1.00E00
excitatory postsynaptic potential (GO:0060079)	71	0	.30	-	 < 0.2	1.00E00
ectodermal cell fate commitment (GO:0001712)	2	0	.01	-	 < 0.2	1.00E00
microtubule-based movement (GO:0007018)	250	0	1.05	-	 < 0.2	1.00E00
regulation of postsynaptic membrane potential (GO:0060078)	102	0	.43	-	 < 0.2	1.00E00
endodermal cell fate commitment (GO:0001711)	13	0	.05	-	 < 0.2	1.00E00
microtubule-based process (GO:0007017)	581	3	2.43	+	1.23	1.00E00
mesodermal cell fate commitment (GO:0001710)	13	0	.05	-	 < 0.2	1.00E00
cytoskeletal anchoring at plasma membrane (GO:0007016)	10	0	.04	-	 < 0.2	1.00E00
actin filament organization (GO:0007015)	207	3	.87	+	3.46	1.00E00
plasma membrane raft organization (GO:0044857)	5	1	.02	+	47.73	1.00E00
regulation of resting membrane potential (GO:0060075)	7	0	.03	-	 < 0.2	1.00E00
actin ubiquitination (GO:0007014)	1	0	.00	-	 < 0.2	1.00E00
synapse maturation (GO:0060074)	9	0	.04	-	 < 0.2	1.00E00
micturition (GO:0060073)	7	0	.03	-	 < 0.2	1.00E00
plasma membrane raft assembly (GO:0044854)	5	1	.02	+	47.73	1.00E00
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	101	0	.42	-	 < 0.2	1.00E00
cytoskeleton organization (GO:0007010)	962	11	4.03	+	2.73	1.00E00
canonical Wnt signaling pathway (GO:0060070)	95	2	.40	+	5.02	1.00E00
hair cycle phase (GO:0044851)	2	0	.01	-	 < 0.2	1.00E00
regulation of vacuole fusion, non-autophagic (GO:0032889)	1	0	.00	-	 < 0.2	1.00E00
regulation of mitotic spindle elongation (GO:0032888)	1	0	.00	-	 < 0.2	1.00E00
regulation of spindle elongation (GO:0032887)	1	0	.00	-	 < 0.2	1.00E00
regulation of microtubule-based process (GO:0032886)	183	2	.77	+	2.61	1.00E00
regulation of polysaccharide biosynthetic process (GO:0032885)	34	3	.14	+	21.06	1.00E00
neuropilin signaling pathway (GO:0038189)	4	0	.02	-	 < 0.2	1.00E00
regulation of CD24 biosynthetic process (GO:2000559)	1	0	.00	-	 < 0.2	1.00E00
cholecystokinin signaling pathway (GO:0038188)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of immunoglobulin production in mucosal tissue (GO:2000558)	1	0	.00	-	 < 0.2	1.00E00
regulation of polysaccharide metabolic process (GO:0032881)	39	3	.16	+	18.36	1.00E00
regulation of immunoglobulin production in mucosal tissue (GO:2000557)	1	0	.00	-	 < 0.2	1.00E00
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of T-helper 1 cell cytokine production (GO:2000556)	1	0	.00	-	 < 0.2	1.00E00
intracellular bile acid receptor signaling pathway (GO:0038185)	1	0	.00	-	 < 0.2	1.00E00
mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038)	2	0	.01	-	 < 0.2	1.00E00
cell surface bile acid receptor signaling pathway (GO:0038184)	1	0	.00	-	 < 0.2	1.00E00
regulation of T-helper 1 cell cytokine production (GO:2000554)	1	0	.00	-	 < 0.2	1.00E00
bile acid signaling pathway (GO:0038183)	3	0	.01	-	 < 0.2	1.00E00
mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of T-helper 2 cell cytokine production (GO:2000553)	6	0	.03	-	 < 0.2	1.00E00
cell fate determination (GO:0001709)	41	2	.17	+	11.64	1.00E00
negative regulation of T-helper 2 cell cytokine production (GO:2000552)	4	0	.02	-	 < 0.2	1.00E00
cell fate specification (GO:0001708)	73	0	.31	-	 < 0.2	1.00E00
renal vesicle induction (GO:0072034)	3	0	.01	-	 < 0.2	1.00E00
regulation of T-helper 2 cell cytokine production (GO:2000551)	10	0	.04	-	 < 0.2	1.00E00
mesoderm formation (GO:0001707)	68	2	.28	+	7.02	1.00E00
nerve growth factor signaling pathway (GO:0038180)	8	0	.03	-	 < 0.2	1.00E00
renal vesicle formation (GO:0072033)	6	0	.03	-	 < 0.2	1.00E00
endoderm formation (GO:0001706)	51	3	.21	+	14.04	1.00E00
proximal convoluted tubule segment 2 development (GO:0072032)	1	0	.00	-	 < 0.2	1.00E00
ectoderm formation (GO:0001705)	3	0	.01	-	 < 0.2	1.00E00
formation of primary germ layer (GO:0001704)	116	5	.49	+	10.29	1.00E00
plasma membrane organization (GO:0007009)	65	3	.27	+	11.02	1.00E00
gastrulation with mouth forming second (GO:0001702)	28	0	.12	-	 < 0.2	1.00E00
outer mitochondrial membrane organization (GO:0007008)	7	0	.03	-	 < 0.2	1.00E00
vagina development (GO:0060068)	10	1	.04	+	23.87	1.00E00
inner mitochondrial membrane organization (GO:0007007)	40	1	.17	+	5.97	1.00E00
estrous cycle (GO:0044849)	17	1	.07	+	14.04	1.00E00
cervix development (GO:0060067)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial membrane organization (GO:0007006)	127	5	.53	+	9.40	1.00E00
biological phase (GO:0044848)	4	0	.02	-	 < 0.2	1.00E00
oviduct development (GO:0060066)	3	0	.01	-	 < 0.2	1.00E00
protein localization to bicellular tight junction (GO:1902396)	1	0	.00	-	 < 0.2	1.00E00
uterus development (GO:0060065)	21	1	.09	+	11.36	1.00E00
telomere maintenance via telomerase (GO:0007004)	18	0	.08	-	 < 0.2	1.00E00
Spemann organizer formation at the anterior end of the primitive streak (GO:0060064)	1	0	.00	-	 < 0.2	1.00E00
Spemann organizer formation (GO:0060061)	3	0	.01	-	 < 0.2	1.00E00
nucleolus organization (GO:0007000)	6	0	.03	-	 < 0.2	1.00E00
post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment or maintenance of cell polarity (GO:0032878)	24	1	.10	+	9.94	1.00E00
positive regulation of DNA endoreduplication (GO:0032877)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of DNA endoreduplication (GO:0032876)	5	0	.02	-	 < 0.2	1.00E00
regulation of DNA endoreduplication (GO:0032875)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of stress-activated MAPK cascade (GO:0032874)	144	2	.60	+	3.31	1.00E00
negative regulation of stress-activated MAPK cascade (GO:0032873)	42	2	.18	+	11.36	1.00E00
neurotrophin signaling pathway (GO:0038179)	23	3	.10	+	31.13	1.00E00
positive regulation of dendritic cell dendrite assembly (GO:2000549)	1	0	.00	-	 < 0.2	1.00E00
complement component C5a signaling pathway (GO:0038178)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of dendritic cell dendrite assembly (GO:2000548)	1	0	.00	-	 < 0.2	1.00E00
regulation of dendritic cell dendrite assembly (GO:2000547)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	4	0	.02	-	 < 0.2	1.00E00
nephron morphogenesis (GO:0072028)	66	2	.28	+	7.23	1.00E00
negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545)	1	0	.00	-	 < 0.2	1.00E00
connecting tubule development (GO:0072027)	1	0	.00	-	 < 0.2	1.00E00
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of gastrulation (GO:2000543)	8	0	.03	-	 < 0.2	1.00E00
interleukin-33-mediated signaling pathway (GO:0038172)	2	0	.01	-	 < 0.2	1.00E00
distal convoluted tubule development (GO:0072025)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of gastrulation (GO:2000542)	7	0	.03	-	 < 0.2	1.00E00
cannabinoid signaling pathway (GO:0038171)	4	0	.02	-	 < 0.2	1.00E00
macula densa development (GO:0072024)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein geranylgeranylation (GO:2000541)	1	0	.00	-	 < 0.2	1.00E00
somatostatin signaling pathway (GO:0038170)	5	0	.02	-	 < 0.2	1.00E00
thick ascending limb development (GO:0072023)	2	0	.01	-	 < 0.2	1.00E00
descending thin limb development (GO:0072022)	1	0	.00	-	 < 0.2	1.00E00
ascending thin limb development (GO:0072021)	4	0	.02	-	 < 0.2	1.00E00
proximal straight tubule development (GO:0072020)	1	0	.00	-	 < 0.2	1.00E00
embryonic retina morphogenesis in camera-type eye (GO:0060059)	8	0	.03	-	 < 0.2	1.00E00
ceramide 1-phosphate transport (GO:1902389)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	4	0	.02	-	 < 0.2	1.00E00
cell cycle G2/M phase transition (GO:0044839)	138	5	.58	+	8.65	1.00E00
mammary gland involution (GO:0060056)	6	1	.03	+	39.78	1.00E00
actomyosin contractile ring organization (GO:0044837)	3	0	.01	-	 < 0.2	1.00E00
angiogenesis involved in wound healing (GO:0060055)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)	8	1	.03	+	29.83	1.00E00
neurofilament cytoskeleton organization (GO:0060052)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of protein glycosylation (GO:0060051)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of protein glycosylation (GO:0060050)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of endoribonuclease activity (GO:1902380)	1	0	.00	-	 < 0.2	1.00E00
modulation by host of viral RNA genome replication (GO:0044830)	2	0	.01	-	 < 0.2	1.00E00
somatostatin receptor signaling pathway (GO:0038169)	5	0	.02	-	 < 0.2	1.00E00
regulation of protein geranylgeranylation (GO:2000539)	1	0	.00	-	 < 0.2	1.00E00
epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of B cell chemotaxis (GO:2000538)	2	0	.01	-	 < 0.2	1.00E00
epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167)	1	0	.00	-	 < 0.2	1.00E00
regulation of B cell chemotaxis (GO:2000537)	2	0	.01	-	 < 0.2	1.00E00
angiotensin-activated signaling pathway (GO:0038166)	11	2	.05	+	43.39	1.00E00
proximal convoluted tubule development (GO:0072019)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of entry of bacterium into host cell (GO:2000536)	2	0	.01	-	 < 0.2	1.00E00
oncostatin-M-mediated signaling pathway (GO:0038165)	4	0	.02	-	 < 0.2	1.00E00
regulation of entry of bacterium into host cell (GO:2000535)	7	1	.03	+	34.09	1.00E00
distal tubule development (GO:0072017)	12	1	.05	+	19.89	1.00E00
positive regulation of renal albumin absorption (GO:2000534)	1	0	.00	-	 < 0.2	1.00E00
thrombopoietin-mediated signaling pathway (GO:0038163)	3	0	.01	-	 < 0.2	1.00E00
glomerular parietal epithelial cell development (GO:0072016)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of renal albumin absorption (GO:2000533)	1	0	.00	-	 < 0.2	1.00E00
erythropoietin-mediated signaling pathway (GO:0038162)	3	0	.01	-	 < 0.2	1.00E00
glomerular visceral epithelial cell development (GO:0072015)	10	1	.04	+	23.87	1.00E00
regulation of renal albumin absorption (GO:2000532)	2	0	.01	-	 < 0.2	1.00E00
prolactin signaling pathway (GO:0038161)	1	0	.00	-	 < 0.2	1.00E00
proximal tubule development (GO:0072014)	6	0	.03	-	 < 0.2	1.00E00
glomerular endothelium development (GO:0072011)	3	1	.01	+	79.55	1.00E00
glomerular epithelium development (GO:0072010)	21	2	.09	+	22.73	1.00E00
regulation of protein glycosylation (GO:0060049)	23	0	.10	-	 < 0.2	1.00E00
cardiac muscle contraction (GO:0060048)	74	0	.31	-	 < 0.2	1.00E00
VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378)	1	0	.00	-	 < 0.2	1.00E00
positive regulation by host of viral genome replication (GO:0044829)	8	0	.03	-	 < 0.2	1.00E00
heart contraction (GO:0060047)	85	0	.36	-	 < 0.2	1.00E00
negative regulation by host of viral genome replication (GO:0044828)	6	0	.03	-	 < 0.2	1.00E00
regulation of acrosome reaction (GO:0060046)	20	0	.08	-	 < 0.2	1.00E00
modulation by host of viral genome replication (GO:0044827)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of cardiac muscle cell proliferation (GO:0060045)	24	3	.10	+	29.83	1.00E00
negative regulation of cardiac muscle cell proliferation (GO:0060044)	13	0	.05	-	 < 0.2	1.00E00
regulation of cardiac muscle cell proliferation (GO:0060043)	40	3	.17	+	17.90	1.00E00
negative regulation of mRNA catabolic process (GO:1902373)	46	1	.19	+	5.19	1.00E00
modulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052433)	6	0	.03	-	 < 0.2	1.00E00
retina morphogenesis in camera-type eye (GO:0060042)	48	0	.20	-	 < 0.2	1.00E00
retina development in camera-type eye (GO:0060041)	135	1	.57	+	1.77	1.00E00
retinal bipolar neuron differentiation (GO:0060040)	4	0	.02	-	 < 0.2	1.00E00
meiotic telomere tethering at nuclear periphery (GO:0044821)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of myeloid dendritic cell chemotaxis (GO:2000529)	1	0	.00	-	 < 0.2	1.00E00
granulocyte colony-stimulating factor signaling pathway (GO:0038158)	2	0	.01	-	 < 0.2	1.00E00
regulation of myeloid dendritic cell chemotaxis (GO:2000527)	1	0	.00	-	 < 0.2	1.00E00
interleukin-3-mediated signaling pathway (GO:0038156)	2	0	.01	-	 < 0.2	1.00E00
nephron epithelium development (GO:0072009)	97	3	.41	+	7.38	1.00E00
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526)	1	0	.00	-	 < 0.2	1.00E00
interleukin-23-mediated signaling pathway (GO:0038155)	2	0	.01	-	 < 0.2	1.00E00
glomerular mesangial cell differentiation (GO:0072008)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of T cell costimulation (GO:2000525)	3	0	.01	-	 < 0.2	1.00E00
interleukin-11-mediated signaling pathway (GO:0038154)	1	0	.00	-	 < 0.2	1.00E00
mesangial cell differentiation (GO:0072007)	7	0	.03	-	 < 0.2	1.00E00
nephron development (GO:0072006)	122	5	.51	+	9.78	1.00E00
regulation of T cell costimulation (GO:2000523)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of immunological synapse formation (GO:2000522)	1	0	.00	-	 < 0.2	1.00E00
kidney field specification (GO:0072004)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of immunological synapse formation (GO:2000521)	2	0	.01	-	 < 0.2	1.00E00
kidney rudiment formation (GO:0072003)	3	0	.01	-	 < 0.2	1.00E00
regulation of immunological synapse formation (GO:2000520)	3	0	.01	-	 < 0.2	1.00E00
renal system development (GO:0072001)	271	7	1.14	+	6.16	1.00E00
pericardium development (GO:0060039)	20	0	.08	-	 < 0.2	1.00E00
negative regulation of RNA catabolic process (GO:1902369)	52	1	.22	+	4.59	1.00E00
cardiac muscle cell proliferation (GO:0060038)	14	0	.06	-	 < 0.2	1.00E00
modulation by host of symbiont molecular function (GO:0052428)	7	0	.03	-	 < 0.2	1.00E00
pharyngeal system development (GO:0060037)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367)	2	0	.01	-	 < 0.2	1.00E00
mitotic G2/M transition checkpoint (GO:0044818)	25	1	.10	+	9.55	1.00E00
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	2	0	.01	-	 < 0.2	1.00E00
notochord cell development (GO:0060035)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.00	-	 < 0.2	1.00E00
notochord cell differentiation (GO:0060034)	1	0	.00	-	 < 0.2	1.00E00
anatomical structure regression (GO:0060033)	11	0	.05	-	 < 0.2	1.00E00
regulation of protein localization to spindle pole body (GO:1902363)	1	0	.00	-	 < 0.2	1.00E00
notochord regression (GO:0060032)	2	0	.01	-	 < 0.2	1.00E00
melanocyte apoptotic process (GO:1902362)	1	0	.00	-	 < 0.2	1.00E00
modulation by host of symbiont catalytic activity (GO:0052422)	3	0	.01	-	 < 0.2	1.00E00
mediolateral intercalation (GO:0060031)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial pyruvate transmembrane transport (GO:1902361)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cellular pH reduction (GO:0032849)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of cellular pH reduction (GO:0032848)	1	1	.00	+	 > 100	1.00E00
regulation of cellular pH reduction (GO:0032847)	5	1	.02	+	47.73	1.00E00
negative regulation of homeostatic process (GO:0032845)	144	4	.60	+	6.63	1.00E00
negative regulation of T-helper 1 cell activation (GO:2000518)	1	0	.00	-	 < 0.2	1.00E00
regulation of T-helper 1 cell activation (GO:2000517)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	30	0	.13	-	 < 0.2	1.00E00
macrophage colony-stimulating factor signaling pathway (GO:0038145)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	21	0	.09	-	 < 0.2	1.00E00
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	48	0	.20	-	 < 0.2	1.00E00
positive regulation of granzyme A production (GO:2000513)	1	0	.00	-	 < 0.2	1.00E00
regulation of granzyme A production (GO:2000511)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dendritic cell chemotaxis (GO:2000510)	9	0	.04	-	 < 0.2	1.00E00
convergent extension involved in organogenesis (GO:0060029)	6	0	.03	-	 < 0.2	1.00E00
metabolism by host of substance in symbiont (GO:0052419)	1	0	.00	-	 < 0.2	1.00E00
convergent extension involved in axis elongation (GO:0060028)	6	0	.03	-	 < 0.2	1.00E00
sulfate transmembrane transport (GO:1902358)	14	0	.06	-	 < 0.2	1.00E00
metabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052418)	1	0	.00	-	 < 0.2	1.00E00
convergent extension involved in gastrulation (GO:0060027)	8	0	.03	-	 < 0.2	1.00E00
metabolism by host of symbiont protein (GO:0052417)	1	0	.00	-	 < 0.2	1.00E00
convergent extension (GO:0060026)	14	0	.06	-	 < 0.2	1.00E00
oxaloacetate(2-) transmembrane transport (GO:1902356)	2	0	.01	-	 < 0.2	1.00E00
metabolism by host of symbiont macromolecule (GO:0052416)	1	0	.00	-	 < 0.2	1.00E00
regulation of synaptic activity (GO:0060025)	3	0	.01	-	 < 0.2	1.00E00
G-quadruplex DNA unwinding (GO:0044806)	7	0	.03	-	 < 0.2	1.00E00
rhythmic synaptic transmission (GO:0060024)	5	0	.02	-	 < 0.2	1.00E00
late nucleophagy (GO:0044805)	3	0	.01	-	 < 0.2	1.00E00
soft palate development (GO:0060023)	5	0	.02	-	 < 0.2	1.00E00
autophagy of nucleus (GO:0044804)	19	0	.08	-	 < 0.2	1.00E00
hard palate development (GO:0060022)	6	0	.03	-	 < 0.2	1.00E00
phosphagen metabolic process (GO:0006599)	1	0	.00	-	 < 0.2	1.00E00
multi-organism membrane organization (GO:0044803)	8	0	.03	-	 < 0.2	1.00E00
palate development (GO:0060021)	92	1	.39	+	2.59	1.00E00
polyamine catabolic process (GO:0006598)	6	0	.03	-	 < 0.2	1.00E00
Bergmann glial cell differentiation (GO:0060020)	8	1	.03	+	29.83	1.00E00
spermine biosynthetic process (GO:0006597)	2	0	.01	-	 < 0.2	1.00E00
polyamine biosynthetic process (GO:0006596)	13	0	.05	-	 < 0.2	1.00E00
multi-organism membrane fusion (GO:0044800)	7	0	.03	-	 < 0.2	1.00E00
polyamine metabolic process (GO:0006595)	17	0	.07	-	 < 0.2	1.00E00
ornithine catabolic process (GO:0006593)	1	0	.00	-	 < 0.2	1.00E00
ornithine biosynthetic process (GO:0006592)	1	0	.00	-	 < 0.2	1.00E00
glomerular basement membrane development (GO:0032836)	10	0	.04	-	 < 0.2	1.00E00
ornithine metabolic process (GO:0006591)	9	0	.04	-	 < 0.2	1.00E00
thyroid hormone generation (GO:0006590)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)	2	0	.01	-	 < 0.2	1.00E00
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)	2	0	.01	-	 < 0.2	1.00E00
regulation of dendritic cell chemotaxis (GO:2000508)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of energy homeostasis (GO:2000507)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of energy homeostasis (GO:2000506)	2	0	.01	-	 < 0.2	1.00E00
regulation of energy homeostasis (GO:2000505)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of blood vessel remodeling (GO:2000504)	3	0	.01	-	 < 0.2	1.00E00
ERBB2-ERBB3 signaling pathway (GO:0038133)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of natural killer cell chemotaxis (GO:2000503)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of natural killer cell chemotaxis (GO:2000502)	2	0	.01	-	 < 0.2	1.00E00
regulation of natural killer cell chemotaxis (GO:2000501)	8	0	.03	-	 < 0.2	1.00E00
radial glial cell differentiation (GO:0060019)	10	1	.04	+	23.87	1.00E00
astrocyte fate commitment (GO:0060018)	4	0	.02	-	 < 0.2	1.00E00
parathyroid gland development (GO:0060017)	7	0	.03	-	 < 0.2	1.00E00
granulosa cell development (GO:0060016)	1	0	.00	-	 < 0.2	1.00E00
negative regulation by host of symbiont molecular function (GO:0052405)	6	0	.03	-	 < 0.2	1.00E00
granulosa cell differentiation (GO:0060014)	2	0	.01	-	 < 0.2	1.00E00
righting reflex (GO:0060013)	9	0	.04	-	 < 0.2	1.00E00
negative regulation by host of symbiont catalytic activity (GO:0052403)	2	0	.01	-	 < 0.2	1.00E00
synaptic transmission, glycinergic (GO:0060012)	7	0	.03	-	 < 0.2	1.00E00
octopamine biosynthetic process (GO:0006589)	3	0	.01	-	 < 0.2	1.00E00
Sertoli cell proliferation (GO:0060011)	5	0	.02	-	 < 0.2	1.00E00
Sertoli cell fate commitment (GO:0060010)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of chromosome condensation (GO:1902340)	1	0	.00	-	 < 0.2	1.00E00
indolalkylamine metabolic process (GO:0006586)	17	0	.07	-	 < 0.2	1.00E00
dopamine biosynthetic process from tyrosine (GO:0006585)	1	0	.00	-	 < 0.2	1.00E00
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	3	0	.01	-	 < 0.2	1.00E00
catecholamine metabolic process (GO:0006584)	43	1	.18	+	5.55	1.00E00
melanin biosynthetic process from tyrosine (GO:0006583)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of natural killer cell differentiation involved in immune response (GO:0032827)	3	0	.01	-	 < 0.2	1.00E00
melanin metabolic process (GO:0006582)	14	1	.06	+	17.05	1.00E00
regulation of natural killer cell differentiation involved in immune response (GO:0032826)	4	0	.02	-	 < 0.2	1.00E00
acetylcholine catabolic process (GO:0006581)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of natural killer cell differentiation (GO:0032825)	8	1	.03	+	29.83	1.00E00
ethanolamine metabolic process (GO:0006580)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of natural killer cell differentiation (GO:0032824)	3	0	.01	-	 < 0.2	1.00E00
regulation of natural killer cell differentiation (GO:0032823)	13	1	.05	+	18.36	1.00E00
ERBB3 signaling pathway (GO:0038129)	2	1	.01	+	 > 100	1.00E00
toll-like receptor TLR6:TLR2 signaling pathway (GO:0038124)	4	0	.02	-	 < 0.2	1.00E00
toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)	3	0	.01	-	 < 0.2	1.00E00
Sertoli cell development (GO:0060009)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	4	0	.02	-	 < 0.2	1.00E00
Sertoli cell differentiation (GO:0060008)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	6	0	.03	-	 < 0.2	1.00E00
linear vestibuloocular reflex (GO:0060007)	1	0	.00	-	 < 0.2	1.00E00
regulation of apoptotic process involved in morphogenesis (GO:1902337)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of retinal ganglion cell axon guidance (GO:1902336)	2	0	.01	-	 < 0.2	1.00E00
vestibular reflex (GO:0060005)	4	0	.02	-	 < 0.2	1.00E00
reflex (GO:0060004)	20	0	.08	-	 < 0.2	1.00E00
copper ion export (GO:0060003)	2	0	.01	-	 < 0.2	1.00E00
amino-acid betaine catabolic process (GO:0006579)	3	0	.01	-	 < 0.2	1.00E00
amino-acid betaine biosynthetic process (GO:0006578)	7	0	.03	-	 < 0.2	1.00E00
amino-acid betaine metabolic process (GO:0006577)	17	0	.07	-	 < 0.2	1.00E00
cellular biogenic amine metabolic process (GO:0006576)	54	0	.23	-	 < 0.2	1.00E00
cellular modified amino acid metabolic process (GO:0006575)	181	3	.76	+	3.96	1.00E00
positive regulation of natural killer cell proliferation (GO:0032819)	7	0	.03	-	 < 0.2	1.00E00
valine catabolic process (GO:0006574)	4	0	.02	-	 < 0.2	1.00E00
valine metabolic process (GO:0006573)	9	1	.04	+	26.52	1.00E00
regulation of natural killer cell proliferation (GO:0032817)	9	0	.04	-	 < 0.2	1.00E00
tyrosine catabolic process (GO:0006572)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of natural killer cell activation (GO:0032816)	18	1	.08	+	13.26	1.00E00
negative regulation of natural killer cell activation (GO:0032815)	7	0	.03	-	 < 0.2	1.00E00
tyrosine metabolic process (GO:0006570)	9	0	.04	-	 < 0.2	1.00E00
regulation of natural killer cell activation (GO:0032814)	29	1	.12	+	8.23	1.00E00
positive regulation of epinephrine secretion (GO:0032812)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of epinephrine secretion (GO:0032811)	4	0	.02	-	 < 0.2	1.00E00
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	1	0	.00	-	 < 0.2	1.00E00
chemokine (C-C motif) ligand 19 signaling pathway (GO:0038115)	1	0	.00	-	 < 0.2	1.00E00
interleukin-21-mediated signaling pathway (GO:0038114)	1	0	.00	-	 < 0.2	1.00E00
interleukin-9-mediated signaling pathway (GO:0038113)	1	0	.00	-	 < 0.2	1.00E00
interleukin-8-mediated signaling pathway (GO:0038112)	2	0	.01	-	 < 0.2	1.00E00
interleukin-2-mediated signaling pathway (GO:0038110)	4	0	.02	-	 < 0.2	1.00E00
otic vesicle development (GO:0071599)	14	0	.06	-	 < 0.2	1.00E00
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	0	.01	-	 < 0.2	1.00E00
lymphocyte aggregation (GO:0071593)	4	0	.02	-	 < 0.2	1.00E00
tryptophan catabolic process (GO:0006569)	10	0	.04	-	 < 0.2	1.00E00
tryptophan metabolic process (GO:0006568)	12	0	.05	-	 < 0.2	1.00E00
threonine catabolic process (GO:0006567)	2	0	.01	-	 < 0.2	1.00E00
threonine metabolic process (GO:0006566)	2	0	.01	-	 < 0.2	1.00E00
L-serine catabolic process (GO:0006565)	3	0	.01	-	 < 0.2	1.00E00
L-serine biosynthetic process (GO:0006564)	6	0	.03	-	 < 0.2	1.00E00
lacrimal gland development (GO:0032808)	7	0	.03	-	 < 0.2	1.00E00
L-serine metabolic process (GO:0006563)	11	0	.05	-	 < 0.2	1.00E00
proline catabolic process (GO:0006562)	4	0	.02	-	 < 0.2	1.00E00
proline biosynthetic process (GO:0006561)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	2	0	.01	-	 < 0.2	1.00E00
proline metabolic process (GO:0006560)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	2	0	.01	-	 < 0.2	1.00E00
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	5	0	.02	-	 < 0.2	1.00E00
Kit signaling pathway (GO:0038109)	2	0	.01	-	 < 0.2	1.00E00
low-density lipoprotein particle receptor catabolic process (GO:0032802)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	4	0	.02	-	 < 0.2	1.00E00
receptor catabolic process (GO:0032801)	26	0	.11	-	 < 0.2	1.00E00
nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107)	3	0	.01	-	 < 0.2	1.00E00
receptor biosynthetic process (GO:0032800)	5	0	.02	-	 < 0.2	1.00E00
sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.00	-	 < 0.2	1.00E00
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.00	-	 < 0.2	1.00E00
CAAX-box protein processing (GO:0071586)	3	0	.01	-	 < 0.2	1.00E00
detoxification of cadmium ion (GO:0071585)	1	0	.00	-	 < 0.2	1.00E00
nuclear DNA replication termination (GO:1902317)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of zinc ion transmembrane import (GO:0071584)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of zinc ion transmembrane transport (GO:0071583)	1	0	.00	-	 < 0.2	1.00E00
nuclear cell cycle DNA replication initiation (GO:1902315)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of zinc ion transport (GO:0071582)	1	0	.00	-	 < 0.2	1.00E00
regulation of zinc ion transmembrane import (GO:0071581)	1	0	.00	-	 < 0.2	1.00E00
regulation of zinc ion transmembrane transport (GO:0071580)	1	0	.00	-	 < 0.2	1.00E00
L-phenylalanine catabolic process (GO:0006559)	11	0	.05	-	 < 0.2	1.00E00
regulation of copper ion transmembrane transport (GO:1902311)	1	0	.00	-	 < 0.2	1.00E00
L-phenylalanine metabolic process (GO:0006558)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of peptidyl-serine dephosphorylation (GO:1902310)	2	0	.01	-	 < 0.2	1.00E00
S-adenosylmethioninamine biosynthetic process (GO:0006557)	1	0	.00	-	 < 0.2	1.00E00
S-adenosylmethionine biosynthetic process (GO:0006556)	3	0	.01	-	 < 0.2	1.00E00
methionine metabolic process (GO:0006555)	20	0	.08	-	 < 0.2	1.00E00
lysine catabolic process (GO:0006554)	12	0	.05	-	 < 0.2	1.00E00
lysine metabolic process (GO:0006553)	13	0	.05	-	 < 0.2	1.00E00
leucine catabolic process (GO:0006552)	5	0	.02	-	 < 0.2	1.00E00
leucine metabolic process (GO:0006551)	7	0	.03	-	 < 0.2	1.00E00
isoleucine catabolic process (GO:0006550)	2	0	.01	-	 < 0.2	1.00E00
hepatocyte cell migration (GO:0002194)	1	0	.00	-	 < 0.2	1.00E00
IRES-dependent translational initiation of linear mRNA (GO:0002192)	2	1	.01	+	 > 100	1.00E00
cap-dependent translational initiation (GO:0002191)	2	0	.01	-	 < 0.2	1.00E00
cap-independent translational initiation (GO:0002190)	2	1	.01	+	 > 100	1.00E00
regulation of zinc ion transport (GO:0071579)	2	0	.01	-	 < 0.2	1.00E00
zinc II ion transmembrane import (GO:0071578)	7	0	.03	-	 < 0.2	1.00E00
zinc II ion transmembrane transport (GO:0071577)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of peptidyl-serine dephosphorylation (GO:1902309)	3	0	.01	-	 < 0.2	1.00E00
regulation of peptidyl-serine dephosphorylation (GO:1902308)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of sodium ion transmembrane transport (GO:1902307)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of sodium ion transmembrane transport (GO:1902306)	11	0	.05	-	 < 0.2	1.00E00
regulation of sodium ion transmembrane transport (GO:1902305)	59	0	.25	-	 < 0.2	1.00E00
positive regulation of potassium ion export (GO:1902304)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of potassium ion export (GO:1902303)	2	0	.01	-	 < 0.2	1.00E00
regulation of potassium ion export (GO:1902302)	5	0	.02	-	 < 0.2	1.00E00
isoleucine metabolic process (GO:0006549)	5	1	.02	+	47.73	1.00E00
histidine catabolic process (GO:0006548)	8	0	.03	-	 < 0.2	1.00E00
histidine metabolic process (GO:0006547)	10	0	.04	-	 < 0.2	1.00E00
glycine catabolic process (GO:0006546)	3	0	.01	-	 < 0.2	1.00E00
glycine biosynthetic process (GO:0006545)	6	0	.03	-	 < 0.2	1.00E00
glycine metabolic process (GO:0006544)	15	0	.06	-	 < 0.2	1.00E00
glutamine catabolic process (GO:0006543)	3	0	.01	-	 < 0.2	1.00E00
glutamine biosynthetic process (GO:0006542)	2	0	.01	-	 < 0.2	1.00E00
glutamine metabolic process (GO:0006541)	23	0	.10	-	 < 0.2	1.00E00
glutamate decarboxylation to succinate (GO:0006540)	3	0	.01	-	 < 0.2	1.00E00
translation reinitiation (GO:0002188)	3	0	.01	-	 < 0.2	1.00E00
acetylcholine receptor signaling pathway (GO:0095500)	23	0	.10	-	 < 0.2	1.00E00
cytoplasmic translational termination (GO:0002184)	2	0	.01	-	 < 0.2	1.00E00
cytoplasmic translational initiation (GO:0002183)	17	1	.07	+	14.04	1.00E00
cytoplasmic translation (GO:0002181)	46	1	.19	+	5.19	1.00E00
protein ufmylation (GO:0071569)	6	0	.03	-	 < 0.2	1.00E00
cellular response to transforming growth factor beta stimulus (GO:0071560)	144	3	.60	+	4.97	1.00E00
glutamate catabolic process (GO:0006538)	8	0	.03	-	 < 0.2	1.00E00
glutamate biosynthetic process (GO:0006537)	5	0	.02	-	 < 0.2	1.00E00
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	13	1	.05	+	18.36	1.00E00
glutamate metabolic process (GO:0006536)	29	0	.12	-	 < 0.2	1.00E00
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	5	1	.02	+	47.73	1.00E00
cysteine biosynthetic process from serine (GO:0006535)	2	0	.01	-	 < 0.2	1.00E00
cysteine metabolic process (GO:0006534)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of chromosome segregation (GO:0051985)	30	2	.13	+	15.91	1.00E00
aspartate catabolic process (GO:0006533)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of chromosome segregation (GO:0051984)	24	1	.10	+	9.94	1.00E00
RNA acetylation (GO:1990884)	1	0	.00	-	 < 0.2	1.00E00
aspartate biosynthetic process (GO:0006532)	3	0	.01	-	 < 0.2	1.00E00
regulation of chromosome segregation (GO:0051983)	96	3	.40	+	7.46	1.00E00
aspartate metabolic process (GO:0006531)	11	0	.05	-	 < 0.2	1.00E00
rRNA acetylation (GO:1990882)	1	0	.00	-	 < 0.2	1.00E00
asparagine catabolic process (GO:0006530)	2	0	.01	-	 < 0.2	1.00E00
male germ cell proliferation (GO:0002176)	2	0	.01	-	 < 0.2	1.00E00
protein localization to paranode region of axon (GO:0002175)	4	0	.02	-	 < 0.2	1.00E00
response to transforming growth factor beta (GO:0071559)	149	3	.62	+	4.81	1.00E00
histone H3-K27 demethylation (GO:0071557)	5	0	.02	-	 < 0.2	1.00E00
cell wall organization or biogenesis (GO:0071554)	15	0	.06	-	 < 0.2	1.00E00
death-inducing signaling complex assembly (GO:0071550)	8	1	.03	+	29.83	1.00E00
asparagine biosynthetic process (GO:0006529)	2	0	.01	-	 < 0.2	1.00E00
asparagine metabolic process (GO:0006528)	5	0	.02	-	 < 0.2	1.00E00
arginine catabolic process (GO:0006527)	8	0	.03	-	 < 0.2	1.00E00
arginine biosynthetic process (GO:0006526)	7	0	.03	-	 < 0.2	1.00E00
lysophospholipid transport (GO:0051977)	2	0	.01	-	 < 0.2	1.00E00
arginine metabolic process (GO:0006525)	18	0	.08	-	 < 0.2	1.00E00
alanine catabolic process (GO:0006524)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of telomerase activity (GO:0051974)	11	2	.05	+	43.39	1.00E00
alanine metabolic process (GO:0006522)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of telomerase activity (GO:0051973)	36	1	.15	+	6.63	1.00E00
regulation of cellular amino acid metabolic process (GO:0006521)	62	0	.26	-	 < 0.2	1.00E00
regulation of telomerase activity (GO:0051972)	48	3	.20	+	14.92	1.00E00
cellular amino acid metabolic process (GO:0006520)	313	2	1.31	+	1.52	1.00E00
positive regulation of transmission of nerve impulse (GO:0051971)	7	1	.03	+	34.09	1.00E00
negative regulation of transmission of nerve impulse (GO:0051970)	5	0	.02	-	 < 0.2	1.00E00
inositol phosphate catabolic process (GO:0071545)	11	0	.05	-	 < 0.2	1.00E00
diphosphoinositol polyphosphate catabolic process (GO:0071544)	1	0	.00	-	 < 0.2	1.00E00
diphosphoinositol polyphosphate metabolic process (GO:0071543)	4	0	.02	-	 < 0.2	1.00E00
dopaminergic neuron differentiation (GO:0071542)	31	0	.13	-	 < 0.2	1.00E00
peptide metabolic process (GO:0006518)	537	8	2.25	+	3.56	1.00E00
regulation of transmission of nerve impulse (GO:0051969)	18	1	.08	+	13.26	1.00E00
cellular response to chemokine (GO:1990869)	7	0	.03	-	 < 0.2	1.00E00
protein deglycosylation (GO:0006517)	36	0	.15	-	 < 0.2	1.00E00
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	22	1	.09	+	10.85	1.00E00
response to chemokine (GO:1990868)	7	0	.03	-	 < 0.2	1.00E00
glycoprotein catabolic process (GO:0006516)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	14	0	.06	-	 < 0.2	1.00E00
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	27	0	.11	-	 < 0.2	1.00E00
regulation of synaptic transmission, glutamatergic (GO:0051966)	60	1	.25	+	3.98	1.00E00
positive regulation of synapse assembly (GO:0051965)	64	0	.27	-	 < 0.2	1.00E00
protein monoubiquitination (GO:0006513)	60	0	.25	-	 < 0.2	1.00E00
negative regulation of synapse assembly (GO:0051964)	6	0	.03	-	 < 0.2	1.00E00
regulation of synapse assembly (GO:0051963)	85	0	.36	-	 < 0.2	1.00E00
ubiquitin-dependent protein catabolic process (GO:0006511)	493	6	2.07	+	2.90	1.00E00
positive regulation of nervous system development (GO:0051962)	477	3	2.00	+	1.50	1.00E00
desmosome assembly (GO:0002159)	4	1	.02	+	59.66	1.00E00
negative regulation of nervous system development (GO:0051961)	272	5	1.14	+	4.39	1.00E00
osteoclast proliferation (GO:0002158)	3	0	.01	-	 < 0.2	1.00E00
regulation of nervous system development (GO:0051960)	800	10	3.35	+	2.98	1.00E00
regulation of thyroid hormone mediated signaling pathway (GO:0002155)	4	0	.02	-	 < 0.2	1.00E00
thyroid hormone mediated signaling pathway (GO:0002154)	1	0	.00	-	 < 0.2	1.00E00
bile acid conjugation (GO:0002152)	1	0	.00	-	 < 0.2	1.00E00
post-mating behavior (GO:0045297)	1	0	.00	-	 < 0.2	1.00E00
protein localization to centrosome (GO:0071539)	20	0	.08	-	 < 0.2	1.00E00
SH2 domain-mediated complex assembly (GO:0071538)	1	0	.00	-	 < 0.2	1.00E00
mRNA cis splicing, via spliceosome (GO:0045292)	18	0	.08	-	 < 0.2	1.00E00
membrane protein ectodomain proteolysis (GO:0006509)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of relaxation of cardiac muscle (GO:1901899)	2	0	.01	-	 < 0.2	1.00E00
proteolysis (GO:0006508)	1327	14	5.56	+	2.52	1.00E00
negative regulation of relaxation of cardiac muscle (GO:1901898)	2	0	.01	-	 < 0.2	1.00E00
cellular response to endothelin (GO:1990859)	1	0	.00	-	 < 0.2	1.00E00
GPI anchor release (GO:0006507)	1	0	.00	-	 < 0.2	1.00E00
methotrexate transport (GO:0051958)	2	0	.01	-	 < 0.2	1.00E00
regulation of relaxation of cardiac muscle (GO:1901897)	7	0	.03	-	 < 0.2	1.00E00
GPI anchor biosynthetic process (GO:0006506)	32	0	.13	-	 < 0.2	1.00E00
positive regulation of amino acid transport (GO:0051957)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of calcium-transporting ATPase activity (GO:1901896)	4	0	.02	-	 < 0.2	1.00E00
GPI anchor metabolic process (GO:0006505)	33	0	.14	-	 < 0.2	1.00E00
negative regulation of amino acid transport (GO:0051956)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of calcium-transporting ATPase activity (GO:1901895)	3	0	.01	-	 < 0.2	1.00E00
regulation of amino acid transport (GO:0051955)	30	0	.13	-	 < 0.2	1.00E00
regulation of calcium-transporting ATPase activity (GO:1901894)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of amine transport (GO:0051954)	33	0	.14	-	 < 0.2	1.00E00
negative regulation of amine transport (GO:0051953)	23	0	.10	-	 < 0.2	1.00E00
C-terminal protein lipidation (GO:0006501)	77	0	.32	-	 < 0.2	1.00E00
regulation of amine transport (GO:0051952)	79	0	.33	-	 < 0.2	1.00E00
hypochlorous acid biosynthetic process (GO:0002149)	1	0	.00	-	 < 0.2	1.00E00
N-terminal protein palmitoylation (GO:0006500)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cell junction assembly (GO:1901890)	31	1	.13	+	7.70	1.00E00
hypochlorous acid metabolic process (GO:0002148)	1	0	.00	-	 < 0.2	1.00E00
tRNA wobble position uridine thiolation (GO:0002143)	3	0	.01	-	 < 0.2	1.00E00
cementum mineralization (GO:0071529)	2	0	.01	-	 < 0.2	1.00E00
tRNA re-export from nucleus (GO:0071528)	1	0	.00	-	 < 0.2	1.00E00
semaphorin-plexin signaling pathway (GO:0071526)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of cell junction assembly (GO:1901889)	20	1	.08	+	11.93	1.00E00
regulation of cell junction assembly (GO:1901888)	81	3	.34	+	8.84	1.00E00
regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	0	.00	-	 < 0.2	1.00E00
adaptive thermogenesis (GO:1990845)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of protein depolymerization (GO:1901881)	18	0	.08	-	 < 0.2	1.00E00
regulation of amino acid uptake involved in synaptic transmission (GO:0051941)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein depolymerization (GO:1901880)	55	0	.23	-	 < 0.2	1.00E00
retinoic acid biosynthetic process (GO:0002138)	8	0	.03	-	 < 0.2	1.00E00
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	8	0	.03	-	 < 0.2	1.00E00
establishment of imprinting at mating-type locus (GO:0071516)	1	0	.00	-	 < 0.2	1.00E00
genetic imprinting at mating-type locus (GO:0071515)	1	0	.00	-	 < 0.2	1.00E00
genetic imprinting (GO:0071514)	23	1	.10	+	10.38	1.00E00
regulation of protein depolymerization (GO:1901879)	73	0	.31	-	 < 0.2	1.00E00
gamma-aminobutyric acid import (GO:0051939)	1	0	.00	-	 < 0.2	1.00E00
response to endothelin (GO:1990839)	1	0	.00	-	 < 0.2	1.00E00
L-glutamate import (GO:0051938)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of calcium ion binding (GO:1901877)	2	0	.01	-	 < 0.2	1.00E00
catecholamine transport (GO:0051937)	15	0	.06	-	 < 0.2	1.00E00
regulation of calcium ion binding (GO:1901876)	2	0	.01	-	 < 0.2	1.00E00
glutamate reuptake (GO:0051935)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of post-translational protein modification (GO:1901874)	2	0	.01	-	 < 0.2	1.00E00
catecholamine uptake involved in synaptic transmission (GO:0051934)	5	0	.02	-	 < 0.2	1.00E00
regulation of post-translational protein modification (GO:1901873)	2	0	.01	-	 < 0.2	1.00E00
response to odorant (GO:1990834)	4	0	.02	-	 < 0.2	1.00E00
amino acid neurotransmitter reuptake (GO:0051933)	1	0	.00	-	 < 0.2	1.00E00
synaptic transmission, GABAergic (GO:0051932)	7	0	.03	-	 < 0.2	1.00E00
regulation of sensory perception (GO:0051931)	33	0	.14	-	 < 0.2	1.00E00
regulation of sensory perception of pain (GO:0051930)	33	0	.14	-	 < 0.2	1.00E00
cellular response to leukemia inhibitory factor (GO:1990830)	97	1	.41	+	2.46	1.00E00
tRNA wobble base cytosine methylation (GO:0002127)	1	0	.00	-	 < 0.2	1.00E00
maternal aggressive behavior (GO:0002125)	3	0	.01	-	 < 0.2	1.00E00
inter-male aggressive behavior (GO:0002121)	2	0	.01	-	 < 0.2	1.00E00
cellular response to mycophenolic acid (GO:0071506)	2	0	.01	-	 < 0.2	1.00E00
response to mycophenolic acid (GO:0071505)	2	0	.01	-	 < 0.2	1.00E00
cellular response to heparin (GO:0071504)	5	0	.02	-	 < 0.2	1.00E00
secretion of lysosomal enzymes (GO:0033299)	4	0	.02	-	 < 0.2	1.00E00
response to heparin (GO:0071503)	6	0	.03	-	 < 0.2	1.00E00
cellular response to temperature stimulus (GO:0071502)	5	0	.02	-	 < 0.2	1.00E00
cellular response to sterol depletion (GO:0071501)	8	0	.03	-	 < 0.2	1.00E00
cellular response to nitrosative stress (GO:0071500)	4	1	.02	+	59.66	1.00E00
positive regulation of calcium ion transport (GO:0051928)	107	4	.45	+	8.92	1.00E00
hepatocyte dedifferentiation (GO:1990828)	1	0	.00	-	 < 0.2	1.00E00
T-tubule organization (GO:0033292)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of calcium ion transport (GO:0051926)	60	1	.25	+	3.98	1.00E00
regulation of calcium ion transport (GO:0051924)	227	5	.95	+	5.26	1.00E00
sulfation (GO:0051923)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of muscle tissue development (GO:1901862)	47	2	.20	+	10.16	1.00E00
response to leukemia inhibitory factor (GO:1990823)	97	1	.41	+	2.46	1.00E00
basic amino acid transmembrane transport (GO:1990822)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of mitochondrial DNA metabolic process (GO:1901860)	2	0	.01	-	 < 0.2	1.00E00
aggressive behavior (GO:0002118)	8	0	.03	-	 < 0.2	1.00E00
store-operated calcium entry (GO:0002115)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of mitochondrial DNA metabolic process (GO:1901859)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of fibrinolysis (GO:0051919)	4	0	.02	-	 < 0.2	1.00E00
regulation of mitochondrial DNA metabolic process (GO:1901858)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of fibrinolysis (GO:0051918)	10	1	.04	+	23.87	1.00E00
positive regulation of cellular respiration (GO:1901857)	6	1	.03	+	39.78	1.00E00
regulation of fibrinolysis (GO:0051917)	14	1	.06	+	17.05	1.00E00
negative regulation of cellular respiration (GO:1901856)	3	0	.01	-	 < 0.2	1.00E00
response to vitamin D (GO:0033280)	31	0	.13	-	 < 0.2	1.00E00
tRNA wobble cytosine modification (GO:0002101)	3	0	.01	-	 < 0.2	1.00E00
tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.00	-	 < 0.2	1.00E00
cell proliferation in midbrain (GO:0033278)	6	0	.03	-	 < 0.2	1.00E00
abortive mitotic cell cycle (GO:0033277)	2	0	.01	-	 < 0.2	1.00E00
actin-myosin filament sliding (GO:0033275)	38	0	.16	-	 < 0.2	1.00E00
response to vitamin B2 (GO:0033274)	1	0	.00	-	 < 0.2	1.00E00
endoplasmic reticulum tubular network membrane organization (GO:1990809)	1	0	.00	-	 < 0.2	1.00E00
response to vitamin (GO:0033273)	90	4	.38	+	10.61	1.00E00
positive regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901846)	1	0	.00	-	 < 0.2	1.00E00
establishment of pigment granule localization (GO:0051905)	23	0	.10	-	 < 0.2	1.00E00
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	7	1	.03	+	34.09	1.00E00
pigment granule transport (GO:0051904)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of high voltage-gated calcium channel activity (GO:1901843)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of high voltage-gated calcium channel activity (GO:1901842)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of mitochondrial depolarization (GO:0051902)	6	2	.03	+	79.55	1.00E00
regulation of high voltage-gated calcium channel activity (GO:1901841)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of mitochondrial depolarization (GO:0051901)	10	0	.04	-	 < 0.2	1.00E00
regulation of mitochondrial depolarization (GO:0051900)	20	2	.08	+	23.87	1.00E00
protein palmitoleylation (GO:0045234)	1	0	.00	-	 < 0.2	1.00E00
RNA localization to nucleus (GO:0090685)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901838)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901837)	4	0	.02	-	 < 0.2	1.00E00
regulation of nuclear cell cycle DNA replication (GO:0033262)	13	0	.05	-	 < 0.2	1.00E00
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	0	.00	-	 < 0.2	1.00E00
nuclear DNA replication (GO:0033260)	38	2	.16	+	12.56	1.00E00
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	0	.00	-	 < 0.2	1.00E00
external encapsulating structure organization (GO:0045229)	3	1	.01	+	79.55	1.00E00
extracellular polysaccharide biosynthetic process (GO:0045226)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of CD4 biosynthetic process (GO:0045225)	1	0	.00	-	 < 0.2	1.00E00
calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676)	1	0	.00	-	 < 0.2	1.00E00
intermicrovillar adhesion (GO:0090675)	2	0	.01	-	 < 0.2	1.00E00
regulation of CD4 biosynthetic process (GO:0045223)	1	0	.00	-	 < 0.2	1.00E00
endothelial cell-matrix adhesion (GO:0090673)	1	1	.00	+	 > 100	1.00E00
negative regulation of FasL biosynthetic process (GO:0045221)	1	0	.00	-	 < 0.2	1.00E00
telomerase RNA localization (GO:0090672)	1	0	.00	-	 < 0.2	1.00E00
telomerase RNA localization to Cajal body (GO:0090671)	1	0	.00	-	 < 0.2	1.00E00
RNA localization to Cajal body (GO:0090670)	4	0	.02	-	 < 0.2	1.00E00
regulation of FasL biosynthetic process (GO:0045219)	1	0	.00	-	 < 0.2	1.00E00
zonula adherens maintenance (GO:0045218)	3	0	.01	-	 < 0.2	1.00E00
telomerase RNA stabilization (GO:0090669)	4	0	.02	-	 < 0.2	1.00E00
cell-cell junction maintenance (GO:0045217)	11	0	.05	-	 < 0.2	1.00E00
scaRNA localization to Cajal body (GO:0090666)	4	0	.02	-	 < 0.2	1.00E00
sarcomere organization (GO:0045214)	39	0	.16	-	 < 0.2	1.00E00
neurotransmitter receptor metabolic process (GO:0045213)	4	1	.02	+	59.66	1.00E00
neurotransmitter receptor biosynthetic process (GO:0045212)	1	0	.00	-	 < 0.2	1.00E00
ATP hydrolysis coupled transmembrane transport (GO:0090662)	76	1	.32	+	3.14	1.00E00
FasL biosynthetic process (GO:0045210)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cellular amine catabolic process (GO:0033242)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular amine catabolic process (GO:0033241)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cellular amine metabolic process (GO:0033240)	9	0	.04	-	 < 0.2	1.00E00
beta-carotene metabolic process (GO:1901810)	1	0	.00	-	 < 0.2	1.00E00
MAPK phosphatase export from nucleus, leptomycin B sensitive (GO:0045209)	1	0	.00	-	 < 0.2	1.00E00
gastrin-induced gastric acid secretion (GO:0001698)	1	0	.00	-	 < 0.2	1.00E00
MAPK phosphatase export from nucleus (GO:0045208)	1	0	.00	-	 < 0.2	1.00E00
walking behavior (GO:0090659)	31	0	.13	-	 < 0.2	1.00E00
histamine-induced gastric acid secretion (GO:0001697)	1	0	.00	-	 < 0.2	1.00E00
gastric acid secretion (GO:0001696)	7	0	.03	-	 < 0.2	1.00E00
telomeric loop disassembly (GO:0090657)	10	0	.04	-	 < 0.2	1.00E00
histamine catabolic process (GO:0001695)	1	0	.00	-	 < 0.2	1.00E00
t-circle formation (GO:0090656)	11	0	.05	-	 < 0.2	1.00E00
histamine biosynthetic process (GO:0001694)	2	0	.01	-	 < 0.2	1.00E00
MAPK export from nucleus (GO:0045204)	2	0	.01	-	 < 0.2	1.00E00
histamine metabolic process (GO:0001692)	4	0	.02	-	 < 0.2	1.00E00
establishment of neuroblast polarity (GO:0045200)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular amine metabolic process (GO:0033239)	5	0	.02	-	 < 0.2	1.00E00
cellular response to oxygen-glucose deprivation (GO:0090650)	5	0	.02	-	 < 0.2	1.00E00
regulation of cellular amine metabolic process (GO:0033238)	81	0	.34	-	 < 0.2	1.00E00
positive regulation of protein sumoylation (GO:0033235)	12	1	.05	+	19.89	1.00E00
negative regulation of protein sumoylation (GO:0033234)	11	0	.05	-	 < 0.2	1.00E00
regulation of protein sumoylation (GO:0033233)	23	1	.10	+	10.38	1.00E00
carbohydrate export (GO:0033231)	1	0	.00	-	 < 0.2	1.00E00
beta-glucoside catabolic process (GO:1901805)	1	0	.00	-	 < 0.2	1.00E00
beta-glucoside metabolic process (GO:1901804)	1	0	.00	-	 < 0.2	1.00E00
response to oxygen-glucose deprivation (GO:0090649)	5	0	.02	-	 < 0.2	1.00E00
response to environmental enrichment (GO:0090648)	1	0	.00	-	 < 0.2	1.00E00
modulation of age-related behavioral decline (GO:0090647)	6	0	.03	-	 < 0.2	1.00E00
mitochondrial tRNA processing (GO:0090646)	5	0	.02	-	 < 0.2	1.00E00
tRNA 5'-leader removal (GO:0001682)	12	0	.05	-	 < 0.2	1.00E00
tRNA 3'-terminal CCA addition (GO:0001680)	1	0	.00	-	 < 0.2	1.00E00
dsRNA transport (GO:0033227)	5	0	.02	-	 < 0.2	1.00E00
cellular glucose homeostasis (GO:0001678)	84	3	.35	+	8.52	1.00E00
long-chain fatty acid metabolic process (GO:0001676)	98	0	.41	-	 < 0.2	1.00E00
acrosome assembly (GO:0001675)	14	0	.06	-	 < 0.2	1.00E00
regulation of chromatin assembly or disassembly (GO:0001672)	9	0	.04	-	 < 0.2	1.00E00
activation of GTPase activity (GO:0090630)	90	0	.38	-	 < 0.2	1.00E00
ferric iron import (GO:0033216)	5	0	.02	-	 < 0.2	1.00E00
iron assimilation by chelation and transport (GO:0033214)	1	0	.00	-	 < 0.2	1.00E00
iron assimilation (GO:0033212)	1	0	.00	-	 < 0.2	1.00E00
adiponectin-activated signaling pathway (GO:0033211)	6	0	.03	-	 < 0.2	1.00E00
leptin-mediated signaling pathway (GO:0033210)	9	0	.04	-	 < 0.2	1.00E00
ameboidal-type cell migration (GO:0001667)	147	2	.62	+	3.25	1.00E00
mRNA cleavage involved in gene silencing by siRNA (GO:0090625)	1	0	.00	-	 < 0.2	1.00E00
behavioral fear response (GO:0001662)	29	3	.12	+	24.69	1.00E00
conditioned taste aversion (GO:0001661)	5	0	.02	-	 < 0.2	1.00E00
fever generation (GO:0001660)	5	0	.02	-	 < 0.2	1.00E00
tumor necrosis factor-mediated signaling pathway (GO:0033209)	129	1	.54	+	1.85	1.00E00
meiotic cytokinesis (GO:0033206)	7	0	.03	-	 < 0.2	1.00E00
temperature homeostasis (GO:0001659)	30	0	.13	-	 < 0.2	1.00E00
branching involved in ureteric bud morphogenesis (GO:0001658)	44	1	.18	+	5.42	1.00E00
ureteric bud development (GO:0001657)	85	1	.36	+	2.81	1.00E00
metanephros development (GO:0001656)	81	2	.34	+	5.89	1.00E00
mitochondrial mRNA 3'-end processing (GO:0090616)	1	0	.00	-	 < 0.2	1.00E00
eye development (GO:0001654)	340	4	1.42	+	2.81	1.00E00
mitochondrial mRNA processing (GO:0090615)	1	0	.00	-	 < 0.2	1.00E00
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	5	0	.02	-	 < 0.2	1.00E00
trans-Golgi network to recycling endosome transport (GO:0044795)	1	0	.00	-	 < 0.2	1.00E00
positive regulation by host of viral process (GO:0044794)	14	0	.06	-	 < 0.2	1.00E00
negative regulation by host of viral process (GO:0044793)	9	0	.04	-	 < 0.2	1.00E00
positive regulation by host of viral release from host cell (GO:0044791)	6	0	.03	-	 < 0.2	1.00E00
negative regulation by host of viral release from host cell (GO:0044790)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interleukin-18-mediated signaling pathway (GO:2000494)	1	0	.00	-	 < 0.2	1.00E00
osteoblast differentiation (GO:0001649)	121	5	.51	+	9.86	1.00E00
regulation of interleukin-18-mediated signaling pathway (GO:2000492)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of hepatic stellate cell activation (GO:2000491)	4	1	.02	+	59.66	1.00E00
negative regulation of hepatic stellate cell activation (GO:2000490)	2	0	.01	-	 < 0.2	1.00E00
modulation by host of viral release from host cell (GO:0044789)	6	0	.03	-	 < 0.2	1.00E00
modulation by host of viral process (GO:0044788)	22	0	.09	-	 < 0.2	1.00E00
cell cycle DNA replication (GO:0044786)	39	2	.16	+	12.24	1.00E00
metaphase/anaphase transition of cell cycle (GO:0044784)	4	0	.02	-	 < 0.2	1.00E00
cilium organization (GO:0044782)	342	1	1.43	-	.70	1.00E00
regulation of hepatic stellate cell activation (GO:2000489)	6	1	.03	+	39.78	1.00E00
positive regulation of glutamine transport (GO:2000487)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glutamine transport (GO:2000486)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutamine transport (GO:2000485)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-8 secretion (GO:2000484)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of interleukin-8 secretion (GO:2000483)	7	0	.03	-	 < 0.2	1.00E00
regulation of interleukin-8 secretion (GO:2000482)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	8	0	.03	-	 < 0.2	1.00E00
meiotic spindle checkpoint (GO:0044779)	1	0	.00	-	 < 0.2	1.00E00
meiotic DNA integrity checkpoint (GO:0044778)	3	0	.01	-	 < 0.2	1.00E00
regulation of cAMP-dependent protein kinase activity (GO:2000479)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of metanephric glomerular visceral epithelial cell development (GO:2000478)	1	0	.00	-	 < 0.2	1.00E00
regulation of metanephric glomerular visceral epithelial cell development (GO:2000477)	1	0	.00	-	 < 0.2	1.00E00
regulation of opioid receptor signaling pathway (GO:2000474)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of hematopoietic stem cell migration (GO:2000473)	2	0	.01	-	 < 0.2	1.00E00
regulation of hematopoietic stem cell migration (GO:2000471)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of peroxidase activity (GO:2000470)	1	0	.00	-	 < 0.2	1.00E00
multi-organism transport (GO:0044766)	71	1	.30	+	3.36	1.00E00
multi-organism cellular process (GO:0044764)	23	0	.10	-	 < 0.2	1.00E00
entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction (GO:0052370)	1	0	.00	-	 < 0.2	1.00E00
low-density lipoprotein receptor particle metabolic process (GO:0032799)	11	0	.05	-	 < 0.2	1.00E00
uropod organization (GO:0032796)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of CREB transcription factor activity (GO:0032793)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of peroxidase activity (GO:2000469)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of CREB transcription factor activity (GO:0032792)	6	0	.03	-	 < 0.2	1.00E00
sequestering of BMP from receptor via BMP binding (GO:0038098)	2	0	.01	-	 < 0.2	1.00E00
regulation of peroxidase activity (GO:2000468)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of glycogen (starch) synthase activity (GO:2000467)	4	1	.02	+	59.66	1.00E00
ribosome disassembly (GO:0032790)	8	0	.03	-	 < 0.2	1.00E00
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)	132	5	.55	+	9.04	1.00E00
negative regulation of glycogen (starch) synthase activity (GO:2000466)	3	1	.01	+	79.55	1.00E00
regulation of glycogen (starch) synthase activity (GO:2000465)	7	1	.03	+	34.09	1.00E00
Fc-gamma receptor signaling pathway (GO:0038094)	136	5	.57	+	8.77	1.00E00
positive regulation of astrocyte chemotaxis (GO:2000464)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of excitatory postsynaptic potential (GO:2000463)	25	0	.10	-	 < 0.2	1.00E00
nodal signaling pathway (GO:0038092)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)	3	1	.01	+	79.55	1.00E00
catabolism by host of substance in symbiont (GO:0052364)	1	0	.00	-	 < 0.2	1.00E00
catabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052363)	1	0	.00	-	 < 0.2	1.00E00
catabolism by host of symbiont protein (GO:0052362)	1	0	.00	-	 < 0.2	1.00E00
response to human chorionic gonadotropin (GO:0044752)	3	0	.01	-	 < 0.2	1.00E00
catabolism by organism of macromolecule in other organism involved in symbiotic interaction (GO:0052361)	1	0	.00	-	 < 0.2	1.00E00
catabolism by host of symbiont macromolecule (GO:0052360)	1	0	.00	-	 < 0.2	1.00E00
unsaturated monocarboxylic acid metabolic process (GO:0032789)	1	0	.00	-	 < 0.2	1.00E00
saturated monocarboxylic acid metabolic process (GO:0032788)	1	0	.00	-	 < 0.2	1.00E00
monocarboxylic acid metabolic process (GO:0032787)	484	5	2.03	+	2.47	1.00E00
positive regulation of DNA-templated transcription, elongation (GO:0032786)	24	0	.10	-	 < 0.2	1.00E00
negative regulation of DNA-templated transcription, elongation (GO:0032785)	14	0	.06	-	 < 0.2	1.00E00
regulation of DNA-templated transcription, elongation (GO:0032784)	44	0	.18	-	 < 0.2	1.00E00
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	6	0	.03	-	 < 0.2	1.00E00
bile acid secretion (GO:0032782)	7	0	.03	-	 < 0.2	1.00E00
regulation of astrocyte chemotaxis (GO:2000458)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ATPase activity (GO:0032781)	53	0	.22	-	 < 0.2	1.00E00
negative regulation of ATPase activity (GO:0032780)	14	0	.06	-	 < 0.2	1.00E00
VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086)	3	1	.01	+	79.55	1.00E00
vascular endothelial growth factor signaling pathway (GO:0038084)	14	1	.06	+	17.05	1.00E00
positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-tyrosine autophosphorylation (GO:0038083)	47	3	.20	+	15.23	1.00E00
regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)	2	0	.01	-	 < 0.2	1.00E00
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	2	0	.01	-	 < 0.2	1.00E00
cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	1	.01	+	 > 100	1.00E00
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.00	-	 < 0.2	1.00E00
cell cycle DNA replication termination (GO:1902294)	1	0	.00	-	 < 0.2	1.00E00
amino acid transmembrane import (GO:0044745)	9	0	.04	-	 < 0.2	1.00E00
cell cycle DNA replication initiation (GO:1902292)	1	0	.00	-	 < 0.2	1.00E00
protein transmembrane import into intracellular organelle (GO:0044743)	44	0	.18	-	 < 0.2	1.00E00
DNA methylation on cytosine (GO:0032776)	5	0	.02	-	 < 0.2	1.00E00
DNA methylation on adenine (GO:0032775)	1	0	.00	-	 < 0.2	1.00E00
RNA biosynthetic process (GO:0032774)	2598	16	10.89	+	1.47	1.00E00
positive regulation of monophenol monooxygenase activity (GO:0032773)	1	1	.00	+	 > 100	1.00E00
regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)	3	0	.01	-	 < 0.2	1.00E00
regulation of monophenol monooxygenase activity (GO:0032771)	1	1	.00	+	 > 100	1.00E00
positive regulation of monooxygenase activity (GO:0032770)	25	2	.10	+	19.09	1.00E00
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	1	0	.00	-	 < 0.2	1.00E00
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	5	0	.02	-	 < 0.2	1.00E00
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	6	0	.03	-	 < 0.2	1.00E00
neuron projection extension involved in neuron projection guidance (GO:1902284)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of primary amine oxidase activity (GO:1902283)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of monooxygenase activity (GO:0032769)	12	1	.05	+	19.89	1.00E00
positive regulation of mast cell cytokine production (GO:0032765)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of mast cell cytokine production (GO:0032764)	2	0	.01	-	 < 0.2	1.00E00
regulation of mast cell cytokine production (GO:0032763)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of monocyte extravasation (GO:2000439)	2	0	.01	-	 < 0.2	1.00E00
mast cell cytokine production (GO:0032762)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of monocyte extravasation (GO:2000438)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lymphotoxin A production (GO:0032761)	1	0	.00	-	 < 0.2	1.00E00
regulation of monocyte extravasation (GO:2000437)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of tumor necrosis factor production (GO:0032760)	66	2	.28	+	7.23	1.00E00
p38MAPK cascade (GO:0038066)	6	1	.03	+	39.78	1.00E00
collagen-activated signaling pathway (GO:0038065)	12	2	.05	+	39.78	1.00E00
negative regulation of protein neddylation (GO:2000435)	4	1	.02	+	59.66	1.00E00
regulation of protein neddylation (GO:2000434)	4	1	.02	+	59.66	1.00E00
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	10	1	.04	+	23.87	1.00E00
NIK/NF-kappaB signaling (GO:0038061)	86	1	.36	+	2.78	1.00E00
nitric oxide-cGMP-mediated signaling pathway (GO:0038060)	2	0	.01	-	 < 0.2	1.00E00
DNA methylation or demethylation (GO:0044728)	64	0	.27	-	 < 0.2	1.00E00
DNA demethylation of male pronucleus (GO:0044727)	2	0	.01	-	 < 0.2	1.00E00
protection of DNA demethylation of female pronucleus (GO:0044726)	1	0	.00	-	 < 0.2	1.00E00
chromatin reprogramming in the zygote (GO:0044725)	3	0	.01	-	 < 0.2	1.00E00
modification by organism of membrane in other organism involved in symbiotic interaction (GO:0052332)	1	0	.00	-	 < 0.2	1.00E00
hemolysis in other organism involved in symbiotic interaction (GO:0052331)	2	0	.01	-	 < 0.2	1.00E00
protein import into peroxisome matrix, substrate release (GO:0044721)	1	0	.00	-	 < 0.2	1.00E00
positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052330)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of TRAIL production (GO:0032759)	2	1	.01	+	 > 100	1.00E00
positive regulation of interleukin-8 production (GO:0032757)	46	1	.19	+	5.19	1.00E00
positive regulation of interleukin-6 production (GO:0032755)	72	1	.30	+	3.31	1.00E00
positive regulation of interleukin-5 production (GO:0032754)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of interleukin-4 production (GO:0032753)	22	1	.09	+	10.85	1.00E00
positive regulation of interleukin-3 production (GO:0032752)	2	1	.01	+	 > 100	1.00E00
positive regulation of apoptotic cell clearance (GO:2000427)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of apoptotic cell clearance (GO:2000426)	2	0	.01	-	 < 0.2	1.00E00
regulation of apoptotic cell clearance (GO:2000425)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of eosinophil chemotaxis (GO:2000424)	2	0	.01	-	 < 0.2	1.00E00
regulation of eosinophil chemotaxis (GO:2000422)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of eosinophil extravasation (GO:2000420)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of polyamine transmembrane transport (GO:1902269)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of polyamine transmembrane transport (GO:1902268)	3	0	.01	-	 < 0.2	1.00E00
regulation of polyamine transmembrane transport (GO:1902267)	5	0	.02	-	 < 0.2	1.00E00
apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	3	0	.01	-	 < 0.2	1.00E00
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of delayed rectifier potassium channel activity (GO:1902261)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of interleukin-23 production (GO:0032747)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of interleukin-2 production (GO:0032743)	31	0	.13	-	 < 0.2	1.00E00
regulation of eosinophil extravasation (GO:2000419)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of eosinophil migration (GO:2000418)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of interleukin-18 production (GO:0032741)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of eosinophil migration (GO:2000417)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-17 production (GO:0032740)	13	0	.05	-	 < 0.2	1.00E00
regulation of eosinophil migration (GO:2000416)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of fibronectin-dependent thymocyte migration (GO:2000415)	1	0	.00	-	 < 0.2	1.00E00
transforming growth factor-beta secretion (GO:0038044)	2	0	.01	-	 < 0.2	1.00E00
interleukin-5-mediated signaling pathway (GO:0038043)	2	0	.01	-	 < 0.2	1.00E00
regulation of fibronectin-dependent thymocyte migration (GO:2000413)	1	0	.00	-	 < 0.2	1.00E00
dimeric G-protein coupled receptor signaling pathway (GO:0038042)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of thymocyte migration (GO:2000412)	2	0	.01	-	 < 0.2	1.00E00
regulation of thymocyte migration (GO:2000410)	3	0	.01	-	 < 0.2	1.00E00
regulation of delayed rectifier potassium channel activity (GO:1902259)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257)	2	0	.01	-	 < 0.2	1.00E00
regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	20	1	.08	+	11.93	1.00E00
phytoalexin metabolic process (GO:0052314)	2	0	.01	-	 < 0.2	1.00E00
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	27	1	.11	+	8.84	1.00E00
N-terminal protein myristoylation (GO:0006499)	4	0	.02	-	 < 0.2	1.00E00
modulation of transcription in other organism involved in symbiotic interaction (GO:0052312)	27	1	.11	+	8.84	1.00E00
negative regulation of erythrocyte apoptotic process (GO:1902251)	1	0	.00	-	 < 0.2	1.00E00
N-terminal protein lipidation (GO:0006498)	5	0	.02	-	 < 0.2	1.00E00
regulation of erythrocyte apoptotic process (GO:1902250)	1	0	.00	-	 < 0.2	1.00E00
protein lipidation (GO:0006497)	147	0	.62	-	 < 0.2	1.00E00
positive regulation of interleukin-15 production (GO:0032738)	1	0	.00	-	 < 0.2	1.00E00
protein O-linked glycosylation (GO:0006493)	109	0	.46	-	 < 0.2	1.00E00
positive regulation of interleukin-13 production (GO:0032736)	14	1	.06	+	17.05	1.00E00
N-glycan processing (GO:0006491)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of interleukin-12 production (GO:0032735)	32	1	.13	+	7.46	1.00E00
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of interleukin-10 production (GO:0032733)	30	1	.13	+	7.96	1.00E00
positive regulation of T cell extravasation (GO:2000409)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-1 production (GO:0032732)	43	0	.18	-	 < 0.2	1.00E00
positive regulation of interleukin-1 beta production (GO:0032731)	36	0	.15	-	 < 0.2	1.00E00
regulation of T cell extravasation (GO:2000407)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-1 alpha production (GO:0032730)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of T cell migration (GO:2000406)	24	0	.10	-	 < 0.2	1.00E00
negative regulation of T cell migration (GO:2000405)	3	0	.01	-	 < 0.2	1.00E00
regulation of T cell migration (GO:2000404)	31	0	.13	-	 < 0.2	1.00E00
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of lymphocyte migration (GO:2000403)	29	0	.12	-	 < 0.2	1.00E00
negative regulation of lymphocyte migration (GO:2000402)	8	0	.03	-	 < 0.2	1.00E00
non-canonical Wnt signaling pathway via JNK cascade (GO:0038031)	5	0	.02	-	 < 0.2	1.00E00
regulation of lymphocyte migration (GO:2000401)	45	0	.19	-	 < 0.2	1.00E00
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030)	6	0	.03	-	 < 0.2	1.00E00
negative regulation by organism of innate immune response in other organism involved in symbiotic interaction (GO:0052309)	1	0	.00	-	 < 0.2	1.00E00
modulation by organism of innate immune response in other organism involved in symbiotic interaction (GO:0052306)	1	0	.00	-	 < 0.2	1.00E00
dolichyl diphosphate biosynthetic process (GO:0006489)	7	0	.03	-	 < 0.2	1.00E00
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	20	0	.08	-	 < 0.2	1.00E00
protein N-linked glycosylation (GO:0006487)	72	0	.30	-	 < 0.2	1.00E00
protein glycosylation (GO:0006486)	273	0	1.14	-	 < 0.2	1.00E00
positive regulation of interferon-gamma production (GO:0032729)	64	0	.27	-	 < 0.2	1.00E00
positive regulation of interferon-beta production (GO:0032728)	33	0	.14	-	 < 0.2	1.00E00
positive regulation of interferon-alpha production (GO:0032727)	23	1	.10	+	10.38	1.00E00
protein demethylation (GO:0006482)	32	0	.13	-	 < 0.2	1.00E00
C-terminal protein methylation (GO:0006481)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	14	1	.06	+	17.05	1.00E00
N-terminal protein amino acid methylation (GO:0006480)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of fractalkine production (GO:0032724)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of connective tissue growth factor production (GO:0032723)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of chemokine production (GO:0032722)	53	0	.22	-	 < 0.2	1.00E00
insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)	4	0	.02	-	 < 0.2	1.00E00
apolipoprotein A-I-mediated signaling pathway (GO:0038027)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of tumor necrosis factor production (GO:0032720)	47	2	.20	+	10.16	1.00E00
reelin-mediated signaling pathway (GO:0038026)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239)	1	0	.00	-	 < 0.2	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	19	1	.08	+	12.56	1.00E00
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	32	1	.13	+	7.46	1.00E00
negative regulation of positive thymic T cell selection (GO:1902233)	1	0	.00	-	 < 0.2	1.00E00
regulation of positive thymic T cell selection (GO:1902232)	2	0	.01	-	 < 0.2	1.00E00
protein methylation (GO:0006479)	132	1	.55	+	1.81	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	7	0	.03	-	 < 0.2	1.00E00
peptidyl-tyrosine sulfation (GO:0006478)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	28	2	.12	+	17.05	1.00E00
protein sulfation (GO:0006477)	7	0	.03	-	 < 0.2	1.00E00
protein deacetylation (GO:0006476)	62	0	.26	-	 < 0.2	1.00E00
internal protein amino acid acetylation (GO:0006475)	113	2	.47	+	4.22	1.00E00
N-terminal protein amino acid acetylation (GO:0006474)	15	0	.06	-	 < 0.2	1.00E00
protein acetylation (GO:0006473)	129	2	.54	+	3.70	1.00E00
negative regulation of interleukin-8 production (GO:0032717)	18	0	.08	-	 < 0.2	1.00E00
protein ADP-ribosylation (GO:0006471)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of interleukin-6 production (GO:0032715)	37	0	.16	-	 < 0.2	1.00E00
protein dephosphorylation (GO:0006470)	194	2	.81	+	2.46	1.00E00
negative regulation of interleukin-5 production (GO:0032714)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of interleukin-4 production (GO:0032713)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of interleukin-3 production (GO:0032712)	1	0	.00	-	 < 0.2	1.00E00
Wnt receptor catabolic process (GO:0038018)	2	0	.01	-	 < 0.2	1.00E00
insulin receptor internalization (GO:0038016)	2	0	.01	-	 < 0.2	1.00E00
cellular response to laminar fluid shear stress (GO:0071499)	8	1	.03	+	29.83	1.00E00
cellular response to fluid shear stress (GO:0071498)	19	2	.08	+	25.12	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	36	2	.15	+	13.26	1.00E00
positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	2	0	.01	-	 < 0.2	1.00E00
cellular response to UV-C (GO:0071494)	4	1	.02	+	59.66	1.00E00
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	3	0	.01	-	 < 0.2	1.00E00
cellular response to UV-B (GO:0071493)	8	2	.03	+	59.66	1.00E00
negative regulation of acrosome reaction (GO:1902225)	1	0	.00	-	 < 0.2	1.00E00
cellular response to UV-A (GO:0071492)	3	1	.01	+	79.55	1.00E00
ketone body metabolic process (GO:1902224)	12	0	.05	-	 < 0.2	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	11	0	.05	-	 < 0.2	1.00E00
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220)	1	0	.00	-	 < 0.2	1.00E00
response to amine (GO:0014075)	39	1	.16	+	6.12	1.00E00
signal peptide processing (GO:0006465)	20	0	.08	-	 < 0.2	1.00E00
response to purine-containing compound (GO:0014074)	149	2	.62	+	3.20	1.00E00
steroid hormone receptor complex assembly (GO:0006463)	1	0	.00	-	 < 0.2	1.00E00
response to isoquinoline alkaloid (GO:0014072)	33	2	.14	+	14.46	1.00E00
negative regulation of interleukin-23 production (GO:0032707)	2	0	.01	-	 < 0.2	1.00E00
protein complex assembly (GO:0006461)	1099	14	4.60	+	3.04	1.00E00
negative regulation of interleukin-2 production (GO:0032703)	20	0	.08	-	 < 0.2	1.00E00
regulation of signal transduction by receptor internalization (GO:0038009)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of interleukin-18 production (GO:0032701)	2	0	.01	-	 < 0.2	1.00E00
netrin-activated signaling pathway (GO:0038007)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of interleukin-17 production (GO:0032700)	12	0	.05	-	 < 0.2	1.00E00
opioid receptor signaling pathway (GO:0038003)	8	0	.03	-	 < 0.2	1.00E00
endocrine signaling (GO:0038002)	1	0	.00	-	 < 0.2	1.00E00
paracrine signaling (GO:0038001)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	5	0	.02	-	 < 0.2	1.00E00
cellular response to high light intensity (GO:0071486)	1	0	.00	-	 < 0.2	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	6	0	.03	-	 < 0.2	1.00E00
cellular response to absence of light (GO:0071485)	1	0	.00	-	 < 0.2	1.00E00
cellular response to light intensity (GO:0071484)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-4-mediated signaling pathway (GO:1902216)	2	0	.01	-	 < 0.2	1.00E00
cellular response to blue light (GO:0071483)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of interleukin-4-mediated signaling pathway (GO:1902215)	1	0	.00	-	 < 0.2	1.00E00
regulation of interleukin-4-mediated signaling pathway (GO:1902214)	3	0	.01	-	 < 0.2	1.00E00
cellular response to X-ray (GO:0071481)	11	1	.05	+	21.70	1.00E00
positive regulation of prolactin signaling pathway (GO:1902213)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	66	3	.28	+	10.85	1.00E00
regulation of prolactin signaling pathway (GO:1902211)	1	0	.00	-	 < 0.2	1.00E00
'de novo' protein folding (GO:0006458)	37	0	.16	-	 < 0.2	1.00E00
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	12	1	.05	+	19.89	1.00E00
protein folding (GO:0006457)	234	0	.98	-	 < 0.2	1.00E00
positive regulation of serotonin secretion (GO:0014064)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of serotonin secretion (GO:0014063)	4	0	.02	-	 < 0.2	1.00E00
regulation of serotonin secretion (GO:0014062)	7	0	.03	-	 < 0.2	1.00E00
translational frameshifting (GO:0006452)	3	0	.01	-	 < 0.2	1.00E00
regulation of norepinephrine secretion (GO:0014061)	17	0	.07	-	 < 0.2	1.00E00
translational readthrough (GO:0006451)	8	0	.03	-	 < 0.2	1.00E00
regulation of epinephrine secretion (GO:0014060)	5	0	.02	-	 < 0.2	1.00E00
regulation of translational fidelity (GO:0006450)	19	0	.08	-	 < 0.2	1.00E00
tRNA wobble uridine modification (GO:0002098)	9	0	.04	-	 < 0.2	1.00E00
tRNA wobble base modification (GO:0002097)	13	0	.05	-	 < 0.2	1.00E00
auditory receptor cell morphogenesis (GO:0002093)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of receptor internalization (GO:0002092)	24	1	.10	+	9.94	1.00E00
negative regulation of receptor internalization (GO:0002091)	9	0	.04	-	 < 0.2	1.00E00
regulation of receptor internalization (GO:0002090)	38	1	.16	+	6.28	1.00E00
cellular hypotonic salinity response (GO:0071477)	3	0	.01	-	 < 0.2	1.00E00
cellular hypotonic response (GO:0071476)	8	0	.03	-	 < 0.2	1.00E00
cellular hyperosmotic salinity response (GO:0071475)	3	0	.01	-	 < 0.2	1.00E00
cellular hyperosmotic response (GO:0071474)	10	1	.04	+	23.87	1.00E00
negative regulation of interleukin-2-mediated signaling pathway (GO:1902206)	1	0	.00	-	 < 0.2	1.00E00
regulation of interleukin-2-mediated signaling pathway (GO:1902205)	1	0	.00	-	 < 0.2	1.00E00
cellular response to salt stress (GO:0071472)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204)	1	0	.00	-	 < 0.2	1.00E00
cellular response to non-ionic osmotic stress (GO:0071471)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203)	1	0	.00	-	 < 0.2	1.00E00
regulation of dopamine secretion (GO:0014059)	28	0	.12	-	 < 0.2	1.00E00
C-terminal protein amino acid modification (GO:0018410)	85	0	.36	-	 < 0.2	1.00E00
cellular response to osmotic stress (GO:0071470)	29	2	.12	+	16.46	1.00E00
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	4	0	.02	-	 < 0.2	1.00E00
regulation of translational termination (GO:0006449)	8	0	.03	-	 < 0.2	1.00E00
regulation of translational elongation (GO:0006448)	37	1	.16	+	6.45	1.00E00
positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)	2	0	.01	-	 < 0.2	1.00E00
membrane depolarization (GO:0051899)	64	3	.27	+	11.19	1.00E00
regulation of translational initiation by iron (GO:0006447)	3	0	.01	-	 < 0.2	1.00E00
regulation of acetylcholine secretion, neurotransmission (GO:0014056)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of protein kinase B signaling (GO:0051898)	38	1	.16	+	6.28	1.00E00
regulation of translational initiation (GO:0006446)	77	2	.32	+	6.20	1.00E00
positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of focal adhesion assembly (GO:0051895)	15	1	.06	+	15.91	1.00E00
regulation of gamma-aminobutyric acid secretion (GO:0014052)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of focal adhesion assembly (GO:0051894)	24	0	.10	-	 < 0.2	1.00E00
gamma-aminobutyric acid secretion (GO:0014051)	4	0	.02	-	 < 0.2	1.00E00
regulation of focal adhesion assembly (GO:0051893)	53	1	.22	+	4.50	1.00E00
negative regulation of glutamate secretion (GO:0014050)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cardioblast differentiation (GO:0051892)	2	0	.01	-	 < 0.2	1.00E00
cellular response to glial cell derived neurotrophic factor (GO:1990792)	2	0	.01	-	 < 0.2	1.00E00
lens morphogenesis in camera-type eye (GO:0002089)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of cardioblast differentiation (GO:0051891)	5	0	.02	-	 < 0.2	1.00E00
dorsal root ganglion development (GO:1990791)	4	0	.02	-	 < 0.2	1.00E00
lens development in camera-type eye (GO:0002088)	67	0	.28	-	 < 0.2	1.00E00
regulation of cardioblast differentiation (GO:0051890)	7	0	.03	-	 < 0.2	1.00E00
response to glial cell derived neurotrophic factor (GO:1990790)	2	0	.01	-	 < 0.2	1.00E00
regulation of respiratory gaseous exchange by neurological system process (GO:0002087)	13	0	.05	-	 < 0.2	1.00E00
diaphragm contraction (GO:0002086)	2	0	.01	-	 < 0.2	1.00E00
inhibition of neuroepithelial cell differentiation (GO:0002085)	4	0	.02	-	 < 0.2	1.00E00
protein depalmitoylation (GO:0002084)	4	0	.02	-	 < 0.2	1.00E00
regulation of oxidative phosphorylation (GO:0002082)	18	1	.08	+	13.26	1.00E00
cellular response to alkaline pH (GO:0071469)	2	0	.01	-	 < 0.2	1.00E00
cellular response to acidic pH (GO:0071468)	11	0	.05	-	 < 0.2	1.00E00
cellular response to pH (GO:0071467)	20	0	.08	-	 < 0.2	1.00E00
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)	7	0	.03	-	 < 0.2	1.00E00
cellular response to xenobiotic stimulus (GO:0071466)	110	0	.46	-	 < 0.2	1.00E00
cellular response to hydrostatic pressure (GO:0071464)	2	0	.01	-	 < 0.2	1.00E00
cellular response to water stimulus (GO:0071462)	5	0	.02	-	 < 0.2	1.00E00
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	5	0	.02	-	 < 0.2	1.00E00
cellular response to redox state (GO:0071461)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of glutamate secretion (GO:0014049)	10	0	.04	-	 < 0.2	1.00E00
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.00	-	 < 0.2	1.00E00
cellular response to cell-matrix adhesion (GO:0071460)	2	0	.01	-	 < 0.2	1.00E00
regulation of glutamate secretion (GO:0014048)	16	0	.07	-	 < 0.2	1.00E00
valyl-tRNA aminoacylation (GO:0006438)	3	0	.01	-	 < 0.2	1.00E00
glutamate secretion (GO:0014047)	29	0	.12	-	 < 0.2	1.00E00
tyrosyl-tRNA aminoacylation (GO:0006437)	2	0	.01	-	 < 0.2	1.00E00
tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.01	-	 < 0.2	1.00E00
establishment of endothelial blood-brain barrier (GO:0014045)	4	0	.02	-	 < 0.2	1.00E00
threonyl-tRNA aminoacylation (GO:0006435)	3	0	.01	-	 < 0.2	1.00E00
Schwann cell development (GO:0014044)	26	2	.11	+	18.36	1.00E00
negative regulation of timing of anagen (GO:0051886)	1	0	.00	-	 < 0.2	1.00E00
cellular response to dsDNA (GO:1990786)	1	0	.00	-	 < 0.2	1.00E00
seryl-tRNA aminoacylation (GO:0006434)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of neuron maturation (GO:0014043)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of timing of anagen (GO:0051885)	2	0	.01	-	 < 0.2	1.00E00
response to water-immersion restraint stress (GO:1990785)	3	1	.01	+	79.55	1.00E00
prolyl-tRNA aminoacylation (GO:0006433)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neuron maturation (GO:0014042)	4	1	.02	+	59.66	1.00E00
regulation of timing of anagen (GO:0051884)	4	0	.02	-	 < 0.2	1.00E00
response to dsDNA (GO:1990784)	1	0	.00	-	 < 0.2	1.00E00
phenylalanyl-tRNA aminoacylation (GO:0006432)	4	0	.02	-	 < 0.2	1.00E00
regulation of neuron maturation (GO:0014041)	9	1	.04	+	26.52	1.00E00
killing of cells in other organism involved in symbiotic interaction (GO:0051883)	15	0	.06	-	 < 0.2	1.00E00
methionyl-tRNA aminoacylation (GO:0006431)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of Schwann cell differentiation (GO:0014040)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial depolarization (GO:0051882)	4	1	.02	+	59.66	1.00E00
lysyl-tRNA aminoacylation (GO:0006430)	1	1	.00	+	 > 100	1.00E00
acrosome matrix dispersal (GO:0002077)	1	0	.00	-	 < 0.2	1.00E00
osteoblast development (GO:0002076)	17	0	.07	-	 < 0.2	1.00E00
extraocular skeletal muscle development (GO:0002074)	5	0	.02	-	 < 0.2	1.00E00
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	8	0	.03	-	 < 0.2	1.00E00
glandular epithelial cell maturation (GO:0002071)	3	0	.01	-	 < 0.2	1.00E00
epithelial cell maturation (GO:0002070)	15	2	.06	+	31.82	1.00E00
protein localization to chromosome, centromeric region (GO:0071459)	17	0	.07	-	 < 0.2	1.00E00
cellular response to hyperoxia (GO:0071455)	7	1	.03	+	34.09	1.00E00
cellular response to anoxia (GO:0071454)	1	0	.00	-	 < 0.2	1.00E00
cellular response to superoxide (GO:0071451)	15	0	.06	-	 < 0.2	1.00E00
cellular response to oxygen radical (GO:0071450)	15	0	.06	-	 < 0.2	1.00E00
leucyl-tRNA aminoacylation (GO:0006429)	2	0	.01	-	 < 0.2	1.00E00
regulation of Schwann cell differentiation (GO:0014038)	3	0	.01	-	 < 0.2	1.00E00
isoleucyl-tRNA aminoacylation (GO:0006428)	2	0	.01	-	 < 0.2	1.00E00
Schwann cell differentiation (GO:0014037)	32	3	.13	+	22.37	1.00E00
histidyl-tRNA aminoacylation (GO:0006427)	2	0	.01	-	 < 0.2	1.00E00
neural crest cell fate specification (GO:0014036)	2	0	.01	-	 < 0.2	1.00E00
lateral element assembly (GO:0051878)	1	0	.00	-	 < 0.2	1.00E00
protein localization to cell periphery (GO:1990778)	178	3	.75	+	4.02	1.00E00
glycyl-tRNA aminoacylation (GO:0006426)	2	0	.01	-	 < 0.2	1.00E00
pigment granule aggregation in cell center (GO:0051877)	2	0	.01	-	 < 0.2	1.00E00
glutaminyl-tRNA aminoacylation (GO:0006425)	2	0	.01	-	 < 0.2	1.00E00
neural crest cell fate commitment (GO:0014034)	4	0	.02	-	 < 0.2	1.00E00
glutamyl-tRNA aminoacylation (GO:0006424)	2	0	.01	-	 < 0.2	1.00E00
neural crest cell differentiation (GO:0014033)	69	3	.29	+	10.38	1.00E00
pigment granule localization (GO:0051875)	25	0	.10	-	 < 0.2	1.00E00
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.01	-	 < 0.2	1.00E00
neural crest cell development (GO:0014032)	61	3	.26	+	11.74	1.00E00
tumor necrosis factor secretion (GO:1990774)	1	0	.00	-	 < 0.2	1.00E00
aspartyl-tRNA aminoacylation (GO:0006422)	1	0	.00	-	 < 0.2	1.00E00
mesenchymal cell development (GO:0014031)	65	4	.27	+	14.69	1.00E00
killing by host of symbiont cells (GO:0051873)	10	0	.04	-	 < 0.2	1.00E00
asparaginyl-tRNA aminoacylation (GO:0006421)	3	0	.01	-	 < 0.2	1.00E00
columnar/cuboidal epithelial cell maturation (GO:0002069)	7	1	.03	+	34.09	1.00E00
arginyl-tRNA aminoacylation (GO:0006420)	4	0	.02	-	 < 0.2	1.00E00
clathrin-dependent extracellular exosome endocytosis (GO:1990771)	1	0	.00	-	 < 0.2	1.00E00
glandular epithelial cell development (GO:0002068)	18	1	.08	+	13.26	1.00E00
glandular epithelial cell differentiation (GO:0002067)	39	1	.16	+	6.12	1.00E00
columnar/cuboidal epithelial cell development (GO:0002066)	48	2	.20	+	9.94	1.00E00
columnar/cuboidal epithelial cell differentiation (GO:0002065)	96	4	.40	+	9.94	1.00E00
chondrocyte development (GO:0002063)	23	0	.10	-	 < 0.2	1.00E00
chondrocyte differentiation (GO:0002062)	64	1	.27	+	3.73	1.00E00
cellular response to lipid hydroperoxide (GO:0071449)	1	0	.00	-	 < 0.2	1.00E00
cellular response to hydroperoxide (GO:0071447)	8	1	.03	+	29.83	1.00E00
cellular response to pheromone (GO:0071444)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of histone H3-K14 acetylation (GO:0071442)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of histone H3-K14 acetylation (GO:0071441)	1	0	.00	-	 < 0.2	1.00E00
neural crest formation (GO:0014029)	11	0	.05	-	 < 0.2	1.00E00
regulation of histone H3-K14 acetylation (GO:0071440)	6	0	.03	-	 < 0.2	1.00E00
alanyl-tRNA aminoacylation (GO:0006419)	3	0	.01	-	 < 0.2	1.00E00
notochord formation (GO:0014028)	4	0	.02	-	 < 0.2	1.00E00
tRNA aminoacylation for protein translation (GO:0006418)	49	1	.21	+	4.87	1.00E00
general adaptation syndrome, behavioral process (GO:0051867)	1	0	.00	-	 < 0.2	1.00E00
translational termination (GO:0006415)	96	0	.40	-	 < 0.2	1.00E00
general adaptation syndrome (GO:0051866)	2	0	.01	-	 < 0.2	1.00E00
translational elongation (GO:0006414)	121	1	.51	+	1.97	1.00E00
protein autoubiquitination (GO:0051865)	56	1	.23	+	4.26	1.00E00
translational initiation (GO:0006413)	143	2	.60	+	3.34	1.00E00
neural plate elongation (GO:0014022)	3	0	.01	-	 < 0.2	1.00E00
translation (GO:0006412)	383	6	1.60	+	3.74	1.00E00
primary neural tube formation (GO:0014020)	97	2	.41	+	4.92	1.00E00
positive regulation of mesenchymal cell proliferation (GO:0002053)	29	0	.12	-	 < 0.2	1.00E00
positive regulation of neuroblast proliferation (GO:0002052)	21	0	.09	-	 < 0.2	1.00E00
osteoblast fate commitment (GO:0002051)	4	0	.02	-	 < 0.2	1.00E00
maintenance of epithelial cell apical/basal polarity (GO:0045199)	12	0	.05	-	 < 0.2	1.00E00
establishment of epithelial cell apical/basal polarity (GO:0045198)	12	0	.05	-	 < 0.2	1.00E00
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	36	0	.15	-	 < 0.2	1.00E00
establishment or maintenance of neuroblast polarity (GO:0045196)	3	0	.01	-	 < 0.2	1.00E00
sodium ion export (GO:0071436)	9	0	.04	-	 < 0.2	1.00E00
regulation of isotype switching (GO:0045191)	31	0	.13	-	 < 0.2	1.00E00
potassium ion export (GO:0071435)	9	0	.04	-	 < 0.2	1.00E00
isotype switching (GO:0045190)	17	0	.07	-	 < 0.2	1.00E00
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)	33	0	.14	-	 < 0.2	1.00E00
tRNA export from nucleus (GO:0006409)	33	0	.14	-	 < 0.2	1.00E00
negative regulation of proteasomal protein catabolic process (GO:1901799)	45	0	.19	-	 < 0.2	1.00E00
snRNA export from nucleus (GO:0006408)	2	0	.01	-	 < 0.2	1.00E00
neuroblast fate commitment (GO:0014017)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of signal transduction by p53 class mediator (GO:1901798)	22	2	.09	+	21.70	1.00E00
rRNA export from nucleus (GO:0006407)	3	0	.01	-	 < 0.2	1.00E00
neuroblast differentiation (GO:0014016)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of signal transduction by p53 class mediator (GO:1901797)	29	2	.12	+	16.46	1.00E00
mRNA export from nucleus (GO:0006406)	107	1	.45	+	2.23	1.00E00
positive regulation of gliogenesis (GO:0014015)	51	0	.21	-	 < 0.2	1.00E00
RNA export from nucleus (GO:0006405)	137	1	.57	+	1.74	1.00E00
negative regulation of gliogenesis (GO:0014014)	40	0	.17	-	 < 0.2	1.00E00
RNA import into nucleus (GO:0006404)	3	0	.01	-	 < 0.2	1.00E00
regulation of gliogenesis (GO:0014013)	101	1	.42	+	2.36	1.00E00
mitotic spindle microtubule depolymerization (GO:1990755)	1	0	.00	-	 < 0.2	1.00E00
RNA localization (GO:0006403)	222	2	.93	+	2.15	1.00E00
peripheral nervous system axon regeneration (GO:0014012)	5	0	.02	-	 < 0.2	1.00E00
mRNA catabolic process (GO:0006402)	212	1	.89	+	1.13	1.00E00
RNA catabolic process (GO:0006401)	240	1	1.01	-	.99	1.00E00
Schwann cell proliferation (GO:0014010)	2	0	.01	-	 < 0.2	1.00E00
disruption by host of symbiont cells (GO:0051852)	11	0	.05	-	 < 0.2	1.00E00
tRNA modification (GO:0006400)	71	0	.30	-	 < 0.2	1.00E00
modification by host of symbiont morphology or physiology (GO:0051851)	64	1	.27	+	3.73	1.00E00
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	7	0	.03	-	 < 0.2	1.00E00
cell migration involved in sprouting angiogenesis (GO:0002042)	15	0	.06	-	 < 0.2	1.00E00
intussusceptive angiogenesis (GO:0002041)	1	0	.00	-	 < 0.2	1.00E00
connective tissue growth factor biosynthetic process (GO:0045189)	1	0	.00	-	 < 0.2	1.00E00
sprouting angiogenesis (GO:0002040)	46	0	.19	-	 < 0.2	1.00E00
regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	8	0	.03	-	 < 0.2	1.00E00
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	21	0	.09	-	 < 0.2	1.00E00
zonula adherens assembly (GO:0045186)	1	0	.00	-	 < 0.2	1.00E00
maintenance of protein location (GO:0045185)	93	2	.39	+	5.13	1.00E00
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)	16	0	.07	-	 < 0.2	1.00E00
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	107	1	.45	+	2.23	1.00E00
ribonucleoprotein complex export from nucleus (GO:0071426)	126	1	.53	+	1.89	1.00E00
hematopoietic stem cell proliferation (GO:0071425)	15	0	.06	-	 < 0.2	1.00E00
malate transmembrane transport (GO:0071423)	2	0	.01	-	 < 0.2	1.00E00
succinate transmembrane transport (GO:0071422)	4	0	.02	-	 < 0.2	1.00E00
manganese ion transmembrane transport (GO:0071421)	8	0	.03	-	 < 0.2	1.00E00
glial cell proliferation (GO:0014009)	11	1	.05	+	21.70	1.00E00
cellular response to histamine (GO:0071420)	8	0	.03	-	 < 0.2	1.00E00
cellular detoxification (GO:1990748)	88	0	.37	-	 < 0.2	1.00E00
microglia development (GO:0014005)	3	0	.01	-	 < 0.2	1.00E00
microglia differentiation (GO:0014004)	3	0	.01	-	 < 0.2	1.00E00
oligodendrocyte development (GO:0014003)	38	0	.16	-	 < 0.2	1.00E00
astrocyte development (GO:0014002)	27	1	.11	+	8.84	1.00E00
primary miRNA methylation (GO:1990744)	1	0	.00	-	 < 0.2	1.00E00
protein sialylation (GO:1990743)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of L-glutamate transport (GO:0002038)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of L-glutamate transport (GO:0002037)	1	0	.00	-	 < 0.2	1.00E00
regulation of L-glutamate transport (GO:0002036)	2	0	.01	-	 < 0.2	1.00E00
brain renin-angiotensin system (GO:0002035)	5	0	.02	-	 < 0.2	1.00E00
regulation of blood vessel diameter by renin-angiotensin (GO:0002034)	4	0	.02	-	 < 0.2	1.00E00
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033)	1	0	.00	-	 < 0.2	1.00E00
desensitization of G-protein coupled receptor protein signaling pathway by arrestin (GO:0002032)	2	0	.01	-	 < 0.2	1.00E00
G-protein coupled receptor internalization (GO:0002031)	12	0	.05	-	 < 0.2	1.00E00
apical protein localization (GO:0045176)	10	0	.04	-	 < 0.2	1.00E00
basal protein localization (GO:0045175)	1	0	.00	-	 < 0.2	1.00E00
cellular response to amine stimulus (GO:0071418)	1	0	.00	-	 < 0.2	1.00E00
cellular response to purine-containing compound (GO:0071415)	9	0	.04	-	 < 0.2	1.00E00
cellular response to hydroxyisoflavone (GO:0071413)	1	0	.00	-	 < 0.2	1.00E00
cellular response to genistein (GO:0071412)	1	0	.00	-	 < 0.2	1.00E00
cytolysis by host of symbiont cells (GO:0051838)	1	0	.00	-	 < 0.2	1.00E00
response to manganese-induced endoplasmic reticulum stress (GO:1990737)	3	0	.01	-	 < 0.2	1.00E00
translocation of molecules into other organism involved in symbiotic interaction (GO:0051836)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of synapse structural plasticity (GO:0051835)	4	0	.02	-	 < 0.2	1.00E00
evasion or tolerance of defenses of other organism involved in symbiotic interaction (GO:0051834)	4	0	.02	-	 < 0.2	1.00E00
suppression of defenses of other organism involved in symbiotic interaction (GO:0051833)	1	0	.00	-	 < 0.2	1.00E00
avoidance of defenses of other organism involved in symbiotic interaction (GO:0051832)	4	0	.02	-	 < 0.2	1.00E00
desensitization of G-protein coupled receptor protein signaling pathway (GO:0002029)	15	0	.06	-	 < 0.2	1.00E00
regulation of sodium ion transport (GO:0002028)	85	1	.36	+	2.81	1.00E00
regulation of heart rate (GO:0002027)	91	2	.38	+	5.25	1.00E00
regulation of the force of heart contraction (GO:0002026)	28	1	.12	+	8.52	1.00E00
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025)	3	0	.01	-	 < 0.2	1.00E00
diet induced thermogenesis (GO:0002024)	9	0	.04	-	 < 0.2	1.00E00
reduction of food intake in response to dietary excess (GO:0002023)	2	0	.01	-	 < 0.2	1.00E00
response to dietary excess (GO:0002021)	21	0	.09	-	 < 0.2	1.00E00
cell-cell signaling involved in cell fate commitment (GO:0045168)	2	0	.01	-	 < 0.2	1.00E00
cell fate commitment (GO:0045165)	227	6	.95	+	6.31	1.00E00
cellular response to cycloheximide (GO:0071409)	3	0	.01	-	 < 0.2	1.00E00
clustering of voltage-gated potassium channels (GO:0045163)	3	0	.01	-	 < 0.2	1.00E00
clustering of voltage-gated sodium channels (GO:0045162)	7	0	.03	-	 < 0.2	1.00E00
neuronal ion channel clustering (GO:0045161)	12	0	.05	-	 < 0.2	1.00E00
cellular response to low-density lipoprotein particle stimulus (GO:0071404)	14	1	.06	+	17.05	1.00E00
cellular response to high density lipoprotein particle stimulus (GO:0071403)	1	0	.00	-	 < 0.2	1.00E00
response to ATP (GO:0033198)	32	0	.13	-	 < 0.2	1.00E00
cellular response to lipoprotein particle stimulus (GO:0071402)	19	1	.08	+	12.56	1.00E00
response to vitamin E (GO:0033197)	13	0	.05	-	 < 0.2	1.00E00
cellular response to triglyceride (GO:0071401)	1	0	.00	-	 < 0.2	1.00E00
cellular response to oleic acid (GO:0071400)	2	0	.01	-	 < 0.2	1.00E00
response to hydroperoxide (GO:0033194)	17	1	.07	+	14.04	1.00E00
primary miRNA modification (GO:1990729)	1	0	.00	-	 < 0.2	1.00E00
regulation of synapse structural plasticity (GO:0051823)	9	0	.04	-	 < 0.2	1.00E00
regulation of renal output by angiotensin (GO:0002019)	3	0	.01	-	 < 0.2	1.00E00
dissemination or transmission of organism from other organism involved in symbiotic interaction (GO:0051821)	1	0	.00	-	 < 0.2	1.00E00
renin-angiotensin regulation of aldosterone production (GO:0002018)	4	0	.02	-	 < 0.2	1.00E00
regulation of blood volume by renal aldosterone (GO:0002017)	2	0	.01	-	 < 0.2	1.00E00
regulation of blood volume by renin-angiotensin (GO:0002016)	10	0	.04	-	 < 0.2	1.00E00
morphogenesis of an epithelial sheet (GO:0002011)	46	2	.19	+	10.38	1.00E00
response to vitamin A (GO:0033189)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of histone ubiquitination (GO:0033184)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of histone ubiquitination (GO:0033183)	3	0	.01	-	 < 0.2	1.00E00
disruption of cells of other organism involved in symbiotic interaction (GO:0051818)	16	0	.07	-	 < 0.2	1.00E00
regulation of histone ubiquitination (GO:0033182)	9	0	.04	-	 < 0.2	1.00E00
modification of morphology or physiology of other organism involved in symbiotic interaction (GO:0051817)	100	1	.42	+	2.39	1.00E00
xylulose biosynthetic process (GO:0005999)	2	0	.01	-	 < 0.2	1.00E00
leukotriene A4 metabolic process (GO:1901751)	1	0	.00	-	 < 0.2	1.00E00
xylulose catabolic process (GO:0005998)	1	0	.00	-	 < 0.2	1.00E00
leukotriene D4 biosynthetic process (GO:1901750)	10	0	.04	-	 < 0.2	1.00E00
xylulose metabolic process (GO:0005997)	4	0	.02	-	 < 0.2	1.00E00
detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007)	1	0	.00	-	 < 0.2	1.00E00
monosaccharide metabolic process (GO:0005996)	198	5	.83	+	6.03	1.00E00
angiotensin catabolic process in blood (GO:0002005)	3	0	.01	-	 < 0.2	1.00E00
trehalose catabolic process (GO:0005993)	1	0	.00	-	 < 0.2	1.00E00
angiotensin maturation (GO:0002003)	11	1	.05	+	21.70	1.00E00
regulation of angiotensin levels in blood (GO:0002002)	12	1	.05	+	19.89	1.00E00
trehalose metabolic process (GO:0005991)	1	0	.00	-	 < 0.2	1.00E00
renin secretion into blood stream (GO:0002001)	1	0	.00	-	 < 0.2	1.00E00
male anatomical structure morphogenesis (GO:0090598)	4	1	.02	+	59.66	1.00E00
sensory organ morphogenesis (GO:0090596)	256	2	1.07	+	1.86	1.00E00
meiotic sister chromatid segregation (GO:0045144)	9	0	.04	-	 < 0.2	1.00E00
homologous chromosome segregation (GO:0045143)	61	2	.26	+	7.82	1.00E00
inflammatory response to wounding (GO:0090594)	5	0	.02	-	 < 0.2	1.00E00
meiotic telomere clustering (GO:0045141)	14	1	.06	+	17.05	1.00E00
leukotriene D4 metabolic process (GO:1901748)	10	0	.04	-	 < 0.2	1.00E00
presynaptic active zone organization (GO:1990709)	2	0	.01	-	 < 0.2	1.00E00
calcineurin-NFAT signaling cascade (GO:0033173)	8	0	.03	-	 < 0.2	1.00E00
translocation of peptides or proteins into other organism involved in symbiotic interaction (GO:0051808)	1	0	.00	-	 < 0.2	1.00E00
conditioned place preference (GO:1990708)	1	0	.00	-	 < 0.2	1.00E00
evasion or tolerance of defense response of other organism involved in symbiotic interaction (GO:0051807)	2	0	.01	-	 < 0.2	1.00E00
evasion or tolerance of immune response of other organism involved in symbiotic interaction (GO:0051805)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cytolysis in other organism involved in symbiotic interaction (GO:0051803)	1	0	.00	-	 < 0.2	1.00E00
lactose biosynthetic process (GO:0005989)	3	0	.01	-	 < 0.2	1.00E00
regulation of cytolysis in other organism involved in symbiotic interaction (GO:0051802)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of myoblast fusion (GO:1901741)	19	1	.08	+	12.56	1.00E00
lactose metabolic process (GO:0005988)	3	0	.01	-	 < 0.2	1.00E00
cytolysis in other organism involved in symbiotic interaction (GO:0051801)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of myoblast fusion (GO:1901740)	2	0	.01	-	 < 0.2	1.00E00
nucleolar chromatin organization (GO:1990700)	1	0	.00	-	 < 0.2	1.00E00
sucrose biosynthetic process (GO:0005986)	2	0	.01	-	 < 0.2	1.00E00
sucrose metabolic process (GO:0005985)	3	0	.01	-	 < 0.2	1.00E00
disaccharide metabolic process (GO:0005984)	10	0	.04	-	 < 0.2	1.00E00
starch catabolic process (GO:0005983)	1	0	.00	-	 < 0.2	1.00E00
starch metabolic process (GO:0005982)	1	0	.00	-	 < 0.2	1.00E00
regulation of glycogen catabolic process (GO:0005981)	6	0	.03	-	 < 0.2	1.00E00
glycogen catabolic process (GO:0005980)	19	0	.08	-	 < 0.2	1.00E00
development of primary sexual characteristics (GO:0045137)	217	6	.91	+	6.60	1.00E00
development of secondary sexual characteristics (GO:0045136)	9	0	.04	-	 < 0.2	1.00E00
meiotic chromosome segregation (GO:0045132)	89	2	.37	+	5.36	1.00E00
histone H3-K9 demethylation (GO:0033169)	14	0	.06	-	 < 0.2	1.00E00
conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168)	1	0	.00	-	 < 0.2	1.00E00
regulation of myoblast fusion (GO:1901739)	21	1	.09	+	11.36	1.00E00
regulation of vitamin A metabolic process (GO:1901738)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein import into nucleus, translocation (GO:0033160)	13	1	.05	+	18.36	1.00E00
regulation of glycogen biosynthetic process (GO:0005979)	27	3	.11	+	26.52	1.00E00
positive regulation of platelet aggregation (GO:1901731)	2	0	.01	-	 < 0.2	1.00E00
glycogen biosynthetic process (GO:0005978)	26	1	.11	+	9.18	1.00E00
glycogen metabolic process (GO:0005977)	56	2	.23	+	8.52	1.00E00
polysaccharide metabolic process (GO:0005976)	78	2	.33	+	6.12	1.00E00
carbohydrate metabolic process (GO:0005975)	471	6	1.97	+	3.04	1.00E00
negative regulation of reciprocal meiotic recombination (GO:0045128)	1	0	.00	-	 < 0.2	1.00E00
dsDNA loop formation (GO:0090579)	3	0	.01	-	 < 0.2	1.00E00
regulation of bone resorption (GO:0045124)	37	3	.16	+	19.35	1.00E00
cellular extravasation (GO:0045123)	28	1	.12	+	8.52	1.00E00
negative regulation of protein import into nucleus, translocation (GO:0033159)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein import into nucleus, translocation (GO:0033158)	20	2	.08	+	23.87	1.00E00
T cell receptor V(D)J recombination (GO:0033153)	5	0	.02	-	 < 0.2	1.00E00
NADPH oxidation (GO:0070995)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of histone deacetylase activity (GO:1901727)	6	0	.03	-	 < 0.2	1.00E00
immunoglobulin V(D)J recombination (GO:0033152)	5	0	.02	-	 < 0.2	1.00E00
detection of oxidative stress (GO:0070994)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of histone deacetylase activity (GO:1901726)	1	0	.00	-	 < 0.2	1.00E00
V(D)J recombination (GO:0033151)	15	1	.06	+	15.91	1.00E00
regulation of histone deacetylase activity (GO:1901725)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of cell proliferation involved in kidney development (GO:1901724)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of cell proliferation involved in kidney development (GO:1901723)	6	0	.03	-	 < 0.2	1.00E00
regulation of cell proliferation involved in kidney development (GO:1901722)	13	0	.05	-	 < 0.2	1.00E00
azole transport (GO:0045117)	17	0	.07	-	 < 0.2	1.00E00
protein neddylation (GO:0045116)	13	0	.05	-	 < 0.2	1.00E00
regulation of integrin biosynthetic process (GO:0045113)	4	1	.02	+	59.66	1.00E00
integrin biosynthetic process (GO:0045112)	1	0	.00	-	 < 0.2	1.00E00
intermediate filament bundle assembly (GO:0045110)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	9	1	.04	+	26.52	1.00E00
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	14	0	.06	-	 < 0.2	1.00E00
oxidative demethylation (GO:0070989)	12	0	.05	-	 < 0.2	1.00E00
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	38	2	.16	+	12.56	1.00E00
demethylation (GO:0070988)	59	0	.25	-	 < 0.2	1.00E00
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	16	1	.07	+	14.92	1.00E00
error-free translesion synthesis (GO:0070987)	19	1	.08	+	12.56	1.00E00
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	33	0	.14	-	 < 0.2	1.00E00
left/right axis specification (GO:0070986)	13	0	.05	-	 < 0.2	1.00E00
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	75	2	.31	+	6.36	1.00E00
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	20	0	.08	-	 < 0.2	1.00E00
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	2	0	.01	-	 < 0.2	1.00E00
L-asparagine metabolic process (GO:0070982)	1	0	.00	-	 < 0.2	1.00E00
L-asparagine biosynthetic process (GO:0070981)	1	0	.00	-	 < 0.2	1.00E00
biphenyl catabolic process (GO:0070980)	1	0	.00	-	 < 0.2	1.00E00
intermediate filament organization (GO:0045109)	22	1	.09	+	10.85	1.00E00
regulation of intermediate filament polymerization or depolymerization (GO:0045108)	1	0	.00	-	 < 0.2	1.00E00
regulation of membrane permeability (GO:0090559)	83	4	.35	+	11.50	1.00E00
establishment of endothelial intestinal barrier (GO:0090557)	10	0	.04	-	 < 0.2	1.00E00
intermediate filament polymerization or depolymerization (GO:0045105)	1	0	.00	-	 < 0.2	1.00E00
intermediate filament cytoskeleton organization (GO:0045104)	41	2	.17	+	11.64	1.00E00
intermediate filament-based process (GO:0045103)	42	2	.18	+	11.36	1.00E00
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	22	0	.09	-	 < 0.2	1.00E00
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	26	1	.11	+	9.18	1.00E00
protein K11-linked ubiquitination (GO:0070979)	28	0	.12	-	 < 0.2	1.00E00
bone maturation (GO:0070977)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of glucokinase activity (GO:0033133)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of glucokinase activity (GO:0033132)	5	0	.02	-	 < 0.2	1.00E00
mesenchymal cell differentiation involved in bone development (GO:1901706)	1	0	.00	-	 < 0.2	1.00E00
regulation of glucokinase activity (GO:0033131)	10	0	.04	-	 < 0.2	1.00E00
protein localization to endoplasmic reticulum exit site (GO:0070973)	4	0	.02	-	 < 0.2	1.00E00
protein localization to endoplasmic reticulum (GO:0070972)	125	0	.52	-	 < 0.2	1.00E00
interleukin-2 secretion (GO:0070970)	3	0	.01	-	 < 0.2	1.00E00
detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)	2	0	.01	-	 < 0.2	1.00E00
detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581)	2	0	.01	-	 < 0.2	1.00E00
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	36	0	.15	-	 < 0.2	1.00E00
positive regulation of histone phosphorylation (GO:0033129)	8	2	.03	+	59.66	1.00E00
negative regulation of histone phosphorylation (GO:0033128)	3	0	.01	-	 < 0.2	1.00E00
regulation of histone phosphorylation (GO:0033127)	13	2	.05	+	36.72	1.00E00
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of purine nucleotide catabolic process (GO:0033123)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neutrophil mediated killing of fungus (GO:0070965)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of purine nucleotide catabolic process (GO:0033122)	2	0	.01	-	 < 0.2	1.00E00
regulation of purine nucleotide catabolic process (GO:0033121)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of RNA splicing (GO:0033120)	32	1	.13	+	7.46	1.00E00
positive regulation of neutrophil mediated killing of bacterium (GO:0070962)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neutrophil mediated cytotoxicity (GO:0070960)	2	0	.01	-	 < 0.2	1.00E00
medium-chain fatty acid transport (GO:0001579)	2	0	.01	-	 < 0.2	1.00E00
microtubule bundle formation (GO:0001578)	85	1	.36	+	2.81	1.00E00
globoside biosynthetic process (GO:0001576)	1	0	.00	-	 < 0.2	1.00E00
globoside metabolic process (GO:0001575)	2	0	.01	-	 < 0.2	1.00E00
ganglioside biosynthetic process (GO:0001574)	9	0	.04	-	 < 0.2	1.00E00
ganglioside metabolic process (GO:0001573)	17	0	.07	-	 < 0.2	1.00E00
lactosylceramide biosynthetic process (GO:0001572)	1	0	.00	-	 < 0.2	1.00E00
vasculogenesis (GO:0001570)	66	2	.28	+	7.23	1.00E00
negative regulation of RNA splicing (GO:0033119)	27	0	.11	-	 < 0.2	1.00E00
regulation of neutrophil mediated killing of fungus (GO:0070953)	1	0	.00	-	 < 0.2	1.00E00
regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951)	1	0	.00	-	 < 0.2	1.00E00
regulation of neutrophil mediated killing of bacterium (GO:0070950)	1	0	.00	-	 < 0.2	1.00E00
branching involved in blood vessel morphogenesis (GO:0001569)	29	0	.12	-	 < 0.2	1.00E00
cell septum assembly (GO:0090529)	1	0	.00	-	 < 0.2	1.00E00
actin filament reorganization (GO:0090527)	7	0	.03	-	 < 0.2	1.00E00
regulation of gluconeogenesis involved in cellular glucose homeostasis (GO:0090526)	3	0	.01	-	 < 0.2	1.00E00
response to protozoan (GO:0001562)	24	0	.10	-	 < 0.2	1.00E00
fatty acid alpha-oxidation (GO:0001561)	8	0	.03	-	 < 0.2	1.00E00
regulation of cell growth by extracellular stimulus (GO:0001560)	3	0	.01	-	 < 0.2	1.00E00
glomerular visceral epithelial cell migration (GO:0090521)	4	0	.02	-	 < 0.2	1.00E00
sphingolipid mediated signaling pathway (GO:0090520)	12	0	.05	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex assembly (GO:0033108)	96	0	.40	-	 < 0.2	1.00E00
regulation of neutrophil mediated killing of symbiont cell (GO:0070949)	2	0	.01	-	 < 0.2	1.00E00
regulation of neutrophil mediated cytotoxicity (GO:0070948)	2	0	.01	-	 < 0.2	1.00E00
neutrophil mediated killing of fungus (GO:0070947)	1	0	.00	-	 < 0.2	1.00E00
neutrophil mediated killing of gram-positive bacterium (GO:0070946)	1	0	.00	-	 < 0.2	1.00E00
neutrophil mediated killing of gram-negative bacterium (GO:0070945)	4	0	.02	-	 < 0.2	1.00E00
neutrophil mediated killing of bacterium (GO:0070944)	6	0	.03	-	 < 0.2	1.00E00
neutrophil mediated killing of symbiont cell (GO:0070943)	6	0	.03	-	 < 0.2	1.00E00
neutrophil mediated cytotoxicity (GO:0070942)	6	0	.03	-	 < 0.2	1.00E00
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	5	0	.02	-	 < 0.2	1.00E00
oocyte maturation (GO:0001556)	19	2	.08	+	25.12	1.00E00
oocyte growth (GO:0001555)	3	0	.01	-	 < 0.2	1.00E00
luteolysis (GO:0001554)	5	0	.02	-	 < 0.2	1.00E00
luteinization (GO:0001553)	8	0	.03	-	 < 0.2	1.00E00
ovarian cumulus expansion (GO:0001550)	2	0	.01	-	 < 0.2	1.00E00
protein K48-linked ubiquitination (GO:0070936)	47	0	.20	-	 < 0.2	1.00E00
tooth eruption (GO:0044691)	3	0	.01	-	 < 0.2	1.00E00
3'-UTR-mediated mRNA stabilization (GO:0070935)	18	1	.08	+	13.26	1.00E00
CRD-mediated mRNA stabilization (GO:0070934)	5	0	.02	-	 < 0.2	1.00E00
histone H4 deacetylation (GO:0070933)	9	0	.04	-	 < 0.2	1.00E00
histone H3 deacetylation (GO:0070932)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.01	-	 < 0.2	1.00E00
regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of lamellipodium morphogenesis (GO:2000394)	7	1	.03	+	34.09	1.00E00
negative regulation of lamellipodium morphogenesis (GO:2000393)	2	0	.01	-	 < 0.2	1.00E00
regulation of lamellipodium morphogenesis (GO:2000392)	11	1	.05	+	21.70	1.00E00
positive regulation of neutrophil extravasation (GO:2000391)	4	0	.02	-	 < 0.2	1.00E00
antral ovarian follicle growth (GO:0001547)	5	0	.02	-	 < 0.2	1.00E00
preantral ovarian follicle growth (GO:0001546)	3	0	.01	-	 < 0.2	1.00E00
primary ovarian follicle growth (GO:0001545)	3	1	.01	+	79.55	1.00E00
initiation of primordial ovarian follicle growth (GO:0001544)	1	0	.00	-	 < 0.2	1.00E00
epiboly involved in wound healing (GO:0090505)	23	1	.10	+	10.38	1.00E00
ovarian follicle rupture (GO:0001543)	1	0	.00	-	 < 0.2	1.00E00
epiboly (GO:0090504)	24	1	.10	+	9.94	1.00E00
ovulation from ovarian follicle (GO:0001542)	9	0	.04	-	 < 0.2	1.00E00
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	35	0	.15	-	 < 0.2	1.00E00
ovarian follicle development (GO:0001541)	53	3	.22	+	13.51	1.00E00
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	81	0	.34	-	 < 0.2	1.00E00
RNA phosphodiester bond hydrolysis (GO:0090501)	144	0	.60	-	 < 0.2	1.00E00
endocardial cushion to mesenchymal transition (GO:0090500)	4	0	.02	-	 < 0.2	1.00E00
regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.00	-	 < 0.2	1.00E00
organelle assembly (GO:0070925)	679	2	2.85	-	.70	1.00E00
small RNA loading onto RISC (GO:0070922)	9	1	.04	+	26.52	1.00E00
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	16	1	.07	+	14.92	1.00E00
regulation of neutrophil extravasation (GO:2000389)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of antral ovarian follicle growth (GO:2000388)	1	0	.00	-	 < 0.2	1.00E00
regulation of antral ovarian follicle growth (GO:2000387)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ovarian follicle development (GO:2000386)	2	1	.01	+	 > 100	1.00E00
negative regulation of ectoderm development (GO:2000384)	1	0	.00	-	 < 0.2	1.00E00
regulation of ectoderm development (GO:2000383)	1	0	.00	-	 < 0.2	1.00E00
cilium or flagellum-dependent cell motility (GO:0001539)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of mesoderm development (GO:2000382)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of mesoderm development (GO:2000381)	8	0	.03	-	 < 0.2	1.00E00
regulation of mesoderm development (GO:2000380)	16	0	.07	-	 < 0.2	1.00E00
production of small RNA involved in gene silencing by RNA (GO:0070918)	30	1	.13	+	7.96	1.00E00
UV-damage excision repair (GO:0070914)	11	0	.05	-	 < 0.2	1.00E00
global genome nucleotide-excision repair (GO:0070911)	32	0	.13	-	 < 0.2	1.00E00
negative regulation of reactive oxygen species metabolic process (GO:2000378)	50	3	.21	+	14.32	1.00E00
positive regulation of oxygen metabolic process (GO:2000376)	1	0	.00	-	 < 0.2	1.00E00
regulation of oxygen metabolic process (GO:2000374)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	6	0	.03	-	 < 0.2	1.00E00
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of clathrin-dependent endocytosis (GO:2000370)	7	0	.03	-	 < 0.2	1.00E00
retinoid metabolic process (GO:0001523)	89	0	.37	-	 < 0.2	1.00E00
pseudouridine synthesis (GO:0001522)	18	0	.08	-	 < 0.2	1.00E00
transepithelial L-ascorbic acid transport (GO:0070904)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial tRNA thio-modification (GO:0070903)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial tRNA pseudouridine synthesis (GO:0070902)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial tRNA methylation (GO:0070901)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of interleukin-13 production (GO:0032696)	6	0	.03	-	 < 0.2	1.00E00
mitochondrial tRNA modification (GO:0070900)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of interleukin-12 production (GO:0032695)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of interleukin-10 production (GO:0032693)	17	1	.07	+	14.04	1.00E00
regulation of clathrin-dependent endocytosis (GO:2000369)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of interleukin-1 production (GO:0032692)	24	1	.10	+	9.94	1.00E00
positive regulation of acrosomal vesicle exocytosis (GO:2000368)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of interleukin-1 beta production (GO:0032691)	18	1	.08	+	13.26	1.00E00
regulation of acrosomal vesicle exocytosis (GO:2000367)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of interleukin-1 alpha production (GO:0032690)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of STAT protein import into nucleus (GO:2000366)	3	0	.01	-	 < 0.2	1.00E00
regulation of STAT protein import into nucleus (GO:2000364)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of prostaglandin-E synthase activity (GO:2000363)	2	0	.01	-	 < 0.2	1.00E00
peptide amidation (GO:0001519)	2	0	.01	-	 < 0.2	1.00E00
regulation of prostaglandin-E synthase activity (GO:2000361)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of binding of sperm to zona pellucida (GO:2000360)	4	0	.02	-	 < 0.2	1.00E00
prostaglandin biosynthetic process (GO:0001516)	18	0	.08	-	 < 0.2	1.00E00
selenocysteine incorporation (GO:0001514)	8	0	.03	-	 < 0.2	1.00E00
RNA methylation (GO:0001510)	67	0	.28	-	 < 0.2	1.00E00
pore formation in membrane of other organism during symbiotic interaction (GO:0044657)	1	0	.00	-	 < 0.2	1.00E00
suppression of defense response of other organism involved in symbiotic interaction (GO:0052261)	1	0	.00	-	 < 0.2	1.00E00
adhesion of symbiont to host cell (GO:0044650)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of interferon-gamma production (GO:0032689)	32	2	.13	+	14.92	1.00E00
negative regulation of interferon-beta production (GO:0032688)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of interferon-alpha production (GO:0032687)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of hepatocyte growth factor production (GO:0032686)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685)	1	0	.00	-	 < 0.2	1.00E00
regulation of binding of sperm to zona pellucida (GO:2000359)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of chemokine production (GO:0032682)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of kidney smooth muscle cell differentiation (GO:2000358)	1	0	.00	-	 < 0.2	1.00E00
regulation of lymphotoxin A production (GO:0032681)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of kidney smooth muscle cell differentiation (GO:2000357)	1	0	.00	-	 < 0.2	1.00E00
regulation of tumor necrosis factor production (GO:0032680)	113	4	.47	+	8.45	1.00E00
regulation of kidney smooth muscle cell differentiation (GO:2000356)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ovarian follicle development (GO:2000355)	1	0	.00	-	 < 0.2	1.00E00
regulation of ovarian follicle development (GO:2000354)	5	1	.02	+	47.73	1.00E00
positive regulation of endothelial cell apoptotic process (GO:2000353)	15	1	.06	+	15.91	1.00E00
negative regulation of endothelial cell apoptotic process (GO:2000352)	26	1	.11	+	9.18	1.00E00
action potential (GO:0001508)	102	0	.43	-	 < 0.2	1.00E00
regulation of endothelial cell apoptotic process (GO:2000351)	41	2	.17	+	11.64	1.00E00
acetylcholine catabolic process in synaptic cleft (GO:0001507)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of CD40 signaling pathway (GO:2000350)	1	0	.00	-	 < 0.2	1.00E00
regulation of neurotransmitter levels (GO:0001505)	186	0	.78	-	 < 0.2	1.00E00
neurotransmitter uptake (GO:0001504)	12	0	.05	-	 < 0.2	1.00E00
cartilage condensation (GO:0001502)	21	1	.09	+	11.36	1.00E00
skeletal system development (GO:0001501)	469	3	1.97	+	1.53	1.00E00
histone H3-K4 dimethylation (GO:0044648)	1	0	.00	-	 < 0.2	1.00E00
modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0052255)	3	0	.01	-	 < 0.2	1.00E00
induction by organism of defense response of other organism involved in symbiotic interaction (GO:0052251)	2	0	.01	-	 < 0.2	1.00E00
modulation of signal transduction in other organism involved in symbiotic interaction (GO:0052250)	2	0	.01	-	 < 0.2	1.00E00
regulation of TRAIL production (GO:0032679)	2	1	.01	+	 > 100	1.00E00
regulation of interleukin-8 production (GO:0032677)	65	1	.27	+	3.67	1.00E00
regulation of interleukin-6 production (GO:0032675)	110	1	.46	+	2.17	1.00E00
regulation of interleukin-5 production (GO:0032674)	19	0	.08	-	 < 0.2	1.00E00
regulation of interleukin-4 production (GO:0032673)	28	1	.12	+	8.52	1.00E00
negative regulation of CD40 signaling pathway (GO:2000349)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-3 production (GO:0032672)	3	1	.01	+	79.55	1.00E00
regulation of CD40 signaling pathway (GO:2000348)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of hepatocyte proliferation (GO:2000347)	7	1	.03	+	34.09	1.00E00
negative regulation of hepatocyte proliferation (GO:2000346)	4	0	.02	-	 < 0.2	1.00E00
regulation of hepatocyte proliferation (GO:2000345)	14	1	.06	+	17.05	1.00E00
positive regulation of acrosome reaction (GO:2000344)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	2	0	.01	-	 < 0.2	1.00E00
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of viral release from host cell (GO:1902188)	16	0	.07	-	 < 0.2	1.00E00
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.00	-	 < 0.2	1.00E00
modulation of programmed cell death in other organism involved in symbiotic interaction (GO:0052248)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of viral release from host cell (GO:1902187)	15	0	.06	-	 < 0.2	1.00E00
peptidyl-lysine acetylation (GO:0018394)	111	2	.47	+	4.30	1.00E00
regulation of viral release from host cell (GO:1902186)	31	0	.13	-	 < 0.2	1.00E00
internal peptidyl-lysine acetylation (GO:0018393)	108	2	.45	+	4.42	1.00E00
regulation of interleukin-23 production (GO:0032667)	8	0	.03	-	 < 0.2	1.00E00
regulation of interleukin-2 production (GO:0032663)	53	0	.22	-	 < 0.2	1.00E00
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	3	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-18 production (GO:0032661)	7	0	.03	-	 < 0.2	1.00E00
regulation of interleukin-17 production (GO:0032660)	23	0	.10	-	 < 0.2	1.00E00
positive regulation of blood microparticle formation (GO:2000334)	2	0	.01	-	 < 0.2	1.00E00
regulation of blood microparticle formation (GO:2000332)	2	0	.01	-	 < 0.2	1.00E00
regulation of terminal button organization (GO:2000331)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of T-helper 17 cell lineage commitment (GO:2000330)	4	0	.02	-	 < 0.2	1.00E00
fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	6	1	.03	+	39.78	1.00E00
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	20	1	.08	+	11.93	1.00E00
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	30	2	.13	+	15.91	1.00E00
positive regulation of keratinocyte apoptotic process (GO:1902174)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of keratinocyte apoptotic process (GO:1902173)	1	0	.00	-	 < 0.2	1.00E00
regulation of keratinocyte apoptotic process (GO:1902172)	6	0	.03	-	 < 0.2	1.00E00
modulation of phagocytosis in other organism involved in symbiotic interaction (GO:0052231)	1	0	.00	-	 < 0.2	1.00E00
cellular response to reactive nitrogen species (GO:1902170)	19	0	.08	-	 < 0.2	1.00E00
regulation of interleukin-15 production (GO:0032658)	1	0	.00	-	 < 0.2	1.00E00
regulation of interleukin-13 production (GO:0032656)	20	1	.08	+	11.93	1.00E00
regulation of interleukin-12 production (GO:0032655)	52	1	.22	+	4.59	1.00E00
regulation of interleukin-10 production (GO:0032653)	45	1	.19	+	5.30	1.00E00
negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	3	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-1 production (GO:0032652)	71	1	.30	+	3.36	1.00E00
regulation of T-helper 17 cell lineage commitment (GO:2000328)	7	0	.03	-	 < 0.2	1.00E00
regulation of interleukin-1 beta production (GO:0032651)	58	1	.24	+	4.11	1.00E00
positive regulation of ligand-dependent nuclear receptor transcription coactivator activity (GO:2000327)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-1 alpha production (GO:0032650)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of ligand-dependent nuclear receptor transcription coactivator activity (GO:2000326)	1	0	.00	-	 < 0.2	1.00E00
regulation of ligand-dependent nuclear receptor transcription coactivator activity (GO:2000325)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	6	0	.03	-	 < 0.2	1.00E00
regulation of glucocorticoid receptor signaling pathway (GO:2000322)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of T-helper 17 cell differentiation (GO:2000321)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of T-helper 17 cell differentiation (GO:2000320)	7	0	.03	-	 < 0.2	1.00E00
protein myristoylation (GO:0018377)	5	0	.02	-	 < 0.2	1.00E00
metabolism of macromolecule in other organism involved in symbiotic interaction (GO:0052229)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	1	0	.00	-	 < 0.2	1.00E00
catabolism of substance in other organism involved in symbiotic interaction (GO:0052227)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	13	0	.05	-	 < 0.2	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	3	0	.01	-	 < 0.2	1.00E00
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161)	1	0	.00	-	 < 0.2	1.00E00
regulation of interferon-gamma production (GO:0032649)	94	2	.39	+	5.08	1.00E00
regulation of interferon-beta production (GO:0032648)	49	0	.21	-	 < 0.2	1.00E00
regulation of interferon-alpha production (GO:0032647)	29	1	.12	+	8.23	1.00E00
regulation of hepatocyte growth factor production (GO:0032646)	1	0	.00	-	 < 0.2	1.00E00
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	16	1	.07	+	14.92	1.00E00
regulation of fractalkine production (GO:0032644)	1	0	.00	-	 < 0.2	1.00E00
regulation of connective tissue growth factor production (GO:0032643)	1	0	.00	-	 < 0.2	1.00E00
regulation of T-helper 17 cell differentiation (GO:2000319)	12	0	.05	-	 < 0.2	1.00E00
regulation of chemokine production (GO:0032642)	73	0	.31	-	 < 0.2	1.00E00
positive regulation of T-helper 17 type immune response (GO:2000318)	7	0	.03	-	 < 0.2	1.00E00
lymphotoxin A production (GO:0032641)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of T-helper 17 type immune response (GO:2000317)	7	0	.03	-	 < 0.2	1.00E00
tumor necrosis factor production (GO:0032640)	5	0	.02	-	 < 0.2	1.00E00
regulation of T-helper 17 type immune response (GO:2000316)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	1	0	.00	-	 < 0.2	1.00E00
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	2	0	.01	-	 < 0.2	1.00E00
regulation of kainate selective glutamate receptor activity (GO:2000312)	3	0	.01	-	 < 0.2	1.00E00
regulation of AMPA receptor activity (GO:2000311)	21	0	.09	-	 < 0.2	1.00E00
regulation of NMDA receptor activity (GO:2000310)	17	0	.07	-	 < 0.2	1.00E00
regulation of cyclic nucleotide-gated ion channel activity (GO:1902159)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-glutamine methylation (GO:0018364)	3	0	.01	-	 < 0.2	1.00E00
metabolism of substance in other organism involved in symbiotic interaction (GO:0052214)	1	0	.00	-	 < 0.2	1.00E00
regulation of response to DNA damage checkpoint signaling (GO:1902153)	1	0	.00	-	 < 0.2	1.00E00
interaction with symbiont via secreted substance involved in symbiotic interaction (GO:0052213)	1	0	.00	-	 < 0.2	1.00E00
tRNA metabolic process (GO:0006399)	185	1	.78	+	1.29	1.00E00
modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction (GO:0052212)	1	0	.00	-	 < 0.2	1.00E00
regulation of response to DNA integrity checkpoint signaling (GO:1902151)	1	0	.00	-	 < 0.2	1.00E00
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	5	0	.02	-	 < 0.2	1.00E00
mRNA processing (GO:0006397)	456	1	1.91	-	.52	1.00E00
RNA processing (GO:0006396)	884	3	3.70	-	.81	1.00E00
termination of mitochondrial transcription (GO:0006393)	2	0	.01	-	 < 0.2	1.00E00
interleukin-8 production (GO:0032637)	7	0	.03	-	 < 0.2	1.00E00
transcription initiation from mitochondrial promoter (GO:0006391)	3	0	.01	-	 < 0.2	1.00E00
interleukin-6 production (GO:0032635)	10	0	.04	-	 < 0.2	1.00E00
transcription from mitochondrial promoter (GO:0006390)	11	0	.05	-	 < 0.2	1.00E00
interleukin-5 production (GO:0032634)	1	0	.00	-	 < 0.2	1.00E00
interleukin-4 production (GO:0032633)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309)	2	0	.01	-	 < 0.2	1.00E00
interleukin-3 production (GO:0032632)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308)	1	0	.00	-	 < 0.2	1.00E00
regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of ceramide biosynthetic process (GO:2000304)	9	1	.04	+	26.52	1.00E00
regulation of ceramide biosynthetic process (GO:2000303)	14	1	.06	+	17.05	1.00E00
positive regulation of synaptic vesicle exocytosis (GO:2000302)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of synaptic vesicle exocytosis (GO:2000301)	4	0	.02	-	 < 0.2	1.00E00
regulation of synaptic vesicle exocytosis (GO:2000300)	26	0	.11	-	 < 0.2	1.00E00
regulation of response to cell cycle checkpoint signaling (GO:1902145)	1	0	.00	-	 < 0.2	1.00E00
protein-pyridoxal-5-phosphate linkage (GO:0018352)	2	0	.01	-	 < 0.2	1.00E00
modulation of molecular function in other organism involved in symbiotic interaction (GO:0052205)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of molecular function in other organism involved in symbiotic interaction (GO:0052204)	8	0	.03	-	 < 0.2	1.00E00
protein esterification (GO:0018350)	1	0	.00	-	 < 0.2	1.00E00
modulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052203)	4	0	.02	-	 < 0.2	1.00E00
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	15	0	.06	-	 < 0.2	1.00E00
response to host defenses (GO:0052200)	7	0	.03	-	 < 0.2	1.00E00
termination of RNA polymerase III transcription (GO:0006386)	1	0	.00	-	 < 0.2	1.00E00
transcription initiation from RNA polymerase III promoter (GO:0006384)	8	0	.03	-	 < 0.2	1.00E00
transcription from RNA polymerase III promoter (GO:0006383)	42	0	.18	-	 < 0.2	1.00E00
adenosine to inosine editing (GO:0006382)	5	1	.02	+	47.73	1.00E00
interleukin-21 production (GO:0032625)	1	0	.00	-	 < 0.2	1.00E00
interleukin-2 production (GO:0032623)	8	0	.03	-	 < 0.2	1.00E00
interleukin-18 production (GO:0032621)	2	0	.01	-	 < 0.2	1.00E00
interleukin-17 production (GO:0032620)	3	0	.01	-	 < 0.2	1.00E00
protein palmitoylation (GO:0018345)	23	0	.10	-	 < 0.2	1.00E00
protein geranylgeranylation (GO:0018344)	6	0	.03	-	 < 0.2	1.00E00
protein farnesylation (GO:0018343)	4	0	.02	-	 < 0.2	1.00E00
protein prenylation (GO:0018342)	10	0	.04	-	 < 0.2	1.00E00
mRNA cleavage (GO:0006379)	23	0	.10	-	 < 0.2	1.00E00
mRNA polyadenylation (GO:0006378)	31	0	.13	-	 < 0.2	1.00E00
mRNA splice site selection (GO:0006376)	28	0	.12	-	 < 0.2	1.00E00
interleukin-15 production (GO:0032618)	1	0	.00	-	 < 0.2	1.00E00
interleukin-13 production (GO:0032616)	2	0	.01	-	 < 0.2	1.00E00
interleukin-12 production (GO:0032615)	4	1	.02	+	59.66	1.00E00
7-methylguanosine mRNA capping (GO:0006370)	33	0	.14	-	 < 0.2	1.00E00
interleukin-10 production (GO:0032613)	4	1	.02	+	59.66	1.00E00
interleukin-1 production (GO:0032612)	14	0	.06	-	 < 0.2	1.00E00
interleukin-1 beta production (GO:0032611)	13	0	.05	-	 < 0.2	1.00E00
interleukin-1 alpha production (GO:0032610)	1	0	.00	-	 < 0.2	1.00E00
cellular response to fatty acid (GO:0071398)	57	3	.24	+	12.56	1.00E00
cellular response to cholesterol (GO:0071397)	13	0	.05	-	 < 0.2	1.00E00
cellular response to jasmonic acid stimulus (GO:0071395)	4	0	.02	-	 < 0.2	1.00E00
cellular response to testosterone stimulus (GO:0071394)	8	2	.03	+	59.66	1.00E00
cellular response to progesterone stimulus (GO:0071393)	3	1	.01	+	79.55	1.00E00
cellular response to estradiol stimulus (GO:0071392)	39	2	.16	+	12.24	1.00E00
cellular response to estrogen stimulus (GO:0071391)	13	1	.05	+	18.36	1.00E00
termination of RNA polymerase II transcription (GO:0006369)	69	0	.29	-	 < 0.2	1.00E00
transcription elongation from RNA polymerase II promoter (GO:0006368)	96	1	.40	+	2.49	1.00E00
transcription initiation from RNA polymerase II promoter (GO:0006367)	154	2	.65	+	3.10	1.00E00
transcription from RNA polymerase II promoter (GO:0006366)	810	11	3.39	+	3.24	1.00E00
interferon-gamma production (GO:0032609)	17	0	.07	-	 < 0.2	1.00E00
rRNA processing (GO:0006364)	259	1	1.09	-	.92	1.00E00
interferon-beta production (GO:0032608)	3	0	.01	-	 < 0.2	1.00E00
termination of RNA polymerase I transcription (GO:0006363)	31	0	.13	-	 < 0.2	1.00E00
interferon-alpha production (GO:0032607)	2	0	.01	-	 < 0.2	1.00E00
transcription elongation from RNA polymerase I promoter (GO:0006362)	30	0	.13	-	 < 0.2	1.00E00
type I interferon production (GO:0032606)	8	0	.03	-	 < 0.2	1.00E00
transcription initiation from RNA polymerase I promoter (GO:0006361)	34	0	.14	-	 < 0.2	1.00E00
transcription from RNA polymerase I promoter (GO:0006360)	36	0	.15	-	 < 0.2	1.00E00
granulocyte macrophage colony-stimulating factor production (GO:0032604)	2	0	.01	-	 < 0.2	1.00E00
chemokine production (GO:0032602)	10	0	.04	-	 < 0.2	1.00E00
connective tissue growth factor production (GO:0032601)	1	0	.00	-	 < 0.2	1.00E00
chemokine receptor transport out of membrane raft (GO:0032600)	1	0	.00	-	 < 0.2	1.00E00
cellular response to mineralocorticoid stimulus (GO:0071389)	6	0	.03	-	 < 0.2	1.00E00
cellular response to cortisol stimulus (GO:0071387)	1	0	.00	-	 < 0.2	1.00E00
cellular response to corticosterone stimulus (GO:0071386)	3	0	.01	-	 < 0.2	1.00E00
cellular response to glucocorticoid stimulus (GO:0071385)	59	4	.25	+	16.18	1.00E00
positive regulation of organelle assembly (GO:1902117)	63	2	.26	+	7.58	1.00E00
cellular response to corticosteroid stimulus (GO:0071384)	62	4	.26	+	15.40	1.00E00
negative regulation of organelle assembly (GO:1902116)	31	0	.13	-	 < 0.2	1.00E00
enzyme active site formation via L-cysteine sulfinic acid (GO:0018323)	1	0	.00	-	 < 0.2	1.00E00
cellular response to steroid hormone stimulus (GO:0071383)	196	6	.82	+	7.31	1.00E00
regulation of organelle assembly (GO:1902115)	157	3	.66	+	4.56	1.00E00
protein tyrosinylation (GO:0018322)	1	0	.00	-	 < 0.2	1.00E00
cellular response to prostaglandin E stimulus (GO:0071380)	18	1	.08	+	13.26	1.00E00
regulation of transcription from RNA polymerase III promoter (GO:0006359)	27	1	.11	+	8.84	1.00E00
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	17	1	.07	+	14.04	1.00E00
regulation of transcription from RNA polymerase I promoter (GO:0006356)	34	0	.14	-	 < 0.2	1.00E00
DNA-templated transcription, elongation (GO:0006354)	111	1	.47	+	2.15	1.00E00
DNA-templated transcription, termination (GO:0006353)	108	0	.45	-	 < 0.2	1.00E00
DNA-templated transcription, initiation (GO:0006352)	191	2	.80	+	2.50	1.00E00
transcription, DNA-templated (GO:0006351)	2588	16	10.84	+	1.48	1.00E00
intracellular transport of virus (GO:0075733)	55	0	.23	-	 < 0.2	1.00E00
viral penetration into host nucleus (GO:0075732)	2	0	.01	-	 < 0.2	1.00E00
cellular response to prostaglandin stimulus (GO:0071379)	23	1	.10	+	10.38	1.00E00
protein C-linked glycosylation via tryptophan (GO:0018317)	7	0	.03	-	 < 0.2	1.00E00
cellular response to glucagon stimulus (GO:0071377)	40	0	.17	-	 < 0.2	1.00E00
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	4	0	.02	-	 < 0.2	1.00E00
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	5	0	.02	-	 < 0.2	1.00E00
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	23	1	.10	+	10.38	1.00E00
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of leukocyte differentiation (GO:1902107)	135	5	.57	+	8.84	1.00E00
cellular response to parathyroid hormone stimulus (GO:0071374)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of leukocyte differentiation (GO:1902106)	92	2	.39	+	5.19	1.00E00
cellular response to luteinizing hormone stimulus (GO:0071373)	3	0	.01	-	 < 0.2	1.00E00
peptidyl-serine ADP-ribosylation (GO:0018312)	3	0	.01	-	 < 0.2	1.00E00
cellular response to follicle-stimulating hormone stimulus (GO:0071372)	12	0	.05	-	 < 0.2	1.00E00
cellular response to gonadotropin stimulus (GO:0071371)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	2	0	.01	-	 < 0.2	1.00E00
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	2	0	.01	-	 < 0.2	1.00E00
regulation of gene expression by genetic imprinting (GO:0006349)	18	1	.08	+	13.26	1.00E00
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	7	0	.03	-	 < 0.2	1.00E00
chromatin silencing at telomere (GO:0006348)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of hair follicle development (GO:0051799)	4	1	.02	+	59.66	1.00E00
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	22	2	.09	+	21.70	1.00E00
positive regulation of hair follicle development (GO:0051798)	12	0	.05	-	 < 0.2	1.00E00
methylation-dependent chromatin silencing (GO:0006346)	11	0	.05	-	 < 0.2	1.00E00
regulation of hair follicle development (GO:0051797)	19	1	.08	+	12.56	1.00E00
protein depalmitoleylation (GO:1990697)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of timing of catagen (GO:0051796)	1	1	.00	+	 > 100	1.00E00
maintenance of chromatin silencing (GO:0006344)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of timing of catagen (GO:0051795)	3	0	.01	-	 < 0.2	1.00E00
establishment of chromatin silencing (GO:0006343)	1	0	.00	-	 < 0.2	1.00E00
regulation of timing of catagen (GO:0051794)	4	1	.02	+	59.66	1.00E00
chromatin silencing (GO:0006342)	66	1	.28	+	3.62	1.00E00
medium-chain fatty acid catabolic process (GO:0051793)	2	0	.01	-	 < 0.2	1.00E00
medium-chain fatty acid biosynthetic process (GO:0051792)	2	0	.01	-	 < 0.2	1.00E00
medium-chain fatty acid metabolic process (GO:0051791)	7	0	.03	-	 < 0.2	1.00E00
short-chain fatty acid biosynthetic process (GO:0051790)	4	0	.02	-	 < 0.2	1.00E00
enzyme active site formation (GO:0018307)	2	0	.01	-	 < 0.2	1.00E00
cellular response to ether (GO:0071362)	7	0	.03	-	 < 0.2	1.00E00
cellular response to ethanol (GO:0071361)	15	0	.06	-	 < 0.2	1.00E00
cellular response to exogenous dsRNA (GO:0071360)	16	1	.07	+	14.92	1.00E00
chromatin remodeling (GO:0006338)	154	3	.65	+	4.65	1.00E00
nucleosome disassembly (GO:0006337)	18	0	.08	-	 < 0.2	1.00E00
response to misfolded protein (GO:0051788)	25	0	.10	-	 < 0.2	1.00E00
DNA replication-independent nucleosome assembly (GO:0006336)	39	0	.16	-	 < 0.2	1.00E00
DNA replication-dependent nucleosome assembly (GO:0006335)	10	1	.04	+	23.87	1.00E00
nucleosome assembly (GO:0006334)	118	1	.49	+	2.02	1.00E00
positive regulation of nuclear division (GO:0051785)	63	1	.26	+	3.79	1.00E00
chromatin assembly or disassembly (GO:0006333)	154	3	.65	+	4.65	1.00E00
negative regulation of nuclear division (GO:0051784)	49	3	.21	+	14.61	1.00E00
regulation of nuclear division (GO:0051783)	185	5	.78	+	6.45	1.00E00
negative regulation of cell division (GO:0051782)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of cell division (GO:0051781)	83	0	.35	-	 < 0.2	1.00E00
behavioral response to nutrient (GO:0051780)	1	0	.00	-	 < 0.2	1.00E00
establishment of integrated proviral latency (GO:0075713)	8	0	.03	-	 < 0.2	1.00E00
cellular response to dsRNA (GO:0071359)	52	2	.22	+	9.18	1.00E00
cellular response to type I interferon (GO:0071357)	65	2	.27	+	7.34	1.00E00
cellular response to tumor necrosis factor (GO:0071356)	239	3	1.00	+	3.00	1.00E00
cellular response to interleukin-9 (GO:0071355)	1	0	.00	-	 < 0.2	1.00E00
cellular response to interleukin-6 (GO:0071354)	27	0	.11	-	 < 0.2	1.00E00
cellular response to interleukin-4 (GO:0071353)	28	2	.12	+	17.05	1.00E00
cellular response to interleukin-2 (GO:0071352)	5	0	.02	-	 < 0.2	1.00E00
cellular response to interleukin-18 (GO:0071351)	6	1	.03	+	39.78	1.00E00
cellular response to interleukin-15 (GO:0071350)	3	0	.01	-	 < 0.2	1.00E00
response to redox state (GO:0051775)	13	0	.05	-	 < 0.2	1.00E00
DNA packaging (GO:0006323)	176	4	.74	+	5.42	1.00E00
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)	14	0	.06	-	 < 0.2	1.00E00
cellular response to interleukin-12 (GO:0071349)	56	0	.23	-	 < 0.2	1.00E00
cellular response to interleukin-11 (GO:0071348)	1	0	.00	-	 < 0.2	1.00E00
cellular response to interleukin-1 (GO:0071347)	88	0	.37	-	 < 0.2	1.00E00
cellular response to interferon-gamma (GO:0071346)	127	2	.53	+	3.76	1.00E00
diphosphate metabolic process (GO:0071344)	2	0	.01	-	 < 0.2	1.00E00
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	9	0	.04	-	 < 0.2	1.00E00
regulation of nitric-oxide synthase biosynthetic process (GO:0051769)	18	0	.08	-	 < 0.2	1.00E00
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668)	6	0	.03	-	 < 0.2	1.00E00
transposition, DNA-mediated (GO:0006313)	2	0	.01	-	 < 0.2	1.00E00
actin crosslink formation (GO:0051764)	12	0	.05	-	 < 0.2	1.00E00
mitotic recombination (GO:0006312)	19	1	.08	+	12.56	1.00E00
meiotic gene conversion (GO:0006311)	4	0	.02	-	 < 0.2	1.00E00
DNA recombination (GO:0006310)	212	2	.89	+	2.25	1.00E00
positive regulation of hair follicle cell proliferation (GO:0071338)	2	0	.01	-	 < 0.2	1.00E00
regulation of hair follicle cell proliferation (GO:0071336)	2	0	.01	-	 < 0.2	1.00E00
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	9	0	.04	-	 < 0.2	1.00E00
cellular response to glucose stimulus (GO:0071333)	67	2	.28	+	7.12	1.00E00
cellular response to fructose stimulus (GO:0071332)	5	1	.02	+	47.73	1.00E00
cellular response to hexose stimulus (GO:0071331)	70	2	.29	+	6.82	1.00E00
apoptotic DNA fragmentation (GO:0006309)	15	1	.06	+	15.91	1.00E00
DNA catabolic process (GO:0006308)	27	1	.11	+	8.84	1.00E00
DNA dealkylation involved in DNA repair (GO:0006307)	10	0	.04	-	 < 0.2	1.00E00
homologous chromosome movement towards spindle pole involved in homologous chromosome segregation (GO:0051758)	1	0	.00	-	 < 0.2	1.00E00
DNA methylation (GO:0006306)	49	0	.21	-	 < 0.2	1.00E00
DNA alkylation (GO:0006305)	49	0	.21	-	 < 0.2	1.00E00
DNA modification (GO:0006304)	85	0	.36	-	 < 0.2	1.00E00
double-strand break repair via nonhomologous end joining (GO:0006303)	53	1	.22	+	4.50	1.00E00
meiotic sister chromatid cohesion, centromeric (GO:0051754)	5	0	.02	-	 < 0.2	1.00E00
sebum secreting cell proliferation (GO:1990654)	1	0	.00	-	 < 0.2	1.00E00
double-strand break repair (GO:0006302)	161	2	.67	+	2.96	1.00E00
postreplication repair (GO:0006301)	54	1	.23	+	4.42	1.00E00
innate immune response (GO:0045087)	675	6	2.83	+	2.12	1.00E00
positive regulation of interleukin-2 biosynthetic process (GO:0045086)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of interleukin-2 biosynthetic process (GO:0045085)	4	0	.02	-	 < 0.2	1.00E00
cellular response to sucrose stimulus (GO:0071329)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interleukin-12 biosynthetic process (GO:0045084)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of interleukin-12 biosynthetic process (GO:0045083)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interleukin-10 biosynthetic process (GO:0045082)	2	0	.01	-	 < 0.2	1.00E00
cellular response to monosaccharide stimulus (GO:0071326)	71	2	.30	+	6.72	1.00E00
negative regulation of interleukin-10 biosynthetic process (GO:0045081)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of chemokine biosynthetic process (GO:0045080)	11	0	.05	-	 < 0.2	1.00E00
cellular response to disaccharide stimulus (GO:0071324)	1	0	.00	-	 < 0.2	1.00E00
cellular response to carbohydrate stimulus (GO:0071322)	79	2	.33	+	6.04	1.00E00
cellular response to cGMP (GO:0071321)	6	0	.03	-	 < 0.2	1.00E00
cellular response to cAMP (GO:0071320)	51	0	.21	-	 < 0.2	1.00E00
glutathione derivative biosynthetic process (GO:1901687)	22	0	.09	-	 < 0.2	1.00E00
glutathione derivative metabolic process (GO:1901685)	22	0	.09	-	 < 0.2	1.00E00
cellular response to prolactin (GO:1990646)	2	0	.01	-	 < 0.2	1.00E00
arsenate ion transmembrane transport (GO:1901684)	1	0	.00	-	 < 0.2	1.00E00
response to iron ion starvation (GO:1990641)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of chemokine biosynthetic process (GO:0045079)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of interferon-gamma biosynthetic process (GO:0045078)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of interferon-gamma biosynthetic process (GO:0045077)	4	0	.02	-	 < 0.2	1.00E00
regulation of interleukin-2 biosynthetic process (GO:0045076)	18	0	.08	-	 < 0.2	1.00E00
regulation of interleukin-12 biosynthetic process (GO:0045075)	9	0	.04	-	 < 0.2	1.00E00
regulation of interleukin-10 biosynthetic process (GO:0045074)	3	0	.01	-	 < 0.2	1.00E00
cellular response to ATP (GO:0071318)	13	0	.05	-	 < 0.2	1.00E00
regulation of chemokine biosynthetic process (GO:0045073)	14	0	.06	-	 < 0.2	1.00E00
cellular response to isoquinoline alkaloid (GO:0071317)	4	0	.02	-	 < 0.2	1.00E00
regulation of interferon-gamma biosynthetic process (GO:0045072)	16	0	.07	-	 < 0.2	1.00E00
cellular response to nicotine (GO:0071316)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of viral genome replication (GO:0045071)	52	1	.22	+	4.59	1.00E00
cellular response to morphine (GO:0071315)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of viral genome replication (GO:0045070)	34	1	.14	+	7.02	1.00E00
cellular response to cocaine (GO:0071314)	4	0	.02	-	 < 0.2	1.00E00
cellular response to caffeine (GO:0071313)	8	0	.03	-	 < 0.2	1.00E00
cellular response to alkaloid (GO:0071312)	34	2	.14	+	14.04	1.00E00
nucleotide transmembrane transport (GO:1901679)	7	0	.03	-	 < 0.2	1.00E00
iron coordination entity transport (GO:1901678)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of histone H3-K27 acetylation (GO:1901676)	1	0	.00	-	 < 0.2	1.00E00
response to prolactin (GO:1990637)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of histone H3-K27 acetylation (GO:1901675)	1	0	.00	-	 < 0.2	1.00E00
regulation of histone H3-K27 acetylation (GO:1901674)	3	0	.01	-	 < 0.2	1.00E00
regulation of mitotic spindle assembly (GO:1901673)	20	1	.08	+	11.93	1.00E00
positive regulation of superoxide dismutase activity (GO:1901671)	3	0	.01	-	 < 0.2	1.00E00
regulation of viral genome replication (GO:0045069)	83	2	.35	+	5.75	1.00E00
regulatory T cell differentiation (GO:0045066)	5	0	.02	-	 < 0.2	1.00E00
cytotoxic T cell differentiation (GO:0045065)	1	0	.00	-	 < 0.2	1.00E00
T-helper 2 cell differentiation (GO:0045064)	4	0	.02	-	 < 0.2	1.00E00
T-helper 1 cell differentiation (GO:0045063)	7	0	.03	-	 < 0.2	1.00E00
cellular response to vitamin K (GO:0071307)	2	0	.01	-	 < 0.2	1.00E00
extrathymic T cell selection (GO:0045062)	1	0	.00	-	 < 0.2	1.00E00
cellular response to vitamin E (GO:0071306)	2	0	.01	-	 < 0.2	1.00E00
thymic T cell selection (GO:0045061)	19	0	.08	-	 < 0.2	1.00E00
cellular response to vitamin D (GO:0071305)	14	0	.06	-	 < 0.2	1.00E00
negative thymic T cell selection (GO:0045060)	12	0	.05	-	 < 0.2	1.00E00
cellular response to vitamin B1 (GO:0071301)	1	1	.00	+	 > 100	1.00E00
cellular response to retinoic acid (GO:0071300)	70	0	.29	-	 < 0.2	1.00E00
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	2	0	.01	-	 < 0.2	1.00E00
regulation of superoxide dismutase activity (GO:1901668)	4	0	.02	-	 < 0.2	1.00E00
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of immature T cell proliferation in thymus (GO:0033092)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of immature T cell proliferation (GO:0033091)	3	0	.01	-	 < 0.2	1.00E00
protein de-ADP-ribosylation (GO:0051725)	4	0	.02	-	 < 0.2	1.00E00
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	3	0	.01	-	 < 0.2	1.00E00
quinone biosynthetic process (GO:1901663)	16	0	.07	-	 < 0.2	1.00E00
quinone catabolic process (GO:1901662)	3	0	.01	-	 < 0.2	1.00E00
quinone metabolic process (GO:1901661)	30	1	.13	+	7.96	1.00E00
calcium ion export (GO:1901660)	8	0	.03	-	 < 0.2	1.00E00
positive thymic T cell selection (GO:0045059)	8	0	.03	-	 < 0.2	1.00E00
T cell selection (GO:0045058)	38	2	.16	+	12.56	1.00E00
transcytosis (GO:0045056)	18	1	.08	+	13.26	1.00E00
regulated exocytosis (GO:0045055)	685	11	2.87	+	3.83	1.00E00
constitutive secretory pathway (GO:0045054)	2	0	.01	-	 < 0.2	1.00E00
protein retention in Golgi apparatus (GO:0045053)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of T cell differentiation in thymus (GO:0033089)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of immature T cell proliferation in thymus (GO:0033088)	5	1	.02	+	47.73	1.00E00
negative regulation of immature T cell proliferation (GO:0033087)	6	1	.03	+	39.78	1.00E00
negative regulation of T cell differentiation in thymus (GO:0033085)	9	1	.04	+	26.52	1.00E00
glycosyl compound biosynthetic process (GO:1901659)	50	0	.21	-	 < 0.2	1.00E00
regulation of immature T cell proliferation in thymus (GO:0033084)	7	1	.03	+	34.09	1.00E00
glycosyl compound catabolic process (GO:1901658)	38	0	.16	-	 < 0.2	1.00E00
histone H3-K9 deacetylation (GO:1990619)	2	0	.01	-	 < 0.2	1.00E00
regulation of immature T cell proliferation (GO:0033083)	9	1	.04	+	26.52	1.00E00
glycosyl compound metabolic process (GO:1901657)	149	1	.62	+	1.60	1.00E00
regulation of extrathymic T cell differentiation (GO:0033082)	2	0	.01	-	 < 0.2	1.00E00
glycoside transport (GO:1901656)	2	0	.01	-	 < 0.2	1.00E00
regulation of T cell differentiation in thymus (GO:0033081)	24	1	.10	+	9.94	1.00E00
immature T cell proliferation in thymus (GO:0033080)	1	0	.00	-	 < 0.2	1.00E00
cytolysis in other organism (GO:0051715)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of cytolysis in other organism (GO:0051714)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial magnesium ion transmembrane transport (GO:1990614)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cytolysis in other organism (GO:0051713)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial membrane fusion (GO:1990613)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of killing of cells of other organism (GO:0051712)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of killing of cells of other organism (GO:0051711)	1	0	.00	-	 < 0.2	1.00E00
regulation of cytolysis in other organism (GO:0051710)	4	0	.02	-	 < 0.2	1.00E00
protein insertion into ER membrane (GO:0045048)	6	0	.03	-	 < 0.2	1.00E00
protein targeting to ER (GO:0045047)	102	0	.43	-	 < 0.2	1.00E00
protein import into peroxisome membrane (GO:0045046)	6	0	.03	-	 < 0.2	1.00E00
dopamine uptake (GO:0090494)	5	0	.02	-	 < 0.2	1.00E00
catecholamine uptake (GO:0090493)	5	0	.02	-	 < 0.2	1.00E00
protein import into mitochondrial intermembrane space (GO:0045041)	2	0	.01	-	 < 0.2	1.00E00
protein import into mitochondrial outer membrane (GO:0045040)	5	0	.02	-	 < 0.2	1.00E00
immature T cell proliferation (GO:0033079)	1	0	.00	-	 < 0.2	1.00E00
extrathymic T cell differentiation (GO:0033078)	1	0	.00	-	 < 0.2	1.00E00
T cell differentiation in thymus (GO:0033077)	46	1	.19	+	5.19	1.00E00
isoquinoline alkaloid metabolic process (GO:0033076)	3	0	.01	-	 < 0.2	1.00E00
regulation of killing of cells of other organism (GO:0051709)	14	0	.06	-	 < 0.2	1.00E00
intracellular protein transport in other organism involved in symbiotic interaction (GO:0051708)	2	0	.01	-	 < 0.2	1.00E00
multi-organism behavior (GO:0051705)	64	0	.27	-	 < 0.2	1.00E00
intraspecies interaction between organisms (GO:0051703)	49	0	.21	-	 < 0.2	1.00E00
nucleoside transmembrane transport (GO:1901642)	7	0	.03	-	 < 0.2	1.00E00
dark adaptation (GO:1990603)	1	0	.00	-	 < 0.2	1.00E00
interaction with symbiont (GO:0051702)	68	2	.28	+	7.02	1.00E00
protein import into mitochondrial inner membrane (GO:0045039)	7	0	.03	-	 < 0.2	1.00E00
secondary metabolite catabolic process (GO:0090487)	3	0	.01	-	 < 0.2	1.00E00
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	7	0	.03	-	 < 0.2	1.00E00
purine nucleotide-sugar transmembrane transport (GO:0090480)	2	0	.01	-	 < 0.2	1.00E00
XDP catabolic process (GO:1901639)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of presynaptic membrane organization (GO:1901631)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of presynaptic membrane organization (GO:1901630)	1	0	.00	-	 < 0.2	1.00E00
plasma membrane fusion (GO:0045026)	33	0	.14	-	 < 0.2	1.00E00
G0 to G1 transition (GO:0045023)	2	0	.01	-	 < 0.2	1.00E00
early endosome to late endosome transport (GO:0045022)	22	0	.09	-	 < 0.2	1.00E00
dibasic protein processing (GO:0090472)	1	0	.00	-	 < 0.2	1.00E00
cellular pigmentation (GO:0033059)	49	1	.21	+	4.87	1.00E00
directional locomotion (GO:0033058)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.00	-	 < 0.2	1.00E00
RNA polymerase III transcriptional preinitiation complex assembly (GO:0070898)	2	0	.01	-	 < 0.2	1.00E00
DNA-templated transcriptional preinitiation complex assembly (GO:0070897)	23	0	.10	-	 < 0.2	1.00E00
regulation of presynaptic membrane organization (GO:1901629)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of postsynaptic membrane organization (GO:1901628)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of transposon integration (GO:0070895)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.00	-	 < 0.2	1.00E00
regulation of transposon integration (GO:0070894)	2	0	.01	-	 < 0.2	1.00E00
regulation of postsynaptic membrane organization (GO:1901626)	11	1	.05	+	21.70	1.00E00
cellular response to ergosterol (GO:1901625)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lymphocyte chemotaxis (GO:1901624)	3	0	.01	-	 < 0.2	1.00E00
regulation of lymphocyte chemotaxis (GO:1901623)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	6	0	.03	-	 < 0.2	1.00E00
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of nitric oxide biosynthetic process (GO:0045019)	14	1	.06	+	17.05	1.00E00
glycerolipid biosynthetic process (GO:0045017)	245	4	1.03	+	3.90	1.00E00
mitochondrial magnesium ion transport (GO:0045016)	1	0	.00	-	 < 0.2	1.00E00
arginine import (GO:0090467)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription by glucose (GO:0045014)	2	0	.01	-	 < 0.2	1.00E00
carbon catabolite repression of transcription (GO:0045013)	2	0	.01	-	 < 0.2	1.00E00
actin nucleation (GO:0045010)	34	0	.14	-	 < 0.2	1.00E00
negative regulation of mitotic sister chromatid segregation (GO:0033048)	27	2	.11	+	17.68	1.00E00
regulation of mitotic sister chromatid segregation (GO:0033047)	61	3	.26	+	11.74	1.00E00
platelet alpha granule organization (GO:0070889)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of sister chromatid segregation (GO:0033046)	29	2	.12	+	16.46	1.00E00
regulation of sister chromatid segregation (GO:0033045)	72	3	.30	+	9.94	1.00E00
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	9	2	.04	+	53.04	1.00E00
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	4	0	.02	-	 < 0.2	1.00E00
organic hydroxy compound biosynthetic process (GO:1901617)	159	2	.67	+	3.00	1.00E00
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	17	2	.07	+	28.08	1.00E00
organic hydroxy compound catabolic process (GO:1901616)	65	0	.27	-	 < 0.2	1.00E00
organic hydroxy compound metabolic process (GO:1901615)	421	4	1.76	+	2.27	1.00E00
depyrimidination (GO:0045008)	8	0	.03	-	 < 0.2	1.00E00
depurination (GO:0045007)	3	0	.01	-	 < 0.2	1.00E00
DNA deamination (GO:0045006)	10	0	.04	-	 < 0.2	1.00E00
DNA-dependent DNA replication maintenance of fidelity (GO:0045005)	32	2	.13	+	14.92	1.00E00
DNA replication proofreading (GO:0045004)	2	0	.01	-	 < 0.2	1.00E00
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	10	0	.04	-	 < 0.2	1.00E00
double-strand break repair via single-strand annealing (GO:0045002)	5	0	.02	-	 < 0.2	1.00E00
polysaccharide localization (GO:0033037)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of vesicle transport along microtubule (GO:1901609)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of myeloid cell apoptotic process (GO:0033034)	9	1	.04	+	26.52	1.00E00
regulation of vesicle transport along microtubule (GO:1901608)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of myeloid cell apoptotic process (GO:0033033)	14	1	.06	+	17.05	1.00E00
positive regulation of glycogen metabolic process (GO:0070875)	17	2	.07	+	28.08	1.00E00
alpha-amino acid biosynthetic process (GO:1901607)	64	0	.27	-	 < 0.2	1.00E00
regulation of myeloid cell apoptotic process (GO:0033032)	27	2	.11	+	17.68	1.00E00
negative regulation of glycogen metabolic process (GO:0070874)	8	1	.03	+	29.83	1.00E00
alpha-amino acid catabolic process (GO:1901606)	97	0	.41	-	 < 0.2	1.00E00
positive regulation of neutrophil apoptotic process (GO:0033031)	5	0	.02	-	 < 0.2	1.00E00
regulation of glycogen metabolic process (GO:0070873)	32	3	.13	+	22.37	1.00E00
alpha-amino acid metabolic process (GO:1901605)	212	1	.89	+	1.13	1.00E00
negative regulation of neutrophil apoptotic process (GO:0033030)	1	0	.00	-	 < 0.2	1.00E00
regulation of neutrophil apoptotic process (GO:0033029)	6	0	.03	-	 < 0.2	1.00E00
myeloid cell apoptotic process (GO:0033028)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of mast cell apoptotic process (GO:0033026)	2	0	.01	-	 < 0.2	1.00E00
regulation of mast cell apoptotic process (GO:0033025)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	9	0	.04	-	 < 0.2	1.00E00
regulation of protein exit from endoplasmic reticulum (GO:0070861)	21	0	.09	-	 < 0.2	1.00E00
protein localization to nuclear envelope (GO:0090435)	9	1	.04	+	26.52	1.00E00
positive regulation of bile acid biosynthetic process (GO:0070859)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of bile acid biosynthetic process (GO:0070858)	4	0	.02	-	 < 0.2	1.00E00
tetrapyrrole catabolic process (GO:0033015)	7	0	.03	-	 < 0.2	1.00E00
regulation of bile acid biosynthetic process (GO:0070857)	10	0	.04	-	 < 0.2	1.00E00
tetrapyrrole biosynthetic process (GO:0033014)	29	0	.12	-	 < 0.2	1.00E00
tetrapyrrole metabolic process (GO:0033013)	59	0	.25	-	 < 0.2	1.00E00
activation of meiosis (GO:0090427)	3	0	.01	-	 < 0.2	1.00E00
acinar cell differentiation (GO:0090425)	1	0	.00	-	 < 0.2	1.00E00
naphthalene-containing compound metabolic process (GO:0090420)	2	1	.01	+	 > 100	1.00E00
positive regulation of mast cell activation involved in immune response (GO:0033008)	14	1	.06	+	17.05	1.00E00
negative regulation of mast cell activation involved in immune response (GO:0033007)	7	0	.03	-	 < 0.2	1.00E00
regulation of mast cell activation involved in immune response (GO:0033006)	30	2	.13	+	15.91	1.00E00
positive regulation of mast cell activation (GO:0033005)	17	1	.07	+	14.04	1.00E00
negative regulation of mast cell activation (GO:0033004)	11	0	.05	-	 < 0.2	1.00E00
Hsp90 deacetylation (GO:0070846)	1	0	.00	-	 < 0.2	1.00E00
regulation of mast cell activation (GO:0033003)	38	2	.16	+	12.56	1.00E00
polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.00	-	 < 0.2	1.00E00
muscle cell proliferation (GO:0033002)	19	0	.08	-	 < 0.2	1.00E00
polyubiquitinated protein transport (GO:0070844)	1	0	.00	-	 < 0.2	1.00E00
misfolded protein transport (GO:0070843)	1	0	.00	-	 < 0.2	1.00E00
aggresome assembly (GO:0070842)	5	0	.02	-	 < 0.2	1.00E00
inclusion body assembly (GO:0070841)	6	0	.03	-	 < 0.2	1.00E00
doxorubicin metabolic process (GO:0044598)	8	1	.03	+	29.83	1.00E00
daunorubicin metabolic process (GO:0044597)	8	1	.03	+	29.83	1.00E00
malonate catabolic process (GO:0090410)	1	0	.00	-	 < 0.2	1.00E00
divalent metal ion export (GO:0070839)	2	0	.01	-	 < 0.2	1.00E00
divalent metal ion transport (GO:0070838)	290	1	1.22	-	.82	1.00E00
dehydroascorbic acid transport (GO:0070837)	4	0	.02	-	 < 0.2	1.00E00
caveola assembly (GO:0070836)	4	1	.02	+	59.66	1.00E00
basement membrane assembly (GO:0070831)	3	0	.01	-	 < 0.2	1.00E00
bicellular tight junction assembly (GO:0070830)	34	0	.14	-	 < 0.2	1.00E00
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	1	0	.00	-	 < 0.2	1.00E00
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of synapse maturation (GO:2000297)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of hydrogen peroxide catabolic process (GO:2000296)	2	0	.01	-	 < 0.2	1.00E00
regulation of hydrogen peroxide catabolic process (GO:2000295)	3	0	.01	-	 < 0.2	1.00E00
regulation of myoblast proliferation (GO:2000291)	14	0	.06	-	 < 0.2	1.00E00
regulation of myotome development (GO:2000290)	1	0	.00	-	 < 0.2	1.00E00
organophosphate biosynthetic process (GO:0090407)	509	9	2.13	+	4.22	1.00E00
negative regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052199)	3	0	.01	-	 < 0.2	1.00E00
oxidative stress-induced premature senescence (GO:0090403)	4	1	.02	+	59.66	1.00E00
oncogene-induced cell senescence (GO:0090402)	2	0	.01	-	 < 0.2	1.00E00
heterochromatin maintenance (GO:0070829)	1	0	.00	-	 < 0.2	1.00E00
heterochromatin organization (GO:0070828)	12	1	.05	+	19.89	1.00E00
movement in environment of other organism involved in symbiotic interaction (GO:0052192)	6	0	.03	-	 < 0.2	1.00E00
chromatin maintenance (GO:0070827)	3	0	.01	-	 < 0.2	1.00E00
positive regulation by symbiont of host phagocytosis (GO:0052191)	1	0	.00	-	 < 0.2	1.00E00
modulation by symbiont of host phagocytosis (GO:0052190)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of myoblast proliferation (GO:2000288)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of myotome development (GO:2000287)	1	0	.00	-	 < 0.2	1.00E00
receptor internalization involved in canonical Wnt signaling pathway (GO:2000286)	3	1	.01	+	79.55	1.00E00
positive regulation of cellular amino acid biosynthetic process (GO:2000284)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cellular amino acid biosynthetic process (GO:2000283)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular amino acid biosynthetic process (GO:2000282)	2	0	.01	-	 < 0.2	1.00E00
peripheral nervous system neuron axonogenesis (GO:0048936)	3	0	.01	-	 < 0.2	1.00E00
regulation of root development (GO:2000280)	1	0	.00	-	 < 0.2	1.00E00
peripheral nervous system neuron development (GO:0048935)	13	0	.05	-	 < 0.2	1.00E00
peripheral nervous system neuron differentiation (GO:0048934)	13	0	.05	-	 < 0.2	1.00E00
modification of cellular component in other organism involved in symbiotic interaction (GO:0052188)	1	0	.00	-	 < 0.2	1.00E00
modification of structure of other organism involved in symbiotic interaction (GO:0052185)	1	0	.00	-	 < 0.2	1.00E00
modification by host of symbiont morphology or physiology via secreted substance (GO:0052182)	1	0	.00	-	 < 0.2	1.00E00
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	6	0	.03	-	 < 0.2	1.00E00
[2Fe-2S] cluster assembly (GO:0044571)	4	0	.02	-	 < 0.2	1.00E00
hydrogen sulfide biosynthetic process (GO:0070814)	3	0	.01	-	 < 0.2	1.00E00
hydrogen sulfide metabolic process (GO:0070813)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of DNA biosynthetic process (GO:2000279)	38	2	.16	+	12.56	1.00E00
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	2	0	.01	-	 < 0.2	1.00E00
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of receptor activity (GO:2000273)	47	0	.20	-	 < 0.2	1.00E00
negative regulation of receptor activity (GO:2000272)	39	2	.16	+	12.24	1.00E00
positive regulation of fibroblast apoptotic process (GO:2000271)	7	1	.03	+	34.09	1.00E00
negative regulation of fibroblast apoptotic process (GO:2000270)	7	0	.03	-	 < 0.2	1.00E00
lateral line system development (GO:0048925)	2	0	.01	-	 < 0.2	1.00E00
dendritic cell proliferation (GO:0044565)	2	0	.01	-	 < 0.2	1.00E00
response to defenses of other organism involved in symbiotic interaction (GO:0052173)	7	0	.03	-	 < 0.2	1.00E00
negative regulation by symbiont of host innate immune response (GO:0052170)	1	0	.00	-	 < 0.2	1.00E00
protein transport out of membrane raft (GO:0032599)	1	0	.00	-	 < 0.2	1.00E00
B cell receptor transport into membrane raft (GO:0032597)	1	0	.00	-	 < 0.2	1.00E00
protein transport into membrane raft (GO:0032596)	6	0	.03	-	 < 0.2	1.00E00
B cell receptor transport within lipid bilayer (GO:0032595)	1	0	.00	-	 < 0.2	1.00E00
protein transport within lipid bilayer (GO:0032594)	23	0	.10	-	 < 0.2	1.00E00
regulation of fibroblast apoptotic process (GO:2000269)	15	1	.06	+	15.91	1.00E00
regulation of blood coagulation, intrinsic pathway (GO:2000266)	1	0	.00	-	 < 0.2	1.00E00
modulation by symbiont of host innate immune response (GO:0052167)	1	0	.00	-	 < 0.2	1.00E00
relaxation of smooth muscle (GO:0044557)	7	0	.03	-	 < 0.2	1.00E00
secondary metabolite biosynthetic process (GO:0044550)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of protein activation cascade (GO:2000259)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of protein activation cascade (GO:2000258)	11	0	.05	-	 < 0.2	1.00E00
ER-dependent peroxisome organization (GO:0032581)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein activation cascade (GO:2000257)	112	0	.47	-	 < 0.2	1.00E00
positive regulation of male germ cell proliferation (GO:2000256)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of male germ cell proliferation (GO:2000255)	3	0	.01	-	 < 0.2	1.00E00
regulation of male germ cell proliferation (GO:2000254)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of feeding behavior (GO:2000253)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of feeding behavior (GO:2000252)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of actin cytoskeleton reorganization (GO:2000251)	18	0	.08	-	 < 0.2	1.00E00
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	47	3	.20	+	15.23	1.00E00
NLRP3 inflammasome complex assembly (GO:0044546)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of flagellated sperm motility (GO:1902093)	11	0	.05	-	 < 0.2	1.00E00
positive regulation by symbiont of host apoptotic process (GO:0052151)	2	0	.01	-	 < 0.2	1.00E00
modulation by symbiont of host apoptotic process (GO:0052150)	5	0	.02	-	 < 0.2	1.00E00
regulation of actin cytoskeleton reorganization (GO:2000249)	34	0	.14	-	 < 0.2	1.00E00
response to vitamin K (GO:0032571)	5	0	.02	-	 < 0.2	1.00E00
response to progesterone (GO:0032570)	43	3	.18	+	16.65	1.00E00
positive regulation of reproductive process (GO:2000243)	54	2	.23	+	8.84	1.00E00
negative regulation of reproductive process (GO:2000242)	54	1	.23	+	4.42	1.00E00
regulation of reproductive process (GO:2000241)	136	3	.57	+	5.26	1.00E00
protein-chromophore linkage (GO:0018298)	15	0	.06	-	 < 0.2	1.00E00
long-chain fatty acid import (GO:0044539)	7	0	.03	-	 < 0.2	1.00E00
modulation by symbiont of host catalytic activity (GO:0052148)	1	0	.00	-	 < 0.2	1.00E00
protein-FAD linkage (GO:0018293)	2	0	.01	-	 < 0.2	1.00E00
regulation of circulating fibrinogen levels (GO:0044537)	1	0	.00	-	 < 0.2	1.00E00
signal release from synapse (GO:0099643)	102	0	.43	-	 < 0.2	1.00E00
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of calcium ion import into sarcoplasmic reticulum (GO:1902082)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of apoptotic process in other organism (GO:0044533)	3	0	.01	-	 < 0.2	1.00E00
anterograde axonal protein transport (GO:0099641)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081)	3	0	.01	-	 < 0.2	1.00E00
modulation of apoptotic process in other organism (GO:0044532)	6	0	.03	-	 < 0.2	1.00E00
axo-dendritic protein transport (GO:0099640)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080)	4	0	.02	-	 < 0.2	1.00E00
modulation of programmed cell death in other organism (GO:0044531)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of rRNA processing (GO:2000234)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of rRNA processing (GO:2000233)	2	0	.01	-	 < 0.2	1.00E00
regulation of rRNA processing (GO:2000232)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of pancreatic stellate cell proliferation (GO:2000231)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.00	-	 < 0.2	1.00E00
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	6	0	.03	-	 < 0.2	1.00E00
endosome to plasma membrane protein transport (GO:0099638)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of lateral motor column neuron migration (GO:1902078)	1	0	.00	-	 < 0.2	1.00E00
neurotransmitter receptor transport (GO:0099637)	14	0	.06	-	 < 0.2	1.00E00
regulation of mitochondrial mRNA stability (GO:0044528)	1	0	.00	-	 < 0.2	1.00E00
regulation of lateral motor column neuron migration (GO:1902076)	1	0	.00	-	 < 0.2	1.00E00
iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.01	-	 < 0.2	1.00E00
cellular response to salt (GO:1902075)	5	0	.02	-	 < 0.2	1.00E00
metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.01	-	 < 0.2	1.00E00
response to salt (GO:1902074)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073)	1	0	.00	-	 < 0.2	1.00E00
protein sulfhydration (GO:0044524)	1	0	.00	-	 < 0.2	1.00E00
protein transport within plasma membrane (GO:0099632)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902072)	1	0	.00	-	 < 0.2	1.00E00
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of sphingolipid mediated signaling pathway (GO:1902070)	1	0	.00	-	 < 0.2	1.00E00
regulation of pancreatic stellate cell proliferation (GO:2000229)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.00	-	 < 0.2	1.00E00
regulation of pancreatic A cell differentiation (GO:2000226)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of testosterone biosynthetic process (GO:2000225)	2	0	.01	-	 < 0.2	1.00E00
regulation of testosterone biosynthetic process (GO:2000224)	3	0	.01	-	 < 0.2	1.00E00
protein N-linked glycosylation via asparagine (GO:0018279)	45	0	.19	-	 < 0.2	1.00E00
protein deamination (GO:0018277)	2	0	.01	-	 < 0.2	1.00E00
neurotransmitter receptor diffusion trapping (GO:0099628)	1	0	.00	-	 < 0.2	1.00E00
regulation of sphingolipid mediated signaling pathway (GO:1902068)	1	0	.00	-	 < 0.2	1.00E00
movement in host environment (GO:0052126)	6	0	.03	-	 < 0.2	1.00E00
ventricular cardiac muscle cell membrane repolarization (GO:0099625)	8	0	.03	-	 < 0.2	1.00E00
response to L-glutamate (GO:1902065)	9	1	.04	+	26.52	1.00E00
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272)	1	0	.00	-	 < 0.2	1.00E00
atrial cardiac muscle cell membrane repolarization (GO:0099624)	5	0	.02	-	 < 0.2	1.00E00
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	23	0	.10	-	 < 0.2	1.00E00
cardiac muscle cell membrane repolarization (GO:0099622)	16	0	.07	-	 < 0.2	1.00E00
mitochondrial translation (GO:0032543)	108	0	.45	-	 < 0.2	1.00E00
positive regulation of glutamate metabolic process (GO:2000213)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glutamate metabolic process (GO:2000212)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutamate metabolic process (GO:2000211)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of anoikis (GO:2000210)	7	0	.03	-	 < 0.2	1.00E00
RNA polymerase III type 1 promoter transcriptional preinitiation complex assembly (GO:0000999)	1	0	.00	-	 < 0.2	1.00E00
isopeptide cross-linking (GO:0018262)	2	0	.01	-	 < 0.2	1.00E00
protein localization to axon (GO:0099612)	1	0	.00	-	 < 0.2	1.00E00
mismatch repair (GO:0006298)	32	1	.13	+	7.46	1.00E00
modification by symbiont of host structure (GO:0052111)	1	0	.00	-	 < 0.2	1.00E00
nucleotide-excision repair, DNA gap filling (GO:0006297)	23	1	.10	+	10.38	1.00E00
modulation of signal transduction in other organism (GO:0044501)	2	0	.01	-	 < 0.2	1.00E00
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	37	1	.16	+	6.45	1.00E00
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	22	0	.09	-	 < 0.2	1.00E00
nucleotide-excision repair, preincision complex assembly (GO:0006294)	29	0	.12	-	 < 0.2	1.00E00
nucleotide-excision repair, preincision complex stabilization (GO:0006293)	21	0	.09	-	 < 0.2	1.00E00
regulation of cell projection size (GO:0032536)	13	0	.05	-	 < 0.2	1.00E00
regulation of cellular component size (GO:0032535)	337	6	1.41	+	4.25	1.00E00
pyrimidine dimer repair (GO:0006290)	7	0	.03	-	 < 0.2	1.00E00
regulation of microvillus assembly (GO:0032534)	6	0	.03	-	 < 0.2	1.00E00
regulation of microvillus length (GO:0032532)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.00	-	 < 0.2	1.00E00
regulation of microvillus organization (GO:0032530)	13	0	.05	-	 < 0.2	1.00E00
regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.00	-	 < 0.2	1.00E00
regulation of ribosomal subunit export from nucleus (GO:2000200)	1	0	.00	-	 < 0.2	1.00E00
lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607)	1	0	.00	-	 < 0.2	1.00E00
microtubule plus-end directed mitotic chromosome migration (GO:0099606)	1	0	.00	-	 < 0.2	1.00E00
quorum sensing involved in interaction with host (GO:0052106)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Fas signaling pathway (GO:1902045)	1	0	.00	-	 < 0.2	1.00E00
regulation of Fas signaling pathway (GO:1902044)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	17	1	.07	+	14.04	1.00E00
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	36	3	.15	+	19.89	1.00E00
nucleotide-excision repair (GO:0006289)	114	4	.48	+	8.37	1.00E00
regulation of neurotransmitter receptor activity (GO:0099601)	42	0	.18	-	 < 0.2	1.00E00
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	57	3	.24	+	12.56	1.00E00
base-excision repair, DNA ligation (GO:0006288)	3	0	.01	-	 < 0.2	1.00E00
base-excision repair, gap-filling (GO:0006287)	5	0	.02	-	 < 0.2	1.00E00
base-excision repair, base-free sugar-phosphate removal (GO:0006286)	2	0	.01	-	 < 0.2	1.00E00
base-excision repair, AP site formation (GO:0006285)	10	0	.04	-	 < 0.2	1.00E00
base-excision repair (GO:0006284)	42	1	.18	+	5.68	1.00E00
microvillus organization (GO:0032528)	13	0	.05	-	 < 0.2	1.00E00
transcription-coupled nucleotide-excision repair (GO:0006283)	73	2	.31	+	6.54	1.00E00
protein exit from endoplasmic reticulum (GO:0032527)	19	0	.08	-	 < 0.2	1.00E00
regulation of DNA repair (GO:0006282)	93	4	.39	+	10.26	1.00E00
response to retinoic acid (GO:0032526)	107	2	.45	+	4.46	1.00E00
DNA repair (GO:0006281)	489	7	2.05	+	3.42	1.00E00
somite rostral/caudal axis specification (GO:0032525)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of hematopoietic stem cell differentiation (GO:1902038)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	2	0	.01	-	 < 0.2	1.00E00
regulation of hematopoietic stem cell differentiation (GO:1902036)	77	1	.32	+	3.10	1.00E00
protein O-linked glycosylation via threonine (GO:0018243)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of hematopoietic stem cell proliferation (GO:1902035)	5	0	.02	-	 < 0.2	1.00E00
protein O-linked glycosylation via serine (GO:0018242)	6	0	.03	-	 < 0.2	1.00E00
regulation of hematopoietic stem cell proliferation (GO:1902033)	7	0	.03	-	 < 0.2	1.00E00
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	3	0	.01	-	 < 0.2	1.00E00
regulation of NADP metabolic process (GO:1902031)	7	0	.03	-	 < 0.2	1.00E00
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	7	0	.03	-	 < 0.2	1.00E00
RNA-dependent DNA biosynthetic process (GO:0006278)	33	0	.14	-	 < 0.2	1.00E00
regulation of DNA replication (GO:0006275)	119	4	.50	+	8.02	1.00E00
DNA replication termination (GO:0006274)	1	0	.00	-	 < 0.2	1.00E00
lagging strand elongation (GO:0006273)	9	0	.04	-	 < 0.2	1.00E00
leading strand elongation (GO:0006272)	3	1	.01	+	79.55	1.00E00
positive regulation of phosphoprotein phosphatase activity (GO:0032516)	14	1	.06	+	17.05	1.00E00
DNA strand elongation involved in DNA replication (GO:0006271)	18	1	.08	+	13.26	1.00E00
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	17	0	.07	-	 < 0.2	1.00E00
DNA replication initiation (GO:0006270)	37	0	.16	-	 < 0.2	1.00E00
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	6	0	.03	-	 < 0.2	1.00E00
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	6	0	.03	-	 < 0.2	1.00E00
cellular response to L-ascorbic acid (GO:0071298)	1	0	.00	-	 < 0.2	1.00E00
cellular response to vitamin (GO:0071295)	23	1	.10	+	10.38	1.00E00
cellular response to zinc ion (GO:0071294)	19	0	.08	-	 < 0.2	1.00E00
rRNA 5'-end processing (GO:0000967)	3	0	.01	-	 < 0.2	1.00E00
RNA 5'-end processing (GO:0000966)	6	0	.03	-	 < 0.2	1.00E00
L-histidine transport (GO:1902024)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial RNA 3'-end processing (GO:0000965)	3	0	.01	-	 < 0.2	1.00E00
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	6	0	.03	-	 < 0.2	1.00E00
L-arginine transport (GO:1902023)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial RNA 5'-end processing (GO:0000964)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	6	0	.03	-	 < 0.2	1.00E00
L-lysine transport (GO:1902022)	4	0	.02	-	 < 0.2	1.00E00
mitochondrial RNA processing (GO:0000963)	6	0	.03	-	 < 0.2	1.00E00
DNA replication, synthesis of RNA primer (GO:0006269)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	2	0	.01	-	 < 0.2	1.00E00
DNA unwinding involved in DNA replication (GO:0006268)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	2	0	.01	-	 < 0.2	1.00E00
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	2	0	.01	-	 < 0.2	1.00E00
regulation of mitochondrial RNA catabolic process (GO:0000960)	4	0	.02	-	 < 0.2	1.00E00
DNA ligation (GO:0006266)	21	1	.09	+	11.36	1.00E00
DNA topological change (GO:0006265)	9	0	.04	-	 < 0.2	1.00E00
endosome transport via multivesicular body sorting pathway (GO:0032509)	15	0	.06	-	 < 0.2	1.00E00
mitochondrial DNA replication (GO:0006264)	7	0	.03	-	 < 0.2	1.00E00
DNA duplex unwinding (GO:0032508)	75	0	.31	-	 < 0.2	1.00E00
maintenance of protein location in cell (GO:0032507)	60	2	.25	+	7.96	1.00E00
cytokinetic process (GO:0032506)	18	0	.08	-	 < 0.2	1.00E00
DNA-dependent DNA replication (GO:0006261)	115	2	.48	+	4.15	1.00E00
DNA replication (GO:0006260)	214	4	.90	+	4.46	1.00E00
cellular response to mercury ion (GO:0071288)	3	0	.01	-	 < 0.2	1.00E00
cellular response to manganese ion (GO:0071287)	9	0	.04	-	 < 0.2	1.00E00
regulation of cilium-dependent cell motility (GO:1902019)	6	0	.03	-	 < 0.2	1.00E00
cellular response to magnesium ion (GO:0071286)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of cilium assembly (GO:1902018)	8	0	.03	-	 < 0.2	1.00E00
mitochondrial RNA metabolic process (GO:0000959)	34	0	.14	-	 < 0.2	1.00E00
cellular response to lithium ion (GO:0071285)	13	2	.05	+	36.72	1.00E00
regulation of cilium assembly (GO:1902017)	42	0	.18	-	 < 0.2	1.00E00
mitochondrial mRNA catabolic process (GO:0000958)	3	0	.01	-	 < 0.2	1.00E00
cellular response to lead ion (GO:0071284)	4	0	.02	-	 < 0.2	1.00E00
mitochondrial RNA catabolic process (GO:0000957)	3	0	.01	-	 < 0.2	1.00E00
cellular response to iron(III) ion (GO:0071283)	2	1	.01	+	 > 100	1.00E00
nuclear-transcribed mRNA catabolic process (GO:0000956)	199	1	.83	+	1.20	1.00E00
cellular response to iron ion (GO:0071281)	10	1	.04	+	23.87	1.00E00
cellular response to copper ion (GO:0071280)	13	0	.05	-	 < 0.2	1.00E00
DNA metabolic process (GO:0006259)	787	8	3.30	+	2.43	1.00E00
UDP-glucose catabolic process (GO:0006258)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	1	0	.00	-	 < 0.2	1.00E00
UDP catabolic process (GO:0006256)	1	0	.00	-	 < 0.2	1.00E00
dCTP catabolic process (GO:0006253)	1	0	.00	-	 < 0.2	1.00E00
cellular response to cobalt ion (GO:0071279)	4	0	.02	-	 < 0.2	1.00E00
peptidyl-aspartic acid phosphorylation (GO:0018217)	1	0	.00	-	 < 0.2	1.00E00
cellular response to calcium ion (GO:0071277)	59	1	.25	+	4.05	1.00E00
peptidyl-arginine methylation (GO:0018216)	16	0	.07	-	 < 0.2	1.00E00
cellular response to aluminum ion (GO:0071275)	1	0	.00	-	 < 0.2	1.00E00
protein carboxylation (GO:0018214)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of amyloid-beta formation (GO:1902004)	9	0	.04	-	 < 0.2	1.00E00
peptidyl-tryptophan modification (GO:0018211)	7	0	.03	-	 < 0.2	1.00E00
regulation of amyloid-beta formation (GO:1902003)	15	0	.06	-	 < 0.2	1.00E00
fatty acid transmembrane transport (GO:1902001)	12	0	.05	-	 < 0.2	1.00E00
protein delipidation (GO:0051697)	4	0	.02	-	 < 0.2	1.00E00
pyrimidine nucleotide catabolic process (GO:0006244)	14	0	.06	-	 < 0.2	1.00E00
actin filament uncapping (GO:0051695)	2	0	.01	-	 < 0.2	1.00E00
pointed-end actin filament capping (GO:0051694)	7	0	.03	-	 < 0.2	1.00E00
actin filament capping (GO:0051693)	32	0	.13	-	 < 0.2	1.00E00
CTP biosynthetic process (GO:0006241)	15	0	.06	-	 < 0.2	1.00E00
cellular oligosaccharide catabolic process (GO:0051692)	2	0	.01	-	 < 0.2	1.00E00
protein K69-linked ufmylation (GO:1990592)	5	0	.02	-	 < 0.2	1.00E00
cellular oligosaccharide metabolic process (GO:0051691)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-proline modification (GO:0018208)	59	0	.25	-	 < 0.2	1.00E00
homocysteine biosynthetic process (GO:0071268)	1	0	.00	-	 < 0.2	1.00E00
L-methionine salvage (GO:0071267)	7	0	.03	-	 < 0.2	1.00E00
peptidyl-methionine modification (GO:0018206)	12	0	.05	-	 < 0.2	1.00E00
'de novo' L-methionine biosynthetic process (GO:0071266)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-lysine modification (GO:0018205)	299	5	1.25	+	3.99	1.00E00
L-methionine biosynthetic process (GO:0071265)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of translational initiation in response to starvation (GO:0071264)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-histidine modification (GO:0018202)	10	1	.04	+	23.87	1.00E00
regulation of translational initiation in response to starvation (GO:0071262)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-glycine modification (GO:0018201)	3	0	.01	-	 < 0.2	1.00E00
peptidyl-glutamic acid modification (GO:0018200)	35	0	.15	-	 < 0.2	1.00E00
cellular response to mechanical stimulus (GO:0071260)	79	4	.33	+	12.08	1.00E00
CMP salvage (GO:0006238)	1	0	.00	-	 < 0.2	1.00E00
dTTP biosynthetic process (GO:0006235)	4	0	.02	-	 < 0.2	1.00E00
maintenance of ER location (GO:0051685)	2	0	.01	-	 < 0.2	1.00E00
dTDP biosynthetic process (GO:0006233)	2	0	.01	-	 < 0.2	1.00E00
maintenance of Golgi location (GO:0051684)	3	0	.01	-	 < 0.2	1.00E00
establishment of Golgi localization (GO:0051683)	8	0	.03	-	 < 0.2	1.00E00
dTMP biosynthetic process (GO:0006231)	3	0	.01	-	 < 0.2	1.00E00
cellular response to magnetism (GO:0071259)	2	0	.01	-	 < 0.2	1.00E00
cellular response to gravity (GO:0071258)	1	0	.00	-	 < 0.2	1.00E00
cellular response to electrical stimulus (GO:0071257)	13	0	.05	-	 < 0.2	1.00E00
cellular response to nitrite (GO:0071250)	1	0	.00	-	 < 0.2	1.00E00
UTP biosynthetic process (GO:0006228)	10	0	.04	-	 < 0.2	1.00E00
peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.00	-	 < 0.2	1.00E00
septin ring assembly (GO:0000921)	1	0	.00	-	 < 0.2	1.00E00
dUDP biosynthetic process (GO:0006227)	2	0	.01	-	 < 0.2	1.00E00
cell separation after cytokinesis (GO:0000920)	17	0	.07	-	 < 0.2	1.00E00
dUMP biosynthetic process (GO:0006226)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial L-ornithine transmembrane transport (GO:1990575)	1	0	.00	-	 < 0.2	1.00E00
UMP biosynthetic process (GO:0006222)	10	0	.04	-	 < 0.2	1.00E00
membrane disruption in other organism (GO:0051673)	5	0	.02	-	 < 0.2	1.00E00
potassium ion import across plasma membrane (GO:1990573)	9	0	.04	-	 < 0.2	1.00E00
pyrimidine nucleotide biosynthetic process (GO:0006221)	33	0	.14	-	 < 0.2	1.00E00
pyrimidine nucleotide metabolic process (GO:0006220)	47	0	.20	-	 < 0.2	1.00E00
GDP-mannose transmembrane transport (GO:1990570)	1	0	.00	-	 < 0.2	1.00E00
transport of viral material towards nucleus (GO:0075606)	1	0	.00	-	 < 0.2	1.00E00
cellular response to chromate (GO:0071247)	1	0	.00	-	 < 0.2	1.00E00
cellular response to carbon monoxide (GO:0071245)	1	0	.00	-	 < 0.2	1.00E00
division septum assembly (GO:0000917)	1	0	.00	-	 < 0.2	1.00E00
cellular response to arsenic-containing substance (GO:0071243)	15	0	.06	-	 < 0.2	1.00E00
actomyosin contractile ring contraction (GO:0000916)	1	0	.00	-	 < 0.2	1.00E00
cellular response to ammonium ion (GO:0071242)	61	2	.26	+	7.82	1.00E00
actomyosin contractile ring assembly (GO:0000915)	3	0	.01	-	 < 0.2	1.00E00
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	3	0	.01	-	 < 0.2	1.00E00
uridine catabolic process (GO:0006218)	1	0	.00	-	 < 0.2	1.00E00
UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	2	0	.01	-	 < 0.2	1.00E00
localization within membrane (GO:0051668)	97	1	.41	+	2.46	1.00E00
cytokinesis (GO:0000910)	85	2	.36	+	5.62	1.00E00
cytidine catabolic process (GO:0006216)	9	0	.04	-	 < 0.2	1.00E00
thymidine catabolic process (GO:0006214)	1	0	.00	-	 < 0.2	1.00E00
membrane raft localization (GO:0051665)	9	0	.04	-	 < 0.2	1.00E00
pyrimidine nucleoside metabolic process (GO:0006213)	49	0	.21	-	 < 0.2	1.00E00
nuclear pore localization (GO:0051664)	2	0	.01	-	 < 0.2	1.00E00
protein polyufmylation (GO:1990564)	5	0	.02	-	 < 0.2	1.00E00
uracil catabolic process (GO:0006212)	2	0	.01	-	 < 0.2	1.00E00
5-methylcytosine catabolic process (GO:0006211)	1	0	.00	-	 < 0.2	1.00E00
thymine catabolic process (GO:0006210)	3	0	.01	-	 < 0.2	1.00E00
maintenance of centrosome location (GO:0051661)	6	0	.03	-	 < 0.2	1.00E00
establishment of centrosome localization (GO:0051660)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of cellular response to alcohol (GO:1905959)	1	0	.00	-	 < 0.2	1.00E00
cellular response to antibiotic (GO:0071236)	16	2	.07	+	29.83	1.00E00
regulation of cellular response to alcohol (GO:1905957)	1	0	.00	-	 < 0.2	1.00E00
cellular response to leucine (GO:0071233)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of lipid localization (GO:1905954)	75	1	.31	+	3.18	1.00E00
negative regulation of lipid localization (GO:1905953)	40	1	.17	+	5.97	1.00E00
cellular response to folic acid (GO:0071231)	2	0	.01	-	 < 0.2	1.00E00
regulation of lipid localization (GO:1905952)	129	3	.54	+	5.55	1.00E00
cellular response to amino acid stimulus (GO:0071230)	61	3	.26	+	11.74	1.00E00
monosaccharide transmembrane transport (GO:1905950)	21	0	.09	-	 < 0.2	1.00E00
pyrimidine nucleobase catabolic process (GO:0006208)	3	0	.01	-	 < 0.2	1.00E00
maintenance of mitochondrion location (GO:0051659)	2	0	.01	-	 < 0.2	1.00E00
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	6	0	.03	-	 < 0.2	1.00E00
pyrimidine nucleobase metabolic process (GO:0006206)	18	1	.08	+	13.26	1.00E00
maintenance of organelle location (GO:0051657)	12	0	.05	-	 < 0.2	1.00E00
establishment of organelle localization (GO:0051656)	405	2	1.70	+	1.18	1.00E00
response to capsazepine (GO:1901594)	1	0	.00	-	 < 0.2	1.00E00
dGTP catabolic process (GO:0006203)	3	0	.01	-	 < 0.2	1.00E00
establishment of mitochondrion localization (GO:0051654)	20	0	.08	-	 < 0.2	1.00E00
spindle localization (GO:0051653)	41	0	.17	-	 < 0.2	1.00E00
maintenance of location in cell (GO:0051651)	81	2	.34	+	5.89	1.00E00
establishment of vesicle localization (GO:0051650)	233	0	.98	-	 < 0.2	1.00E00
cellular response to acid chemical (GO:0071229)	197	6	.83	+	7.27	1.00E00
cellular response to tumor cell (GO:0071228)	1	0	.00	-	 < 0.2	1.00E00
cellular response to molecule of fungal origin (GO:0071226)	2	1	.01	+	 > 100	1.00E00
cellular response to muramyl dipeptide (GO:0071225)	5	0	.02	-	 < 0.2	1.00E00
cellular response to peptidoglycan (GO:0071224)	5	0	.02	-	 < 0.2	1.00E00
cellular response to lipoteichoic acid (GO:0071223)	11	1	.05	+	21.70	1.00E00
cellular response to bacterial lipopeptide (GO:0071221)	6	0	.03	-	 < 0.2	1.00E00
cellular response to bacterial lipoprotein (GO:0071220)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of gonad development (GO:1905941)	11	1	.05	+	21.70	1.00E00
negative regulation of gonad development (GO:1905940)	5	0	.02	-	 < 0.2	1.00E00
establishment of localization in cell (GO:0051649)	1730	16	7.25	+	2.21	1.00E00
vesicle localization (GO:0051648)	245	0	1.03	-	 < 0.2	1.00E00
nucleus localization (GO:0051647)	23	0	.10	-	 < 0.2	1.00E00
mitochondrion localization (GO:0051646)	40	1	.17	+	5.97	1.00E00
regulation of acid-sensing ion channel activity (GO:1901585)	1	0	.00	-	 < 0.2	1.00E00
Golgi localization (GO:0051645)	13	0	.05	-	 < 0.2	1.00E00
endoplasmic reticulum localization (GO:0051643)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582)	1	0	.00	-	 < 0.2	1.00E00
centrosome localization (GO:0051642)	27	0	.11	-	 < 0.2	1.00E00
negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial transmembrane transport (GO:1990542)	33	0	.14	-	 < 0.2	1.00E00
regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)	1	0	.00	-	 < 0.2	1.00E00
organelle localization (GO:0051640)	594	4	2.49	+	1.61	1.00E00
cellular response to misfolded protein (GO:0071218)	23	0	.10	-	 < 0.2	1.00E00
regulation of gonad development (GO:1905939)	18	1	.08	+	13.26	1.00E00
cellular response to external biotic stimulus (GO:0071217)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of germ cell proliferation (GO:1905938)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of germ cell proliferation (GO:1905937)	3	0	.01	-	 < 0.2	1.00E00
regulation of germ cell proliferation (GO:1905936)	4	0	.02	-	 < 0.2	1.00E00
protein targeting to vacuole involved in autophagy (GO:0071211)	4	0	.02	-	 < 0.2	1.00E00
actin filament network formation (GO:0051639)	10	0	.04	-	 < 0.2	1.00E00
fructose import across plasma membrane (GO:1990539)	1	0	.00	-	 < 0.2	1.00E00
barbed-end actin filament uncapping (GO:0051638)	1	0	.00	-	 < 0.2	1.00E00
organic substance biosynthetic process (GO:1901576)	4758	35	19.94	+	1.76	1.00E00
organic substance catabolic process (GO:1901575)	1647	10	6.90	+	1.45	1.00E00
neuron projection maintenance (GO:1990535)	6	0	.03	-	 < 0.2	1.00E00
fatty acid derivative transport (GO:1901571)	32	0	.13	-	 < 0.2	1.00E00
fatty acid derivative biosynthetic process (GO:1901570)	86	2	.36	+	5.55	1.00E00
positive regulation of invadopodium disassembly (GO:1905929)	1	0	.00	-	 < 0.2	1.00E00
establishment of protein localization to juxtaparanode region of axon (GO:0071206)	1	0	.00	-	 < 0.2	1.00E00
regulation of invadopodium disassembly (GO:1905927)	1	0	.00	-	 < 0.2	1.00E00
protein localization to juxtaparanode region of axon (GO:0071205)	5	0	.02	-	 < 0.2	1.00E00
fatty acid derivative catabolic process (GO:1901569)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of CoA-transferase activity (GO:1905920)	1	0	.00	-	 < 0.2	1.00E00
fatty acid derivative metabolic process (GO:1901568)	156	2	.65	+	3.06	1.00E00
organonitrogen compound biosynthetic process (GO:1901566)	1434	9	6.01	+	1.50	1.00E00
organonitrogen compound catabolic process (GO:1901565)	984	8	4.12	+	1.94	1.00E00
response to camptothecin (GO:1901563)	5	0	.02	-	 < 0.2	1.00E00
bone regeneration (GO:1990523)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of norepinephrine uptake (GO:0051622)	1	0	.00	-	 < 0.2	1.00E00
response to benomyl (GO:1901561)	1	0	.00	-	 < 0.2	1.00E00
regulation of norepinephrine uptake (GO:0051621)	1	0	.00	-	 < 0.2	1.00E00
regulation of CoA-transferase activity (GO:1905918)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of calcium ion export from cell (GO:1905913)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcium ion export from cell (GO:1905912)	1	0	.00	-	 < 0.2	1.00E00
response to metformin (GO:1901558)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial pyrimidine nucleotide import (GO:1990519)	2	0	.01	-	 < 0.2	1.00E00
response to fenofibrate (GO:1901557)	1	0	.00	-	 < 0.2	1.00E00
response to paclitaxel (GO:1901555)	1	0	.00	-	 < 0.2	1.00E00
histamine uptake (GO:0051615)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of endothelial cell development (GO:1901552)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of serotonin uptake (GO:0051612)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of endothelial cell development (GO:1901551)	1	0	.00	-	 < 0.2	1.00E00
regulation of serotonin uptake (GO:0051611)	3	0	.01	-	 < 0.2	1.00E00
regulation of endothelial cell development (GO:1901550)	12	0	.05	-	 < 0.2	1.00E00
piRNA biosynthetic process (GO:1990511)	5	0	.02	-	 < 0.2	1.00E00
serotonin uptake (GO:0051610)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of excitatory postsynaptic potential (GO:0090394)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of amyloid fibril formation (GO:1905908)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of amyloid fibril formation (GO:1905907)	4	0	.02	-	 < 0.2	1.00E00
regulation of amyloid fibril formation (GO:1905906)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of mesoderm formation (GO:1905904)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mesoderm formation (GO:1905903)	4	0	.02	-	 < 0.2	1.00E00
regulation of mesoderm formation (GO:1905902)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of smooth muscle tissue development (GO:1905901)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of smooth muscle tissue development (GO:1905900)	1	0	.00	-	 < 0.2	1.00E00
histamine transport (GO:0051608)	8	0	.03	-	 < 0.2	1.00E00
defense response to virus (GO:0051607)	181	2	.76	+	2.64	1.00E00
detection of stimulus (GO:0051606)	677	2	2.84	-	.71	1.00E00
response to raffinose (GO:1901545)	1	0	.00	-	 < 0.2	1.00E00
mitotic DNA replication maintenance of fidelity (GO:1990505)	2	1	.01	+	 > 100	1.00E00
protein maturation (GO:0051604)	204	2	.85	+	2.34	1.00E00
dense core granule exocytosis (GO:1990504)	5	0	.02	-	 < 0.2	1.00E00
proteolysis involved in cellular protein catabolic process (GO:0051603)	556	6	2.33	+	2.58	1.00E00
response to electrical stimulus (GO:0051602)	44	2	.18	+	10.85	1.00E00
dense core granule maturation (GO:1990502)	2	0	.01	-	 < 0.2	1.00E00
exocyst localization (GO:0051601)	8	0	.03	-	 < 0.2	1.00E00
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.00	-	 < 0.2	1.00E00
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	1	0	.00	-	 < 0.2	1.00E00
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	1	0	.00	-	 < 0.2	1.00E00
phagosome-lysosome fusion (GO:0090385)	7	0	.03	-	 < 0.2	1.00E00
phagosome acidification (GO:0090383)	27	0	.11	-	 < 0.2	1.00E00
phagosome maturation (GO:0090382)	40	0	.17	-	 < 0.2	1.00E00
regulation of heart induction (GO:0090381)	4	0	.02	-	 < 0.2	1.00E00
changes to DNA methylation involved in embryo development (GO:1901538)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of DNA demethylation (GO:1901537)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA demethylation (GO:1901536)	3	0	.01	-	 < 0.2	1.00E00
regulation of DNA demethylation (GO:1901535)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	6	0	.03	-	 < 0.2	1.00E00
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	87	1	.36	+	2.74	1.00E00
negative regulation of cholesterol efflux (GO:0090370)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of anion channel activity (GO:1901529)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of mitophagy (GO:1901526)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of mitophagy (GO:1901525)	6	1	.03	+	39.78	1.00E00
regulation of mitophagy (GO:1901524)	15	1	.06	+	15.91	1.00E00
icosanoid catabolic process (GO:1901523)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	28	1	.12	+	8.52	1.00E00
negative regulation of mRNA modification (GO:0090367)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mRNA modification (GO:0090366)	1	0	.00	-	 < 0.2	1.00E00
regulation of mRNA modification (GO:0090365)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of platelet-derived growth factor production (GO:0090362)	2	0	.01	-	 < 0.2	1.00E00
regulation of platelet-derived growth factor production (GO:0090361)	3	0	.01	-	 < 0.2	1.00E00
phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	1	0	.00	-	 < 0.2	1.00E00
response to biotin (GO:0070781)	2	0	.01	-	 < 0.2	1.00E00
regulation of tryptophan metabolic process (GO:0090357)	1	0	.00	-	 < 0.2	1.00E00
efferent axon development in a lateral line nerve (GO:0048894)	1	0	.00	-	 < 0.2	1.00E00
lateral line nerve development (GO:0048892)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cellular organofluorine metabolic process (GO:0090350)	1	0	.00	-	 < 0.2	1.00E00
D-aspartate import (GO:0070779)	4	0	.02	-	 < 0.2	1.00E00
L-aspartate transport (GO:0070778)	6	0	.03	-	 < 0.2	1.00E00
D-aspartate transport (GO:0070777)	4	0	.02	-	 < 0.2	1.00E00
regulation of endothelial tube morphogenesis (GO:1901509)	4	0	.02	-	 < 0.2	1.00E00
ether biosynthetic process (GO:1901503)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of cellular organohalogen metabolic process (GO:0090349)	1	0	.00	-	 < 0.2	1.00E00
neuromast hair cell differentiation (GO:0048886)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular organofluorine metabolic process (GO:0090348)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular organohalogen metabolic process (GO:0090347)	1	0	.00	-	 < 0.2	1.00E00
neuromast development (GO:0048884)	1	0	.00	-	 < 0.2	1.00E00
cellular organofluorine metabolic process (GO:0090346)	1	0	.00	-	 < 0.2	1.00E00
cellular organohalogen metabolic process (GO:0090345)	1	0	.00	-	 < 0.2	1.00E00
lateral line development (GO:0048882)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell aging (GO:0090344)	18	1	.08	+	13.26	1.00E00
positive regulation of cell aging (GO:0090343)	11	1	.05	+	21.70	1.00E00
sensory system development (GO:0048880)	5	0	.02	-	 < 0.2	1.00E00
regulation of cell aging (GO:0090342)	38	2	.16	+	12.56	1.00E00
negative regulation of secretion of lysosomal enzymes (GO:0090341)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.00	-	 < 0.2	1.00E00
chemical homeostasis (GO:0048878)	972	11	4.07	+	2.70	1.00E00
homeostasis of number of retina cells (GO:0048877)	1	0	.00	-	 < 0.2	1.00E00
chemical homeostasis within a tissue (GO:0048875)	10	0	.04	-	 < 0.2	1.00E00
homeostasis of number of cells in a free-living population (GO:0048874)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of brown fat cell differentiation (GO:0090336)	7	1	.03	+	34.09	1.00E00
homeostasis of number of cells within a tissue (GO:0048873)	32	1	.13	+	7.46	1.00E00
regulation of brown fat cell differentiation (GO:0090335)	13	1	.05	+	18.36	1.00E00
multicellular organismal homeostasis (GO:0048871)	288	4	1.21	+	3.31	1.00E00
negative regulation of platelet aggregation (GO:0090331)	11	1	.05	+	21.70	1.00E00
stem cell fate determination (GO:0048867)	3	0	.01	-	 < 0.2	1.00E00
regulation of DNA-dependent DNA replication (GO:0090329)	47	1	.20	+	5.08	1.00E00
stem cell fate specification (GO:0048866)	4	0	.02	-	 < 0.2	1.00E00
stem cell fate commitment (GO:0048865)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	2	0	.01	-	 < 0.2	1.00E00
stem cell development (GO:0048864)	65	3	.27	+	11.02	1.00E00
positive regulation of locomotion involved in locomotory behavior (GO:0090326)	1	0	.00	-	 < 0.2	1.00E00
stem cell differentiation (GO:0048863)	137	3	.57	+	5.23	1.00E00
regulation of locomotion involved in locomotory behavior (GO:0090325)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of oxidative phosphorylation (GO:0090324)	6	0	.03	-	 < 0.2	1.00E00
leukemia inhibitory factor signaling pathway (GO:0048861)	4	0	.02	-	 < 0.2	1.00E00
regulation of superoxide metabolic process (GO:0090322)	29	3	.12	+	24.69	1.00E00
positive regulation of chylomicron remnant clearance (GO:0090321)	1	0	.00	-	 < 0.2	1.00E00
regulation of chylomicron remnant clearance (GO:0090320)	1	0	.00	-	 < 0.2	1.00E00
response to interleukin-6 (GO:0070741)	31	0	.13	-	 < 0.2	1.00E00
formation of anatomical boundary (GO:0048859)	5	0	.02	-	 < 0.2	1.00E00
cell projection morphogenesis (GO:0048858)	462	7	1.94	+	3.62	1.00E00
neural nucleus development (GO:0048857)	64	2	.27	+	7.46	1.00E00
adenohypophysis morphogenesis (GO:0048855)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of intracellular protein transport (GO:0090317)	88	0	.37	-	 < 0.2	1.00E00
brain morphogenesis (GO:0048854)	35	1	.15	+	6.82	1.00E00
forebrain morphogenesis (GO:0048853)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of protein targeting to membrane (GO:0090315)	6	0	.03	-	 < 0.2	1.00E00
diencephalon morphogenesis (GO:0048852)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of protein targeting to membrane (GO:0090314)	28	0	.12	-	 < 0.2	1.00E00
regulation of protein targeting to membrane (GO:0090313)	34	0	.14	-	 < 0.2	1.00E00
hypophysis morphogenesis (GO:0048850)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of protein deacetylation (GO:0090312)	23	1	.10	+	10.38	1.00E00
regulation of protein deacetylation (GO:0090311)	39	1	.16	+	6.12	1.00E00
negative regulation of methylation-dependent chromatin silencing (GO:0090310)	3	0	.01	-	 < 0.2	1.00E00
histone H3-K27 methylation (GO:0070734)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.00	-	 < 0.2	1.00E00
regulation of ribonucleoprotein complex localization (GO:2000197)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of female gonad development (GO:2000196)	3	1	.01	+	79.55	1.00E00
negative regulation of female gonad development (GO:2000195)	4	0	.02	-	 < 0.2	1.00E00
regulation of female gonad development (GO:2000194)	12	1	.05	+	19.89	1.00E00
positive regulation of fatty acid transport (GO:2000193)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of fatty acid transport (GO:2000192)	8	1	.03	+	29.83	1.00E00
positive regulation of methylation-dependent chromatin silencing (GO:0090309)	4	0	.02	-	 < 0.2	1.00E00
regulation of fatty acid transport (GO:2000191)	24	2	.10	+	19.89	1.00E00
axon extension involved in axon guidance (GO:0048846)	8	0	.03	-	 < 0.2	1.00E00
regulation of methylation-dependent chromatin silencing (GO:0090308)	10	0	.04	-	 < 0.2	1.00E00
venous blood vessel morphogenesis (GO:0048845)	10	0	.04	-	 < 0.2	1.00E00
mitotic spindle assembly (GO:0090307)	40	0	.17	-	 < 0.2	1.00E00
artery morphogenesis (GO:0048844)	58	3	.24	+	12.34	1.00E00
spindle assembly involved in meiosis (GO:0090306)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of axon extension involved in axon guidance (GO:0048843)	9	0	.04	-	 < 0.2	1.00E00
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	286	2	1.20	+	1.67	1.00E00
positive regulation of axon extension involved in axon guidance (GO:0048842)	7	0	.03	-	 < 0.2	1.00E00
nucleic acid metabolic process (GO:0090304)	3977	23	16.66	+	1.38	1.00E00
regulation of axon extension involved in axon guidance (GO:0048841)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of wound healing (GO:0090303)	50	2	.21	+	9.55	1.00E00
otolith development (GO:0048840)	5	0	.02	-	 < 0.2	1.00E00
interspecies quorum sensing (GO:0052097)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of neural crest formation (GO:0090301)	1	0	.00	-	 < 0.2	1.00E00
neurotransmitter receptor internalization (GO:0099590)	4	0	.02	-	 < 0.2	1.00E00
response to cholesterol (GO:0070723)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of cholesterol homeostasis (GO:2000189)	5	0	.02	-	 < 0.2	1.00E00
regulation of cholesterol homeostasis (GO:2000188)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of phosphate transmembrane transport (GO:2000187)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphate transmembrane transport (GO:2000185)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of progesterone biosynthetic process (GO:2000184)	1	0	.00	-	 < 0.2	1.00E00
inner ear development (GO:0048839)	185	2	.78	+	2.58	1.00E00
regulation of progesterone biosynthetic process (GO:2000182)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of blood vessel morphogenesis (GO:2000181)	83	1	.35	+	2.88	1.00E00
inorganic ion import across plasma membrane (GO:0099587)	31	0	.13	-	 < 0.2	1.00E00
sodium-dependent organic cation transport (GO:0070715)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neural precursor cell proliferation (GO:2000179)	48	0	.20	-	 < 0.2	1.00E00
negative regulation of neural precursor cell proliferation (GO:2000178)	20	0	.08	-	 < 0.2	1.00E00
regulation of neural precursor cell proliferation (GO:2000177)	81	1	.34	+	2.95	1.00E00
positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.00	-	 < 0.2	1.00E00
regulation of pro-T cell differentiation (GO:2000174)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of branching morphogenesis of a nerve (GO:2000173)	1	0	.00	-	 < 0.2	1.00E00
regulation of branching morphogenesis of a nerve (GO:2000172)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of dendrite development (GO:2000171)	29	1	.12	+	8.23	1.00E00
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	2	0	.01	-	 < 0.2	1.00E00
formation of extrachromosomal circular DNA (GO:0001325)	11	0	.05	-	 < 0.2	1.00E00
enucleate erythrocyte development (GO:0048822)	2	0	.01	-	 < 0.2	1.00E00
erythrocyte development (GO:0048821)	25	1	.10	+	9.55	1.00E00
hair follicle maturation (GO:0048820)	9	0	.04	-	 < 0.2	1.00E00
detection of peptidoglycan (GO:0032499)	2	0	.01	-	 < 0.2	1.00E00
detection of muramyl dipeptide (GO:0032498)	1	0	.00	-	 < 0.2	1.00E00
detection of lipopolysaccharide (GO:0032497)	4	0	.02	-	 < 0.2	1.00E00
response to muramyl dipeptide (GO:0032495)	16	2	.07	+	29.83	1.00E00
response to peptidoglycan (GO:0032494)	12	0	.05	-	 < 0.2	1.00E00
response to bacterial lipoprotein (GO:0032493)	7	0	.03	-	 < 0.2	1.00E00
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	7	0	.03	-	 < 0.2	1.00E00
regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167)	1	0	.00	-	 < 0.2	1.00E00
detection of molecule of bacterial origin (GO:0032490)	11	0	.05	-	 < 0.2	1.00E00
regulation of hair follicle maturation (GO:0048819)	8	1	.03	+	29.83	1.00E00
positive regulation of hair follicle maturation (GO:0048818)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of hair follicle maturation (GO:0048817)	2	1	.01	+	 > 100	1.00E00
age-dependent response to reactive oxygen species (GO:0001315)	1	0	.00	-	 < 0.2	1.00E00
regulation of dendrite morphogenesis (GO:0048814)	80	0	.34	-	 < 0.2	1.00E00
dendrite morphogenesis (GO:0048813)	56	0	.23	-	 < 0.2	1.00E00
neuron projection morphogenesis (GO:0048812)	454	7	1.90	+	3.68	1.00E00
motile cilium assembly (GO:0044458)	24	0	.10	-	 < 0.2	1.00E00
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	3	0	.01	-	 < 0.2	1.00E00
entry of symbiont into host cell by promotion of host phagocytosis (GO:0052066)	1	0	.00	-	 < 0.2	1.00E00
chemical synaptic transmission, postsynaptic (GO:0099565)	80	2	.34	+	5.97	1.00E00
modification of synaptic structure (GO:0099563)	4	0	.02	-	 < 0.2	1.00E00
synaptic membrane adhesion (GO:0099560)	3	0	.01	-	 < 0.2	1.00E00
regulation of Cdc42 protein signal transduction (GO:0032489)	7	0	.03	-	 < 0.2	1.00E00
Cdc42 protein signal transduction (GO:0032488)	4	0	.02	-	 < 0.2	1.00E00
regulation of Rap protein signal transduction (GO:0032487)	3	0	.01	-	 < 0.2	1.00E00
Rap protein signal transduction (GO:0032486)	10	0	.04	-	 < 0.2	1.00E00
regulation of Ral protein signal transduction (GO:0032485)	3	0	.01	-	 < 0.2	1.00E00
regulation of Rab protein signal transduction (GO:0032483)	4	0	.02	-	 < 0.2	1.00E00
Rab protein signal transduction (GO:0032482)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ubiquitin-specific protease activity (GO:2000158)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of type I interferon production (GO:0032481)	76	2	.32	+	6.28	1.00E00
negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of type I interferon production (GO:0032480)	48	0	.20	-	 < 0.2	1.00E00
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	2	0	.01	-	 < 0.2	1.00E00
male genitalia morphogenesis (GO:0048808)	4	1	.02	+	59.66	1.00E00
regulation of ubiquitin-specific protease activity (GO:2000152)	4	0	.02	-	 < 0.2	1.00E00
female genitalia morphogenesis (GO:0048807)	3	0	.01	-	 < 0.2	1.00E00
genitalia development (GO:0048806)	48	2	.20	+	9.94	1.00E00
age-dependent response to oxidative stress (GO:0001306)	1	0	.00	-	 < 0.2	1.00E00
replicative cell aging (GO:0001302)	5	0	.02	-	 < 0.2	1.00E00
maintenance of synapse structure (GO:0099558)	3	0	.01	-	 < 0.2	1.00E00
trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)	1	0	.00	-	 < 0.2	1.00E00
chronological cell aging (GO:0001300)	2	1	.01	+	 > 100	1.00E00
negative regulation by symbiont of host molecular function (GO:0052056)	2	0	.01	-	 < 0.2	1.00E00
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	1	0	.00	-	 < 0.2	1.00E00
modulation by symbiont of host molecular function (GO:0052055)	2	0	.01	-	 < 0.2	1.00E00
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	1	0	.00	-	 < 0.2	1.00E00
trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	2	0	.01	-	 < 0.2	1.00E00
negative regulation by symbiont of host catalytic activity (GO:0052053)	1	0	.00	-	 < 0.2	1.00E00
trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	2	0	.01	-	 < 0.2	1.00E00
trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)	1	0	.00	-	 < 0.2	1.00E00
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	5	0	.02	-	 < 0.2	1.00E00
regulation of type I interferon production (GO:0032479)	124	2	.52	+	3.85	1.00E00
otolith formation (GO:0032475)	1	0	.00	-	 < 0.2	1.00E00
otolith morphogenesis (GO:0032474)	3	0	.01	-	 < 0.2	1.00E00
Golgi calcium ion transport (GO:0032472)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cell motility (GO:2000146)	243	4	1.02	+	3.93	1.00E00
positive regulation of DNA-templated transcription, initiation (GO:2000144)	27	2	.11	+	17.68	1.00E00
negative regulation of DNA-templated transcription, initiation (GO:2000143)	6	0	.03	-	 < 0.2	1.00E00
regulation of DNA-templated transcription, initiation (GO:2000142)	36	2	.15	+	13.26	1.00E00
peptidyl-glutamine modification (GO:0018199)	4	0	.02	-	 < 0.2	1.00E00
peptidyl-cysteine modification (GO:0018198)	21	0	.09	-	 < 0.2	1.00E00
peptidyl-aspartic acid modification (GO:0018197)	3	0	.01	-	 < 0.2	1.00E00
peptidyl-asparagine modification (GO:0018196)	46	0	.19	-	 < 0.2	1.00E00
trans-synaptic signaling by nitric oxide (GO:0099548)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-arginine modification (GO:0018195)	26	0	.11	-	 < 0.2	1.00E00
peptidyl-alanine modification (GO:0018194)	1	0	.00	-	 < 0.2	1.00E00
interaction with other organism via secreted substance involved in symbiotic interaction (GO:0052047)	2	1	.01	+	 > 100	1.00E00
trans-synaptic signaling by trans-synaptic complex (GO:0099545)	2	0	.01	-	 < 0.2	1.00E00
enzyme active site formation via cysteine modification to L-cysteine persulfide (GO:0018192)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-serine octanoylation (GO:0018191)	1	0	.00	-	 < 0.2	1.00E00
trans-synaptic signaling by soluble gas (GO:0099543)	2	0	.01	-	 < 0.2	1.00E00
protein octanoylation (GO:0018190)	1	0	.00	-	 < 0.2	1.00E00
modification by symbiont of host cellular component (GO:0052043)	1	0	.00	-	 < 0.2	1.00E00
trans-synaptic signaling by endocannabinoid (GO:0099542)	3	0	.01	-	 < 0.2	1.00E00
positive regulation by symbiont of host programmed cell death (GO:0052042)	3	0	.01	-	 < 0.2	1.00E00
trans-synaptic signaling by lipid (GO:0099541)	3	0	.01	-	 < 0.2	1.00E00
negative regulation by symbiont of host programmed cell death (GO:0052041)	4	0	.02	-	 < 0.2	1.00E00
trans-synaptic signaling by neuropeptide (GO:0099540)	1	0	.00	-	 < 0.2	1.00E00
modulation by symbiont of host programmed cell death (GO:0052040)	6	0	.03	-	 < 0.2	1.00E00
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	23	1	.10	+	10.38	1.00E00
Golgi calcium ion homeostasis (GO:0032468)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cytokinesis (GO:0032467)	36	0	.15	-	 < 0.2	1.00E00
negative regulation of cytokinesis (GO:0032466)	7	0	.03	-	 < 0.2	1.00E00
regulation of cytokinesis (GO:0032465)	65	1	.27	+	3.67	1.00E00
positive regulation of protein homooligomerization (GO:0032464)	11	1	.05	+	21.70	1.00E00
negative regulation of protein homooligomerization (GO:0032463)	13	2	.05	+	36.72	1.00E00
regulation of protein homooligomerization (GO:0032462)	24	3	.10	+	29.83	1.00E00
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of protein oligomerization (GO:0032461)	25	2	.10	+	19.09	1.00E00
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein oligomerization (GO:0032460)	18	2	.08	+	26.52	1.00E00
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	17	0	.07	-	 < 0.2	1.00E00
synaptic signaling via neuropeptide (GO:0099538)	1	0	.00	-	 < 0.2	1.00E00
trans-synaptic signaling (GO:0099537)	413	3	1.73	+	1.73	1.00E00
negative regulation by symbiont of host defense response (GO:0052037)	1	0	.00	-	 < 0.2	1.00E00
synaptic signaling (GO:0099536)	413	3	1.73	+	1.73	1.00E00
synaptic vesicle endosomal processing (GO:0099532)	2	0	.01	-	 < 0.2	1.00E00
presynaptic process involved in chemical synaptic transmission (GO:0099531)	107	0	.45	-	 < 0.2	1.00E00
modulation by symbiont of host defense response (GO:0052031)	3	0	.01	-	 < 0.2	1.00E00
slow endocytic recycling (GO:0032458)	1	0	.00	-	 < 0.2	1.00E00
endocytic recycling (GO:0032456)	27	0	.11	-	 < 0.2	1.00E00
nerve growth factor processing (GO:0032455)	4	0	.02	-	 < 0.2	1.00E00
regulation of endocannabinoid signaling pathway (GO:2000124)	2	0	.01	-	 < 0.2	1.00E00
regulation of removal of superoxide radicals (GO:2000121)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of sodium-dependent phosphate transport (GO:2000120)	1	0	.00	-	 < 0.2	1.00E00
negative regulation by symbiont of host signal transduction pathway (GO:0052029)	1	0	.00	-	 < 0.2	1.00E00
protein nucleotidylation (GO:0018175)	1	0	.00	-	 < 0.2	1.00E00
modulation by symbiont of host signal transduction pathway (GO:0052027)	2	0	.01	-	 < 0.2	1.00E00
presynapse to nucleus signaling pathway (GO:0099526)	2	0	.01	-	 < 0.2	1.00E00
translocation of molecules into host (GO:0044417)	9	0	.04	-	 < 0.2	1.00E00
modulation by symbiont of host transcription (GO:0052026)	1	0	.00	-	 < 0.2	1.00E00
presynaptic dense core vesicle exocytosis (GO:0099525)	4	0	.02	-	 < 0.2	1.00E00
induction by symbiont of host defense response (GO:0044416)	2	0	.01	-	 < 0.2	1.00E00
modification by symbiont of host cell membrane (GO:0052025)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-cysteine oxidation (GO:0018171)	3	0	.01	-	 < 0.2	1.00E00
evasion or tolerance of host defenses (GO:0044415)	4	0	.02	-	 < 0.2	1.00E00
suppression of host defenses (GO:0044414)	1	0	.00	-	 < 0.2	1.00E00
avoidance of host defenses (GO:0044413)	4	0	.02	-	 < 0.2	1.00E00
protein urmylation (GO:0032447)	2	0	.01	-	 < 0.2	1.00E00
protein modification by small protein conjugation (GO:0032446)	796	8	3.34	+	2.40	1.00E00
fructose import (GO:0032445)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of sodium-dependent phosphate transport (GO:2000119)	1	0	.00	-	 < 0.2	1.00E00
regulation of sodium-dependent phosphate transport (GO:2000118)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	111	4	.47	+	8.60	1.00E00
regulation of establishment of cell polarity (GO:2000114)	21	1	.09	+	11.36	1.00E00
positive regulation of macrophage apoptotic process (GO:2000111)	3	1	.01	+	79.55	1.00E00
negative regulation of macrophage apoptotic process (GO:2000110)	5	0	.02	-	 < 0.2	1.00E00
dense core granule cytoskeletal transport (GO:0099519)	1	0	.00	-	 < 0.2	1.00E00
C-terminal protein-tyrosinylation (GO:0018166)	1	0	.00	-	 < 0.2	1.00E00
vesicle cytoskeletal trafficking (GO:0099518)	44	0	.18	-	 < 0.2	1.00E00
synaptic vesicle transport along microtubule (GO:0099517)	17	0	.07	-	 < 0.2	1.00E00
actin filament-based transport (GO:0099515)	9	0	.04	-	 < 0.2	1.00E00
adhesion of symbiont to host (GO:0044406)	10	0	.04	-	 < 0.2	1.00E00
synaptic vesicle cytoskeletal transport (GO:0099514)	17	0	.07	-	 < 0.2	1.00E00
peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	0	.00	-	 < 0.2	1.00E00
cAMP catabolic process (GO:0006198)	14	0	.06	-	 < 0.2	1.00E00
AMP catabolic process (GO:0006196)	2	0	.01	-	 < 0.2	1.00E00
purine nucleotide catabolic process (GO:0006195)	42	0	.18	-	 < 0.2	1.00E00
endosome localization (GO:0032439)	4	0	.02	-	 < 0.2	1.00E00
melanosome organization (GO:0032438)	25	0	.10	-	 < 0.2	1.00E00
ITP catabolic process (GO:0006193)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	28	0	.12	-	 < 0.2	1.00E00
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	117	5	.49	+	10.20	1.00E00
regulation of macrophage apoptotic process (GO:2000109)	9	1	.04	+	26.52	1.00E00
positive regulation of leukocyte apoptotic process (GO:2000108)	31	3	.13	+	23.10	1.00E00
activation of phospholipase A2 activity (GO:0032431)	4	1	.02	+	59.66	1.00E00
thermosensory behavior (GO:0040040)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of leukocyte apoptotic process (GO:2000107)	47	1	.20	+	5.08	1.00E00
positive regulation of phospholipase A2 activity (GO:0032430)	5	1	.02	+	47.73	1.00E00
regulation of leukocyte apoptotic process (GO:2000106)	84	4	.35	+	11.36	1.00E00
positive regulation of DNA-dependent DNA replication (GO:2000105)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of DNA-dependent DNA replication (GO:2000104)	19	1	.08	+	12.56	1.00E00
positive regulation of mammary stem cell proliferation (GO:2000103)	1	0	.00	-	 < 0.2	1.00E00
regulation of mammary stem cell proliferation (GO:2000101)	1	0	.00	-	 < 0.2	1.00E00
protein oxidation (GO:0018158)	7	0	.03	-	 < 0.2	1.00E00
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	1	0	.00	-	 < 0.2	1.00E00
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153)	2	0	.01	-	 < 0.2	1.00E00
synaptic vesicle cycle (GO:0099504)	100	0	.42	-	 < 0.2	1.00E00
'de novo' IMP biosynthetic process (GO:0006189)	6	0	.03	-	 < 0.2	1.00E00
IMP biosynthetic process (GO:0006188)	10	0	.04	-	 < 0.2	1.00E00
vesicle fusion to plasma membrane (GO:0099500)	12	0	.05	-	 < 0.2	1.00E00
dGDP phosphorylation (GO:0006186)	1	0	.00	-	 < 0.2	1.00E00
dGDP biosynthetic process (GO:0006185)	1	0	.00	-	 < 0.2	1.00E00
regulation of phospholipase A2 activity (GO:0032429)	9	1	.04	+	26.52	1.00E00
polar body extrusion after meiotic divisions (GO:0040038)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	12	0	.05	-	 < 0.2	1.00E00
GTP biosynthetic process (GO:0006183)	12	0	.05	-	 < 0.2	1.00E00
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	27	0	.11	-	 < 0.2	1.00E00
cGMP biosynthetic process (GO:0006182)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of mismatch repair (GO:0032425)	2	0	.01	-	 < 0.2	1.00E00
regulation of development, heterochronic (GO:0040034)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of translation, ncRNA-mediated (GO:0040033)	12	0	.05	-	 < 0.2	1.00E00
regulation of mismatch repair (GO:0032423)	3	0	.01	-	 < 0.2	1.00E00
post-embryonic body morphogenesis (GO:0040032)	1	0	.00	-	 < 0.2	1.00E00
snRNA modification (GO:0040031)	6	0	.03	-	 < 0.2	1.00E00
regulation of molecular function, epigenetic (GO:0040030)	2	0	.01	-	 < 0.2	1.00E00
peptide cross-linking (GO:0018149)	59	2	.25	+	8.09	1.00E00
keratan sulfate biosynthetic process (GO:0018146)	29	0	.12	-	 < 0.2	1.00E00
guanine salvage (GO:0006178)	1	0	.00	-	 < 0.2	1.00E00
GMP biosynthetic process (GO:0006177)	3	0	.01	-	 < 0.2	1.00E00
regulation of gene expression, epigenetic (GO:0040029)	216	5	.91	+	5.52	1.00E00
dATP biosynthetic process (GO:0006175)	1	0	.00	-	 < 0.2	1.00E00
dADP phosphorylation (GO:0006174)	1	0	.00	-	 < 0.2	1.00E00
lysosome localization (GO:0032418)	39	0	.16	-	 < 0.2	1.00E00
dADP biosynthetic process (GO:0006173)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of sodium:proton antiporter activity (GO:0032417)	4	0	.02	-	 < 0.2	1.00E00
ADP biosynthetic process (GO:0006172)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of sodium:proton antiporter activity (GO:0032416)	2	0	.01	-	 < 0.2	1.00E00
cAMP biosynthetic process (GO:0006171)	17	0	.07	-	 < 0.2	1.00E00
regulation of sodium:proton antiporter activity (GO:0032415)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of ion transmembrane transporter activity (GO:0032414)	80	0	.34	-	 < 0.2	1.00E00
negative regulation of ion transmembrane transporter activity (GO:0032413)	66	1	.28	+	3.62	1.00E00
regulation of ion transmembrane transporter activity (GO:0032412)	218	1	.91	+	1.09	1.00E00
positive regulation of transporter activity (GO:0032411)	88	1	.37	+	2.71	1.00E00
regulation of meiotic nuclear division (GO:0040020)	31	0	.13	-	 < 0.2	1.00E00
negative regulation of transporter activity (GO:0032410)	74	1	.31	+	3.23	1.00E00
heterocycle biosynthetic process (GO:0018130)	3015	22	12.63	+	1.74	1.00E00
adenosine salvage (GO:0006169)	1	0	.00	-	 < 0.2	1.00E00
adenine salvage (GO:0006168)	2	0	.01	-	 < 0.2	1.00E00
AMP biosynthetic process (GO:0006167)	7	0	.03	-	 < 0.2	1.00E00
purine ribonucleoside salvage (GO:0006166)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of embryonic development (GO:0040019)	34	1	.14	+	7.02	1.00E00
nucleoside diphosphate phosphorylation (GO:0006165)	56	1	.23	+	4.26	1.00E00
regulation of transporter activity (GO:0032409)	237	3	.99	+	3.02	1.00E00
positive regulation of multicellular organism growth (GO:0040018)	35	1	.15	+	6.82	1.00E00
purine nucleotide biosynthetic process (GO:0006164)	128	2	.54	+	3.73	1.00E00
purine nucleotide metabolic process (GO:0006163)	384	3	1.61	+	1.86	1.00E00
embryonic cleavage (GO:0040016)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of multicellular organism growth (GO:0040015)	13	0	.05	-	 < 0.2	1.00E00
regulation of multicellular organism growth (GO:0040014)	72	2	.30	+	6.63	1.00E00
negative regulation of locomotion (GO:0040013)	274	4	1.15	+	3.48	1.00E00
melanosome transport (GO:0032402)	21	0	.09	-	 < 0.2	1.00E00
establishment of melanosome localization (GO:0032401)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of growth rate (GO:0040010)	2	0	.01	-	 < 0.2	1.00E00
melanosome localization (GO:0032400)	24	0	.10	-	 < 0.2	1.00E00
protein hydroxylation (GO:0018126)	23	0	.10	-	 < 0.2	1.00E00
peptidyl-cysteine methylation (GO:0018125)	3	0	.01	-	 < 0.2	1.00E00
deoxyadenosine catabolic process (GO:0006157)	1	0	.00	-	 < 0.2	1.00E00
regulation of growth rate (GO:0040009)	4	0	.02	-	 < 0.2	1.00E00
adenosine catabolic process (GO:0006154)	3	0	.01	-	 < 0.2	1.00E00
purine nucleoside catabolic process (GO:0006152)	8	0	.03	-	 < 0.2	1.00E00
establishment of mitotic spindle localization (GO:0040001)	26	0	.11	-	 < 0.2	1.00E00
histone H2A-S1 phosphorylation (GO:0043990)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-cysteine S-nitrosylation (GO:0018119)	6	0	.03	-	 < 0.2	1.00E00
regulation of smooth muscle tissue development (GO:1905899)	1	0	.00	-	 < 0.2	1.00E00
protein adenylylation (GO:0018117)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	36	3	.15	+	19.89	1.00E00
regulation of response to endoplasmic reticulum stress (GO:1905897)	75	4	.31	+	12.73	1.00E00
mitotic spindle checkpoint (GO:0071174)	20	2	.08	+	23.87	1.00E00
negative regulation of cellular response to tunicamycin (GO:1905895)	1	0	.00	-	 < 0.2	1.00E00
spindle assembly checkpoint (GO:0071173)	20	2	.08	+	23.87	1.00E00
regulation of cellular response to tunicamycin (GO:1905894)	1	0	.00	-	 < 0.2	1.00E00
site-specific DNA replication termination at RTS1 barrier (GO:0071171)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cellular response to thapsigargin (GO:1905892)	1	0	.00	-	 < 0.2	1.00E00
site-specific DNA replication termination (GO:0071170)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular response to thapsigargin (GO:1905891)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.00	-	 < 0.2	1.00E00
inosine catabolic process (GO:0006148)	1	0	.00	-	 < 0.2	1.00E00
response to hydrostatic pressure (GO:0051599)	6	0	.03	-	 < 0.2	1.00E00
guanine catabolic process (GO:0006147)	1	0	.00	-	 < 0.2	1.00E00
meiotic recombination checkpoint (GO:0051598)	2	0	.01	-	 < 0.2	1.00E00
histone H3-S28 phosphorylation (GO:0043988)	3	0	.01	-	 < 0.2	1.00E00
response to methylmercury (GO:0051597)	8	0	.03	-	 < 0.2	1.00E00
purine nucleobase catabolic process (GO:0006145)	4	0	.02	-	 < 0.2	1.00E00
histone H3-S10 phosphorylation (GO:0043987)	6	1	.03	+	39.78	1.00E00
methylglyoxal catabolic process (GO:0051596)	3	0	.01	-	 < 0.2	1.00E00
purine nucleobase metabolic process (GO:0006144)	21	0	.09	-	 < 0.2	1.00E00
response to methylglyoxal (GO:0051595)	2	1	.01	+	 > 100	1.00E00
histone H4-R3 methylation (GO:0043985)	6	0	.03	-	 < 0.2	1.00E00
detection of glucose (GO:0051594)	3	0	.01	-	 < 0.2	1.00E00
histone H4-K16 acetylation (GO:0043984)	13	0	.05	-	 < 0.2	1.00E00
response to folic acid (GO:0051593)	11	1	.05	+	21.70	1.00E00
histone H4-K12 acetylation (GO:0043983)	7	1	.03	+	34.09	1.00E00
response to calcium ion (GO:0051592)	122	3	.51	+	5.87	1.00E00
regulation of nucleotide metabolic process (GO:0006140)	266	4	1.11	+	3.59	1.00E00
histone H4-K8 acetylation (GO:0043982)	15	0	.06	-	 < 0.2	1.00E00
response to cAMP (GO:0051591)	98	2	.41	+	4.87	1.00E00
histone H4-K5 acetylation (GO:0043981)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of neurotransmitter transport (GO:0051590)	17	0	.07	-	 < 0.2	1.00E00
modulation by virus of host immune response (GO:0075528)	3	0	.01	-	 < 0.2	1.00E00
viral translational termination-reinitiation (GO:0075525)	5	0	.02	-	 < 0.2	1.00E00
IRES-dependent viral translational initiation (GO:0075522)	10	0	.04	-	 < 0.2	1.00E00
microtubule-dependent intracellular transport of viral material towards nucleus (GO:0075521)	1	0	.00	-	 < 0.2	1.00E00
establishment of protein localization to chromatin (GO:0071169)	7	0	.03	-	 < 0.2	1.00E00
protein localization to chromatin (GO:0071168)	17	1	.07	+	14.04	1.00E00
ribonucleoprotein complex import into nucleus (GO:0071167)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-histidine phosphorylation (GO:0018106)	1	0	.00	-	 < 0.2	1.00E00
ribonucleoprotein complex localization (GO:0071166)	128	1	.54	+	1.86	1.00E00
protein C-linked glycosylation (GO:0018103)	7	0	.03	-	 < 0.2	1.00E00
DNA replication preinitiation complex assembly (GO:0071163)	3	0	.01	-	 < 0.2	1.00E00
protein citrullination (GO:0018101)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of oogenesis (GO:1905881)	4	0	.02	-	 < 0.2	1.00E00
nucleobase-containing compound metabolic process (GO:0006139)	4538	28	19.01	+	1.47	1.00E00
negative regulation of oogenesis (GO:1905880)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of neurotransmitter transport (GO:0051589)	15	0	.06	-	 < 0.2	1.00E00
regulation of neurotransmitter transport (GO:0051588)	67	0	.28	-	 < 0.2	1.00E00
positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	0	.00	-	 < 0.2	1.00E00
regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	8	0	.03	-	 < 0.2	1.00E00
dopamine uptake involved in synaptic transmission (GO:0051583)	5	0	.02	-	 < 0.2	1.00E00
histone H3-K4 acetylation (GO:0043973)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neurotransmitter uptake (GO:0051582)	4	0	.02	-	 < 0.2	1.00E00
histone H3-K23 acetylation (GO:0043972)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of neurotransmitter uptake (GO:0051581)	3	0	.01	-	 < 0.2	1.00E00
mRNA pseudouridine synthesis (GO:1990481)	4	0	.02	-	 < 0.2	1.00E00
regulation of neurotransmitter uptake (GO:0051580)	14	0	.06	-	 < 0.2	1.00E00
histone H3-K9 acetylation (GO:0043970)	2	0	.01	-	 < 0.2	1.00E00
microtubule-dependent intracellular transport of viral material (GO:0075519)	1	0	.00	-	 < 0.2	1.00E00
regulation of oogenesis (GO:1905879)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of cell cycle arrest (GO:0071157)	24	1	.10	+	9.94	1.00E00
negative regulation of postsynaptic density organization (GO:1905875)	1	0	.00	-	 < 0.2	1.00E00
regulation of postsynaptic density organization (GO:1905874)	4	1	.02	+	59.66	1.00E00
negative regulation of protein localization to cell leading edge (GO:1905872)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to cell leading edge (GO:1905871)	1	0	.00	-	 < 0.2	1.00E00
regulation of arginine metabolic process (GO:0000821)	2	0	.01	-	 < 0.2	1.00E00
glycerophosphate shuttle (GO:0006127)	2	0	.01	-	 < 0.2	1.00E00
histone H2B acetylation (GO:0043969)	1	0	.00	-	 < 0.2	1.00E00
response to ultrasound (GO:1990478)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutamine family amino acid metabolic process (GO:0000820)	5	0	.02	-	 < 0.2	1.00E00
histone H2A acetylation (GO:0043968)	16	0	.07	-	 < 0.2	1.00E00
histone H4 acetylation (GO:0043967)	52	2	.22	+	9.18	1.00E00
histone H3 acetylation (GO:0043966)	45	2	.19	+	10.61	1.00E00
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of histone H3-K9 methylation (GO:0051574)	9	0	.04	-	 < 0.2	1.00E00
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of histone H3-K9 methylation (GO:0051573)	11	0	.05	-	 < 0.2	1.00E00
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of histone H3-K4 methylation (GO:0051572)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	49	0	.21	-	 < 0.2	1.00E00
positive regulation of histone H3-K4 methylation (GO:0051571)	16	0	.07	-	 < 0.2	1.00E00
regulation of histone H3-K9 methylation (GO:0051570)	22	0	.09	-	 < 0.2	1.00E00
negative regulation of fatty acid beta-oxidation (GO:0031999)	5	1	.02	+	47.73	1.00E00
endocytosis involved in viral entry into host cell (GO:0075509)	3	1	.01	+	79.55	1.00E00
regulation of fatty acid beta-oxidation (GO:0031998)	16	2	.07	+	29.83	1.00E00
mRNA export from nucleus in response to heat stress (GO:0031990)	2	0	.01	-	 < 0.2	1.00E00
epididymis development (GO:1905867)	4	0	.02	-	 < 0.2	1.00E00
sister chromatid segregation (GO:0000819)	188	2	.79	+	2.54	1.00E00
invadopodium organization (GO:1905863)	1	0	.00	-	 < 0.2	1.00E00
resolution of mitotic recombination intermediates (GO:0071140)	2	0	.01	-	 < 0.2	1.00E00
oxidative phosphorylation (GO:0006119)	101	1	.42	+	2.36	1.00E00
positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.00	-	 < 0.2	1.00E00
regulation of histone H3-K4 methylation (GO:0051569)	26	0	.11	-	 < 0.2	1.00E00
acetaldehyde metabolic process (GO:0006117)	1	0	.00	-	 < 0.2	1.00E00
histone H3-K4 methylation (GO:0051568)	32	0	.13	-	 < 0.2	1.00E00
NADH oxidation (GO:0006116)	4	0	.02	-	 < 0.2	1.00E00
histone H3-K9 methylation (GO:0051567)	10	0	.04	-	 < 0.2	1.00E00
glycerol biosynthetic process (GO:0006114)	4	0	.02	-	 < 0.2	1.00E00
energy reserve metabolic process (GO:0006112)	71	2	.30	+	6.72	1.00E00
cellular component maintenance (GO:0043954)	30	0	.13	-	 < 0.2	1.00E00
smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563)	2	0	.01	-	 < 0.2	1.00E00
regulation of gluconeogenesis (GO:0006111)	39	1	.16	+	6.12	1.00E00
negative regulation of mitochondrial calcium ion concentration (GO:0051562)	3	0	.01	-	 < 0.2	1.00E00
regulation of glycolytic process (GO:0006110)	67	0	.28	-	 < 0.2	1.00E00
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of cAMP-mediated signaling (GO:0043951)	8	0	.03	-	 < 0.2	1.00E00
mitochondrial calcium ion homeostasis (GO:0051560)	23	0	.10	-	 < 0.2	1.00E00
positive regulation of cAMP-mediated signaling (GO:0043950)	12	0	.05	-	 < 0.2	1.00E00
bombesin receptor signaling pathway (GO:0031989)	2	0	.01	-	 < 0.2	1.00E00
locomotion involved in locomotory behavior (GO:0031987)	6	0	.03	-	 < 0.2	1.00E00
resolution of recombination intermediates (GO:0071139)	2	0	.01	-	 < 0.2	1.00E00
regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of heparan sulfate binding (GO:1905855)	1	0	.00	-	 < 0.2	1.00E00
regulation of heparan sulfate binding (GO:1905853)	1	0	.00	-	 < 0.2	1.00E00
regulation of carbohydrate metabolic process (GO:0006109)	187	5	.78	+	6.38	1.00E00
malate metabolic process (GO:0006108)	8	0	.03	-	 < 0.2	1.00E00
oxaloacetate metabolic process (GO:0006107)	12	1	.05	+	19.89	1.00E00
regulation of cAMP-mediated signaling (GO:0043949)	25	0	.10	-	 < 0.2	1.00E00
fumarate metabolic process (GO:0006106)	3	0	.01	-	 < 0.2	1.00E00
succinate metabolic process (GO:0006105)	11	1	.05	+	21.70	1.00E00
positive regulation by host of symbiont catalytic activity (GO:0043947)	1	0	.00	-	 < 0.2	1.00E00
succinyl-CoA metabolic process (GO:0006104)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0043946)	1	0	.00	-	 < 0.2	1.00E00
2-oxoglutarate metabolic process (GO:0006103)	18	1	.08	+	13.26	1.00E00
isocitrate metabolic process (GO:0006102)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of lymphangiogenesis (GO:1901492)	2	0	.01	-	 < 0.2	1.00E00
citrate metabolic process (GO:0006101)	35	1	.15	+	6.82	1.00E00
flavone metabolic process (GO:0051552)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of lymphangiogenesis (GO:1901491)	3	0	.01	-	 < 0.2	1.00E00
regulation of lymphangiogenesis (GO:1901490)	5	0	.02	-	 < 0.2	1.00E00
cellular stress response to acidic pH (GO:1990451)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular response to gamma radiation (GO:1905843)	1	1	.00	+	 > 100	1.00E00
positive regulation of keratinocyte migration (GO:0051549)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of keratinocyte migration (GO:0051548)	2	1	.01	+	 > 100	1.00E00
regulation of keratinocyte migration (GO:0051547)	10	1	.04	+	23.87	1.00E00
keratinocyte migration (GO:0051546)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of elastin biosynthetic process (GO:0051545)	1	0	.00	-	 < 0.2	1.00E00
regulation of elastin biosynthetic process (GO:0051543)	1	0	.00	-	 < 0.2	1.00E00
macromolecular complex subunit organization (GO:0043933)	1760	15	7.37	+	2.03	1.00E00
elastin biosynthetic process (GO:0051542)	1	0	.00	-	 < 0.2	1.00E00
intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442)	1	0	.00	-	 < 0.2	1.00E00
ossification involved in bone remodeling (GO:0043932)	4	0	.02	-	 < 0.2	1.00E00
elastin metabolic process (GO:0051541)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441)	5	1	.02	+	47.73	1.00E00
ossification involved in bone maturation (GO:0043931)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	12	2	.05	+	39.78	1.00E00
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.01	-	 < 0.2	1.00E00
regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of spindle assembly (GO:1905832)	4	0	.02	-	 < 0.2	1.00E00
histone biotinylation (GO:0071110)	1	0	.00	-	 < 0.2	1.00E00
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928)	33	0	.14	-	 < 0.2	1.00E00
pyruvate transmembrane transport (GO:1901475)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of NFAT protein import into nucleus (GO:0051534)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of NFAT protein import into nucleus (GO:0051533)	6	0	.03	-	 < 0.2	1.00E00
positive regulation by host of viral transcription (GO:0043923)	16	1	.07	+	14.92	1.00E00
regulation of NFAT protein import into nucleus (GO:0051532)	11	0	.05	-	 < 0.2	1.00E00
negative regulation by host of viral transcription (GO:0043922)	12	1	.05	+	19.89	1.00E00
NFAT protein import into nucleus (GO:0051531)	1	1	.00	+	 > 100	1.00E00
modulation by host of viral transcription (GO:0043921)	26	1	.11	+	9.18	1.00E00
mineralocorticoid receptor signaling pathway (GO:0031959)	2	0	.01	-	 < 0.2	1.00E00
corticosteroid receptor signaling pathway (GO:0031958)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of protein autophosphorylation (GO:0031954)	24	2	.10	+	19.89	1.00E00
superior temporal gyrus development (GO:0071109)	2	0	.01	-	 < 0.2	1.00E00
protein K48-linked deubiquitination (GO:0071108)	26	0	.11	-	 < 0.2	1.00E00
response to parathyroid hormone (GO:0071107)	13	1	.05	+	18.36	1.00E00
adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)	2	0	.01	-	 < 0.2	1.00E00
response to interleukin-11 (GO:0071105)	2	0	.01	-	 < 0.2	1.00E00
response to interleukin-9 (GO:0071104)	3	0	.01	-	 < 0.2	1.00E00
DNA conformation change (GO:0071103)	260	4	1.09	+	3.67	1.00E00
positive regulation of chromosome separation (GO:1905820)	8	0	.03	-	 < 0.2	1.00E00
miRNA transport (GO:1990428)	1	0	.00	-	 < 0.2	1.00E00
mitotic recombination-dependent replication fork processing (GO:1990426)	2	1	.01	+	 > 100	1.00E00
positive regulation of glucocorticoid biosynthetic process (GO:0031948)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glucocorticoid biosynthetic process (GO:0031947)	5	0	.02	-	 < 0.2	1.00E00
regulation of glucocorticoid biosynthetic process (GO:0031946)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of glucocorticoid metabolic process (GO:0031945)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glucocorticoid metabolic process (GO:0031944)	5	0	.02	-	 < 0.2	1.00E00
regulation of glucocorticoid metabolic process (GO:0031943)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of chromatin silencing at telomere (GO:0031940)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of chromosome separation (GO:1905819)	25	2	.10	+	19.09	1.00E00
regulation of chromosome separation (GO:1905818)	55	3	.23	+	13.02	1.00E00
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	8	2	.03	+	59.66	1.00E00
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	2	0	.01	-	 < 0.2	1.00E00
regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903)	223	4	.93	+	4.28	1.00E00
positive regulation of multi-organism process (GO:0043902)	176	3	.74	+	4.07	1.00E00
negative regulation of multi-organism process (GO:0043901)	171	2	.72	+	2.79	1.00E00
regulation of multi-organism process (GO:0043900)	390	6	1.63	+	3.67	1.00E00
regulation of chromatin silencing at telomere (GO:0031938)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of chromatin silencing (GO:0031937)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of chromatin silencing (GO:0031936)	9	0	.04	-	 < 0.2	1.00E00
regulation of chromatin silencing (GO:0031935)	22	0	.09	-	 < 0.2	1.00E00
regulation of neural crest formation (GO:0090299)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mitochondrial DNA replication (GO:0090298)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of mitochondrial DNA replication (GO:0090297)	1	0	.00	-	 < 0.2	1.00E00
mitochondria-nucleus signaling pathway (GO:0031930)	1	0	.00	-	 < 0.2	1.00E00
regulation of mitochondrial DNA replication (GO:0090296)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of synapse organization (GO:1905809)	13	0	.05	-	 < 0.2	1.00E00
nitrogen catabolite activation of transcription (GO:0090294)	1	0	.00	-	 < 0.2	1.00E00
nitrogen catabolite regulation of transcription (GO:0090293)	1	0	.00	-	 < 0.2	1.00E00
nuclear matrix anchoring at nuclear membrane (GO:0090292)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of osteoclast proliferation (GO:0090291)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of osteoclast proliferation (GO:0090290)	3	0	.01	-	 < 0.2	1.00E00
regulation of cellular response to manganese ion (GO:1905802)	1	0	.00	-	 < 0.2	1.00E00
adenine nucleotide transport (GO:0051503)	13	0	.05	-	 < 0.2	1.00E00
embryonic brain development (GO:1990403)	9	0	.04	-	 < 0.2	1.00E00
embryonic liver development (GO:1990402)	1	0	.00	-	 < 0.2	1.00E00
embryonic lung development (GO:1990401)	1	0	.00	-	 < 0.2	1.00E00
regulation of osteoclast proliferation (GO:0090289)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cellular response to growth factor stimulus (GO:0090288)	131	3	.55	+	5.47	1.00E00
regulation of cellular response to growth factor stimulus (GO:0090287)	249	3	1.04	+	2.88	1.00E00
cytoskeletal anchoring at nuclear membrane (GO:0090286)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of protein glycosylation in Golgi (GO:0090285)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein glycosylation in Golgi (GO:0090284)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein glycosylation in Golgi (GO:0090283)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of calcium ion import (GO:0090281)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of calcium ion import (GO:0090280)	19	1	.08	+	12.56	1.00E00
positive regulation of synaptic plasticity (GO:0031915)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of synaptic plasticity (GO:0031914)	4	0	.02	-	 < 0.2	1.00E00
regulation of calcium ion import (GO:0090279)	37	1	.16	+	6.45	1.00E00
negative regulation of peptide hormone secretion (GO:0090278)	43	2	.18	+	11.10	1.00E00
positive regulation of peptide hormone secretion (GO:0090277)	92	1	.39	+	2.59	1.00E00
regulation of peptide hormone secretion (GO:0090276)	206	5	.86	+	5.79	1.00E00
positive regulation of somatostatin secretion (GO:0090274)	2	0	.01	-	 < 0.2	1.00E00
regulation of somatostatin secretion (GO:0090273)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of fibroblast growth factor production (GO:0090272)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of fibroblast growth factor production (GO:0090271)	3	0	.01	-	 < 0.2	1.00E00
regulation of fibroblast growth factor production (GO:0090270)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of response to alcohol (GO:1901421)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	7	0	.03	-	 < 0.2	1.00E00
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	13	1	.05	+	18.36	1.00E00
positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265)	2	0	.01	-	 < 0.2	1.00E00
regulation of immune complex clearance by monocytes and macrophages (GO:0090264)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of canonical Wnt signaling pathway (GO:0090263)	124	2	.52	+	3.85	1.00E00
positive regulation of inclusion body assembly (GO:0090261)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of retinal ganglion cell axon guidance (GO:0090260)	2	0	.01	-	 < 0.2	1.00E00
regulation of response to alcohol (GO:1901419)	1	0	.00	-	 < 0.2	1.00E00
seminal clot liquefaction (GO:0070684)	1	0	.00	-	 < 0.2	1.00E00
proteasome regulatory particle assembly (GO:0070682)	3	0	.01	-	 < 0.2	1.00E00
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	3	0	.01	-	 < 0.2	1.00E00
animal organ maturation (GO:0048799)	18	0	.08	-	 < 0.2	1.00E00
regulation of retinal ganglion cell axon guidance (GO:0090259)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of mitochondrial fission (GO:0090258)	3	0	.01	-	 < 0.2	1.00E00
pronephros development (GO:0048793)	8	0	.03	-	 < 0.2	1.00E00
spontaneous exocytosis of neurotransmitter (GO:0048792)	1	0	.00	-	 < 0.2	1.00E00
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	28	0	.12	-	 < 0.2	1.00E00
maintenance of presynaptic active zone structure (GO:0048790)	1	0	.00	-	 < 0.2	1.00E00
protein localization involved in establishment of planar polarity (GO:0090251)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)	9	0	.04	-	 < 0.2	1.00E00
intralumenal vesicle formation (GO:0070676)	2	0	.01	-	 < 0.2	1.00E00
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	11	0	.05	-	 < 0.2	1.00E00
response to interleukin-18 (GO:0070673)	9	1	.04	+	26.52	1.00E00
response to interleukin-15 (GO:0070672)	6	0	.03	-	 < 0.2	1.00E00
response to interleukin-12 (GO:0070671)	57	0	.24	-	 < 0.2	1.00E00
response to interleukin-4 (GO:0070670)	31	2	.13	+	15.40	1.00E00
cytoskeletal matrix organization at active zone (GO:0048789)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell motility involved in somitogenic axis elongation (GO:0090249)	2	0	.01	-	 < 0.2	1.00E00
convergent extension involved in somitogenesis (GO:0090246)	1	0	.00	-	 < 0.2	1.00E00
axis elongation involved in somitogenesis (GO:0090245)	4	0	.02	-	 < 0.2	1.00E00
Wnt signaling pathway involved in somitogenesis (GO:0090244)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of histone H4 acetylation (GO:0090241)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of histone H4 acetylation (GO:0090240)	7	0	.03	-	 < 0.2	1.00E00
response to interleukin-2 (GO:0070669)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of mast cell proliferation (GO:0070668)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mast cell proliferation (GO:0070667)	1	0	.00	-	 < 0.2	1.00E00
regulation of mast cell proliferation (GO:0070666)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of leukocyte proliferation (GO:0070664)	77	4	.32	+	12.40	1.00E00
mast cell proliferation (GO:0070662)	1	0	.00	-	 < 0.2	1.00E00
leukocyte proliferation (GO:0070661)	90	2	.38	+	5.30	1.00E00
regulation of histone H4 acetylation (GO:0090239)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of arachidonic acid secretion (GO:0090238)	5	0	.02	-	 < 0.2	1.00E00
regulation of arachidonic acid secretion (GO:0090237)	6	1	.03	+	39.78	1.00E00
erythrophore differentiation (GO:0048773)	1	0	.00	-	 < 0.2	1.00E00
regulation of metaphase plate congression (GO:0090235)	7	0	.03	-	 < 0.2	1.00E00
regulation of kinetochore assembly (GO:0090234)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of spindle checkpoint (GO:0090233)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of spindle checkpoint (GO:0090232)	8	1	.03	+	29.83	1.00E00
regulation of spindle checkpoint (GO:0090231)	15	2	.06	+	31.82	1.00E00
regulation of centromere complex assembly (GO:0090230)	5	0	.02	-	 < 0.2	1.00E00
nonfunctional rRNA decay (GO:0070651)	1	0	.00	-	 < 0.2	1.00E00
actin filament bundle distribution (GO:0070650)	1	0	.00	-	 < 0.2	1.00E00
sarcomerogenesis (GO:0048769)	3	0	.01	-	 < 0.2	1.00E00
cardiac endothelial to mesenchymal transition (GO:0140074)	1	0	.00	-	 < 0.2	1.00E00
mesenchymal cell differentiation (GO:0048762)	132	5	.55	+	9.04	1.00E00
regulation of spindle organization (GO:0090224)	39	1	.16	+	6.12	1.00E00
centrosome-templated microtubule nucleation (GO:0090222)	1	0	.00	-	 < 0.2	1.00E00
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	15	1	.06	+	15.91	1.00E00
formin-nucleated actin cable assembly (GO:0070649)	3	0	.01	-	 < 0.2	1.00E00
protein modification by small protein conjugation or removal (GO:0070647)	1007	13	4.22	+	3.08	1.00E00
protein modification by small protein removal (GO:0070646)	302	6	1.27	+	4.74	1.00E00
vitamin D3 metabolic process (GO:0070640)	4	0	.02	-	 < 0.2	1.00E00
peptidyl-lysine butyrylation (GO:0140067)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-lysine crotonylation (GO:0140066)	1	0	.00	-	 < 0.2	1.00E00
pigment granule maturation (GO:0048757)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of lipid kinase activity (GO:0090219)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of lipid kinase activity (GO:0090218)	34	3	.14	+	21.06	1.00E00
branching morphogenesis of a nerve (GO:0048755)	5	0	.02	-	 < 0.2	1.00E00
branching morphogenesis of an epithelial tube (GO:0048754)	130	3	.54	+	5.51	1.00E00
pigment granule organization (GO:0048753)	26	1	.11	+	9.18	1.00E00
semicircular canal morphogenesis (GO:0048752)	7	0	.03	-	 < 0.2	1.00E00
spongiotrophoblast layer developmental growth (GO:0090214)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of establishment of blood-brain barrier (GO:0090212)	2	0	.01	-	 < 0.2	1.00E00
regulation of establishment of blood-brain barrier (GO:0090210)	3	0	.01	-	 < 0.2	1.00E00
pyridine nucleoside catabolic process (GO:0070638)	1	0	.00	-	 < 0.2	1.00E00
pyridine nucleoside metabolic process (GO:0070637)	1	0	.00	-	 < 0.2	1.00E00
transepithelial ammonium transport (GO:0070634)	3	0	.01	-	 < 0.2	1.00E00
transepithelial transport (GO:0070633)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	2	1	.01	+	 > 100	1.00E00
regulation of smooth muscle cell-matrix adhesion (GO:2000097)	3	1	.01	+	79.55	1.00E00
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	8	0	.03	-	 < 0.2	1.00E00
dendrite arborization (GO:0140059)	2	0	.01	-	 < 0.2	1.00E00
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	13	0	.05	-	 < 0.2	1.00E00
neuron projection arborization (GO:0140058)	4	0	.02	-	 < 0.2	1.00E00
compound eye development (GO:0048749)	2	0	.01	-	 < 0.2	1.00E00
organelle localization by membrane tethering (GO:0140056)	156	1	.65	+	1.53	1.00E00
muscle fiber development (GO:0048747)	46	0	.19	-	 < 0.2	1.00E00
negative regulation of triglyceride metabolic process (GO:0090209)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of triglyceride metabolic process (GO:0090208)	19	0	.08	-	 < 0.2	1.00E00
smooth muscle tissue development (GO:0048745)	21	0	.09	-	 < 0.2	1.00E00
regulation of triglyceride metabolic process (GO:0090207)	33	0	.14	-	 < 0.2	1.00E00
mitochondrial gene expression (GO:0140053)	124	0	.52	-	 < 0.2	1.00E00
negative regulation of cholesterol metabolic process (GO:0090206)	5	0	.02	-	 < 0.2	1.00E00
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of skeletal muscle fiber development (GO:0048743)	9	1	.04	+	26.52	1.00E00
positive regulation of cholesterol metabolic process (GO:0090205)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of endocardial cushion to mesenchymal transition (GO:0140051)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle fiber development (GO:0048742)	13	1	.05	+	18.36	1.00E00
protein localization to nuclear pore (GO:0090204)	3	0	.01	-	 < 0.2	1.00E00
skeletal muscle fiber development (GO:0048741)	24	0	.10	-	 < 0.2	1.00E00
gene looping (GO:0090202)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of release of cytochrome c from mitochondria (GO:0090201)	17	1	.07	+	14.04	1.00E00
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	8	1	.03	+	29.83	1.00E00
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	29	2	.12	+	16.46	1.00E00
ferrous iron import (GO:0070627)	3	0	.01	-	 < 0.2	1.00E00
glucose import in response to insulin stimulus (GO:0044381)	2	0	.01	-	 < 0.2	1.00E00
zymogen granule exocytosis (GO:0070625)	1	0	.00	-	 < 0.2	1.00E00
protein localization to cytoskeleton (GO:0044380)	35	0	.15	-	 < 0.2	1.00E00
regulation of endocardial cushion to mesenchymal transition (GO:0140049)	1	0	.00	-	 < 0.2	1.00E00
cardiac muscle fiber development (GO:0048739)	9	0	.04	-	 < 0.2	1.00E00
cardiac muscle tissue development (GO:0048738)	155	4	.65	+	6.16	1.00E00
positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081)	1	0	.00	-	 < 0.2	1.00E00
appendage development (GO:0048736)	173	0	.72	-	 < 0.2	1.00E00
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080)	1	0	.00	-	 < 0.2	1.00E00
sebaceous gland development (GO:0048733)	7	0	.03	-	 < 0.2	1.00E00
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.00	-	 < 0.2	1.00E00
epidermis morphogenesis (GO:0048730)	29	2	.12	+	16.46	1.00E00
RNA polymerase II complex import to nucleus (GO:0044376)	3	0	.01	-	 < 0.2	1.00E00
regulation of peroxisome size (GO:0044375)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein processing (GO:0070613)	170	3	.71	+	4.21	1.00E00
regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of type B pancreatic cell development (GO:2000078)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of type B pancreatic cell development (GO:2000077)	2	1	.01	+	 > 100	1.00E00
regulation of type B pancreatic cell development (GO:2000074)	8	1	.03	+	29.83	1.00E00
disruption of cells of other organism (GO:0044364)	50	0	.21	-	 < 0.2	1.00E00
negative regulation of molecular function in other organism (GO:0044362)	8	0	.03	-	 < 0.2	1.00E00
regulation of centromeric sister chromatid cohesion (GO:0070602)	4	0	.02	-	 < 0.2	1.00E00
centromeric sister chromatid cohesion (GO:0070601)	7	0	.03	-	 < 0.2	1.00E00
DNA geometric change (GO:0032392)	85	1	.36	+	2.81	1.00E00
regulation of root morphogenesis (GO:2000067)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cortisol biosynthetic process (GO:2000066)	1	0	.00	-	 < 0.2	1.00E00
exocytic process (GO:0140029)	60	1	.25	+	3.98	1.00E00
negative regulation of cortisol biosynthetic process (GO:2000065)	4	0	.02	-	 < 0.2	1.00E00
regulation of cortisol biosynthetic process (GO:2000064)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of ureter smooth muscle cell differentiation (GO:2000063)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ureter smooth muscle cell differentiation (GO:2000062)	1	0	.00	-	 < 0.2	1.00E00
regulation of ureter smooth muscle cell differentiation (GO:2000061)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060)	92	2	.39	+	5.19	1.00E00
negative regulation of oligodendrocyte differentiation (GO:0048715)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of oligodendrocyte differentiation (GO:0048714)	17	0	.07	-	 < 0.2	1.00E00
regulation of oligodendrocyte differentiation (GO:0048713)	31	0	.13	-	 < 0.2	1.00E00
negative regulation of astrocyte differentiation (GO:0048712)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of astrocyte differentiation (GO:0048711)	10	0	.04	-	 < 0.2	1.00E00
modulation of molecular function in other organism (GO:0044359)	9	0	.04	-	 < 0.2	1.00E00
regulation of astrocyte differentiation (GO:0048710)	25	0	.10	-	 < 0.2	1.00E00
clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine (GO:0044356)	1	0	.00	-	 < 0.2	1.00E00
clearance of foreign intracellular DNA (GO:0044355)	1	0	.00	-	 < 0.2	1.00E00
macropinocytosis (GO:0044351)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of intracellular transport (GO:0032387)	124	0	.52	-	 < 0.2	1.00E00
positive regulation of intracellular cholesterol transport (GO:0032385)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of intracellular cholesterol transport (GO:0032384)	1	0	.00	-	 < 0.2	1.00E00
regulation of intracellular cholesterol transport (GO:0032383)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059)	14	1	.06	+	17.05	1.00E00
positive regulation of intracellular sterol transport (GO:0032382)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058)	108	3	.45	+	6.63	1.00E00
negative regulation of intracellular sterol transport (GO:0032381)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057)	1	0	.00	-	 < 0.2	1.00E00
regulation of intracellular sterol transport (GO:0032380)	7	0	.03	-	 < 0.2	1.00E00
regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000055)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	2	0	.01	-	 < 0.2	1.00E00
oligodendrocyte differentiation (GO:0048709)	65	1	.27	+	3.67	1.00E00
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	3	0	.01	-	 < 0.2	1.00E00
astrocyte differentiation (GO:0048708)	44	2	.18	+	10.85	1.00E00
D-aspartate import across plasma membrane (GO:0140016)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	5	0	.02	-	 < 0.2	1.00E00
histone displacement (GO:0001207)	1	0	.00	-	 < 0.2	1.00E00
embryonic skeletal system development (GO:0048706)	122	0	.51	-	 < 0.2	1.00E00
mitotic nuclear division (GO:0140014)	136	2	.57	+	3.51	1.00E00
regulation of non-canonical Wnt signaling pathway (GO:2000050)	20	0	.08	-	 < 0.2	1.00E00
skeletal system morphogenesis (GO:0048705)	214	1	.90	+	1.12	1.00E00
meiotic nuclear division (GO:0140013)	153	3	.64	+	4.68	1.00E00
embryonic skeletal system morphogenesis (GO:0048704)	93	0	.39	-	 < 0.2	1.00E00
embryonic viscerocranium morphogenesis (GO:0048703)	10	0	.04	-	 < 0.2	1.00E00
embryonic neurocranium morphogenesis (GO:0048702)	7	0	.03	-	 < 0.2	1.00E00
embryonic cranial skeleton morphogenesis (GO:0048701)	45	0	.19	-	 < 0.2	1.00E00
DNA excision (GO:0044349)	1	0	.00	-	 < 0.2	1.00E00
fibroblast apoptotic process (GO:0044346)	3	0	.01	-	 < 0.2	1.00E00
stromal-epithelial cell signaling involved in prostate gland development (GO:0044345)	1	0	.00	-	 < 0.2	1.00E00
cellular response to fibroblast growth factor stimulus (GO:0044344)	113	1	.47	+	2.11	1.00E00
type B pancreatic cell proliferation (GO:0044342)	8	0	.03	-	 < 0.2	1.00E00
sodium-dependent phosphate transport (GO:0044341)	7	0	.03	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of intracellular lipid transport (GO:0032379)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of intracellular lipid transport (GO:0032378)	1	0	.00	-	 < 0.2	1.00E00
regulation of intracellular lipid transport (GO:0032377)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of cholesterol transport (GO:0032376)	20	0	.08	-	 < 0.2	1.00E00
negative regulation of cholesterol transport (GO:0032375)	12	0	.05	-	 < 0.2	1.00E00
regulation of cholesterol transport (GO:0032374)	43	0	.18	-	 < 0.2	1.00E00
positive regulation of sterol transport (GO:0032373)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of sterol transport (GO:0032372)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	4	0	.02	-	 < 0.2	1.00E00
regulation of sterol transport (GO:0032371)	43	0	.18	-	 < 0.2	1.00E00
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of lipid transport (GO:0032370)	55	1	.23	+	4.34	1.00E00
L-aspartate import across plasma membrane (GO:0140009)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cardiac cell fate specification (GO:2000044)	1	0	.00	-	 < 0.2	1.00E00
regulation of cardiac cell fate specification (GO:2000043)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041)	2	0	.01	-	 < 0.2	1.00E00
regulation of planar cell polarity pathway involved in axis elongation (GO:2000040)	2	0	.01	-	 < 0.2	1.00E00
protein polyglutamylation (GO:0018095)	10	0	.04	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339)	3	0	.01	-	 < 0.2	1.00E00
protein polyglycylation (GO:0018094)	4	0	.02	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	2	0	.01	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	3	0	.01	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335)	2	0	.01	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334)	2	0	.01	-	 < 0.2	1.00E00
Wnt signaling pathway involved in dorsal/ventral axis specification (GO:0044332)	5	0	.02	-	 < 0.2	1.00E00
cell-cell adhesion mediated by cadherin (GO:0044331)	4	1	.02	+	59.66	1.00E00
canonical Wnt signaling pathway involved in positive regulation of wound healing (GO:0044330)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lipid transport (GO:0032369)	27	1	.11	+	8.84	1.00E00
regulation of lipid transport (GO:0032368)	101	3	.42	+	7.09	1.00E00
intracellular cholesterol transport (GO:0032367)	11	0	.05	-	 < 0.2	1.00E00
intracellular sterol transport (GO:0032366)	11	0	.05	-	 < 0.2	1.00E00
intracellular lipid transport (GO:0032365)	24	0	.10	-	 < 0.2	1.00E00
oxygen homeostasis (GO:0032364)	6	0	.03	-	 < 0.2	1.00E00
pyridoxal phosphate catabolic process (GO:0032361)	1	0	.00	-	 < 0.2	1.00E00
regulation of stem cell population maintenance (GO:2000036)	23	0	.10	-	 < 0.2	1.00E00
regulation of stem cell division (GO:2000035)	8	0	.03	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion (GO:0044329)	1	0	.00	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration (GO:0044328)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription involved in anterior/posterior axis specification (GO:0044324)	2	0	.01	-	 < 0.2	1.00E00
response to leptin (GO:0044321)	21	0	.09	-	 < 0.2	1.00E00
cellular response to leptin stimulus (GO:0044320)	17	0	.07	-	 < 0.2	1.00E00
response to follicle-stimulating hormone (GO:0032354)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of hormone biosynthetic process (GO:0032353)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of hormone metabolic process (GO:0032352)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of hormone metabolic process (GO:0032351)	7	0	.03	-	 < 0.2	1.00E00
regulation of organ morphogenesis (GO:2000027)	255	3	1.07	+	2.81	1.00E00
regulation of hormone metabolic process (GO:0032350)	27	0	.11	-	 < 0.2	1.00E00
regulation of L-glutamate import (GO:1900920)	2	0	.01	-	 < 0.2	1.00E00
regulation of ion homeostasis (GO:2000021)	206	4	.86	+	4.63	1.00E00
positive regulation of male gonad development (GO:2000020)	8	0	.03	-	 < 0.2	1.00E00
N-terminal peptidyl-lysine acetylation (GO:0018076)	3	0	.01	-	 < 0.2	1.00E00
wound healing, spreading of cells (GO:0044319)	23	1	.10	+	10.38	1.00E00
protein K27-linked ubiquitination (GO:0044314)	5	0	.02	-	 < 0.2	1.00E00
protein K6-linked deubiquitination (GO:0044313)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of aldosterone biosynthetic process (GO:0032349)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of aldosterone biosynthetic process (GO:0032348)	4	0	.02	-	 < 0.2	1.00E00
regulation of aldosterone biosynthetic process (GO:0032347)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of aldosterone metabolic process (GO:0032346)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of aldosterone metabolic process (GO:0032345)	4	0	.02	-	 < 0.2	1.00E00
regulation of aldosterone metabolic process (GO:0032344)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of male gonad development (GO:2000019)	1	0	.00	-	 < 0.2	1.00E00
aldosterone biosynthetic process (GO:0032342)	3	0	.01	-	 < 0.2	1.00E00
regulation of male gonad development (GO:2000018)	9	0	.04	-	 < 0.2	1.00E00
aldosterone metabolic process (GO:0032341)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of determination of dorsal identity (GO:2000017)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of determination of dorsal identity (GO:2000016)	2	0	.01	-	 < 0.2	1.00E00
regulation of determination of dorsal identity (GO:2000015)	4	0	.02	-	 < 0.2	1.00E00
regulation of adaxial/abaxial pattern formation (GO:2000011)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein localization to cell surface (GO:2000010)	13	1	.05	+	18.36	1.00E00
protein-cofactor linkage (GO:0018065)	13	0	.05	-	 < 0.2	1.00E00
cytochrome c-heme linkage (GO:0018063)	1	0	.00	-	 < 0.2	1.00E00
tricarboxylic acid cycle (GO:0006099)	31	0	.13	-	 < 0.2	1.00E00
pentose-phosphate shunt (GO:0006098)	14	1	.06	+	17.05	1.00E00
glyoxylate cycle (GO:0006097)	2	0	.01	-	 < 0.2	1.00E00
glycolytic process (GO:0006096)	38	1	.16	+	6.28	1.00E00
gluconeogenesis (GO:0006094)	46	0	.19	-	 < 0.2	1.00E00
generation of precursor metabolites and energy (GO:0006091)	313	4	1.31	+	3.05	1.00E00
pyruvate metabolic process (GO:0006090)	67	1	.28	+	3.56	1.00E00
negative regulation of protein localization to cell surface (GO:2000009)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of chondrocyte differentiation (GO:0032332)	18	0	.08	-	 < 0.2	1.00E00
regulation of protein localization to cell surface (GO:2000008)	33	1	.14	+	7.23	1.00E00
negative regulation of chondrocyte differentiation (GO:0032331)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007)	1	0	.00	-	 < 0.2	1.00E00
regulation of chondrocyte differentiation (GO:0032330)	45	0	.19	-	 < 0.2	1.00E00
regulation of metanephric comma-shaped body morphogenesis (GO:2000006)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of metanephric S-shaped body morphogenesis (GO:2000005)	1	0	.00	-	 < 0.2	1.00E00
regulation of metanephric S-shaped body morphogenesis (GO:2000004)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of DNA damage checkpoint (GO:2000003)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA damage checkpoint (GO:2000002)	5	0	.02	-	 < 0.2	1.00E00
regulation of DNA damage checkpoint (GO:2000001)	16	0	.07	-	 < 0.2	1.00E00
peptidyl-lysine oxidation (GO:0018057)	1	0	.00	-	 < 0.2	1.00E00
lactate metabolic process (GO:0006089)	13	0	.05	-	 < 0.2	1.00E00
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	8	0	.03	-	 < 0.2	1.00E00
acetyl-CoA biosynthetic process (GO:0006085)	13	0	.05	-	 < 0.2	1.00E00
serine transport (GO:0032329)	11	0	.05	-	 < 0.2	1.00E00
acetyl-CoA metabolic process (GO:0006084)	27	1	.11	+	8.84	1.00E00
alanine transport (GO:0032328)	10	0	.04	-	 < 0.2	1.00E00
acetate metabolic process (GO:0006083)	3	0	.01	-	 < 0.2	1.00E00
organic acid metabolic process (GO:0006082)	995	8	4.17	+	1.92	1.00E00
cellular aldehyde metabolic process (GO:0006081)	66	1	.28	+	3.62	1.00E00
molybdopterin cofactor biosynthetic process (GO:0032324)	7	0	.03	-	 < 0.2	1.00E00
cellular glucan metabolic process (GO:0006073)	57	2	.24	+	8.37	1.00E00
glycerol-3-phosphate metabolic process (GO:0006072)	8	0	.03	-	 < 0.2	1.00E00
glycerol metabolic process (GO:0006071)	18	0	.08	-	 < 0.2	1.00E00
prostaglandin secretion (GO:0032310)	3	0	.01	-	 < 0.2	1.00E00
syncytium formation by plasma membrane fusion (GO:0000768)	27	0	.11	-	 < 0.2	1.00E00
protein amidation (GO:0018032)	1	0	.00	-	 < 0.2	1.00E00
ethanol oxidation (GO:0006069)	12	0	.05	-	 < 0.2	1.00E00
ethanol catabolic process (GO:0006068)	12	0	.05	-	 < 0.2	1.00E00
ethanol metabolic process (GO:0006067)	21	0	.09	-	 < 0.2	1.00E00
alcohol metabolic process (GO:0006066)	279	3	1.17	+	2.57	1.00E00
UDP-glucuronate biosynthetic process (GO:0006065)	3	0	.01	-	 < 0.2	1.00E00
icosanoid secretion (GO:0032309)	28	0	.12	-	 < 0.2	1.00E00
glucuronate catabolic process (GO:0006064)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of prostaglandin secretion (GO:0032308)	10	0	.04	-	 < 0.2	1.00E00
uronic acid metabolic process (GO:0006063)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of prostaglandin secretion (GO:0032307)	1	0	.00	-	 < 0.2	1.00E00
sorbitol catabolic process (GO:0006062)	1	0	.00	-	 < 0.2	1.00E00
regulation of prostaglandin secretion (GO:0032306)	11	0	.05	-	 < 0.2	1.00E00
sorbitol biosynthetic process (GO:0006061)	1	1	.00	+	 > 100	1.00E00
positive regulation of icosanoid secretion (GO:0032305)	15	0	.06	-	 < 0.2	1.00E00
sorbitol metabolic process (GO:0006060)	2	1	.01	+	 > 100	1.00E00
negative regulation of icosanoid secretion (GO:0032304)	4	0	.02	-	 < 0.2	1.00E00
regulation of icosanoid secretion (GO:0032303)	18	1	.08	+	13.26	1.00E00
peptidyl-lysine dimethylation (GO:0018027)	12	0	.05	-	 < 0.2	1.00E00
peptidyl-lysine monomethylation (GO:0018026)	9	0	.04	-	 < 0.2	1.00E00
peptidyl-lysine trimethylation (GO:0018023)	27	0	.11	-	 < 0.2	1.00E00
peptidyl-lysine methylation (GO:0018022)	80	0	.34	-	 < 0.2	1.00E00
hexitol metabolic process (GO:0006059)	3	1	.01	+	79.55	1.00E00
mannoprotein biosynthetic process (GO:0006057)	1	0	.00	-	 < 0.2	1.00E00
mannoprotein metabolic process (GO:0006056)	1	0	.00	-	 < 0.2	1.00E00
CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	1	0	.00	-	 < 0.2	1.00E00
N-acetylneuraminate metabolic process (GO:0006054)	9	0	.04	-	 < 0.2	1.00E00
N-acetylmannosamine metabolic process (GO:0006051)	2	0	.01	-	 < 0.2	1.00E00
mannosamine metabolic process (GO:0006050)	2	0	.01	-	 < 0.2	1.00E00
regulation of intraciliary retrograde transport (GO:1905799)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.00	-	 < 0.2	1.00E00
cellular response to puromycin (GO:1905795)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of phospholipid biosynthetic process (GO:0071073)	9	1	.04	+	26.52	1.00E00
response to puromycin (GO:1905794)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of phospholipid biosynthetic process (GO:0071072)	4	0	.02	-	 < 0.2	1.00E00
protein localization to pericentriolar material (GO:1905793)	2	0	.01	-	 < 0.2	1.00E00
N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.00	-	 < 0.2	1.00E00
regulation of phospholipid biosynthetic process (GO:0071071)	14	1	.06	+	17.05	1.00E00
UDP-N-acetylglucosamine catabolic process (GO:0006049)	1	0	.00	-	 < 0.2	1.00E00
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	9	0	.04	-	 < 0.2	1.00E00
karyogamy (GO:0000741)	1	0	.00	-	 < 0.2	1.00E00
UDP-N-acetylglucosamine metabolic process (GO:0006047)	14	0	.06	-	 < 0.2	1.00E00
N-acetylglucosamine catabolic process (GO:0006046)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of stress fiber assembly (GO:0051497)	20	0	.08	-	 < 0.2	1.00E00
N-acetylglucosamine biosynthetic process (GO:0006045)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of stress fiber assembly (GO:0051496)	49	0	.21	-	 < 0.2	1.00E00
N-acetylglucosamine metabolic process (GO:0006044)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of cytoskeleton organization (GO:0051495)	199	1	.83	+	1.20	1.00E00
glucosamine catabolic process (GO:0006043)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cytoskeleton organization (GO:0051494)	119	1	.50	+	2.01	1.00E00
regulation of cytoskeleton organization (GO:0051493)	459	8	1.92	+	4.16	1.00E00
glucosamine metabolic process (GO:0006041)	4	0	.02	-	 < 0.2	1.00E00
regulation of stress fiber assembly (GO:0051492)	78	1	.33	+	3.06	1.00E00
amino sugar metabolic process (GO:0006040)	37	0	.16	-	 < 0.2	1.00E00
positive regulation of filopodium assembly (GO:0051491)	30	0	.13	-	 < 0.2	1.00E00
negative regulation of filopodium assembly (GO:0051490)	4	1	.02	+	59.66	1.00E00
protein K33-linked ubiquitination (GO:1990390)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.01	-	 < 0.2	1.00E00
DNA catabolic process, exonucleolytic (GO:0000738)	2	0	.01	-	 < 0.2	1.00E00
DNA catabolic process, endonucleolytic (GO:0000737)	19	1	.08	+	12.56	1.00E00
peptidyl-lysine N6-acetylation (GO:0018003)	2	0	.01	-	 < 0.2	1.00E00
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	2	0	.01	-	 < 0.2	1.00E00
DNA strand renaturation (GO:0000733)	9	1	.04	+	26.52	1.00E00
NMDA selective glutamate receptor signaling pathway (GO:0098989)	2	0	.01	-	 < 0.2	1.00E00
strand displacement (GO:0000732)	26	2	.11	+	18.36	1.00E00
regulation of filopodium assembly (GO:0051489)	43	1	.18	+	5.55	1.00E00
DNA synthesis involved in DNA repair (GO:0000731)	75	3	.31	+	9.55	1.00E00
cell wall chitin metabolic process (GO:0006037)	1	0	.00	-	 < 0.2	1.00E00
DNA recombinase assembly (GO:0000730)	10	0	.04	-	 < 0.2	1.00E00
mitotic cleavage furrow ingression (GO:1990386)	1	0	.00	-	 < 0.2	1.00E00
hyaloid vascular plexus regression (GO:1990384)	1	0	.00	-	 < 0.2	1.00E00
chitin catabolic process (GO:0006032)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482)	29	0	.12	-	 < 0.2	1.00E00
chitin metabolic process (GO:0006030)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cytosolic calcium ion concentration (GO:0051481)	15	0	.06	-	 < 0.2	1.00E00
regulation of cytosolic calcium ion concentration (GO:0051480)	285	2	1.19	+	1.67	1.00E00
negative regulation of exonuclease activity (GO:1905778)	2	0	.01	-	 < 0.2	1.00E00
regulation of exonuclease activity (GO:1905777)	2	0	.01	-	 < 0.2	1.00E00
DNA double-strand break processing (GO:0000729)	22	1	.09	+	10.85	1.00E00
positive regulation of DNA helicase activity (GO:1905776)	1	0	.00	-	 < 0.2	1.00E00
double-strand break repair via break-induced replication (GO:0000727)	5	0	.02	-	 < 0.2	1.00E00
regulation of DNA helicase activity (GO:1905774)	1	0	.00	-	 < 0.2	1.00E00
non-recombinational repair (GO:0000726)	58	1	.24	+	4.11	1.00E00
recombinational repair (GO:0000725)	85	2	.36	+	5.62	1.00E00
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of mesodermal cell differentiation (GO:1905772)	1	0	.00	-	 < 0.2	1.00E00
double-strand break repair via homologous recombination (GO:0000724)	84	2	.35	+	5.68	1.00E00
negative regulation of mesodermal cell differentiation (GO:1905771)	4	0	.02	-	 < 0.2	1.00E00
telomere maintenance (GO:0000723)	91	3	.38	+	7.87	1.00E00
proteoglycan metabolic process (GO:0006029)	82	0	.34	-	 < 0.2	1.00E00
regulation of mesodermal cell differentiation (GO:1905770)	7	0	.03	-	 < 0.2	1.00E00
telomere maintenance via recombination (GO:0000722)	12	1	.05	+	19.89	1.00E00
lipid transport across blood brain barrier (GO:1990379)	1	0	.00	-	 < 0.2	1.00E00
glycosaminoglycan catabolic process (GO:0006027)	62	0	.26	-	 < 0.2	1.00E00
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	3	0	.01	-	 < 0.2	1.00E00
aminoglycan catabolic process (GO:0006026)	67	0	.28	-	 < 0.2	1.00E00
excitatory chemical synaptic transmission (GO:0098976)	2	0	.01	-	 < 0.2	1.00E00
glycosaminoglycan biosynthetic process (GO:0006024)	103	1	.43	+	2.32	1.00E00
postsynaptic actin cytoskeleton organization (GO:0098974)	1	0	.00	-	 < 0.2	1.00E00
aminoglycan biosynthetic process (GO:0006023)	104	1	.44	+	2.29	1.00E00
aminoglycan metabolic process (GO:0006022)	161	2	.67	+	2.96	1.00E00
anterograde dendritic transport of mitochondrion (GO:0098972)	1	0	.00	-	 < 0.2	1.00E00
inositol biosynthetic process (GO:0006021)	4	0	.02	-	 < 0.2	1.00E00
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	2	0	.01	-	 < 0.2	1.00E00
inositol metabolic process (GO:0006020)	11	0	.05	-	 < 0.2	1.00E00
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	1	0	.00	-	 < 0.2	1.00E00
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049)	2	0	.01	-	 < 0.2	1.00E00
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)	3	0	.01	-	 < 0.2	1.00E00
polyadenylation-dependent mRNA catabolic process (GO:0071047)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.00	-	 < 0.2	1.00E00
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	6	0	.03	-	 < 0.2	1.00E00
regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.00	-	 < 0.2	1.00E00
nuclear histone mRNA catabolic process (GO:0071045)	1	0	.00	-	 < 0.2	1.00E00
nucleotide-excision repair, DNA damage removal (GO:0000718)	1	0	.00	-	 < 0.2	1.00E00
histone mRNA catabolic process (GO:0071044)	11	1	.05	+	21.70	1.00E00
negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	3	0	.01	-	 < 0.2	1.00E00
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	22	0	.09	-	 < 0.2	1.00E00
CUT metabolic process (GO:0071043)	4	0	.02	-	 < 0.2	1.00E00
regulation of protection from non-homologous end joining at telomere (GO:1905764)	3	0	.01	-	 < 0.2	1.00E00
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	4	0	.02	-	 < 0.2	1.00E00
nucleotide-excision repair, DNA damage recognition (GO:0000715)	23	1	.10	+	10.38	1.00E00
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	10	0	.04	-	 < 0.2	1.00E00
resolution of meiotic recombination intermediates (GO:0000712)	14	0	.06	-	 < 0.2	1.00E00
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	1	0	.00	-	 < 0.2	1.00E00
meiotic DNA repair synthesis (GO:0000711)	3	0	.01	-	 < 0.2	1.00E00
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	4	0	.02	-	 < 0.2	1.00E00
meiotic mismatch repair (GO:0000710)	2	0	.01	-	 < 0.2	1.00E00
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of corticotropin-releasing hormone secretion (GO:0051466)	2	0	.01	-	 < 0.2	1.00E00
D-ribose metabolic process (GO:0006014)	3	0	.01	-	 < 0.2	1.00E00
mannose metabolic process (GO:0006013)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of cortisol secretion (GO:0051464)	4	0	.02	-	 < 0.2	1.00E00
galactose metabolic process (GO:0006012)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of cortisol secretion (GO:0051463)	1	0	.00	-	 < 0.2	1.00E00
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	1	0	.00	-	 < 0.2	1.00E00
UDP-glucose metabolic process (GO:0006011)	5	0	.02	-	 < 0.2	1.00E00
regulation of cortisol secretion (GO:0051462)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of corticotropin secretion (GO:0051461)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of corticotropin secretion (GO:0051460)	1	0	.00	-	 < 0.2	1.00E00
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	5	0	.02	-	 < 0.2	1.00E00
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	6	0	.03	-	 < 0.2	1.00E00
CUT catabolic process (GO:0071034)	4	0	.02	-	 < 0.2	1.00E00
meiotic DNA recombinase assembly (GO:0000707)	6	0	.03	-	 < 0.2	1.00E00
nuclear retention of pre-mRNA at the site of transcription (GO:0071033)	6	0	.03	-	 < 0.2	1.00E00
meiotic DNA double-strand break processing (GO:0000706)	4	0	.02	-	 < 0.2	1.00E00
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.01	-	 < 0.2	1.00E00
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cardioblast cell fate specification (GO:0009997)	1	0	.00	-	 < 0.2	1.00E00
regulation of corticotropin secretion (GO:0051459)	6	0	.03	-	 < 0.2	1.00E00
glucose catabolic process (GO:0006007)	29	1	.12	+	8.23	1.00E00
negative regulation of cell fate specification (GO:0009996)	6	0	.03	-	 < 0.2	1.00E00
corticotropin secretion (GO:0051458)	2	0	.01	-	 < 0.2	1.00E00
anterograde axonal transport of mitochondrion (GO:0098957)	1	0	.00	-	 < 0.2	1.00E00
glucose metabolic process (GO:0006006)	113	4	.47	+	8.45	1.00E00
maintenance of protein location in nucleus (GO:0051457)	17	0	.07	-	 < 0.2	1.00E00
attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation (GO:0051456)	1	0	.00	-	 < 0.2	1.00E00
fucose metabolic process (GO:0006004)	16	0	.07	-	 < 0.2	1.00E00
attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation (GO:0051455)	1	0	.00	-	 < 0.2	1.00E00
fructose 2,6-bisphosphate metabolic process (GO:0006003)	5	0	.02	-	 < 0.2	1.00E00
cellular water homeostasis (GO:0009992)	2	0	.01	-	 < 0.2	1.00E00
intracellular pH elevation (GO:0051454)	6	1	.03	+	39.78	1.00E00
receptor diffusion trapping (GO:0098953)	1	0	.00	-	 < 0.2	1.00E00
fructose 6-phosphate metabolic process (GO:0006002)	9	0	.04	-	 < 0.2	1.00E00
regulation of intracellular pH (GO:0051453)	92	1	.39	+	2.59	1.00E00
fructose catabolic process (GO:0006001)	5	0	.02	-	 < 0.2	1.00E00
intracellular pH reduction (GO:0051452)	45	0	.19	-	 < 0.2	1.00E00
fructose metabolic process (GO:0006000)	15	1	.06	+	15.91	1.00E00
myoblast migration (GO:0051451)	11	0	.05	-	 < 0.2	1.00E00
myoblast proliferation (GO:0051450)	4	0	.02	-	 < 0.2	1.00E00
nuclear ncRNA surveillance (GO:0071029)	6	0	.03	-	 < 0.2	1.00E00
nuclear mRNA surveillance (GO:0071028)	14	0	.06	-	 < 0.2	1.00E00
nuclear RNA surveillance (GO:0071027)	14	0	.06	-	 < 0.2	1.00E00
hard palate morphogenesis (GO:1905748)	3	0	.01	-	 < 0.2	1.00E00
cytoplasmic RNA surveillance (GO:0071026)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of saliva secretion (GO:1905747)	3	0	.01	-	 < 0.2	1.00E00
RNA surveillance (GO:0071025)	16	0	.07	-	 < 0.2	1.00E00
cell-cell recognition (GO:0009988)	67	0	.28	-	 < 0.2	1.00E00
negative regulation of transforming growth factor beta activation (GO:1901389)	1	0	.00	-	 < 0.2	1.00E00
regulation of transforming growth factor beta activation (GO:1901388)	1	0	.00	-	 < 0.2	1.00E00
gap junction-mediated intercellular transport (GO:1990349)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of voltage-gated calcium channel activity (GO:1901387)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of meiotic cell cycle (GO:0051447)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of voltage-gated calcium channel activity (GO:1901386)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of meiotic cell cycle (GO:0051446)	17	0	.07	-	 < 0.2	1.00E00
regulation of voltage-gated calcium channel activity (GO:1901385)	37	0	.16	-	 < 0.2	1.00E00
regulation of meiotic cell cycle (GO:0051445)	43	0	.18	-	 < 0.2	1.00E00
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	86	2	.36	+	5.55	1.00E00
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	104	2	.44	+	4.59	1.00E00
retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942)	1	0	.00	-	 < 0.2	1.00E00
regulation of chorionic trophoblast cell proliferation (GO:1901382)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of potassium ion transmembrane transport (GO:1901381)	34	0	.14	-	 < 0.2	1.00E00
positive regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle (GO:0051441)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of potassium ion transmembrane transport (GO:1901380)	20	1	.08	+	11.93	1.00E00
regulation of ubiquitin-protein ligase activity involved in meiotic cell cycle (GO:0051440)	1	0	.00	-	 < 0.2	1.00E00
telomeric 3' overhang formation (GO:0031860)	4	0	.02	-	 < 0.2	1.00E00
dendritic transport of mitochondrion (GO:0098939)	1	0	.00	-	 < 0.2	1.00E00
regulation of potassium ion transmembrane transport (GO:1901379)	71	1	.30	+	3.36	1.00E00
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439)	73	2	.31	+	6.54	1.00E00
regulation of ubiquitin-protein transferase activity (GO:0051438)	125	3	.52	+	5.73	1.00E00
anterograde dendritic transport (GO:0098937)	3	0	.01	-	 < 0.2	1.00E00
organic heteropentacyclic compound catabolic process (GO:1901377)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437)	77	2	.32	+	6.20	1.00E00
organic heteropentacyclic compound metabolic process (GO:1901376)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436)	72	1	.30	+	3.31	1.00E00
dendritic transport (GO:0098935)	3	0	.01	-	 < 0.2	1.00E00
acetate ester transport (GO:1901374)	4	0	.02	-	 < 0.2	1.00E00
cytidine deamination (GO:0009972)	9	0	.04	-	 < 0.2	1.00E00
lipid hydroperoxide transport (GO:1901373)	1	0	.00	-	 < 0.2	1.00E00
axonal transport (GO:0098930)	39	0	.16	-	 < 0.2	1.00E00
response to magnetism (GO:0071000)	4	0	.02	-	 < 0.2	1.00E00
presynaptic signal transduction (GO:0098928)	2	0	.01	-	 < 0.2	1.00E00
vesicle-mediated transport between endosomal compartments (GO:0098927)	24	0	.10	-	 < 0.2	1.00E00
retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	1	0	.00	-	 < 0.2	1.00E00
retrograde trans-synaptic signaling by soluble gas (GO:0098923)	1	0	.00	-	 < 0.2	1.00E00
organic cyclic compound biosynthetic process (GO:1901362)	3153	24	13.21	+	1.82	1.00E00
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	1	0	.00	-	 < 0.2	1.00E00
organic cyclic compound catabolic process (GO:1901361)	451	2	1.89	+	1.06	1.00E00
retrograde trans-synaptic signaling by lipid (GO:0098920)	1	0	.00	-	 < 0.2	1.00E00
organic cyclic compound metabolic process (GO:1901360)	4975	31	20.85	+	1.49	1.00E00
protection from non-homologous end joining at telomere (GO:0031848)	7	0	.03	-	 < 0.2	1.00E00
protein localization to perinuclear region of cytoplasm (GO:1905719)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cornification (GO:1905716)	1	0	.00	-	 < 0.2	1.00E00
regulation of cornification (GO:1905715)	1	0	.00	-	 < 0.2	1.00E00
response to phosphatidylethanolamine (GO:1905711)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of membrane permeability (GO:1905710)	21	1	.09	+	11.36	1.00E00
epidermal cell fate specification (GO:0009957)	3	0	.01	-	 < 0.2	1.00E00
radial pattern formation (GO:0009956)	1	0	.00	-	 < 0.2	1.00E00
microtubule nucleation by microtubule organizing center (GO:0051418)	7	0	.03	-	 < 0.2	1.00E00
retrograde trans-synaptic signaling (GO:0098917)	3	0	.01	-	 < 0.2	1.00E00
anterograde trans-synaptic signaling (GO:0098916)	406	3	1.70	+	1.76	1.00E00
proximal/distal pattern formation (GO:0009954)	32	0	.13	-	 < 0.2	1.00E00
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915)	8	0	.03	-	 < 0.2	1.00E00
response to rapamycin (GO:1901355)	2	0	.01	-	 < 0.2	1.00E00
dorsal/ventral pattern formation (GO:0009953)	86	0	.36	-	 < 0.2	1.00E00
interphase microtubule nucleation by interphase microtubule organizing center (GO:0051415)	6	0	.03	-	 < 0.2	1.00E00
membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914)	5	0	.02	-	 < 0.2	1.00E00
anterior/posterior pattern specification (GO:0009952)	197	2	.83	+	2.42	1.00E00
response to cortisol (GO:0051414)	4	0	.02	-	 < 0.2	1.00E00
cellular response to insulin-like growth factor stimulus (GO:1990314)	8	0	.03	-	 < 0.2	1.00E00
response to cortisone (GO:0051413)	1	0	.00	-	 < 0.2	1.00E00
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	3	0	.01	-	 < 0.2	1.00E00
dorsal/ventral axis specification (GO:0009950)	15	0	.06	-	 < 0.2	1.00E00
response to corticosterone (GO:0051412)	18	2	.08	+	26.52	1.00E00
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	14	1	.06	+	17.05	1.00E00
regulation of atrial cardiac muscle cell action potential (GO:0098910)	6	0	.03	-	 < 0.2	1.00E00
cell-cell signaling involved in cell-cell junction organization (GO:1901350)	1	0	.00	-	 < 0.2	1.00E00
detoxification of nitrogen compound (GO:0051410)	5	0	.02	-	 < 0.2	1.00E00
regulation of release of cytochrome c from mitochondria (GO:0090199)	45	3	.19	+	15.91	1.00E00
negative regulation of chemokine secretion (GO:0090198)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of chemokine secretion (GO:0090197)	12	0	.05	-	 < 0.2	1.00E00
regulation of chemokine secretion (GO:0090196)	13	0	.05	-	 < 0.2	1.00E00
chemokine secretion (GO:0090195)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of membrane permeability (GO:1905709)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of glomerulus development (GO:0090194)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of glomerulus development (GO:0090193)	10	0	.04	-	 < 0.2	1.00E00
regulation of glomerulus development (GO:0090192)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	4	0	.02	-	 < 0.2	1.00E00
cellular response to paclitaxel (GO:1905705)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	19	0	.08	-	 < 0.2	1.00E00
polarity specification of anterior/posterior axis (GO:0009949)	2	0	.01	-	 < 0.2	1.00E00
anterior/posterior axis specification (GO:0009948)	51	0	.21	-	 < 0.2	1.00E00
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	8	1	.03	+	29.83	1.00E00
response to nitrosative stress (GO:0051409)	8	1	.03	+	29.83	1.00E00
regulation of neuronal action potential (GO:0098908)	5	0	.02	-	 < 0.2	1.00E00
proximal/distal axis specification (GO:0009946)	4	0	.02	-	 < 0.2	1.00E00
regulation of SA node cell action potential (GO:0098907)	2	0	.01	-	 < 0.2	1.00E00
regulation of Purkinje myocyte action potential (GO:0098906)	1	0	.00	-	 < 0.2	1.00E00
regulation of bundle of His cell action potential (GO:0098905)	2	0	.01	-	 < 0.2	1.00E00
regulation of AV node cell action potential (GO:0098904)	3	0	.01	-	 < 0.2	1.00E00
response to leptomycin B (GO:1901344)	2	0	.01	-	 < 0.2	1.00E00
regulation of membrane repolarization during action potential (GO:0098903)	8	1	.03	+	29.83	1.00E00
negative regulation of vasculature development (GO:1901343)	90	1	.38	+	2.65	1.00E00
stress-activated MAPK cascade (GO:0051403)	104	4	.44	+	9.18	1.00E00
regulation of membrane depolarization during action potential (GO:0098902)	6	0	.03	-	 < 0.2	1.00E00
regulation of vasculature development (GO:1901342)	256	3	1.07	+	2.80	1.00E00
regulation of cardiac muscle cell action potential (GO:0098901)	27	1	.11	+	8.84	1.00E00
positive regulation of store-operated calcium channel activity (GO:1901341)	6	0	.03	-	 < 0.2	1.00E00
regulation of action potential (GO:0098900)	48	1	.20	+	4.97	1.00E00
negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.00	-	 < 0.2	1.00E00
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	23	0	.10	-	 < 0.2	1.00E00
negative regulation of pancreatic juice secretion (GO:0090188)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of pancreatic juice secretion (GO:0090187)	2	0	.01	-	 < 0.2	1.00E00
regulation of pancreatic juice secretion (GO:0090186)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of kidney development (GO:0090185)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of kidney development (GO:0090184)	40	1	.17	+	5.97	1.00E00
regulation of kidney development (GO:0090183)	54	1	.23	+	4.42	1.00E00
regulation of secretion of lysosomal enzymes (GO:0090182)	2	0	.01	-	 < 0.2	1.00E00
regulation of cholesterol metabolic process (GO:0090181)	53	1	.22	+	4.50	1.00E00
regulation of store-operated calcium channel activity (GO:1901339)	8	0	.03	-	 < 0.2	1.00E00
thioester transport (GO:1901337)	1	0	.00	-	 < 0.2	1.00E00
planar cell polarity pathway involved in neural tube closure (GO:0090179)	13	0	.05	-	 < 0.2	1.00E00
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	15	0	.06	-	 < 0.2	1.00E00
establishment of planar polarity involved in neural tube closure (GO:0090177)	2	0	.01	-	 < 0.2	1.00E00
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment of planar polarity (GO:0090175)	114	0	.48	-	 < 0.2	1.00E00
organelle membrane fusion (GO:0090174)	102	0	.43	-	 < 0.2	1.00E00
chondrocyte morphogenesis (GO:0090171)	1	0	.00	-	 < 0.2	1.00E00
regulation of Golgi inheritance (GO:0090170)	4	1	.02	+	59.66	1.00E00
dendrite self-avoidance (GO:0070593)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of heart induction (GO:1901321)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of heart induction (GO:1901320)	1	0	.00	-	 < 0.2	1.00E00
regulation of spindle assembly (GO:0090169)	26	1	.11	+	9.18	1.00E00
Golgi reassembly (GO:0090168)	4	0	.02	-	 < 0.2	1.00E00
Golgi disassembly (GO:0090166)	6	0	.03	-	 < 0.2	1.00E00
asymmetric Golgi ribbon formation (GO:0090164)	2	0	.01	-	 < 0.2	1.00E00
establishment of epithelial cell polarity (GO:0090162)	27	0	.11	-	 < 0.2	1.00E00
Golgi ribbon formation (GO:0090161)	11	0	.05	-	 < 0.2	1.00E00
Golgi to lysosome transport (GO:0090160)	8	0	.03	-	 < 0.2	1.00E00
cellular component macromolecule biosynthetic process (GO:0070589)	1	0	.00	-	 < 0.2	1.00E00
calcium ion transmembrane transport (GO:0070588)	189	0	.79	-	 < 0.2	1.00E00
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	9	0	.04	-	 < 0.2	1.00E00
cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.00	-	 < 0.2	1.00E00
protein localization to mitochondrion (GO:0070585)	75	2	.31	+	6.36	1.00E00
negative regulation of flagellated sperm motility (GO:1901318)	4	0	.02	-	 < 0.2	1.00E00
mitochondrion morphogenesis (GO:0070584)	21	0	.09	-	 < 0.2	1.00E00
regulation of flagellated sperm motility (GO:1901317)	16	0	.07	-	 < 0.2	1.00E00
hormone transport (GO:0009914)	86	1	.36	+	2.78	1.00E00
epidermal cell differentiation (GO:0009913)	310	4	1.30	+	3.08	1.00E00
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	3	0	.01	-	 < 0.2	1.00E00
auditory receptor cell fate commitment (GO:0009912)	6	0	.03	-	 < 0.2	1.00E00
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of collateral sprouting in absence of injury (GO:0048698)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of collateral sprouting in absence of injury (GO:0048697)	2	0	.01	-	 < 0.2	1.00E00
regulation of collateral sprouting in absence of injury (GO:0048696)	3	0	.01	-	 < 0.2	1.00E00
endoplasmic reticulum membrane organization (GO:0090158)	3	0	.01	-	 < 0.2	1.00E00
cellular sphingolipid homeostasis (GO:0090156)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of sphingolipid biosynthetic process (GO:0090155)	4	0	.02	-	 < 0.2	1.00E00
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of axon extension involved in regeneration (GO:0048692)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of sphingolipid biosynthetic process (GO:0090154)	9	1	.04	+	26.52	1.00E00
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of axon extension involved in regeneration (GO:0048691)	1	0	.00	-	 < 0.2	1.00E00
regulation of sphingolipid biosynthetic process (GO:0090153)	14	1	.06	+	17.05	1.00E00
regulation of axon extension involved in regeneration (GO:0048690)	2	0	.01	-	 < 0.2	1.00E00
establishment of protein localization to mitochondrial membrane (GO:0090151)	12	0	.05	-	 < 0.2	1.00E00
establishment of protein localization to membrane (GO:0090150)	218	2	.91	+	2.19	1.00E00
cadmium ion transmembrane transport (GO:0070574)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of spermidine biosynthetic process (GO:1901307)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neuron projection regeneration (GO:0070572)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of neuron projection regeneration (GO:0070571)	14	0	.06	-	 < 0.2	1.00E00
regulation of spermidine biosynthetic process (GO:1901304)	1	0	.00	-	 < 0.2	1.00E00
regulation of neuron projection regeneration (GO:0070570)	26	0	.11	-	 < 0.2	1.00E00
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	1	0	.00	-	 < 0.2	1.00E00
regulation of nitric-oxide synthase activity (GO:0050999)	44	3	.18	+	16.27	1.00E00
regulation of cargo loading into COPII-coated vesicle (GO:1901301)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of lipid catabolic process (GO:0050996)	22	2	.09	+	21.70	1.00E00
negative regulation of lipid catabolic process (GO:0050995)	22	1	.09	+	10.85	1.00E00
regulation of lipid catabolic process (GO:0050994)	51	3	.21	+	14.04	1.00E00
dimethylallyl diphosphate metabolic process (GO:0050993)	2	0	.01	-	 < 0.2	1.00E00
dimethylallyl diphosphate biosynthetic process (GO:0050992)	2	0	.01	-	 < 0.2	1.00E00
RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript (GO:0001189)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of sprouting of injured axon (GO:0048688)	1	0	.00	-	 < 0.2	1.00E00
RNA polymerase I transcriptional preinitiation complex assembly (GO:0001188)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of sprouting of injured axon (GO:0048687)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial membrane fission (GO:0090149)	2	0	.01	-	 < 0.2	1.00E00
regulation of sprouting of injured axon (GO:0048686)	2	0	.01	-	 < 0.2	1.00E00
membrane fission (GO:0090148)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685)	1	0	.00	-	 < 0.2	1.00E00
regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	1	0	.00	-	 < 0.2	1.00E00
sprouting of injured axon (GO:0048682)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of axon regeneration (GO:0048681)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of axon regeneration (GO:0048680)	6	0	.03	-	 < 0.2	1.00E00
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript (GO:0001180)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of mitochondrial fission (GO:0090141)	15	0	.06	-	 < 0.2	1.00E00
regulation of mitochondrial fission (GO:0090140)	23	0	.10	-	 < 0.2	1.00E00
positive regulation of vitamin D receptor signaling pathway (GO:0070564)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	0	.01	-	 < 0.2	1.00E00
regulation of vitamin D receptor signaling pathway (GO:0070562)	6	0	.03	-	 < 0.2	1.00E00
vitamin D receptor signaling pathway (GO:0070561)	3	0	.01	-	 < 0.2	1.00E00
protein secretion by platelet (GO:0070560)	2	0	.01	-	 < 0.2	1.00E00
regulation of axon regeneration (GO:0048679)	22	0	.09	-	 < 0.2	1.00E00
detection of mechanical stimulus (GO:0050982)	45	1	.19	+	5.30	1.00E00
response to axon injury (GO:0048678)	44	2	.18	+	10.85	1.00E00
axon extension involved in regeneration (GO:0048677)	1	0	.00	-	 < 0.2	1.00E00
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	0	.00	-	 < 0.2	1.00E00
axon extension (GO:0048675)	34	0	.14	-	 < 0.2	1.00E00
epithelial cell-cell adhesion (GO:0090136)	17	0	.07	-	 < 0.2	1.00E00
actin filament branching (GO:0090135)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of collateral sprouting (GO:0048672)	10	0	.04	-	 < 0.2	1.00E00
cell migration involved in mesendoderm migration (GO:0090134)	2	0	.01	-	 < 0.2	1.00E00
transcription, RNA-templated (GO:0001172)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of collateral sprouting (GO:0048671)	11	0	.05	-	 < 0.2	1.00E00
mesendoderm migration (GO:0090133)	2	0	.01	-	 < 0.2	1.00E00
reverse transcription (GO:0001171)	1	0	.00	-	 < 0.2	1.00E00
regulation of collateral sprouting (GO:0048670)	20	0	.08	-	 < 0.2	1.00E00
epithelium migration (GO:0090132)	83	2	.35	+	5.75	1.00E00
mesenchyme migration (GO:0090131)	5	0	.02	-	 < 0.2	1.00E00
tissue migration (GO:0090130)	90	2	.38	+	5.30	1.00E00
response to interleukin-1 (GO:0070555)	114	2	.48	+	4.19	1.00E00
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	2	0	.01	-	 < 0.2	1.00E00
sensory perception of touch (GO:0050975)	3	0	.01	-	 < 0.2	1.00E00
detection of mechanical stimulus involved in sensory perception (GO:0050974)	27	1	.11	+	8.84	1.00E00
detection of mechanical stimulus involved in equilibrioception (GO:0050973)	1	0	.00	-	 < 0.2	1.00E00
collateral sprouting in absence of injury (GO:0048669)	2	0	.01	-	 < 0.2	1.00E00
collateral sprouting (GO:0048668)	8	0	.03	-	 < 0.2	1.00E00
cell morphogenesis involved in neuron differentiation (GO:0048667)	403	6	1.69	+	3.55	1.00E00
positive regulation of synapse maturation (GO:0090129)	9	0	.04	-	 < 0.2	1.00E00
neuron development (GO:0048666)	763	11	3.20	+	3.44	1.00E00
regulation of synapse maturation (GO:0090128)	12	0	.05	-	 < 0.2	1.00E00
neuron fate specification (GO:0048665)	34	0	.14	-	 < 0.2	1.00E00
neuron fate determination (GO:0048664)	9	0	.04	-	 < 0.2	1.00E00
protein complex assembly involved in synapse maturation (GO:0090126)	1	0	.00	-	 < 0.2	1.00E00
neuron fate commitment (GO:0048663)	70	2	.29	+	6.82	1.00E00
negative regulation of smooth muscle cell proliferation (GO:0048662)	38	0	.16	-	 < 0.2	1.00E00
cholesterol ester hydrolysis involved in cholesterol transport (GO:0090122)	1	0	.00	-	 < 0.2	1.00E00
histone H3-K36 demethylation (GO:0070544)	10	0	.04	-	 < 0.2	1.00E00
response to linoleic acid (GO:0070543)	2	0	.01	-	 < 0.2	1.00E00
response to fatty acid (GO:0070542)	87	3	.36	+	8.23	1.00E00
response to platinum ion (GO:0070541)	2	0	.01	-	 < 0.2	1.00E00
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	3	0	.01	-	 < 0.2	1.00E00
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	10	1	.04	+	23.87	1.00E00
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	16	0	.07	-	 < 0.2	1.00E00
detection of calcium ion (GO:0005513)	12	0	.05	-	 < 0.2	1.00E00
smooth muscle cell proliferation (GO:0048659)	4	0	.02	-	 < 0.2	1.00E00
detection of light stimulus involved in sensory perception (GO:0050962)	16	0	.07	-	 < 0.2	1.00E00
detection of temperature stimulus involved in sensory perception (GO:0050961)	16	0	.07	-	 < 0.2	1.00E00
detection of temperature stimulus involved in thermoception (GO:0050960)	1	0	.00	-	 < 0.2	1.00E00
vesicle-mediated cholesterol transport (GO:0090119)	2	0	.01	-	 < 0.2	1.00E00
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	3	0	.01	-	 < 0.2	1.00E00
C-5 methylation of cytosine (GO:0090116)	3	0	.01	-	 < 0.2	1.00E00
COPII-coated vesicle budding (GO:0090114)	66	0	.28	-	 < 0.2	1.00E00
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	1	0	.00	-	 < 0.2	1.00E00
cargo loading into COPII-coated vesicle (GO:0090110)	11	0	.05	-	 < 0.2	1.00E00
histone H2A K63-linked deubiquitination (GO:0070537)	3	0	.01	-	 < 0.2	1.00E00
protein K63-linked deubiquitination (GO:0070536)	26	0	.11	-	 < 0.2	1.00E00
histone H2A K63-linked ubiquitination (GO:0070535)	2	0	.01	-	 < 0.2	1.00E00
protein K63-linked ubiquitination (GO:0070534)	37	1	.16	+	6.45	1.00E00
equilibrioception (GO:0050957)	7	0	.03	-	 < 0.2	1.00E00
thermoception (GO:0050955)	3	0	.01	-	 < 0.2	1.00E00
sensory perception of mechanical stimulus (GO:0050954)	163	2	.68	+	2.93	1.00E00
sensory perception of light stimulus (GO:0050953)	210	1	.88	+	1.14	1.00E00
sensory perception of temperature stimulus (GO:0050951)	22	0	.09	-	 < 0.2	1.00E00
regulation of cell-substrate junction assembly (GO:0090109)	53	1	.22	+	4.50	1.00E00
positive regulation of high-density lipoprotein particle assembly (GO:0090108)	1	0	.00	-	 < 0.2	1.00E00
animal organ formation (GO:0048645)	35	2	.15	+	13.64	1.00E00
regulation of high-density lipoprotein particle assembly (GO:0090107)	3	0	.01	-	 < 0.2	1.00E00
muscle organ morphogenesis (GO:0048644)	81	1	.34	+	2.95	1.00E00
positive regulation of skeletal muscle tissue development (GO:0048643)	26	2	.11	+	18.36	1.00E00
negative regulation of skeletal muscle tissue development (GO:0048642)	13	0	.05	-	 < 0.2	1.00E00
pancreatic epsilon cell differentiation (GO:0090104)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle tissue development (GO:0048641)	52	2	.22	+	9.18	1.00E00
cochlea morphogenesis (GO:0090103)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of developmental growth (GO:0048640)	84	2	.35	+	5.68	1.00E00
cochlea development (GO:0090102)	48	0	.20	-	 < 0.2	1.00E00
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	108	3	.45	+	6.63	1.00E00
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	101	0	.42	-	 < 0.2	1.00E00
protein kinase C signaling (GO:0070528)	13	0	.05	-	 < 0.2	1.00E00
small molecule biosynthetic process (GO:0044283)	447	6	1.87	+	3.20	1.00E00
platelet aggregation (GO:0070527)	41	0	.17	-	 < 0.2	1.00E00
small molecule catabolic process (GO:0044282)	363	1	1.52	-	.66	1.00E00
small molecule metabolic process (GO:0044281)	1814	15	7.60	+	1.97	1.00E00
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of pigment cell differentiation (GO:0050942)	7	1	.03	+	34.09	1.00E00
negative regulation of muscle organ development (GO:0048635)	47	2	.20	+	10.16	1.00E00
positive regulation of skeletal muscle tissue growth (GO:0048633)	5	1	.02	+	47.73	1.00E00
negative regulation of skeletal muscle tissue growth (GO:0048632)	2	0	.01	-	 < 0.2	1.00E00
regulation of skeletal muscle tissue growth (GO:0048631)	7	1	.03	+	34.09	1.00E00
skeletal muscle tissue growth (GO:0048630)	3	0	.01	-	 < 0.2	1.00E00
cell wall disruption in other organism (GO:0044278)	1	0	.00	-	 < 0.2	1.00E00
cellular carbohydrate catabolic process (GO:0044275)	34	0	.14	-	 < 0.2	1.00E00
sulfur compound catabolic process (GO:0044273)	53	0	.22	-	 < 0.2	1.00E00
sulfur compound biosynthetic process (GO:0044272)	193	1	.81	+	1.24	1.00E00
cellular nitrogen compound biosynthetic process (GO:0044271)	3467	26	14.53	+	1.79	1.00E00
cellular nitrogen compound catabolic process (GO:0044270)	405	2	1.70	+	1.18	1.00E00
positive regulation of histone H4-K20 methylation (GO:0070512)	1	0	.00	-	 < 0.2	1.00E00
regulation of histone H4-K20 methylation (GO:0070510)	1	0	.00	-	 < 0.2	1.00E00
regulation of pigment cell differentiation (GO:0050932)	9	1	.04	+	26.52	1.00E00
pigment cell differentiation (GO:0050931)	29	1	.12	+	8.23	1.00E00
myoblast development (GO:0048627)	2	0	.01	-	 < 0.2	1.00E00
induction of positive chemotaxis (GO:0050930)	15	0	.06	-	 < 0.2	1.00E00
myoblast fate commitment (GO:0048625)	5	0	.02	-	 < 0.2	1.00E00
post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.00	-	 < 0.2	1.00E00
multicellular organismal protein metabolic process (GO:0044268)	5	0	.02	-	 < 0.2	1.00E00
multicellular organismal macromolecule catabolic process (GO:0044266)	4	0	.02	-	 < 0.2	1.00E00
cellular macromolecule catabolic process (GO:0044265)	855	8	3.58	+	2.23	1.00E00
calcium ion import (GO:0070509)	35	0	.15	-	 < 0.2	1.00E00
cellular polysaccharide metabolic process (GO:0044264)	72	2	.30	+	6.63	1.00E00
cholesterol import (GO:0070508)	6	0	.03	-	 < 0.2	1.00E00
regulation of microtubule cytoskeleton organization (GO:0070507)	153	2	.64	+	3.12	1.00E00
cellular carbohydrate metabolic process (GO:0044262)	150	3	.63	+	4.77	1.00E00
positive regulation of DNA-dependent DNA replication initiation (GO:0032298)	2	0	.01	-	 < 0.2	1.00E00
induction of negative chemotaxis (GO:0050929)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of positive chemotaxis (GO:0050928)	1	0	.00	-	 < 0.2	1.00E00
peripheral nervous system axon ensheathment (GO:0032292)	23	2	.10	+	20.75	1.00E00
positive regulation of positive chemotaxis (GO:0050927)	26	1	.11	+	9.18	1.00E00
axon ensheathment in central nervous system (GO:0032291)	17	0	.07	-	 < 0.2	1.00E00
regulation of positive chemotaxis (GO:0050926)	27	1	.11	+	8.84	1.00E00
peripheral nervous system myelin formation (GO:0032290)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of negative chemotaxis (GO:0050925)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of negative chemotaxis (GO:0050924)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial RNA modification (GO:1900864)	9	0	.04	-	 < 0.2	1.00E00
regulation of negative chemotaxis (GO:0050923)	4	0	.02	-	 < 0.2	1.00E00
embryonic hindgut morphogenesis (GO:0048619)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of chemotaxis (GO:0050922)	37	0	.16	-	 < 0.2	1.00E00
positive regulation of chemotaxis (GO:0050921)	133	5	.56	+	8.97	1.00E00
embryonic foregut morphogenesis (GO:0048617)	9	0	.04	-	 < 0.2	1.00E00
regulation of chemotaxis (GO:0050920)	181	5	.76	+	6.59	1.00E00
embryonic ectodermal digestive tract morphogenesis (GO:0048613)	1	0	.00	-	 < 0.2	1.00E00
embryonic ectodermal digestive tract development (GO:0048611)	2	0	.01	-	 < 0.2	1.00E00
multicellular organismal macromolecule metabolic process (GO:0044259)	85	2	.36	+	5.62	1.00E00
intestinal lipid catabolic process (GO:0044258)	1	0	.00	-	 < 0.2	1.00E00
cellular protein catabolic process (GO:0044257)	583	6	2.44	+	2.46	1.00E00
protein digestion (GO:0044256)	4	0	.02	-	 < 0.2	1.00E00
cellular lipid metabolic process (GO:0044255)	984	13	4.12	+	3.15	1.00E00
multicellular organismal protein catabolic process (GO:0044254)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of multicellular organismal metabolic process (GO:0044253)	26	2	.11	+	18.36	1.00E00
negative regulation of multicellular organismal metabolic process (GO:0044252)	10	1	.04	+	23.87	1.00E00
central nervous system myelin formation (GO:0032289)	3	0	.01	-	 < 0.2	1.00E00
myelin assembly (GO:0032288)	18	0	.08	-	 < 0.2	1.00E00
peripheral nervous system myelin maintenance (GO:0032287)	7	2	.03	+	68.19	1.00E00
central nervous system myelin maintenance (GO:0032286)	4	0	.02	-	 < 0.2	1.00E00
negative chemotaxis (GO:0050919)	36	1	.15	+	6.63	1.00E00
positive chemotaxis (GO:0050918)	41	1	.17	+	5.82	1.00E00
sensory perception of umami taste (GO:0050917)	6	0	.03	-	 < 0.2	1.00E00
sensory perception of sweet taste (GO:0050916)	6	0	.03	-	 < 0.2	1.00E00
sensory perception of sour taste (GO:0050915)	5	0	.02	-	 < 0.2	1.00E00
sensory perception of bitter taste (GO:0050913)	41	0	.17	-	 < 0.2	1.00E00
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	42	0	.18	-	 < 0.2	1.00E00
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	429	0	1.80	-	 < 0.2	1.00E00
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	13	0	.05	-	 < 0.2	1.00E00
cellular biosynthetic process (GO:0044249)	4666	33	19.55	+	1.69	1.00E00
negative regulation of exit from mitosis (GO:0001100)	1	0	.00	-	 < 0.2	1.00E00
cellular catabolic process (GO:0044248)	1645	10	6.89	+	1.45	1.00E00
cellular polysaccharide catabolic process (GO:0044247)	20	0	.08	-	 < 0.2	1.00E00
regulation of multicellular organismal metabolic process (GO:0044246)	39	3	.16	+	18.36	1.00E00
polysaccharide digestion (GO:0044245)	6	0	.03	-	 < 0.2	1.00E00
multicellular organismal catabolic process (GO:0044243)	73	2	.31	+	6.54	1.00E00
cellular lipid catabolic process (GO:0044242)	171	0	.72	-	 < 0.2	1.00E00
lipid digestion (GO:0044241)	16	0	.07	-	 < 0.2	1.00E00
multicellular organismal lipid catabolic process (GO:0044240)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of gonadotropin secretion (GO:0032278)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of gonadotropin secretion (GO:0032277)	7	0	.03	-	 < 0.2	1.00E00
regulation of gonadotropin secretion (GO:0032276)	11	0	.05	-	 < 0.2	1.00E00
luteinizing hormone secretion (GO:0032275)	4	0	.02	-	 < 0.2	1.00E00
gonadotropin secretion (GO:0032274)	5	0	.02	-	 < 0.2	1.00E00
sensory perception of taste (GO:0050909)	65	0	.27	-	 < 0.2	1.00E00
positive regulation of protein polymerization (GO:0032273)	109	1	.46	+	2.19	1.00E00
detection of light stimulus involved in visual perception (GO:0050908)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of protein polymerization (GO:0032272)	58	1	.24	+	4.11	1.00E00
detection of chemical stimulus involved in sensory perception (GO:0050907)	474	0	1.99	-	 < 0.2	1.00E00
regulation of protein polymerization (GO:0032271)	187	3	.78	+	3.83	1.00E00
detection of stimulus involved in sensory perception (GO:0050906)	526	1	2.20	-	.45	1.00E00
positive regulation of calcineurin-mediated signaling (GO:0106058)	9	2	.04	+	53.04	1.00E00
neuromuscular process (GO:0050905)	103	1	.43	+	2.32	1.00E00
negative regulation of calcineurin-mediated signaling (GO:0106057)	4	0	.02	-	 < 0.2	1.00E00
diapedesis (GO:0050904)	3	1	.01	+	79.55	1.00E00
regulation of calcineurin-mediated signaling (GO:0106056)	17	2	.07	+	28.08	1.00E00
leukocyte adhesive activation (GO:0050902)	2	0	.01	-	 < 0.2	1.00E00
leukocyte tethering or rolling (GO:0050901)	15	0	.06	-	 < 0.2	1.00E00
leukocyte migration (GO:0050900)	363	8	1.52	+	5.26	1.00E00
multicellular organism metabolic process (GO:0044236)	105	2	.44	+	4.55	1.00E00
IMP salvage (GO:0032264)	4	0	.02	-	 < 0.2	1.00E00
pyrimidine nucleotide salvage (GO:0032262)	5	0	.02	-	 < 0.2	1.00E00
regulation of cellular response to osmotic stress (GO:0106049)	7	0	.03	-	 < 0.2	1.00E00
purine nucleotide salvage (GO:0032261)	7	0	.03	-	 < 0.2	1.00E00
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.00	-	 < 0.2	1.00E00
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.00	-	 < 0.2	1.00E00
guanine deglycation (GO:0106044)	1	0	.00	-	 < 0.2	1.00E00
methylation (GO:0032259)	301	1	1.26	-	.79	1.00E00
dense core granule localization (GO:0032253)	1	0	.00	-	 < 0.2	1.00E00
secretory granule localization (GO:0032252)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826)	1	0	.00	-	 < 0.2	1.00E00
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	5	0	.02	-	 < 0.2	1.00E00
neuron projection fasciculation (GO:0106030)	20	0	.08	-	 < 0.2	1.00E00
CTP salvage (GO:0044211)	3	0	.01	-	 < 0.2	1.00E00
'de novo' CTP biosynthetic process (GO:0044210)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of nucleoside transport (GO:0032244)	1	0	.00	-	 < 0.2	1.00E00
regulation of nucleoside transport (GO:0032242)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of nucleobase-containing compound transport (GO:0032241)	5	0	.02	-	 < 0.2	1.00E00
neuron projection retraction (GO:0106028)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of nucleobase-containing compound transport (GO:0032240)	2	0	.01	-	 < 0.2	1.00E00
neuron projection organization (GO:0106027)	32	0	.13	-	 < 0.2	1.00E00
positive regulation of vesicle docking (GO:0106022)	1	0	.00	-	 < 0.2	1.00E00
regulation of vesicle docking (GO:0106020)	2	0	.01	-	 < 0.2	1.00E00
AMP salvage (GO:0044209)	2	0	.01	-	 < 0.2	1.00E00
'de novo' AMP biosynthetic process (GO:0044208)	3	0	.01	-	 < 0.2	1.00E00
UMP salvage (GO:0044206)	5	0	.02	-	 < 0.2	1.00E00
'de novo' UMP biosynthetic process (GO:0044205)	3	0	.01	-	 < 0.2	1.00E00
regulation of nucleobase-containing compound transport (GO:0032239)	15	0	.06	-	 < 0.2	1.00E00
activation of store-operated calcium channel activity (GO:0032237)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of actin filament bundle assembly (GO:0032233)	57	0	.24	-	 < 0.2	1.00E00
negative regulation of actin filament bundle assembly (GO:0032232)	23	0	.10	-	 < 0.2	1.00E00
regulation of actin filament bundle assembly (GO:0032231)	89	1	.37	+	2.68	1.00E00
positive regulation of synaptic transmission, GABAergic (GO:0032230)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of inflammatory response to wounding (GO:0106015)	1	0	.00	-	 < 0.2	1.00E00
regulation of inflammatory response to wounding (GO:0106014)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of synaptic transmission, GABAergic (GO:0032229)	6	0	.03	-	 < 0.2	1.00E00
regulation of synaptic transmission, GABAergic (GO:0032228)	32	0	.13	-	 < 0.2	1.00E00
negative regulation of synaptic transmission, dopaminergic (GO:0032227)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of synaptic transmission, dopaminergic (GO:0032226)	7	0	.03	-	 < 0.2	1.00E00
regulation of synaptic transmission, dopaminergic (GO:0032225)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of synaptic transmission, cholinergic (GO:0032224)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of synaptic transmission, cholinergic (GO:0032223)	1	0	.00	-	 < 0.2	1.00E00
regulation of synaptic transmission, cholinergic (GO:0032222)	10	0	.04	-	 < 0.2	1.00E00
RNA 5'-cap (guanine-N7)-methylation (GO:0106005)	2	0	.01	-	 < 0.2	1.00E00
tRNA (guanine-N7)-methylation (GO:0106004)	2	0	.01	-	 < 0.2	1.00E00
intestinal hexose absorption (GO:0106001)	6	0	.03	-	 < 0.2	1.00E00
riboflavin transport (GO:0032218)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of telomere maintenance via semi-conservative replication (GO:0032214)	2	0	.01	-	 < 0.2	1.00E00
regulation of telomere maintenance via semi-conservative replication (GO:0032213)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of telomere maintenance via telomerase (GO:0032212)	34	2	.14	+	14.04	1.00E00
negative regulation of telomere maintenance via telomerase (GO:0032211)	21	1	.09	+	11.36	1.00E00
regulation of telomere maintenance via telomerase (GO:0032210)	54	3	.23	+	13.26	1.00E00
negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.00	-	 < 0.2	1.00E00
regulation of telomere maintenance via recombination (GO:0032207)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of telomere maintenance (GO:0032206)	49	2	.21	+	9.74	1.00E00
negative regulation of telomere maintenance (GO:0032205)	37	2	.16	+	12.90	1.00E00
regulation of telomere maintenance (GO:0032204)	79	3	.33	+	9.06	1.00E00
telomere formation via telomerase (GO:0032203)	1	0	.00	-	 < 0.2	1.00E00
telomere assembly (GO:0032202)	4	0	.02	-	 < 0.2	1.00E00
telomere maintenance via semi-conservative replication (GO:0032201)	25	1	.10	+	9.55	1.00E00
telomere organization (GO:0032200)	94	4	.39	+	10.16	1.00E00
positive regulation of polysome binding (GO:1905698)	1	0	.00	-	 < 0.2	1.00E00
regulation of polysome binding (GO:1905696)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of phosphatidic acid biosynthetic process (GO:1905695)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphatidic acid biosynthetic process (GO:1905693)	1	0	.00	-	 < 0.2	1.00E00
regulation of nerve growth factor receptor activity (GO:0051394)	1	0	.00	-	 < 0.2	1.00E00
tRNA acetylation (GO:0051391)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of diacylglycerol kinase activity (GO:1905689)	1	0	.00	-	 < 0.2	1.00E00
regulation of diacylglycerol kinase activity (GO:1905687)	1	0	.00	-	 < 0.2	1.00E00
inactivation of MAPKK activity (GO:0051389)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	5	0	.02	-	 < 0.2	1.00E00
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	4	0	.02	-	 < 0.2	1.00E00
modification of dendritic spine (GO:0098886)	2	0	.01	-	 < 0.2	1.00E00
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	11	0	.05	-	 < 0.2	1.00E00
response to mineralocorticoid (GO:0051385)	28	3	.12	+	25.57	1.00E00
postsynaptic neurotransmitter receptor internalization (GO:0098884)	1	0	.00	-	 < 0.2	1.00E00
synapse disassembly (GO:0098883)	1	0	.00	-	 < 0.2	1.00E00
kinetochore organization (GO:0051383)	15	0	.06	-	 < 0.2	1.00E00
kinetochore assembly (GO:0051382)	11	0	.05	-	 < 0.2	1.00E00
exocytic insertion of neurotransmitter receptor to plasma membrane (GO:0098881)	4	0	.02	-	 < 0.2	1.00E00
RNA localization to chromatin (GO:1990280)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lysosome organization (GO:1905672)	1	0	.00	-	 < 0.2	1.00E00
regulation of lysosome organization (GO:1905671)	3	0	.01	-	 < 0.2	1.00E00
neurotransmitter receptor transport to plasma membrane (GO:0098877)	11	0	.05	-	 < 0.2	1.00E00
vesicle-mediated transport to the plasma membrane (GO:0098876)	67	0	.28	-	 < 0.2	1.00E00
action potential propagation (GO:0098870)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of protein localization to endosome (GO:1905668)	6	0	.03	-	 < 0.2	1.00E00
regulation of protein localization to endosome (GO:1905666)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of calcium ion import across plasma membrane (GO:1905665)	2	0	.01	-	 < 0.2	1.00E00
regulation of calcium ion import across plasma membrane (GO:1905664)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663)	2	0	.01	-	 < 0.2	1.00E00
cellular oxidant detoxification (GO:0098869)	84	0	.35	-	 < 0.2	1.00E00
regulation of telomerase RNA reverse transcriptase activity (GO:1905661)	2	0	.01	-	 < 0.2	1.00E00
bone growth (GO:0098868)	22	0	.09	-	 < 0.2	1.00E00
response to gold nanoparticle (GO:1990268)	1	0	.00	-	 < 0.2	1.00E00
response to transition metal nanoparticle (GO:1990267)	1	0	.00	-	 < 0.2	1.00E00
cellular response to potassium ion starvation (GO:0051365)	3	1	.01	+	79.55	1.00E00
neutrophil migration (GO:1990266)	72	3	.30	+	9.94	1.00E00
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	2	0	.01	-	 < 0.2	1.00E00
anti-Mullerian hormone signaling pathway (GO:1990262)	1	0	.00	-	 < 0.2	1.00E00
pre-mRNA catabolic process (GO:1990261)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of artery morphogenesis (GO:1905653)	2	0	.01	-	 < 0.2	1.00E00
regulation of artery morphogenesis (GO:1905651)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	6	0	.03	-	 < 0.2	1.00E00
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	10	0	.04	-	 < 0.2	1.00E00
intestinal lipid absorption (GO:0098856)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297)	1	0	.00	-	 < 0.2	1.00E00
histone glutamine methylation (GO:1990258)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296)	1	0	.00	-	 < 0.2	1.00E00
proprioception involved in equilibrioception (GO:0051355)	1	0	.00	-	 < 0.2	1.00E00
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	2	0	.01	-	 < 0.2	1.00E00
signal clustering (GO:1990256)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of oxidoreductase activity (GO:0051354)	26	1	.11	+	9.18	1.00E00
positive regulation of oxidoreductase activity (GO:0051353)	45	2	.19	+	10.61	1.00E00
nucleoside phosphate biosynthetic process (GO:1901293)	205	4	.86	+	4.66	1.00E00
negative regulation of ligase activity (GO:0051352)	2	0	.01	-	 < 0.2	1.00E00
nucleoside phosphate catabolic process (GO:1901292)	68	0	.28	-	 < 0.2	1.00E00
cellular response to leucine starvation (GO:1990253)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of ligase activity (GO:0051351)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of double-strand break repair via single-strand annealing (GO:1901291)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lyase activity (GO:0051350)	37	1	.16	+	6.45	1.00E00
proline import across plasma membrane (GO:1905647)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of DNA methylation (GO:1905643)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA methylation (GO:1905642)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lyase activity (GO:0051349)	61	2	.26	+	7.82	1.00E00
post-embryonic animal morphogenesis (GO:0009886)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of hydrolase activity (GO:0051346)	419	6	1.76	+	3.42	1.00E00
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	5	0	.02	-	 < 0.2	1.00E00
histone H2A-T120 phosphorylation (GO:1990245)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	3	0	.01	-	 < 0.2	1.00E00
embryonic pattern specification (GO:0009880)	66	0	.28	-	 < 0.2	1.00E00
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	7	0	.03	-	 < 0.2	1.00E00
regulation of oxidoreductase activity (GO:0051341)	88	4	.37	+	10.85	1.00E00
protein transport along microtubule (GO:0098840)	51	0	.21	-	 < 0.2	1.00E00
regulation of ligase activity (GO:0051340)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to chromatin (GO:1905634)	5	0	.02	-	 < 0.2	1.00E00
regulation of lyase activity (GO:0051339)	97	2	.41	+	4.92	1.00E00
reduced folate transmembrane transport (GO:0098838)	1	0	.00	-	 < 0.2	1.00E00
lipooligosaccharide biosynthetic process (GO:1901271)	1	0	.00	-	 < 0.2	1.00E00
intestinal folate absorption (GO:0098829)	1	0	.00	-	 < 0.2	1.00E00
modulation of inhibitory postsynaptic potential (GO:0098828)	7	0	.03	-	 < 0.2	1.00E00
lipooligosaccharide metabolic process (GO:1901269)	1	0	.00	-	 < 0.2	1.00E00
paranodal junction maintenance (GO:1990227)	1	0	.00	-	 < 0.2	1.00E00
carbohydrate derivative transport (GO:1901264)	57	0	.24	-	 < 0.2	1.00E00
peptidyl-cysteine modification to L-cysteine persulfide (GO:0098822)	1	0	.00	-	 < 0.2	1.00E00
meiotic cell cycle (GO:0051321)	217	3	.91	+	3.30	1.00E00
positive regulation of miRNA mediated inhibition of translation (GO:1905618)	2	0	.01	-	 < 0.2	1.00E00
regulation of miRNA mediated inhibition of translation (GO:1905616)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mRNA cap binding (GO:1905612)	1	0	.00	-	 < 0.2	1.00E00
regulation of mRNA cap binding (GO:1905610)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of macrophage colony-stimulating factor production (GO:1901258)	2	0	.01	-	 < 0.2	1.00E00
determination of bilateral symmetry (GO:0009855)	120	0	.50	-	 < 0.2	1.00E00
negative regulation of macrophage colony-stimulating factor production (GO:1901257)	1	0	.00	-	 < 0.2	1.00E00
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	2	0	.01	-	 < 0.2	1.00E00
modulation of excitatory postsynaptic potential (GO:0098815)	38	0	.16	-	 < 0.2	1.00E00
regulation of macrophage colony-stimulating factor production (GO:1901256)	4	0	.02	-	 < 0.2	1.00E00
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	9	0	.04	-	 < 0.2	1.00E00
spontaneous synaptic transmission (GO:0098814)	2	0	.01	-	 < 0.2	1.00E00
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.01	-	 < 0.2	1.00E00
nuclear chromosome segregation (GO:0098813)	259	3	1.09	+	2.76	1.00E00
positive regulation of intracellular transport of viral material (GO:1901254)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of intracellular transport of viral material (GO:1901253)	2	0	.01	-	 < 0.2	1.00E00
regulation of intracellular transport of viral material (GO:1901252)	3	0	.01	-	 < 0.2	1.00E00
meiotic metaphase plate congression (GO:0051311)	2	0	.01	-	 < 0.2	1.00E00
neurotransmitter reuptake (GO:0098810)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of lung goblet cell differentiation (GO:1901251)	1	0	.00	-	 < 0.2	1.00E00
metaphase plate congression (GO:0051310)	51	1	.21	+	4.68	1.00E00
negative regulation of lung goblet cell differentiation (GO:1901250)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096)	1	0	.00	-	 < 0.2	1.00E00
regulation of metanephric cap mesenchymal cell proliferation (GO:0090095)	1	0	.00	-	 < 0.2	1.00E00
metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of presynapse assembly (GO:1905608)	2	0	.01	-	 < 0.2	1.00E00
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	215	3	.90	+	3.33	1.00E00
positive regulation of extracellular matrix disassembly (GO:0090091)	7	0	.03	-	 < 0.2	1.00E00
regulation of presynapse assembly (GO:1905606)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of canonical Wnt signaling pathway (GO:0090090)	167	5	.70	+	7.15	1.00E00
negative regulation of maintenance of permeability of blood-brain barrier (GO:1905604)	1	0	.00	-	 < 0.2	1.00E00
regulation of maintenance of permeability of blood-brain barrier (GO:1905603)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601)	1	0	.00	-	 < 0.2	1.00E00
regulation of lung goblet cell differentiation (GO:1901249)	2	0	.01	-	 < 0.2	1.00E00
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	3	0	.01	-	 < 0.2	1.00E00
male meiosis chromosome separation (GO:0051308)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lung ciliated cell differentiation (GO:1901248)	1	0	.00	-	 < 0.2	1.00E00
meiotic chromosome separation (GO:0051307)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of lung ciliated cell differentiation (GO:1901247)	1	0	.00	-	 < 0.2	1.00E00
mitotic sister chromatid separation (GO:0051306)	3	0	.01	-	 < 0.2	1.00E00
regulation of lung ciliated cell differentiation (GO:1901246)	2	0	.01	-	 < 0.2	1.00E00
chromosome movement towards spindle pole (GO:0051305)	6	0	.03	-	 < 0.2	1.00E00
chromosome separation (GO:0051304)	24	0	.10	-	 < 0.2	1.00E00
establishment of chromosome localization (GO:0051303)	72	2	.30	+	6.63	1.00E00
regulation of cell division (GO:0051302)	138	1	.58	+	1.73	1.00E00
regulation of renal system process (GO:0098801)	35	0	.15	-	 < 0.2	1.00E00
cell division (GO:0051301)	488	4	2.04	+	1.96	1.00E00
regulation of dipeptide transport (GO:0090089)	2	0	.01	-	 < 0.2	1.00E00
regulation of oligopeptide transport (GO:0090088)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein deubiquitination (GO:0090086)	4	0	.02	-	 < 0.2	1.00E00
regulation of protein deubiquitination (GO:0090085)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of inclusion body assembly (GO:0090084)	11	0	.05	-	 < 0.2	1.00E00
regulation of inclusion body assembly (GO:0090083)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082)	2	0	.01	-	 < 0.2	1.00E00
regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)	5	0	.02	-	 < 0.2	1.00E00
abscission (GO:0009838)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of convergent extension involved in axis elongation (GO:1901233)	1	0	.00	-	 < 0.2	1.00E00
regulation of convergent extension involved in axis elongation (GO:1901232)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231)	1	0	.00	-	 < 0.2	1.00E00
foam cell differentiation (GO:0090077)	7	0	.03	-	 < 0.2	1.00E00
relaxation of skeletal muscle (GO:0090076)	2	0	.01	-	 < 0.2	1.00E00
relaxation of muscle (GO:0090075)	20	0	.08	-	 < 0.2	1.00E00
negative regulation of protein homodimerization activity (GO:0090074)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of protein homodimerization activity (GO:0090073)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of ribosome biogenesis (GO:0090071)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of ribosome biogenesis (GO:0090070)	9	0	.04	-	 < 0.2	1.00E00
interleukin-1-mediated signaling pathway (GO:0070498)	16	0	.07	-	 < 0.2	1.00E00
regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229)	1	0	.00	-	 < 0.2	1.00E00
unidimensional cell growth (GO:0009826)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228)	5	0	.02	-	 < 0.2	1.00E00
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227)	1	0	.00	-	 < 0.2	1.00E00
thrombin-activated receptor signaling pathway (GO:0070493)	9	0	.04	-	 < 0.2	1.00E00
alkaloid catabolic process (GO:0009822)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	41	1	.17	+	5.82	1.00E00
negative regulation of NIK/NF-kappaB signaling (GO:1901223)	11	0	.05	-	 < 0.2	1.00E00
alkaloid metabolic process (GO:0009820)	7	0	.03	-	 < 0.2	1.00E00
regulation of NIK/NF-kappaB signaling (GO:1901222)	57	1	.24	+	4.19	1.00E00
negative regulation of cardiac chamber morphogenesis (GO:1901220)	1	0	.00	-	 < 0.2	1.00E00
regulation of ribosome biogenesis (GO:0090069)	13	0	.05	-	 < 0.2	1.00E00
regulation of anatomical structure size (GO:0090066)	469	8	1.97	+	4.07	1.00E00
regulation of production of siRNA involved in RNA interference (GO:0090065)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of microtubule nucleation (GO:0090063)	4	0	.02	-	 < 0.2	1.00E00
T cell aggregation (GO:0070489)	2	0	.01	-	 < 0.2	1.00E00
neutrophil aggregation (GO:0070488)	2	0	.01	-	 < 0.2	1.00E00
monocyte aggregation (GO:0070487)	3	0	.01	-	 < 0.2	1.00E00
defense response to fungus, incompatible interaction (GO:0009817)	1	0	.00	-	 < 0.2	1.00E00
leukocyte aggregation (GO:0070486)	10	0	.04	-	 < 0.2	1.00E00
regulation of cardiac chamber morphogenesis (GO:1901219)	1	0	.00	-	 < 0.2	1.00E00
defense response, incompatible interaction (GO:0009814)	1	0	.00	-	 < 0.2	1.00E00
detection of hypoxia (GO:0070483)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of neuron death (GO:1901215)	189	6	.79	+	7.58	1.00E00
flavonoid metabolic process (GO:0009812)	15	0	.06	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213)	14	0	.06	-	 < 0.2	1.00E00
stilbene metabolic process (GO:0009810)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cardiac chamber formation (GO:1901211)	1	0	.00	-	 < 0.2	1.00E00
regulation of cardiac chamber formation (GO:1901210)	1	0	.00	-	 < 0.2	1.00E00
embryonic morphogenesis (GO:0048598)	562	8	2.35	+	3.40	1.00E00
post-embryonic camera-type eye morphogenesis (GO:0048597)	3	0	.01	-	 < 0.2	1.00E00
embryonic camera-type eye morphogenesis (GO:0048596)	26	0	.11	-	 < 0.2	1.00E00
camera-type eye morphogenesis (GO:0048593)	111	1	.47	+	2.15	1.00E00
eye morphogenesis (GO:0048592)	148	1	.62	+	1.61	1.00E00
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	10	0	.04	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.00	-	 < 0.2	1.00E00
rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.01	-	 < 0.2	1.00E00
rRNA base methylation (GO:0070475)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of heart looping (GO:1901208)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of uterine smooth muscle contraction (GO:0070474)	8	0	.03	-	 < 0.2	1.00E00
regulation of heart looping (GO:1901207)	2	0	.01	-	 < 0.2	1.00E00
coumarin metabolic process (GO:0009804)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of uterine smooth muscle contraction (GO:0070473)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of adrenergic receptor signaling pathway involved in heart process (GO:1901206)	1	0	.00	-	 < 0.2	1.00E00
regulation of uterine smooth muscle contraction (GO:0070472)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of adrenergic receptor signaling pathway involved in heart process (GO:1901205)	2	0	.01	-	 < 0.2	1.00E00
uterine smooth muscle contraction (GO:0070471)	1	0	.00	-	 < 0.2	1.00E00
regulation of adrenergic receptor signaling pathway involved in heart process (GO:1901204)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of extracellular matrix assembly (GO:1901203)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of extracellular matrix assembly (GO:1901202)	1	0	.00	-	 < 0.2	1.00E00
regulation of extracellular matrix assembly (GO:1901201)	13	0	.05	-	 < 0.2	1.00E00
determination of affect (GO:0050894)	1	0	.00	-	 < 0.2	1.00E00
sensory processing (GO:0050893)	4	0	.02	-	 < 0.2	1.00E00
intestinal absorption (GO:0050892)	30	0	.13	-	 < 0.2	1.00E00
developmental cell growth (GO:0048588)	86	0	.36	-	 < 0.2	1.00E00
multicellular organismal water homeostasis (GO:0050891)	63	1	.26	+	3.79	1.00E00
cognition (GO:0050890)	269	6	1.13	+	5.32	1.00E00
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	23	0	.10	-	 < 0.2	1.00E00
positive regulation of deacetylase activity (GO:0090045)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of tubulin deacetylation (GO:0090044)	1	0	.00	-	 < 0.2	1.00E00
regulation of tubulin deacetylation (GO:0090043)	6	0	.03	-	 < 0.2	1.00E00
tubulin deacetylation (GO:0090042)	2	0	.01	-	 < 0.2	1.00E00
nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080)	1	0	.00	-	 < 0.2	1.00E00
plus-end specific microtubule depolymerization (GO:0070462)	1	0	.00	-	 < 0.2	1.00E00
endocrine process (GO:0050886)	47	1	.20	+	5.08	1.00E00
neuromuscular process controlling balance (GO:0050885)	53	0	.22	-	 < 0.2	1.00E00
neuromuscular process controlling posture (GO:0050884)	16	0	.07	-	 < 0.2	1.00E00
musculoskeletal movement, spinal reflex action (GO:0050883)	3	0	.01	-	 < 0.2	1.00E00
voluntary musculoskeletal movement (GO:0050882)	5	0	.02	-	 < 0.2	1.00E00
nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079)	1	0	.00	-	 < 0.2	1.00E00
musculoskeletal movement (GO:0050881)	38	2	.16	+	12.56	1.00E00
regulation of blood vessel size (GO:0050880)	137	3	.57	+	5.23	1.00E00
negative regulation of protein kinase C signaling (GO:0090038)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein kinase C signaling (GO:0090037)	8	0	.03	-	 < 0.2	1.00E00
regulation of protein kinase C signaling (GO:0090036)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	2	0	.01	-	 < 0.2	1.00E00
regulation of chaperone-mediated protein complex assembly (GO:0090034)	2	0	.01	-	 < 0.2	1.00E00
long-day photoperiodism (GO:0048571)	1	0	.00	-	 < 0.2	1.00E00
notochord morphogenesis (GO:0048570)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of steroid hormone biosynthetic process (GO:0090032)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of steroid hormone biosynthetic process (GO:0090031)	3	0	.01	-	 < 0.2	1.00E00
regulation of steroid hormone biosynthetic process (GO:0090030)	9	0	.04	-	 < 0.2	1.00E00
prolactin secretion (GO:0070459)	4	0	.02	-	 < 0.2	1.00E00
cellular detoxification of nitrogen compound (GO:0070458)	3	0	.01	-	 < 0.2	1.00E00
multicellular organismal movement (GO:0050879)	38	2	.16	+	12.56	1.00E00
nervous system process (GO:0050877)	1275	10	5.34	+	1.87	1.00E00
brown fat cell differentiation (GO:0050873)	31	0	.13	-	 < 0.2	1.00E00
post-embryonic animal organ development (GO:0048569)	17	0	.07	-	 < 0.2	1.00E00
white fat cell differentiation (GO:0050872)	13	0	.05	-	 < 0.2	1.00E00
embryonic organ development (GO:0048568)	422	4	1.77	+	2.26	1.00E00
positive regulation of B cell activation (GO:0050871)	133	4	.56	+	7.18	1.00E00
ectodermal digestive tract morphogenesis (GO:0048567)	1	0	.00	-	 < 0.2	1.00E00
embryonic digestive tract development (GO:0048566)	35	0	.15	-	 < 0.2	1.00E00
digestive tract development (GO:0048565)	126	4	.53	+	7.58	1.00E00
negative regulation of monocyte chemotaxis (GO:0090027)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of monocyte chemotaxis (GO:0090026)	19	1	.08	+	12.56	1.00E00
post-embryonic animal organ morphogenesis (GO:0048563)	9	0	.04	-	 < 0.2	1.00E00
regulation of monocyte chemotaxis (GO:0090025)	24	1	.10	+	9.94	1.00E00
embryonic organ morphogenesis (GO:0048562)	287	1	1.20	-	.83	1.00E00
negative regulation of neutrophil chemotaxis (GO:0090024)	2	0	.01	-	 < 0.2	1.00E00
establishment of animal organ orientation (GO:0048561)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neutrophil chemotaxis (GO:0090023)	29	0	.12	-	 < 0.2	1.00E00
establishment of anatomical structure orientation (GO:0048560)	3	0	.01	-	 < 0.2	1.00E00
regulation of neutrophil chemotaxis (GO:0090022)	34	0	.14	-	 < 0.2	1.00E00
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	0	.00	-	 < 0.2	1.00E00
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	9	1	.04	+	26.52	1.00E00
negative regulation of B cell activation (GO:0050869)	32	3	.13	+	22.37	1.00E00
negative regulation of T cell activation (GO:0050868)	100	3	.42	+	7.16	1.00E00
positive regulation of T cell receptor signaling pathway (GO:0050862)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of B cell receptor signaling pathway (GO:0050861)	7	0	.03	-	 < 0.2	1.00E00
embryonic digestive tract morphogenesis (GO:0048557)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of T cell receptor signaling pathway (GO:0050860)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of pinocytosis (GO:0048550)	5	1	.02	+	47.73	1.00E00
transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	3	0	.01	-	 < 0.2	1.00E00
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	6	0	.03	-	 < 0.2	1.00E00
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of B cell receptor signaling pathway (GO:0050859)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	23	0	.10	-	 < 0.2	1.00E00
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	21	0	.09	-	 < 0.2	1.00E00
regulation of T cell receptor signaling pathway (GO:0050856)	37	0	.16	-	 < 0.2	1.00E00
regulation of B cell receptor signaling pathway (GO:0050855)	21	0	.09	-	 < 0.2	1.00E00
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	55	0	.23	-	 < 0.2	1.00E00
B cell receptor signaling pathway (GO:0050853)	93	3	.39	+	7.70	1.00E00
positive regulation of pinocytosis (GO:0048549)	4	1	.02	+	59.66	1.00E00
T cell receptor signaling pathway (GO:0050852)	155	3	.65	+	4.62	1.00E00
regulation of pinocytosis (GO:0048548)	9	2	.04	+	53.04	1.00E00
antigen receptor-mediated signaling pathway (GO:0050851)	242	5	1.01	+	4.93	1.00E00
positive regulation of calcium-mediated signaling (GO:0050850)	37	3	.16	+	19.35	1.00E00
primitive streak formation (GO:0090009)	11	0	.05	-	 < 0.2	1.00E00
digestive tract morphogenesis (GO:0048546)	49	2	.21	+	9.74	1.00E00
Peyer's patch development (GO:0048541)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	0	.00	-	 < 0.2	1.00E00
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	2	0	.01	-	 < 0.2	1.00E00
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	3	0	.01	-	 < 0.2	1.00E00
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	9	0	.04	-	 < 0.2	1.00E00
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)	29	0	.12	-	 < 0.2	1.00E00
antibiotic metabolic process (GO:0016999)	2	0	.01	-	 < 0.2	1.00E00
cell wall macromolecule catabolic process (GO:0016998)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of calcium-mediated signaling (GO:0050849)	16	0	.07	-	 < 0.2	1.00E00
regulation of calcium-mediated signaling (GO:0050848)	77	3	.32	+	9.30	1.00E00
progesterone receptor signaling pathway (GO:0050847)	5	1	.02	+	47.73	1.00E00
bone marrow development (GO:0048539)	7	0	.03	-	 < 0.2	1.00E00
mucosal-associated lymphoid tissue development (GO:0048537)	7	0	.03	-	 < 0.2	1.00E00
spleen development (GO:0048536)	36	1	.15	+	6.63	1.00E00
lymph node development (GO:0048535)	18	0	.08	-	 < 0.2	1.00E00
anatomical structure arrangement (GO:0048532)	18	0	.08	-	 < 0.2	1.00E00
hemolysis in other organism (GO:0044179)	2	0	.01	-	 < 0.2	1.00E00
cellular response to cold (GO:0070417)	7	0	.03	-	 < 0.2	1.00E00
defense response to fungus (GO:0050832)	37	0	.16	-	 < 0.2	1.00E00
defense response to Gram-positive bacterium (GO:0050830)	84	1	.35	+	2.84	1.00E00
negative regulation of viral process (GO:0048525)	92	2	.39	+	5.19	1.00E00
positive regulation of viral process (GO:0048524)	106	2	.44	+	4.50	1.00E00
transcription initiation from RNA polymerase III type 1 promoter (GO:0001022)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of behavior (GO:0048521)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of behavior (GO:0048520)	24	0	.10	-	 < 0.2	1.00E00
carbamoyl phosphate biosynthetic process (GO:0070409)	1	0	.00	-	 < 0.2	1.00E00
carbamoyl phosphate metabolic process (GO:0070408)	1	0	.00	-	 < 0.2	1.00E00
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.00	-	 < 0.2	1.00E00
reverse transcription involved in RNA-mediated transposition (GO:0032199)	1	0	.00	-	 < 0.2	1.00E00
transposition, RNA-mediated (GO:0032197)	3	0	.01	-	 < 0.2	1.00E00
transposition (GO:0032196)	5	0	.02	-	 < 0.2	1.00E00
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	1	0	.00	-	 < 0.2	1.00E00
defense response to Gram-negative bacterium (GO:0050829)	79	1	.33	+	3.02	1.00E00
regulation of liquid surface tension (GO:0050828)	2	0	.01	-	 < 0.2	1.00E00
poly(A)+ mRNA export from nucleus (GO:0016973)	14	1	.06	+	17.05	1.00E00
peptide antigen stabilization (GO:0050823)	1	0	.00	-	 < 0.2	1.00E00
peptide stabilization (GO:0050822)	1	0	.00	-	 < 0.2	1.00E00
protein stabilization (GO:0050821)	159	4	.67	+	6.00	1.00E00
positive regulation of coagulation (GO:0050820)	26	1	.11	+	9.18	1.00E00
spermatid differentiation (GO:0048515)	141	0	.59	-	 < 0.2	1.00E00
circadian behavior (GO:0048512)	22	1	.09	+	10.85	1.00E00
histone H3-K14 acetylation (GO:0044154)	2	1	.01	+	 > 100	1.00E00
septin cytoskeleton organization (GO:0032185)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of coagulation (GO:0050819)	50	2	.21	+	9.55	1.00E00
negative regulation of D-amino-acid oxidase activity (GO:1900758)	1	0	.00	-	 < 0.2	1.00E00
regulation of D-amino-acid oxidase activity (GO:1900757)	1	0	.00	-	 < 0.2	1.00E00
regulation of acyl-CoA biosynthetic process (GO:0050812)	14	0	.06	-	 < 0.2	1.00E00
transcription from RNA polymerase III type 2 promoter (GO:0001009)	1	0	.00	-	 < 0.2	1.00E00
regulation of steroid biosynthetic process (GO:0050810)	82	2	.34	+	5.82	1.00E00
regulation of timing of cell differentiation (GO:0048505)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of growth of symbiont involved in interaction with host (GO:0044148)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of development of symbiont involved in interaction with host (GO:0044147)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of growth of symbiont involved in interaction with host (GO:0044146)	16	0	.07	-	 < 0.2	1.00E00
modulation of development of symbiont involved in interaction with host (GO:0044145)	1	0	.00	-	 < 0.2	1.00E00
modulation of growth of symbiont involved in interaction with host (GO:0044144)	17	0	.07	-	 < 0.2	1.00E00
glutathione deglycation (GO:0036531)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of growth of symbiont on or near host surface (GO:0044140)	1	0	.00	-	 < 0.2	1.00E00
protein deglycation, methylglyoxal removal (GO:0036530)	1	0	.00	-	 < 0.2	1.00E00
synapse organization (GO:0050808)	172	3	.72	+	4.16	1.00E00
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	5	0	.02	-	 < 0.2	1.00E00
regulation of synapse organization (GO:0050807)	126	1	.53	+	1.89	1.00E00
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of synaptic transmission (GO:0050806)	124	2	.52	+	3.85	1.00E00
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of synaptic transmission (GO:0050805)	67	0	.28	-	 < 0.2	1.00E00
positive regulation of p38MAPK cascade (GO:1900745)	20	1	.08	+	11.93	1.00E00
modulation of chemical synaptic transmission (GO:0050804)	313	2	1.31	+	1.52	1.00E00
regulation of p38MAPK cascade (GO:1900744)	31	1	.13	+	7.70	1.00E00
regulation of synapse structure or activity (GO:0050803)	131	1	.55	+	1.82	1.00E00
circadian sleep/wake cycle, sleep (GO:0050802)	4	0	.02	-	 < 0.2	1.00E00
ion homeostasis (GO:0050801)	683	6	2.86	+	2.10	1.00E00
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)	31	3	.13	+	23.10	1.00E00
modulation of growth of symbiont on or near host (GO:0044139)	1	0	.00	-	 < 0.2	1.00E00
protein deglycation, glyoxal removal (GO:0036529)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-lysine deglycation (GO:0036528)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-arginine deglycation (GO:0036527)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-cysteine deglycation (GO:0036526)	1	0	.00	-	 < 0.2	1.00E00
protein deglycation (GO:0036525)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of growth of symbiont in host (GO:0044130)	16	0	.07	-	 < 0.2	1.00E00
astrocyte-dopaminergic neuron signaling (GO:0036520)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)	31	3	.13	+	23.10	1.00E00
positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway (GO:1900738)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway (GO:1900737)	1	0	.00	-	 < 0.2	1.00E00
regulation of phospholipase C-activating G-protein coupled receptor signaling pathway (GO:1900736)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of growth of symbiont in host (GO:0044128)	1	0	.00	-	 < 0.2	1.00E00
chemorepulsion of dopaminergic neuron axon (GO:0036518)	2	0	.01	-	 < 0.2	1.00E00
chemoattraction of serotonergic neuron axon (GO:0036517)	1	0	.00	-	 < 0.2	1.00E00
regulation of growth of symbiont in host (GO:0044126)	17	0	.07	-	 < 0.2	1.00E00
serotonergic neuron axon guidance (GO:0036515)	4	0	.02	-	 < 0.2	1.00E00
dopaminergic neuron axon guidance (GO:0036514)	5	0	.02	-	 < 0.2	1.00E00
trimming of second mannose on A branch (GO:0036512)	2	0	.01	-	 < 0.2	1.00E00
trimming of first mannose on A branch (GO:0036511)	2	0	.01	-	 < 0.2	1.00E00
trimming of terminal mannose on C branch (GO:0036510)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of uterine smooth muscle relaxation (GO:1900721)	1	0	.00	-	 < 0.2	1.00E00
trimming of terminal mannose on B branch (GO:0036509)	2	0	.01	-	 < 0.2	1.00E00
protein alpha-1,2-demannosylation (GO:0036508)	24	0	.10	-	 < 0.2	1.00E00
growth of symbiont in host (GO:0044117)	3	0	.01	-	 < 0.2	1.00E00
protein demannosylation (GO:0036507)	24	0	.10	-	 < 0.2	1.00E00
growth of symbiont involved in interaction with host (GO:0044116)	3	0	.01	-	 < 0.2	1.00E00
maintenance of unfolded protein (GO:0036506)	3	0	.01	-	 < 0.2	1.00E00
ERAD pathway (GO:0036503)	85	0	.36	-	 < 0.2	1.00E00
development involved in symbiotic interaction (GO:0044111)	1	0	.00	-	 < 0.2	1.00E00
growth involved in symbiotic interaction (GO:0044110)	3	0	.01	-	 < 0.2	1.00E00
ATF6-mediated unfolded protein response (GO:0036500)	9	1	.04	+	26.52	1.00E00
activation of protein kinase B activity (GO:0032148)	26	3	.11	+	27.54	1.00E00
protein desumoylation (GO:0016926)	8	0	.03	-	 < 0.2	1.00E00
regulation of uterine smooth muscle relaxation (GO:1900719)	1	0	.00	-	 < 0.2	1.00E00
protein sumoylation (GO:0016925)	77	3	.32	+	9.30	1.00E00
cellular alcohol biosynthetic process (GO:0044108)	5	0	.02	-	 < 0.2	1.00E00
cellular alcohol metabolic process (GO:0044107)	5	0	.02	-	 < 0.2	1.00E00
cellular amine metabolic process (GO:0044106)	55	0	.23	-	 < 0.2	1.00E00
embryonic axis specification (GO:0000578)	36	0	.15	-	 < 0.2	1.00E00
sequestering of zinc ion (GO:0032119)	4	0	.02	-	 < 0.2	1.00E00
regulation of carbohydrate phosphatase activity (GO:0032113)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of response to nutrient levels (GO:0032109)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of response to nutrient levels (GO:0032108)	14	0	.06	-	 < 0.2	1.00E00
regulation of response to nutrient levels (GO:0032107)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of response to extracellular stimulus (GO:0032106)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of response to extracellular stimulus (GO:0032105)	14	0	.06	-	 < 0.2	1.00E00
regulation of response to extracellular stimulus (GO:0032104)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of response to external stimulus (GO:0032103)	279	7	1.17	+	5.99	1.00E00
negative regulation of response to external stimulus (GO:0032102)	269	3	1.13	+	2.66	1.00E00
positive regulation of appetite (GO:0032100)	4	0	.02	-	 < 0.2	1.00E00
cell dedifferentiation (GO:0043697)	5	0	.02	-	 < 0.2	1.00E00
dedifferentiation (GO:0043696)	5	0	.02	-	 < 0.2	1.00E00
reverse cholesterol transport (GO:0043691)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of low-density lipoprotein receptor activity (GO:1905598)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of low-density lipoprotein particle receptor binding (GO:1905596)	1	0	.00	-	 < 0.2	1.00E00
regulation of low-density lipoprotein particle receptor binding (GO:1905595)	2	0	.01	-	 < 0.2	1.00E00
centrosome separation (GO:0051299)	8	0	.03	-	 < 0.2	1.00E00
fibronectin fibril organization (GO:1905590)	1	0	.00	-	 < 0.2	1.00E00
centrosome duplication (GO:0051298)	31	1	.13	+	7.70	1.00E00
post-translational protein modification (GO:0043687)	440	3	1.84	+	1.63	1.00E00
establishment of meiotic spindle orientation (GO:0051296)	1	0	.00	-	 < 0.2	1.00E00
mRNA cleavage involved in gene silencing (GO:0098795)	2	0	.01	-	 < 0.2	1.00E00
co-translational protein modification (GO:0043686)	3	0	.01	-	 < 0.2	1.00E00
establishment of meiotic spindle localization (GO:0051295)	5	0	.02	-	 < 0.2	1.00E00
establishment of spindle orientation (GO:0051294)	28	0	.12	-	 < 0.2	1.00E00
establishment of spindle localization (GO:0051293)	36	0	.15	-	 < 0.2	1.00E00
xenophagy (GO:0098792)	4	0	.02	-	 < 0.2	1.00E00
nuclear pore complex assembly (GO:0051292)	10	0	.04	-	 < 0.2	1.00E00
protein heterooligomerization (GO:0051291)	103	2	.43	+	4.63	1.00E00
protein heterotetramerization (GO:0051290)	24	1	.10	+	9.94	1.00E00
positive regulation of L-arginine import across plasma membrane (GO:1905589)	1	0	.00	-	 < 0.2	1.00E00
pre-mRNA cleavage required for polyadenylation (GO:0098789)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of low-density lipoprotein particle clearance (GO:1905581)	1	0	.00	-	 < 0.2	1.00E00
protein homotetramerization (GO:0051289)	72	2	.30	+	6.63	1.00E00
positive regulation of ERBB3 signaling pathway (GO:1905580)	1	0	.00	-	 < 0.2	1.00E00
mRNA cleavage involved in mRNA processing (GO:0098787)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of sequestering of calcium ion (GO:0051284)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of sequestering of calcium ion (GO:0051283)	46	0	.19	-	 < 0.2	1.00E00
regulation of sequestering of calcium ion (GO:0051282)	111	1	.47	+	2.15	1.00E00
ncRNA transcription (GO:0098781)	93	0	.39	-	 < 0.2	1.00E00
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	37	1	.16	+	6.45	1.00E00
response to mitochondrial depolarisation (GO:0098780)	18	0	.08	-	 < 0.2	1.00E00
exosomal secretion (GO:1990182)	4	1	.02	+	59.66	1.00E00
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	11	0	.05	-	 < 0.2	1.00E00
mitochondrial tRNA 3'-end processing (GO:1990180)	1	0	.00	-	 < 0.2	1.00E00
regulation of ERBB3 signaling pathway (GO:1905578)	1	0	.00	-	 < 0.2	1.00E00
ganglioside GM1 transport to membrane (GO:1905572)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779)	8	0	.03	-	 < 0.2	1.00E00
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	74	1	.31	+	3.23	1.00E00
regulation of phosphoprotein phosphatase activity (GO:0043666)	40	1	.17	+	5.97	1.00E00
skin epidermis development (GO:0098773)	75	3	.31	+	9.55	1.00E00
inorganic ion homeostasis (GO:0098771)	656	5	2.75	+	1.82	1.00E00
protein localization to nucleoplasm (GO:1990173)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular component movement (GO:0051271)	259	4	1.09	+	3.69	1.00E00
G-protein coupled receptor catabolic process (GO:1990172)	2	0	.01	-	 < 0.2	1.00E00
stress response to cadmium ion (GO:1990170)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of vascular endothelial cell proliferation (GO:1905564)	3	0	.01	-	 < 0.2	1.00E00
regulation of vascular endothelial cell proliferation (GO:1905562)	3	0	.01	-	 < 0.2	1.00E00
stress response to copper ion (GO:1990169)	2	0	.01	-	 < 0.2	1.00E00
protein K33-linked deubiquitination (GO:1990168)	3	0	.01	-	 < 0.2	1.00E00
protein K27-linked deubiquitination (GO:1990167)	3	0	.01	-	 < 0.2	1.00E00
protein localization to site of double-strand break (GO:1990166)	3	0	.01	-	 < 0.2	1.00E00
recognition of apoptotic cell (GO:0043654)	7	0	.03	-	 < 0.2	1.00E00
histone H2A phosphorylation (GO:1990164)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	9	0	.04	-	 < 0.2	1.00E00
protein tetramerization (GO:0051262)	125	3	.52	+	5.73	1.00E00
engulfment of apoptotic cell (GO:0043652)	5	0	.02	-	 < 0.2	1.00E00
protein depolymerization (GO:0051261)	28	0	.12	-	 < 0.2	1.00E00
linoleic acid metabolic process (GO:0043651)	17	0	.07	-	 < 0.2	1.00E00
protein homooligomerization (GO:0051260)	299	4	1.25	+	3.19	1.00E00
dicarboxylic acid biosynthetic process (GO:0043650)	13	0	.05	-	 < 0.2	1.00E00
positive regulation blood vessel branching (GO:1905555)	2	0	.01	-	 < 0.2	1.00E00
regulation of blood vessel branching (GO:1905553)	2	0	.01	-	 < 0.2	1.00E00
specification of symmetry (GO:0009799)	121	0	.51	-	 < 0.2	1.00E00
positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	2	0	.01	-	 < 0.2	1.00E00
axis specification (GO:0009798)	88	0	.37	-	 < 0.2	1.00E00
cellular response to interleukin-8 (GO:0098759)	3	0	.01	-	 < 0.2	1.00E00
protein oligomerization (GO:0051259)	475	7	1.99	+	3.52	1.00E00
response to interleukin-8 (GO:0098758)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein localization to endoplasmic reticulum (GO:1905550)	2	0	.01	-	 < 0.2	1.00E00
dicarboxylic acid catabolic process (GO:0043649)	18	0	.08	-	 < 0.2	1.00E00
protein polymerization (GO:0051258)	82	1	.34	+	2.91	1.00E00
cellular response to interleukin-21 (GO:0098757)	1	0	.00	-	 < 0.2	1.00E00
dicarboxylic acid metabolic process (GO:0043648)	99	1	.41	+	2.41	1.00E00
meiotic spindle midzone assembly (GO:0051257)	1	0	.00	-	 < 0.2	1.00E00
response to interleukin-21 (GO:0098756)	1	0	.00	-	 < 0.2	1.00E00
regulation of mitotic cell cycle, embryonic (GO:0009794)	4	0	.02	-	 < 0.2	1.00E00
inositol phosphate metabolic process (GO:0043647)	54	1	.23	+	4.42	1.00E00
mitotic spindle midzone assembly (GO:0051256)	10	0	.04	-	 < 0.2	1.00E00
spindle midzone assembly (GO:0051255)	12	0	.05	-	 < 0.2	1.00E00
detoxification (GO:0098754)	93	0	.39	-	 < 0.2	1.00E00
negative regulation of formation of translation preinitiation complex (GO:1901194)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic development (GO:0009791)	98	2	.41	+	4.87	1.00E00
regulation of formation of translation preinitiation complex (GO:1901193)	1	0	.00	-	 < 0.2	1.00E00
bone cell development (GO:0098751)	22	1	.09	+	10.85	1.00E00
negative regulation of lymphocyte activation (GO:0051250)	132	5	.55	+	9.04	1.00E00
cellular response to nutrient (GO:0031670)	34	2	.14	+	14.04	1.00E00
positive regulation of telomeric heterochromatin assembly (GO:1905549)	1	0	.00	-	 < 0.2	1.00E00
regulation of telomeric heterochromatin assembly (GO:1905547)	1	0	.00	-	 < 0.2	1.00E00
cellular response to phenylpropanoid (GO:1905546)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.00	-	 < 0.2	1.00E00
cerebellar neuron development (GO:0098749)	1	0	.00	-	 < 0.2	1.00E00
regulation of L-arginine import across plasma membrane (GO:1905541)	1	0	.00	-	 < 0.2	1.00E00
regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ephrin receptor signaling pathway (GO:1901189)	1	0	.00	-	 < 0.2	1.00E00
regulation of asymmetric cell division (GO:0009786)	4	0	.02	-	 < 0.2	1.00E00
blue light signaling pathway (GO:0009785)	2	0	.01	-	 < 0.2	1.00E00
fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)	1	0	.00	-	 < 0.2	1.00E00
regulation of ephrin receptor signaling pathway (GO:1901187)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ERBB signaling pathway (GO:1901186)	39	1	.16	+	6.12	1.00E00
cell aggregation (GO:0098743)	22	1	.09	+	10.85	1.00E00
maintenance of translational fidelity (GO:1990145)	2	0	.01	-	 < 0.2	1.00E00
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	7	0	.03	-	 < 0.2	1.00E00
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	224	6	.94	+	6.39	1.00E00
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	1	0	.00	-	 < 0.2	1.00E00
polyadenylation-dependent RNA catabolic process (GO:0043633)	8	0	.03	-	 < 0.2	1.00E00
modification-dependent macromolecule catabolic process (GO:0043632)	508	6	2.13	+	2.82	1.00E00
RNA polyadenylation (GO:0043631)	33	0	.14	-	 < 0.2	1.00E00
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	8	1	.03	+	29.83	1.00E00
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	13	0	.05	-	 < 0.2	1.00E00
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	24	1	.10	+	9.94	1.00E00
lipopolysaccharide-mediated signaling pathway (GO:0031663)	32	3	.13	+	22.37	1.00E00
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle (GO:0031662)	2	1	.01	+	 > 100	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle (GO:0031660)	2	1	.01	+	 > 100	1.00E00
positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537)	1	0	.00	-	 < 0.2	1.00E00
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	1	0	.00	-	 < 0.2	1.00E00
import across plasma membrane (GO:0098739)	50	0	.21	-	 < 0.2	1.00E00
ncRNA polyadenylation (GO:0043629)	1	0	.00	-	 < 0.2	1.00E00
sequestering of metal ion (GO:0051238)	11	0	.05	-	 < 0.2	1.00E00
ncRNA 3'-end processing (GO:0043628)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of the force of heart contraction (GO:0098736)	1	0	.00	-	 < 0.2	1.00E00
neuron projection extension (GO:1990138)	60	0	.25	-	 < 0.2	1.00E00
establishment of RNA localization (GO:0051236)	201	2	.84	+	2.37	1.00E00
positive regulation of the force of heart contraction (GO:0098735)	5	0	.02	-	 < 0.2	1.00E00
maintenance of location (GO:0051235)	150	2	.63	+	3.18	1.00E00
macromolecule depalmitoylation (GO:0098734)	5	0	.02	-	 < 0.2	1.00E00
cellular protein complex disassembly (GO:0043624)	129	1	.54	+	1.85	1.00E00
macromolecule deacylation (GO:0098732)	68	0	.28	-	 < 0.2	1.00E00
epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134)	1	0	.00	-	 < 0.2	1.00E00
cellular protein complex assembly (GO:0043623)	416	3	1.74	+	1.72	1.00E00
meiotic spindle elongation (GO:0051232)	1	0	.00	-	 < 0.2	1.00E00
cortical microtubule organization (GO:0043622)	4	0	.02	-	 < 0.2	1.00E00
spindle elongation (GO:0051231)	12	0	.05	-	 < 0.2	1.00E00
spindle disassembly (GO:0051230)	1	0	.00	-	 < 0.2	1.00E00
regulation of DNA-templated transcription in response to stress (GO:0043620)	121	4	.51	+	7.89	1.00E00
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659)	8	2	.03	+	59.66	1.00E00
negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031658)	1	0	.00	-	 < 0.2	1.00E00
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657)	9	2	.04	+	53.04	1.00E00
positive regulation of heat generation (GO:0031652)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of heat generation (GO:0031651)	1	0	.00	-	 < 0.2	1.00E00
regulation of heat generation (GO:0031650)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of protein autoubiquitination (GO:1905524)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of macrophage migration (GO:1905523)	16	2	.07	+	29.83	1.00E00
negative regulation of macrophage migration (GO:1905522)	6	0	.03	-	 < 0.2	1.00E00
regulation of macrophage migration (GO:1905521)	25	2	.10	+	19.09	1.00E00
germline stem cell asymmetric division (GO:0098728)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of presynaptic active zone assembly (GO:1905520)	2	0	.01	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	11	0	.05	-	 < 0.2	1.00E00
mitotic spindle disassembly (GO:0051228)	1	0	.00	-	 < 0.2	1.00E00
maintenance of cell number (GO:0098727)	140	3	.59	+	5.11	1.00E00
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	115	4	.48	+	8.30	1.00E00
symmetric cell division (GO:0098725)	1	0	.00	-	 < 0.2	1.00E00
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	5	0	.02	-	 < 0.2	1.00E00
keratinocyte proliferation (GO:0043616)	12	0	.05	-	 < 0.2	1.00E00
spindle assembly (GO:0051225)	74	0	.31	-	 < 0.2	1.00E00
positive regulation of trophoblast cell migration (GO:1901165)	4	0	.02	-	 < 0.2	1.00E00
retrograde transport, endosome to plasma membrane (GO:1990126)	20	0	.08	-	 < 0.2	1.00E00
astrocyte cell migration (GO:0043615)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of protein transport (GO:0051224)	203	3	.85	+	3.53	1.00E00
negative regulation of trophoblast cell migration (GO:1901164)	5	0	.02	-	 < 0.2	1.00E00
asymmetric stem cell division (GO:0098722)	9	0	.04	-	 < 0.2	1.00E00
regulation of trophoblast cell migration (GO:1901163)	9	0	.04	-	 < 0.2	1.00E00
primary amino compound biosynthetic process (GO:1901162)	5	0	.02	-	 < 0.2	1.00E00
cytoplasmic sequestering of protein (GO:0051220)	26	0	.11	-	 < 0.2	1.00E00
primary amino compound metabolic process (GO:1901160)	13	0	.05	-	 < 0.2	1.00E00
regulation of carbohydrate utilization (GO:0043610)	2	0	.01	-	 < 0.2	1.00E00
heat generation (GO:0031649)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of neurological system process (GO:0031646)	24	2	.10	+	19.89	1.00E00
negative regulation of neurological system process (GO:0031645)	17	0	.07	-	 < 0.2	1.00E00
regulation of neurological system process (GO:0031644)	72	2	.30	+	6.63	1.00E00
positive regulation of myelination (GO:0031643)	13	1	.05	+	18.36	1.00E00
negative regulation of myelination (GO:0031642)	7	0	.03	-	 < 0.2	1.00E00
regulation of myelination (GO:0031641)	34	2	.14	+	14.04	1.00E00
killing of cells of other organism (GO:0031640)	50	0	.21	-	 < 0.2	1.00E00
regulation of presynaptic active zone assembly (GO:1905518)	2	0	.01	-	 < 0.2	1.00E00
macrophage migration (GO:1905517)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of fertilization (GO:1905516)	11	0	.05	-	 < 0.2	1.00E00
non-motile cilium assembly (GO:1905515)	40	0	.17	-	 < 0.2	1.00E00
sodium ion import across plasma membrane (GO:0098719)	13	0	.05	-	 < 0.2	1.00E00
hexose mediated signaling (GO:0009757)	2	0	.01	-	 < 0.2	1.00E00
xylulose 5-phosphate biosynthetic process (GO:1901159)	5	0	.02	-	 < 0.2	1.00E00
carbohydrate mediated signaling (GO:0009756)	4	0	.02	-	 < 0.2	1.00E00
hormone-mediated signaling pathway (GO:0009755)	166	2	.70	+	2.88	1.00E00
cartilage development (GO:0051216)	152	2	.64	+	3.14	1.00E00
B cell receptor apoptotic signaling pathway (GO:1990117)	1	0	.00	-	 < 0.2	1.00E00
response to jasmonic acid (GO:0009753)	4	0	.02	-	 < 0.2	1.00E00
formamide metabolic process (GO:0043606)	4	0	.02	-	 < 0.2	1.00E00
cellular amide catabolic process (GO:0043605)	3	0	.01	-	 < 0.2	1.00E00
response to salicylic acid (GO:0009751)	1	0	.00	-	 < 0.2	1.00E00
amide biosynthetic process (GO:0043604)	480	6	2.01	+	2.98	1.00E00
L-glutamate import across plasma membrane (GO:0098712)	6	0	.03	-	 < 0.2	1.00E00
response to fructose (GO:0009750)	8	1	.03	+	29.83	1.00E00
cellular amide metabolic process (GO:0043603)	695	10	2.91	+	3.43	1.00E00
iron ion import across plasma membrane (GO:0098711)	8	0	.03	-	 < 0.2	1.00E00
nitrate catabolic process (GO:0043602)	1	0	.00	-	 < 0.2	1.00E00
plasminogen activation (GO:0031639)	11	0	.05	-	 < 0.2	1.00E00
zymogen activation (GO:0031638)	32	0	.13	-	 < 0.2	1.00E00
adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635)	2	0	.01	-	 < 0.2	1.00E00
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	3	0	.01	-	 < 0.2	1.00E00
protein localization to microtubule organizing center (GO:1905508)	20	0	.08	-	 < 0.2	1.00E00
response to glucose (GO:0009749)	135	4	.57	+	7.07	1.00E00
release of sequestered calcium ion into cytosol (GO:0051209)	46	0	.19	-	 < 0.2	1.00E00
response to hexose (GO:0009746)	140	4	.59	+	6.82	1.00E00
sequestering of calcium ion (GO:0051208)	4	0	.02	-	 < 0.2	1.00E00
ferrous iron import across plasma membrane (GO:0098707)	2	0	.01	-	 < 0.2	1.00E00
ferric iron import across plasma membrane (GO:0098706)	4	0	.02	-	 < 0.2	1.00E00
protein linear deubiquitination (GO:1990108)	2	0	.01	-	 < 0.2	1.00E00
response to sucrose (GO:0009744)	7	0	.03	-	 < 0.2	1.00E00
copper ion import across plasma membrane (GO:0098705)	1	0	.00	-	 < 0.2	1.00E00
response to carbohydrate (GO:0009743)	169	5	.71	+	7.06	1.00E00
protein insertion into membrane (GO:0051205)	24	1	.10	+	9.94	1.00E00
carbohydrate import across plasma membrane (GO:0098704)	1	0	.00	-	 < 0.2	1.00E00
protein insertion into mitochondrial membrane (GO:0051204)	9	0	.04	-	 < 0.2	1.00E00
calcium ion import across plasma membrane (GO:0098703)	9	0	.04	-	 < 0.2	1.00E00
insulin catabolic process (GO:1901143)	2	0	.01	-	 < 0.2	1.00E00
insulin metabolic process (GO:1901142)	7	0	.03	-	 < 0.2	1.00E00
neurotransmitter loading into synaptic vesicle (GO:0098700)	7	0	.03	-	 < 0.2	1.00E00
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	12	0	.05	-	 < 0.2	1.00E00
telomeric loop formation (GO:0031627)	3	0	.01	-	 < 0.2	1.00E00
receptor internalization (GO:0031623)	57	2	.24	+	8.37	1.00E00
positive regulation of fever generation (GO:0031622)	7	0	.03	-	 < 0.2	1.00E00
regulation of fever generation (GO:0031620)	8	0	.03	-	 < 0.2	1.00E00
carbohydrate derivative biosynthetic process (GO:1901137)	604	4	2.53	+	1.58	1.00E00
carbohydrate derivative catabolic process (GO:1901136)	176	0	.74	-	 < 0.2	1.00E00
carbohydrate derivative metabolic process (GO:1901135)	1092	7	4.58	+	1.53	1.00E00
detection of hexose stimulus (GO:0009732)	3	0	.01	-	 < 0.2	1.00E00
detection of carbohydrate stimulus (GO:0009730)	3	0	.01	-	 < 0.2	1.00E00
detection of endogenous stimulus (GO:0009726)	3	0	.01	-	 < 0.2	1.00E00
gentamycin metabolic process (GO:1901128)	1	0	.00	-	 < 0.2	1.00E00
detection of lipoteichoic acid (GO:0070392)	1	0	.00	-	 < 0.2	1.00E00
response to lipoteichoic acid (GO:0070391)	11	1	.05	+	21.70	1.00E00
tRNA-guanine transglycosylation (GO:0101030)	2	0	.01	-	 < 0.2	1.00E00
detection of hormone stimulus (GO:0009720)	1	0	.00	-	 < 0.2	1.00E00
chaperone cofactor-dependent protein refolding (GO:0070389)	7	0	.03	-	 < 0.2	1.00E00
Harderian gland development (GO:0070384)	4	0	.02	-	 < 0.2	1.00E00
DNA cytosine deamination (GO:0070383)	6	0	.03	-	 < 0.2	1.00E00
catechol-containing compound biosynthetic process (GO:0009713)	19	0	.08	-	 < 0.2	1.00E00
catechol-containing compound metabolic process (GO:0009712)	43	1	.18	+	5.55	1.00E00
synaptic vesicle membrane organization (GO:0048499)	4	0	.02	-	 < 0.2	1.00E00
maintenance of animal organ identity (GO:0048496)	5	0	.02	-	 < 0.2	1.00E00
anterograde synaptic vesicle transport (GO:0048490)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of ERK5 cascade (GO:0070378)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of ERK5 cascade (GO:0070377)	1	0	.00	-	 < 0.2	1.00E00
regulation of ERK5 cascade (GO:0070376)	3	0	.01	-	 < 0.2	1.00E00
ERK5 cascade (GO:0070375)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	61	3	.26	+	11.74	1.00E00
ERK1 and ERK2 cascade (GO:0070371)	27	2	.11	+	17.68	1.00E00
cellular heat acclimation (GO:0070370)	3	0	.01	-	 < 0.2	1.00E00
activated T cell proliferation (GO:0050798)	5	0	.02	-	 < 0.2	1.00E00
regulation of insulin secretion (GO:0050796)	177	4	.74	+	5.39	1.00E00
regulation of behavior (GO:0050795)	67	0	.28	-	 < 0.2	1.00E00
synaptic vesicle transport (GO:0048489)	112	0	.47	-	 < 0.2	1.00E00
regulation of viral process (GO:0050792)	194	3	.81	+	3.69	1.00E00
synaptic vesicle endocytosis (GO:0048488)	29	0	.12	-	 < 0.2	1.00E00
parasympathetic nervous system development (GO:0048486)	19	0	.08	-	 < 0.2	1.00E00
sympathetic nervous system development (GO:0048485)	21	0	.09	-	 < 0.2	1.00E00
enteric nervous system development (GO:0048484)	11	0	.05	-	 < 0.2	1.00E00
autonomic nervous system development (GO:0048483)	43	0	.18	-	 < 0.2	1.00E00
positive regulation of hepatocyte differentiation (GO:0070368)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of hepatocyte differentiation (GO:0070367)	1	0	.00	-	 < 0.2	1.00E00
regulation of hepatocyte differentiation (GO:0070366)	2	0	.01	-	 < 0.2	1.00E00
hepatocyte differentiation (GO:0070365)	11	1	.05	+	21.70	1.00E00
detoxification of mercury ion (GO:0050787)	2	0	.01	-	 < 0.2	1.00E00
cocaine metabolic process (GO:0050783)	1	0	.00	-	 < 0.2	1.00E00
replication fork protection (GO:0048478)	6	1	.03	+	39.78	1.00E00
actin polymerization-dependent cell motility (GO:0070358)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of white fat cell proliferation (GO:0070352)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of white fat cell proliferation (GO:0070351)	1	0	.00	-	 < 0.2	1.00E00
regulation of white fat cell proliferation (GO:0070350)	4	0	.02	-	 < 0.2	1.00E00
RNA destabilization (GO:0050779)	23	0	.10	-	 < 0.2	1.00E00
negative regulation of immune response (GO:0050777)	138	3	.58	+	5.19	1.00E00
positive regulation of dendrite morphogenesis (GO:0050775)	34	0	.14	-	 < 0.2	1.00E00
negative regulation of dendrite morphogenesis (GO:0050774)	16	0	.07	-	 < 0.2	1.00E00
regulation of dendrite development (GO:0050773)	134	3	.56	+	5.34	1.00E00
positive regulation of axonogenesis (GO:0050772)	78	2	.33	+	6.12	1.00E00
negative regulation of axonogenesis (GO:0050771)	54	0	.23	-	 < 0.2	1.00E00
regulation of axonogenesis (GO:0050770)	160	2	.67	+	2.98	1.00E00
PERK-mediated unfolded protein response (GO:0036499)	12	0	.05	-	 < 0.2	1.00E00
IRE1-mediated unfolded protein response (GO:0036498)	58	2	.24	+	8.23	1.00E00
regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of brown fat cell proliferation (GO:0070349)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.00	-	 < 0.2	1.00E00
regulation of brown fat cell proliferation (GO:0070347)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of fat cell proliferation (GO:0070346)	4	0	.02	-	 < 0.2	1.00E00
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of fat cell proliferation (GO:0070345)	6	0	.03	-	 < 0.2	1.00E00
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	3	0	.01	-	 < 0.2	1.00E00
regulation of fat cell proliferation (GO:0070344)	11	0	.05	-	 < 0.2	1.00E00
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	6	0	.03	-	 < 0.2	1.00E00
detection of bacterial lipopeptide (GO:0070340)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of neurogenesis (GO:0050769)	416	3	1.74	+	1.72	1.00E00
negative regulation of neurogenesis (GO:0050768)	252	5	1.06	+	4.74	1.00E00
regulation of neurogenesis (GO:0050767)	710	10	2.97	+	3.36	1.00E00
positive regulation of phagocytosis (GO:0050766)	46	1	.19	+	5.19	1.00E00
negative regulation of phagocytosis (GO:0050765)	16	0	.07	-	 < 0.2	1.00E00
regulation of phagocytosis (GO:0050764)	69	2	.29	+	6.92	1.00E00
negative regulation of thymidylate synthase biosynthetic process (GO:0050760)	1	0	.00	-	 < 0.2	1.00E00
ventral trunk neural crest cell migration (GO:0036486)	4	0	.02	-	 < 0.2	1.00E00
response to bacterial lipopeptide (GO:0070339)	6	0	.03	-	 < 0.2	1.00E00
trunk neural crest cell migration (GO:0036484)	4	0	.02	-	 < 0.2	1.00E00
membrane biogenesis (GO:0044091)	34	2	.14	+	14.04	1.00E00
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of vacuole organization (GO:0044090)	12	0	.05	-	 < 0.2	1.00E00
regulation of thymidylate synthase biosynthetic process (GO:0050758)	2	0	.01	-	 < 0.2	1.00E00
chemokine metabolic process (GO:0050755)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of fractalkine biosynthetic process (GO:0050754)	1	0	.00	-	 < 0.2	1.00E00
regulation of fractalkine biosynthetic process (GO:0050752)	1	0	.00	-	 < 0.2	1.00E00
regulation of vacuole organization (GO:0044088)	41	0	.17	-	 < 0.2	1.00E00
neuron death in response to oxidative stress (GO:0036475)	1	0	.00	-	 < 0.2	1.00E00
triglyceride homeostasis (GO:0070328)	32	1	.13	+	7.46	1.00E00
cell death in response to hydrogen peroxide (GO:0036474)	2	0	.01	-	 < 0.2	1.00E00
thyroid hormone transport (GO:0070327)	9	0	.04	-	 < 0.2	1.00E00
cell death in response to oxidative stress (GO:0036473)	19	2	.08	+	25.12	1.00E00
cellular response to glyoxal (GO:0036471)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lipoprotein metabolic process (GO:0050748)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of lipoprotein metabolic process (GO:0050747)	5	0	.02	-	 < 0.2	1.00E00
regulation of lipoprotein metabolic process (GO:0050746)	15	0	.06	-	 < 0.2	1.00E00
synaptic vesicle recycling via endosome (GO:0036466)	2	0	.01	-	 < 0.2	1.00E00
synaptic vesicle recycling (GO:0036465)	37	0	.16	-	 < 0.2	1.00E00
positive regulation of G0 to G1 transition (GO:0070318)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of G0 to G1 transition (GO:0070317)	4	0	.02	-	 < 0.2	1.00E00
regulation of G0 to G1 transition (GO:0070316)	8	0	.03	-	 < 0.2	1.00E00
TRAIL-activated apoptotic signaling pathway (GO:0036462)	3	0	.01	-	 < 0.2	1.00E00
G1 to G0 transition involved in cell differentiation (GO:0070315)	3	0	.01	-	 < 0.2	1.00E00
regulation of anion transport (GO:0044070)	109	3	.46	+	6.57	1.00E00
G1 to G0 transition (GO:0070314)	7	0	.03	-	 < 0.2	1.00E00
olefin metabolic process (GO:1900673)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	47	3	.20	+	15.23	1.00E00
modulation by symbiont of host cellular process (GO:0044068)	29	0	.12	-	 < 0.2	1.00E00
regulation of respiratory system process (GO:0044065)	16	0	.07	-	 < 0.2	1.00E00
lens fiber cell morphogenesis (GO:0070309)	5	0	.02	-	 < 0.2	1.00E00
lens fiber cell development (GO:0070307)	13	0	.05	-	 < 0.2	1.00E00
regulation of excretion (GO:0044062)	25	0	.10	-	 < 0.2	1.00E00
lens fiber cell differentiation (GO:0070306)	26	0	.11	-	 < 0.2	1.00E00
response to cGMP (GO:0070305)	7	0	.03	-	 < 0.2	1.00E00
cap mRNA methylation (GO:0036451)	2	0	.01	-	 < 0.2	1.00E00
regulation of endocrine process (GO:0044060)	45	0	.19	-	 < 0.2	1.00E00
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	145	2	.61	+	3.29	1.00E00
negative regulation of appetite (GO:0032099)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	42	2	.18	+	11.36	1.00E00
regulation of appetite (GO:0032098)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of response to food (GO:0032097)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of response to food (GO:0032096)	12	0	.05	-	 < 0.2	1.00E00
regulation of response to food (GO:0032095)	18	0	.08	-	 < 0.2	1.00E00
response to food (GO:0032094)	23	2	.10	+	20.75	1.00E00
positive regulation of inflammatory response (GO:0050729)	112	4	.47	+	8.52	1.00E00
negative regulation of inflammatory response (GO:0050728)	112	1	.47	+	2.13	1.00E00
positive regulation of protein binding (GO:0032092)	90	2	.38	+	5.30	1.00E00
regulation of inflammatory response (GO:0050727)	384	7	1.61	+	4.35	1.00E00
negative regulation of protein binding (GO:0032091)	90	2	.38	+	5.30	1.00E00
positive regulation of interleukin-1 alpha biosynthetic process (GO:0050726)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interleukin-1 beta biosynthetic process (GO:0050725)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-1 beta biosynthetic process (GO:0050722)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-1 alpha biosynthetic process (GO:0050721)	1	0	.00	-	 < 0.2	1.00E00
interleukin-1 beta biosynthetic process (GO:0050720)	1	0	.00	-	 < 0.2	1.00E00
regulation of digestive system process (GO:0044058)	41	0	.17	-	 < 0.2	1.00E00
neuronal stem cell division (GO:0036445)	13	0	.05	-	 < 0.2	1.00E00
mitochondrial calcium uptake (GO:0036444)	10	0	.04	-	 < 0.2	1.00E00
translocation of peptides or proteins into host cell cytoplasm (GO:0044053)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	76	1	.32	+	3.14	1.00E00
positive regulation of interleukin-1 beta secretion (GO:0050718)	27	0	.11	-	 < 0.2	1.00E00
positive regulation of interleukin-1 alpha secretion (GO:0050717)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of interleukin-1 secretion (GO:0050716)	30	0	.13	-	 < 0.2	1.00E00
negative regulation of interleukin-1 beta secretion (GO:0050713)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of interleukin-1 alpha secretion (GO:0050712)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of interleukin-1 secretion (GO:0050711)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of cytokine secretion (GO:0050710)	58	1	.24	+	4.11	1.00E00
regulation of modification of postsynaptic structure (GO:0099159)	1	0	.00	-	 < 0.2	1.00E00
maintenance of lens transparency (GO:0036438)	4	0	.02	-	 < 0.2	1.00E00
glucan metabolic process (GO:0044042)	57	2	.24	+	8.37	1.00E00
positive regulation of endodeoxyribonuclease activity (GO:0032079)	4	2	.02	+	 > 100	1.00E00
negative regulation of endodeoxyribonuclease activity (GO:0032078)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of deoxyribonuclease activity (GO:0032076)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of nuclease activity (GO:0032074)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of protein secretion (GO:0050709)	115	3	.48	+	6.23	1.00E00
regulation of restriction endodeoxyribonuclease activity (GO:0032072)	1	0	.00	-	 < 0.2	1.00E00
regulation of endodeoxyribonuclease activity (GO:0032071)	8	2	.03	+	59.66	1.00E00
regulation of interleukin-1 beta secretion (GO:0050706)	37	0	.16	-	 < 0.2	1.00E00
regulation of interleukin-1 alpha secretion (GO:0050705)	5	0	.02	-	 < 0.2	1.00E00
regulation of interleukin-1 secretion (GO:0050704)	42	0	.18	-	 < 0.2	1.00E00
interleukin-1 alpha secretion (GO:0050703)	1	0	.00	-	 < 0.2	1.00E00
interleukin-1 beta secretion (GO:0050702)	8	0	.03	-	 < 0.2	1.00E00
interleukin-1 secretion (GO:0050701)	10	0	.04	-	 < 0.2	1.00E00
cell wall macromolecule biosynthetic process (GO:0044038)	1	0	.00	-	 < 0.2	1.00E00
cell wall macromolecule metabolic process (GO:0044036)	15	0	.06	-	 < 0.2	1.00E00
multi-organism catabolic process (GO:0044035)	1	0	.00	-	 < 0.2	1.00E00
multi-organism metabolic process (GO:0044033)	7	0	.03	-	 < 0.2	1.00E00
regulation of DNA methylation (GO:0044030)	21	1	.09	+	11.36	1.00E00
regulation of nuclease activity (GO:0032069)	27	3	.11	+	26.52	1.00E00
nucleolus to nucleoplasm transport (GO:0032066)	2	0	.01	-	 < 0.2	1.00E00
bleb assembly (GO:0032060)	10	0	.04	-	 < 0.2	1.00E00
hypomethylation of CpG island (GO:0044029)	2	0	.01	-	 < 0.2	1.00E00
DNA hypomethylation (GO:0044028)	2	0	.01	-	 < 0.2	1.00E00
hypermethylation of CpG island (GO:0044027)	2	1	.01	+	 > 100	1.00E00
DNA hypermethylation (GO:0044026)	3	1	.01	+	79.55	1.00E00
ATP hydrolysis coupled anion transmembrane transport (GO:0099133)	13	0	.05	-	 < 0.2	1.00E00
ATP hydrolysis coupled cation transmembrane transport (GO:0099132)	58	1	.24	+	4.11	1.00E00
histone citrullination (GO:0036414)	5	0	.02	-	 < 0.2	1.00E00
ATP hydrolysis coupled ion transmembrane transport (GO:0099131)	70	1	.29	+	3.41	1.00E00
histone H3-R26 citrullination (GO:0036413)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of translational initiation in response to stress (GO:0032058)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of translational initiation in response to stress (GO:0032057)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of translation in response to stress (GO:0032056)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of translation in response to stress (GO:0032055)	10	0	.04	-	 < 0.2	1.00E00
ciliary basal body organization (GO:0032053)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of monocyte aggregation (GO:1900625)	3	0	.01	-	 < 0.2	1.00E00
regulation of monocyte aggregation (GO:1900623)	3	0	.01	-	 < 0.2	1.00E00
acetate ester biosynthetic process (GO:1900620)	2	0	.01	-	 < 0.2	1.00E00
conversion of ds siRNA to ss siRNA (GO:0036404)	1	0	.00	-	 < 0.2	1.00E00
cardiolipin biosynthetic process (GO:0032049)	7	0	.03	-	 < 0.2	1.00E00
cardiolipin metabolic process (GO:0032048)	13	0	.05	-	 < 0.2	1.00E00
acetate ester metabolic process (GO:1900619)	4	0	.02	-	 < 0.2	1.00E00
mitochondrial DNA metabolic process (GO:0032042)	12	0	.05	-	 < 0.2	1.00E00
microtubule-based protein transport (GO:0099118)	51	0	.21	-	 < 0.2	1.00E00
dissemination or transmission of symbiont from host (GO:0044007)	1	0	.00	-	 < 0.2	1.00E00
box H/ACA snoRNA 3'-end processing (GO:0000495)	1	0	.00	-	 < 0.2	1.00E00
box C/D snoRNA 3'-end processing (GO:0000494)	2	0	.01	-	 < 0.2	1.00E00
disruption by symbiont of host cell (GO:0044004)	5	0	.02	-	 < 0.2	1.00E00
box H/ACA snoRNP assembly (GO:0000493)	2	0	.01	-	 < 0.2	1.00E00
modification by symbiont of host morphology or physiology (GO:0044003)	43	0	.18	-	 < 0.2	1.00E00
microtubule-based transport (GO:0099111)	128	0	.54	-	 < 0.2	1.00E00
box C/D snoRNP assembly (GO:0000492)	7	0	.03	-	 < 0.2	1.00E00
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	9	0	.04	-	 < 0.2	1.00E00
maturation of 5S rRNA (GO:0000481)	1	0	.00	-	 < 0.2	1.00E00
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	6	0	.03	-	 < 0.2	1.00E00
response to magnesium ion (GO:0032026)	18	1	.08	+	13.26	1.00E00
response to cobalt ion (GO:0032025)	10	1	.04	+	23.87	1.00E00
positive regulation of insulin secretion (GO:0032024)	70	0	.29	-	 < 0.2	1.00E00
trypsinogen activation (GO:0032023)	1	0	.00	-	 < 0.2	1.00E00
ISG15-protein conjugation (GO:0032020)	6	0	.03	-	 < 0.2	1.00E00
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	14	0	.06	-	 < 0.2	1.00E00
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	15	0	.06	-	 < 0.2	1.00E00
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	3	0	.01	-	 < 0.2	1.00E00
maturation of LSU-rRNA (GO:0000470)	23	0	.10	-	 < 0.2	1.00E00
regulation of ARF protein signal transduction (GO:0032012)	17	0	.07	-	 < 0.2	1.00E00
cleavage involved in rRNA processing (GO:0000469)	24	0	.10	-	 < 0.2	1.00E00
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	5	0	.02	-	 < 0.2	1.00E00
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	20	0	.08	-	 < 0.2	1.00E00
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	9	0	.04	-	 < 0.2	1.00E00
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	37	0	.16	-	 < 0.2	1.00E00
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	2	0	.01	-	 < 0.2	1.00E00
maturation of 5.8S rRNA (GO:0000460)	32	0	.13	-	 < 0.2	1.00E00
tetrahydrofolate interconversion (GO:0035999)	10	0	.04	-	 < 0.2	1.00E00
7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of TOR signaling (GO:0032008)	35	2	.15	+	13.64	1.00E00
detection of muscle stretch (GO:0035995)	4	0	.02	-	 < 0.2	1.00E00
deltoid tuberosity development (GO:0035993)	3	0	.01	-	 < 0.2	1.00E00
tendon formation (GO:0035992)	3	0	.01	-	 < 0.2	1.00E00
tendon cell differentiation (GO:0035990)	3	0	.01	-	 < 0.2	1.00E00
cell-cell signaling by wnt (GO:0198738)	348	3	1.46	+	2.06	1.00E00
positive regulation of fatty acid beta-oxidation (GO:0032000)	9	1	.04	+	26.52	1.00E00
exonucleolytic trimming involved in rRNA processing (GO:0000459)	5	0	.02	-	 < 0.2	1.00E00
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	2	0	.01	-	 < 0.2	1.00E00
snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	3	0	.01	-	 < 0.2	1.00E00
enzyme-directed rRNA 2'-O-methylation (GO:0000453)	2	0	.01	-	 < 0.2	1.00E00
rRNA 2'-O-methylation (GO:0000451)	4	0	.02	-	 < 0.2	1.00E00
tendon development (GO:0035989)	5	0	.02	-	 < 0.2	1.00E00
chondrocyte proliferation (GO:0035988)	11	0	.05	-	 < 0.2	1.00E00
endodermal cell differentiation (GO:0035987)	41	2	.17	+	11.64	1.00E00
senescence-associated heterochromatin focus assembly (GO:0035986)	3	1	.01	+	79.55	1.00E00
cellular response to trichostatin A (GO:0035984)	4	0	.02	-	 < 0.2	1.00E00
response to trichostatin A (GO:0035983)	4	0	.02	-	 < 0.2	1.00E00
response to host (GO:0075136)	7	0	.03	-	 < 0.2	1.00E00
hemoglobin metabolic process (GO:0020027)	10	0	.04	-	 < 0.2	1.00E00
immortalization of host cell (GO:0020021)	2	0	.01	-	 < 0.2	1.00E00
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	2	0	.01	-	 < 0.2	1.00E00
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	9	0	.04	-	 < 0.2	1.00E00
postsynaptic specialization assembly (GO:0098698)	5	0	.02	-	 < 0.2	1.00E00
skin morphogenesis (GO:0043589)	9	2	.04	+	53.04	1.00E00
negative regulation of coenzyme metabolic process (GO:0051198)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of coenzyme metabolic process (GO:0051197)	19	0	.08	-	 < 0.2	1.00E00
histone H2A-S139 phosphorylation (GO:0035978)	1	0	.00	-	 < 0.2	1.00E00
tongue morphogenesis (GO:0043587)	9	0	.04	-	 < 0.2	1.00E00
regulation of coenzyme metabolic process (GO:0051196)	88	0	.37	-	 < 0.2	1.00E00
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	4	0	.02	-	 < 0.2	1.00E00
tongue development (GO:0043586)	21	1	.09	+	11.36	1.00E00
negative regulation of cofactor metabolic process (GO:0051195)	12	0	.05	-	 < 0.2	1.00E00
nose morphogenesis (GO:0043585)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cofactor metabolic process (GO:0051194)	19	0	.08	-	 < 0.2	1.00E00
regulation of synaptic vesicle cycle (GO:0098693)	40	1	.17	+	5.97	1.00E00
nose development (GO:0043584)	16	0	.07	-	 < 0.2	1.00E00
regulation of cofactor metabolic process (GO:0051193)	88	0	.37	-	 < 0.2	1.00E00
ear development (GO:0043583)	210	4	.88	+	4.55	1.00E00
aggrephagy (GO:0035973)	6	0	.03	-	 < 0.2	1.00E00
peptidyl-histidine dephosphorylation (GO:0035971)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-threonine dephosphorylation (GO:0035970)	12	1	.05	+	19.89	1.00E00
evasion or tolerance of host immune response (GO:0020012)	2	0	.01	-	 < 0.2	1.00E00
carbon catabolite repression of transcription from RNA polymerase II promoter (GO:0000437)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of motor neuron migration (GO:1905485)	1	0	.00	-	 < 0.2	1.00E00
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.00	-	 < 0.2	1.00E00
regulation of motor neuron migration (GO:1905483)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0000433)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	3	0	.01	-	 < 0.2	1.00E00
prosthetic group metabolic process (GO:0051189)	7	0	.03	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.00	-	 < 0.2	1.00E00
cofactor biosynthetic process (GO:0051188)	175	1	.73	+	1.36	1.00E00
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	3	0	.01	-	 < 0.2	1.00E00
nuclear matrix organization (GO:0043578)	3	0	.01	-	 < 0.2	1.00E00
cofactor catabolic process (GO:0051187)	20	0	.08	-	 < 0.2	1.00E00
cofactor metabolic process (GO:0051186)	357	4	1.50	+	2.67	1.00E00
cellular response to topologically incorrect protein (GO:0035967)	140	2	.59	+	3.41	1.00E00
regulation of respiratory gaseous exchange (GO:0043576)	23	0	.10	-	 < 0.2	1.00E00
lens fiber cell apoptotic process (GO:1990086)	4	0	.02	-	 < 0.2	1.00E00
response to topologically incorrect protein (GO:0035966)	181	2	.76	+	2.64	1.00E00
cardiolipin acyl-chain remodeling (GO:0035965)	6	0	.03	-	 < 0.2	1.00E00
peroxisomal transport (GO:0043574)	18	0	.08	-	 < 0.2	1.00E00
COPI-coated vesicle budding (GO:0035964)	4	0	.02	-	 < 0.2	1.00E00
coenzyme transport (GO:0051182)	3	0	.01	-	 < 0.2	1.00E00
cellular response to interleukin-13 (GO:0035963)	3	0	.01	-	 < 0.2	1.00E00
cofactor transport (GO:0051181)	25	0	.10	-	 < 0.2	1.00E00
response to interleukin-13 (GO:0035962)	4	0	.02	-	 < 0.2	1.00E00
vitamin transport (GO:0051180)	35	0	.15	-	 < 0.2	1.00E00
maintenance of DNA repeat elements (GO:0043570)	4	0	.02	-	 < 0.2	1.00E00
negative regulation by symbiont of host transmembrane receptor-mediated signal transduction (GO:0075114)	1	0	.00	-	 < 0.2	1.00E00
modulation by symbiont of host transmembrane receptor-mediated signal transduction (GO:0075112)	1	0	.00	-	 < 0.2	1.00E00
negative regulation by symbiont of host receptor-mediated signal transduction (GO:0075111)	1	0	.00	-	 < 0.2	1.00E00
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of protein localization to membrane (GO:1905476)	29	0	.12	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in stem cell proliferation (GO:1905474)	1	0	.00	-	 < 0.2	1.00E00
mitophagy (GO:0000423)	6	0	.03	-	 < 0.2	1.00E00
regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter (GO:0098679)	2	0	.01	-	 < 0.2	1.00E00
autophagy of mitochondrion (GO:0000422)	42	1	.18	+	5.68	1.00E00
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	7	0	.03	-	 < 0.2	1.00E00
cartilage homeostasis (GO:1990079)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	13	2	.05	+	36.72	1.00E00
meiotic sister chromatid cohesion (GO:0051177)	8	0	.03	-	 < 0.2	1.00E00
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	23	3	.10	+	31.13	1.00E00
positive regulation of sulfur metabolic process (GO:0051176)	6	0	.03	-	 < 0.2	1.00E00
polyuridylation-dependent mRNA catabolic process (GO:1990074)	1	0	.00	-	 < 0.2	1.00E00
cellular response to nitrogen levels (GO:0043562)	12	0	.05	-	 < 0.2	1.00E00
modulation by symbiont of host receptor-mediated signal transduction (GO:0075109)	1	0	.00	-	 < 0.2	1.00E00
wybutosine biosynthetic process (GO:0031591)	2	0	.01	-	 < 0.2	1.00E00
wybutosine metabolic process (GO:0031590)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of clathrin-coated pit assembly (GO:1905469)	1	0	.00	-	 < 0.2	1.00E00
regulation of clathrin-coated pit assembly (GO:1905468)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of histone H3-K36 methylation (GO:0000416)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of DNA duplex unwinding (GO:1905464)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of histone H3-K36 methylation (GO:0000415)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA duplex unwinding (GO:1905463)	1	0	.00	-	 < 0.2	1.00E00
regulation of histone H3-K36 methylation (GO:0000414)	4	0	.02	-	 < 0.2	1.00E00
regulation of DNA duplex unwinding (GO:1905462)	2	0	.01	-	 < 0.2	1.00E00
protein peptidyl-prolyl isomerization (GO:0000413)	44	0	.18	-	 < 0.2	1.00E00
histone peptidyl-prolyl isomerization (GO:0000412)	1	0	.00	-	 < 0.2	1.00E00
potassium ion export from cell (GO:0098668)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription by galactose (GO:0000411)	1	0	.00	-	 < 0.2	1.00E00
nuclear export (GO:0051168)	164	2	.69	+	2.91	1.00E00
regulation of translational initiation in response to stress (GO:0043558)	13	0	.05	-	 < 0.2	1.00E00
xylulose 5-phosphate metabolic process (GO:0051167)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter (GO:0035948)	4	1	.02	+	59.66	1.00E00
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter (GO:0035947)	6	1	.03	+	39.78	1.00E00
regulation of translation in response to oxidative stress (GO:0043556)	1	0	.00	-	 < 0.2	1.00E00
G-protein coupled serotonin receptor signaling pathway (GO:0098664)	24	0	.10	-	 < 0.2	1.00E00
mitochondrial mRNA surveillance (GO:0035946)	1	0	.00	-	 < 0.2	1.00E00
regulation of translation in response to stress (GO:0043555)	21	0	.09	-	 < 0.2	1.00E00
L-xylitol metabolic process (GO:0051164)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.00	-	 < 0.2	1.00E00
inorganic cation transmembrane transport (GO:0098662)	556	3	2.33	+	1.29	1.00E00
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	4	0	.02	-	 < 0.2	1.00E00
inorganic anion transmembrane transport (GO:0098661)	125	0	.52	-	 < 0.2	1.00E00
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	31	3	.13	+	23.10	1.00E00
inorganic ion transmembrane transport (GO:0098660)	654	3	2.74	+	1.09	1.00E00
L-xylitol catabolic process (GO:0051160)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	3	0	.01	-	 < 0.2	1.00E00
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	5	0	.02	-	 < 0.2	1.00E00
activation of phospholipase D activity (GO:0031584)	6	0	.03	-	 < 0.2	1.00E00
phospholipase D-activating G-protein coupled receptor signaling pathway (GO:0031583)	1	0	.00	-	 < 0.2	1.00E00
hemidesmosome assembly (GO:0031581)	12	0	.05	-	 < 0.2	1.00E00
membrane raft distribution (GO:0031580)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription by galactose (GO:0000409)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	3	0	.01	-	 < 0.2	1.00E00
regulation of lymphoid progenitor cell differentiation (GO:1905456)	8	0	.03	-	 < 0.2	1.00E00
regulation of myeloid progenitor cell differentiation (GO:1905453)	1	0	.00	-	 < 0.2	1.00E00
phenylpropanoid metabolic process (GO:0009698)	7	0	.03	-	 < 0.2	1.00E00
inorganic cation import across plasma membrane (GO:0098659)	31	0	.13	-	 < 0.2	1.00E00
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	2	0	.01	-	 < 0.2	1.00E00
import into cell (GO:0098657)	60	0	.25	-	 < 0.2	1.00E00
positive regulation of autophagosome maturation (GO:1901098)	7	0	.03	-	 < 0.2	1.00E00
anion transmembrane transport (GO:0098656)	258	0	1.08	-	 < 0.2	1.00E00
negative regulation of autophagosome maturation (GO:1901097)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of GTPase activity (GO:0043547)	666	9	2.79	+	3.23	1.00E00
glucose 6-phosphate metabolic process (GO:0051156)	23	1	.10	+	10.38	1.00E00
cation transmembrane transport (GO:0098655)	621	3	2.60	+	1.15	1.00E00
regulation of autophagosome maturation (GO:1901096)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of striated muscle cell differentiation (GO:0051155)	58	3	.24	+	12.34	1.00E00
ethylene metabolic process (GO:0009692)	1	0	.00	-	 < 0.2	1.00E00
molybdopterin cofactor metabolic process (GO:0043545)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of striated muscle cell differentiation (GO:0051154)	32	3	.13	+	22.37	1.00E00
negative regulation of protein homotetramerization (GO:1901094)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein homotetramerization (GO:1901093)	2	0	.01	-	 < 0.2	1.00E00
corticosterone secretion (GO:0035934)	1	0	.00	-	 < 0.2	1.00E00
protein acylation (GO:0043543)	159	2	.67	+	3.00	1.00E00
positive regulation of smooth muscle cell differentiation (GO:0051152)	11	0	.05	-	 < 0.2	1.00E00
glucocorticoid secretion (GO:0035933)	2	0	.01	-	 < 0.2	1.00E00
endothelial cell migration (GO:0043542)	61	2	.26	+	7.82	1.00E00
negative regulation of smooth muscle cell differentiation (GO:0051151)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of protein tetramerization (GO:1901091)	2	0	.01	-	 < 0.2	1.00E00
aldosterone secretion (GO:0035932)	1	0	.00	-	 < 0.2	1.00E00
regulation of smooth muscle cell differentiation (GO:0051150)	27	0	.11	-	 < 0.2	1.00E00
regulation of protein tetramerization (GO:1901090)	2	0	.01	-	 < 0.2	1.00E00
activation of protein kinase C activity (GO:1990051)	2	0	.01	-	 < 0.2	1.00E00
mineralocorticoid secretion (GO:0035931)	1	0	.00	-	 < 0.2	1.00E00
membrane raft organization (GO:0031579)	22	1	.09	+	10.85	1.00E00
corticosteroid hormone secretion (GO:0035930)	3	0	.01	-	 < 0.2	1.00E00
spindle checkpoint (GO:0031577)	23	2	.10	+	20.75	1.00E00
intra-S DNA damage checkpoint (GO:0031573)	16	0	.07	-	 < 0.2	1.00E00
G2 DNA damage checkpoint (GO:0031572)	33	3	.14	+	21.70	1.00E00
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	4	1	.02	+	59.66	1.00E00
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	2	0	.01	-	 < 0.2	1.00E00
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	6	1	.03	+	39.78	1.00E00
positive regulation of clathrin coat assembly (GO:1905445)	1	0	.00	-	 < 0.2	1.00E00
regulation of clathrin coat assembly (GO:1905443)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of muscle cell differentiation (GO:0051148)	67	3	.28	+	10.69	1.00E00
steroid hormone secretion (GO:0035929)	5	0	.02	-	 < 0.2	1.00E00
regulation of actin phosphorylation (GO:0043538)	1	0	.00	-	 < 0.2	1.00E00
anterograde neuronal dense core vesicle transport (GO:1990048)	1	0	.00	-	 < 0.2	1.00E00
rRNA import into mitochondrion (GO:0035928)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of blood vessel endothelial cell migration (GO:0043537)	26	0	.11	-	 < 0.2	1.00E00
benzylpenicillin metabolic process (GO:1901086)	1	0	.00	-	 < 0.2	1.00E00
RNA import into mitochondrion (GO:0035927)	5	0	.02	-	 < 0.2	1.00E00
smooth muscle cell differentiation (GO:0051145)	32	0	.13	-	 < 0.2	1.00E00
stress-induced mitochondrial fusion (GO:1990046)	1	0	.00	-	 < 0.2	1.00E00
induced systemic resistance (GO:0009682)	1	0	.00	-	 < 0.2	1.00E00
chemokine (C-C motif) ligand 2 secretion (GO:0035926)	3	0	.01	-	 < 0.2	1.00E00
regulation of blood vessel endothelial cell migration (GO:0043535)	59	4	.25	+	16.18	1.00E00
blood vessel endothelial cell migration (GO:0043534)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of NK T cell proliferation (GO:0051142)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of relaxation of smooth muscle (GO:1901082)	1	0	.00	-	 < 0.2	1.00E00
foramen ovale closure (GO:0035922)	2	0	.01	-	 < 0.2	1.00E00
regulation of NK T cell proliferation (GO:0051140)	4	0	.02	-	 < 0.2	1.00E00
regulation of relaxation of smooth muscle (GO:1901080)	1	0	.00	-	 < 0.2	1.00E00
desmosome disassembly (GO:0035921)	1	0	.00	-	 < 0.2	1.00E00
non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1905438)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433)	1	0	.00	-	 < 0.2	1.00E00
regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of relaxation of muscle (GO:1901079)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of NK T cell differentiation (GO:0051138)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of relaxation of muscle (GO:1901078)	6	0	.03	-	 < 0.2	1.00E00
regulation of relaxation of muscle (GO:1901077)	14	0	.06	-	 < 0.2	1.00E00
regulation of NK T cell differentiation (GO:0051136)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of engulfment of apoptotic cell (GO:1901076)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of NK T cell activation (GO:0051135)	7	0	.03	-	 < 0.2	1.00E00
calcium ion import into sarcoplasmic reticulum (GO:1990036)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of NK T cell activation (GO:0051134)	1	0	.00	-	 < 0.2	1.00E00
regulation of engulfment of apoptotic cell (GO:1901074)	2	0	.01	-	 < 0.2	1.00E00
pore formation in membrane of other organism (GO:0035915)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of neuron apoptotic process (GO:0043524)	139	5	.58	+	8.58	1.00E00
regulation of NK T cell activation (GO:0051133)	8	0	.03	-	 < 0.2	1.00E00
glucosamine-containing compound biosynthetic process (GO:1901073)	2	0	.01	-	 < 0.2	1.00E00
calcium ion export from cell (GO:1990034)	4	0	.02	-	 < 0.2	1.00E00
skeletal muscle cell differentiation (GO:0035914)	54	1	.23	+	4.42	1.00E00
NK T cell activation (GO:0051132)	2	0	.01	-	 < 0.2	1.00E00
glucosamine-containing compound catabolic process (GO:1901072)	9	0	.04	-	 < 0.2	1.00E00
chaperone-mediated protein complex assembly (GO:0051131)	17	0	.07	-	 < 0.2	1.00E00
glucosamine-containing compound metabolic process (GO:1901071)	23	0	.10	-	 < 0.2	1.00E00
dorsal aorta morphogenesis (GO:0035912)	8	0	.03	-	 < 0.2	1.00E00
guanosine-containing compound biosynthetic process (GO:1901070)	14	0	.06	-	 < 0.2	1.00E00
ascending aorta morphogenesis (GO:0035910)	4	0	.02	-	 < 0.2	1.00E00
regulation of DNA-templated transcription, termination (GO:0031554)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550)	1	0	.00	-	 < 0.2	1.00E00
response to glycine (GO:1905429)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426)	2	0	.01	-	 < 0.2	1.00E00
regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of plant organ morphogenesis (GO:1905422)	1	0	.00	-	 < 0.2	1.00E00
trans-Golgi network membrane organization (GO:0098629)	1	0	.00	-	 < 0.2	1.00E00
regulation of plant organ morphogenesis (GO:1905421)	1	0	.00	-	 < 0.2	1.00E00
guanosine-containing compound catabolic process (GO:1901069)	2	0	.01	-	 < 0.2	1.00E00
regulation of myosin II filament organization (GO:0043519)	1	0	.00	-	 < 0.2	1.00E00
guanosine-containing compound metabolic process (GO:1901068)	51	0	.21	-	 < 0.2	1.00E00
vasomotion (GO:1990029)	1	0	.00	-	 < 0.2	1.00E00
aorta morphogenesis (GO:0035909)	27	2	.11	+	17.68	1.00E00
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	13	2	.05	+	36.72	1.00E00
positive regulation of actin nucleation (GO:0051127)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	15	2	.06	+	31.82	1.00E00
negative regulation of actin nucleation (GO:0051126)	7	0	.03	-	 < 0.2	1.00E00
dorsal aorta development (GO:0035907)	9	0	.04	-	 < 0.2	1.00E00
regulation of actin nucleation (GO:0051125)	24	0	.10	-	 < 0.2	1.00E00
synaptic growth at neuromuscular junction (GO:0051124)	2	0	.01	-	 < 0.2	1.00E00
ascending aorta development (GO:0035905)	4	0	.02	-	 < 0.2	1.00E00
RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123)	17	0	.07	-	 < 0.2	1.00E00
aorta development (GO:0035904)	44	2	.18	+	10.85	1.00E00
hepoxilin biosynthetic process (GO:0051122)	5	0	.02	-	 < 0.2	1.00E00
hepoxilin metabolic process (GO:0051121)	5	0	.02	-	 < 0.2	1.00E00
RNA polymerase III complex localization to nucleus (GO:1990022)	3	0	.01	-	 < 0.2	1.00E00
response to immobilization stress (GO:0035902)	27	1	.11	+	8.84	1.00E00
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	1	0	.00	-	 < 0.2	1.00E00
response to isolation stress (GO:0035900)	8	0	.03	-	 < 0.2	1.00E00
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	2	0	.01	-	 < 0.2	1.00E00
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	4	0	.02	-	 < 0.2	1.00E00
sperm flagellum movement involved in flagellated sperm motility (GO:1905419)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of JUN kinase activity (GO:0043508)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of JUN kinase activity (GO:0043507)	68	1	.28	+	3.51	1.00E00
regulation of JUN kinase activity (GO:0043506)	83	1	.35	+	2.88	1.00E00
response to salt stress (GO:0009651)	21	0	.09	-	 < 0.2	1.00E00
mitochondrial DNA repair (GO:0043504)	4	0	.02	-	 < 0.2	1.00E00
sarcosine catabolic process (GO:1901053)	1	0	.00	-	 < 0.2	1.00E00
UV protection (GO:0009650)	13	0	.05	-	 < 0.2	1.00E00
skeletal muscle fiber adaptation (GO:0043503)	2	0	.01	-	 < 0.2	1.00E00
sarcosine metabolic process (GO:1901052)	1	0	.00	-	 < 0.2	1.00E00
skeletal muscle adaptation (GO:0043501)	11	1	.05	+	21.70	1.00E00
muscle adaptation (GO:0043500)	32	1	.13	+	7.46	1.00E00
positive regulation of exit from mitosis (GO:0031536)	6	0	.03	-	 < 0.2	1.00E00
actin cytoskeleton reorganization (GO:0031532)	56	1	.23	+	4.26	1.00E00
negative regulation of creatine transmembrane transporter activity (GO:1905408)	2	0	.01	-	 < 0.2	1.00E00
regulation of creatine transmembrane transporter activity (GO:1905407)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)	1	1	.00	+	 > 100	1.00E00
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	1	0	.00	-	 < 0.2	1.00E00
entrainment of circadian clock (GO:0009649)	25	1	.10	+	9.55	1.00E00
regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	2	1	.01	+	 > 100	1.00E00
photoperiodism (GO:0009648)	23	1	.10	+	10.38	1.00E00
response to absence of light (GO:0009646)	1	0	.00	-	 < 0.2	1.00E00
retinal cell apoptotic process (GO:1990009)	2	0	.01	-	 < 0.2	1.00E00
response to low light intensity stimulus (GO:0009645)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA ligation (GO:0051107)	1	0	.00	-	 < 0.2	1.00E00
response to high light intensity (GO:0009644)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of DNA ligation (GO:0051106)	5	0	.02	-	 < 0.2	1.00E00
regulation of DNA ligation (GO:0051105)	6	0	.03	-	 < 0.2	1.00E00
response to light intensity (GO:0009642)	11	0	.05	-	 < 0.2	1.00E00
DNA ligation involved in DNA repair (GO:0051103)	12	0	.05	-	 < 0.2	1.00E00
DNA ligation involved in DNA recombination (GO:0051102)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of L-arginine import (GO:1901042)	1	0	.00	-	 < 0.2	1.00E00
regulation of DNA binding (GO:0051101)	111	3	.47	+	6.45	1.00E00
negative regulation of binding (GO:0051100)	148	3	.62	+	4.84	1.00E00
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	10	0	.04	-	 < 0.2	1.00E00
amyloid fibril formation (GO:1990000)	9	2	.04	+	53.04	1.00E00
ruffle organization (GO:0031529)	22	0	.09	-	 < 0.2	1.00E00
response to blue light (GO:0009637)	2	0	.01	-	 < 0.2	1.00E00
response to herbicide (GO:0009635)	7	0	.03	-	 < 0.2	1.00E00
cold acclimation (GO:0009631)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of response to reactive oxygen species (GO:1901033)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of response to reactive oxygen species (GO:1901032)	18	0	.08	-	 < 0.2	1.00E00
regulation of response to reactive oxygen species (GO:1901031)	36	0	.15	-	 < 0.2	1.00E00
response to gravity (GO:0009629)	10	2	.04	+	47.73	1.00E00
sarcoplasmic reticulum calcium ion transport (GO:0070296)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	8	0	.03	-	 < 0.2	1.00E00
renal water absorption (GO:0070295)	4	0	.02	-	 < 0.2	1.00E00
renal sodium ion absorption (GO:0070294)	4	0	.02	-	 < 0.2	1.00E00
response to nematode (GO:0009624)	3	0	.01	-	 < 0.2	1.00E00
renal absorption (GO:0070293)	14	0	.06	-	 < 0.2	1.00E00
ripoptosome assembly involved in necroptotic process (GO:1901026)	3	0	.01	-	 < 0.2	1.00E00
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	1	0	.00	-	 < 0.2	1.00E00
N-acylethanolamine metabolic process (GO:0070291)	3	0	.01	-	 < 0.2	1.00E00
response to fungus (GO:0009620)	52	1	.22	+	4.59	1.00E00
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	30	0	.13	-	 < 0.2	1.00E00
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	35	0	.15	-	 < 0.2	1.00E00
telomeric heterochromatin assembly (GO:0031509)	1	0	.00	-	 < 0.2	1.00E00
pericentric heterochromatin assembly (GO:0031508)	3	0	.01	-	 < 0.2	1.00E00
heterochromatin assembly (GO:0031507)	9	1	.04	+	26.52	1.00E00
cell wall glycoprotein biosynthetic process (GO:0031506)	1	0	.00	-	 < 0.2	1.00E00
protein complex localization (GO:0031503)	78	0	.33	-	 < 0.2	1.00E00
axonemal dynein complex assembly (GO:0070286)	31	0	.13	-	 < 0.2	1.00E00
regulation of calcium ion transmembrane transporter activity (GO:1901019)	85	0	.36	-	 < 0.2	1.00E00
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	23	0	.10	-	 < 0.2	1.00E00
response to virus (GO:0009615)	268	6	1.12	+	5.34	1.00E00
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	17	1	.07	+	14.04	1.00E00
regulation of potassium ion transmembrane transporter activity (GO:1901016)	52	1	.22	+	4.59	1.00E00
intermediate mesodermal cell differentiation (GO:0048392)	1	0	.00	-	 < 0.2	1.00E00
intermediate mesoderm formation (GO:0048391)	1	0	.00	-	 < 0.2	1.00E00
intermediate mesoderm morphogenesis (GO:0048390)	1	0	.00	-	 < 0.2	1.00E00
response to symbiotic bacterium (GO:0009609)	2	0	.01	-	 < 0.2	1.00E00
extracellular matrix constituent secretion (GO:0070278)	3	0	.01	-	 < 0.2	1.00E00
response to symbiont (GO:0009608)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998)	1	0	.00	-	 < 0.2	1.00E00
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	6	0	.03	-	 < 0.2	1.00E00
ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	5	0	.02	-	 < 0.2	1.00E00
proton-transporting ATP synthase complex biogenesis (GO:0070272)	4	0	.02	-	 < 0.2	1.00E00
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	11	0	.05	-	 < 0.2	1.00E00
protein complex biogenesis (GO:0070271)	1100	14	4.61	+	3.04	1.00E00
ubiquinone-6 metabolic process (GO:1901004)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of fermentation (GO:1901003)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.00	-	 < 0.2	1.00E00
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.00	-	 < 0.2	1.00E00
intermediate mesoderm development (GO:0048389)	2	0	.01	-	 < 0.2	1.00E00
endosomal lumen acidification (GO:0048388)	3	0	.01	-	 < 0.2	1.00E00
regulation of defense response to virus by host (GO:0050691)	41	1	.17	+	5.82	1.00E00
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	9	0	.04	-	 < 0.2	1.00E00
regulation of defense response to virus by virus (GO:0050690)	30	0	.13	-	 < 0.2	1.00E00
positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	4	0	.02	-	 < 0.2	1.00E00
regulation of retinoic acid receptor signaling pathway (GO:0048385)	16	0	.07	-	 < 0.2	1.00E00
retinoic acid receptor signaling pathway (GO:0048384)	17	0	.07	-	 < 0.2	1.00E00
mesendoderm development (GO:0048382)	5	0	.02	-	 < 0.2	1.00E00
pyroptosis (GO:0070269)	8	0	.03	-	 < 0.2	1.00E00
cornification (GO:0070268)	113	1	.47	+	2.11	1.00E00
oncosis (GO:0070267)	1	0	.00	-	 < 0.2	1.00E00
necroptotic process (GO:0070266)	21	0	.09	-	 < 0.2	1.00E00
necrotic cell death (GO:0070265)	28	0	.12	-	 < 0.2	1.00E00
negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-serine dephosphorylation (GO:0070262)	8	0	.03	-	 < 0.2	1.00E00
regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of defense response to virus by host (GO:0050689)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of endosome organization (GO:1904980)	1	0	.00	-	 < 0.2	1.00E00
regulation of defense response to virus (GO:0050688)	73	1	.31	+	3.27	1.00E00
negative regulation of defense response to virus (GO:0050687)	22	0	.09	-	 < 0.2	1.00E00
negative regulation of mRNA processing (GO:0050686)	32	0	.13	-	 < 0.2	1.00E00
positive regulation of mRNA processing (GO:0050685)	27	1	.11	+	8.84	1.00E00
regulation of mRNA processing (GO:0050684)	113	1	.47	+	2.11	1.00E00
regulation of lateral mesodermal cell fate specification (GO:0048378)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of epithelial cell proliferation (GO:0050680)	119	5	.50	+	10.03	1.00E00
lateral mesodermal cell differentiation (GO:0048371)	1	0	.00	-	 < 0.2	1.00E00
lateral mesoderm formation (GO:0048370)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mucus secretion (GO:0070257)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of endosome organization (GO:1904979)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mucus secretion (GO:0070256)	2	0	.01	-	 < 0.2	1.00E00
regulation of endosome organization (GO:1904978)	4	0	.02	-	 < 0.2	1.00E00
regulation of mucus secretion (GO:0070255)	9	0	.04	-	 < 0.2	1.00E00
lymphatic endothelial cell migration (GO:1904977)	1	0	.00	-	 < 0.2	1.00E00
mucus secretion (GO:0070254)	2	0	.01	-	 < 0.2	1.00E00
cellular response to bleomycin (GO:1904976)	2	0	.01	-	 < 0.2	1.00E00
somatostatin secretion (GO:0070253)	2	0	.01	-	 < 0.2	1.00E00
response to bleomycin (GO:1904975)	2	0	.01	-	 < 0.2	1.00E00
actin-mediated cell contraction (GO:0070252)	84	0	.35	-	 < 0.2	1.00E00
positive regulation of viral translation (GO:1904973)	1	0	.00	-	 < 0.2	1.00E00
regulation of viral translation (GO:1904971)	1	0	.00	-	 < 0.2	1.00E00
brush border assembly (GO:1904970)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of urothelial cell proliferation (GO:0050677)	1	0	.00	-	 < 0.2	1.00E00
regulation of urothelial cell proliferation (GO:0050675)	1	0	.00	-	 < 0.2	1.00E00
urothelial cell proliferation (GO:0050674)	1	0	.00	-	 < 0.2	1.00E00
epithelial cell proliferation (GO:0050673)	86	2	.36	+	5.55	1.00E00
lateral mesoderm morphogenesis (GO:0048369)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of lymphocyte proliferation (GO:0050672)	73	4	.31	+	13.08	1.00E00
lateral mesoderm development (GO:0048368)	11	0	.05	-	 < 0.2	1.00E00
TCR signalosome assembly (GO:0036399)	1	0	.00	-	 < 0.2	1.00E00
regulation of natural killer cell apoptotic process (GO:0070247)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of thymocyte apoptotic process (GO:0070245)	6	1	.03	+	39.78	1.00E00
negative regulation of thymocyte apoptotic process (GO:0070244)	8	0	.03	-	 < 0.2	1.00E00
regulation of thymocyte apoptotic process (GO:0070243)	14	1	.06	+	17.05	1.00E00
thymocyte apoptotic process (GO:0070242)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of activated T cell autonomous cell death (GO:0070241)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cytochrome-c oxidase activity (GO:1904960)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of homocysteine metabolic process (GO:0050668)	1	0	.00	-	 < 0.2	1.00E00
homocysteine metabolic process (GO:0050667)	12	0	.05	-	 < 0.2	1.00E00
regulation of homocysteine metabolic process (GO:0050666)	2	0	.01	-	 < 0.2	1.00E00
hydrogen peroxide biosynthetic process (GO:0050665)	9	0	.04	-	 < 0.2	1.00E00
cytokine secretion (GO:0050663)	44	0	.18	-	 < 0.2	1.00E00
paraxial mesoderm structural organization (GO:0048352)	1	0	.00	-	 < 0.2	1.00E00
pre-replicative complex assembly (GO:0036388)	2	0	.01	-	 < 0.2	1.00E00
regulation of activated T cell autonomous cell death (GO:0070239)	1	0	.00	-	 < 0.2	1.00E00
regulation of cytochrome-c oxidase activity (GO:1904959)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of activation-induced cell death of T cells (GO:0070236)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	3	0	.01	-	 < 0.2	1.00E00
regulation of activation-induced cell death of T cells (GO:0070235)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of T cell apoptotic process (GO:0070234)	15	2	.06	+	31.82	1.00E00
regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of T cell apoptotic process (GO:0070233)	20	0	.08	-	 < 0.2	1.00E00
planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation (GO:1904955)	1	0	.00	-	 < 0.2	1.00E00
regulation of T cell apoptotic process (GO:0070232)	35	2	.15	+	13.64	1.00E00
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954)	4	0	.02	-	 < 0.2	1.00E00
T cell apoptotic process (GO:0070231)	16	1	.07	+	14.92	1.00E00
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of lymphocyte apoptotic process (GO:0070230)	20	2	.08	+	23.87	1.00E00
negative regulation of establishment of protein localization (GO:1904950)	207	3	.87	+	3.46	1.00E00
RNA transport (GO:0050658)	199	1	.83	+	1.20	1.00E00
nucleic acid transport (GO:0050657)	199	1	.83	+	1.20	1.00E00
dermatan sulfate proteoglycan metabolic process (GO:0050655)	16	0	.07	-	 < 0.2	1.00E00
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	42	0	.18	-	 < 0.2	1.00E00
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)	2	0	.01	-	 < 0.2	1.00E00
dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050652)	1	0	.00	-	 < 0.2	1.00E00
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	15	0	.06	-	 < 0.2	1.00E00
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	29	0	.12	-	 < 0.2	1.00E00
paraxial mesodermal cell fate commitment (GO:0048343)	2	0	.01	-	 < 0.2	1.00E00
paraxial mesodermal cell differentiation (GO:0048342)	2	0	.01	-	 < 0.2	1.00E00
paraxial mesoderm formation (GO:0048341)	8	0	.03	-	 < 0.2	1.00E00
microtubule polymerization based movement (GO:0099098)	1	0	.00	-	 < 0.2	1.00E00
paraxial mesoderm morphogenesis (GO:0048340)	11	0	.05	-	 < 0.2	1.00E00
calcitriol biosynthetic process from calciol (GO:0036378)	3	0	.01	-	 < 0.2	1.00E00
sodium ion export from cell (GO:0036376)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of lymphocyte apoptotic process (GO:0070229)	31	0	.13	-	 < 0.2	1.00E00
mitochondrial calcium release (GO:0099093)	2	0	.01	-	 < 0.2	1.00E00
regulation of lymphocyte apoptotic process (GO:0070228)	56	2	.23	+	8.52	1.00E00
lymphocyte apoptotic process (GO:0070227)	19	1	.08	+	12.56	1.00E00
positive regulation of pyloric antrum smooth muscle contraction (GO:0120072)	1	0	.00	-	 < 0.2	1.00E00
midbrain dopaminergic neuron differentiation (GO:1904948)	12	0	.05	-	 < 0.2	1.00E00
opsin transport (GO:0036372)	1	0	.00	-	 < 0.2	1.00E00
regulation of pyloric antrum smooth muscle contraction (GO:0120071)	1	0	.00	-	 < 0.2	1.00E00
folic acid import into mitochondrion (GO:1904947)	1	0	.00	-	 < 0.2	1.00E00
protein localization to T-tubule (GO:0036371)	1	0	.00	-	 < 0.2	1.00E00
sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221)	4	0	.02	-	 < 0.2	1.00E00
paraxial mesoderm development (GO:0048339)	18	0	.08	-	 < 0.2	1.00E00
mesoderm structural organization (GO:0048338)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mesodermal cell fate specification (GO:0048337)	1	0	.00	-	 < 0.2	1.00E00
mesodermal cell differentiation (GO:0048333)	26	1	.11	+	9.18	1.00E00
mesoderm morphogenesis (GO:0048332)	70	2	.29	+	6.82	1.00E00
transcription factor catabolic process (GO:0036369)	2	1	.01	+	 > 100	1.00E00
light adaption (GO:0036367)	1	0	.00	-	 < 0.2	1.00E00
postsynaptic specialization organization (GO:0099084)	9	0	.04	-	 < 0.2	1.00E00
transforming growth factor beta activation (GO:0036363)	1	0	.00	-	 < 0.2	1.00E00
planar cell polarity pathway involved in axon guidance (GO:1904938)	5	0	.02	-	 < 0.2	1.00E00
interneuron migration (GO:1904936)	5	0	.02	-	 < 0.2	1.00E00
protein auto-ADP-ribosylation (GO:0070213)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of cell proliferation in midbrain (GO:1904935)	1	0	.00	-	 < 0.2	1.00E00
protein poly-ADP-ribosylation (GO:0070212)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of cell proliferation in midbrain (GO:1904934)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell proliferation in midbrain (GO:1904933)	2	0	.01	-	 < 0.2	1.00E00
axial mesodermal cell fate specification (GO:0048327)	1	0	.00	-	 < 0.2	1.00E00
axial mesodermal cell fate commitment (GO:0048322)	1	0	.00	-	 < 0.2	1.00E00
axial mesodermal cell differentiation (GO:0048321)	1	0	.00	-	 < 0.2	1.00E00
axial mesoderm formation (GO:0048320)	3	0	.01	-	 < 0.2	1.00E00
renal potassium excretion (GO:0036359)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of small intestinal transit (GO:0120058)	2	0	.01	-	 < 0.2	1.00E00
mitochondrion-derived vesicle mediated transport (GO:0099075)	3	0	.01	-	 < 0.2	1.00E00
regulation of small intestinal transit (GO:0120057)	2	0	.01	-	 < 0.2	1.00E00
mitochondrion to lysosome transport (GO:0099074)	3	0	.01	-	 < 0.2	1.00E00
protein heterotrimerization (GO:0070208)	14	1	.06	+	17.05	1.00E00
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	12	0	.05	-	 < 0.2	1.00E00
protein homotrimerization (GO:0070207)	29	0	.12	-	 < 0.2	1.00E00
histone H2A-K119 monoubiquitination (GO:0036353)	8	0	.03	-	 < 0.2	1.00E00
protein trimerization (GO:0070206)	52	1	.22	+	4.59	1.00E00
histone H2A-K15 ubiquitination (GO:0036352)	1	0	.00	-	 < 0.2	1.00E00
histone H2A-K13 ubiquitination (GO:0036351)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment of protein localization to telomere (GO:0070203)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925)	12	0	.05	-	 < 0.2	1.00E00
regulation of establishment of protein localization to chromosome (GO:0070202)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924)	1	0	.00	-	 < 0.2	1.00E00
regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923)	13	0	.05	-	 < 0.2	1.00E00
establishment of protein localization to telomere (GO:0070200)	6	1	.03	+	39.78	1.00E00
axial mesoderm morphogenesis (GO:0048319)	4	0	.02	-	 < 0.2	1.00E00
axial mesoderm development (GO:0048318)	8	0	.03	-	 < 0.2	1.00E00
Golgi inheritance (GO:0048313)	10	0	.04	-	 < 0.2	1.00E00
intracellular distribution of mitochondria (GO:0048312)	8	1	.03	+	29.83	1.00E00
mitochondrion distribution (GO:0048311)	13	1	.05	+	18.36	1.00E00
postsynapse assembly (GO:0099068)	14	1	.06	+	17.05	1.00E00
snRNA (adenine-N6)-methylation (GO:0120049)	1	0	.00	-	 < 0.2	1.00E00
platelet maturation (GO:0036345)	2	0	.01	-	 < 0.2	1.00E00
platelet morphogenesis (GO:0036344)	20	1	.08	+	11.93	1.00E00
psychomotor behavior (GO:0036343)	4	1	.02	+	59.66	1.00E00
post-anal tail morphogenesis (GO:0036342)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of establishment of macromolecular complex localization to telomere (GO:1904914)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment of macromolecular complex localization to telomere (GO:1904913)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.00	-	 < 0.2	1.00E00
organelle inheritance (GO:0048308)	11	0	.05	-	 < 0.2	1.00E00
immunoglobulin secretion (GO:0048305)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of isotype switching to IgG isotypes (GO:0048304)	10	0	.04	-	 < 0.2	1.00E00
regulation of isotype switching to IgG isotypes (GO:0048302)	13	0	.05	-	 < 0.2	1.00E00
plasma membrane bounded cell projection morphogenesis (GO:0120039)	458	7	1.92	+	3.65	1.00E00
Fas signaling pathway (GO:0036337)	2	0	.01	-	 < 0.2	1.00E00
presynapse assembly (GO:0099054)	16	0	.07	-	 < 0.2	1.00E00
plasma membrane bounded cell projection organization (GO:0120036)	1039	11	4.35	+	2.53	1.00E00
dendritic cell migration (GO:0036336)	22	0	.09	-	 < 0.2	1.00E00
regulation of plasma membrane bounded cell projection organization (GO:0120035)	575	9	2.41	+	3.74	1.00E00
intestinal stem cell homeostasis (GO:0036335)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	90	0	.38	-	 < 0.2	1.00E00
epidermal stem cell homeostasis (GO:0036334)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	22	1	.09	+	10.85	1.00E00
hepatocyte homeostasis (GO:0036333)	1	0	.00	-	 < 0.2	1.00E00
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	154	2	.65	+	3.10	1.00E00
negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.01	-	 < 0.2	1.00E00
plasma membrane bounded cell projection assembly (GO:0120031)	415	1	1.74	-	.58	1.00E00
regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.01	-	 < 0.2	1.00E00
ESCRT III complex disassembly (GO:1904903)	10	0	.04	-	 < 0.2	1.00E00
ESCRT III complex assembly (GO:1904902)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of purine nucleotide metabolic process (GO:1900544)	144	4	.60	+	6.63	1.00E00
negative regulation of purine nucleotide metabolic process (GO:1900543)	71	1	.30	+	3.36	1.00E00
regulation of purine nucleotide metabolic process (GO:1900542)	259	4	1.09	+	3.69	1.00E00
clearance of foreign intracellular nucleic acids (GO:0099046)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of osmosensory signaling pathway (GO:0120028)	1	0	.00	-	 < 0.2	1.00E00
regulation of osmosensory signaling pathway (GO:0120027)	1	0	.00	-	 < 0.2	1.00E00
vesicle tethering to endoplasmic reticulum (GO:0099044)	2	0	.01	-	 < 0.2	1.00E00
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	2	0	.01	-	 < 0.2	1.00E00
vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323)	1	0	.00	-	 < 0.2	1.00E00
ceramide translocation (GO:0099040)	1	0	.00	-	 < 0.2	1.00E00
ghrelin secretion (GO:0036321)	1	0	.00	-	 < 0.2	1.00E00
palmitic acid biosynthetic process (GO:1900535)	1	0	.00	-	 < 0.2	1.00E00
palmitic acid metabolic process (GO:1900533)	1	0	.00	-	 < 0.2	1.00E00
sphingolipid translocation (GO:0099039)	2	0	.01	-	 < 0.2	1.00E00
cellular response to sterol (GO:0036315)	16	0	.07	-	 < 0.2	1.00E00
response to sterol (GO:0036314)	24	0	.10	-	 < 0.2	1.00E00
intermembrane sphingolipid transfer (GO:0120012)	1	0	.00	-	 < 0.2	1.00E00
intermembrane lipid transfer (GO:0120009)	7	0	.03	-	 < 0.2	1.00E00
protein localization to M-band (GO:0036309)	2	0	.01	-	 < 0.2	1.00E00
plasma membrane invagination (GO:0099024)	95	0	.40	-	 < 0.2	1.00E00
embryonic heart tube elongation (GO:0036306)	1	0	.00	-	 < 0.2	1.00E00
ameloblast differentiation (GO:0036305)	1	0	.00	-	 < 0.2	1.00E00
vesicle tethering (GO:0099022)	2	0	.01	-	 < 0.2	1.00E00
umbilical cord morphogenesis (GO:0036304)	2	0	.01	-	 < 0.2	1.00E00
lymph vessel morphogenesis (GO:0036303)	15	0	.06	-	 < 0.2	1.00E00
atrioventricular canal development (GO:0036302)	7	0	.03	-	 < 0.2	1.00E00
mRNA splicing, via spliceosome (GO:0000398)	285	0	1.19	-	 < 0.2	1.00E00
mRNA 5'-splice site recognition (GO:0000395)	6	0	.03	-	 < 0.2	1.00E00
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	16	0	.07	-	 < 0.2	1.00E00
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	6	0	.03	-	 < 0.2	1.00E00
neuronal dense core vesicle exocytosis (GO:0099011)	4	0	.02	-	 < 0.2	1.00E00
modification of postsynaptic structure (GO:0099010)	2	0	.01	-	 < 0.2	1.00E00
spliceosomal complex disassembly (GO:0000390)	3	0	.01	-	 < 0.2	1.00E00
autophagy involved in symbiotic interaction (GO:0075071)	5	0	.02	-	 < 0.2	1.00E00
mRNA 3'-splice site recognition (GO:0000389)	6	0	.03	-	 < 0.2	1.00E00
spliceosomal snRNP assembly (GO:0000387)	38	0	.16	-	 < 0.2	1.00E00
calmodulin dependent kinase signaling pathway (GO:0099004)	4	0	.02	-	 < 0.2	1.00E00
vesicle-mediated transport in synapse (GO:0099003)	113	0	.47	-	 < 0.2	1.00E00
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	41	0	.17	-	 < 0.2	1.00E00
alternative mRNA splicing, via spliceosome (GO:0000380)	16	0	.07	-	 < 0.2	1.00E00
tRNA-type intron splice site recognition and cleavage (GO:0000379)	3	0	.01	-	 < 0.2	1.00E00
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	285	0	1.19	-	 < 0.2	1.00E00
RNA splicing, via transesterification reactions (GO:0000375)	288	0	1.21	-	 < 0.2	1.00E00
parathyroid hormone secretion (GO:0035898)	1	0	.00	-	 < 0.2	1.00E00
proteolysis in other organism (GO:0035897)	6	0	.03	-	 < 0.2	1.00E00
exit from host cell (GO:0035891)	6	0	.03	-	 < 0.2	1.00E00
exit from host (GO:0035890)	6	0	.03	-	 < 0.2	1.00E00
autophagy of host cells involved in interaction with symbiont (GO:0075044)	5	0	.02	-	 < 0.2	1.00E00
cis assembly of pre-catalytic spliceosome (GO:0000354)	2	0	.01	-	 < 0.2	1.00E00
generation of catalytic spliceosome for second transesterification step (GO:0000350)	4	0	.02	-	 < 0.2	1.00E00
regulation of protein heterodimerization activity (GO:0043497)	10	2	.04	+	47.73	1.00E00
regulation of protein homodimerization activity (GO:0043496)	22	2	.09	+	21.70	1.00E00
vascular smooth muscle cell differentiation (GO:0035886)	14	0	.06	-	 < 0.2	1.00E00
enteroendocrine cell differentiation (GO:0035883)	20	1	.08	+	11.93	1.00E00
amacrine cell differentiation (GO:0035881)	5	0	.02	-	 < 0.2	1.00E00
malate-aspartate shuttle (GO:0043490)	2	0	.01	-	 < 0.2	1.00E00
embryonic nail plate morphogenesis (GO:0035880)	3	0	.01	-	 < 0.2	1.00E00
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.01	-	 < 0.2	1.00E00
response to flavonoid (GO:1905395)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of binding (GO:0051099)	167	3	.70	+	4.29	1.00E00
learned vocalization behavior or vocal learning (GO:0098598)	10	0	.04	-	 < 0.2	1.00E00
RNA stabilization (GO:0043489)	43	1	.18	+	5.55	1.00E00
observational learning (GO:0098597)	8	0	.03	-	 < 0.2	1.00E00
plasma membrane lactate transport (GO:0035879)	3	0	.01	-	 < 0.2	1.00E00
regulation of mRNA stability (GO:0043488)	154	4	.65	+	6.20	1.00E00
negative regulation of helicase activity (GO:0051097)	3	1	.01	+	79.55	1.00E00
imitative learning (GO:0098596)	7	0	.03	-	 < 0.2	1.00E00
nail development (GO:0035878)	10	0	.04	-	 < 0.2	1.00E00
regulation of RNA stability (GO:0043487)	163	4	.68	+	5.86	1.00E00
positive regulation of helicase activity (GO:0051096)	6	0	.03	-	 < 0.2	1.00E00
histone exchange (GO:0043486)	45	0	.19	-	 < 0.2	1.00E00
regulation of helicase activity (GO:0051095)	9	1	.04	+	26.52	1.00E00
endosome to pigment granule transport (GO:0043485)	10	0	.04	-	 < 0.2	1.00E00
regulation of RNA splicing (GO:0043484)	119	1	.50	+	2.01	1.00E00
cellular response to copper ion starvation (GO:0035874)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	138	1	.58	+	1.73	1.00E00
lactate transmembrane transport (GO:0035873)	6	0	.03	-	 < 0.2	1.00E00
cellular pigment accumulation (GO:0043482)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091)	245	4	1.03	+	3.90	1.00E00
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	30	0	.13	-	 < 0.2	1.00E00
protein K11-linked deubiquitination (GO:0035871)	10	0	.04	-	 < 0.2	1.00E00
protein deneddylation (GO:0000338)	10	1	.04	+	23.87	1.00E00
positive regulation of protein localization to presynapse (GO:1905386)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein localization to presynapse (GO:1905384)	2	0	.01	-	 < 0.2	1.00E00
protein localization to presynapse (GO:1905383)	1	0	.00	-	 < 0.2	1.00E00
constitutive protein ectodomain proteolysis (GO:0051089)	1	0	.00	-	 < 0.2	1.00E00
PMA-inducible membrane protein ectodomain proteolysis (GO:0051088)	3	0	.01	-	 < 0.2	1.00E00
cellular response to virus (GO:0098586)	30	3	.13	+	23.87	1.00E00
chaperone mediated protein folding independent of cofactor (GO:0051086)	1	0	.00	-	 < 0.2	1.00E00
pigment accumulation (GO:0043476)	12	0	.05	-	 < 0.2	1.00E00
chaperone mediated protein folding requiring cofactor (GO:0051085)	12	0	.05	-	 < 0.2	1.00E00
'de novo' posttranslational protein folding (GO:0051084)	19	0	.08	-	 < 0.2	1.00E00
learned vocalization behavior (GO:0098583)	3	0	.01	-	 < 0.2	1.00E00
cellular response to potassium ion (GO:0035865)	8	0	.03	-	 < 0.2	1.00E00
pigment metabolic process involved in pigmentation (GO:0043474)	4	0	.02	-	 < 0.2	1.00E00
'de novo' cotranslational protein folding (GO:0051083)	2	0	.01	-	 < 0.2	1.00E00
innate vocalization behavior (GO:0098582)	2	0	.01	-	 < 0.2	1.00E00
response to potassium ion (GO:0035864)	14	0	.06	-	 < 0.2	1.00E00
pigmentation (GO:0043473)	92	1	.39	+	2.59	1.00E00
detection of external biotic stimulus (GO:0098581)	21	0	.09	-	 < 0.2	1.00E00
dITP catabolic process (GO:0035863)	1	0	.00	-	 < 0.2	1.00E00
nuclear envelope disassembly (GO:0051081)	48	3	.20	+	14.92	1.00E00
dITP metabolic process (GO:0035862)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular carbohydrate catabolic process (GO:0043471)	12	1	.05	+	19.89	1.00E00
regulation of carbohydrate catabolic process (GO:0043470)	76	1	.32	+	3.14	1.00E00
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	5	0	.02	-	 < 0.2	1.00E00
ceramide phosphoethanolamine biosynthetic process (GO:1905373)	2	0	.01	-	 < 0.2	1.00E00
ceramide phosphoethanolamine metabolic process (GO:1905371)	2	0	.01	-	 < 0.2	1.00E00
re-entry into mitotic cell cycle (GO:0000320)	2	0	.01	-	 < 0.2	1.00E00
regulation of generation of precursor metabolites and energy (GO:0043467)	123	4	.52	+	7.76	1.00E00
regulation of fermentation (GO:0043465)	3	0	.01	-	 < 0.2	1.00E00
megakaryocyte development (GO:0035855)	16	0	.07	-	 < 0.2	1.00E00
eosinophil fate commitment (GO:0035854)	2	0	.01	-	 < 0.2	1.00E00
chromosome passenger complex localization to spindle midzone (GO:0035853)	1	0	.00	-	 < 0.2	1.00E00
regulation of ATPase activity (GO:0043462)	75	0	.31	-	 < 0.2	1.00E00
horizontal cell localization (GO:0035852)	1	0	.00	-	 < 0.2	1.00E00
proton-transporting ATP synthase complex assembly (GO:0043461)	4	0	.02	-	 < 0.2	1.00E00
epithelial cell differentiation involved in kidney development (GO:0035850)	32	1	.13	+	7.46	1.00E00
chromatin disassembly (GO:0031498)	18	0	.08	-	 < 0.2	1.00E00
chromatin assembly (GO:0031497)	134	3	.56	+	5.34	1.00E00
regulation of mating type switching (GO:0031494)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of intralumenal vesicle formation (GO:1905366)	2	0	.01	-	 < 0.2	1.00E00
regulation of intralumenal vesicle formation (GO:1905365)	2	0	.01	-	 < 0.2	1.00E00
dihydrolipoamide metabolic process (GO:0051068)	1	0	.00	-	 < 0.2	1.00E00
nephric duct elongation (GO:0035849)	1	0	.00	-	 < 0.2	1.00E00
regulation of cellular respiration (GO:0043457)	24	1	.10	+	9.94	1.00E00
dihydrobiopterin metabolic process (GO:0051066)	2	0	.01	-	 < 0.2	1.00E00
uterine epithelium development (GO:0035847)	1	0	.00	-	 < 0.2	1.00E00
regulation of pentose-phosphate shunt (GO:0043456)	5	0	.02	-	 < 0.2	1.00E00
oviduct epithelium development (GO:0035846)	1	0	.00	-	 < 0.2	1.00E00
regulation of secondary metabolic process (GO:0043455)	12	1	.05	+	19.89	1.00E00
photoreceptor cell outer segment organization (GO:0035845)	9	0	.04	-	 < 0.2	1.00E00
cloaca development (GO:0035844)	4	0	.02	-	 < 0.2	1.00E00
protein localization to meiotic spindle (GO:1905359)	1	0	.00	-	 < 0.2	1.00E00
spine apparatus assembly (GO:1905355)	1	0	.00	-	 < 0.2	1.00E00
response to oxygen radical (GO:0000305)	21	0	.09	-	 < 0.2	1.00E00
response to superoxide (GO:0000303)	18	0	.08	-	 < 0.2	1.00E00
detection of virus (GO:0009597)	5	0	.02	-	 < 0.2	1.00E00
retrograde transport, vesicle recycling within Golgi (GO:0000301)	12	0	.05	-	 < 0.2	1.00E00
cellular alkene metabolic process (GO:0043449)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of small GTPase mediated signal transduction (GO:0051058)	54	0	.23	-	 < 0.2	1.00E00
detection of biotic stimulus (GO:0009595)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of small GTPase mediated signal transduction (GO:0051057)	59	3	.25	+	12.14	1.00E00
regulation of small GTPase mediated signal transduction (GO:0051056)	316	7	1.32	+	5.29	1.00E00
detection of chemical stimulus (GO:0009593)	509	0	2.13	-	 < 0.2	1.00E00
negative regulation of lipid biosynthetic process (GO:0051055)	47	1	.20	+	5.08	1.00E00
negative regulation of DNA metabolic process (GO:0051053)	126	4	.53	+	7.58	1.00E00
detection of gravity (GO:0009590)	1	0	.00	-	 < 0.2	1.00E00
prostaglandin catabolic process (GO:1905344)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-serine acetylation (GO:0017198)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein localization to kinetochore (GO:1905342)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of protein localization to kinetochore (GO:1905341)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-methionine acetylation (GO:0017196)	6	0	.03	-	 < 0.2	1.00E00
regulation of protein localization to kinetochore (GO:1905340)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of secretion (GO:0051048)	206	5	.86	+	5.79	1.00E00
acetoacetic acid metabolic process (GO:0043438)	1	0	.00	-	 < 0.2	1.00E00
detection of visible light (GO:0009584)	41	0	.17	-	 < 0.2	1.00E00
detection of light stimulus (GO:0009583)	57	0	.24	-	 < 0.2	1.00E00
oxoacid metabolic process (GO:0043436)	978	8	4.10	+	1.95	1.00E00
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	7	0	.03	-	 < 0.2	1.00E00
detection of abiotic stimulus (GO:0009582)	121	1	.51	+	1.97	1.00E00
rubidium ion transport (GO:0035826)	1	0	.00	-	 < 0.2	1.00E00
response to corticotropin-releasing hormone (GO:0043435)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	16	0	.07	-	 < 0.2	1.00E00
detection of other organism (GO:0098543)	16	0	.07	-	 < 0.2	1.00E00
detection of external stimulus (GO:0009581)	118	1	.49	+	2.02	1.00E00
homologous recombination (GO:0035825)	47	1	.20	+	5.08	1.00E00
regulation of membrane protein ectodomain proteolysis (GO:0051043)	23	0	.10	-	 < 0.2	1.00E00
defense response to other organism (GO:0098542)	469	6	1.97	+	3.05	1.00E00
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433)	143	1	.60	+	1.67	1.00E00
negative regulation of calcium-independent cell-cell adhesion (GO:0051042)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of calcium-independent cell-cell adhesion (GO:0051041)	1	0	.00	-	 < 0.2	1.00E00
gene conversion (GO:0035822)	5	0	.02	-	 < 0.2	1.00E00
regulation of calcium-independent cell-cell adhesion (GO:0051040)	2	0	.01	-	 < 0.2	1.00E00
modification of morphology or physiology of other organism (GO:0035821)	138	1	.58	+	1.73	1.00E00
nuclear envelope reassembly (GO:0031468)	18	0	.08	-	 < 0.2	1.00E00
glycine betaine transport (GO:0031460)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of aggrephagy (GO:1905337)	1	0	.00	-	 < 0.2	1.00E00
regulation of aggrephagy (GO:1905335)	1	0	.00	-	 < 0.2	1.00E00
regulation of gastric motility (GO:1905333)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of morphogenesis of an epithelium (GO:1905332)	33	1	.14	+	7.23	1.00E00
peptidyl-glutamic acid carboxylation (GO:0017187)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of morphogenesis of an epithelium (GO:1905331)	18	0	.08	-	 < 0.2	1.00E00
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	1	0	.00	-	 < 0.2	1.00E00
regulation of morphogenesis of an epithelium (GO:1905330)	181	1	.76	+	1.32	1.00E00
peptidyl-lysine hydroxylation (GO:0017185)	8	0	.03	-	 < 0.2	1.00E00
regulation of transcription involved in meiotic cell cycle (GO:0051037)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	8	1	.03	+	29.83	1.00E00
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	5	0	.02	-	 < 0.2	1.00E00
regulation of endosome size (GO:0051036)	5	0	.02	-	 < 0.2	1.00E00
centriole assembly (GO:0098534)	21	0	.09	-	 < 0.2	1.00E00
peptidyl-diphthamide metabolic process (GO:0017182)	8	1	.03	+	29.83	1.00E00
histone H3-K27 trimethylation (GO:0098532)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of renal sodium excretion (GO:0035815)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of renal sodium excretion (GO:0035814)	6	0	.03	-	 < 0.2	1.00E00
tRNA transport (GO:0051031)	35	0	.15	-	 < 0.2	1.00E00
regulation of renal sodium excretion (GO:0035813)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of strand invasion (GO:0098530)	1	0	.00	-	 < 0.2	1.00E00
snRNA transport (GO:0051030)	3	0	.01	-	 < 0.2	1.00E00
renal sodium excretion (GO:0035812)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of urine volume (GO:0035811)	6	0	.03	-	 < 0.2	1.00E00
anthranilate metabolic process (GO:0043420)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of urine volume (GO:0035810)	13	0	.05	-	 < 0.2	1.00E00
glycine betaine biosynthetic process (GO:0031456)	2	0	.01	-	 < 0.2	1.00E00
glycine betaine metabolic process (GO:0031455)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of heterochromatin assembly (GO:0031453)	2	0	.01	-	 < 0.2	1.00E00
tracheoesophageal septum formation (GO:1905327)	1	0	.00	-	 < 0.2	1.00E00
telomerase holoenzyme complex assembly (GO:1905323)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of mesenchymal stem cell migration (GO:1905322)	1	0	.00	-	 < 0.2	1.00E00
rRNA transport (GO:0051029)	6	0	.03	-	 < 0.2	1.00E00
skeletal muscle fiber differentiation (GO:0098528)	2	0	.01	-	 < 0.2	1.00E00
regulation of mesenchymal stem cell migration (GO:1905320)	1	0	.00	-	 < 0.2	1.00E00
mRNA transport (GO:0051028)	156	1	.65	+	1.53	1.00E00
fertilization (GO:0009566)	163	1	.68	+	1.46	1.00E00
homocysteine catabolic process (GO:0043418)	3	0	.01	-	 < 0.2	1.00E00
regulation of urine volume (GO:0035809)	22	1	.09	+	10.85	1.00E00
chiasma assembly (GO:0051026)	8	0	.03	-	 < 0.2	1.00E00
regulation of skeletal muscle tissue regeneration (GO:0043416)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of immunoglobulin secretion (GO:0051025)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of immunoglobulin secretion (GO:0051024)	11	2	.05	+	43.39	1.00E00
positive regulation of skeletal muscle tissue regeneration (GO:0043415)	5	0	.02	-	 < 0.2	1.00E00
regulation of immunoglobulin secretion (GO:0051023)	17	2	.07	+	28.08	1.00E00
macromolecule methylation (GO:0043414)	235	1	.98	+	1.02	1.00E00
macromolecule glycosylation (GO:0043413)	273	0	1.14	-	 < 0.2	1.00E00
egg coat formation (GO:0035803)	3	0	.01	-	 < 0.2	1.00E00
adrenal cortex formation (GO:0035802)	2	0	.01	-	 < 0.2	1.00E00
adrenal cortex development (GO:0035801)	2	0	.01	-	 < 0.2	1.00E00
regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	2	0	.01	-	 < 0.2	1.00E00
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	2	0	.01	-	 < 0.2	1.00E00
regulation of heterochromatin assembly (GO:0031445)	2	0	.01	-	 < 0.2	1.00E00
slow-twitch skeletal muscle fiber contraction (GO:0031444)	2	0	.01	-	 < 0.2	1.00E00
fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mRNA 3'-end processing (GO:0031442)	8	1	.03	+	29.83	1.00E00
negative regulation of mRNA 3'-end processing (GO:0031441)	9	0	.04	-	 < 0.2	1.00E00
regulation of mRNA 3'-end processing (GO:0031440)	21	1	.09	+	11.36	1.00E00
inferior endocardial cushion morphogenesis (GO:1905317)	1	0	.00	-	 < 0.2	1.00E00
semi-lunar valve development (GO:1905314)	16	1	.07	+	14.92	1.00E00
transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312)	3	0	.01	-	 < 0.2	1.00E00
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310)	3	0	.01	-	 < 0.2	1.00E00
actin filament bundle assembly (GO:0051017)	50	1	.21	+	4.77	1.00E00
barbed-end actin filament capping (GO:0051016)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of MAP kinase activity (GO:0043407)	73	3	.31	+	9.81	1.00E00
actin filament severing (GO:0051014)	8	0	.03	-	 < 0.2	1.00E00
microtubule severing (GO:0051013)	7	0	.03	-	 < 0.2	1.00E00
skeletal muscle tissue regeneration (GO:0043403)	27	2	.11	+	17.68	1.00E00
microtubule sliding (GO:0051012)	2	0	.01	-	 < 0.2	1.00E00
glucocorticoid mediated signaling pathway (GO:0043402)	1	0	.00	-	 < 0.2	1.00E00
steroid hormone mediated signaling pathway (GO:0043401)	128	2	.54	+	3.73	1.00E00
cortisol secretion (GO:0043400)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mRNA cleavage (GO:0031439)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mRNA cleavage (GO:0031438)	1	0	.00	-	 < 0.2	1.00E00
regulation of mRNA cleavage (GO:0031437)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.00	-	 < 0.2	1.00E00
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcium ion-dependent exocytosis (GO:0017158)	66	0	.28	-	 < 0.2	1.00E00
negative regulation of macropinocytosis (GO:1905302)	1	0	.00	-	 < 0.2	1.00E00
regulation of exocytosis (GO:0017157)	172	2	.72	+	2.78	1.00E00
regulation of macropinocytosis (GO:1905301)	1	0	.00	-	 < 0.2	1.00E00
calcium ion regulated exocytosis (GO:0017156)	73	0	.31	-	 < 0.2	1.00E00
polynucleotide 5' dephosphorylation (GO:0098507)	2	0	.01	-	 < 0.2	1.00E00
polynucleotide 3' dephosphorylation (GO:0098506)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of lipoprotein lipase activity (GO:0051006)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of lipoprotein lipase activity (GO:0051005)	5	0	.02	-	 < 0.2	1.00E00
DNA 3' dephosphorylation involved in DNA repair (GO:0098504)	1	0	.00	-	 < 0.2	1.00E00
regulation of lipoprotein lipase activity (GO:0051004)	23	0	.10	-	 < 0.2	1.00E00
DNA 3' dephosphorylation (GO:0098503)	1	0	.00	-	 < 0.2	1.00E00
DNA dephosphorylation (GO:0098502)	3	0	.01	-	 < 0.2	1.00E00
polynucleotide dephosphorylation (GO:0098501)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of nitric-oxide synthase activity (GO:0051001)	8	1	.03	+	29.83	1.00E00
positive regulation of nitric-oxide synthase activity (GO:0051000)	18	1	.08	+	13.26	1.00E00
response to methotrexate (GO:0031427)	4	0	.02	-	 < 0.2	1.00E00
keratinization (GO:0031424)	227	2	.95	+	2.10	1.00E00
negative regulation of translation (GO:0017148)	145	2	.61	+	3.29	1.00E00
stem cell division (GO:0017145)	33	1	.14	+	7.23	1.00E00
drug metabolic process (GO:0017144)	35	0	.15	-	 < 0.2	1.00E00
insecticide metabolic process (GO:0017143)	2	0	.01	-	 < 0.2	1.00E00
establishment of protein localization to chromosome (GO:0070199)	13	1	.05	+	18.36	1.00E00
protein localization to chromosome, telomeric region (GO:0070198)	15	1	.06	+	15.91	1.00E00
meiotic attachment of telomere to nuclear envelope (GO:0070197)	8	0	.03	-	 < 0.2	1.00E00
synaptonemal complex disassembly (GO:0070194)	2	1	.01	+	 > 100	1.00E00
synaptonemal complex organization (GO:0070193)	25	1	.10	+	9.55	1.00E00
chromosome organization involved in meiotic cell cycle (GO:0070192)	69	1	.29	+	3.46	1.00E00
oxylipin metabolic process (GO:0031407)	1	0	.00	-	 < 0.2	1.00E00
kynurenine metabolic process (GO:0070189)	10	0	.04	-	 < 0.2	1.00E00
nucleologenesis (GO:0017126)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184)	1	0	.00	-	 < 0.2	1.00E00
phospholipid scrambling (GO:0017121)	12	0	.05	-	 < 0.2	1.00E00
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	5	0	.02	-	 < 0.2	1.00E00
regulation of Golgi to plasma membrane protein transport (GO:0042996)	8	0	.03	-	 < 0.2	1.00E00
cytoplasmic sequestering of transcription factor (GO:0042994)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of transcription factor import into nucleus (GO:0042993)	48	3	.20	+	14.92	1.00E00
positive regulation of isotype switching to IgA isotypes (GO:0048298)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of transcription factor import into nucleus (GO:0042992)	38	0	.16	-	 < 0.2	1.00E00
negative regulation of isotype switching to IgA isotypes (GO:0048297)	1	0	.00	-	 < 0.2	1.00E00
regulation of isotype switching to IgA isotypes (GO:0048296)	6	0	.03	-	 < 0.2	1.00E00
regulation of transcription factor import into nucleus (GO:0042990)	91	3	.38	+	7.87	1.00E00
positive regulation of isotype switching to IgE isotypes (GO:0048295)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of isotype switching to IgE isotypes (GO:0048294)	3	0	.01	-	 < 0.2	1.00E00
regulation of isotype switching to IgE isotypes (GO:0048293)	7	0	.03	-	 < 0.2	1.00E00
isotype switching to IgG isotypes (GO:0048291)	1	0	.00	-	 < 0.2	1.00E00
isotype switching to IgA isotypes (GO:0048290)	1	0	.00	-	 < 0.2	1.00E00
D-serine biosynthetic process (GO:0070179)	1	0	.00	-	 < 0.2	1.00E00
D-serine metabolic process (GO:0070178)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of hepatic stellate cell proliferation (GO:1904899)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of enamel mineralization (GO:0070175)	3	0	.01	-	 < 0.2	1.00E00
regulation of hepatic stellate cell proliferation (GO:1904897)	1	0	.00	-	 < 0.2	1.00E00
ESCRT complex disassembly (GO:1904896)	10	0	.04	-	 < 0.2	1.00E00
regulation of enamel mineralization (GO:0070173)	5	0	.02	-	 < 0.2	1.00E00
ESCRT complex assembly (GO:1904895)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of STAT cascade (GO:1904894)	74	2	.31	+	6.45	1.00E00
positive regulation of tooth mineralization (GO:0070172)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of STAT cascade (GO:1904893)	52	1	.22	+	4.59	1.00E00
negative regulation of tooth mineralization (GO:0070171)	2	0	.01	-	 < 0.2	1.00E00
regulation of STAT cascade (GO:1904892)	152	3	.64	+	4.71	1.00E00
regulation of tooth mineralization (GO:0070170)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of excitatory synapse assembly (GO:1904891)	1	0	.00	-	 < 0.2	1.00E00
sequestering of actin monomers (GO:0042989)	7	0	.03	-	 < 0.2	1.00E00
amyloid precursor protein catabolic process (GO:0042987)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of amyloid precursor protein biosynthetic process (GO:0042986)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	6	0	.03	-	 < 0.2	1.00E00
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	9	0	.04	-	 < 0.2	1.00E00
amyloid precursor protein metabolic process (GO:0042982)	15	0	.06	-	 < 0.2	1.00E00
lung alveolus development (GO:0048286)	39	1	.16	+	6.12	1.00E00
organelle fission (GO:0048285)	305	4	1.28	+	3.13	1.00E00
organelle fusion (GO:0048284)	120	0	.50	-	 < 0.2	1.00E00
vesicle fusion with Golgi apparatus (GO:0048280)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of biomineral tissue development (GO:0070169)	41	0	.17	-	 < 0.2	1.00E00
negative regulation of biomineral tissue development (GO:0070168)	19	0	.08	-	 < 0.2	1.00E00
regulation of biomineral tissue development (GO:0070167)	76	0	.32	-	 < 0.2	1.00E00
regulation of excitatory synapse assembly (GO:1904889)	1	0	.00	-	 < 0.2	1.00E00
cranial skeletal system development (GO:1904888)	63	0	.26	-	 < 0.2	1.00E00
enamel mineralization (GO:0070166)	11	0	.05	-	 < 0.2	1.00E00
Wnt signalosome assembly (GO:1904887)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of adiponectin secretion (GO:0070165)	2	0	.01	-	 < 0.2	1.00E00
beta-catenin destruction complex disassembly (GO:1904886)	22	1	.09	+	10.85	1.00E00
negative regulation of adiponectin secretion (GO:0070164)	4	0	.02	-	 < 0.2	1.00E00
beta-catenin destruction complex assembly (GO:1904885)	5	0	.02	-	 < 0.2	1.00E00
regulation of adiponectin secretion (GO:0070163)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	1	.01	+	 > 100	1.00E00
regulation of telomerase catalytic core complex assembly (GO:1904882)	2	1	.01	+	 > 100	1.00E00
activation of Janus kinase activity (GO:0042976)	5	0	.02	-	 < 0.2	1.00E00
vesicle docking (GO:0048278)	59	0	.25	-	 < 0.2	1.00E00
mitochondrial threonyl-tRNA aminoacylation (GO:0070159)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	2	1	.01	+	 > 100	1.00E00
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of DNA ligase activity (GO:1904877)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA ligase activity (GO:1904876)	1	0	.00	-	 < 0.2	1.00E00
regulation of DNA ligase activity (GO:1904875)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	15	0	.06	-	 < 0.2	1.00E00
regulation of telomerase RNA localization to Cajal body (GO:1904872)	18	0	.08	-	 < 0.2	1.00E00
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein localization to Cajal body (GO:1904871)	8	0	.03	-	 < 0.2	1.00E00
clathrin coat assembly (GO:0048268)	18	0	.08	-	 < 0.2	1.00E00
behavioral response to pain (GO:0048266)	14	0	.06	-	 < 0.2	1.00E00
response to pain (GO:0048265)	30	0	.13	-	 < 0.2	1.00E00
determination of ventral identity (GO:0048264)	1	0	.00	-	 < 0.2	1.00E00
determination of dorsal identity (GO:0048263)	5	0	.02	-	 < 0.2	1.00E00
regulation of centriole-centriole cohesion (GO:0030997)	3	0	.01	-	 < 0.2	1.00E00
determination of dorsal/ventral asymmetry (GO:0048262)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of receptor-mediated endocytosis (GO:0048261)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of receptor-mediated endocytosis (GO:0048260)	51	2	.21	+	9.36	1.00E00
interstrand cross-link repair (GO:0036297)	49	0	.21	-	 < 0.2	1.00E00
response to increased oxygen levels (GO:0036296)	27	3	.11	+	26.52	1.00E00
cellular response to increased oxygen levels (GO:0036295)	14	1	.06	+	17.05	1.00E00
regulation of protein localization to Cajal body (GO:1904869)	8	0	.03	-	 < 0.2	1.00E00
DNA rewinding (GO:0036292)	2	0	.01	-	 < 0.2	1.00E00
protein localization to Cajal body (GO:1904867)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.00	-	 < 0.2	1.00E00
protein trans-autophosphorylation (GO:0036290)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of beta-catenin-TCF complex assembly (GO:1904864)	1	0	.00	-	 < 0.2	1.00E00
synaptic vesicle budding (GO:0070142)	5	0	.02	-	 < 0.2	1.00E00
regulation of beta-catenin-TCF complex assembly (GO:1904863)	1	0	.00	-	 < 0.2	1.00E00
inhibitory synapse assembly (GO:1904862)	3	0	.01	-	 < 0.2	1.00E00
excitatory synapse assembly (GO:1904861)	10	0	.04	-	 < 0.2	1.00E00
regulation of receptor-mediated endocytosis (GO:0048259)	82	2	.34	+	5.82	1.00E00
lipoprotein transport (GO:0042953)	16	0	.07	-	 < 0.2	1.00E00
mRNA stabilization (GO:0048255)	39	1	.16	+	6.12	1.00E00
snoRNA localization (GO:0048254)	4	0	.02	-	 < 0.2	1.00E00
elastic fiber assembly (GO:0048251)	7	0	.03	-	 < 0.2	1.00E00
mitochondrial iron ion transport (GO:0048250)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-serine autophosphorylation (GO:0036289)	6	1	.03	+	39.78	1.00E00
positive regulation of mitochondrial translation (GO:0070131)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of mitochondrial translation (GO:0070130)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of establishment of protein localization to telomere (GO:1904851)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.00	-	 < 0.2	1.00E00
glucoside transport (GO:0042946)	1	0	.00	-	 < 0.2	1.00E00
D-serine transport (GO:0042942)	2	0	.01	-	 < 0.2	1.00E00
lymphocyte chemotaxis (GO:0048247)	43	0	.18	-	 < 0.2	1.00E00
D-alanine transport (GO:0042941)	1	0	.00	-	 < 0.2	1.00E00
macrophage chemotaxis (GO:0048246)	13	0	.05	-	 < 0.2	1.00E00
D-amino acid transport (GO:0042940)	6	0	.03	-	 < 0.2	1.00E00
eosinophil chemotaxis (GO:0048245)	9	0	.04	-	 < 0.2	1.00E00
norepinephrine secretion (GO:0048243)	1	0	.00	-	 < 0.2	1.00E00
epinephrine transport (GO:0048241)	1	0	.00	-	 < 0.2	1.00E00
sperm capacitation (GO:0048240)	25	0	.10	-	 < 0.2	1.00E00
thiamine pyrophosphate transport (GO:0030974)	2	0	.01	-	 < 0.2	1.00E00
regulation of mitochondrial translation (GO:0070129)	17	0	.07	-	 < 0.2	1.00E00
retrograde protein transport, ER to cytosol (GO:0030970)	16	0	.07	-	 < 0.2	1.00E00
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	4	0	.02	-	 < 0.2	1.00E00
mitochondrial translational termination (GO:0070126)	88	0	.37	-	 < 0.2	1.00E00
negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial translational elongation (GO:0070125)	86	0	.36	-	 < 0.2	1.00E00
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	7	0	.03	-	 < 0.2	1.00E00
mitochondrial translational initiation (GO:0070124)	2	0	.01	-	 < 0.2	1.00E00
cellular response to L-glutamine (GO:1904845)	3	0	.01	-	 < 0.2	1.00E00
response to L-glutamine (GO:1904844)	3	0	.01	-	 < 0.2	1.00E00
Kupffer's vesicle development (GO:0070121)	1	0	.00	-	 < 0.2	1.00E00
cellular response to nitroglycerin (GO:1904843)	1	0	.00	-	 < 0.2	1.00E00
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	5	0	.02	-	 < 0.2	1.00E00
response to nitroglycerin (GO:1904842)	1	0	.00	-	 < 0.2	1.00E00
tripeptide transport (GO:0042939)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein targeting to vacuolar membrane (GO:1900483)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of DNA recombination at telomere (GO:0048239)	2	0	.01	-	 < 0.2	1.00E00
enterobactin transport (GO:0042930)	1	0	.00	-	 < 0.2	1.00E00
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response (GO:0030969)	1	0	.00	-	 < 0.2	1.00E00
endoplasmic reticulum unfolded protein response (GO:0030968)	115	2	.48	+	4.15	1.00E00
male gamete generation (GO:0048232)	527	5	2.21	+	2.26	1.00E00
swimming behavior (GO:0036269)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-arginine hydroxylation (GO:0030961)	3	0	.01	-	 < 0.2	1.00E00
RNA (guanine-N7)-methylation (GO:0036265)	6	0	.03	-	 < 0.2	1.00E00
beta-catenin-TCF complex assembly (GO:1904837)	30	0	.13	-	 < 0.2	1.00E00
7-methylguanosine cap hypermethylation (GO:0036261)	1	0	.00	-	 < 0.2	1.00E00
RNA capping (GO:0036260)	34	0	.14	-	 < 0.2	1.00E00
dorsal root ganglion morphogenesis (GO:1904835)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of removal of superoxide radicals (GO:1904833)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of aortic smooth muscle cell differentiation (GO:1904831)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477)	1	0	.00	-	 < 0.2	1.00E00
plasma membrane to endosome transport (GO:0048227)	8	0	.03	-	 < 0.2	1.00E00
glucocorticoid receptor signaling pathway (GO:0042921)	8	0	.03	-	 < 0.2	1.00E00
astral microtubule organization (GO:0030953)	7	0	.03	-	 < 0.2	1.00E00
multivesicular body assembly (GO:0036258)	30	0	.13	-	 < 0.2	1.00E00
establishment or maintenance of cytoskeleton polarity (GO:0030952)	7	1	.03	+	34.09	1.00E00
multivesicular body organization (GO:0036257)	31	0	.13	-	 < 0.2	1.00E00
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	3	0	.01	-	 < 0.2	1.00E00
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	4	1	.02	+	59.66	1.00E00
response to methylamine (GO:0036255)	1	0	.00	-	 < 0.2	1.00E00
regulation of aortic smooth muscle cell differentiation (GO:1904829)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.00	-	 < 0.2	1.00E00
interleukin-27-mediated signaling pathway (GO:0070106)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	1	0	.00	-	 < 0.2	1.00E00
regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of interleukin-6-mediated signaling pathway (GO:0070104)	2	0	.01	-	 < 0.2	1.00E00
regulation of interleukin-6-mediated signaling pathway (GO:0070103)	3	0	.01	-	 < 0.2	1.00E00
peroxisome transport along microtubule (GO:0036250)	1	0	.00	-	 < 0.2	1.00E00
interleukin-6-mediated signaling pathway (GO:0070102)	9	0	.04	-	 < 0.2	1.00E00
purine nucleobase transmembrane transport (GO:1904823)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of chemokine-mediated signaling pathway (GO:0070100)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	7	0	.03	-	 < 0.2	1.00E00
Golgi vesicle prefusion complex stabilization (GO:0048213)	2	0	.01	-	 < 0.2	1.00E00
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	27	0	.11	-	 < 0.2	1.00E00
Golgi vesicle docking (GO:0048211)	1	0	.00	-	 < 0.2	1.00E00
Golgi vesicle fusion to target membrane (GO:0048210)	2	0	.01	-	 < 0.2	1.00E00
cellular response to menadione (GO:0036245)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein localization to chromosome, telomeric region (GO:1904814)	14	0	.06	-	 < 0.2	1.00E00
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.00	-	 < 0.2	1.00E00
xenobiotic transport (GO:0042908)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of long term synaptic depression (GO:1900454)	5	0	.02	-	 < 0.2	1.00E00
9-cis-retinoic acid metabolic process (GO:0042905)	4	0	.02	-	 < 0.2	1.00E00
9-cis-retinoic acid biosynthetic process (GO:0042904)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of long term synaptic depression (GO:1900453)	3	0	.01	-	 < 0.2	1.00E00
regulation of long term synaptic depression (GO:1900452)	11	0	.05	-	 < 0.2	1.00E00
regulation of vesicle targeting, to, from or within Golgi (GO:0048209)	2	0	.01	-	 < 0.2	1.00E00
COPII vesicle coating (GO:0048208)	62	0	.26	-	 < 0.2	1.00E00
positive regulation of glutamate receptor signaling pathway (GO:1900451)	8	0	.03	-	 < 0.2	1.00E00
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	62	0	.26	-	 < 0.2	1.00E00
negative regulation of glutamate receptor signaling pathway (GO:1900450)	1	0	.00	-	 < 0.2	1.00E00
COPI coating of Golgi vesicle (GO:0048205)	4	0	.02	-	 < 0.2	1.00E00
vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	0	.01	-	 < 0.2	1.00E00
Golgi transport vesicle coating (GO:0048200)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of protein oxidation (GO:1904808)	2	0	.01	-	 < 0.2	1.00E00
glycine import (GO:0036233)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein oxidation (GO:1904806)	2	0	.01	-	 < 0.2	1.00E00
regulation of translation involved in cellular response to UV (GO:1904803)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of neuron remodeling (GO:1904800)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutamate receptor signaling pathway (GO:1900449)	37	0	.16	-	 < 0.2	1.00E00
L-glutamine import (GO:0036229)	1	0	.00	-	 < 0.2	1.00E00
protein localization to nuclear inner membrane (GO:0036228)	2	0	.01	-	 < 0.2	1.00E00
peptidyl-serine acetylation (GO:0030920)	2	0	.01	-	 < 0.2	1.00E00
midbrain-hindbrain boundary development (GO:0030917)	9	0	.04	-	 < 0.2	1.00E00
otic vesicle formation (GO:0030916)	8	0	.03	-	 < 0.2	1.00E00
paranodal junction assembly (GO:0030913)	7	0	.03	-	 < 0.2	1.00E00
olfactory placode formation (GO:0030910)	4	0	.02	-	 < 0.2	1.00E00
cellular response to stem cell factor stimulus (GO:0036216)	2	0	.01	-	 < 0.2	1.00E00
response to stem cell factor (GO:0036215)	2	0	.01	-	 < 0.2	1.00E00
contractile ring contraction (GO:0036213)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of defense response to bacterium (GO:1900426)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of defense response to bacterium (GO:1900425)	5	0	.02	-	 < 0.2	1.00E00
regulation of defense response to bacterium (GO:1900424)	14	0	.06	-	 < 0.2	1.00E00
protein splicing (GO:0030908)	2	0	.01	-	 < 0.2	1.00E00
notochord development (GO:0030903)	18	0	.08	-	 < 0.2	1.00E00
hindbrain development (GO:0030902)	143	2	.60	+	3.34	1.00E00
midbrain development (GO:0030901)	88	2	.37	+	5.42	1.00E00
positive regulation of phospholipid biosynthetic process by positive regulation of transcription from RNA polymerase II promoter (GO:1900413)	1	1	.00	+	 > 100	1.00E00
spermine transport (GO:0000296)	1	0	.00	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)	2	0	.01	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	35	0	.15	-	 < 0.2	1.00E00
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of cellular response to oxidative stress (GO:1900409)	19	1	.08	+	12.56	1.00E00
negative regulation of cellular response to oxidative stress (GO:1900408)	42	1	.18	+	5.68	1.00E00
regulation of cellular response to oxidative stress (GO:1900407)	73	2	.31	+	6.54	1.00E00
regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter (GO:1900402)	9	1	.04	+	26.52	1.00E00
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	30	0	.13	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	67	0	.28	-	 < 0.2	1.00E00
mitotic cytokinesis (GO:0000281)	42	1	.18	+	5.68	1.00E00
nuclear division (GO:0000280)	275	4	1.15	+	3.47	1.00E00
Rac protein signal transduction (GO:0016601)	20	0	.08	-	 < 0.2	1.00E00
polysaccharide catabolic process (GO:0000272)	22	0	.09	-	 < 0.2	1.00E00
polysaccharide biosynthetic process (GO:0000271)	41	1	.17	+	5.82	1.00E00
peptidoglycan metabolic process (GO:0000270)	7	0	.03	-	 < 0.2	1.00E00
mitochondrial fission (GO:0000266)	23	0	.10	-	 < 0.2	1.00E00
ureter maturation (GO:0035799)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of mitochondrial membrane permeability (GO:0035795)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of mitochondrial membrane permeability (GO:0035794)	19	1	.08	+	12.56	1.00E00
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	3	1	.01	+	79.55	1.00E00
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	7	1	.03	+	34.09	1.00E00
platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790)	1	0	.00	-	 < 0.2	1.00E00
allantoin catabolic process (GO:0000256)	1	0	.00	-	 < 0.2	1.00E00
allantoin metabolic process (GO:0000255)	5	1	.02	+	47.73	1.00E00
metanephric mesenchymal cell migration (GO:0035789)	1	1	.00	+	 > 100	1.00E00
regulation of corticotropin-releasing hormone secretion (GO:0043397)	3	0	.01	-	 < 0.2	1.00E00
cell migration involved in metanephros development (GO:0035788)	1	1	.00	+	 > 100	1.00E00
cell migration involved in kidney development (GO:0035787)	2	1	.01	+	 > 100	1.00E00
protein complex oligomerization (GO:0035786)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of DNA binding (GO:0043392)	51	1	.21	+	4.68	1.00E00
CD4-positive, alpha-beta T cell costimulation (GO:0035783)	1	0	.00	-	 < 0.2	1.00E00
mature natural killer cell chemotaxis (GO:0035782)	1	0	.00	-	 < 0.2	1.00E00
aflatoxin B1 metabolic process (GO:0043390)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neural crest cell differentiation (GO:1905294)	3	0	.01	-	 < 0.2	1.00E00
spliceosomal complex assembly (GO:0000245)	56	0	.23	-	 < 0.2	1.00E00
spliceosomal tri-snRNP complex assembly (GO:0000244)	12	0	.05	-	 < 0.2	1.00E00
regulation of neural crest cell differentiation (GO:1905292)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of DNA binding (GO:0043388)	49	2	.21	+	9.74	1.00E00
mycotoxin catabolic process (GO:0043387)	1	0	.00	-	 < 0.2	1.00E00
mycotoxin metabolic process (GO:0043385)	2	0	.01	-	 < 0.2	1.00E00
negative T cell selection (GO:0043383)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	29	0	.12	-	 < 0.2	1.00E00
positive regulation of memory T cell differentiation (GO:0043382)	6	0	.03	-	 < 0.2	1.00E00
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	7	1	.03	+	34.09	1.00E00
interleukin-13-mediated signaling pathway (GO:0035772)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of memory T cell differentiation (GO:0043381)	1	0	.00	-	 < 0.2	1.00E00
regulation of memory T cell differentiation (GO:0043380)	8	0	.03	-	 < 0.2	1.00E00
interleukin-4-mediated signaling pathway (GO:0035771)	4	0	.02	-	 < 0.2	1.00E00
regulation of CAMKK-AMPK signaling cascade (GO:1905289)	1	0	.00	-	 < 0.2	1.00E00
fibrous ring of heart morphogenesis (GO:1905285)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of retrograde transport, endosome to Golgi (GO:1905281)	1	0	.00	-	 < 0.2	1.00E00
memory T cell differentiation (GO:0043379)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	1	0	.00	-	 < 0.2	1.00E00
B cell chemotaxis across high endothelial venule (GO:0035769)	1	0	.00	-	 < 0.2	1.00E00
endothelial cell chemotaxis to fibroblast growth factor (GO:0035768)	1	0	.00	-	 < 0.2	1.00E00
regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	2	0	.01	-	 < 0.2	1.00E00
endothelial cell chemotaxis (GO:0035767)	10	0	.04	-	 < 0.2	1.00E00
CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)	1	1	.00	+	 > 100	1.00E00
cell chemotaxis to fibroblast growth factor (GO:0035766)	1	0	.00	-	 < 0.2	1.00E00
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	9	1	.04	+	26.52	1.00E00
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	26	0	.11	-	 < 0.2	1.00E00
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	16	0	.07	-	 < 0.2	1.00E00
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	40	0	.17	-	 < 0.2	1.00E00
regulation of retrograde transport, endosome to Golgi (GO:1905279)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of epithelial tube formation (GO:1905278)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of epithelial tube formation (GO:1905277)	1	0	.00	-	 < 0.2	1.00E00
regulation of epithelial tube formation (GO:1905276)	19	0	.08	-	 < 0.2	1.00E00
microtubule cytoskeleton organization (GO:0000226)	389	3	1.63	+	1.84	1.00E00
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905273)	1	0	.00	-	 < 0.2	1.00E00
regulation of proton-transporting ATP synthase activity, rotational mechanism (GO:1905271)	1	0	.00	-	 < 0.2	1.00E00
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	14	1	.06	+	17.05	1.00E00
positive T cell selection (GO:0043368)	23	1	.10	+	10.38	1.00E00
mesangial cell-matrix adhesion (GO:0035759)	2	0	.01	-	 < 0.2	1.00E00
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	33	0	.14	-	 < 0.2	1.00E00
beta selection (GO:0043366)	2	1	.01	+	 > 100	1.00E00
B cell chemotaxis (GO:0035754)	6	0	.03	-	 < 0.2	1.00E00
lysosomal lumen pH elevation (GO:0035752)	1	0	.00	-	 < 0.2	1.00E00
regulation of lysosomal lumen pH (GO:0035751)	12	0	.05	-	 < 0.2	1.00E00
protein localization to myelin sheath abaxonal region (GO:0035750)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein ubiquitination (GO:0031398)	185	3	.78	+	3.87	1.00E00
negative regulation of protein ubiquitination (GO:0031397)	140	3	.59	+	5.11	1.00E00
regulation of protein ubiquitination (GO:0031396)	266	4	1.11	+	3.59	1.00E00
positive regulation of prostaglandin biosynthetic process (GO:0031394)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.01	-	 < 0.2	1.00E00
regulation of prostaglandin biosynthetic process (GO:0031392)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of chromatin organization (GO:1905268)	49	0	.21	-	 < 0.2	1.00E00
endonucleolytic cleavage involved in tRNA processing (GO:1905267)	3	0	.01	-	 < 0.2	1.00E00
meiotic spindle organization (GO:0000212)	14	0	.06	-	 < 0.2	1.00E00
natural killer cell chemotaxis (GO:0035747)	3	0	.01	-	 < 0.2	1.00E00
T-helper 2 cell cytokine production (GO:0035745)	3	0	.01	-	 < 0.2	1.00E00
enucleate erythrocyte differentiation (GO:0043353)	6	0	.03	-	 < 0.2	1.00E00
T-helper 1 cell cytokine production (GO:0035744)	5	0	.02	-	 < 0.2	1.00E00
CD4-positive, alpha-beta T cell cytokine production (GO:0035743)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.01	-	 < 0.2	1.00E00
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.01	-	 < 0.2	1.00E00
protein polyubiquitination (GO:0000209)	288	2	1.21	+	1.66	1.00E00
regulation of RNA binding transcription factor activity (GO:1905255)	1	0	.00	-	 < 0.2	1.00E00
intraciliary transport involved in cilium assembly (GO:0035735)	40	0	.17	-	 < 0.2	1.00E00
hepatic stellate cell activation (GO:0035733)	1	0	.00	-	 < 0.2	1.00E00
nitric oxide storage (GO:0035732)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of aspartic-type peptidase activity (GO:1905247)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of aspartic-type peptidase activity (GO:1905246)	1	0	.00	-	 < 0.2	1.00E00
regulation of aspartic-type peptidase activity (GO:1905245)	6	0	.03	-	 < 0.2	1.00E00
regulation of modification of synaptic structure (GO:1905244)	4	0	.02	-	 < 0.2	1.00E00
cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)	1	0	.00	-	 < 0.2	1.00E00
response to 3,3',5-triiodo-L-thyronine (GO:1905242)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240)	1	0	.00	-	 < 0.2	1.00E00
cellular response to hepatocyte growth factor stimulus (GO:0035729)	14	0	.06	-	 < 0.2	1.00E00
response to hepatocyte growth factor (GO:0035728)	16	0	.07	-	 < 0.2	1.00E00
common myeloid progenitor cell proliferation (GO:0035726)	7	0	.03	-	 < 0.2	1.00E00
protein unfolding (GO:0043335)	2	0	.01	-	 < 0.2	1.00E00
sodium ion transmembrane transport (GO:0035725)	105	0	.44	-	 < 0.2	1.00E00
interleukin-15-mediated signaling pathway (GO:0035723)	3	0	.01	-	 < 0.2	1.00E00
response to dsRNA (GO:0043331)	83	3	.35	+	8.63	1.00E00
interleukin-12-mediated signaling pathway (GO:0035722)	56	0	.23	-	 < 0.2	1.00E00
response to exogenous dsRNA (GO:0043330)	46	2	.19	+	10.38	1.00E00
intraciliary retrograde transport (GO:0035721)	11	0	.05	-	 < 0.2	1.00E00
intraciliary anterograde transport (GO:0035720)	3	0	.01	-	 < 0.2	1.00E00
N-terminal protein amino acid modification (GO:0031365)	26	0	.11	-	 < 0.2	1.00E00
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239)	1	0	.00	-	 < 0.2	1.00E00
response to cyclosporin A (GO:1905237)	2	0	.01	-	 < 0.2	1.00E00
response to quercetin (GO:1905235)	1	0	.00	-	 < 0.2	1.00E00
response to codeine (GO:1905233)	1	0	.00	-	 < 0.2	1.00E00
cellular response to L-glutamate (GO:1905232)	3	0	.01	-	 < 0.2	1.00E00
cellular response to borneol (GO:1905231)	1	0	.00	-	 < 0.2	1.00E00
response to borneol (GO:1905230)	1	0	.00	-	 < 0.2	1.00E00
response to insecticide (GO:0017085)	9	1	.04	+	26.52	1.00E00
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	4	0	.02	-	 < 0.2	1.00E00
pigment metabolic process involved in developmental pigmentation (GO:0043324)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of natural killer cell degranulation (GO:0043323)	2	0	.01	-	 < 0.2	1.00E00
cellular response to nitrogen dioxide (GO:0035714)	1	0	.00	-	 < 0.2	1.00E00
response to nitrogen dioxide (GO:0035713)	1	0	.00	-	 < 0.2	1.00E00
regulation of natural killer cell degranulation (GO:0043321)	2	0	.01	-	 < 0.2	1.00E00
T-helper 2 cell activation (GO:0035712)	1	0	.00	-	 < 0.2	1.00E00
natural killer cell degranulation (GO:0043320)	5	0	.02	-	 < 0.2	1.00E00
T-helper 1 cell activation (GO:0035711)	2	0	.01	-	 < 0.2	1.00E00
CD4-positive, alpha-beta T cell activation (GO:0035710)	36	0	.15	-	 < 0.2	1.00E00
cellular response to thyrotropin-releasing hormone (GO:1905229)	1	0	.00	-	 < 0.2	1.00E00
regulation of adhesion of symbiont to host epithelial cell (GO:1905226)	1	0	.00	-	 < 0.2	1.00E00
response to thyrotropin-releasing hormone (GO:1905225)	2	0	.01	-	 < 0.2	1.00E00
clathrin-coated pit assembly (GO:1905224)	1	0	.00	-	 < 0.2	1.00E00
epicardium morphogenesis (GO:1905223)	1	0	.00	-	 < 0.2	1.00E00
atrioventricular canal morphogenesis (GO:1905222)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cytotoxic T cell degranulation (GO:0043318)	2	0	.01	-	 < 0.2	1.00E00
memory T cell activation (GO:0035709)	1	0	.00	-	 < 0.2	1.00E00
regulation of cytotoxic T cell degranulation (GO:0043317)	2	0	.01	-	 < 0.2	1.00E00
cytotoxic T cell degranulation (GO:0043316)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neutrophil degranulation (GO:0043315)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of neutrophil degranulation (GO:0043314)	2	0	.01	-	 < 0.2	1.00E00
T-helper 17 cell chemotaxis (GO:0035705)	1	0	.00	-	 < 0.2	1.00E00
regulation of neutrophil degranulation (GO:0043313)	8	1	.03	+	29.83	1.00E00
helper T cell chemotaxis (GO:0035704)	1	0	.00	-	 < 0.2	1.00E00
neutrophil degranulation (GO:0043312)	482	8	2.02	+	3.96	1.00E00
positive regulation of eosinophil degranulation (GO:0043311)	2	0	.01	-	 < 0.2	1.00E00
hematopoietic stem cell migration (GO:0035701)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of eosinophil degranulation (GO:0043310)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of defense response (GO:0031348)	171	4	.72	+	5.58	1.00E00
positive regulation of cell projection organization (GO:0031346)	338	5	1.42	+	3.53	1.00E00
negative regulation of cell projection organization (GO:0031345)	155	3	.65	+	4.62	1.00E00
positive regulation of cell killing (GO:0031343)	45	1	.19	+	5.30	1.00E00
negative regulation of cell killing (GO:0031342)	21	1	.09	+	11.36	1.00E00
regulation of cell killing (GO:0031341)	69	1	.29	+	3.46	1.00E00
positive regulation of vesicle fusion (GO:0031340)	8	0	.03	-	 < 0.2	1.00E00
response to astaxanthin (GO:1905217)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of RNA binding (GO:1905216)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of RNA binding (GO:1905215)	1	0	.00	-	 < 0.2	1.00E00
regulation of RNA binding (GO:1905214)	11	0	.05	-	 < 0.2	1.00E00
regulation of eosinophil degranulation (GO:0043309)	3	0	.01	-	 < 0.2	1.00E00
eosinophil degranulation (GO:0043308)	3	0	.01	-	 < 0.2	1.00E00
eosinophil activation (GO:0043307)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of mast cell degranulation (GO:0043306)	14	1	.06	+	17.05	1.00E00
respiratory chain complex III assembly (GO:0017062)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of mast cell degranulation (GO:0043305)	6	0	.03	-	 < 0.2	1.00E00
7-methylguanosine RNA capping (GO:0009452)	34	0	.14	-	 < 0.2	1.00E00
regulation of mast cell degranulation (GO:0043304)	30	2	.13	+	15.91	1.00E00
RNA modification (GO:0009451)	135	1	.57	+	1.77	1.00E00
mast cell degranulation (GO:0043303)	17	0	.07	-	 < 0.2	1.00E00
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of leukocyte degranulation (GO:0043302)	22	1	.09	+	10.85	1.00E00
negative regulation of leukocyte degranulation (GO:0043301)	11	0	.05	-	 < 0.2	1.00E00
regulation of leukocyte degranulation (GO:0043300)	44	2	.18	+	10.85	1.00E00
negative regulation of vesicle fusion (GO:0031339)	5	0	.02	-	 < 0.2	1.00E00
regulation of vesicle fusion (GO:0031338)	71	0	.30	-	 < 0.2	1.00E00
positive regulation of sulfur amino acid metabolic process (GO:0031337)	1	0	.00	-	 < 0.2	1.00E00
regulation of sulfur amino acid metabolic process (GO:0031335)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of protein complex assembly (GO:0031333)	119	5	.50	+	10.03	1.00E00
positive regulation of cardiocyte differentiation (GO:1905209)	26	1	.11	+	9.18	1.00E00
positive regulation of hydrogen peroxide-induced cell death (GO:1905206)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of connective tissue replacement (GO:1905205)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of connective tissue replacement (GO:1905204)	1	0	.00	-	 < 0.2	1.00E00
regulation of connective tissue replacement (GO:1905203)	2	0	.01	-	 < 0.2	1.00E00
gamma-aminobutyric acid biosynthetic process (GO:0009449)	3	0	.01	-	 < 0.2	1.00E00
gamma-aminobutyric acid metabolic process (GO:0009448)	4	0	.02	-	 < 0.2	1.00E00
putrescine catabolic process (GO:0009447)	3	0	.01	-	 < 0.2	1.00E00
putrescine biosynthetic process (GO:0009446)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0017055)	2	0	.01	-	 < 0.2	1.00E00
putrescine metabolic process (GO:0009445)	7	0	.03	-	 < 0.2	1.00E00
pyruvate oxidation (GO:0009444)	1	0	.00	-	 < 0.2	1.00E00
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.00	-	 < 0.2	1.00E00
glycolate metabolic process (GO:0009441)	3	0	.01	-	 < 0.2	1.00E00
cyanate catabolic process (GO:0009440)	2	0	.01	-	 < 0.2	1.00E00
cyanate metabolic process (GO:0009439)	2	0	.01	-	 < 0.2	1.00E00
methylglyoxal metabolic process (GO:0009438)	6	0	.03	-	 < 0.2	1.00E00
carnitine metabolic process (GO:0009437)	13	0	.05	-	 < 0.2	1.00E00
glyoxylate catabolic process (GO:0009436)	3	0	.01	-	 < 0.2	1.00E00
NAD biosynthetic process (GO:0009435)	27	0	.11	-	 < 0.2	1.00E00
regulation of chemokine-mediated signaling pathway (GO:0070099)	8	0	.03	-	 < 0.2	1.00E00
chemokine-mediated signaling pathway (GO:0070098)	74	0	.31	-	 < 0.2	1.00E00
mitochondrial outer membrane translocase complex assembly (GO:0070096)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of glucagon secretion (GO:0070094)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glucagon secretion (GO:0070093)	3	0	.01	-	 < 0.2	1.00E00
regulation of glucagon secretion (GO:0070092)	6	0	.03	-	 < 0.2	1.00E00
glucagon secretion (GO:0070091)	1	0	.00	-	 < 0.2	1.00E00
ubiquitin-dependent endocytosis (GO:0070086)	2	0	.01	-	 < 0.2	1.00E00
glycosylation (GO:0070085)	284	0	1.19	-	 < 0.2	1.00E00
response to water (GO:0009415)	15	1	.06	+	15.91	1.00E00
protein initiator methionine removal (GO:0070084)	1	0	.00	-	 < 0.2	1.00E00
response to water deprivation (GO:0009414)	9	1	.04	+	26.52	1.00E00
response to xenobiotic stimulus (GO:0009410)	117	0	.49	-	 < 0.2	1.00E00
vesicle targeting, to, from or within Golgi (GO:0048199)	67	0	.28	-	 < 0.2	1.00E00
antibiotic transport (GO:0042891)	1	0	.00	-	 < 0.2	1.00E00
Golgi vesicle budding (GO:0048194)	73	0	.31	-	 < 0.2	1.00E00
Golgi vesicle transport (GO:0048193)	333	0	1.40	-	 < 0.2	1.00E00
histone H4-R3 demethylation (GO:0070079)	1	0	.00	-	 < 0.2	1.00E00
response to cold (GO:0009409)	49	0	.21	-	 < 0.2	1.00E00
histone H3-R2 demethylation (GO:0070078)	1	0	.00	-	 < 0.2	1.00E00
response to heat (GO:0009408)	94	3	.39	+	7.62	1.00E00
regulation of neuron remodeling (GO:1904799)	1	0	.00	-	 < 0.2	1.00E00
histone arginine demethylation (GO:0070077)	1	0	.00	-	 < 0.2	1.00E00
histone lysine demethylation (GO:0070076)	28	0	.12	-	 < 0.2	1.00E00
positive regulation of core promoter binding (GO:1904798)	6	0	.03	-	 < 0.2	1.00E00
toxin catabolic process (GO:0009407)	3	0	.01	-	 < 0.2	1.00E00
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	101	3	.42	+	7.09	1.00E00
tear secretion (GO:0070075)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of core promoter binding (GO:1904797)	1	0	.00	-	 < 0.2	1.00E00
protein nitrosylation (GO:0017014)	6	0	.03	-	 < 0.2	1.00E00
regulation of core promoter binding (GO:1904796)	7	0	.03	-	 < 0.2	1.00E00
pathogenesis (GO:0009405)	2	0	.01	-	 < 0.2	1.00E00
toxin metabolic process (GO:0009404)	15	0	.06	-	 < 0.2	1.00E00
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	10	0	.04	-	 < 0.2	1.00E00
toxin biosynthetic process (GO:0009403)	1	0	.00	-	 < 0.2	1.00E00
proton-transporting two-sector ATPase complex assembly (GO:0070071)	14	0	.06	-	 < 0.2	1.00E00
regulation of euchromatin binding (GO:1904793)	1	0	.00	-	 < 0.2	1.00E00
proton-transporting V-type ATPase complex assembly (GO:0070070)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of shelterin complex assembly (GO:1904792)	1	0	.00	-	 < 0.2	1.00E00
regulation of shelterin complex assembly (GO:1904790)	1	0	.00	-	 < 0.2	1.00E00
amide transport (GO:0042886)	1405	13	5.89	+	2.21	1.00E00
cysteine transport (GO:0042883)	1	0	.00	-	 < 0.2	1.00E00
protein-tetrapyrrole linkage (GO:0017006)	1	0	.00	-	 < 0.2	1.00E00
cytochrome complex assembly (GO:0017004)	33	0	.14	-	 < 0.2	1.00E00
protein-heme linkage (GO:0017003)	1	0	.00	-	 < 0.2	1.00E00
NLRP1 inflammasome complex assembly (GO:1904784)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of NMDA glutamate receptor activity (GO:1904783)	1	0	.00	-	 < 0.2	1.00E00
'de novo' actin filament nucleation (GO:0070060)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of NMDA glutamate receptor activity (GO:1904782)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein localization to centrosome (GO:1904781)	4	0	.02	-	 < 0.2	1.00E00
arachidonic acid secretion (GO:0050482)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of hepatocyte growth factor biosynthetic process (GO:0048178)	1	0	.00	-	 < 0.2	1.00E00
regulation of hepatocyte growth factor biosynthetic process (GO:0048176)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of short-term neuronal synaptic plasticity (GO:0048174)	1	0	.00	-	 < 0.2	1.00E00
regulation of short-term neuronal synaptic plasticity (GO:0048172)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	5	0	.02	-	 < 0.2	1.00E00
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	32	2	.13	+	14.92	1.00E00
regulation of protein localization to centrosome (GO:1904779)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of protein localization to cell cortex (GO:1904778)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of protein localization to cell cortex (GO:1904777)	1	0	.00	-	 < 0.2	1.00E00
mRNA endonucleolytic cleavage involved in unfolded protein response (GO:0070055)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to cell cortex (GO:1904776)	7	0	.03	-	 < 0.2	1.00E00
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.00	-	 < 0.2	1.00E00
neuron cellular homeostasis (GO:0070050)	9	0	.04	-	 < 0.2	1.00E00
response to tetrachloromethane (GO:1904772)	1	0	.00	-	 < 0.2	1.00E00
pyruvate biosynthetic process (GO:0042866)	6	1	.03	+	39.78	1.00E00
regulation of long-term neuronal synaptic plasticity (GO:0048169)	25	0	.10	-	 < 0.2	1.00E00
regulation of neuronal synaptic plasticity (GO:0048168)	52	0	.22	-	 < 0.2	1.00E00
regulation of synaptic plasticity (GO:0048167)	155	1	.65	+	1.54	1.00E00
fused antrum stage (GO:0048165)	2	0	.01	-	 < 0.2	1.00E00
multi-layer follicle stage (GO:0048162)	3	0	.01	-	 < 0.2	1.00E00
primary follicle stage (GO:0048160)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of B cell proliferation (GO:0030890)	42	2	.18	+	11.36	1.00E00
negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	1	0	.00	-	 < 0.2	1.00E00
chaperone-mediated autophagy translocation complex disassembly (GO:1904764)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of myofibroblast differentiation (GO:1904761)	2	0	.01	-	 < 0.2	1.00E00
regulation of myofibroblast differentiation (GO:1904760)	3	0	.01	-	 < 0.2	1.00E00
L-alanine catabolic process (GO:0042853)	4	0	.02	-	 < 0.2	1.00E00
L-alanine metabolic process (GO:0042851)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of myeloid dendritic cell activation (GO:0030887)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of myeloid dendritic cell activation (GO:0030886)	3	0	.01	-	 < 0.2	1.00E00
regulation of myeloid dendritic cell activation (GO:0030885)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	12	2	.05	+	39.78	1.00E00
negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	3	0	.01	-	 < 0.2	1.00E00
regulation of vascular associated smooth muscle cell migration (GO:1904752)	15	2	.06	+	31.82	1.00E00
positive regulation of protein localization to nucleolus (GO:1904751)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of protein localization to nucleolus (GO:1904750)	1	0	.00	-	 < 0.2	1.00E00
behavioral response to ethanol (GO:0048149)	15	0	.06	-	 < 0.2	1.00E00
D-xylose catabolic process (GO:0042843)	1	0	.00	-	 < 0.2	1.00E00
behavioral response to cocaine (GO:0048148)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of fibroblast proliferation (GO:0048147)	31	1	.13	+	7.70	1.00E00
regulation of iron ion import (GO:1900390)	2	0	.01	-	 < 0.2	1.00E00
D-glucuronate catabolic process (GO:0042840)	1	0	.00	-	 < 0.2	1.00E00
thyroid gland development (GO:0030878)	25	2	.10	+	19.09	1.00E00
fibroblast proliferation (GO:0048144)	2	0	.01	-	 < 0.2	1.00E00
astrocyte activation (GO:0048143)	8	1	.03	+	29.83	1.00E00
osteoclast maturation (GO:0036179)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to nucleolus (GO:1904749)	6	0	.03	-	 < 0.2	1.00E00
regulation of apoptotic process involved in development (GO:1904748)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of apoptotic process involved in development (GO:1904747)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of apoptotic process involved in development (GO:1904746)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of telomeric DNA binding (GO:1904744)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of telomeric DNA binding (GO:1904743)	2	0	.01	-	 < 0.2	1.00E00
protein arginylation (GO:0016598)	2	0	.01	-	 < 0.2	1.00E00
regulation of telomeric DNA binding (GO:1904742)	4	0	.02	-	 < 0.2	1.00E00
D-glucuronate metabolic process (GO:0042839)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter (GO:1900387)	1	0	.00	-	 < 0.2	1.00E00
regulation of synaptic plasticity by receptor localization to synapse (GO:1900383)	1	0	.00	-	 < 0.2	1.00E00
defense response to protozoan (GO:0042832)	22	0	.09	-	 < 0.2	1.00E00
spermatocyte division (GO:0048137)	1	0	.00	-	 < 0.2	1.00E00
male germ-line stem cell asymmetric division (GO:0048133)	4	0	.02	-	 < 0.2	1.00E00
cortical actin cytoskeleton organization (GO:0030866)	29	0	.12	-	 < 0.2	1.00E00
cortical cytoskeleton organization (GO:0030865)	34	0	.14	-	 < 0.2	1.00E00
positive regulation of polarized epithelial cell differentiation (GO:0030862)	2	0	.01	-	 < 0.2	1.00E00
regulation of polarized epithelial cell differentiation (GO:0030860)	3	0	.01	-	 < 0.2	1.00E00
phenotypic switching (GO:0036166)	1	0	.00	-	 < 0.2	1.00E00
cell-abiotic substrate adhesion (GO:0036164)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904736)	1	0	.00	-	 < 0.2	1.00E00
regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904735)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of electron carrier activity (GO:1904734)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of electron carrier activity (GO:1904733)	1	0	.00	-	 < 0.2	1.00E00
regulation of electron carrier activity (GO:1904732)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of intestinal lipid absorption (GO:1904730)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of secondary metabolite biosynthetic process (GO:1900378)	4	1	.02	+	59.66	1.00E00
negative regulation of secondary metabolite biosynthetic process (GO:1900377)	3	0	.01	-	 < 0.2	1.00E00
nucleosome positioning (GO:0016584)	8	0	.03	-	 < 0.2	1.00E00
regulation of secondary metabolite biosynthetic process (GO:1900376)	7	1	.03	+	34.09	1.00E00
amyloid-beta metabolic process (GO:0050435)	16	1	.07	+	14.92	1.00E00
positive regulation of viral transcription (GO:0050434)	43	1	.18	+	5.55	1.00E00
regulation of catecholamine secretion (GO:0050433)	48	0	.20	-	 < 0.2	1.00E00
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	107	3	.45	+	6.69	1.00E00
negative regulation of purine nucleotide biosynthetic process (GO:1900372)	49	1	.21	+	4.87	1.00E00
catecholamine secretion (GO:0050432)	3	0	.01	-	 < 0.2	1.00E00
pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.01	-	 < 0.2	1.00E00
regulation of purine nucleotide biosynthetic process (GO:1900371)	155	3	.65	+	4.62	1.00E00
pyridoxal phosphate metabolic process (GO:0042822)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of RNA interference (GO:1900370)	1	0	.00	-	 < 0.2	1.00E00
vitamin B6 catabolic process (GO:0042820)	1	0	.00	-	 < 0.2	1.00E00
polarized epithelial cell differentiation (GO:0030859)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of epithelial cell differentiation (GO:0030858)	57	0	.24	-	 < 0.2	1.00E00
negative regulation of epithelial cell differentiation (GO:0030857)	39	3	.16	+	18.36	1.00E00
regulation of epithelial cell differentiation (GO:0030856)	133	4	.56	+	7.18	1.00E00
positive regulation of granulocyte differentiation (GO:0030854)	8	0	.03	-	 < 0.2	1.00E00
inner dynein arm assembly (GO:0036159)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of granulocyte differentiation (GO:0030853)	10	0	.04	-	 < 0.2	1.00E00
outer dynein arm assembly (GO:0036158)	17	0	.07	-	 < 0.2	1.00E00
regulation of granulocyte differentiation (GO:0030852)	17	0	.07	-	 < 0.2	1.00E00
granulocyte differentiation (GO:0030851)	17	0	.07	-	 < 0.2	1.00E00
prostate gland development (GO:0030850)	41	1	.17	+	5.82	1.00E00
acylglycerol acyl-chain remodeling (GO:0036155)	8	0	.03	-	 < 0.2	1.00E00
regulation of intestinal lipid absorption (GO:1904729)	7	0	.03	-	 < 0.2	1.00E00
triglyceride acyl-chain remodeling (GO:0036153)	1	0	.00	-	 < 0.2	1.00E00
phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	26	0	.11	-	 < 0.2	1.00E00
phosphatidylcholine acyl-chain remodeling (GO:0036151)	27	0	.11	-	 < 0.2	1.00E00
phosphatidylserine acyl-chain remodeling (GO:0036150)	21	0	.09	-	 < 0.2	1.00E00
protein deubiquitination (GO:0016579)	286	6	1.20	+	5.01	1.00E00
negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723)	1	0	.00	-	 < 0.2	1.00E00
histone deubiquitination (GO:0016578)	21	2	.09	+	22.73	1.00E00
positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response (GO:1904722)	1	0	.00	-	 < 0.2	1.00E00
histone demethylation (GO:0016577)	30	0	.13	-	 < 0.2	1.00E00
negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response (GO:1904721)	1	0	.00	-	 < 0.2	1.00E00
histone dephosphorylation (GO:0016576)	6	0	.03	-	 < 0.2	1.00E00
regulation of mRNA endonucleolytic cleavage involved in unfolded protein response (GO:1904720)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of RNA interference (GO:1900369)	2	1	.01	+	 > 100	1.00E00
vitamin B6 biosynthetic process (GO:0042819)	3	0	.01	-	 < 0.2	1.00E00
histone deacetylation (GO:0016575)	60	0	.25	-	 < 0.2	1.00E00
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	6	0	.03	-	 < 0.2	1.00E00
regulation of RNA interference (GO:1900368)	3	1	.01	+	79.55	1.00E00
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	24	0	.10	-	 < 0.2	1.00E00
histone ubiquitination (GO:0016574)	39	0	.16	-	 < 0.2	1.00E00
histone acetylation (GO:0016573)	103	2	.43	+	4.63	1.00E00
vitamin B6 metabolic process (GO:0042816)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of mRNA polyadenylation (GO:1900365)	2	0	.01	-	 < 0.2	1.00E00
histone methylation (GO:0016571)	87	0	.36	-	 < 0.2	1.00E00
negative regulation of mRNA polyadenylation (GO:1900364)	8	0	.03	-	 < 0.2	1.00E00
histone modification (GO:0016570)	356	8	1.49	+	5.36	1.00E00
regulation of mRNA polyadenylation (GO:1900363)	11	0	.05	-	 < 0.2	1.00E00
phospholipase C-inhibiting G-protein coupled receptor signaling pathway (GO:0030845)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of intermediate filament depolymerization (GO:0030844)	1	0	.00	-	 < 0.2	1.00E00
phosphatidylinositol acyl-chain remodeling (GO:0036149)	16	0	.07	-	 < 0.2	1.00E00
phosphatidylglycerol acyl-chain remodeling (GO:0036148)	17	0	.07	-	 < 0.2	1.00E00
regulation of intermediate filament depolymerization (GO:0030842)	1	0	.00	-	 < 0.2	1.00E00
cellular response to mycotoxin (GO:0036146)	2	0	.01	-	 < 0.2	1.00E00
dendritic cell homeostasis (GO:0036145)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of AMPA glutamate receptor clustering (GO:1904719)	1	0	.00	-	 < 0.2	1.00E00
regulation of AMPA glutamate receptor clustering (GO:1904717)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of chaperone-mediated autophagy (GO:1904716)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of chaperone-mediated autophagy (GO:1904715)	3	0	.01	-	 < 0.2	1.00E00
regulation of chaperone-mediated autophagy (GO:1904714)	8	0	.03	-	 < 0.2	1.00E00
covalent chromatin modification (GO:0016569)	475	8	1.99	+	4.02	1.00E00
protein ubiquitination (GO:0016567)	712	8	2.98	+	2.68	1.00E00
regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711)	1	0	.00	-	 < 0.2	1.00E00
protein import into peroxisome matrix, translocation (GO:0016561)	3	0	.01	-	 < 0.2	1.00E00
protein import into peroxisome matrix, docking (GO:0016560)	4	0	.02	-	 < 0.2	1.00E00
establishment of body hair planar orientation (GO:0048105)	4	0	.02	-	 < 0.2	1.00E00
establishment of body hair or bristle planar orientation (GO:0048104)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of actin filament polymerization (GO:0030838)	84	1	.35	+	2.84	1.00E00
somatic stem cell division (GO:0048103)	22	1	.09	+	10.85	1.00E00
negative regulation of actin filament polymerization (GO:0030837)	47	1	.20	+	5.08	1.00E00
positive regulation of actin filament depolymerization (GO:0030836)	13	0	.05	-	 < 0.2	1.00E00
autophagic cell death (GO:0048102)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of actin filament depolymerization (GO:0030835)	35	0	.15	-	 < 0.2	1.00E00
regulation of actin filament depolymerization (GO:0030834)	49	0	.21	-	 < 0.2	1.00E00
regulation of actin filament polymerization (GO:0030833)	147	3	.62	+	4.87	1.00E00
regulation of actin filament length (GO:0030832)	167	3	.70	+	4.29	1.00E00
peptidyl-histidine hydroxylation (GO:0036138)	1	0	.00	-	 < 0.2	1.00E00
regulation of granulosa cell apoptotic process (GO:1904708)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of vascular smooth muscle cell proliferation (GO:1904707)	18	2	.08	+	26.52	1.00E00
negative regulation of vascular smooth muscle cell proliferation (GO:1904706)	9	0	.04	-	 < 0.2	1.00E00
regulation of vascular smooth muscle cell proliferation (GO:1904705)	26	2	.11	+	18.36	1.00E00
peroxisome fission (GO:0016559)	10	0	.04	-	 < 0.2	1.00E00
protein import into peroxisome matrix (GO:0016558)	12	0	.05	-	 < 0.2	1.00E00
peroxisome membrane biogenesis (GO:0016557)	4	0	.02	-	 < 0.2	1.00E00
mRNA modification (GO:0016556)	15	0	.06	-	 < 0.2	1.00E00
cytidine to uridine editing (GO:0016554)	4	0	.02	-	 < 0.2	1.00E00
base conversion or substitution editing (GO:0016553)	11	1	.05	+	21.70	1.00E00
positive regulation of cGMP biosynthetic process (GO:0030828)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of cGMP biosynthetic process (GO:0030827)	2	0	.01	-	 < 0.2	1.00E00
regulation of cGMP biosynthetic process (GO:0030826)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of cGMP metabolic process (GO:0030825)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of cGMP metabolic process (GO:0030824)	2	0	.01	-	 < 0.2	1.00E00
regulation of cGMP metabolic process (GO:0030823)	28	0	.12	-	 < 0.2	1.00E00
positive regulation of cAMP catabolic process (GO:0030822)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cAMP catabolic process (GO:0030821)	2	0	.01	-	 < 0.2	1.00E00
regulation of cAMP catabolic process (GO:0030820)	4	0	.02	-	 < 0.2	1.00E00
histone H3-K9 trimethylation (GO:0036124)	5	0	.02	-	 < 0.2	1.00E00
histone H3-K9 dimethylation (GO:0036123)	3	0	.01	-	 < 0.2	1.00E00
protein autoprocessing (GO:0016540)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of cAMP biosynthetic process (GO:0030819)	82	3	.34	+	8.73	1.00E00
negative regulation of cAMP biosynthetic process (GO:0030818)	44	1	.18	+	5.42	1.00E00
regulation of cAMP biosynthetic process (GO:0030817)	126	3	.53	+	5.68	1.00E00
positive regulation of cAMP metabolic process (GO:0030816)	92	3	.39	+	7.78	1.00E00
negative regulation of cAMP metabolic process (GO:0030815)	48	1	.20	+	4.97	1.00E00
regulation of cAMP metabolic process (GO:0030814)	144	3	.60	+	4.97	1.00E00
positive regulation of nucleotide catabolic process (GO:0030813)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of nucleotide catabolic process (GO:0030812)	2	0	.01	-	 < 0.2	1.00E00
regulation of nucleotide catabolic process (GO:0030811)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of nucleotide biosynthetic process (GO:0030810)	107	3	.45	+	6.69	1.00E00
long-chain fatty-acyl-CoA catabolic process (GO:0036116)	1	0	.00	-	 < 0.2	1.00E00
fatty-acyl-CoA catabolic process (GO:0036115)	1	0	.00	-	 < 0.2	1.00E00
medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	1	0	.00	-	 < 0.2	1.00E00
medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	3	0	.01	-	 < 0.2	1.00E00
very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	1	0	.00	-	 < 0.2	1.00E00
intein-mediated protein splicing (GO:0016539)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of nucleotide biosynthetic process (GO:0030809)	49	1	.21	+	4.87	1.00E00
regulation of nucleotide biosynthetic process (GO:0030808)	156	3	.65	+	4.59	1.00E00
positive regulation of cyclic nucleotide catabolic process (GO:0030807)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cyclic nucleotide catabolic process (GO:0030806)	2	0	.01	-	 < 0.2	1.00E00
regulation of cyclic nucleotide catabolic process (GO:0030805)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of cyclic nucleotide biosynthetic process (GO:0030804)	100	3	.42	+	7.16	1.00E00
alpha-linolenic acid metabolic process (GO:0036109)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of cyclic nucleotide biosynthetic process (GO:0030803)	46	1	.19	+	5.19	1.00E00
regulation of cyclic nucleotide biosynthetic process (GO:0030802)	146	3	.61	+	4.90	1.00E00
positive regulation of cyclic nucleotide metabolic process (GO:0030801)	112	3	.47	+	6.39	1.00E00
negative regulation of cyclic nucleotide metabolic process (GO:0030800)	50	1	.21	+	4.77	1.00E00
leukotriene B4 metabolic process (GO:0036102)	4	0	.02	-	 < 0.2	1.00E00
leukotriene B4 catabolic process (GO:0036101)	4	0	.02	-	 < 0.2	1.00E00
leukotriene catabolic process (GO:0036100)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of angiogenesis (GO:0016525)	81	1	.34	+	2.95	1.00E00
MAPK import into nucleus (GO:0000189)	1	0	.00	-	 < 0.2	1.00E00
inactivation of MAPK activity (GO:0000188)	26	2	.11	+	18.36	1.00E00
activation of MAPKK activity (GO:0000186)	54	2	.23	+	8.84	1.00E00
activation of MAPKKK activity (GO:0000185)	18	0	.08	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	119	0	.50	-	 < 0.2	1.00E00
chromatin silencing at rDNA (GO:0000183)	11	1	.05	+	21.70	1.00E00
inactivation of MAPK activity involved in osmosensory signaling pathway (GO:0000173)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein K48-linked ubiquitination (GO:0061945)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of protein K48-linked ubiquitination (GO:0061944)	1	0	.00	-	 < 0.2	1.00E00
phosphorelay signal transduction system (GO:0000160)	9	2	.04	+	53.04	1.00E00
monocyte extravasation (GO:0035696)	1	0	.00	-	 < 0.2	1.00E00
mitophagy by induced vacuole formation (GO:0035695)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial protein catabolic process (GO:0035694)	5	0	.02	-	 < 0.2	1.00E00
macrophage migration inhibitory factor signaling pathway (GO:0035691)	1	0	.00	-	 < 0.2	1.00E00
cellular response to drug (GO:0035690)	69	2	.29	+	6.92	1.00E00
positive regulation of erythrocyte enucleation (GO:0061931)	1	0	.00	-	 < 0.2	1.00E00
regulation of erythrocyte enucleation (GO:0061930)	1	0	.00	-	 < 0.2	1.00E00
rRNA modification (GO:0000154)	39	0	.16	-	 < 0.2	1.00E00
leukocyte degranulation (GO:0043299)	503	8	2.11	+	3.80	1.00E00
apical junction assembly (GO:0043297)	43	0	.18	-	 < 0.2	1.00E00
helper T cell extravasation (GO:0035684)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-lysine propionylation (GO:0061921)	1	0	.00	-	 < 0.2	1.00E00
process utilizing autophagic mechanism (GO:0061919)	250	4	1.05	+	3.82	1.00E00
neuromast hair cell development (GO:0035675)	1	0	.00	-	 < 0.2	1.00E00
tricarboxylic acid transmembrane transport (GO:0035674)	2	0	.01	-	 < 0.2	1.00E00
oligopeptide transmembrane transport (GO:0035672)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	123	3	.52	+	5.82	1.00E00
selective autophagy (GO:0061912)	19	0	.08	-	 < 0.2	1.00E00
establishment of mitotic spindle orientation (GO:0000132)	22	0	.09	-	 < 0.2	1.00E00
response to alkaloid (GO:0043279)	111	3	.47	+	6.45	1.00E00
response to morphine (GO:0043278)	33	2	.14	+	14.46	1.00E00
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	2	0	.01	-	 < 0.2	1.00E00
apoptotic cell clearance (GO:0043277)	27	1	.11	+	8.84	1.00E00
TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	2	0	.01	-	 < 0.2	1.00E00
anoikis (GO:0043276)	11	2	.05	+	43.39	1.00E00
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	29	0	.12	-	 < 0.2	1.00E00
TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665)	1	0	.00	-	 < 0.2	1.00E00
TIRAP-dependent toll-like receptor signaling pathway (GO:0035664)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ion transport (GO:0043271)	136	3	.57	+	5.26	1.00E00
positive regulation of ion transport (GO:0043270)	242	6	1.01	+	5.92	1.00E00
glial cell activation (GO:0061900)	24	2	.10	+	19.89	1.00E00
positive regulation of vascular smooth muscle cell dedifferentiation (GO:1905176)	1	0	.00	-	 < 0.2	1.00E00
regulation of vascular smooth muscle cell dedifferentiation (GO:1905174)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein localization to phagocytic vesicle (GO:1905171)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter (GO:0000122)	814	11	3.41	+	3.23	1.00E00
regulation of ion transport (GO:0043269)	633	10	2.65	+	3.77	1.00E00
positive regulation of potassium ion transport (GO:0043268)	41	0	.17	-	 < 0.2	1.00E00
Wnt signaling pathway involved in wound healing, spreading of epidermal cells (GO:0035659)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of potassium ion transport (GO:0043267)	28	1	.12	+	8.52	1.00E00
regulation of potassium ion transport (GO:0043266)	90	1	.38	+	2.65	1.00E00
interleukin-18-mediated signaling pathway (GO:0035655)	5	1	.02	+	47.73	1.00E00
replication fork processing (GO:0031297)	28	2	.12	+	17.05	1.00E00
B cell costimulation (GO:0031296)	4	0	.02	-	 < 0.2	1.00E00
membrane protein intracellular domain proteolysis (GO:0031293)	16	0	.07	-	 < 0.2	1.00E00
Ran protein signal transduction (GO:0031291)	2	0	.01	-	 < 0.2	1.00E00
retinal ganglion cell axon guidance (GO:0031290)	19	0	.08	-	 < 0.2	1.00E00
regulation of protein localization to phagocytic vesicle (GO:1905169)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lysosomal protein catabolic process (GO:1905167)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of lysosomal protein catabolic process (GO:1905166)	3	0	.01	-	 < 0.2	1.00E00
regulation of lysosomal protein catabolic process (GO:1905165)	6	0	.03	-	 < 0.2	1.00E00
regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117)	2	0	.01	-	 < 0.2	1.00E00
regulation of phagosome maturation (GO:1905162)	1	0	.00	-	 < 0.2	1.00E00
regulation of carbohydrate biosynthetic process (GO:0043255)	84	4	.35	+	11.36	1.00E00
endosome to melanosome transport (GO:0035646)	10	0	.04	-	 < 0.2	1.00E00
enteric smooth muscle cell differentiation (GO:0035645)	1	0	.00	-	 < 0.2	1.00E00
phosphoanandamide dephosphorylation (GO:0035644)	1	0	.00	-	 < 0.2	1.00E00
sodium-independent organic anion transport (GO:0043252)	30	0	.13	-	 < 0.2	1.00E00
sodium-dependent organic anion transport (GO:0043251)	1	0	.00	-	 < 0.2	1.00E00
locomotory exploration behavior (GO:0035641)	14	1	.06	+	17.05	1.00E00
exploration behavior (GO:0035640)	28	1	.12	+	8.52	1.00E00
positive regulation of guanylate cyclase activity (GO:0031284)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of guanylate cyclase activity (GO:0031283)	2	0	.01	-	 < 0.2	1.00E00
regulation of guanylate cyclase activity (GO:0031282)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of cyclase activity (GO:0031281)	61	3	.26	+	11.74	1.00E00
negative regulation of cyclase activity (GO:0031280)	35	1	.15	+	6.82	1.00E00
positive regulation of membrane invagination (GO:1905155)	9	1	.04	+	26.52	1.00E00
negative regulation of membrane invagination (GO:1905154)	2	0	.01	-	 < 0.2	1.00E00
histidine biosynthetic process (GO:0000105)	2	0	.01	-	 < 0.2	1.00E00
regulation of membrane invagination (GO:1905153)	12	1	.05	+	19.89	1.00E00
positive regulation of voltage-gated sodium channel activity (GO:1905152)	1	0	.00	-	 < 0.2	1.00E00
sulfate assimilation (GO:0000103)	3	0	.01	-	 < 0.2	1.00E00
FMN biosynthetic process (GO:0009398)	1	0	.00	-	 < 0.2	1.00E00
regulation of voltage-gated sodium channel activity (GO:1905150)	3	0	.01	-	 < 0.2	1.00E00
folic acid-containing compound catabolic process (GO:0009397)	3	0	.01	-	 < 0.2	1.00E00
erythrocyte maturation (GO:0043249)	11	1	.05	+	21.70	1.00E00
folic acid-containing compound biosynthetic process (GO:0009396)	10	0	.04	-	 < 0.2	1.00E00
sulfur amino acid transport (GO:0000101)	6	0	.03	-	 < 0.2	1.00E00
proteasome assembly (GO:0043248)	14	0	.06	-	 < 0.2	1.00E00
phospholipid catabolic process (GO:0009395)	31	0	.13	-	 < 0.2	1.00E00
2'-deoxyribonucleotide metabolic process (GO:0009394)	30	0	.13	-	 < 0.2	1.00E00
telomere maintenance in response to DNA damage (GO:0043247)	10	0	.04	-	 < 0.2	1.00E00
signal maturation (GO:0035638)	1	0	.00	-	 < 0.2	1.00E00
multicellular organismal signaling (GO:0035637)	128	1	.54	+	1.86	1.00E00
regulation of protein complex disassembly (GO:0043244)	99	0	.41	-	 < 0.2	1.00E00
entry of bacterium into host cell (GO:0035635)	12	2	.05	+	39.78	1.00E00
positive regulation of protein complex disassembly (GO:0043243)	34	0	.14	-	 < 0.2	1.00E00
response to stilbenoid (GO:0035634)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of protein complex disassembly (GO:0043242)	62	0	.26	-	 < 0.2	1.00E00
maintenance of permeability of blood-brain barrier (GO:0035633)	3	0	.01	-	 < 0.2	1.00E00
protein complex disassembly (GO:0043241)	186	2	.78	+	2.57	1.00E00
bone mineralization involved in bone maturation (GO:0035630)	5	0	.02	-	 < 0.2	1.00E00
regulation of cyclase activity (GO:0031279)	95	3	.40	+	7.54	1.00E00
regulation of lateral pseudopodium assembly (GO:0031275)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of pseudopodium assembly (GO:0031274)	13	0	.05	-	 < 0.2	1.00E00
regulation of pseudopodium assembly (GO:0031272)	14	0	.06	-	 < 0.2	1.00E00
lysosomal protein catabolic process (GO:1905146)	3	0	.01	-	 < 0.2	1.00E00
cellular response to acetylcholine (GO:1905145)	23	0	.10	-	 < 0.2	1.00E00
response to acetylcholine (GO:1905144)	23	0	.10	-	 < 0.2	1.00E00
eukaryotic translation initiation factor 2 complex assembly (GO:1905143)	1	0	.00	-	 < 0.2	1.00E00
translational attenuation (GO:0009386)	2	0	.01	-	 < 0.2	1.00E00
ceramide transport (GO:0035627)	7	0	.03	-	 < 0.2	1.00E00
epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway (GO:0035625)	4	0	.02	-	 < 0.2	1.00E00
receptor transactivation (GO:0035624)	5	0	.02	-	 < 0.2	1.00E00
renal glucose absorption (GO:0035623)	1	0	.00	-	 < 0.2	1.00E00
intrahepatic bile duct development (GO:0035622)	1	0	.00	-	 < 0.2	1.00E00
ER to Golgi ceramide transport (GO:0035621)	2	0	.01	-	 < 0.2	1.00E00
pseudopodium assembly (GO:0031269)	2	0	.01	-	 < 0.2	1.00E00
pseudopodium organization (GO:0031268)	3	1	.01	+	79.55	1.00E00
negative regulation of meiotic chromosome separation (GO:1905133)	2	0	.01	-	 < 0.2	1.00E00
regulation of meiotic chromosome separation (GO:1905132)	2	0	.01	-	 < 0.2	1.00E00
stress granule disassembly (GO:0035617)	3	0	.01	-	 < 0.2	1.00E00
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	4	0	.02	-	 < 0.2	1.00E00
quorum sensing (GO:0009372)	1	0	.00	-	 < 0.2	1.00E00
protein branching point deglutamylation (GO:0035611)	1	0	.00	-	 < 0.2	1.00E00
protein side chain deglutamylation (GO:0035610)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.00	-	 < 0.2	1.00E00
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.00	-	 < 0.2	1.00E00
regulation of glucosylceramidase activity (GO:1905123)	2	0	.01	-	 < 0.2	1.00E00
polyamine import (GO:1905122)	1	0	.00	-	 < 0.2	1.00E00
C-terminal protein deglutamylation (GO:0035609)	5	0	.02	-	 < 0.2	1.00E00
myelin maintenance (GO:0043217)	12	2	.05	+	39.78	1.00E00
protein deglutamylation (GO:0035608)	8	0	.03	-	 < 0.2	1.00E00
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)	2	0	.01	-	 < 0.2	1.00E00
daunorubicin transport (GO:0043215)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	2	0	.01	-	 < 0.2	1.00E00
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604)	1	0	.00	-	 < 0.2	1.00E00
fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603)	1	0	.00	-	 < 0.2	1.00E00
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow (GO:0035602)	1	0	.00	-	 < 0.2	1.00E00
protein deacylation (GO:0035601)	67	0	.28	-	 < 0.2	1.00E00
tRNA methylthiolation (GO:0035600)	2	0	.01	-	 < 0.2	1.00E00
actin rod assembly (GO:0031247)	2	0	.01	-	 < 0.2	1.00E00
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	427	4	1.79	+	2.24	1.00E00
response to leucine (GO:0043201)	11	1	.05	+	21.70	1.00E00
auditory behavior (GO:0031223)	13	0	.05	-	 < 0.2	1.00E00
biomineral tissue development (GO:0031214)	76	0	.32	-	 < 0.2	1.00E00
posttranslational protein targeting to membrane, translocation (GO:0031204)	2	0	.01	-	 < 0.2	1.00E00
oligosaccharide catabolic process (GO:0009313)	13	0	.05	-	 < 0.2	1.00E00
oligosaccharide biosynthetic process (GO:0009312)	18	0	.08	-	 < 0.2	1.00E00
oligosaccharide metabolic process (GO:0009311)	55	0	.23	-	 < 0.2	1.00E00
amine catabolic process (GO:0009310)	23	0	.10	-	 < 0.2	1.00E00
tRNA transcription from RNA polymerase III promoter (GO:0042797)	6	0	.03	-	 < 0.2	1.00E00
snRNA transcription from RNA polymerase III promoter (GO:0042796)	6	0	.03	-	 < 0.2	1.00E00
snRNA transcription from RNA polymerase II promoter (GO:0042795)	70	0	.29	-	 < 0.2	1.00E00
5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791)	6	0	.03	-	 < 0.2	1.00E00
transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:0042790)	4	0	.02	-	 < 0.2	1.00E00
chromatin-mediated maintenance of transcription (GO:0048096)	9	1	.04	+	26.52	1.00E00
amine biosynthetic process (GO:0009309)	24	0	.10	-	 < 0.2	1.00E00
amine metabolic process (GO:0009308)	64	0	.27	-	 < 0.2	1.00E00
protein secretion (GO:0009306)	133	1	.56	+	1.79	1.00E00
protein biotinylation (GO:0009305)	1	0	.00	-	 < 0.2	1.00E00
tRNA transcription (GO:0009304)	7	0	.03	-	 < 0.2	1.00E00
rRNA transcription (GO:0009303)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of vascular smooth muscle contraction (GO:1904694)	3	0	.01	-	 < 0.2	1.00E00
midbrain morphogenesis (GO:1904693)	3	0	.01	-	 < 0.2	1.00E00
snRNA transcription (GO:0009301)	70	0	.29	-	 < 0.2	1.00E00
positive regulation of type B pancreatic cell proliferation (GO:1904692)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of type B pancreatic cell proliferation (GO:1904691)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cytoplasmic translational initiation (GO:1904690)	3	0	.01	-	 < 0.2	1.00E00
mRNA transcription from RNA polymerase II promoter (GO:0042789)	20	0	.08	-	 < 0.2	1.00E00
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787)	139	3	.58	+	5.15	1.00E00
positive regulation of developmental pigmentation (GO:0048087)	9	1	.04	+	26.52	1.00E00
tRNA 3'-end processing (GO:0042780)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of developmental pigmentation (GO:0048086)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cytoplasmic translational initiation (GO:1904689)	1	0	.00	-	 < 0.2	1.00E00
regulation of cytoplasmic translational initiation (GO:1904688)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of metalloendopeptidase activity (GO:1904685)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of metalloendopeptidase activity (GO:1904684)	4	0	.02	-	 < 0.2	1.00E00
regulation of metalloendopeptidase activity (GO:1904683)	6	0	.03	-	 < 0.2	1.00E00
response to 3-methylcholanthrene (GO:1904681)	1	0	.00	-	 < 0.2	1.00E00
tRNA 3'-trailer cleavage (GO:0042779)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial ATP synthesis coupled proton transport (GO:0042776)	21	1	.09	+	11.36	1.00E00
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	92	1	.39	+	2.59	1.00E00
plasma membrane ATP synthesis coupled electron transport (GO:0042774)	1	0	.00	-	 < 0.2	1.00E00
ATP synthesis coupled electron transport (GO:0042773)	93	1	.39	+	2.57	1.00E00
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	30	3	.13	+	23.87	1.00E00
positive regulation of eye pigmentation (GO:0048075)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of eye pigmentation (GO:0048074)	1	0	.00	-	 < 0.2	1.00E00
regulation of eye pigmentation (GO:0048073)	3	0	.01	-	 < 0.2	1.00E00
regulation of developmental pigmentation (GO:0048070)	17	1	.07	+	14.04	1.00E00
positive regulation of somatic stem cell division (GO:1904677)	1	0	.00	-	 < 0.2	1.00E00
regulation of somatic stem cell division (GO:1904675)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of somatic stem cell population maintenance (GO:1904674)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of somatic stem cell population maintenance (GO:1904673)	4	0	.02	-	 < 0.2	1.00E00
regulation of somatic stem cell population maintenance (GO:1904672)	6	0	.03	-	 < 0.2	1.00E00
DNA damage response, detection of DNA damage (GO:0042769)	38	1	.16	+	6.28	1.00E00
nucleosome mobilization (GO:0042766)	1	0	.00	-	 < 0.2	1.00E00
eye pigmentation (GO:0048069)	6	0	.03	-	 < 0.2	1.00E00
regulation of sulfur metabolic process (GO:0042762)	22	0	.09	-	 < 0.2	1.00E00
very long-chain fatty acid biosynthetic process (GO:0042761)	13	0	.05	-	 < 0.2	1.00E00
developmental pigmentation (GO:0048066)	40	1	.17	+	5.97	1.00E00
very long-chain fatty acid catabolic process (GO:0042760)	5	0	.02	-	 < 0.2	1.00E00
regulation of cyclic nucleotide metabolic process (GO:0030799)	169	3	.71	+	4.24	1.00E00
positive regulation of ubiquitin protein ligase activity (GO:1904668)	85	2	.36	+	5.62	1.00E00
germ cell proliferation (GO:0036093)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of ubiquitin protein ligase activity (GO:1904667)	79	2	.33	+	6.04	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091)	5	0	.02	-	 < 0.2	1.00E00
regulation of ubiquitin protein ligase activity (GO:1904666)	94	3	.39	+	7.62	1.00E00
cleavage furrow ingression (GO:0036090)	2	0	.01	-	 < 0.2	1.00E00
long-chain fatty acid biosynthetic process (GO:0042759)	10	0	.04	-	 < 0.2	1.00E00
long-chain fatty acid catabolic process (GO:0042758)	8	0	.03	-	 < 0.2	1.00E00
drinking behavior (GO:0042756)	10	0	.04	-	 < 0.2	1.00E00
eating behavior (GO:0042755)	28	0	.12	-	 < 0.2	1.00E00
negative regulation of circadian rhythm (GO:0042754)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of circadian rhythm (GO:0042753)	18	0	.08	-	 < 0.2	1.00E00
regulation of circadian rhythm (GO:0042752)	100	2	.42	+	4.77	1.00E00
compound eye corneal lens development (GO:0048058)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic eye morphogenesis (GO:0048050)	7	0	.03	-	 < 0.2	1.00E00
cleavage furrow formation (GO:0036089)	7	0	.03	-	 < 0.2	1.00E00
D-serine catabolic process (GO:0036088)	1	0	.00	-	 < 0.2	1.00E00
GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.00	-	 < 0.2	1.00E00
glucose transmembrane transport (GO:1904659)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of fat cell apoptotic process (GO:1904651)	1	0	.00	-	 < 0.2	1.00E00
regulation of circadian sleep/wake cycle (GO:0042749)	23	0	.10	-	 < 0.2	1.00E00
circadian sleep/wake cycle, non-REM sleep (GO:0042748)	1	0	.00	-	 < 0.2	1.00E00
circadian sleep/wake cycle, REM sleep (GO:0042747)	3	0	.01	-	 < 0.2	1.00E00
circadian sleep/wake cycle (GO:0042745)	7	0	.03	-	 < 0.2	1.00E00
hydrogen peroxide catabolic process (GO:0042744)	19	0	.08	-	 < 0.2	1.00E00
hydrogen peroxide metabolic process (GO:0042743)	31	1	.13	+	7.70	1.00E00
embryonic eye morphogenesis (GO:0048048)	35	0	.15	-	 < 0.2	1.00E00
defense response to bacterium (GO:0042742)	282	4	1.18	+	3.39	1.00E00
focal adhesion assembly (GO:0048041)	24	3	.10	+	29.83	1.00E00
purine nucleotide-sugar transport (GO:0036079)	3	0	.01	-	 < 0.2	1.00E00
replacement ossification (GO:0036075)	27	0	.11	-	 < 0.2	1.00E00
regulation of fat cell apoptotic process (GO:1904649)	1	0	.00	-	 < 0.2	1.00E00
direct ossification (GO:0036072)	6	0	.03	-	 < 0.2	1.00E00
response to rotenone (GO:1904647)	1	0	.00	-	 < 0.2	1.00E00
cellular response to amyloid-beta (GO:1904646)	24	0	.10	-	 < 0.2	1.00E00
N-glycan fucosylation (GO:0036071)	1	0	.00	-	 < 0.2	1.00E00
response to amyloid-beta (GO:1904645)	27	0	.11	-	 < 0.2	1.00E00
response to methionine (GO:1904640)	3	0	.01	-	 < 0.2	1.00E00
exogenous drug catabolic process (GO:0042738)	12	0	.05	-	 < 0.2	1.00E00
drug catabolic process (GO:0042737)	15	0	.06	-	 < 0.2	1.00E00
embryonic digit morphogenesis (GO:0042733)	63	0	.26	-	 < 0.2	1.00E00
D-xylose metabolic process (GO:0042732)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)	1	0	.00	-	 < 0.2	1.00E00
fibrinolysis (GO:0042730)	21	1	.09	+	11.36	1.00E00
heme O biosynthetic process (GO:0048034)	1	0	.00	-	 < 0.2	1.00E00
heme o metabolic process (GO:0048033)	1	0	.00	-	 < 0.2	1.00E00
protein O-linked fucosylation (GO:0036066)	15	0	.06	-	 < 0.2	1.00E00
fucosylation (GO:0036065)	27	0	.11	-	 < 0.2	1.00E00
cellular response to resveratrol (GO:1904639)	1	0	.00	-	 < 0.2	1.00E00
response to resveratrol (GO:1904638)	1	0	.00	-	 < 0.2	1.00E00
cellular response to ionomycin (GO:1904637)	6	0	.03	-	 < 0.2	1.00E00
response to ionomycin (GO:1904636)	6	0	.03	-	 < 0.2	1.00E00
slit diaphragm assembly (GO:0036060)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of glomerular visceral epithelial cell apoptotic process (GO:1904635)	1	0	.00	-	 < 0.2	1.00E00
regulation of glomerular visceral epithelial cell apoptotic process (GO:1904633)	1	0	.00	-	 < 0.2	1.00E00
farnesol catabolic process (GO:0016488)	2	0	.01	-	 < 0.2	1.00E00
farnesol metabolic process (GO:0016487)	2	0	.01	-	 < 0.2	1.00E00
response to glucoside (GO:1904631)	1	0	.00	-	 < 0.2	1.00E00
peptide hormone processing (GO:0016486)	33	1	.14	+	7.23	1.00E00
regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)	1	0	.00	-	 < 0.2	1.00E00
protein processing (GO:0016485)	148	2	.62	+	3.23	1.00E00
flavin-containing compound catabolic process (GO:0042728)	1	0	.00	-	 < 0.2	1.00E00
flavin-containing compound biosynthetic process (GO:0042727)	2	0	.01	-	 < 0.2	1.00E00
regulation of proteinase activated receptor activity (GO:1900276)	1	0	.00	-	 < 0.2	1.00E00
flavin-containing compound metabolic process (GO:0042726)	8	0	.03	-	 < 0.2	1.00E00
cytosolic transport (GO:0016482)	130	0	.54	-	 < 0.2	1.00E00
negative regulation of phospholipase C activity (GO:1900275)	2	0	.01	-	 < 0.2	1.00E00
regulation of phospholipase C activity (GO:1900274)	38	3	.16	+	18.84	1.00E00
positive regulation of long-term synaptic potentiation (GO:1900273)	16	0	.07	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase III promoter (GO:0016480)	3	0	.01	-	 < 0.2	1.00E00
thiamine-containing compound metabolic process (GO:0042723)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of long-term synaptic potentiation (GO:1900272)	6	0	.03	-	 < 0.2	1.00E00
regulation of long-term synaptic potentiation (GO:1900271)	28	0	.12	-	 < 0.2	1.00E00
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	22	0	.09	-	 < 0.2	1.00E00
regulation of mRNA splicing, via spliceosome (GO:0048024)	79	0	.33	-	 < 0.2	1.00E00
positive regulation of melanin biosynthetic process (GO:0048023)	4	1	.02	+	59.66	1.00E00
negative regulation of melanin biosynthetic process (GO:0048022)	3	0	.01	-	 < 0.2	1.00E00
regulation of melanin biosynthetic process (GO:0048021)	7	1	.03	+	34.09	1.00E00
filtration diaphragm assembly (GO:0036058)	1	0	.00	-	 < 0.2	1.00E00
cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	7	0	.03	-	 < 0.2	1.00E00
response to phorbol 13-acetate 12-myristate (GO:1904627)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase I promoter (GO:0016479)	6	0	.03	-	 < 0.2	1.00E00
regulation of embryonic cell shape (GO:0016476)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	7	0	.03	-	 < 0.2	1.00E00
regulation of DNA-directed DNA polymerase activity (GO:1900262)	7	0	.03	-	 < 0.2	1.00E00
sperm ejaculation (GO:0042713)	6	0	.03	-	 < 0.2	1.00E00
maternal behavior (GO:0042711)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260)	1	0	.00	-	 < 0.2	1.00E00
inositol phosphate-mediated signaling (GO:0048016)	19	0	.08	-	 < 0.2	1.00E00
Tie signaling pathway (GO:0048014)	3	0	.01	-	 < 0.2	1.00E00
ephrin receptor signaling pathway (GO:0048013)	87	1	.36	+	2.74	1.00E00
hepatocyte growth factor receptor signaling pathway (GO:0048012)	12	0	.05	-	 < 0.2	1.00E00
peptidyl-lysine desuccinylation (GO:0036049)	1	0	.00	-	 < 0.2	1.00E00
protein desuccinylation (GO:0036048)	1	0	.00	-	 < 0.2	1.00E00
peptidyl-lysine demalonylation (GO:0036047)	1	0	.00	-	 < 0.2	1.00E00
protein demalonylation (GO:0036046)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of actin binding (GO:1904618)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of actin binding (GO:1904617)	1	0	.00	-	 < 0.2	1.00E00
regulation of actin binding (GO:1904616)	2	0	.01	-	 < 0.2	1.00E00
response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	1	0	.00	-	 < 0.2	1.00E00
regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259)	1	0	.00	-	 < 0.2	1.00E00
eye photoreceptor cell fate commitment (GO:0042706)	1	0	.00	-	 < 0.2	1.00E00
uterine wall breakdown (GO:0042704)	2	0	.01	-	 < 0.2	1.00E00
menstruation (GO:0042703)	1	0	.00	-	 < 0.2	1.00E00
platelet-derived growth factor receptor signaling pathway (GO:0048008)	34	2	.14	+	14.04	1.00E00
antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	7	0	.03	-	 < 0.2	1.00E00
progesterone secretion (GO:0042701)	2	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)	1	0	.00	-	 < 0.2	1.00E00
luteinizing hormone signaling pathway (GO:0042700)	3	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	7	0	.03	-	 < 0.2	1.00E00
antigen processing and presentation of peptide antigen (GO:0048002)	185	1	.78	+	1.29	1.00E00
CD8-positive, alpha-beta T cell activation (GO:0036037)	10	2	.04	+	47.73	1.00E00
sequestering of triglyceride (GO:0030730)	4	0	.02	-	 < 0.2	1.00E00
osteoclast development (GO:0036035)	6	1	.03	+	39.78	1.00E00
recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of advanced glycation end-product receptor activity (GO:1904604)	1	0	.00	-	 < 0.2	1.00E00
regulation of advanced glycation end-product receptor activity (GO:1904603)	1	0	.00	-	 < 0.2	1.00E00
gene silencing (GO:0016458)	149	2	.62	+	3.20	1.00E00
negative regulation of cytoplasmic translational elongation (GO:1900248)	2	0	.01	-	 < 0.2	1.00E00
regulation of cytoplasmic translational elongation (GO:1900247)	10	1	.04	+	23.87	1.00E00
positive regulation of RIG-I signaling pathway (GO:1900246)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of MDA-5 signaling pathway (GO:1900245)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of synaptic vesicle endocytosis (GO:1900244)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of synaptic vesicle endocytosis (GO:1900243)	1	0	.00	-	 < 0.2	1.00E00
regulation of synaptic vesicle endocytosis (GO:1900242)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of phenotypic switching (GO:1900241)	1	0	.00	-	 < 0.2	1.00E00
ovulation (GO:0030728)	20	0	.08	-	 < 0.2	1.00E00
embryonic skeletal limb joint morphogenesis (GO:0036023)	3	0	.01	-	 < 0.2	1.00E00
limb joint morphogenesis (GO:0036022)	3	0	.01	-	 < 0.2	1.00E00
somatic recombination of immunoglobulin gene segments (GO:0016447)	23	0	.10	-	 < 0.2	1.00E00
regulation of phenotypic switching (GO:1900239)	3	0	.01	-	 < 0.2	1.00E00
somatic hypermutation of immunoglobulin genes (GO:0016446)	16	0	.07	-	 < 0.2	1.00E00
somatic diversification of immunoglobulins (GO:0016445)	33	0	.14	-	 < 0.2	1.00E00
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	3	1	.01	+	79.55	1.00E00
somatic cell DNA recombination (GO:0016444)	33	1	.14	+	7.23	1.00E00
posttranscriptional gene silencing (GO:0016441)	52	1	.22	+	4.59	1.00E00
P granule organization (GO:0030719)	2	0	.01	-	 < 0.2	1.00E00
germ-line stem cell population maintenance (GO:0030718)	3	0	.01	-	 < 0.2	1.00E00
cellular response to erythropoietin (GO:0036018)	6	0	.03	-	 < 0.2	1.00E00
response to erythropoietin (GO:0036017)	7	0	.03	-	 < 0.2	1.00E00
cellular response to interleukin-3 (GO:0036016)	5	1	.02	+	47.73	1.00E00
response to interleukin-3 (GO:0036015)	5	1	.02	+	47.73	1.00E00
protein localization to endosome (GO:0036010)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of astrocyte activation (GO:0061889)	1	0	.00	-	 < 0.2	1.00E00
regulation of astrocyte activation (GO:0061888)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of single-species biofilm formation in or on host organism (GO:1900229)	2	0	.01	-	 < 0.2	1.00E00
regulation of single-species biofilm formation in or on host organism (GO:1900228)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mini excitatory postsynaptic potential (GO:0061885)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	5	0	.02	-	 < 0.2	1.00E00
regulation of mini excitatory postsynaptic potential (GO:0061884)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	4	0	.02	-	 < 0.2	1.00E00
regulation of NLRP3 inflammasome complex assembly (GO:1900225)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of amyloid-beta clearance (GO:1900223)	5	0	.02	-	 < 0.2	1.00E00
regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of amyloid-beta clearance (GO:1900222)	3	0	.01	-	 < 0.2	1.00E00
regulation of amyloid-beta clearance (GO:1900221)	9	0	.04	-	 < 0.2	1.00E00
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220)	2	0	.01	-	 < 0.2	1.00E00
cytoskeleton-dependent intracellular transport (GO:0030705)	149	0	.62	-	 < 0.2	1.00E00
vitelline membrane formation (GO:0030704)	1	0	.00	-	 < 0.2	1.00E00
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	8	0	.03	-	 < 0.2	1.00E00
response to macrophage colony-stimulating factor (GO:0036005)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	25	2	.10	+	19.09	1.00E00
negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218)	2	0	.01	-	 < 0.2	1.00E00
regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215)	2	0	.01	-	 < 0.2	1.00E00
regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212)	3	0	.01	-	 < 0.2	1.00E00
regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cardiolipin metabolic process (GO:1900210)	1	0	.00	-	 < 0.2	1.00E00
sulfur amino acid catabolic process (GO:0000098)	10	0	.04	-	 < 0.2	1.00E00
sulfur amino acid biosynthetic process (GO:0000097)	17	0	.07	-	 < 0.2	1.00E00
sulfur amino acid metabolic process (GO:0000096)	37	0	.16	-	 < 0.2	1.00E00
regulation of cardiolipin metabolic process (GO:1900208)	1	0	.00	-	 < 0.2	1.00E00
G2/M transition of mitotic cell cycle (GO:0000086)	136	5	.57	+	8.77	1.00E00
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	28	1	.12	+	8.52	1.00E00
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of neuroblast migration (GO:0061855)	1	0	.00	-	 < 0.2	1.00E00
regulation of neuroblast migration (GO:0061853)	1	0	.00	-	 < 0.2	1.00E00
DNA replication checkpoint (GO:0000076)	16	0	.07	-	 < 0.2	1.00E00
mitotic sister chromatid segregation (GO:0000070)	101	2	.42	+	4.73	1.00E00
response to cholecystokinin (GO:0061847)	1	0	.00	-	 < 0.2	1.00E00
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	48	0	.20	-	 < 0.2	1.00E00
microtubule organizing center localization (GO:0061842)	28	0	.12	-	 < 0.2	1.00E00
mitochondrial ornithine transport (GO:0000066)	3	0	.01	-	 < 0.2	1.00E00
protein import into nucleus, translocation (GO:0000060)	28	1	.12	+	8.52	1.00E00
purinergic nucleotide receptor signaling pathway (GO:0035590)	24	0	.10	-	 < 0.2	1.00E00
protein localization to tricellular tight junction (GO:0061833)	2	1	.01	+	 > 100	1.00E00
ribosomal small subunit export from nucleus (GO:0000056)	7	0	.03	-	 < 0.2	1.00E00
ribosomal large subunit export from nucleus (GO:0000055)	9	0	.04	-	 < 0.2	1.00E00
ribosomal subunit export from nucleus (GO:0000054)	14	0	.06	-	 < 0.2	1.00E00
argininosuccinate metabolic process (GO:0000053)	1	0	.00	-	 < 0.2	1.00E00
citrulline metabolic process (GO:0000052)	6	0	.03	-	 < 0.2	1.00E00
G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589)	15	0	.06	-	 < 0.2	1.00E00
urea cycle (GO:0000050)	12	0	.05	-	 < 0.2	1.00E00
G-protein coupled purinergic receptor signaling pathway (GO:0035588)	21	0	.09	-	 < 0.2	1.00E00
purinergic receptor signaling pathway (GO:0035587)	30	0	.13	-	 < 0.2	1.00E00
calcium-mediated signaling using extracellular calcium source (GO:0035585)	2	0	.01	-	 < 0.2	1.00E00
calcium-mediated signaling using intracellular calcium source (GO:0035584)	21	0	.09	-	 < 0.2	1.00E00
sequestering of TGFbeta in extracellular matrix (GO:0035583)	3	0	.01	-	 < 0.2	1.00E00
sequestering of BMP in extracellular matrix (GO:0035582)	4	0	.02	-	 < 0.2	1.00E00
sequestering of extracellular ligand from receptor (GO:0035581)	8	0	.03	-	 < 0.2	1.00E00
telomeric D-loop disassembly (GO:0061820)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	6	0	.03	-	 < 0.2	1.00E00
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	8	0	.03	-	 < 0.2	1.00E00
autophagosome assembly (GO:0000045)	54	0	.23	-	 < 0.2	1.00E00
protein targeting to Golgi (GO:0000042)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090)	1	0	.00	-	 < 0.2	1.00E00
transition metal ion transport (GO:0000041)	110	0	.46	-	 < 0.2	1.00E00
telomeric DNA-containing double minutes formation (GO:0061819)	3	0	.01	-	 < 0.2	1.00E00
histone H4-K20 demethylation (GO:0035574)	2	0	.01	-	 < 0.2	1.00E00
N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.00	-	 < 0.2	1.00E00
vacuolar sequestering (GO:0043181)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.00	-	 < 0.2	1.00E00
molecular hydrogen transport (GO:0015993)	2	0	.01	-	 < 0.2	1.00E00
proton transport (GO:0015992)	149	1	.62	+	1.60	1.00E00
ATP hydrolysis coupled proton transport (GO:0015991)	27	0	.11	-	 < 0.2	1.00E00
regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089)	1	0	.00	-	 < 0.2	1.00E00
electron transport coupled proton transport (GO:0015990)	1	0	.00	-	 < 0.2	1.00E00
very long-chain fatty acid metabolic process (GO:0000038)	31	0	.13	-	 < 0.2	1.00E00
cell wall mannoprotein biosynthetic process (GO:0000032)	1	0	.00	-	 < 0.2	1.00E00
rhythmic excitation (GO:0043179)	1	0	.00	-	 < 0.2	1.00E00
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.00	-	 < 0.2	1.00E00
non-canonical Wnt signaling pathway (GO:0035567)	138	0	.58	-	 < 0.2	1.00E00
regulation of metanephros size (GO:0035566)	2	0	.01	-	 < 0.2	1.00E00
nucleoside salvage (GO:0043174)	17	0	.07	-	 < 0.2	1.00E00
regulation of pronephros size (GO:0035565)	1	0	.00	-	 < 0.2	1.00E00
nucleotide salvage (GO:0043173)	14	0	.06	-	 < 0.2	1.00E00
regulation of kidney size (GO:0035564)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of chromatin binding (GO:0035563)	13	0	.05	-	 < 0.2	1.00E00
peptide catabolic process (GO:0043171)	34	0	.14	-	 < 0.2	1.00E00
negative regulation of chromatin binding (GO:0035562)	8	0	.03	-	 < 0.2	1.00E00
regulation of chromatin binding (GO:0035561)	22	0	.09	-	 < 0.2	1.00E00
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	28	0	.12	-	 < 0.2	1.00E00
ATP synthesis coupled proton transport (GO:0015986)	29	1	.12	+	8.23	1.00E00
energy coupled proton transport, down electrochemical gradient (GO:0015985)	29	1	.12	+	8.23	1.00E00
energy derivation by oxidation of organic compounds (GO:0015980)	240	3	1.01	+	2.98	1.00E00
negative regulation of interleukin-17 secretion (GO:1905077)	1	0	.00	-	 < 0.2	1.00E00
ribosomal small subunit assembly (GO:0000028)	21	0	.09	-	 < 0.2	1.00E00
regulation of interleukin-17 secretion (GO:1905076)	1	0	.00	-	 < 0.2	1.00E00
ribosomal large subunit assembly (GO:0000027)	30	0	.13	-	 < 0.2	1.00E00
positive regulation of occluding junction disassembly (GO:1905075)	3	0	.01	-	 < 0.2	1.00E00
regulation of occluding junction disassembly (GO:1905073)	3	0	.01	-	 < 0.2	1.00E00
maltose metabolic process (GO:0000023)	3	0	.01	-	 < 0.2	1.00E00
mitotic spindle elongation (GO:0000022)	11	0	.05	-	 < 0.2	1.00E00
D-alanine catabolic process (GO:0055130)	1	0	.00	-	 < 0.2	1.00E00
cell envelope organization (GO:0043163)	3	1	.01	+	79.55	1.00E00
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	18	0	.08	-	 < 0.2	1.00E00
oxidative single-stranded RNA demethylation (GO:0035553)	3	0	.01	-	 < 0.2	1.00E00
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	296	5	1.24	+	4.03	1.00E00
oxidative single-stranded DNA demethylation (GO:0035552)	3	0	.01	-	 < 0.2	1.00E00
L-proline biosynthetic process (GO:0055129)	5	0	.02	-	 < 0.2	1.00E00
allantois development (GO:1905069)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068)	1	0	.00	-	 < 0.2	1.00E00
regulation of mitotic recombination (GO:0000019)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067)	1	0	.00	-	 < 0.2	1.00E00
regulation of DNA recombination (GO:0000018)	73	1	.31	+	3.27	1.00E00
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of vascular smooth muscle cell differentiation (GO:1905065)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of vascular smooth muscle cell differentiation (GO:1905064)	3	0	.01	-	 < 0.2	1.00E00
digestive system development (GO:0055123)	139	5	.58	+	8.58	1.00E00
regulation of vascular smooth muscle cell differentiation (GO:1905063)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of cardioblast proliferation (GO:1905062)	1	0	.00	-	 < 0.2	1.00E00
single strand break repair (GO:0000012)	10	0	.04	-	 < 0.2	1.00E00
vacuole inheritance (GO:0000011)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of interferon-beta secretion (GO:0035549)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of interferon-beta secretion (GO:0035548)	1	0	.00	-	 < 0.2	1.00E00
regulation of interferon-beta secretion (GO:0035547)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	91	4	.38	+	10.49	1.00E00
determination of left/right asymmetry in nervous system (GO:0035545)	1	0	.00	-	 < 0.2	1.00E00
entrainment of circadian clock by photoperiod (GO:0043153)	19	1	.08	+	12.56	1.00E00
negative regulation of SNARE complex assembly (GO:0035544)	2	0	.01	-	 < 0.2	1.00E00
induction of bacterial agglutination (GO:0043152)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of SNARE complex assembly (GO:0035543)	1	0	.00	-	 < 0.2	1.00E00
regulation of SNARE complex assembly (GO:0035542)	9	0	.04	-	 < 0.2	1.00E00
diadenosine polyphosphate catabolic process (GO:0015961)	4	0	.02	-	 < 0.2	1.00E00
relaxation of cardiac muscle (GO:0055119)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of cardiac muscle contraction (GO:0055118)	6	0	.03	-	 < 0.2	1.00E00
regulation of cardiac muscle contraction (GO:0055117)	72	1	.30	+	3.31	1.00E00
oxidation-reduction process (GO:0055114)	937	8	3.93	+	2.04	1.00E00
positive regulation of base-excision repair (GO:1905053)	2	0	.01	-	 < 0.2	1.00E00
epiboly involved in gastrulation with mouth forming second (GO:0055113)	1	0	.00	-	 < 0.2	1.00E00
mRNA transcription (GO:0009299)	27	1	.11	+	8.84	1.00E00
regulation of base-excision repair (GO:1905051)	2	0	.01	-	 < 0.2	1.00E00
GDP-mannose biosynthetic process (GO:0009298)	4	0	.02	-	 < 0.2	1.00E00
ingression involved in gastrulation with mouth forming second (GO:0055111)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial genome maintenance (GO:0000002)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of metallopeptidase activity (GO:1905050)	7	2	.03	+	68.19	1.00E00
stress fiber assembly (GO:0043149)	13	1	.05	+	18.36	1.00E00
snoRNA processing (GO:0043144)	10	0	.04	-	 < 0.2	1.00E00
regulation of translation by machinery localization (GO:0043143)	1	0	.00	-	 < 0.2	1.00E00
peptide modification (GO:0031179)	2	0	.01	-	 < 0.2	1.00E00
diadenosine polyphosphate metabolic process (GO:0015959)	7	2	.03	+	68.19	1.00E00
neuron projection development (GO:0031175)	624	9	2.61	+	3.44	1.00E00
negative regulation of metallopeptidase activity (GO:1905049)	6	0	.03	-	 < 0.2	1.00E00
regulation of metallopeptidase activity (GO:1905048)	13	2	.05	+	36.72	1.00E00
Golgi to transport vesicle transport (GO:0055108)	1	0	.00	-	 < 0.2	1.00E00
Golgi to secretory granule transport (GO:0055107)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Schwann cell proliferation involved in axon regeneration (GO:1905045)	1	0	.00	-	 < 0.2	1.00E00
regulation of Schwann cell proliferation involved in axon regeneration (GO:1905044)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of epithelium regeneration (GO:1905042)	1	0	.00	-	 < 0.2	1.00E00
regulation of epithelium regeneration (GO:1905041)	2	1	.01	+	 > 100	1.00E00
otic placode development (GO:1905040)	1	0	.00	-	 < 0.2	1.00E00
DNA replication, removal of RNA primer (GO:0043137)	4	0	.02	-	 < 0.2	1.00E00
retrograde transport, plasma membrane to Golgi (GO:0035526)	2	0	.01	-	 < 0.2	1.00E00
regulation of hindgut contraction (GO:0043134)	2	0	.01	-	 < 0.2	1.00E00
proline transmembrane transport (GO:0035524)	7	0	.03	-	 < 0.2	1.00E00
protein K29-linked deubiquitination (GO:0035523)	4	0	.02	-	 < 0.2	1.00E00
NAD transport (GO:0043132)	2	0	.01	-	 < 0.2	1.00E00
monoubiquitinated histone H2A deubiquitination (GO:0035522)	4	0	.02	-	 < 0.2	1.00E00
monoubiquitinated histone deubiquitination (GO:0035521)	4	0	.02	-	 < 0.2	1.00E00
monoubiquitinated protein deubiquitination (GO:0035520)	10	0	.04	-	 < 0.2	1.00E00
rRNA methylation (GO:0031167)	26	0	.11	-	 < 0.2	1.00E00
nucleobase-containing small molecule interconversion (GO:0015949)	31	0	.13	-	 < 0.2	1.00E00
metallo-sulfur cluster assembly (GO:0031163)	18	0	.08	-	 < 0.2	1.00E00
phosphatidylinositol catabolic process (GO:0031161)	1	0	.00	-	 < 0.2	1.00E00
formate metabolic process (GO:0015942)	6	0	.03	-	 < 0.2	1.00E00
carboxylic acid transmembrane transport (GO:1905039)	104	0	.44	-	 < 0.2	1.00E00
regulation of membrane lipid metabolic process (GO:1905038)	14	1	.06	+	17.05	1.00E00
autophagosome organization (GO:1905037)	57	0	.24	-	 < 0.2	1.00E00
negative regulation of antifungal innate immune response (GO:1905035)	1	0	.00	-	 < 0.2	1.00E00
regulation of antifungal innate immune response (GO:1905034)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032)	1	0	.00	-	 < 0.2	1.00E00
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	5	0	.02	-	 < 0.2	1.00E00
surfactant homeostasis (GO:0043129)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128)	1	0	.00	-	 < 0.2	1.00E00
protein K29-linked ubiquitination (GO:0035519)	5	0	.02	-	 < 0.2	1.00E00
histone H2A monoubiquitination (GO:0035518)	17	0	.07	-	 < 0.2	1.00E00
regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	55	0	.23	-	 < 0.2	1.00E00
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	185	1	.78	+	1.29	1.00E00
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	243	2	1.02	+	1.96	1.00E00
oxidative RNA demethylation (GO:0035513)	4	0	.02	-	 < 0.2	1.00E00
oxidative DNA demethylation (GO:0035511)	5	0	.02	-	 < 0.2	1.00E00
DNA dealkylation (GO:0035510)	22	0	.09	-	 < 0.2	1.00E00
pantothenate metabolic process (GO:0015939)	8	1	.03	+	29.83	1.00E00
coenzyme A catabolic process (GO:0015938)	1	0	.00	-	 < 0.2	1.00E00
coenzyme A biosynthetic process (GO:0015937)	10	0	.04	-	 < 0.2	1.00E00
coenzyme A metabolic process (GO:0015936)	15	0	.06	-	 < 0.2	1.00E00
nucleobase-containing compound transport (GO:0015931)	237	1	.99	+	1.01	1.00E00
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025)	1	0	.00	-	 < 0.2	1.00E00
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	4	0	.02	-	 < 0.2	1.00E00
response to pH (GO:0009268)	41	1	.17	+	5.82	1.00E00
response to temperature stimulus (GO:0009266)	158	3	.66	+	4.53	1.00E00
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	5	0	.02	-	 < 0.2	1.00E00
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of vascular permeability (GO:0043117)	10	0	.04	-	 < 0.2	1.00E00
deoxyribonucleotide catabolic process (GO:0009264)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of myosin-light-chain-phosphatase activity (GO:0035508)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of vascular permeability (GO:0043116)	13	0	.05	-	 < 0.2	1.00E00
regulation of myosin-light-chain-phosphatase activity (GO:0035507)	7	0	.03	-	 < 0.2	1.00E00
deoxyribonucleotide biosynthetic process (GO:0009263)	14	0	.06	-	 < 0.2	1.00E00
deoxyribonucleotide metabolic process (GO:0009262)	34	0	.14	-	 < 0.2	1.00E00
regulation of vascular permeability (GO:0043114)	33	1	.14	+	7.23	1.00E00
ribonucleotide catabolic process (GO:0009261)	30	0	.13	-	 < 0.2	1.00E00
positive regulation of myosin light chain kinase activity (GO:0035505)	1	0	.00	-	 < 0.2	1.00E00
receptor clustering (GO:0043113)	43	1	.18	+	5.55	1.00E00
ribonucleotide biosynthetic process (GO:0009260)	135	2	.57	+	3.54	1.00E00
regulation of myosin light chain kinase activity (GO:0035504)	1	0	.00	-	 < 0.2	1.00E00
receptor metabolic process (GO:0043112)	97	3	.41	+	7.38	1.00E00
metanephric part of ureteric bud development (GO:0035502)	4	0	.02	-	 < 0.2	1.00E00
replication fork arrest (GO:0043111)	1	0	.00	-	 < 0.2	1.00E00
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	73	0	.31	-	 < 0.2	1.00E00
anaphase-promoting complex-dependent catabolic process (GO:0031145)	81	2	.34	+	5.89	1.00E00
lipopolysaccharide transport (GO:0015920)	2	0	.01	-	 < 0.2	1.00E00
ribonucleotide metabolic process (GO:0009259)	381	3	1.60	+	1.88	1.00E00
regulation of 'de novo' NAD biosynthetic process from tryptophan (GO:1905012)	1	0	.00	-	 < 0.2	1.00E00
10-formyltetrahydrofolate catabolic process (GO:0009258)	2	0	.01	-	 < 0.2	1.00E00
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of L-lysine import across plasma membrane (GO:1905010)	1	0	.00	-	 < 0.2	1.00E00
10-formyltetrahydrofolate metabolic process (GO:0009256)	5	0	.02	-	 < 0.2	1.00E00
peptidoglycan catabolic process (GO:0009253)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of GTP cyclohydrolase I activity (GO:0043105)	1	0	.00	-	 < 0.2	1.00E00
glucan catabolic process (GO:0009251)	20	0	.08	-	 < 0.2	1.00E00
glucan biosynthetic process (GO:0009250)	26	1	.11	+	9.18	1.00E00
hypoxanthine salvage (GO:0043103)	3	0	.01	-	 < 0.2	1.00E00
amino acid salvage (GO:0043102)	7	0	.03	-	 < 0.2	1.00E00
purine-containing compound salvage (GO:0043101)	16	0	.07	-	 < 0.2	1.00E00
peroxisomal membrane transport (GO:0015919)	7	0	.03	-	 < 0.2	1.00E00
sterol transport (GO:0015918)	61	1	.26	+	3.91	1.00E00
aminophospholipid transport (GO:0015917)	6	0	.03	-	 < 0.2	1.00E00
fatty-acyl-CoA transport (GO:0015916)	1	0	.00	-	 < 0.2	1.00E00
sister chromatid biorientation (GO:0031134)	2	0	.01	-	 < 0.2	1.00E00
regulation of axon diameter (GO:0031133)	5	0	.02	-	 < 0.2	1.00E00
phospholipid transport (GO:0015914)	63	0	.26	-	 < 0.2	1.00E00
short-chain fatty acid import (GO:0015913)	1	0	.00	-	 < 0.2	1.00E00
short-chain fatty acid transport (GO:0015912)	1	0	.00	-	 < 0.2	1.00E00
plasma membrane long-chain fatty acid transport (GO:0015911)	1	0	.00	-	 < 0.2	1.00E00
peroxisomal long-chain fatty acid import (GO:0015910)	2	0	.01	-	 < 0.2	1.00E00
regulation of L-lysine import across plasma membrane (GO:1905008)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006)	2	0	.01	-	 < 0.2	1.00E00
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	6	0	.03	-	 < 0.2	1.00E00
picolinic acid biosynthetic process (GO:1905004)	1	0	.00	-	 < 0.2	1.00E00
picolinic acid metabolic process (GO:1905003)	1	0	.00	-	 < 0.2	1.00E00
protein lipoylation (GO:0009249)	8	0	.03	-	 < 0.2	1.00E00
glycolipid biosynthetic process (GO:0009247)	64	0	.27	-	 < 0.2	1.00E00
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	0	.00	-	 < 0.2	1.00E00
lipid A biosynthetic process (GO:0009245)	1	0	.00	-	 < 0.2	1.00E00
isopentenyl diphosphate biosynthetic process (GO:0009240)	5	0	.02	-	 < 0.2	1.00E00
inductive cell-cell signaling (GO:0031129)	1	0	.00	-	 < 0.2	1.00E00
developmental induction (GO:0031128)	27	0	.11	-	 < 0.2	1.00E00
long-chain fatty acid transport (GO:0015909)	55	0	.23	-	 < 0.2	1.00E00
snoRNA 3'-end processing (GO:0031126)	8	0	.03	-	 < 0.2	1.00E00
fatty acid transport (GO:0015908)	70	0	.29	-	 < 0.2	1.00E00
rRNA 3'-end processing (GO:0031125)	11	0	.05	-	 < 0.2	1.00E00
mRNA 3'-end processing (GO:0031124)	77	0	.32	-	 < 0.2	1.00E00
RNA 3'-end processing (GO:0031123)	107	0	.45	-	 < 0.2	1.00E00
cytoplasmic microtubule organization (GO:0031122)	41	0	.17	-	 < 0.2	1.00E00
tetracycline transport (GO:0015904)	1	0	.00	-	 < 0.2	1.00E00
snRNA pseudouridine synthesis (GO:0031120)	4	0	.02	-	 < 0.2	1.00E00
siderophore metabolic process (GO:0009237)	1	0	.00	-	 < 0.2	1.00E00
cobalamin biosynthetic process (GO:0009236)	3	0	.01	-	 < 0.2	1.00E00
cobalamin metabolic process (GO:0009235)	21	0	.09	-	 < 0.2	1.00E00
menaquinone biosynthetic process (GO:0009234)	1	0	.00	-	 < 0.2	1.00E00
menaquinone metabolic process (GO:0009233)	3	0	.01	-	 < 0.2	1.00E00
riboflavin biosynthetic process (GO:0009231)	1	0	.00	-	 < 0.2	1.00E00
tRNA pseudouridine synthesis (GO:0031119)	7	0	.03	-	 < 0.2	1.00E00
rRNA pseudouridine synthesis (GO:0031118)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of microtubule depolymerization (GO:0031117)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of microtubule polymerization (GO:0031116)	23	0	.10	-	 < 0.2	1.00E00
negative regulation of microtubule polymerization (GO:0031115)	11	0	.05	-	 < 0.2	1.00E00
regulation of microtubule depolymerization (GO:0031114)	21	0	.09	-	 < 0.2	1.00E00
regulation of microtubule polymerization (GO:0031113)	38	0	.16	-	 < 0.2	1.00E00
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	26	0	.11	-	 < 0.2	1.00E00
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	30	0	.13	-	 < 0.2	1.00E00
regulation of microtubule polymerization or depolymerization (GO:0031110)	61	0	.26	-	 < 0.2	1.00E00
thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.00	-	 < 0.2	1.00E00
nucleotide-sugar catabolic process (GO:0009227)	2	0	.01	-	 < 0.2	1.00E00
nucleotide-sugar biosynthetic process (GO:0009226)	21	0	.09	-	 < 0.2	1.00E00
nucleotide-sugar metabolic process (GO:0009225)	34	0	.14	-	 < 0.2	1.00E00
CMP biosynthetic process (GO:0009224)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	13	0	.05	-	 < 0.2	1.00E00
pyrimidine ribonucleotide catabolic process (GO:0009222)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	8	0	.03	-	 < 0.2	1.00E00
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	23	0	.10	-	 < 0.2	1.00E00
microtubule polymerization or depolymerization (GO:0031109)	41	0	.17	-	 < 0.2	1.00E00
septin ring organization (GO:0031106)	1	0	.00	-	 < 0.2	1.00E00
dendrite regeneration (GO:0031104)	1	0	.00	-	 < 0.2	1.00E00
axon regeneration (GO:0031103)	19	2	.08	+	25.12	1.00E00
neuron projection regeneration (GO:0031102)	27	2	.11	+	17.68	1.00E00
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	19	0	.08	-	 < 0.2	1.00E00
pyrimidine ribonucleotide metabolic process (GO:0009218)	25	0	.10	-	 < 0.2	1.00E00
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	5	0	.02	-	 < 0.2	1.00E00
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	2	0	.01	-	 < 0.2	1.00E00
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	9	0	.04	-	 < 0.2	1.00E00
cyclic nucleotide catabolic process (GO:0009214)	17	0	.07	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	3	0	.01	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	4	0	.02	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	7	0	.03	-	 < 0.2	1.00E00
follicle-stimulating hormone signaling pathway (GO:0042699)	5	0	.02	-	 < 0.2	1.00E00
thelarche (GO:0042695)	5	0	.02	-	 < 0.2	1.00E00
muscle cell fate specification (GO:0042694)	1	0	.00	-	 < 0.2	1.00E00
muscle cell fate commitment (GO:0042693)	15	0	.06	-	 < 0.2	1.00E00
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	15	0	.06	-	 < 0.2	1.00E00
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	16	0	.07	-	 < 0.2	1.00E00
purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	0	.00	-	 < 0.2	1.00E00
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	53	2	.22	+	9.01	1.00E00
negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597)	1	0	.00	-	 < 0.2	1.00E00
purine ribonucleoside triphosphate metabolic process (GO:0009205)	235	3	.98	+	3.05	1.00E00
regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596)	1	0	.00	-	 < 0.2	1.00E00
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of termination of RNA polymerase II transcription (GO:1904595)	1	0	.00	-	 < 0.2	1.00E00
ribonucleoside triphosphate catabolic process (GO:0009203)	1	0	.00	-	 < 0.2	1.00E00
regulation of termination of RNA polymerase II transcription (GO:1904594)	1	0	.00	-	 < 0.2	1.00E00
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	6	0	.03	-	 < 0.2	1.00E00
ribonucleoside triphosphate biosynthetic process (GO:0009201)	58	2	.24	+	8.23	1.00E00
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of protein import (GO:1904590)	61	0	.26	-	 < 0.2	1.00E00
regulation of cardioblast cell fate specification (GO:0042686)	1	0	.00	-	 < 0.2	1.00E00
cellular response to glycoprotein (GO:1904588)	1	0	.00	-	 < 0.2	1.00E00
response to glycoprotein (GO:1904587)	5	0	.02	-	 < 0.2	1.00E00
cellular response to putrescine (GO:1904586)	1	0	.00	-	 < 0.2	1.00E00
response to putrescine (GO:1904585)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of intracellular mRNA localization (GO:1904582)	2	0	.01	-	 < 0.2	1.00E00
regulation of intracellular mRNA localization (GO:1904580)	2	0	.01	-	 < 0.2	1.00E00
retinal cone cell differentiation (GO:0042670)	9	0	.04	-	 < 0.2	1.00E00
cellular response to thapsigargin (GO:1904579)	2	0	.01	-	 < 0.2	1.00E00
response to thapsigargin (GO:1904578)	2	0	.01	-	 < 0.2	1.00E00
cellular response to tunicamycin (GO:1904577)	1	0	.00	-	 < 0.2	1.00E00
response to tunicamycin (GO:1904576)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of selenocysteine insertion sequence binding (GO:1904574)	1	0	.00	-	 < 0.2	1.00E00
regulation of selenocysteine insertion sequence binding (GO:1904573)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mRNA binding (GO:1904572)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of selenocysteine incorporation (GO:1904570)	1	0	.00	-	 < 0.2	1.00E00
auditory receptor cell fate determination (GO:0042668)	3	0	.01	-	 < 0.2	1.00E00
auditory receptor cell fate specification (GO:0042667)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ectodermal cell fate specification (GO:0042666)	1	0	.00	-	 < 0.2	1.00E00
regulation of ectodermal cell fate specification (GO:0042665)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of endodermal cell fate specification (GO:0042664)	1	0	.00	-	 < 0.2	1.00E00
regulation of endodermal cell fate specification (GO:0042663)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of mesodermal cell fate specification (GO:0042662)	4	0	.02	-	 < 0.2	1.00E00
regulation of mesodermal cell fate specification (GO:0042661)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of cell fate specification (GO:0042660)	2	0	.01	-	 < 0.2	1.00E00
regulation of selenocysteine incorporation (GO:1904569)	1	0	.00	-	 < 0.2	1.00E00
cellular response to wortmannin (GO:1904568)	1	0	.00	-	 < 0.2	1.00E00
response to wortmannin (GO:1904567)	1	0	.00	-	 < 0.2	1.00E00
cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566)	1	0	.00	-	 < 0.2	1.00E00
response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565)	1	0	.00	-	 < 0.2	1.00E00
phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.01	-	 < 0.2	1.00E00
regulation of cell fate specification (GO:0042659)	14	1	.06	+	17.05	1.00E00
evasion or tolerance by virus of host immune response (GO:0030683)	2	0	.01	-	 < 0.2	1.00E00
evasion or tolerance of host defense response (GO:0030682)	2	0	.01	-	 < 0.2	1.00E00
L-tryptophan transmembrane transport (GO:1904556)	1	0	.00	-	 < 0.2	1.00E00
L-proline transmembrane transport (GO:1904555)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of blood vessel diameter (GO:0097756)	38	1	.16	+	6.28	1.00E00
positive regulation of blood vessel diameter (GO:0097755)	58	1	.24	+	4.11	1.00E00
positive regulation of oocyte maturation (GO:1900195)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of oocyte maturation (GO:1900194)	4	0	.02	-	 < 0.2	1.00E00
membrane bending (GO:0097753)	1	0	.00	-	 < 0.2	1.00E00
regulation of oocyte maturation (GO:1900193)	7	0	.03	-	 < 0.2	1.00E00
regulation of DNA stability (GO:0097752)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of single-species biofilm formation (GO:1900191)	2	0	.01	-	 < 0.2	1.00E00
regulation of single-species biofilm formation (GO:1900190)	2	0	.01	-	 < 0.2	1.00E00
anagen (GO:0042640)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of free ubiquitin chain polymerization (GO:1904544)	1	0	.00	-	 < 0.2	1.00E00
regulation of free ubiquitin chain polymerization (GO:1904542)	1	0	.00	-	 < 0.2	1.00E00
membrane tubulation (GO:0097749)	1	0	.00	-	 < 0.2	1.00E00
regulation of blood vessel diameter (GO:0097746)	129	3	.54	+	5.55	1.00E00
negative regulation of clathrin-dependent endocytosis (GO:1900186)	3	0	.01	-	 < 0.2	1.00E00
catagen (GO:0042637)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of hair cycle (GO:0042636)	5	1	.02	+	47.73	1.00E00
positive regulation of hair cycle (GO:0042635)	13	0	.05	-	 < 0.2	1.00E00
regulation of hair cycle (GO:0042634)	27	1	.11	+	8.84	1.00E00
de novo centriole assembly (GO:0097742)	5	0	.02	-	 < 0.2	1.00E00
hair cycle (GO:0042633)	90	4	.38	+	10.61	1.00E00
cholesterol homeostasis (GO:0042632)	63	2	.26	+	7.58	1.00E00
negative regulation of protein localization to nucleus (GO:1900181)	74	0	.31	-	 < 0.2	1.00E00
cellular response to water deprivation (GO:0042631)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.01	-	 < 0.2	1.00E00
regulation of telomeric loop disassembly (GO:1904533)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of actin filament binding (GO:1904531)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of actin filament binding (GO:1904530)	1	0	.00	-	 < 0.2	1.00E00
mating plug formation (GO:0042628)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	2	0	.01	-	 < 0.2	1.00E00
extracellular exosome biogenesis (GO:0097734)	5	1	.02	+	47.73	1.00E00
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170)	1	0	.00	-	 < 0.2	1.00E00
regulation of vitamin metabolic process (GO:0030656)	12	1	.05	+	19.89	1.00E00
beta-lactam antibiotic metabolic process (GO:0030653)	1	0	.00	-	 < 0.2	1.00E00
regulation of actin filament binding (GO:1904529)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of microtubule binding (GO:1904528)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of microtubule binding (GO:1904527)	2	0	.01	-	 < 0.2	1.00E00
regulation of microtubule binding (GO:1904526)	6	0	.03	-	 < 0.2	1.00E00
regulation of glucocorticoid mediated signaling pathway (GO:1900169)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of glial cell-derived neurotrophic factor secretion (GO:1900168)	2	0	.01	-	 < 0.2	1.00E00
regulation of glial cell-derived neurotrophic factor secretion (GO:1900166)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of interleukin-6 secretion (GO:1900165)	7	0	.03	-	 < 0.2	1.00E00
sperm flagellum movement (GO:0097724)	1	0	.00	-	 < 0.2	1.00E00
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164)	3	0	.01	-	 < 0.2	1.00E00
sperm motility (GO:0097722)	75	0	.31	-	 < 0.2	1.00E00
positive regulation of phospholipid scramblase activity (GO:1900163)	1	1	.00	+	 > 100	1.00E00
calcineurin-mediated signaling (GO:0097720)	11	0	.05	-	 < 0.2	1.00E00
regulation of phospholipid scramblase activity (GO:1900161)	1	1	.00	+	 > 100	1.00E00
aminoglycoside antibiotic metabolic process (GO:0030647)	9	1	.04	+	26.52	1.00E00
cellular chloride ion homeostasis (GO:0030644)	6	0	.03	-	 < 0.2	1.00E00
cellular phosphate ion homeostasis (GO:0030643)	9	0	.04	-	 < 0.2	1.00E00
regulation of cellular pH (GO:0030641)	96	2	.40	+	4.97	1.00E00
positive regulation of TORC2 signaling (GO:1904515)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of bone mineralization involved in bone maturation (GO:1900159)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of bone mineralization involved in bone maturation (GO:1900158)	3	0	.01	-	 < 0.2	1.00E00
regulation of bone mineralization involved in bone maturation (GO:1900157)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of bone trabecula formation (GO:1900155)	2	0	.01	-	 < 0.2	1.00E00
regulation of bone trabecula formation (GO:1900154)	2	0	.01	-	 < 0.2	1.00E00
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	16	0	.07	-	 < 0.2	1.00E00
ciliary basal body-plasma membrane docking (GO:0097711)	96	1	.40	+	2.49	1.00E00
negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	1	0	.00	-	 < 0.2	1.00E00
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	16	0	.07	-	 < 0.2	1.00E00
regulation of defense response to fungus (GO:1900150)	2	0	.01	-	 < 0.2	1.00E00
polyketide metabolic process (GO:0030638)	8	1	.03	+	29.83	1.00E00
negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	4	0	.02	-	 < 0.2	1.00E00
regulation of telomere maintenance in response to DNA damage (GO:1904505)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of lipophagy (GO:1904504)	5	0	.02	-	 < 0.2	1.00E00
dendrite development (GO:0016358)	95	0	.40	-	 < 0.2	1.00E00
regulation of lipophagy (GO:1904502)	5	0	.02	-	 < 0.2	1.00E00
regulation of phenotypic switching by transcription from RNA polymerase II promoter (GO:0100057)	1	0	.00	-	 < 0.2	1.00E00
connective tissue replacement (GO:0097709)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of chromatin-mediated maintenance of transcription (GO:1904501)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of Schwann cell migration (GO:1900149)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Schwann cell migration (GO:1900148)	1	0	.00	-	 < 0.2	1.00E00
regulation of Schwann cell migration (GO:1900147)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	2	0	.01	-	 < 0.2	1.00E00
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of oligodendrocyte apoptotic process (GO:1900142)	1	0	.00	-	 < 0.2	1.00E00
regulation of oligodendrocyte apoptotic process (GO:1900141)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of arachidonic acid secretion (GO:1900139)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of phospholipase A2 activity (GO:1900138)	3	0	.01	-	 < 0.2	1.00E00
meiotic chromosome movement towards spindle pole (GO:0016344)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of renin secretion into blood stream (GO:1900135)	2	0	.01	-	 < 0.2	1.00E00
secretory granule maturation (GO:0061792)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of renin secretion into blood stream (GO:1900134)	1	0	.00	-	 < 0.2	1.00E00
regulation of renin secretion into blood stream (GO:1900133)	4	0	.02	-	 < 0.2	1.00E00
calcium-dependent cell-matrix adhesion (GO:0016340)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of lipid binding (GO:1900131)	1	0	.00	-	 < 0.2	1.00E00
regulation of lipid binding (GO:1900130)	1	0	.00	-	 < 0.2	1.00E00
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	27	1	.11	+	8.84	1.00E00
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	21	1	.09	+	11.36	1.00E00
positive regulation of hyaluronan biosynthetic process (GO:1900127)	4	0	.02	-	 < 0.2	1.00E00
establishment or maintenance of polarity of follicular epithelium (GO:0016334)	1	0	.00	-	 < 0.2	1.00E00
morphogenesis of follicular epithelium (GO:0016333)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of hyaluronan biosynthetic process (GO:1900126)	3	0	.01	-	 < 0.2	1.00E00
regulation of hyaluronan biosynthetic process (GO:1900125)	7	0	.03	-	 < 0.2	1.00E00
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	1	0	.00	-	 < 0.2	1.00E00
morphogenesis of embryonic epithelium (GO:0016331)	146	2	.61	+	3.27	1.00E00
vesicle fusion with vesicle (GO:0061782)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of receptor binding (GO:1900122)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of receptor binding (GO:1900121)	13	0	.05	-	 < 0.2	1.00E00
regulation of receptor binding (GO:1900120)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of execution phase of apoptosis (GO:1900119)	13	1	.05	+	18.36	1.00E00
negative regulation of execution phase of apoptosis (GO:1900118)	10	0	.04	-	 < 0.2	1.00E00
regulation of execution phase of apoptosis (GO:1900117)	26	2	.11	+	18.36	1.00E00
extracellular negative regulation of signal transduction (GO:1900116)	18	0	.08	-	 < 0.2	1.00E00
neuron remodeling (GO:0016322)	10	0	.04	-	 < 0.2	1.00E00
extracellular regulation of signal transduction (GO:1900115)	18	0	.08	-	 < 0.2	1.00E00
female meiosis chromosome segregation (GO:0016321)	4	1	.02	+	59.66	1.00E00
positive regulation of histone H3-K9 trimethylation (GO:1900114)	2	0	.01	-	 < 0.2	1.00E00
drug transport across blood-nerve barrier (GO:0061772)	1	0	.00	-	 < 0.2	1.00E00
response to caloric restriction (GO:0061771)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of histone H3-K9 trimethylation (GO:1900113)	6	0	.03	-	 < 0.2	1.00E00
endoplasmic reticulum membrane fusion (GO:0016320)	2	0	.01	-	 < 0.2	1.00E00
regulation of histone H3-K9 trimethylation (GO:1900112)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of histone H3-K9 dimethylation (GO:1900111)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of histone H3-K9 dimethylation (GO:1900110)	2	0	.01	-	 < 0.2	1.00E00
mitochondrion transport along microtubule (GO:0047497)	18	0	.08	-	 < 0.2	1.00E00
vesicle transport along microtubule (GO:0047496)	37	0	.16	-	 < 0.2	1.00E00
regulation of histone H3-K9 dimethylation (GO:1900109)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of lung blood pressure (GO:0061767)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of nodal signaling pathway (GO:1900108)	3	0	.01	-	 < 0.2	1.00E00
regulation of nodal signaling pathway (GO:1900107)	7	0	.03	-	 < 0.2	1.00E00
regulation of heart induction by canonical Wnt signaling pathway (GO:0100012)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of hyaluranon cable assembly (GO:1900106)	3	0	.01	-	 < 0.2	1.00E00
multivesicular body-lysosome fusion (GO:0061763)	2	0	.01	-	 < 0.2	1.00E00
dephosphorylation (GO:0016311)	290	3	1.22	+	2.47	1.00E00
CAMKK-AMPK signaling cascade (GO:0061762)	3	0	.01	-	 < 0.2	1.00E00
regulation of hyaluranon cable assembly (GO:1900104)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	14	2	.06	+	34.09	1.00E00
antifungal innate immune response (GO:0061760)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	11	1	.05	+	21.70	1.00E00
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	25	3	.10	+	28.64	1.00E00
positive regulation of plasma cell differentiation (GO:1900100)	1	1	.00	+	 > 100	1.00E00
response to high density lipoprotein particle (GO:0055099)	3	0	.01	-	 < 0.2	1.00E00
response to low-density lipoprotein particle stimulus (GO:0055098)	4	0	.02	-	 < 0.2	1.00E00
low-density lipoprotein particle mediated signaling (GO:0055096)	3	0	.01	-	 < 0.2	1.00E00
lipoprotein particle mediated signaling (GO:0055095)	3	0	.01	-	 < 0.2	1.00E00
response to lipoprotein particle (GO:0055094)	25	1	.10	+	9.55	1.00E00
regulation of response to osmotic stress (GO:0047484)	10	0	.04	-	 < 0.2	1.00E00
sterol homeostasis (GO:0055092)	63	2	.26	+	7.58	1.00E00
phospholipid homeostasis (GO:0055091)	9	0	.04	-	 < 0.2	1.00E00
acylglycerol homeostasis (GO:0055090)	32	1	.13	+	7.46	1.00E00
leukocyte adhesion to vascular endothelial cell (GO:0061756)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of protein kinase activity by protein phosphorylation (GO:0100002)	1	1	.00	+	 > 100	1.00E00
substrate localization to autophagosome (GO:0061753)	1	0	.00	-	 < 0.2	1.00E00
fatty acid homeostasis (GO:0055089)	13	1	.05	+	18.36	1.00E00
lipid homeostasis (GO:0055088)	107	2	.45	+	4.46	1.00E00
nucleobase-containing small molecule metabolic process (GO:0055086)	574	6	2.41	+	2.49	1.00E00
transmembrane transport (GO:0055085)	1226	6	5.14	+	1.17	1.00E00
monovalent inorganic anion homeostasis (GO:0055083)	19	0	.08	-	 < 0.2	1.00E00
cellular chemical homeostasis (GO:0055082)	680	7	2.85	+	2.46	1.00E00
anion homeostasis (GO:0055081)	43	1	.18	+	5.55	1.00E00
cation homeostasis (GO:0055080)	641	5	2.69	+	1.86	1.00E00
motor behavior (GO:0061744)	5	1	.02	+	47.73	1.00E00
motor learning (GO:0061743)	5	0	.02	-	 < 0.2	1.00E00
chaperone-mediated protein transport involved in chaperone-mediated autophagy (GO:0061741)	2	0	.01	-	 < 0.2	1.00E00
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	3	0	.01	-	 < 0.2	1.00E00
sodium ion homeostasis (GO:0055078)	25	0	.10	-	 < 0.2	1.00E00
transition metal ion homeostasis (GO:0055076)	126	0	.53	-	 < 0.2	1.00E00
potassium ion homeostasis (GO:0055075)	16	0	.07	-	 < 0.2	1.00E00
calcium ion homeostasis (GO:0055074)	399	3	1.67	+	1.79	1.00E00
cadmium ion homeostasis (GO:0055073)	2	0	.01	-	 < 0.2	1.00E00
iron ion homeostasis (GO:0055072)	89	0	.37	-	 < 0.2	1.00E00
manganese ion homeostasis (GO:0055071)	1	0	.00	-	 < 0.2	1.00E00
copper ion homeostasis (GO:0055070)	16	0	.07	-	 < 0.2	1.00E00
carnosine biosynthetic process (GO:0035499)	1	0	.00	-	 < 0.2	1.00E00
carnosine metabolic process (GO:0035498)	2	0	.01	-	 < 0.2	1.00E00
protein lipidation involved in autophagosome assembly (GO:0061739)	4	0	.02	-	 < 0.2	1.00E00
SNARE complex disassembly (GO:0035494)	3	0	.01	-	 < 0.2	1.00E00
late endosomal microautophagy (GO:0061738)	3	0	.01	-	 < 0.2	1.00E00
SNARE complex assembly (GO:0035493)	7	0	.03	-	 < 0.2	1.00E00
leukotriene signaling pathway (GO:0061737)	5	0	.02	-	 < 0.2	1.00E00
engulfment of target by autophagosome (GO:0061736)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of leukotriene production involved in inflammatory response (GO:0035491)	1	1	.00	+	 > 100	1.00E00
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734)	5	0	.02	-	 < 0.2	1.00E00
regulation of leukotriene production involved in inflammatory response (GO:0035490)	1	1	.00	+	 > 100	1.00E00
mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732)	6	0	.03	-	 < 0.2	1.00E00
zinc ion homeostasis (GO:0055069)	22	0	.09	-	 < 0.2	1.00E00
monovalent inorganic cation homeostasis (GO:0055067)	133	2	.56	+	3.59	1.00E00
metal ion homeostasis (GO:0055065)	557	4	2.33	+	1.71	1.00E00
chloride ion homeostasis (GO:0055064)	7	0	.03	-	 < 0.2	1.00E00
phosphate ion homeostasis (GO:0055062)	12	0	.05	-	 < 0.2	1.00E00
pyrimidine nucleoside salvage (GO:0043097)	12	0	.05	-	 < 0.2	1.00E00
purine nucleobase salvage (GO:0043096)	4	0	.02	-	 < 0.2	1.00E00
regulation of GTP cyclohydrolase I activity (GO:0043095)	1	0	.00	-	 < 0.2	1.00E00
cellular metabolic compound salvage (GO:0043094)	36	0	.15	-	 < 0.2	1.00E00
L-amino acid import (GO:0043092)	13	0	.05	-	 < 0.2	1.00E00
gastric emptying (GO:0035483)	3	0	.01	-	 < 0.2	1.00E00
methylglyoxal catabolic process to lactate (GO:0061727)	3	0	.01	-	 < 0.2	1.00E00
mitochondrion disassembly (GO:0061726)	42	1	.18	+	5.68	1.00E00
gastric motility (GO:0035482)	3	0	.01	-	 < 0.2	1.00E00
L-arginine import (GO:0043091)	2	0	.01	-	 < 0.2	1.00E00
amino acid import (GO:0043090)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of Notch signaling pathway involved in heart induction (GO:0035481)	1	0	.00	-	 < 0.2	1.00E00
lipophagy (GO:0061724)	1	0	.00	-	 < 0.2	1.00E00
regulation of Notch signaling pathway involved in heart induction (GO:0035480)	1	0	.00	-	 < 0.2	1.00E00
glycophagy (GO:0061723)	2	0	.01	-	 < 0.2	1.00E00
asymmetric neuroblast division (GO:0055059)	5	0	.02	-	 < 0.2	1.00E00
neuroblast division (GO:0055057)	13	0	.05	-	 < 0.2	1.00E00
regulation of GTPase activity (GO:0043087)	726	10	3.04	+	3.29	1.00E00
penile erection (GO:0043084)	3	0	.01	-	 < 0.2	1.00E00
glucose catabolic process to pyruvate (GO:0061718)	25	1	.10	+	9.55	1.00E00
positive regulation of vascular wound healing (GO:0035470)	3	1	.01	+	79.55	1.00E00
anterior neural tube closure (GO:0061713)	1	0	.00	-	 < 0.2	1.00E00
drug transport (GO:0015893)	29	0	.12	-	 < 0.2	1.00E00
siderophore transport (GO:0015891)	3	0	.01	-	 < 0.2	1.00E00
anastral spindle assembly (GO:0055048)	1	0	.00	-	 < 0.2	1.00E00
determination of pancreatic left/right asymmetry (GO:0035469)	5	0	.02	-	 < 0.2	1.00E00
reticulophagy (GO:0061709)	2	0	.01	-	 < 0.2	1.00E00
vitamin transmembrane transport (GO:0035461)	12	0	.05	-	 < 0.2	1.00E00
cobalamin transport (GO:0015889)	8	0	.03	-	 < 0.2	1.00E00
thiamine transport (GO:0015888)	5	0	.02	-	 < 0.2	1.00E00
pantothenate transmembrane transport (GO:0015887)	1	0	.00	-	 < 0.2	1.00E00
heme transport (GO:0015886)	9	0	.04	-	 < 0.2	1.00E00
folic acid transport (GO:0015884)	8	0	.03	-	 < 0.2	1.00E00
L-ascorbic acid transport (GO:0015882)	2	0	.01	-	 < 0.2	1.00E00
creatine transport (GO:0015881)	2	0	.01	-	 < 0.2	1.00E00
cargo loading into vesicle (GO:0035459)	17	0	.07	-	 < 0.2	1.00E00
cellular response to interferon-beta (GO:0035458)	15	0	.06	-	 < 0.2	1.00E00
cellular response to interferon-alpha (GO:0035457)	12	1	.05	+	19.89	1.00E00
response to interferon-beta (GO:0035456)	23	0	.10	-	 < 0.2	1.00E00
response to interferon-alpha (GO:0035455)	22	2	.09	+	21.70	1.00E00
intercellular bridge organization (GO:0043063)	1	0	.00	-	 < 0.2	1.00E00
extracellular structure organization (GO:0043062)	310	7	1.30	+	5.39	1.00E00
meiotic metaphase I plate congression (GO:0043060)	1	0	.00	-	 < 0.2	1.00E00
stress-activated protein kinase signaling cascade (GO:0031098)	134	5	.56	+	8.91	1.00E00
carnitine transport (GO:0015879)	5	0	.02	-	 < 0.2	1.00E00
biotin transport (GO:0015878)	1	0	.00	-	 < 0.2	1.00E00
acetyl-CoA transport (GO:0015876)	1	0	.00	-	 < 0.2	1.00E00
norepinephrine transport (GO:0015874)	4	0	.02	-	 < 0.2	1.00E00
dopamine transport (GO:0015872)	11	0	.05	-	 < 0.2	1.00E00
choline transport (GO:0015871)	8	0	.03	-	 < 0.2	1.00E00
acetylcholine transport (GO:0015870)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cardiac muscle tissue development (GO:0055026)	28	2	.12	+	17.05	1.00E00
positive regulation of cardiac muscle tissue growth (GO:0055023)	31	3	.13	+	23.10	1.00E00
negative regulation of cardiac muscle tissue growth (GO:0055022)	19	2	.08	+	25.12	1.00E00
positive regulation of cardiac muscle fiber development (GO:0055020)	1	0	.00	-	 < 0.2	1.00E00
borate transmembrane transport (GO:0035445)	1	0	.00	-	 < 0.2	1.00E00
nickel cation transmembrane transport (GO:0035444)	1	0	.00	-	 < 0.2	1.00E00
tripeptide transmembrane transport (GO:0035443)	1	0	.00	-	 < 0.2	1.00E00
cell migration involved in vasculogenesis (GO:0035441)	3	1	.01	+	79.55	1.00E00
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	6	0	.03	-	 < 0.2	1.00E00
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	8	0	.03	-	 < 0.2	1.00E00
purine ribonucleotide transport (GO:0015868)	14	0	.06	-	 < 0.2	1.00E00
ATP transport (GO:0015867)	11	0	.05	-	 < 0.2	1.00E00
ADP transport (GO:0015866)	9	0	.04	-	 < 0.2	1.00E00
purine nucleotide transport (GO:0015865)	15	0	.06	-	 < 0.2	1.00E00
pyrimidine nucleoside transport (GO:0015864)	2	0	.01	-	 < 0.2	1.00E00
nuclear pore distribution (GO:0031081)	2	0	.01	-	 < 0.2	1.00E00
uridine transport (GO:0015862)	1	0	.00	-	 < 0.2	1.00E00
purine nucleoside transmembrane transport (GO:0015860)	2	0	.01	-	 < 0.2	1.00E00
regulation of cardiac muscle fiber development (GO:0055018)	1	0	.00	-	 < 0.2	1.00E00
cardiac muscle tissue growth (GO:0055017)	27	0	.11	-	 < 0.2	1.00E00
ventricular cardiac muscle cell development (GO:0055015)	12	1	.05	+	19.89	1.00E00
atrial cardiac muscle cell development (GO:0055014)	3	0	.01	-	 < 0.2	1.00E00
cardiac muscle cell development (GO:0055013)	49	2	.21	+	9.74	1.00E00
ventricular cardiac muscle cell differentiation (GO:0055012)	18	2	.08	+	26.52	1.00E00
ribonucleoside triphosphate metabolic process (GO:0009199)	240	3	1.01	+	2.98	1.00E00
atrial cardiac muscle cell differentiation (GO:0055011)	3	0	.01	-	 < 0.2	1.00E00
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	48	1	.20	+	4.97	1.00E00
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	2	0	.01	-	 < 0.2	1.00E00
otic placode formation (GO:0043049)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	2	0	.01	-	 < 0.2	1.00E00
pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195)	1	0	.00	-	 < 0.2	1.00E00
dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.00	-	 < 0.2	1.00E00
DNA methylation involved in gamete generation (GO:0043046)	20	0	.08	-	 < 0.2	1.00E00
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	1	0	.00	-	 < 0.2	1.00E00
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	10	0	.04	-	 < 0.2	1.00E00
DNA methylation involved in embryo development (GO:0043045)	8	0	.03	-	 < 0.2	1.00E00
deoxyribonucleoside diphosphate catabolic process (GO:0009192)	1	0	.00	-	 < 0.2	1.00E00
ATP-dependent chromatin remodeling (GO:0043044)	67	0	.28	-	 < 0.2	1.00E00
phosphate ion transmembrane transport (GO:0035435)	19	0	.08	-	 < 0.2	1.00E00
ribonucleoside diphosphate catabolic process (GO:0009191)	6	0	.03	-	 < 0.2	1.00E00
peptide biosynthetic process (GO:0043043)	410	6	1.72	+	3.49	1.00E00
cyclic nucleotide biosynthetic process (GO:0009190)	34	0	.14	-	 < 0.2	1.00E00
copper ion transmembrane transport (GO:0035434)	6	0	.03	-	 < 0.2	1.00E00
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic camera-type eye development (GO:0031077)	7	0	.03	-	 < 0.2	1.00E00
embryonic camera-type eye development (GO:0031076)	38	0	.16	-	 < 0.2	1.00E00
nucleoside transport (GO:0015858)	7	0	.03	-	 < 0.2	1.00E00
pyrimidine nucleobase transport (GO:0015855)	3	0	.01	-	 < 0.2	1.00E00
adenine transport (GO:0015853)	4	0	.02	-	 < 0.2	1.00E00
nucleobase transport (GO:0015851)	9	0	.04	-	 < 0.2	1.00E00
organic hydroxy compound transport (GO:0015850)	135	2	.57	+	3.54	1.00E00
atrial cardiac muscle tissue morphogenesis (GO:0055009)	7	0	.03	-	 < 0.2	1.00E00
cardiac muscle tissue morphogenesis (GO:0055008)	63	1	.26	+	3.79	1.00E00
cardiac muscle cell differentiation (GO:0055007)	81	4	.34	+	11.79	1.00E00
cardiac cell development (GO:0055006)	54	3	.23	+	13.26	1.00E00
ventricular cardiac myofibril assembly (GO:0055005)	3	0	.01	-	 < 0.2	1.00E00
cardiac myofibril assembly (GO:0055003)	15	1	.06	+	15.91	1.00E00
striated muscle cell development (GO:0055002)	124	2	.52	+	3.85	1.00E00
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	4	0	.02	-	 < 0.2	1.00E00
muscle cell development (GO:0055001)	139	2	.58	+	3.43	1.00E00
ribonucleoside diphosphate biosynthetic process (GO:0009188)	4	0	.02	-	 < 0.2	1.00E00
cyclic nucleotide metabolic process (GO:0009187)	56	0	.23	-	 < 0.2	1.00E00
tRNA aminoacylation (GO:0043039)	52	1	.22	+	4.59	1.00E00
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	6	0	.03	-	 < 0.2	1.00E00
amino acid activation (GO:0043038)	53	1	.22	+	4.50	1.00E00
ribonucleoside diphosphate metabolic process (GO:0009185)	63	1	.26	+	3.79	1.00E00
hexose transmembrane transport (GO:0035428)	21	0	.09	-	 < 0.2	1.00E00
purine deoxyribonucleoside diphosphate catabolic process (GO:0009184)	1	0	.00	-	 < 0.2	1.00E00
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	2	0	.01	-	 < 0.2	1.00E00
extracellular matrix-cell signaling (GO:0035426)	5	0	.02	-	 < 0.2	1.00E00
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	4	0	.02	-	 < 0.2	1.00E00
purine ribonucleoside diphosphate catabolic process (GO:0009181)	4	0	.02	-	 < 0.2	1.00E00
autocrine signaling (GO:0035425)	3	0	.01	-	 < 0.2	1.00E00
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of macrophage activation (GO:0043032)	18	1	.08	+	13.26	1.00E00
negative regulation of macrophage activation (GO:0043031)	10	0	.04	-	 < 0.2	1.00E00
regulation of macrophage activation (GO:0043030)	36	2	.15	+	13.26	1.00E00
hair follicle morphogenesis (GO:0031069)	26	2	.11	+	18.36	1.00E00
organic acid transport (GO:0015849)	281	0	1.18	-	 < 0.2	1.00E00
positive regulation of histone deacetylation (GO:0031065)	18	1	.08	+	13.26	1.00E00
putrescine transport (GO:0015847)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of histone deacetylation (GO:0031064)	5	0	.02	-	 < 0.2	1.00E00
polyamine transport (GO:0015846)	4	0	.02	-	 < 0.2	1.00E00
regulation of histone deacetylation (GO:0031063)	27	1	.11	+	8.84	1.00E00
positive regulation of histone methylation (GO:0031062)	35	1	.15	+	6.82	1.00E00
monoamine transport (GO:0015844)	22	1	.09	+	10.85	1.00E00
negative regulation of histone methylation (GO:0031061)	19	0	.08	-	 < 0.2	1.00E00
regulation of histone methylation (GO:0031060)	61	1	.26	+	3.91	1.00E00
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	4	0	.02	-	 < 0.2	1.00E00
urea transport (GO:0015840)	6	0	.03	-	 < 0.2	1.00E00
purine ribonucleoside diphosphate metabolic process (GO:0009179)	61	1	.26	+	3.91	1.00E00
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	5	0	.02	-	 < 0.2	1.00E00
T cell homeostasis (GO:0043029)	35	3	.15	+	20.46	1.00E00
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	6	0	.03	-	 < 0.2	1.00E00
activation of MAPK activity involved in innate immune response (GO:0035419)	2	0	.01	-	 < 0.2	1.00E00
protein localization to synapse (GO:0035418)	25	0	.10	-	 < 0.2	1.00E00
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	10	0	.04	-	 < 0.2	1.00E00
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of catenin import into nucleus (GO:0035414)	11	0	.05	-	 < 0.2	1.00E00
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of catenin import into nucleus (GO:0035413)	12	1	.05	+	19.89	1.00E00
regulation of catenin import into nucleus (GO:0035412)	25	1	.10	+	9.55	1.00E00
catenin import into nucleus (GO:0035411)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of histone modification (GO:0031057)	40	0	.17	-	 < 0.2	1.00E00
amino-acid betaine transport (GO:0015838)	6	0	.03	-	 < 0.2	1.00E00
chromatin remodeling at centromere (GO:0031055)	32	0	.13	-	 < 0.2	1.00E00
amine transport (GO:0015837)	8	0	.03	-	 < 0.2	1.00E00
pre-miRNA processing (GO:0031054)	12	1	.05	+	19.89	1.00E00
primary miRNA processing (GO:0031053)	9	0	.04	-	 < 0.2	1.00E00
chromosome breakage (GO:0031052)	1	0	.00	-	 < 0.2	1.00E00
peptide transport (GO:0015833)	1383	13	5.79	+	2.24	1.00E00
dsRNA fragmentation (GO:0031050)	30	1	.13	+	7.96	1.00E00
purine ribonucleoside monophosphate catabolic process (GO:0009169)	8	0	.03	-	 < 0.2	1.00E00
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	65	2	.27	+	7.34	1.00E00
purine ribonucleoside monophosphate metabolic process (GO:0009167)	248	3	1.04	+	2.89	1.00E00
nucleotide catabolic process (GO:0009166)	62	0	.26	-	 < 0.2	1.00E00
nucleotide biosynthetic process (GO:0009165)	203	4	.85	+	4.70	1.00E00
histone H3-Y41 phosphorylation (GO:0035409)	1	0	.00	-	 < 0.2	1.00E00
nucleoside catabolic process (GO:0009164)	30	0	.13	-	 < 0.2	1.00E00
histone H3-T6 phosphorylation (GO:0035408)	2	1	.01	+	 > 100	1.00E00
positive regulation of lymphotoxin A biosynthetic process (GO:0043017)	1	0	.00	-	 < 0.2	1.00E00
nucleoside biosynthetic process (GO:0009163)	48	0	.20	-	 < 0.2	1.00E00
histone H3-T11 phosphorylation (GO:0035407)	2	1	.01	+	 > 100	1.00E00
regulation of lymphotoxin A biosynthetic process (GO:0043016)	1	0	.00	-	 < 0.2	1.00E00
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	12	0	.05	-	 < 0.2	1.00E00
histone-tyrosine phosphorylation (GO:0035406)	1	0	.00	-	 < 0.2	1.00E00
ribonucleoside monophosphate metabolic process (GO:0009161)	260	3	1.09	+	2.75	1.00E00
histone-threonine phosphorylation (GO:0035405)	7	2	.03	+	68.19	1.00E00
histone-serine phosphorylation (GO:0035404)	12	1	.05	+	19.89	1.00E00
regulation of fusion of sperm to egg plasma membrane (GO:0043012)	1	0	.00	-	 < 0.2	1.00E00
myeloid dendritic cell differentiation (GO:0043011)	19	0	.08	-	 < 0.2	1.00E00
camera-type eye development (GO:0043010)	294	4	1.23	+	3.25	1.00E00
programmed DNA elimination (GO:0031049)	1	0	.00	-	 < 0.2	1.00E00
chromatin silencing by small RNA (GO:0031048)	1	0	.00	-	 < 0.2	1.00E00
gene silencing by RNA (GO:0031047)	77	1	.32	+	3.10	1.00E00
tyrosine transport (GO:0015828)	1	0	.00	-	 < 0.2	1.00E00
tryptophan transport (GO:0015827)	3	0	.01	-	 < 0.2	1.00E00
threonine transport (GO:0015826)	1	0	.00	-	 < 0.2	1.00E00
L-serine transport (GO:0015825)	10	0	.04	-	 < 0.2	1.00E00
proline transport (GO:0015824)	9	0	.04	-	 < 0.2	1.00E00
ornithine transport (GO:0015822)	4	0	.02	-	 < 0.2	1.00E00
methionine transport (GO:0015821)	1	0	.00	-	 < 0.2	1.00E00
leucine transport (GO:0015820)	3	0	.01	-	 < 0.2	1.00E00
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	2	0	.01	-	 < 0.2	1.00E00
ribonucleoside monophosphate catabolic process (GO:0009158)	8	0	.03	-	 < 0.2	1.00E00
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	9	0	.04	-	 < 0.2	1.00E00
ribonucleoside monophosphate biosynthetic process (GO:0009156)	77	2	.32	+	6.20	1.00E00
purine deoxyribonucleotide catabolic process (GO:0009155)	6	0	.03	-	 < 0.2	1.00E00
purine ribonucleotide catabolic process (GO:0009154)	29	0	.12	-	 < 0.2	1.00E00
purine deoxyribonucleotide biosynthetic process (GO:0009153)	3	0	.01	-	 < 0.2	1.00E00
activation of phospholipase A2 activity by calcium-mediated signaling (GO:0043006)	2	1	.01	+	 > 100	1.00E00
purine ribonucleotide biosynthetic process (GO:0009152)	122	2	.51	+	3.91	1.00E00
cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.00	-	 < 0.2	1.00E00
purine deoxyribonucleotide metabolic process (GO:0009151)	11	0	.05	-	 < 0.2	1.00E00
purine ribonucleotide metabolic process (GO:0009150)	366	3	1.53	+	1.96	1.00E00
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.00	-	 < 0.2	1.00E00
Golgi to plasma membrane protein transport (GO:0043001)	25	0	.10	-	 < 0.2	1.00E00
Golgi to plasma membrane CFTR protein transport (GO:0043000)	1	0	.00	-	 < 0.2	1.00E00
lysine transport (GO:0015819)	1	0	.00	-	 < 0.2	1.00E00
histidine transport (GO:0015817)	1	0	.00	-	 < 0.2	1.00E00
myosin filament assembly (GO:0031034)	14	0	.06	-	 < 0.2	1.00E00
glycine transport (GO:0015816)	10	0	.04	-	 < 0.2	1.00E00
myosin filament organization (GO:0031033)	14	0	.06	-	 < 0.2	1.00E00
actomyosin structure organization (GO:0031032)	98	2	.41	+	4.87	1.00E00
L-glutamate transport (GO:0015813)	17	0	.07	-	 < 0.2	1.00E00
gamma-aminobutyric acid transport (GO:0015812)	9	0	.04	-	 < 0.2	1.00E00
L-cystine transport (GO:0015811)	4	0	.02	-	 < 0.2	1.00E00
aspartate transport (GO:0015810)	3	0	.01	-	 < 0.2	1.00E00
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	3	0	.01	-	 < 0.2	1.00E00
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	19	0	.08	-	 < 0.2	1.00E00
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	23	0	.10	-	 < 0.2	1.00E00
purine nucleoside triphosphate catabolic process (GO:0009146)	6	0	.03	-	 < 0.2	1.00E00
purine nucleoside triphosphate biosynthetic process (GO:0009145)	54	2	.23	+	8.84	1.00E00
negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.00	-	 < 0.2	1.00E00
purine nucleoside triphosphate metabolic process (GO:0009144)	242	3	1.01	+	2.96	1.00E00
positive regulation of hemoglobin biosynthetic process (GO:0046985)	3	0	.01	-	 < 0.2	1.00E00
nucleoside triphosphate catabolic process (GO:0009143)	13	0	.05	-	 < 0.2	1.00E00
regulation of hemoglobin biosynthetic process (GO:0046984)	4	0	.02	-	 < 0.2	1.00E00
nucleoside triphosphate biosynthetic process (GO:0009142)	69	2	.29	+	6.92	1.00E00
nucleoside triphosphate metabolic process (GO:0009141)	261	3	1.09	+	2.74	1.00E00
pyrimidine nucleoside diphosphate catabolic process (GO:0009140)	1	0	.00	-	 < 0.2	1.00E00
arginine transport (GO:0015809)	6	0	.03	-	 < 0.2	1.00E00
L-alanine transport (GO:0015808)	7	0	.03	-	 < 0.2	1.00E00
L-amino acid transport (GO:0015807)	61	0	.26	-	 < 0.2	1.00E00
microtubule organizing center organization (GO:0031023)	91	2	.38	+	5.25	1.00E00
S-adenosyl-L-methionine transport (GO:0015805)	1	0	.00	-	 < 0.2	1.00E00
neutral amino acid transport (GO:0015804)	37	0	.16	-	 < 0.2	1.00E00
nuclear migration along microfilament (GO:0031022)	2	0	.01	-	 < 0.2	1.00E00
branched-chain amino acid transport (GO:0015803)	4	0	.02	-	 < 0.2	1.00E00
basic amino acid transport (GO:0015802)	10	0	.04	-	 < 0.2	1.00E00
aromatic amino acid transport (GO:0015801)	5	0	.02	-	 < 0.2	1.00E00
acidic amino acid transport (GO:0015800)	18	0	.08	-	 < 0.2	1.00E00
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	2	0	.01	-	 < 0.2	1.00E00
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	3	0	.01	-	 < 0.2	1.00E00
purine nucleoside diphosphate catabolic process (GO:0009137)	4	0	.02	-	 < 0.2	1.00E00
purine nucleoside diphosphate biosynthetic process (GO:0009136)	4	0	.02	-	 < 0.2	1.00E00
purine nucleoside diphosphate metabolic process (GO:0009135)	61	1	.26	+	3.91	1.00E00
nucleoside diphosphate catabolic process (GO:0009134)	7	0	.03	-	 < 0.2	1.00E00
nucleoside diphosphate biosynthetic process (GO:0009133)	7	0	.03	-	 < 0.2	1.00E00
nucleoside diphosphate metabolic process (GO:0009132)	82	1	.34	+	2.91	1.00E00
pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	15	0	.06	-	 < 0.2	1.00E00
endocrine pancreas development (GO:0031018)	40	2	.17	+	11.93	1.00E00
exocrine pancreas development (GO:0031017)	8	1	.03	+	29.83	1.00E00
pancreas development (GO:0031016)	73	3	.31	+	9.81	1.00E00
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	16	0	.07	-	 < 0.2	1.00E00
purine nucleoside monophosphate catabolic process (GO:0009128)	9	0	.04	-	 < 0.2	1.00E00
purine nucleoside monophosphate biosynthetic process (GO:0009127)	65	2	.27	+	7.34	1.00E00
peptide antigen transport (GO:0046968)	3	0	.01	-	 < 0.2	1.00E00
purine nucleoside monophosphate metabolic process (GO:0009126)	249	3	1.04	+	2.88	1.00E00
cytosol to ER transport (GO:0046967)	2	0	.01	-	 < 0.2	1.00E00
nucleoside monophosphate catabolic process (GO:0009125)	11	0	.05	-	 < 0.2	1.00E00
nucleoside monophosphate biosynthetic process (GO:0009124)	87	2	.36	+	5.49	1.00E00
nucleoside monophosphate metabolic process (GO:0009123)	274	3	1.15	+	2.61	1.00E00
3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963)	2	0	.01	-	 < 0.2	1.00E00
deoxyribonucleoside metabolic process (GO:0009120)	7	0	.03	-	 < 0.2	1.00E00
sensitization (GO:0046960)	2	0	.01	-	 < 0.2	1.00E00
response to brefeldin A (GO:0031001)	1	0	.00	-	 < 0.2	1.00E00
response to caffeine (GO:0031000)	16	0	.07	-	 < 0.2	1.00E00
ribonucleoside metabolic process (GO:0009119)	100	0	.42	-	 < 0.2	1.00E00
nucleotide metabolic process (GO:0009117)	517	6	2.17	+	2.77	1.00E00
habituation (GO:0046959)	5	0	.02	-	 < 0.2	1.00E00
nucleoside metabolic process (GO:0009116)	125	0	.52	-	 < 0.2	1.00E00
nonassociative learning (GO:0046958)	7	0	.03	-	 < 0.2	1.00E00
xanthine catabolic process (GO:0009115)	2	0	.01	-	 < 0.2	1.00E00
purine nucleobase biosynthetic process (GO:0009113)	12	0	.05	-	 < 0.2	1.00E00
nucleobase metabolic process (GO:0009112)	38	1	.16	+	6.28	1.00E00
vitamin catabolic process (GO:0009111)	11	0	.05	-	 < 0.2	1.00E00
vitamin biosynthetic process (GO:0009110)	15	0	.06	-	 < 0.2	1.00E00
ketone body catabolic process (GO:0046952)	4	0	.02	-	 < 0.2	1.00E00
ketone body biosynthetic process (GO:0046951)	9	0	.04	-	 < 0.2	1.00E00
cellular ketone body metabolic process (GO:0046950)	11	0	.05	-	 < 0.2	1.00E00
fear response (GO:0042596)	31	3	.13	+	23.10	1.00E00
behavioral response to starvation (GO:0042595)	2	0	.01	-	 < 0.2	1.00E00
G-protein coupled receptor signaling pathway involved in heart process (GO:0086103)	7	2	.03	+	68.19	1.00E00
glucose homeostasis (GO:0042593)	178	5	.75	+	6.70	1.00E00
peptidyl-lysine deacetylation (GO:0034983)	7	0	.03	-	 < 0.2	1.00E00
mitochondrial protein processing (GO:0034982)	9	0	.04	-	 < 0.2	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	79	1	.33	+	3.02	1.00E00
endothelin receptor signaling pathway (GO:0086100)	2	0	.01	-	 < 0.2	1.00E00
coenzyme catabolic process (GO:0009109)	12	0	.05	-	 < 0.2	1.00E00
coenzyme biosynthetic process (GO:0009108)	132	1	.55	+	1.81	1.00E00
regulation of chromatin-mediated maintenance of transcription (GO:1904499)	1	0	.00	-	 < 0.2	1.00E00
fatty-acyl-CoA biosynthetic process (GO:0046949)	31	1	.13	+	7.70	1.00E00
lipoate biosynthetic process (GO:0009107)	2	0	.01	-	 < 0.2	1.00E00
lipoate metabolic process (GO:0009106)	3	0	.01	-	 < 0.2	1.00E00
hydroxylysine biosynthetic process (GO:0046947)	3	0	.01	-	 < 0.2	1.00E00
hydroxylysine metabolic process (GO:0046946)	3	0	.01	-	 < 0.2	1.00E00
glycoprotein biosynthetic process (GO:0009101)	326	0	1.37	-	 < 0.2	1.00E00
carboxylic acid transport (GO:0046942)	273	0	1.14	-	 < 0.2	1.00E00
glycoprotein metabolic process (GO:0009100)	391	0	1.64	-	 < 0.2	1.00E00
protein localization to ciliary transition zone (GO:1904491)	5	0	.02	-	 < 0.2	1.00E00
vascular endothelial cell response to fluid shear stress (GO:0097699)	1	0	.00	-	 < 0.2	1.00E00
telomere maintenance via base-excision repair (GO:0097698)	1	0	.00	-	 < 0.2	1.00E00
nucleoside monophosphate phosphorylation (GO:0046940)	5	0	.02	-	 < 0.2	1.00E00
STAT cascade (GO:0097696)	50	2	.21	+	9.55	1.00E00
establishment of macromolecular complex localization to telomere (GO:0097695)	2	1	.01	+	 > 100	1.00E00
establishment of RNA localization to telomere (GO:0097694)	2	1	.01	+	 > 100	1.00E00
protein folding in endoplasmic reticulum (GO:0034975)	14	0	.06	-	 < 0.2	1.00E00
histone H3-K4 monomethylation (GO:0097692)	1	0	.00	-	 < 0.2	1.00E00
histone H3-R26 methylation (GO:0034972)	1	0	.00	-	 < 0.2	1.00E00
histone H3-R17 methylation (GO:0034971)	2	0	.01	-	 < 0.2	1.00E00
histone H3-R2 methylation (GO:0034970)	2	0	.01	-	 < 0.2	1.00E00
nucleotide phosphorylation (GO:0046939)	62	1	.26	+	3.85	1.00E00
cellular response to tetrahydrofolate (GO:1904482)	1	0	.00	-	 < 0.2	1.00E00
response to tetrahydrofolate (GO:1904481)	1	0	.00	-	 < 0.2	1.00E00
glutamate receptor clustering (GO:0097688)	4	0	.02	-	 < 0.2	1.00E00
pore complex assembly (GO:0046931)	16	0	.07	-	 < 0.2	1.00E00
histone arginine methylation (GO:0034969)	12	0	.05	-	 < 0.2	1.00E00
histone lysine methylation (GO:0034968)	68	0	.28	-	 < 0.2	1.00E00
retinal metabolic process (GO:0042574)	13	0	.05	-	 < 0.2	1.00E00
retinoic acid metabolic process (GO:0042573)	22	0	.09	-	 < 0.2	1.00E00
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	3	0	.01	-	 < 0.2	1.00E00
box H/ACA snoRNA processing (GO:0034964)	1	0	.00	-	 < 0.2	1.00E00
double-strand break repair via classical nonhomologous end joining (GO:0097680)	3	0	.01	-	 < 0.2	1.00E00
retinol metabolic process (GO:0042572)	31	0	.13	-	 < 0.2	1.00E00
box C/D snoRNA processing (GO:0034963)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of intestinal absorption (GO:1904479)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of neurotransmitter secretion (GO:0046929)	12	0	.05	-	 < 0.2	1.00E00
regulation of intestinal absorption (GO:1904478)	10	0	.04	-	 < 0.2	1.00E00
regulation of neurotransmitter secretion (GO:0046928)	55	0	.23	-	 < 0.2	1.00E00
histone H3-K36 dimethylation (GO:0097676)	3	0	.01	-	 < 0.2	1.00E00
endothelin maturation (GO:0034959)	1	0	.00	-	 < 0.2	1.00E00
pteridine-containing compound catabolic process (GO:0042560)	3	0	.01	-	 < 0.2	1.00E00
leukocyte chemotaxis (GO:0030595)	129	2	.54	+	3.70	1.00E00
neutrophil chemotaxis (GO:0030593)	63	2	.26	+	7.58	1.00E00
positive regulation of tumor necrosis factor secretion (GO:1904469)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of tumor necrosis factor secretion (GO:1904468)	7	0	.03	-	 < 0.2	1.00E00
regulation of tumor necrosis factor secretion (GO:1904467)	15	0	.06	-	 < 0.2	1.00E00
cellular transition metal ion homeostasis (GO:0046916)	97	0	.41	-	 < 0.2	1.00E00
negative regulation of matrix metallopeptidase secretion (GO:1904465)	1	0	.00	-	 < 0.2	1.00E00
regulation of matrix metallopeptidase secretion (GO:1904464)	1	0	.00	-	 < 0.2	1.00E00
pteridine-containing compound biosynthetic process (GO:0042559)	15	0	.06	-	 < 0.2	1.00E00
pteridine-containing compound metabolic process (GO:0042558)	34	0	.14	-	 < 0.2	1.00E00
superoxide anion generation (GO:0042554)	14	0	.06	-	 < 0.2	1.00E00
myelination (GO:0042552)	93	2	.39	+	5.13	1.00E00
neuron maturation (GO:0042551)	33	0	.14	-	 < 0.2	1.00E00
symbiont intracellular protein transport in host (GO:0030581)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neuronal action potential (GO:1904457)	1	0	.00	-	 < 0.2	1.00E00
intracellular transport (GO:0046907)	1535	13	6.43	+	2.02	1.00E00
negative regulation of neuronal action potential (GO:1904456)	1	0	.00	-	 < 0.2	1.00E00
nucleic acid-templated transcription (GO:0097659)	2589	16	10.85	+	1.47	1.00E00
regulation of mitochondrial membrane permeability (GO:0046902)	75	4	.31	+	12.73	1.00E00
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of aspartate secretion (GO:1904450)	1	0	.00	-	 < 0.2	1.00E00
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	0	.01	-	 < 0.2	1.00E00
regulation of plasma cell differentiation (GO:1900098)	1	1	.00	+	 > 100	1.00E00
regulation of dosage compensation by inactivation of X chromosome (GO:1900095)	1	0	.00	-	 < 0.2	1.00E00
cell wall biogenesis (GO:0042546)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094)	3	0	.01	-	 < 0.2	1.00E00
protein N-linked glycosylation via arginine (GO:0042543)	1	0	.00	-	 < 0.2	1.00E00
hemoglobin biosynthetic process (GO:0042541)	5	0	.02	-	 < 0.2	1.00E00
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	6	0	.03	-	 < 0.2	1.00E00
PML body organization (GO:0030578)	4	0	.02	-	 < 0.2	1.00E00
Cajal body organization (GO:0030576)	3	0	.01	-	 < 0.2	1.00E00
nuclear body organization (GO:0030575)	11	0	.05	-	 < 0.2	1.00E00
collagen catabolic process (GO:0030574)	65	2	.27	+	7.34	1.00E00
bile acid catabolic process (GO:0030573)	3	0	.01	-	 < 0.2	1.00E00
regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	1	0	.00	-	 < 0.2	1.00E00
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	4	0	.02	-	 < 0.2	1.00E00
regulation of aspartate secretion (GO:1904448)	1	0	.00	-	 < 0.2	1.00E00
folic acid import across plasma membrane (GO:1904447)	2	0	.01	-	 < 0.2	1.00E00
response to auditory stimulus (GO:0010996)	25	0	.10	-	 < 0.2	1.00E00
free ubiquitin chain polymerization (GO:0010994)	5	0	.02	-	 < 0.2	1.00E00
ubiquitin recycling (GO:0010992)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of SMAD protein complex assembly (GO:0010991)	5	0	.02	-	 < 0.2	1.00E00
regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	0	.00	-	 < 0.2	1.00E00
regulation of SMAD protein complex assembly (GO:0010990)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of ferrous iron import across plasma membrane (GO:1904440)	2	0	.01	-	 < 0.2	1.00E00
amylin receptor signaling pathway (GO:0097647)	7	0	.03	-	 < 0.2	1.00E00
hypotonic salinity response (GO:0042539)	3	0	.01	-	 < 0.2	1.00E00
calcitonin family receptor signaling pathway (GO:0097646)	7	0	.03	-	 < 0.2	1.00E00
hyperosmotic salinity response (GO:0042538)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	27	1	.11	+	8.84	1.00E00
benzene-containing compound metabolic process (GO:0042537)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	5	1	.02	+	47.73	1.00E00
negative regulation of tumor necrosis factor biosynthetic process (GO:0042536)	6	1	.03	+	39.78	1.00E00
negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085)	1	1	.00	+	 > 100	1.00E00
positive regulation of tumor necrosis factor biosynthetic process (GO:0042535)	11	0	.05	-	 < 0.2	1.00E00
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	6	2	.03	+	79.55	1.00E00
regulation of tumor necrosis factor biosynthetic process (GO:0042534)	19	1	.08	+	12.56	1.00E00
negative regulation of arginine catabolic process (GO:1900082)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	11	1	.05	+	21.70	1.00E00
L-ornithine import across plasma membrane (GO:0097640)	1	0	.00	-	 < 0.2	1.00E00
regulation of arginine catabolic process (GO:1900081)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	61	1	.26	+	3.91	1.00E00
negative regulation of low-density lipoprotein particle clearance (GO:0010989)	5	0	.02	-	 < 0.2	1.00E00
regulation of low-density lipoprotein particle clearance (GO:0010988)	10	0	.04	-	 < 0.2	1.00E00
regulation of ferrous iron import across plasma membrane (GO:1904438)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of transferrin receptor binding (GO:1904437)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of high-density lipoprotein particle clearance (GO:0010987)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of lipoprotein particle clearance (GO:0010986)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of lipoprotein particle clearance (GO:0010985)	8	0	.03	-	 < 0.2	1.00E00
regulation of transferrin receptor binding (GO:1904435)	2	0	.01	-	 < 0.2	1.00E00
regulation of lipoprotein particle clearance (GO:0010984)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of ferrous iron binding (GO:1904434)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of high-density lipoprotein particle clearance (GO:0010983)	2	0	.01	-	 < 0.2	1.00E00
regulation of high-density lipoprotein particle clearance (GO:0010982)	3	0	.01	-	 < 0.2	1.00E00
regulation of ferrous iron binding (GO:1904432)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of t-circle formation (GO:1904431)	3	0	.01	-	 < 0.2	1.00E00
L-lysine import across plasma membrane (GO:0097639)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of t-circle formation (GO:1904430)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)	3	0	.01	-	 < 0.2	1.00E00
L-arginine import across plasma membrane (GO:0097638)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cellular response to insulin stimulus (GO:1900078)	27	3	.11	+	26.52	1.00E00
positive regulation of neuromuscular synaptic transmission (GO:1900075)	1	0	.00	-	 < 0.2	1.00E00
regulation of neuromuscular synaptic transmission (GO:1900073)	1	0	.00	-	 < 0.2	1.00E00
regulation of t-circle formation (GO:1904429)	6	0	.03	-	 < 0.2	1.00E00
regulation of vitamin D 24-hydroxylase activity (GO:0010979)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of tubulin deacetylation (GO:1904428)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of neuron projection development (GO:0010977)	131	2	.55	+	3.64	1.00E00
positive regulation of calcium ion transmembrane transport (GO:1904427)	61	2	.26	+	7.82	1.00E00
positive regulation of neuron projection development (GO:0010976)	246	2	1.03	+	1.94	1.00E00
positive regulation of GTP binding (GO:1904426)	1	0	.00	-	 < 0.2	1.00E00
regulation of neuron projection development (GO:0010975)	429	6	1.80	+	3.34	1.00E00
negative regulation of GTP binding (GO:1904425)	2	0	.01	-	 < 0.2	1.00E00
regulation of GTP binding (GO:1904424)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	89	1	.37	+	2.68	1.00E00
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	21	0	.09	-	 < 0.2	1.00E00
transport along microtubule (GO:0010970)	128	0	.54	-	 < 0.2	1.00E00
potassium ion export across plasma membrane (GO:0097623)	4	0	.02	-	 < 0.2	1.00E00
regulation of peroxisome organization (GO:1900063)	3	0	.01	-	 < 0.2	1.00E00
regulation of replicative cell aging (GO:1900062)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ceramide biosynthetic process (GO:1900060)	4	0	.02	-	 < 0.2	1.00E00
female genitalia development (GO:0030540)	18	1	.08	+	13.26	1.00E00
regulation of microtubule nucleation (GO:0010968)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of xenophagy (GO:1904417)	6	0	.03	-	 < 0.2	1.00E00
regulation of polyamine biosynthetic process (GO:0010967)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphate transport (GO:0010966)	5	0	.02	-	 < 0.2	1.00E00
regulation of mitotic sister chromatid separation (GO:0010965)	51	3	.21	+	14.04	1.00E00
regulation of xenophagy (GO:1904415)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of cardiac ventricle development (GO:1904414)	1	0	.00	-	 < 0.2	1.00E00
regulation of L-arginine import (GO:0010963)	2	0	.01	-	 < 0.2	1.00E00
O-glycan processing, core 3 (GO:0016269)	1	0	.00	-	 < 0.2	1.00E00
regulation of glucan biosynthetic process (GO:0010962)	27	3	.11	+	26.52	1.00E00
regulation of cardiac ventricle development (GO:1904412)	1	0	.00	-	 < 0.2	1.00E00
O-glycan processing, core 1 (GO:0016267)	2	0	.01	-	 < 0.2	1.00E00
cellular magnesium ion homeostasis (GO:0010961)	5	0	.02	-	 < 0.2	1.00E00
O-glycan processing (GO:0016266)	59	0	.25	-	 < 0.2	1.00E00
magnesium ion homeostasis (GO:0010960)	11	1	.05	+	21.70	1.00E00
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	71	2	.30	+	6.72	1.00E00
gap junction assembly (GO:0016264)	8	0	.03	-	 < 0.2	1.00E00
pyrimidine-containing compound salvage (GO:0008655)	12	0	.05	-	 < 0.2	1.00E00
phospholipid biosynthetic process (GO:0008654)	272	4	1.14	+	3.51	1.00E00
lipopolysaccharide metabolic process (GO:0008653)	1	0	.00	-	 < 0.2	1.00E00
selenocysteine catabolic process (GO:0016261)	1	0	.00	-	 < 0.2	1.00E00
cellular amino acid biosynthetic process (GO:0008652)	82	0	.34	-	 < 0.2	1.00E00
selenocysteine biosynthetic process (GO:0016260)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of retinoic acid biosynthetic process (GO:1900053)	1	0	.00	-	 < 0.2	1.00E00
regulation of retinoic acid biosynthetic process (GO:1900052)	1	0	.00	-	 < 0.2	1.00E00
serine phosphorylation of STAT protein (GO:0042501)	5	0	.02	-	 < 0.2	1.00E00
male genitalia development (GO:0030539)	23	1	.10	+	10.38	1.00E00
embryonic genitalia morphogenesis (GO:0030538)	3	0	.01	-	 < 0.2	1.00E00
adult behavior (GO:0030534)	147	0	.62	-	 < 0.2	1.00E00
regulation of metal ion transport (GO:0010959)	355	6	1.49	+	4.03	1.00E00
regulation of amino acid import (GO:0010958)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of vitamin D biosynthetic process (GO:0010957)	5	1	.02	+	47.73	1.00E00
positive regulation of nitric oxide metabolic process (GO:1904407)	44	2	.18	+	10.85	1.00E00
negative regulation of nitric oxide metabolic process (GO:1904406)	14	1	.06	+	17.05	1.00E00
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of protein processing (GO:0010955)	43	2	.18	+	11.10	1.00E00
positive regulation of protein processing (GO:0010954)	22	1	.09	+	10.85	1.00E00
response to formaldehyde (GO:1904404)	1	1	.00	+	 > 100	1.00E00
selenocysteine metabolic process (GO:0016259)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of endopeptidase activity (GO:0010951)	247	5	1.03	+	4.83	1.00E00
positive regulation of endopeptidase activity (GO:0010950)	152	3	.64	+	4.71	1.00E00
N-glycan processing to lysosome (GO:0016256)	2	0	.01	-	 < 0.2	1.00E00
response to Thyroid stimulating hormone (GO:1904400)	1	0	.00	-	 < 0.2	1.00E00
attachment of GPI anchor to protein (GO:0016255)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of hemostasis (GO:1900048)	25	1	.10	+	9.55	1.00E00
preassembly of GPI anchor in ER membrane (GO:0016254)	15	0	.06	-	 < 0.2	1.00E00
hexose transport (GO:0008645)	52	1	.22	+	4.59	1.00E00
negative regulation of hemostasis (GO:1900047)	46	2	.19	+	10.38	1.00E00
carbohydrate transport (GO:0008643)	85	2	.36	+	5.62	1.00E00
negative regulation of protein K63-linked ubiquitination (GO:1900045)	4	0	.02	-	 < 0.2	1.00E00
regulation of protein K63-linked ubiquitination (GO:1900044)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of interleukin-2 secretion (GO:1900042)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of interleukin-2 secretion (GO:1900041)	4	0	.02	-	 < 0.2	1.00E00
regulation of interleukin-2 secretion (GO:1900040)	8	0	.03	-	 < 0.2	1.00E00
intracellular receptor signaling pathway (GO:0030522)	175	2	.73	+	2.73	1.00E00
androgen receptor signaling pathway (GO:0030521)	45	1	.19	+	5.30	1.00E00
intracellular estrogen receptor signaling pathway (GO:0030520)	21	1	.09	+	11.36	1.00E00
negative regulation of intestinal phytosterol absorption (GO:0010949)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription by competitive promoter binding (GO:0010944)	10	0	.04	-	 < 0.2	1.00E00
peptidyl-lysine deglutarylation (GO:0061699)	1	0	.00	-	 < 0.2	1.00E00
protein deglutarylation (GO:0061698)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of necrotic cell death (GO:0010940)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of cellular response to hypoxia (GO:1900039)	2	0	.01	-	 < 0.2	1.00E00
RNA interference (GO:0016246)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of cellular response to hypoxia (GO:1900038)	8	0	.03	-	 < 0.2	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	9	1	.04	+	26.52	1.00E00
regulation of cellular response to hypoxia (GO:1900037)	13	0	.05	-	 < 0.2	1.00E00
regulation of autophagosome size (GO:0016243)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cellular response to heat (GO:1900036)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of macroautophagy (GO:0016242)	30	2	.13	+	15.91	1.00E00
negative regulation of cellular response to heat (GO:1900035)	1	0	.00	-	 < 0.2	1.00E00
regulation of macroautophagy (GO:0016241)	163	3	.68	+	4.39	1.00E00
regulation of cellular response to heat (GO:1900034)	78	2	.33	+	6.12	1.00E00
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	18	2	.08	+	26.52	1.00E00
autophagosome membrane docking (GO:0016240)	4	0	.02	-	 < 0.2	1.00E00
intracellular steroid hormone receptor signaling pathway (GO:0030518)	76	2	.32	+	6.28	1.00E00
negative regulation of axon extension (GO:0030517)	26	0	.11	-	 < 0.2	1.00E00
regulation of axon extension (GO:0030516)	80	2	.34	+	5.97	1.00E00
negative regulation of BMP signaling pathway (GO:0030514)	49	1	.21	+	4.87	1.00E00
positive regulation of BMP signaling pathway (GO:0030513)	33	0	.14	-	 < 0.2	1.00E00
respiratory electron transport chain (GO:0022904)	113	1	.47	+	2.11	1.00E00
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	69	3	.29	+	10.38	1.00E00
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	25	0	.10	-	 < 0.2	1.00E00
regulation of BMP signaling pathway (GO:0030510)	88	1	.37	+	2.71	1.00E00
electron transport chain (GO:0022900)	116	1	.49	+	2.06	1.00E00
regulation of necrotic cell death (GO:0010939)	27	1	.11	+	8.84	1.00E00
negative regulation of macrophage cytokine production (GO:0010936)	5	0	.02	-	 < 0.2	1.00E00
regulation of macrophage cytokine production (GO:0010935)	12	0	.05	-	 < 0.2	1.00E00
macrophage cytokine production (GO:0010934)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of macroautophagy (GO:0016239)	59	1	.25	+	4.05	1.00E00
positive regulation of macrophage tolerance induction (GO:0010933)	1	0	.00	-	 < 0.2	1.00E00
regulation of macrophage tolerance induction (GO:0010932)	1	0	.00	-	 < 0.2	1.00E00
hormone-mediated apoptotic signaling pathway (GO:0008628)	5	0	.02	-	 < 0.2	1.00E00
lysosomal microautophagy (GO:0016237)	1	0	.00	-	 < 0.2	1.00E00
macroautophagy (GO:0016236)	147	1	.62	+	1.62	1.00E00
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	2	1	.01	+	 > 100	1.00E00
positive regulation of ruffle assembly (GO:1900029)	12	0	.05	-	 < 0.2	1.00E00
detoxification of inorganic compound (GO:0061687)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of ruffle assembly (GO:1900028)	5	0	.02	-	 < 0.2	1.00E00
granzyme-mediated apoptotic signaling pathway (GO:0008626)	5	0	.02	-	 < 0.2	1.00E00
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	32	3	.13	+	22.37	1.00E00
regulation of ruffle assembly (GO:1900027)	26	1	.11	+	9.18	1.00E00
telomere capping (GO:0016233)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	34	1	.14	+	7.02	1.00E00
chaperone-mediated autophagy (GO:0061684)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	13	0	.05	-	 < 0.2	1.00E00
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	49	1	.21	+	4.87	1.00E00
seminal vesicle morphogenesis (GO:0061682)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein kinase C activity (GO:1900020)	6	1	.03	+	39.78	1.00E00
BMP signaling pathway (GO:0030509)	91	0	.38	-	 < 0.2	1.00E00
inorganic diphosphate transport (GO:0030505)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of bone mineralization (GO:0030502)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of bone mineralization (GO:0030501)	36	0	.15	-	 < 0.2	1.00E00
regulation of bone mineralization (GO:0030500)	67	0	.28	-	 < 0.2	1.00E00
cellular component assembly involved in morphogenesis (GO:0010927)	92	1	.39	+	2.59	1.00E00
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.00	-	 < 0.2	1.00E00
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of phosphatase activity (GO:0010923)	72	0	.30	-	 < 0.2	1.00E00
positive regulation of phosphatase activity (GO:0010922)	26	2	.11	+	18.36	1.00E00
regulation of phosphatase activity (GO:0010921)	109	2	.46	+	4.38	1.00E00
iron-sulfur cluster assembly (GO:0016226)	18	0	.08	-	 < 0.2	1.00E00
regulation of protein kinase C activity (GO:1900019)	6	1	.03	+	39.78	1.00E00
negative regulation of inositol phosphate biosynthetic process (GO:0010920)	1	0	.00	-	 < 0.2	1.00E00
guanosine metabolic process (GO:0008617)	1	0	.00	-	 < 0.2	1.00E00
queuosine biosynthetic process (GO:0008616)	5	0	.02	-	 < 0.2	1.00E00
pyridoxine biosynthetic process (GO:0008615)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cytokine production involved in inflammatory response (GO:1900017)	16	1	.07	+	14.92	1.00E00
pyridoxine metabolic process (GO:0008614)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	10	0	.04	-	 < 0.2	1.00E00
regulation of cytokine production involved in inflammatory response (GO:1900015)	31	2	.13	+	15.40	1.00E00
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	4	0	.02	-	 < 0.2	1.00E00
ether lipid biosynthetic process (GO:0008611)	4	0	.02	-	 < 0.2	1.00E00
lipid biosynthetic process (GO:0008610)	576	8	2.41	+	3.31	1.00E00
evoked neurotransmitter secretion (GO:0061670)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011)	1	0	.00	-	 < 0.2	1.00E00
regulation of corticotropin-releasing hormone receptor activity (GO:1900010)	1	0	.00	-	 < 0.2	1.00E00
regulation of inositol phosphate biosynthetic process (GO:0010919)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of mitochondrial membrane potential (GO:0010918)	8	2	.03	+	59.66	1.00E00
negative regulation of mitochondrial membrane potential (GO:0010917)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	4	0	.02	-	 < 0.2	1.00E00
regulation of very-low-density lipoprotein particle clearance (GO:0010915)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of isomerase activity (GO:0010912)	8	0	.03	-	 < 0.2	1.00E00
spontaneous neurotransmitter secretion (GO:0061669)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial ribosome assembly (GO:0061668)	4	0	.02	-	 < 0.2	1.00E00
regulation of isomerase activity (GO:0010911)	8	0	.03	-	 < 0.2	1.00E00
attachment of spindle microtubules to kinetochore (GO:0008608)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of eating behavior (GO:1903999)	1	0	.00	-	 < 0.2	1.00E00
regulation of eating behavior (GO:1903998)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997)	1	0	.00	-	 < 0.2	1.00E00
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dendrite development (GO:1900006)	69	1	.29	+	3.46	1.00E00
positive regulation of serine-type endopeptidase activity (GO:1900005)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of serine-type endopeptidase activity (GO:1900004)	11	0	.05	-	 < 0.2	1.00E00
regulation of serine-type endopeptidase activity (GO:1900003)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	3	0	.01	-	 < 0.2	1.00E00
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of UDP-glucose catabolic process (GO:0010905)	1	1	.00	+	 > 100	1.00E00
regulation of UDP-glucose catabolic process (GO:0010904)	1	1	.00	+	 > 100	1.00E00
negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902)	2	0	.01	-	 < 0.2	1.00E00
regulation of very-low-density lipoprotein particle remodeling (GO:0010901)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of phosphatidylcholine catabolic process (GO:0010900)	1	0	.00	-	 < 0.2	1.00E00
ferrous iron export across plasma membrane (GO:1903988)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of microglial cell activation (GO:1903980)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of microglial cell activation (GO:1903979)	2	0	.01	-	 < 0.2	1.00E00
histone H3-K9 modification (GO:0061647)	14	0	.06	-	 < 0.2	1.00E00
regulation of microglial cell activation (GO:1903978)	5	1	.02	+	47.73	1.00E00
positive regulation of glial cell migration (GO:1903977)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glial cell migration (GO:1903976)	4	0	.02	-	 < 0.2	1.00E00
regulation of glial cell migration (GO:1903975)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974)	1	0	.00	-	 < 0.2	1.00E00
chemorepulsion of axon (GO:0061643)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903973)	2	0	.01	-	 < 0.2	1.00E00
chemoattraction of axon (GO:0061642)	1	0	.00	-	 < 0.2	1.00E00
CENP-A containing chromatin organization (GO:0061641)	29	0	.12	-	 < 0.2	1.00E00
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	3	0	.01	-	 < 0.2	1.00E00
cytoskeleton-dependent cytokinesis (GO:0061640)	52	1	.22	+	4.59	1.00E00
positive regulation of response to macrophage colony-stimulating factor (GO:1903971)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of response to macrophage colony-stimulating factor (GO:1903970)	2	0	.01	-	 < 0.2	1.00E00
helper T cell enhancement of adaptive immune response (GO:0035397)	1	0	.00	-	 < 0.2	1.00E00
regulation of response to macrophage colony-stimulating factor (GO:1903969)	3	0	.01	-	 < 0.2	1.00E00
monounsaturated fatty acid biosynthetic process (GO:1903966)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein complex stability (GO:0061635)	8	0	.03	-	 < 0.2	1.00E00
monounsaturated fatty acid catabolic process (GO:1903965)	1	0	.00	-	 < 0.2	1.00E00
monounsaturated fatty acid metabolic process (GO:1903964)	3	0	.01	-	 < 0.2	1.00E00
arachidonate transport (GO:1903963)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of anion transmembrane transport (GO:1903961)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of anion transmembrane transport (GO:1903960)	10	1	.04	+	23.87	1.00E00
Roundabout signaling pathway (GO:0035385)	7	0	.03	-	 < 0.2	1.00E00
thioester biosynthetic process (GO:0035384)	43	1	.18	+	5.55	1.00E00
regulation of anion transmembrane transport (GO:1903959)	39	1	.16	+	6.12	1.00E00
thioester metabolic process (GO:0035383)	91	1	.38	+	2.62	1.00E00
pharyngeal arch artery morphogenesis (GO:0061626)	7	0	.03	-	 < 0.2	1.00E00
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of protein targeting to mitochondrion (GO:1903955)	86	3	.36	+	8.33	1.00E00
glycolytic process from galactose (GO:0061623)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903954)	1	0	.00	-	 < 0.2	1.00E00
glycolytic process through glucose-1-phosphate (GO:0061622)	2	0	.01	-	 < 0.2	1.00E00
canonical glycolysis (GO:0061621)	25	1	.10	+	9.55	1.00E00
regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization (GO:1903952)	1	0	.00	-	 < 0.2	1.00E00
glycolytic process through glucose-6-phosphate (GO:0061620)	26	1	.11	+	9.18	1.00E00
carbon dioxide transmembrane transport (GO:0035378)	3	0	.01	-	 < 0.2	1.00E00
transepithelial water transport (GO:0035377)	2	0	.01	-	 < 0.2	1.00E00
sterol import (GO:0035376)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	2	0	.01	-	 < 0.2	1.00E00
protein localization to microtubule (GO:0035372)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of ventricular cardiac muscle cell action potential (GO:1903947)	2	0	.01	-	 < 0.2	1.00E00
glycolytic process through fructose-6-phosphate (GO:0061615)	26	1	.11	+	9.18	1.00E00
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	0	.00	-	 < 0.2	1.00E00
pri-miRNA transcription from RNA polymerase II promoter (GO:0061614)	3	1	.01	+	79.55	1.00E00
negative regulation of hepatocyte apoptotic process (GO:1903944)	1	0	.00	-	 < 0.2	1.00E00
regulation of hepatocyte apoptotic process (GO:1903943)	1	0	.00	-	 < 0.2	1.00E00
myo-inositol transport (GO:0015798)	4	0	.02	-	 < 0.2	1.00E00
mannose to fructose-6-phosphate metabolic process (GO:0061611)	1	0	.00	-	 < 0.2	1.00E00
mannitol transport (GO:0015797)	1	0	.00	-	 < 0.2	1.00E00
glycerol transport (GO:0015793)	6	0	.03	-	 < 0.2	1.00E00
polyol transport (GO:0015791)	11	0	.05	-	 < 0.2	1.00E00
UDP-xylose transport (GO:0015790)	1	0	.00	-	 < 0.2	1.00E00
regulation of TORC2 signaling (GO:1903939)	1	0	.00	-	 < 0.2	1.00E00
response to acrylamide (GO:1903937)	2	0	.01	-	 < 0.2	1.00E00
cellular response to sodium arsenite (GO:1903936)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	7	0	.03	-	 < 0.2	1.00E00
response to sodium arsenite (GO:1903935)	5	0	.02	-	 < 0.2	1.00E00
UDP-N-acetylglucosamine transport (GO:0015788)	2	0	.01	-	 < 0.2	1.00E00
UDP-glucuronic acid transport (GO:0015787)	1	0	.00	-	 < 0.2	1.00E00
UDP-glucose transport (GO:0015786)	1	0	.00	-	 < 0.2	1.00E00
UDP-galactose transport (GO:0015785)	2	0	.01	-	 < 0.2	1.00E00
GDP-mannose transport (GO:0015784)	1	0	.00	-	 < 0.2	1.00E00
GDP-fucose transport (GO:0015783)	2	0	.01	-	 < 0.2	1.00E00
CMP-N-acetylneuraminate transport (GO:0015782)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine nucleotide-sugar transport (GO:0015781)	9	0	.04	-	 < 0.2	1.00E00
nucleotide-sugar transport (GO:0015780)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	3	0	.01	-	 < 0.2	1.00E00
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	12	0	.05	-	 < 0.2	1.00E00
peroxisome proliferator activated receptor signaling pathway (GO:0035357)	8	0	.03	-	 < 0.2	1.00E00
cellular triglyceride homeostasis (GO:0035356)	7	1	.03	+	34.09	1.00E00
cellular response to bisphenol A (GO:1903926)	1	0	.00	-	 < 0.2	1.00E00
FAD transmembrane transport (GO:0035350)	2	0	.01	-	 < 0.2	1.00E00
response to bisphenol A (GO:1903925)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein processing in phagocytic vesicle (GO:1903923)	2	0	.01	-	 < 0.2	1.00E00
regulation of protein processing in phagocytic vesicle (GO:1903921)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of actin filament severing (GO:1903920)	1	0	.00	-	 < 0.2	1.00E00
oligosaccharide transport (GO:0015772)	3	0	.01	-	 < 0.2	1.00E00
sucrose transport (GO:0015770)	3	0	.01	-	 < 0.2	1.00E00
viral budding via host ESCRT complex (GO:0039702)	20	0	.08	-	 < 0.2	1.00E00
coenzyme A transmembrane transport (GO:0035349)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of actin filament severing (GO:1903919)	2	0	.01	-	 < 0.2	1.00E00
regulation of actin filament severing (GO:1903918)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903917)	1	0	.00	-	 < 0.2	1.00E00
regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903916)	1	0	.00	-	 < 0.2	1.00E00
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of receptor clustering (GO:1903911)	5	0	.02	-	 < 0.2	1.00E00
regulation of the force of heart contraction by cardiac conduction (GO:0086092)	2	0	.01	-	 < 0.2	1.00E00
disaccharide transport (GO:0015766)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of receptor clustering (GO:1903910)	1	0	.00	-	 < 0.2	1.00E00
regulation of heart rate by cardiac conduction (GO:0086091)	36	1	.15	+	6.63	1.00E00
mannose transport (GO:0015761)	1	0	.00	-	 < 0.2	1.00E00
glucose-6-phosphate transport (GO:0015760)	6	0	.03	-	 < 0.2	1.00E00
valine biosynthetic process (GO:0009099)	2	0	.01	-	 < 0.2	1.00E00
leucine biosynthetic process (GO:0009098)	2	0	.01	-	 < 0.2	1.00E00
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	18	0	.08	-	 < 0.2	1.00E00
fatty-acyl-CoA metabolic process (GO:0035337)	39	1	.16	+	6.12	1.00E00
cysteine catabolic process (GO:0009093)	3	0	.01	-	 < 0.2	1.00E00
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	24	0	.10	-	 < 0.2	1.00E00
homoserine metabolic process (GO:0009092)	4	0	.02	-	 < 0.2	1.00E00
peptidyl-tyrosine dephosphorylation (GO:0035335)	101	1	.42	+	2.36	1.00E00
regulation of receptor clustering (GO:1903909)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of hippo signaling (GO:0035332)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of hippo signaling (GO:0035331)	8	0	.03	-	 < 0.2	1.00E00
regulation of plasma membrane raft polarization (GO:1903906)	1	0	.00	-	 < 0.2	1.00E00
regulation of hippo signaling (GO:0035330)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of establishment of T cell polarity (GO:1903905)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of establishment of T cell polarity (GO:1903904)	1	0	.00	-	 < 0.2	1.00E00
regulation of establishment of T cell polarity (GO:1903903)	4	0	.02	-	 < 0.2	1.00E00
glucose transport (GO:0015758)	46	1	.19	+	5.19	1.00E00
positive regulation of viral life cycle (GO:1903902)	58	1	.24	+	4.11	1.00E00
negative regulation of viral life cycle (GO:1903901)	75	1	.31	+	3.18	1.00E00
regulation of viral life cycle (GO:1903900)	132	2	.55	+	3.62	1.00E00
fructose transport (GO:0015755)	2	0	.01	-	 < 0.2	1.00E00
methionine catabolic process (GO:0009087)	1	0	.00	-	 < 0.2	1.00E00
methionine biosynthetic process (GO:0009086)	12	0	.05	-	 < 0.2	1.00E00
hippo signaling (GO:0035329)	27	1	.11	+	8.84	1.00E00
lysine biosynthetic process (GO:0009085)	2	0	.01	-	 < 0.2	1.00E00
glutamine family amino acid biosynthetic process (GO:0009084)	20	0	.08	-	 < 0.2	1.00E00
branched-chain amino acid catabolic process (GO:0009083)	21	0	.09	-	 < 0.2	1.00E00
branched-chain amino acid biosynthetic process (GO:0009082)	2	0	.01	-	 < 0.2	1.00E00
branched-chain amino acid metabolic process (GO:0009081)	24	1	.10	+	9.94	1.00E00
pyruvate family amino acid catabolic process (GO:0009080)	5	0	.02	-	 < 0.2	1.00E00
monosaccharide transport (GO:0015749)	54	1	.23	+	4.42	1.00E00
organophosphate ester transport (GO:0015748)	89	0	.37	-	 < 0.2	1.00E00
urate transport (GO:0015747)	10	0	.04	-	 < 0.2	1.00E00
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	6	0	.03	-	 < 0.2	1.00E00
citrate transport (GO:0015746)	4	0	.02	-	 < 0.2	1.00E00
AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072)	1	0	.00	-	 < 0.2	1.00E00
SA node cell to atrial cardiac muscle cell communication (GO:0086070)	9	0	.04	-	 < 0.2	1.00E00
succinate transport (GO:0015744)	4	0	.02	-	 < 0.2	1.00E00
malate transport (GO:0015743)	2	0	.01	-	 < 0.2	1.00E00
alpha-ketoglutarate transport (GO:0015742)	3	0	.01	-	 < 0.2	1.00E00
C4-dicarboxylate transport (GO:0015740)	12	0	.05	-	 < 0.2	1.00E00
pyruvate family amino acid metabolic process (GO:0009078)	5	0	.02	-	 < 0.2	1.00E00
aromatic amino acid family catabolic process (GO:0009074)	20	0	.08	-	 < 0.2	1.00E00
aromatic amino acid family metabolic process (GO:0009072)	28	0	.12	-	 < 0.2	1.00E00
hair cell differentiation (GO:0035315)	37	1	.16	+	6.45	1.00E00
serine family amino acid catabolic process (GO:0009071)	11	0	.05	-	 < 0.2	1.00E00
serine family amino acid biosynthetic process (GO:0009070)	19	0	.08	-	 < 0.2	1.00E00
wound healing, spreading of epidermal cells (GO:0035313)	10	1	.04	+	23.87	1.00E00
bundle of His cell to Purkinje myocyte communication (GO:0086069)	13	0	.05	-	 < 0.2	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	6	0	.03	-	 < 0.2	1.00E00
AV node cell to bundle of His cell communication (GO:0086067)	10	0	.04	-	 < 0.2	1.00E00
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	15	0	.06	-	 < 0.2	1.00E00
cell communication involved in cardiac conduction (GO:0086065)	42	0	.18	-	 < 0.2	1.00E00
sialic acid transport (GO:0015739)	1	0	.00	-	 < 0.2	1.00E00
cell communication by electrical coupling involved in cardiac conduction (GO:0086064)	14	0	.06	-	 < 0.2	1.00E00
taurine transport (GO:0015734)	1	0	.00	-	 < 0.2	1.00E00
prostaglandin transport (GO:0015732)	6	0	.03	-	 < 0.2	1.00E00
serine family amino acid metabolic process (GO:0009069)	42	0	.18	-	 < 0.2	1.00E00
aspartate family amino acid catabolic process (GO:0009068)	21	0	.09	-	 < 0.2	1.00E00
aspartate family amino acid biosynthetic process (GO:0009067)	22	0	.09	-	 < 0.2	1.00E00
aspartate family amino acid metabolic process (GO:0009066)	54	0	.23	-	 < 0.2	1.00E00
glutamine family amino acid catabolic process (GO:0009065)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of protein dephosphorylation (GO:0035308)	24	0	.10	-	 < 0.2	1.00E00
glutamine family amino acid metabolic process (GO:0009064)	68	0	.28	-	 < 0.2	1.00E00
positive regulation of protein dephosphorylation (GO:0035307)	34	2	.14	+	14.04	1.00E00
cellular amino acid catabolic process (GO:0009063)	112	0	.47	-	 < 0.2	1.00E00
positive regulation of dephosphorylation (GO:0035306)	46	3	.19	+	15.56	1.00E00
fatty acid catabolic process (GO:0009062)	87	0	.36	-	 < 0.2	1.00E00
negative regulation of dephosphorylation (GO:0035305)	81	0	.34	-	 < 0.2	1.00E00
anaerobic respiration (GO:0009061)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein dephosphorylation (GO:0035304)	67	2	.28	+	7.12	1.00E00
aerobic respiration (GO:0009060)	60	0	.25	-	 < 0.2	1.00E00
regulation of dephosphorylation (GO:0035303)	143	3	.60	+	5.01	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell communication by electrical coupling (GO:0086055)	1	0	.00	-	 < 0.2	1.00E00
oxaloacetate transport (GO:0015729)	2	0	.01	-	 < 0.2	1.00E00
bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054)	1	0	.00	-	 < 0.2	1.00E00
mevalonate transport (GO:0015728)	1	0	.00	-	 < 0.2	1.00E00
lactate transport (GO:0015727)	6	0	.03	-	 < 0.2	1.00E00
AV node cell to bundle of His cell communication by electrical coupling (GO:0086053)	2	0	.01	-	 < 0.2	1.00E00
membrane repolarization during SA node cell action potential (GO:0086052)	1	0	.00	-	 < 0.2	1.00E00
membrane repolarization during bundle of His cell action potential (GO:0086050)	1	0	.00	-	 < 0.2	1.00E00
formate transport (GO:0015724)	1	0	.00	-	 < 0.2	1.00E00
bilirubin transport (GO:0015723)	1	0	.00	-	 < 0.2	1.00E00
canalicular bile acid transport (GO:0015722)	4	0	.02	-	 < 0.2	1.00E00
bile acid and bile salt transport (GO:0015721)	36	0	.15	-	 < 0.2	1.00E00
macromolecule biosynthetic process (GO:0009059)	3738	26	15.66	+	1.66	1.00E00
biosynthetic process (GO:0009058)	4826	35	20.22	+	1.73	1.00E00
macromolecule catabolic process (GO:0009057)	992	9	4.16	+	2.17	1.00E00
response to cycloheximide (GO:0046898)	5	0	.02	-	 < 0.2	1.00E00
catabolic process (GO:0009056)	1940	14	8.13	+	1.72	1.00E00
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	6	0	.03	-	 < 0.2	1.00E00
pentose-phosphate shunt, oxidative branch (GO:0009051)	3	1	.01	+	79.55	1.00E00
regulation of lipid biosynthetic process (GO:0046890)	166	5	.70	+	7.19	1.00E00
membrane depolarization during bundle of His cell action potential (GO:0086048)	3	0	.01	-	 < 0.2	1.00E00
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047)	3	0	.01	-	 < 0.2	1.00E00
membrane depolarization during SA node cell action potential (GO:0086046)	5	0	.02	-	 < 0.2	1.00E00
membrane depolarization during AV node cell action potential (GO:0086045)	5	0	.02	-	 < 0.2	1.00E00
monocarboxylic acid transport (GO:0015718)	138	0	.58	-	 < 0.2	1.00E00
atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044)	1	0	.00	-	 < 0.2	1.00E00
bundle of His cell action potential (GO:0086043)	5	0	.02	-	 < 0.2	1.00E00
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	7	0	.03	-	 < 0.2	1.00E00
hexose phosphate transport (GO:0015712)	6	0	.03	-	 < 0.2	1.00E00
organic anion transport (GO:0015711)	420	0	1.76	-	 < 0.2	1.00E00
dosage compensation by inactivation of X chromosome (GO:0009048)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of lipid biosynthetic process (GO:0046889)	65	3	.27	+	11.02	1.00E00
negative regulation of hormone secretion (GO:0046888)	66	2	.28	+	7.23	1.00E00
positive regulation of hormone secretion (GO:0046887)	121	1	.51	+	1.97	1.00E00
positive regulation of hormone biosynthetic process (GO:0046886)	7	0	.03	-	 < 0.2	1.00E00
regulation of hormone biosynthetic process (GO:0046885)	17	0	.07	-	 < 0.2	1.00E00
follicle-stimulating hormone secretion (GO:0046884)	2	0	.01	-	 < 0.2	1.00E00
regulation of hormone secretion (GO:0046883)	259	5	1.09	+	4.61	1.00E00
negative regulation of follicle-stimulating hormone secretion (GO:0046882)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of follicle-stimulating hormone secretion (GO:0046881)	6	0	.03	-	 < 0.2	1.00E00
regulation of follicle-stimulating hormone secretion (GO:0046880)	6	0	.03	-	 < 0.2	1.00E00
regulation of cardiac muscle cell membrane potential (GO:0086036)	8	0	.03	-	 < 0.2	1.00E00
thiosulfate transport (GO:0015709)	2	0	.01	-	 < 0.2	1.00E00
nitrite transport (GO:0015707)	1	0	.00	-	 < 0.2	1.00E00
nitrate transport (GO:0015706)	1	0	.00	-	 < 0.2	1.00E00
iodide transport (GO:0015705)	4	0	.02	-	 < 0.2	1.00E00
adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.00	-	 < 0.2	1.00E00
bicarbonate transport (GO:0015701)	43	0	.18	-	 < 0.2	1.00E00
hormone secretion (GO:0046879)	74	1	.31	+	3.23	1.00E00
positive regulation of saliva secretion (GO:0046878)	4	0	.02	-	 < 0.2	1.00E00
regulation of saliva secretion (GO:0046877)	9	0	.04	-	 < 0.2	1.00E00
quinolinate metabolic process (GO:0046874)	5	0	.02	-	 < 0.2	1.00E00
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	5	0	.02	-	 < 0.2	1.00E00
bundle of His cell to Purkinje myocyte signaling (GO:0086028)	5	0	.02	-	 < 0.2	1.00E00
AV node cell to bundle of His cell signaling (GO:0086027)	7	0	.03	-	 < 0.2	1.00E00
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	14	0	.06	-	 < 0.2	1.00E00
adrenergic receptor signaling pathway involved in positive regulation of heart rate (GO:0086024)	1	0	.00	-	 < 0.2	1.00E00
adrenergic receptor signaling pathway involved in heart process (GO:0086023)	4	0	.02	-	 < 0.2	1.00E00
SA node cell to atrial cardiac muscle cell communication by electrical coupling (GO:0086021)	2	0	.01	-	 < 0.2	1.00E00
terpenoid transport (GO:0046865)	1	0	.00	-	 < 0.2	1.00E00
isoprenoid transport (GO:0046864)	1	0	.00	-	 < 0.2	1.00E00
cell-cell signaling involved in cardiac conduction (GO:0086019)	27	0	.11	-	 < 0.2	1.00E00
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	8	0	.03	-	 < 0.2	1.00E00
Purkinje myocyte action potential (GO:0086017)	3	0	.01	-	 < 0.2	1.00E00
AV node cell action potential (GO:0086016)	7	0	.03	-	 < 0.2	1.00E00
SA node cell action potential (GO:0086015)	8	0	.03	-	 < 0.2	1.00E00
atrial cardiac muscle cell action potential (GO:0086014)	14	0	.06	-	 < 0.2	1.00E00
membrane repolarization during cardiac muscle cell action potential (GO:0086013)	16	0	.07	-	 < 0.2	1.00E00
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	17	0	.07	-	 < 0.2	1.00E00
membrane repolarization during action potential (GO:0086011)	16	0	.07	-	 < 0.2	1.00E00
membrane depolarization during action potential (GO:0086010)	42	0	.18	-	 < 0.2	1.00E00
phosphatidylinositol dephosphorylation (GO:0046856)	22	0	.09	-	 < 0.2	1.00E00
inositol phosphate dephosphorylation (GO:0046855)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of bone remodeling (GO:0046852)	15	2	.06	+	31.82	1.00E00
negative regulation of bone remodeling (GO:0046851)	15	0	.06	-	 < 0.2	1.00E00
membrane repolarization (GO:0086009)	19	0	.08	-	 < 0.2	1.00E00
regulation of bone remodeling (GO:0046850)	45	3	.19	+	15.91	1.00E00
detection of diacyl bacterial lipopeptide (GO:0042496)	2	0	.01	-	 < 0.2	1.00E00
ventricular cardiac muscle cell action potential (GO:0086005)	19	0	.08	-	 < 0.2	1.00E00
detection of triacyl bacterial lipopeptide (GO:0042495)	2	0	.01	-	 < 0.2	1.00E00
regulation of cardiac muscle cell contraction (GO:0086004)	35	1	.15	+	6.82	1.00E00
detection of bacterial lipoprotein (GO:0042494)	4	0	.02	-	 < 0.2	1.00E00
cardiac muscle cell contraction (GO:0086003)	38	0	.16	-	 < 0.2	1.00E00
cardiac muscle cell action potential involved in contraction (GO:0086002)	36	0	.15	-	 < 0.2	1.00E00
gamma-delta T cell differentiation (GO:0042492)	3	0	.01	-	 < 0.2	1.00E00
cardiac muscle cell action potential (GO:0086001)	46	0	.19	-	 < 0.2	1.00E00
auditory receptor cell differentiation (GO:0042491)	28	1	.12	+	8.52	1.00E00
mechanoreceptor differentiation (GO:0042490)	60	1	.25	+	3.98	1.00E00
bone remodeling (GO:0046849)	40	1	.17	+	5.97	1.00E00
positive regulation of neuromuscular junction development (GO:1904398)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of neuromuscular junction development (GO:1904397)	2	0	.01	-	 < 0.2	1.00E00
filopodium assembly (GO:0046847)	18	0	.08	-	 < 0.2	1.00E00
regulation of neuromuscular junction development (GO:1904396)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	4	0	.02	-	 < 0.2	1.00E00
response to ciliary neurotrophic factor (GO:1904391)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of odontogenesis of dentin-containing tooth (GO:0042488)	4	0	.02	-	 < 0.2	1.00E00
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of odontogenesis (GO:0042483)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of odontogenesis (GO:0042482)	11	0	.05	-	 < 0.2	1.00E00
regulation of odontogenesis (GO:0042481)	26	0	.11	-	 < 0.2	1.00E00
rod bipolar cell differentiation (GO:1904389)	1	0	.00	-	 < 0.2	1.00E00
phospholipid dephosphorylation (GO:0046839)	33	0	.14	-	 < 0.2	1.00E00
phosphorylated carbohydrate dephosphorylation (GO:0046838)	11	0	.05	-	 < 0.2	1.00E00
cellular response to L-phenylalanine derivative (GO:1904387)	2	0	.01	-	 < 0.2	1.00E00
response to L-phenylalanine derivative (GO:1904386)	6	0	.03	-	 < 0.2	1.00E00
glycolipid transport (GO:0046836)	6	0	.03	-	 < 0.2	1.00E00
carbohydrate phosphorylation (GO:0046835)	24	0	.10	-	 < 0.2	1.00E00
response to sodium phosphate (GO:1904383)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of RNA export from nucleus (GO:0046833)	4	0	.02	-	 < 0.2	1.00E00
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	4	0	.02	-	 < 0.2	1.00E00
Golgi apparatus mannose trimming (GO:1904381)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of RNA export from nucleus (GO:0046832)	2	0	.01	-	 < 0.2	1.00E00
regulation of RNA export from nucleus (GO:0046831)	13	0	.05	-	 < 0.2	1.00E00
endoplasmic reticulum mannose trimming (GO:1904380)	20	0	.08	-	 < 0.2	1.00E00
odontogenesis (GO:0042476)	109	0	.46	-	 < 0.2	1.00E00
odontogenesis of dentin-containing tooth (GO:0042475)	76	0	.32	-	 < 0.2	1.00E00
middle ear morphogenesis (GO:0042474)	19	0	.08	-	 < 0.2	1.00E00
lamellipodium organization (GO:0097581)	40	0	.17	-	 < 0.2	1.00E00
outer ear morphogenesis (GO:0042473)	9	1	.04	+	26.52	1.00E00
inner ear morphogenesis (GO:0042472)	98	0	.41	-	 < 0.2	1.00E00
ear morphogenesis (GO:0042471)	117	1	.49	+	2.04	1.00E00
regulation of transmembrane transporter activity (GO:0022898)	224	2	.94	+	2.13	1.00E00
protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379)	2	0	.01	-	 < 0.2	1.00E00
maintenance of unfolded protein involved in ERAD pathway (GO:1904378)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of protein export from nucleus (GO:0046827)	20	2	.08	+	23.87	1.00E00
negative regulation of protein localization to cell periphery (GO:1904376)	23	0	.10	-	 < 0.2	1.00E00
negative regulation of protein export from nucleus (GO:0046826)	7	0	.03	-	 < 0.2	1.00E00
regulation of protein export from nucleus (GO:0046825)	41	3	.17	+	17.46	1.00E00
response to kainic acid (GO:1904373)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of nucleocytoplasmic transport (GO:0046823)	70	0	.29	-	 < 0.2	1.00E00
positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.00	-	 < 0.2	1.00E00
sequestering of iron ion (GO:0097577)	6	0	.03	-	 < 0.2	1.00E00
vacuole fusion (GO:0097576)	2	0	.01	-	 < 0.2	1.00E00
eye photoreceptor cell development (GO:0042462)	33	0	.14	-	 < 0.2	1.00E00
photoreceptor cell development (GO:0042461)	42	0	.18	-	 < 0.2	1.00E00
fatty acid elongation (GO:0030497)	12	0	.05	-	 < 0.2	1.00E00
maturation of SSU-rRNA (GO:0030490)	53	0	.22	-	 < 0.2	1.00E00
coreceptor-mediated virion attachment to host cell (GO:0046814)	1	0	.00	-	 < 0.2	1.00E00
receptor-mediated virion attachment to host cell (GO:0046813)	5	0	.02	-	 < 0.2	1.00E00
ribonucleoside biosynthetic process (GO:0042455)	41	0	.17	-	 < 0.2	1.00E00
ribonucleoside catabolic process (GO:0042454)	19	0	.08	-	 < 0.2	1.00E00
purine nucleoside biosynthetic process (GO:0042451)	24	0	.10	-	 < 0.2	1.00E00
arginine biosynthetic process via ornithine (GO:0042450)	3	0	.01	-	 < 0.2	1.00E00
tRNA methylation (GO:0030488)	31	0	.13	-	 < 0.2	1.00E00
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	36	2	.15	+	13.26	1.00E00
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	28	1	.12	+	8.52	1.00E00
regulation of telomere maintenance via telomere lengthening (GO:1904356)	61	3	.26	+	11.74	1.00E00
positive regulation of telomere capping (GO:1904355)	17	1	.07	+	14.04	1.00E00
negative regulation of telomere capping (GO:1904354)	8	1	.03	+	29.83	1.00E00
regulation of telomere capping (GO:1904353)	26	2	.11	+	18.36	1.00E00
positive regulation of protein catabolic process in the vacuole (GO:1904352)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of protein catabolic process in the vacuole (GO:1904351)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein catabolic process in the vacuole (GO:1904350)	8	0	.03	-	 < 0.2	1.00E00
progesterone metabolic process (GO:0042448)	14	0	.06	-	 < 0.2	1.00E00
anterior/posterior axis specification, embryo (GO:0008595)	15	0	.06	-	 < 0.2	1.00E00
hormone catabolic process (GO:0042447)	11	0	.05	-	 < 0.2	1.00E00
photoreceptor cell morphogenesis (GO:0008594)	1	0	.00	-	 < 0.2	1.00E00
hormone biosynthetic process (GO:0042446)	53	1	.22	+	4.50	1.00E00
regulation of Notch signaling pathway (GO:0008593)	71	1	.30	+	3.36	1.00E00
calcium ion transmembrane import into cytosol (GO:0097553)	58	0	.24	-	 < 0.2	1.00E00
hormone metabolic process (GO:0042445)	170	2	.71	+	2.81	1.00E00
regulation of Toll signaling pathway (GO:0008592)	1	0	.00	-	 < 0.2	1.00E00
regulation of Wnt signaling pathway, calcium modulating pathway (GO:0008591)	1	0	.00	-	 < 0.2	1.00E00
eye pigment metabolic process (GO:0042441)	4	0	.02	-	 < 0.2	1.00E00
pigment metabolic process (GO:0042440)	64	1	.27	+	3.73	1.00E00
nuclear migration along microtubule (GO:0030473)	3	0	.01	-	 < 0.2	1.00E00
mitotic spindle organization in nucleus (GO:0030472)	1	0	.00	-	 < 0.2	1.00E00
regulation of phosphatidylcholine catabolic process (GO:0010899)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of small intestine smooth muscle contraction (GO:1904349)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of triglyceride catabolic process (GO:0010898)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of triglyceride catabolic process (GO:0010897)	4	0	.02	-	 < 0.2	1.00E00
regulation of small intestine smooth muscle contraction (GO:1904347)	3	0	.01	-	 < 0.2	1.00E00
regulation of triglyceride catabolic process (GO:0010896)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of gastric mucosal blood circulation (GO:1904346)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of steroid biosynthetic process (GO:0010894)	23	1	.10	+	10.38	1.00E00
regulation of gastric mucosal blood circulation (GO:1904344)	1	0	.00	-	 < 0.2	1.00E00
axon midline choice point recognition (GO:0016199)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of steroid biosynthetic process (GO:0010893)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of colon smooth muscle contraction (GO:1904343)	1	0	.00	-	 < 0.2	1.00E00
axon choice point recognition (GO:0016198)	7	0	.03	-	 < 0.2	1.00E00
regulation of smoothened signaling pathway (GO:0008589)	69	0	.29	-	 < 0.2	1.00E00
endosomal transport (GO:0016197)	252	0	1.06	-	 < 0.2	1.00E00
release of cytoplasmic sequestered NF-kappaB (GO:0008588)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of sequestering of triglyceride (GO:0010891)	5	0	.02	-	 < 0.2	1.00E00
regulation of colon smooth muscle contraction (GO:1904341)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of sequestering of triglyceride (GO:0010890)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of dopaminergic neuron differentiation (GO:1904340)	4	0	.02	-	 < 0.2	1.00E00
ethanolamine-containing compound metabolic process (GO:0042439)	7	0	.03	-	 < 0.2	1.00E00
melanin biosynthetic process (GO:0042438)	12	0	.05	-	 < 0.2	1.00E00
female gonad development (GO:0008585)	87	4	.36	+	10.97	1.00E00
male gonad development (GO:0008584)	136	3	.57	+	5.26	1.00E00
vesicle-mediated transport (GO:0016192)	1783	18	7.47	+	2.41	1.00E00
indole-containing compound catabolic process (GO:0042436)	10	0	.04	-	 < 0.2	1.00E00
indole-containing compound biosynthetic process (GO:0042435)	5	0	.02	-	 < 0.2	1.00E00
regulation of synaptic growth at neuromuscular junction (GO:0008582)	5	0	.02	-	 < 0.2	1.00E00
synaptic vesicle uncoating (GO:0016191)	5	0	.02	-	 < 0.2	1.00E00
indole metabolic process (GO:0042431)	1	0	.00	-	 < 0.2	1.00E00
indole-containing compound metabolic process (GO:0042430)	24	0	.10	-	 < 0.2	1.00E00
regulation of sequestering of triglyceride (GO:0010889)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of dopaminergic neuron differentiation (GO:1904339)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of lipid storage (GO:0010888)	17	0	.07	-	 < 0.2	1.00E00
regulation of dopaminergic neuron differentiation (GO:1904338)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of cholesterol storage (GO:0010887)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of cholesterol storage (GO:0010886)	7	0	.03	-	 < 0.2	1.00E00
regulation of cholesterol storage (GO:0010885)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of lipid storage (GO:0010884)	22	0	.09	-	 < 0.2	1.00E00
regulation of lipid storage (GO:0010883)	42	0	.18	-	 < 0.2	1.00E00
synaptic vesicle to endosome fusion (GO:0016189)	1	0	.00	-	 < 0.2	1.00E00
synaptic vesicle maturation (GO:0016188)	9	0	.04	-	 < 0.2	1.00E00
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	22	0	.09	-	 < 0.2	1.00E00
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	17	0	.07	-	 < 0.2	1.00E00
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	25	0	.10	-	 < 0.2	1.00E00
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	3	0	.01	-	 < 0.2	1.00E00
serotonin metabolic process (GO:0042428)	10	0	.04	-	 < 0.2	1.00E00
thymus epithelium morphogenesis (GO:0097536)	2	0	.01	-	 < 0.2	1.00E00
lymphoid lineage cell migration into thymus (GO:0097535)	2	0	.01	-	 < 0.2	1.00E00
serotonin biosynthetic process (GO:0042427)	3	0	.01	-	 < 0.2	1.00E00
choline catabolic process (GO:0042426)	6	0	.03	-	 < 0.2	1.00E00
lymphoid lineage cell migration (GO:0097534)	2	0	.01	-	 < 0.2	1.00E00
synaptic vesicle budding from endosome (GO:0016182)	1	0	.00	-	 < 0.2	1.00E00
catecholamine catabolic process (GO:0042424)	9	0	.04	-	 < 0.2	1.00E00
snRNA processing (GO:0016180)	23	0	.10	-	 < 0.2	1.00E00
mast cell migration (GO:0097531)	6	0	.03	-	 < 0.2	1.00E00
catecholamine biosynthetic process (GO:0042423)	19	0	.08	-	 < 0.2	1.00E00
granulocyte migration (GO:0097530)	80	3	.34	+	8.95	1.00E00
norepinephrine biosynthetic process (GO:0042421)	7	0	.03	-	 < 0.2	1.00E00
dopamine catabolic process (GO:0042420)	8	0	.03	-	 < 0.2	1.00E00
regulation of complement activation, alternative pathway (GO:0030451)	2	0	.01	-	 < 0.2	1.00E00
regulation of complement activation, classical pathway (GO:0030450)	4	0	.02	-	 < 0.2	1.00E00
cholesterol transport involved in cholesterol storage (GO:0010879)	1	0	.00	-	 < 0.2	1.00E00
regulation of myofibroblast contraction (GO:1904328)	1	0	.00	-	 < 0.2	1.00E00
cholesterol storage (GO:0010878)	2	0	.01	-	 < 0.2	1.00E00
protein localization to cytosolic proteasome complex (GO:1904327)	2	0	.01	-	 < 0.2	1.00E00
lipid transport involved in lipid storage (GO:0010877)	2	0	.01	-	 < 0.2	1.00E00
lipid localization (GO:0010876)	298	2	1.25	+	1.60	1.00E00
positive regulation of cholesterol efflux (GO:0010875)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904325)	1	0	.00	-	 < 0.2	1.00E00
regulation of cholesterol efflux (GO:0010874)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of cholesterol esterification (GO:0010873)	9	0	.04	-	 < 0.2	1.00E00
regulation of inhibitory G-protein coupled receptor phosphorylation (GO:1904323)	1	0	.00	-	 < 0.2	1.00E00
regulation of cholesterol esterification (GO:0010872)	11	0	.05	-	 < 0.2	1.00E00
cellular response to forskolin (GO:1904322)	11	0	.05	-	 < 0.2	1.00E00
myeloid leukocyte migration (GO:0097529)	104	3	.44	+	6.88	1.00E00
response to forskolin (GO:1904321)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of receptor biosynthetic process (GO:0010871)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of receptor biosynthetic process (GO:0010870)	11	0	.05	-	 < 0.2	1.00E00
necroptotic signaling pathway (GO:0097527)	6	0	.03	-	 < 0.2	1.00E00
epinephrine biosynthetic process (GO:0042418)	2	0	.01	-	 < 0.2	1.00E00
dopamine metabolic process (GO:0042417)	28	0	.12	-	 < 0.2	1.00E00
dopamine biosynthetic process (GO:0042416)	10	0	.04	-	 < 0.2	1.00E00
norepinephrine metabolic process (GO:0042415)	13	1	.05	+	18.36	1.00E00
epinephrine metabolic process (GO:0042414)	3	0	.01	-	 < 0.2	1.00E00
carnitine catabolic process (GO:0042413)	1	0	.00	-	 < 0.2	1.00E00
taurine biosynthetic process (GO:0042412)	2	0	.01	-	 < 0.2	1.00E00
regulation of complement activation (GO:0030449)	111	0	.47	-	 < 0.2	1.00E00
regulation of receptor biosynthetic process (GO:0010869)	20	0	.08	-	 < 0.2	1.00E00
negative regulation of triglyceride biosynthetic process (GO:0010868)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of triglyceride biosynthetic process (GO:0010867)	11	0	.05	-	 < 0.2	1.00E00
cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904317)	1	0	.00	-	 < 0.2	1.00E00
regulation of triglyceride biosynthetic process (GO:0010866)	16	0	.07	-	 < 0.2	1.00E00
response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine (GO:1904316)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of phospholipase C activity (GO:0010863)	36	3	.15	+	19.89	1.00E00
response to methamphetamine hydrochloride (GO:1904313)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	48	0	.20	-	 < 0.2	1.00E00
cristae formation (GO:0042407)	31	1	.13	+	7.70	1.00E00
thyroid hormone catabolic process (GO:0042404)	2	0	.01	-	 < 0.2	1.00E00
thyroid hormone metabolic process (GO:0042403)	16	0	.07	-	 < 0.2	1.00E00
cellular biogenic amine catabolic process (GO:0042402)	23	0	.10	-	 < 0.2	1.00E00
base-excision repair, AP site formation via deaminated base removal (GO:0097510)	1	0	.00	-	 < 0.2	1.00E00
cellular biogenic amine biosynthetic process (GO:0042401)	23	0	.10	-	 < 0.2	1.00E00
ubiquitin-dependent ERAD pathway (GO:0030433)	68	0	.28	-	 < 0.2	1.00E00
peristalsis (GO:0030432)	10	0	.04	-	 < 0.2	1.00E00
sleep (GO:0030431)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	5	0	.02	-	 < 0.2	1.00E00
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of maternal process involved in parturition (GO:1904303)	1	0	.00	-	 < 0.2	1.00E00
regulation of maternal process involved in parturition (GO:1904301)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcytosis (GO:1904300)	1	0	.00	-	 < 0.2	1.00E00
epidermis development (GO:0008544)	408	7	1.71	+	4.09	1.00E00
fibroblast growth factor receptor signaling pathway (GO:0008543)	84	1	.35	+	2.84	1.00E00
sialylation (GO:0097503)	21	0	.09	-	 < 0.2	1.00E00
visual learning (GO:0008542)	48	0	.20	-	 < 0.2	1.00E00
mannosylation (GO:0097502)	35	0	.15	-	 < 0.2	1.00E00
stress response to metal ion (GO:0097501)	4	0	.02	-	 < 0.2	1.00E00
receptor localization to non-motile cilium (GO:0097500)	5	0	.02	-	 < 0.2	1.00E00
chromosome localization (GO:0050000)	73	2	.31	+	6.54	1.00E00
targeting of mRNA for destruction involved in RNA interference (GO:0030423)	4	0	.02	-	 < 0.2	1.00E00
production of siRNA involved in RNA interference (GO:0030422)	8	0	.03	-	 < 0.2	1.00E00
defecation (GO:0030421)	1	0	.00	-	 < 0.2	1.00E00
regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.00	-	 < 0.2	1.00E00
regulation of chromatin disassembly (GO:0010848)	2	0	.01	-	 < 0.2	1.00E00
regulation of chromatin assembly (GO:0010847)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of reciprocal meiotic recombination (GO:0010845)	2	0	.01	-	 < 0.2	1.00E00
retina layer formation (GO:0010842)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	5	0	.02	-	 < 0.2	1.00E00
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	6	0	.03	-	 < 0.2	1.00E00
respiratory chain complex IV assembly (GO:0008535)	23	0	.10	-	 < 0.2	1.00E00
calcium activated galactosylceramide scrambling (GO:0061591)	5	0	.02	-	 < 0.2	1.00E00
calcium activated phosphatidylcholine scrambling (GO:0061590)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of keratinocyte proliferation (GO:0010839)	13	1	.05	+	18.36	1.00E00
positive regulation of keratinocyte proliferation (GO:0010838)	9	2	.04	+	53.04	1.00E00
regulation of keratinocyte proliferation (GO:0010837)	28	3	.12	+	25.57	1.00E00
negative regulation of protein ADP-ribosylation (GO:0010836)	3	0	.01	-	 < 0.2	1.00E00
regulation of protein ADP-ribosylation (GO:0010835)	9	0	.04	-	 < 0.2	1.00E00
glycoside catabolic process (GO:0016139)	8	0	.03	-	 < 0.2	1.00E00
telomere maintenance via telomere lengthening (GO:0010833)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of myotube differentiation (GO:0010832)	16	1	.07	+	14.92	1.00E00
calcium activated phosphatidylserine scrambling (GO:0061589)	4	0	.02	-	 < 0.2	1.00E00
calcium activated phospholipid scrambling (GO:0061588)	5	0	.02	-	 < 0.2	1.00E00
glycoside metabolic process (GO:0016137)	18	1	.08	+	13.26	1.00E00
positive regulation of myotube differentiation (GO:0010831)	33	2	.14	+	14.46	1.00E00
regulation of myotube differentiation (GO:0010830)	57	3	.24	+	12.56	1.00E00
brassinosteroid biosynthetic process (GO:0016132)	1	0	.00	-	 < 0.2	1.00E00
intestinal epithelial cell migration (GO:0061582)	2	0	.01	-	 < 0.2	1.00E00
brassinosteroid metabolic process (GO:0016131)	1	0	.00	-	 < 0.2	1.00E00
colon epithelial cell migration (GO:0061580)	1	0	.00	-	 < 0.2	1.00E00
DNA-templated viral transcription (GO:0039695)	1	0	.00	-	 < 0.2	1.00E00
viral RNA genome replication (GO:0039694)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of glucose transport (GO:0010829)	16	2	.07	+	29.83	1.00E00
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of centrosome duplication (GO:0010826)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of centrosome duplication (GO:0010825)	7	0	.03	-	 < 0.2	1.00E00
regulation of centrosome duplication (GO:0010824)	37	0	.16	-	 < 0.2	1.00E00
negative regulation of mitochondrion organization (GO:0010823)	49	2	.21	+	9.74	1.00E00
phytosteroid biosynthetic process (GO:0016129)	3	0	.01	-	 < 0.2	1.00E00
phytosteroid metabolic process (GO:0016128)	3	0	.01	-	 < 0.2	1.00E00
sterol catabolic process (GO:0016127)	11	0	.05	-	 < 0.2	1.00E00
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	3	0	.01	-	 < 0.2	1.00E00
sterol biosynthetic process (GO:0016126)	46	1	.19	+	5.19	1.00E00
positive regulation of T cell chemotaxis (GO:0010820)	10	0	.04	-	 < 0.2	1.00E00
sterol metabolic process (GO:0016125)	129	1	.54	+	1.85	1.00E00
xanthophyll metabolic process (GO:0016122)	1	0	.00	-	 < 0.2	1.00E00
actin filament bundle retrograde transport (GO:0061573)	1	0	.00	-	 < 0.2	1.00E00
actin filament bundle organization (GO:0061572)	53	1	.22	+	4.50	1.00E00
carotene catabolic process (GO:0016121)	1	0	.00	-	 < 0.2	1.00E00
TDP phosphorylation (GO:0061571)	1	0	.00	-	 < 0.2	1.00E00
dCDP phosphorylation (GO:0061570)	1	0	.00	-	 < 0.2	1.00E00
negative stranded viral RNA replication (GO:0039689)	3	0	.01	-	 < 0.2	1.00E00
regulation of T cell chemotaxis (GO:0010819)	11	0	.05	-	 < 0.2	1.00E00
T cell chemotaxis (GO:0010818)	12	0	.05	-	 < 0.2	1.00E00
regulation of hormone levels (GO:0010817)	492	8	2.06	+	3.88	1.00E00
calcitonin catabolic process (GO:0010816)	1	0	.00	-	 < 0.2	1.00E00
bradykinin catabolic process (GO:0010815)	5	0	.02	-	 < 0.2	1.00E00
substance P catabolic process (GO:0010814)	1	0	.00	-	 < 0.2	1.00E00
neuropeptide catabolic process (GO:0010813)	2	0	.01	-	 < 0.2	1.00E00
carotene metabolic process (GO:0016119)	2	0	.01	-	 < 0.2	1.00E00
UDP phosphorylation (GO:0061569)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cell-substrate adhesion (GO:0010811)	110	2	.46	+	4.34	1.00E00
positive regulation of PERK-mediated unfolded protein response (GO:1903899)	4	0	.02	-	 < 0.2	1.00E00
GDP phosphorylation (GO:0061568)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of PERK-mediated unfolded protein response (GO:1903898)	5	0	.02	-	 < 0.2	1.00E00
carotenoid metabolic process (GO:0016116)	1	0	.00	-	 < 0.2	1.00E00
dCMP phosphorylation (GO:0061567)	1	0	.00	-	 < 0.2	1.00E00
terpenoid catabolic process (GO:0016115)	6	0	.03	-	 < 0.2	1.00E00
regulation of PERK-mediated unfolded protein response (GO:1903897)	10	0	.04	-	 < 0.2	1.00E00
CMP phosphorylation (GO:0061566)	1	0	.00	-	 < 0.2	1.00E00
terpenoid biosynthetic process (GO:0016114)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of IRE1-mediated unfolded protein response (GO:1903896)	9	0	.04	-	 < 0.2	1.00E00
dAMP phosphorylation (GO:0061565)	1	0	.00	-	 < 0.2	1.00E00
axon development (GO:0061564)	378	7	1.58	+	4.42	1.00E00
negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	2	0	.01	-	 < 0.2	1.00E00
regulation of IRE1-mediated unfolded protein response (GO:1903894)	13	1	.05	+	18.36	1.00E00
negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	1	0	.00	-	 < 0.2	1.00E00
regulation of ATF6-mediated unfolded protein response (GO:1903891)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of synaptic vesicle priming (GO:0010808)	1	0	.00	-	 < 0.2	1.00E00
regulation of synaptic vesicle priming (GO:0010807)	6	0	.03	-	 < 0.2	1.00E00
regulation of lysine import (GO:0010805)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	20	0	.08	-	 < 0.2	1.00E00
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	59	1	.25	+	4.05	1.00E00
tetraterpenoid metabolic process (GO:0016108)	1	0	.00	-	 < 0.2	1.00E00
sesquiterpenoid catabolic process (GO:0016107)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of plant epidermal cell differentiation (GO:1903889)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	28	3	.12	+	25.57	1.00E00
regulation of plant epidermal cell differentiation (GO:1903888)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886)	1	0	.00	-	 < 0.2	1.00E00
diterpenoid catabolic process (GO:0016103)	4	0	.02	-	 < 0.2	1.00E00
diterpenoid biosynthetic process (GO:0016102)	9	0	.04	-	 < 0.2	1.00E00
regulation of chemokine (C-C motif) ligand 20 production (GO:1903884)	1	0	.00	-	 < 0.2	1.00E00
ganglion morphogenesis (GO:0061552)	2	0	.01	-	 < 0.2	1.00E00
diterpenoid metabolic process (GO:0016101)	96	1	.40	+	2.49	1.00E00
positive regulation of interleukin-17-mediated signaling pathway (GO:1903883)	1	0	.00	-	 < 0.2	1.00E00
trigeminal ganglion development (GO:0061551)	5	0	.02	-	 < 0.2	1.00E00
cranial ganglion development (GO:0061550)	6	0	.03	-	 < 0.2	1.00E00
regulation of interleukin-17-mediated signaling pathway (GO:1903881)	1	0	.00	-	 < 0.2	1.00E00
membrane fusion involved in viral entry into host cell (GO:0039663)	7	0	.03	-	 < 0.2	1.00E00
sympathetic ganglion development (GO:0061549)	9	0	.04	-	 < 0.2	1.00E00
ganglion development (GO:0061548)	13	0	.05	-	 < 0.2	1.00E00
ferrous iron transmembrane transport (GO:1903874)	5	0	.02	-	 < 0.2	1.00E00
modulation by virus of host gene expression (GO:0039656)	3	0	.01	-	 < 0.2	1.00E00
suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process (GO:0039650)	1	0	.00	-	 < 0.2	1.00E00
regulation of tube diameter (GO:0035296)	129	3	.54	+	5.55	1.00E00
glycine secretion, neurotransmission (GO:0061537)	1	0	.00	-	 < 0.2	1.00E00
extraembryonic membrane development (GO:1903867)	9	0	.04	-	 < 0.2	1.00E00
glycine secretion (GO:0061536)	1	0	.00	-	 < 0.2	1.00E00
glutamate secretion, neurotransmission (GO:0061535)	1	0	.00	-	 < 0.2	1.00E00
trunk segmentation (GO:0035290)	4	0	.02	-	 < 0.2	1.00E00
gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of oxidative phosphorylation (GO:1903862)	8	1	.03	+	29.83	1.00E00
positive regulation of dendrite extension (GO:1903861)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of dendrite extension (GO:1903860)	2	0	.01	-	 < 0.2	1.00E00
brain segmentation (GO:0035284)	2	0	.01	-	 < 0.2	1.00E00
regulation of dendrite extension (GO:1903859)	20	0	.08	-	 < 0.2	1.00E00
central nervous system segmentation (GO:0035283)	2	0	.01	-	 < 0.2	1.00E00
segmentation (GO:0035282)	92	2	.39	+	5.19	1.00E00
acetylcholine secretion (GO:0061526)	1	0	.00	-	 < 0.2	1.00E00
hindgut development (GO:0061525)	8	0	.03	-	 < 0.2	1.00E00
pre-miRNA export from nucleus (GO:0035281)	2	0	.01	-	 < 0.2	1.00E00
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280)	7	1	.03	+	34.09	1.00E00
cilium disassembly (GO:0061523)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cristae formation (GO:1903852)	1	0	.00	-	 < 0.2	1.00E00
regulation of cristae formation (GO:1903850)	1	0	.00	-	 < 0.2	1.00E00
mRNA cleavage involved in gene silencing by miRNA (GO:0035279)	2	0	.01	-	 < 0.2	1.00E00
miRNA mediated inhibition of translation (GO:0035278)	12	0	.05	-	 < 0.2	1.00E00
macrophage homeostasis (GO:0061519)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of aorta morphogenesis (GO:1903849)	2	0	.01	-	 < 0.2	1.00E00
microglial cell proliferation (GO:0061518)	2	0	.01	-	 < 0.2	1.00E00
macrophage proliferation (GO:0061517)	2	0	.01	-	 < 0.2	1.00E00
exocrine system development (GO:0035272)	46	2	.19	+	10.38	1.00E00
regulation of aorta morphogenesis (GO:1903847)	2	0	.01	-	 < 0.2	1.00E00
myeloid cell development (GO:0061515)	49	2	.21	+	9.74	1.00E00
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	25	0	.10	-	 < 0.2	1.00E00
endocrine system development (GO:0035270)	124	5	.52	+	9.62	1.00E00
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	71	3	.30	+	10.08	1.00E00
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	103	3	.43	+	6.95	1.00E00
protein localization to cilium (GO:0061512)	33	0	.14	-	 < 0.2	1.00E00
inorganic anion transport (GO:0015698)	162	0	.68	-	 < 0.2	1.00E00
centriole elongation (GO:0061511)	2	0	.01	-	 < 0.2	1.00E00
quaternary ammonium group transport (GO:0015697)	9	0	.04	-	 < 0.2	1.00E00
ammonium transport (GO:0015696)	50	1	.21	+	4.77	1.00E00
organic cation transport (GO:0015695)	34	0	.14	-	 < 0.2	1.00E00
mercury ion transport (GO:0015694)	1	0	.00	-	 < 0.2	1.00E00
magnesium ion transport (GO:0015693)	18	0	.08	-	 < 0.2	1.00E00
lead ion transport (GO:0015692)	1	0	.00	-	 < 0.2	1.00E00
cadmium ion transport (GO:0015691)	4	0	.02	-	 < 0.2	1.00E00
protein O-linked mannosylation (GO:0035269)	15	0	.06	-	 < 0.2	1.00E00
protein mannosylation (GO:0035268)	22	0	.09	-	 < 0.2	1.00E00
organ growth (GO:0035265)	74	3	.31	+	9.68	1.00E00
multicellular organism growth (GO:0035264)	84	3	.35	+	8.52	1.00E00
positive regulation of mRNA 3'-UTR binding (GO:1903839)	1	0	.00	-	 < 0.2	1.00E00
CDP phosphorylation (GO:0061508)	1	0	.00	-	 < 0.2	1.00E00
gonad morphogenesis (GO:0035262)	2	0	.01	-	 < 0.2	1.00E00
regulation of mRNA 3'-UTR binding (GO:1903837)	1	0	.00	-	 < 0.2	1.00E00
external genitalia morphogenesis (GO:0035261)	2	0	.01	-	 < 0.2	1.00E00
early endosome to recycling endosome transport (GO:0061502)	2	0	.01	-	 < 0.2	1.00E00
molybdate ion transport (GO:0015689)	1	0	.00	-	 < 0.2	1.00E00
iron chelate transport (GO:0015688)	3	0	.01	-	 < 0.2	1.00E00
signal transduction involved in cellular response to ammonium ion (GO:1903831)	23	0	.10	-	 < 0.2	1.00E00
magnesium ion transmembrane transport (GO:1903830)	17	0	.07	-	 < 0.2	1.00E00
ferrous iron transport (GO:0015684)	5	0	.02	-	 < 0.2	1.00E00
ferric iron transport (GO:0015682)	39	0	.16	-	 < 0.2	1.00E00
intracellular copper ion transport (GO:0015680)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular protein localization (GO:1903828)	144	0	.60	-	 < 0.2	1.00E00
arginine transmembrane transport (GO:1903826)	5	0	.02	-	 < 0.2	1.00E00
organic acid transmembrane transport (GO:1903825)	114	0	.48	-	 < 0.2	1.00E00
negative regulation of telomere single strand break repair (GO:1903824)	1	0	.00	-	 < 0.2	1.00E00
plasma membrane copper ion transport (GO:0015679)	2	0	.01	-	 < 0.2	1.00E00
copper ion import (GO:0015677)	6	0	.03	-	 < 0.2	1.00E00
vanadium ion transport (GO:0015676)	1	0	.00	-	 < 0.2	1.00E00
nickel cation transport (GO:0015675)	1	0	.00	-	 < 0.2	1.00E00
monovalent inorganic cation transport (GO:0015672)	423	3	1.77	+	1.69	1.00E00
oxygen transport (GO:0015671)	14	0	.06	-	 < 0.2	1.00E00
carbon dioxide transport (GO:0015670)	5	0	.02	-	 < 0.2	1.00E00
synaptic transmission, glutamatergic (GO:0035249)	23	0	.10	-	 < 0.2	1.00E00
peptidyl-arginine omega-N-methylation (GO:0035247)	10	0	.04	-	 < 0.2	1.00E00
peptidyl-arginine N-methylation (GO:0035246)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of voltage-gated potassium channel activity (GO:1903818)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of voltage-gated potassium channel activity (GO:1903817)	9	1	.04	+	26.52	1.00E00
positive regulation of collecting lymphatic vessel constriction (GO:1903816)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of collecting lymphatic vessel constriction (GO:1903815)	1	0	.00	-	 < 0.2	1.00E00
regulation of collecting lymphatic vessel constriction (GO:1903814)	2	0	.01	-	 < 0.2	1.00E00
gas transport (GO:0015669)	19	0	.08	-	 < 0.2	1.00E00
tube morphogenesis (GO:0035239)	336	6	1.41	+	4.26	1.00E00
vitamin A biosynthetic process (GO:0035238)	1	0	.00	-	 < 0.2	1.00E00
ionotropic glutamate receptor signaling pathway (GO:0035235)	26	0	.11	-	 < 0.2	1.00E00
ectopic germ cell programmed cell death (GO:0035234)	8	0	.03	-	 < 0.2	1.00E00
L-glutamine import across plasma membrane (GO:1903803)	1	0	.00	-	 < 0.2	1.00E00
L-glutamate(1-) import across plasma membrane (GO:1903802)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800)	8	1	.03	+	29.83	1.00E00
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.00	-	 < 0.2	1.00E00
cell competition in a multicellular organism (GO:0035212)	1	0	.00	-	 < 0.2	1.00E00
transport of virus (GO:0046794)	58	1	.24	+	4.11	1.00E00
viral replication complex formation and maintenance (GO:0046786)	1	0	.00	-	 < 0.2	1.00E00
microtubule polymerization (GO:0046785)	29	0	.12	-	 < 0.2	1.00E00
viral mRNA export from host cell nucleus (GO:0046784)	8	0	.03	-	 < 0.2	1.00E00
regulation of viral transcription (GO:0046782)	67	1	.28	+	3.56	1.00E00
modification by virus of host mRNA processing (GO:0046778)	2	0	.01	-	 < 0.2	1.00E00
viral budding (GO:0046755)	23	0	.10	-	 < 0.2	1.00E00
cellular modified amino acid biosynthetic process (GO:0042398)	39	0	.16	-	 < 0.2	1.00E00
phosphagen biosynthetic process (GO:0042396)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcytosis (GO:1904298)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ERAD pathway (GO:1904294)	14	2	.06	+	34.09	1.00E00
viral capsid secondary envelopment (GO:0046745)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ERAD pathway (GO:1904293)	13	0	.05	-	 < 0.2	1.00E00
regulation of ERAD pathway (GO:1904292)	28	2	.12	+	17.05	1.00E00
protein localization to non-motile cilium (GO:0097499)	10	0	.04	-	 < 0.2	1.00E00
endothelial tube lumen extension (GO:0097498)	2	0	.01	-	 < 0.2	1.00E00
blood vessel endothelial cell delamination (GO:0097497)	1	0	.00	-	 < 0.2	1.00E00
regulation of vesicle size (GO:0097494)	4	0	.02	-	 < 0.2	1.00E00
response to histamine (GO:0034776)	11	0	.05	-	 < 0.2	1.00E00
glutathione transmembrane transport (GO:0034775)	1	0	.00	-	 < 0.2	1.00E00
sympathetic neuron projection guidance (GO:0097491)	4	0	.02	-	 < 0.2	1.00E00
sympathetic neuron projection extension (GO:0097490)	4	0	.02	-	 < 0.2	1.00E00
histone H4-K20 trimethylation (GO:0034773)	6	0	.03	-	 < 0.2	1.00E00
histone H4-K20 methylation (GO:0034770)	9	0	.04	-	 < 0.2	1.00E00
regulation of mitotic DNA damage checkpoint (GO:1904289)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283)	1	0	.00	-	 < 0.2	1.00E00
regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282)	1	0	.00	-	 < 0.2	1.00E00
active induction of host immune response by virus (GO:0046732)	2	0	.01	-	 < 0.2	1.00E00
induction of host immune response by virus (GO:0046730)	2	0	.01	-	 < 0.2	1.00E00
basement membrane disassembly (GO:0034769)	3	0	.01	-	 < 0.2	1.00E00
neuron projection guidance (GO:0097485)	229	5	.96	+	5.21	1.00E00
vitamin K catabolic process (GO:0042377)	2	0	.01	-	 < 0.2	1.00E00
dendrite extension (GO:0097484)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of ion transmembrane transport (GO:0034767)	130	2	.54	+	3.67	1.00E00
phylloquinone catabolic process (GO:0042376)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of ion transmembrane transport (GO:0034766)	84	2	.35	+	5.68	1.00E00
regulation of ion transmembrane transport (GO:0034765)	440	6	1.84	+	3.25	1.00E00
phylloquinone metabolic process (GO:0042374)	3	0	.01	-	 < 0.2	1.00E00
vitamin K metabolic process (GO:0042373)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of transmembrane transport (GO:0034764)	136	2	.57	+	3.51	1.00E00
establishment of synaptic vesicle localization (GO:0097480)	112	0	.47	-	 < 0.2	1.00E00
negative regulation of transmembrane transport (GO:0034763)	90	2	.38	+	5.30	1.00E00
regulation of transmembrane transport (GO:0034762)	455	7	1.91	+	3.67	1.00E00
vitamin K biosynthetic process (GO:0042371)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of iron ion transmembrane transport (GO:0034761)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of iron ion transmembrane transport (GO:0034760)	2	0	.01	-	 < 0.2	1.00E00
positive regulation by virus of viral protein levels in host cell (GO:0046726)	4	0	.02	-	 < 0.2	1.00E00
negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.01	-	 < 0.2	1.00E00
tricellular tight junction assembly (GO:1904274)	1	0	.00	-	 < 0.2	1.00E00
oxalic acid secretion (GO:0046724)	2	0	.01	-	 < 0.2	1.00E00
synaptic vesicle localization (GO:0097479)	115	0	.48	-	 < 0.2	1.00E00
L-proline import across plasma membrane (GO:1904271)	1	0	.00	-	 < 0.2	1.00E00
vitamin D catabolic process (GO:0042369)	3	0	.01	-	 < 0.2	1.00E00
lateral motor column neuron migration (GO:0097477)	3	0	.01	-	 < 0.2	1.00E00
vitamin D biosynthetic process (GO:0042368)	3	0	.01	-	 < 0.2	1.00E00
regulation of iron ion transmembrane transport (GO:0034759)	4	0	.02	-	 < 0.2	1.00E00
spinal cord motor neuron migration (GO:0097476)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of iron ion transport (GO:0034758)	2	0	.01	-	 < 0.2	1.00E00
motor neuron migration (GO:0097475)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of iron ion transport (GO:0034757)	2	0	.01	-	 < 0.2	1.00E00
retinal rod cell apoptotic process (GO:0097473)	1	0	.00	-	 < 0.2	1.00E00
water-soluble vitamin catabolic process (GO:0042365)	2	0	.01	-	 < 0.2	1.00E00
regulation of iron ion transport (GO:0034756)	4	0	.02	-	 < 0.2	1.00E00
water-soluble vitamin biosynthetic process (GO:0042364)	9	0	.04	-	 < 0.2	1.00E00
iron ion transmembrane transport (GO:0034755)	16	0	.07	-	 < 0.2	1.00E00
cellular hormone metabolic process (GO:0034754)	110	1	.46	+	2.17	1.00E00
fat-soluble vitamin catabolic process (GO:0042363)	9	0	.04	-	 < 0.2	1.00E00
fat-soluble vitamin biosynthetic process (GO:0042362)	6	0	.03	-	 < 0.2	1.00E00
menaquinone catabolic process (GO:0042361)	2	0	.01	-	 < 0.2	1.00E00
vitamin E metabolic process (GO:0042360)	4	0	.02	-	 < 0.2	1.00E00
membrane disassembly (GO:0030397)	48	3	.20	+	14.92	1.00E00
fructoselysine metabolic process (GO:0030393)	1	0	.00	-	 < 0.2	1.00E00
regulation by virus of viral protein levels in host cell (GO:0046719)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of Schwann cell chemotaxis (GO:1904268)	1	0	.00	-	 < 0.2	1.00E00
acid secretion (GO:0046717)	78	0	.33	-	 < 0.2	1.00E00
regulation of Schwann cell chemotaxis (GO:1904266)	1	0	.00	-	 < 0.2	1.00E00
muscle cell cellular homeostasis (GO:0046716)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of TORC1 signaling (GO:1904263)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of TORC1 signaling (GO:1904262)	13	1	.05	+	18.36	1.00E00
borate transport (GO:0046713)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	5	0	.02	-	 < 0.2	1.00E00
GDP catabolic process (GO:0046712)	1	0	.00	-	 < 0.2	1.00E00
programmed cell death in response to reactive oxygen species (GO:0097468)	2	0	.01	-	 < 0.2	1.00E00
GDP biosynthetic process (GO:0046711)	1	0	.00	-	 < 0.2	1.00E00
GDP metabolic process (GO:0046710)	14	0	.06	-	 < 0.2	1.00E00
vitamin D metabolic process (GO:0042359)	12	0	.05	-	 < 0.2	1.00E00
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	4	0	.02	-	 < 0.2	1.00E00
thiamine diphosphate metabolic process (GO:0042357)	2	0	.01	-	 < 0.2	1.00E00
L-fucose catabolic process (GO:0042355)	9	0	.04	-	 < 0.2	1.00E00
L-fucose metabolic process (GO:0042354)	9	0	.04	-	 < 0.2	1.00E00
GDP-L-fucose salvage (GO:0042352)	1	0	.00	-	 < 0.2	1.00E00
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	2	0	.01	-	 < 0.2	1.00E00
GDP-L-fucose biosynthetic process (GO:0042350)	3	0	.01	-	 < 0.2	1.00E00
fructosamine metabolic process (GO:0030389)	1	0	.00	-	 < 0.2	1.00E00
fructose 1,6-bisphosphate metabolic process (GO:0030388)	7	0	.03	-	 < 0.2	1.00E00
sperm mitochondrion organization (GO:0030382)	2	0	.01	-	 < 0.2	1.00E00
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	5	0	.02	-	 < 0.2	1.00E00
IDP catabolic process (GO:0046709)	2	0	.01	-	 < 0.2	1.00E00
IDP metabolic process (GO:0046707)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of bile acid metabolic process (GO:1904253)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of bile acid metabolic process (GO:1904252)	4	0	.02	-	 < 0.2	1.00E00
regulation of bile acid metabolic process (GO:1904251)	12	0	.05	-	 < 0.2	1.00E00
heterocycle catabolic process (GO:0046700)	403	2	1.69	+	1.18	1.00E00
negative regulation of NF-kappaB import into nucleus (GO:0042347)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of NF-kappaB import into nucleus (GO:0042346)	26	0	.11	-	 < 0.2	1.00E00
regulation of NF-kappaB import into nucleus (GO:0042345)	47	0	.20	-	 < 0.2	1.00E00
keratan sulfate catabolic process (GO:0042340)	12	0	.05	-	 < 0.2	1.00E00
regulation of peptidyl-threonine phosphorylation (GO:0010799)	40	3	.17	+	17.90	1.00E00
regulation of multivesicular body size involved in endosome transport (GO:0010797)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of polynucleotide adenylyltransferase activity (GO:1904247)	1	0	.00	-	 < 0.2	1.00E00
regulation of multivesicular body size (GO:0010796)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of polynucleotide adenylyltransferase activity (GO:1904246)	1	0	.00	-	 < 0.2	1.00E00
regulation of ubiquinone biosynthetic process (GO:0010795)	1	0	.00	-	 < 0.2	1.00E00
regulation of polynucleotide adenylyltransferase activity (GO:1904245)	2	0	.01	-	 < 0.2	1.00E00
regulation of mRNA export from nucleus (GO:0010793)	6	0	.03	-	 < 0.2	1.00E00
monoterpenoid metabolic process (GO:0016098)	6	0	.03	-	 < 0.2	1.00E00
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.00	-	 < 0.2	1.00E00
keratan sulfate metabolic process (GO:0042339)	34	0	.14	-	 < 0.2	1.00E00
polyprenol catabolic process (GO:0016095)	3	0	.01	-	 < 0.2	1.00E00
polyprenol biosynthetic process (GO:0016094)	2	0	.01	-	 < 0.2	1.00E00
histone H3-K79 methylation (GO:0034729)	1	0	.00	-	 < 0.2	1.00E00
nucleosome organization (GO:0034728)	148	1	.62	+	1.61	1.00E00
polyprenol metabolic process (GO:0016093)	8	0	.03	-	 < 0.2	1.00E00
piecemeal microautophagy of nucleus (GO:0034727)	1	0	.00	-	 < 0.2	1.00E00
cuticle development (GO:0042335)	3	0	.01	-	 < 0.2	1.00E00
DNA replication-independent nucleosome organization (GO:0034724)	40	0	.17	-	 < 0.2	1.00E00
DNA replication-dependent nucleosome organization (GO:0034723)	10	1	.04	+	23.87	1.00E00
histone H3-K4 demethylation, trimethyl-H3-K4-specific (GO:0034721)	2	0	.01	-	 < 0.2	1.00E00
histone H3-K4 demethylation (GO:0034720)	8	0	.03	-	 < 0.2	1.00E00
meiotic sister chromatid cohesion involved in meiosis I (GO:0010789)	1	0	.00	-	 < 0.2	1.00E00
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.00	-	 < 0.2	1.00E00
pericyte cell differentiation (GO:1904238)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	2	1	.01	+	 > 100	1.00E00
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	2	1	.01	+	 > 100	1.00E00
positive regulation of aconitate hydratase activity (GO:1904234)	2	0	.01	-	 < 0.2	1.00E00
regulation of aconitate hydratase activity (GO:1904232)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of succinate dehydrogenase activity (GO:1904231)	2	0	.01	-	 < 0.2	1.00E00
supramolecular fiber organization (GO:0097435)	384	7	1.61	+	4.35	1.00E00
synaptic vesicle priming (GO:0016082)	9	0	.04	-	 < 0.2	1.00E00
synaptic vesicle docking (GO:0016081)	8	0	.03	-	 < 0.2	1.00E00
synaptic vesicle targeting (GO:0016080)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	5	0	.02	-	 < 0.2	1.00E00
regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	6	0	.03	-	 < 0.2	1.00E00
regulation of succinate dehydrogenase activity (GO:1904229)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)	1	1	.00	+	 > 100	1.00E00
regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)	1	1	.00	+	 > 100	1.00E00
negative regulation of glucuronosyltransferase activity (GO:1904224)	8	0	.03	-	 < 0.2	1.00E00
synaptic vesicle exocytosis (GO:0016079)	63	0	.26	-	 < 0.2	1.00E00
regulation of glucuronosyltransferase activity (GO:1904223)	8	0	.03	-	 < 0.2	1.00E00
tRNA catabolic process (GO:0016078)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of serine C-palmitoyltransferase activity (GO:1904222)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	82	0	.34	-	 < 0.2	1.00E00
snoRNA catabolic process (GO:0016077)	1	0	.00	-	 < 0.2	1.00E00
protein maturation by iron-sulfur cluster transfer (GO:0097428)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	139	3	.58	+	5.15	1.00E00
regulation of serine C-palmitoyltransferase activity (GO:1904220)	4	0	.02	-	 < 0.2	1.00E00
rRNA catabolic process (GO:0016075)	17	0	.07	-	 < 0.2	1.00E00
snoRNA metabolic process (GO:0016074)	14	0	.06	-	 < 0.2	1.00E00
snRNA metabolic process (GO:0016073)	87	0	.36	-	 < 0.2	1.00E00
rRNA metabolic process (GO:0016072)	285	1	1.19	-	.84	1.00E00
penicillin metabolic process (GO:0042316)	1	0	.00	-	 < 0.2	1.00E00
mRNA metabolic process (GO:0016071)	668	3	2.80	+	1.07	1.00E00
RNA metabolic process (GO:0016070)	3447	20	14.44	+	1.38	1.00E00
liver regeneration (GO:0097421)	35	2	.15	+	13.64	1.00E00
protein kinase C deactivation (GO:0042313)	1	0	.00	-	 < 0.2	1.00E00
vasodilation (GO:0042311)	31	0	.13	-	 < 0.2	1.00E00
vasoconstriction (GO:0042310)	30	1	.13	+	7.96	1.00E00
regulation of cell morphogenesis involved in differentiation (GO:0010769)	265	3	1.11	+	2.70	1.00E00
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010768)	1	0	.00	-	 < 0.2	1.00E00
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217)	3	0	.01	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767)	3	1	.01	+	79.55	1.00E00
negative regulation of sodium ion transport (GO:0010766)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of sodium ion transport (GO:0010765)	32	1	.13	+	7.46	1.00E00
negative regulation of fibroblast migration (GO:0010764)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of fibroblast migration (GO:0010763)	12	1	.05	+	19.89	1.00E00
negative regulation of iodide transmembrane transport (GO:1904213)	1	0	.00	-	 < 0.2	1.00E00
regulation of fibroblast migration (GO:0010762)	29	1	.12	+	8.23	1.00E00
regulation of iodide transmembrane transport (GO:1904212)	1	0	.00	-	 < 0.2	1.00E00
fibroblast migration (GO:0010761)	10	0	.04	-	 < 0.2	1.00E00
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of macrophage chemotaxis (GO:0010760)	6	0	.03	-	 < 0.2	1.00E00
homoiothermy (GO:0042309)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of protein import into nucleus (GO:0042308)	61	0	.26	-	 < 0.2	1.00E00
immunoglobulin mediated immune response (GO:0016064)	178	1	.75	+	1.34	1.00E00
adaptation of rhodopsin mediated signaling (GO:0016062)	1	0	.00	-	 < 0.2	1.00E00
regulation of fatty acid biosynthetic process (GO:0042304)	39	0	.16	-	 < 0.2	1.00E00
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	4	0	.02	-	 < 0.2	1.00E00
molting cycle (GO:0042303)	90	4	.38	+	10.61	1.00E00
negative regulation of cell migration (GO:0030336)	228	4	.96	+	4.19	1.00E00
positive regulation of macrophage chemotaxis (GO:0010759)	15	2	.06	+	31.82	1.00E00
positive regulation of chemokine (C-C motif) ligand 2 secretion (GO:1904209)	2	0	.01	-	 < 0.2	1.00E00
regulation of macrophage chemotaxis (GO:0010758)	23	2	.10	+	20.75	1.00E00
negative regulation of plasminogen activation (GO:0010757)	6	1	.03	+	39.78	1.00E00
regulation of chemokine (C-C motif) ligand 2 secretion (GO:1904207)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of plasminogen activation (GO:0010756)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of skeletal muscle hypertrophy (GO:1904206)	1	0	.00	-	 < 0.2	1.00E00
regulation of plasminogen activation (GO:0010755)	12	1	.05	+	19.89	1.00E00
negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle hypertrophy (GO:1904204)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cGMP-mediated signaling (GO:0010754)	1	0	.00	-	 < 0.2	1.00E00
regulation of cGMP-mediated signaling (GO:0010752)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of iodide transport (GO:1904202)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	3	0	.01	-	 < 0.2	1.00E00
regulation of iodide transport (GO:1904201)	1	0	.00	-	 < 0.2	1.00E00
rhodopsin mediated signaling pathway (GO:0016056)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of nitric oxide mediated signal transduction (GO:0010750)	1	0	.00	-	 < 0.2	1.00E00
Wnt signaling pathway (GO:0016055)	348	3	1.46	+	2.06	1.00E00
organic acid catabolic process (GO:0016054)	239	0	1.00	-	 < 0.2	1.00E00
organic acid biosynthetic process (GO:0016053)	279	4	1.17	+	3.42	1.00E00
carbohydrate catabolic process (GO:0016052)	112	1	.47	+	2.13	1.00E00
cellular response to raffinose (GO:0097403)	1	0	.00	-	 < 0.2	1.00E00
carbohydrate biosynthetic process (GO:0016051)	125	3	.52	+	5.73	1.00E00
neuroblast migration (GO:0097402)	1	0	.00	-	 < 0.2	1.00E00
vesicle organization (GO:0016050)	320	2	1.34	+	1.49	1.00E00
synaptic vesicle lumen acidification (GO:0097401)	1	0	.00	-	 < 0.2	1.00E00
prenylcysteine metabolic process (GO:0030329)	2	0	.01	-	 < 0.2	1.00E00
prenylcysteine catabolic process (GO:0030328)	2	0	.01	-	 < 0.2	1.00E00
prenylated protein catabolic process (GO:0030327)	3	0	.01	-	 < 0.2	1.00E00
embryonic limb morphogenesis (GO:0030326)	128	0	.54	-	 < 0.2	1.00E00
adrenal gland development (GO:0030325)	22	0	.09	-	 < 0.2	1.00E00
lung development (GO:0030324)	170	5	.71	+	7.02	1.00E00
respiratory tube development (GO:0030323)	174	5	.73	+	6.86	1.00E00
stabilization of membrane potential (GO:0030322)	16	0	.07	-	 < 0.2	1.00E00
transepithelial chloride transport (GO:0030321)	5	0	.02	-	 < 0.2	1.00E00
cellular monovalent inorganic anion homeostasis (GO:0030320)	15	0	.06	-	 < 0.2	1.00E00
regulation of nitric oxide mediated signal transduction (GO:0010749)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of plasma membrane long-chain fatty acid transport (GO:0010748)	4	1	.02	+	59.66	1.00E00
regulation of plasma membrane long-chain fatty acid transport (GO:0010746)	4	1	.02	+	59.66	1.00E00
negative regulation of macrophage derived foam cell differentiation (GO:0010745)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of macrophage derived foam cell differentiation (GO:0010744)	16	1	.07	+	14.92	1.00E00
cell growth (GO:0016049)	146	3	.61	+	4.90	1.00E00
regulation of macrophage derived foam cell differentiation (GO:0010743)	29	1	.12	+	8.23	1.00E00
detection of temperature stimulus (GO:0016048)	20	0	.08	-	 < 0.2	1.00E00
macrophage derived foam cell differentiation (GO:0010742)	7	0	.03	-	 < 0.2	1.00E00
detection of fungus (GO:0016046)	1	0	.00	-	 < 0.2	1.00E00
detection of bacterium (GO:0016045)	15	0	.06	-	 < 0.2	1.00E00
lipid catabolic process (GO:0016042)	273	0	1.14	-	 < 0.2	1.00E00
melanocyte differentiation (GO:0030318)	19	1	.08	+	12.56	1.00E00
flagellated sperm motility (GO:0030317)	72	0	.30	-	 < 0.2	1.00E00
osteoclast differentiation (GO:0030316)	34	2	.14	+	14.04	1.00E00
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of protein kinase A signaling (GO:0010739)	11	0	.05	-	 < 0.2	1.00E00
regulation of protein kinase A signaling (GO:0010738)	25	0	.10	-	 < 0.2	1.00E00
protein kinase A signaling (GO:0010737)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of transcription via serum response element binding (GO:0010735)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of protein glutathionylation (GO:0010734)	2	1	.01	+	 > 100	1.00E00
regulation of protein glutathionylation (GO:0010732)	2	1	.01	+	 > 100	1.00E00
absorption of visible light (GO:0016038)	1	0	.00	-	 < 0.2	1.00E00
light absorption (GO:0016037)	1	0	.00	-	 < 0.2	1.00E00
cellular response to phosphate starvation (GO:0016036)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	3	0	.01	-	 < 0.2	1.00E00
memory T cell proliferation (GO:0061485)	1	0	.00	-	 < 0.2	1.00E00
hematopoietic stem cell homeostasis (GO:0061484)	4	1	.02	+	59.66	1.00E00
tRNA import into mitochondrion (GO:0016031)	2	0	.01	-	 < 0.2	1.00E00
response to TNF agonist (GO:0061481)	1	0	.00	-	 < 0.2	1.00E00
poly-N-acetyllactosamine metabolic process (GO:0030309)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of cell growth (GO:0030307)	155	5	.65	+	7.70	1.00E00
deoxynucleotide transport (GO:0030302)	1	0	.00	-	 < 0.2	1.00E00
cholesterol transport (GO:0030301)	53	1	.22	+	4.50	1.00E00
regulation of intestinal cholesterol absorption (GO:0030300)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	1	0	.00	-	 < 0.2	1.00E00
regulation of hydrogen peroxide biosynthetic process (GO:0010728)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of hydrogen peroxide metabolic process (GO:0010727)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of hydrogen peroxide metabolic process (GO:0010726)	2	0	.01	-	 < 0.2	1.00E00
regulation of primitive erythrocyte differentiation (GO:0010725)	2	0	.01	-	 < 0.2	1.00E00
regulation of definitive erythrocyte differentiation (GO:0010724)	4	0	.02	-	 < 0.2	1.00E00
regulation of ferrochelatase activity (GO:0010722)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell development (GO:0010721)	290	7	1.22	+	5.76	1.00E00
positive regulation of cell development (GO:0010720)	483	4	2.02	+	1.98	1.00E00
response to anticoagulant (GO:0061476)	1	0	.00	-	 < 0.2	1.00E00
CDP-diacylglycerol biosynthetic process (GO:0016024)	13	0	.05	-	 < 0.2	1.00E00
T follicular helper cell differentiation (GO:0061470)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of epithelial to mesenchymal transition (GO:0010719)	26	0	.11	-	 < 0.2	1.00E00
positive regulation of epithelial to mesenchymal transition (GO:0010718)	44	1	.18	+	5.42	1.00E00
regulation of epithelial to mesenchymal transition (GO:0010717)	79	1	.33	+	3.02	1.00E00
negative regulation of extracellular matrix disassembly (GO:0010716)	4	1	.02	+	59.66	1.00E00
regulation of extracellular matrix disassembly (GO:0010715)	15	1	.06	+	15.91	1.00E00
positive regulation of collagen metabolic process (GO:0010714)	26	2	.11	+	18.36	1.00E00
negative regulation of collagen metabolic process (GO:0010713)	9	1	.04	+	26.52	1.00E00
regulation of type B pancreatic cell proliferation (GO:0061469)	11	1	.05	+	21.70	1.00E00
regulation of collagen metabolic process (GO:0010712)	38	3	.16	+	18.84	1.00E00
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of collagen catabolic process (GO:0010711)	1	0	.00	-	 < 0.2	1.00E00
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)	15	1	.06	+	15.91	1.00E00
regulation of collagen catabolic process (GO:0010710)	3	0	.01	-	 < 0.2	1.00E00
gonad development (GO:0008406)	211	6	.88	+	6.79	1.00E00
positive regulation of inorganic anion transmembrane transport (GO:1903797)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of inorganic anion transmembrane transport (GO:1903796)	2	0	.01	-	 < 0.2	1.00E00
regulation of inorganic anion transmembrane transport (GO:1903795)	7	0	.03	-	 < 0.2	1.00E00
protein localization to lysosome (GO:0061462)	31	0	.13	-	 < 0.2	1.00E00
positive regulation of anion transport (GO:1903793)	44	1	.18	+	5.42	1.00E00
negative regulation of anion transport (GO:1903792)	25	1	.10	+	9.55	1.00E00
L-lysine import (GO:0061461)	1	0	.00	-	 < 0.2	1.00E00
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.00	-	 < 0.2	1.00E00
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of norepinephrine secretion (GO:0010701)	4	0	.02	-	 < 0.2	1.00E00
regulation of amino acid transmembrane transport (GO:1903789)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of norepinephrine secretion (GO:0010700)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of glutathione biosynthetic process (GO:1903788)	1	0	.00	-	 < 0.2	1.00E00
regulation of glutathione biosynthetic process (GO:1903786)	1	0	.00	-	 < 0.2	1.00E00
retrotrapezoid nucleus neuron differentiation (GO:0061452)	1	0	.00	-	 < 0.2	1.00E00
retrotrapezoid nucleus development (GO:0061451)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cardiac conduction (GO:1903781)	3	0	.01	-	 < 0.2	1.00E00
suppression by virus of host STAT2 activity (GO:0039564)	1	0	.00	-	 < 0.2	1.00E00
suppression by virus of host STAT1 activity (GO:0039563)	1	0	.00	-	 < 0.2	1.00E00
suppression by virus of host STAT activity (GO:0039562)	1	0	.00	-	 < 0.2	1.00E00
charged-tRNA amino acid modification (GO:0019988)	1	0	.00	-	 < 0.2	1.00E00
connective tissue development (GO:0061448)	199	4	.83	+	4.80	1.00E00
regulation of cardiac conduction (GO:1903779)	69	1	.29	+	3.46	1.00E00
translesion synthesis (GO:0019985)	42	1	.18	+	5.68	1.00E00
protein localization to vacuolar membrane (GO:1903778)	1	0	.00	-	 < 0.2	1.00E00
endocardial cushion cell fate commitment (GO:0061445)	1	0	.00	-	 < 0.2	1.00E00
endocardial cushion cell development (GO:0061444)	1	1	.00	+	 > 100	1.00E00
regulation of DNA double-strand break processing (GO:1903775)	1	0	.00	-	 < 0.2	1.00E00
endocardial cushion cell differentiation (GO:0061443)	2	1	.01	+	 > 100	1.00E00
positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.01	-	 < 0.2	1.00E00
regulation of viral budding via host ESCRT complex (GO:1903772)	5	0	.02	-	 < 0.2	1.00E00
renal artery morphogenesis (GO:0061441)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of beta-galactosidase activity (GO:1903770)	1	0	.00	-	 < 0.2	1.00E00
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	27	1	.11	+	8.84	1.00E00
kidney vasculature morphogenesis (GO:0061439)	7	2	.03	+	68.19	1.00E00
gene silencing by miRNA (GO:0035195)	44	1	.18	+	5.42	1.00E00
renal system vasculature morphogenesis (GO:0061438)	7	2	.03	+	68.19	1.00E00
posttranscriptional gene silencing by RNA (GO:0035194)	51	1	.21	+	4.68	1.00E00
establishment of skin barrier (GO:0061436)	20	0	.08	-	 < 0.2	1.00E00
positive regulation of potassium ion export across plasma membrane (GO:1903766)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of potassium ion export across plasma membrane (GO:1903765)	1	0	.00	-	 < 0.2	1.00E00
regulation of potassium ion export across plasma membrane (GO:1903764)	3	0	.01	-	 < 0.2	1.00E00
cellular response to caloric restriction (GO:0061433)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	2	0	.01	-	 < 0.2	1.00E00
bone trabecula morphogenesis (GO:0061430)	11	0	.05	-	 < 0.2	1.00E00
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	3	0	.01	-	 < 0.2	1.00E00
hatching (GO:0035188)	2	0	.01	-	 < 0.2	1.00E00
signal transduction involved in regulation of aerobic respiration (GO:1903759)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903758)	2	0	.01	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter by histone modification (GO:1903756)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of SUMO transferase activity (GO:1903755)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of p38MAPK cascade (GO:1903753)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	4	0	.02	-	 < 0.2	1.00E00
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of RIG-I signaling pathway (GO:0039536)	8	0	.03	-	 < 0.2	1.00E00
regulation of RIG-I signaling pathway (GO:0039535)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of MDA-5 signaling pathway (GO:0039534)	4	0	.02	-	 < 0.2	1.00E00
regulation of MDA-5 signaling pathway (GO:0039533)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	11	0	.05	-	 < 0.2	1.00E00
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	21	0	.09	-	 < 0.2	1.00E00
MDA-5 signaling pathway (GO:0039530)	3	0	.01	-	 < 0.2	1.00E00
social behavior (GO:0035176)	49	0	.21	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)	4	0	.02	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	79	0	.33	-	 < 0.2	1.00E00
negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	7	0	.03	-	 < 0.2	1.00E00
sexual reproduction (GO:0019953)	790	11	3.31	+	3.32	1.00E00
negative regulation of anterograde synaptic vesicle transport (GO:1903743)	1	0	.00	-	 < 0.2	1.00E00
regulation of anterograde synaptic vesicle transport (GO:1903742)	1	0	.00	-	 < 0.2	1.00E00
RIG-I signaling pathway (GO:0039529)	3	0	.01	-	 < 0.2	1.00E00
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	6	0	.03	-	 < 0.2	1.00E00
modulation by virus of host apoptotic process (GO:0039526)	3	0	.01	-	 < 0.2	1.00E00
suppression by virus of host autophagy (GO:0039521)	1	0	.00	-	 < 0.2	1.00E00
induction by virus of host autophagy (GO:0039520)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic hemopoiesis (GO:0035166)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408)	1	0	.00	-	 < 0.2	1.00E00
embryonic hemopoiesis (GO:0035162)	20	0	.08	-	 < 0.2	1.00E00
modification-dependent protein catabolic process (GO:0019941)	499	6	2.09	+	2.87	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	1	0	.00	-	 < 0.2	1.00E00
modulation by virus of host autophagy (GO:0039519)	2	0	.01	-	 < 0.2	1.00E00
modulation by virus of host catalytic activity (GO:0039516)	1	0	.00	-	 < 0.2	1.00E00
suppression by virus of host JAK-STAT cascade (GO:0039514)	1	0	.00	-	 < 0.2	1.00E00
suppression by virus of host catalytic activity (GO:0039513)	1	0	.00	-	 < 0.2	1.00E00
regulation of plasma membrane organization (GO:1903729)	10	2	.04	+	47.73	1.00E00
cyclic-nucleotide-mediated signaling (GO:0019935)	94	0	.39	-	 < 0.2	1.00E00
cGMP-mediated signaling (GO:0019934)	10	0	.04	-	 < 0.2	1.00E00
cAMP-mediated signaling (GO:0019933)	85	0	.36	-	 < 0.2	1.00E00
negative regulation of phospholipid metabolic process (GO:1903726)	9	0	.04	-	 < 0.2	1.00E00
regulation of tube size (GO:0035150)	138	3	.58	+	5.19	1.00E00
second-messenger-mediated signaling (GO:0019932)	225	2	.94	+	2.12	1.00E00
positive regulation of centriole elongation (GO:1903724)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of centriole elongation (GO:1903723)	1	0	.00	-	 < 0.2	1.00E00
regulation of centriole elongation (GO:1903722)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of I-kappaB phosphorylation (GO:1903721)	3	1	.01	+	79.55	1.00E00
suppression by virus of host molecular function (GO:0039507)	2	0	.01	-	 < 0.2	1.00E00
modulation by virus of host molecular function (GO:0039506)	2	0	.01	-	 < 0.2	1.00E00
suppression by virus of host innate immune response (GO:0039503)	1	0	.00	-	 < 0.2	1.00E00
suppression by virus of host type I interferon-mediated signaling pathway (GO:0039502)	1	0	.00	-	 < 0.2	1.00E00
tube formation (GO:0035148)	147	2	.62	+	3.25	1.00E00
regulation of I-kappaB phosphorylation (GO:1903719)	3	1	.01	+	79.55	1.00E00
cellular response to ammonia (GO:1903718)	1	0	.00	-	 < 0.2	1.00E00
response to ammonia (GO:1903717)	1	0	.00	-	 < 0.2	1.00E00
regulation of aerobic respiration (GO:1903715)	8	0	.03	-	 < 0.2	1.00E00
cysteine transmembrane transport (GO:1903712)	1	0	.00	-	 < 0.2	1.00E00
hindlimb morphogenesis (GO:0035137)	36	0	.15	-	 < 0.2	1.00E00
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	7	0	.03	-	 < 0.2	1.00E00
forelimb morphogenesis (GO:0035136)	39	0	.16	-	 < 0.2	1.00E00
peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918)	4	0	.02	-	 < 0.2	1.00E00
uterine gland development (GO:1903709)	1	0	.00	-	 < 0.2	1.00E00
lipid storage (GO:0019915)	29	1	.12	+	8.23	1.00E00
negative regulation of hemopoiesis (GO:1903707)	128	2	.54	+	3.73	1.00E00
negative regulation of production of siRNA involved in RNA interference (GO:1903704)	1	0	.00	-	 < 0.2	1.00E00
substantia propria of cornea development (GO:1903701)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic forelimb morphogenesis (GO:0035128)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic limb morphogenesis (GO:0035127)	1	0	.00	-	 < 0.2	1.00E00
post-embryonic appendage morphogenesis (GO:0035120)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dendritic spine development (GO:0060999)	40	1	.17	+	5.97	1.00E00
regulation of dendritic spine development (GO:0060998)	67	1	.28	+	3.56	1.00E00
dendritic spine morphogenesis (GO:0060997)	17	0	.07	-	 < 0.2	1.00E00
dendritic spine development (GO:0060996)	27	0	.11	-	 < 0.2	1.00E00
cell-cell signaling involved in kidney development (GO:0060995)	2	0	.01	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994)	2	0	.01	-	 < 0.2	1.00E00
kidney morphogenesis (GO:0060993)	81	2	.34	+	5.89	1.00E00
response to fungicide (GO:0060992)	7	0	.03	-	 < 0.2	1.00E00
embryonic hindlimb morphogenesis (GO:0035116)	28	0	.12	-	 < 0.2	1.00E00
embryonic forelimb morphogenesis (GO:0035115)	31	0	.13	-	 < 0.2	1.00E00
embryonic appendage morphogenesis (GO:0035113)	128	0	.54	-	 < 0.2	1.00E00
genitalia morphogenesis (GO:0035112)	14	1	.06	+	17.05	1.00E00
lipid tube assembly involved in organelle fusion (GO:0060989)	1	0	.00	-	 < 0.2	1.00E00
lipid tube assembly (GO:0060988)	3	0	.01	-	 < 0.2	1.00E00
endocrine hormone secretion (GO:0060986)	13	0	.05	-	 < 0.2	1.00E00
coronary artery morphogenesis (GO:0060982)	9	0	.04	-	 < 0.2	1.00E00
cell migration involved in coronary angiogenesis (GO:0060981)	1	1	.00	+	 > 100	1.00E00
cell migration involved in coronary vasculogenesis (GO:0060980)	1	0	.00	-	 < 0.2	1.00E00
limb morphogenesis (GO:0035108)	148	0	.62	-	 < 0.2	1.00E00
appendage morphogenesis (GO:0035107)	148	0	.62	-	 < 0.2	1.00E00
operant conditioning (GO:0035106)	3	0	.01	-	 < 0.2	1.00E00
sterol regulatory element binding protein import into nucleus (GO:0035105)	1	0	.00	-	 < 0.2	1.00E00
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	4	0	.02	-	 < 0.2	1.00E00
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	3	1	.01	+	79.55	1.00E00
coronary vasculature morphogenesis (GO:0060977)	15	1	.06	+	15.91	1.00E00
coronary vasculature development (GO:0060976)	40	1	.17	+	5.97	1.00E00
cardioblast migration to the midline involved in heart field formation (GO:0060975)	1	0	.00	-	 < 0.2	1.00E00
cell migration involved in heart formation (GO:0060974)	2	0	.01	-	 < 0.2	1.00E00
cell migration involved in heart development (GO:0060973)	13	1	.05	+	18.36	1.00E00
left/right pattern formation (GO:0060972)	21	1	.09	+	11.36	1.00E00
embryonic heart tube left/right pattern formation (GO:0060971)	4	0	.02	-	 < 0.2	1.00E00
decidualization (GO:0046697)	23	0	.10	-	 < 0.2	1.00E00
sperm competition (GO:0046692)	1	0	.00	-	 < 0.2	1.00E00
response to tellurium ion (GO:0046690)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of gene silencing (GO:0060969)	22	1	.09	+	10.85	1.00E00
regulation of gene silencing (GO:0060968)	106	3	.44	+	6.75	1.00E00
negative regulation of gene silencing by RNA (GO:0060967)	13	1	.05	+	18.36	1.00E00
regulation of gene silencing by RNA (GO:0060966)	84	3	.35	+	8.52	1.00E00
negative regulation of gene silencing by miRNA (GO:0060965)	11	0	.05	-	 < 0.2	1.00E00
regulation of gene silencing by miRNA (GO:0060964)	81	2	.34	+	5.89	1.00E00
response to mercury ion (GO:0046689)	11	0	.05	-	 < 0.2	1.00E00
response to copper ion (GO:0046688)	26	0	.11	-	 < 0.2	1.00E00
response to chromate (GO:0046687)	1	0	.00	-	 < 0.2	1.00E00
response to arsenic-containing substance (GO:0046685)	29	1	.12	+	8.23	1.00E00
response to pyrethroid (GO:0046684)	4	0	.02	-	 < 0.2	1.00E00
response to organophosphorus (GO:0046683)	135	2	.57	+	3.54	1.00E00
response to DDT (GO:0046680)	1	1	.00	+	 > 100	1.00E00
endocardial cell fate commitment (GO:0060957)	1	0	.00	-	 < 0.2	1.00E00
endocardial cell differentiation (GO:0060956)	6	1	.03	+	39.78	1.00E00
response to antibiotic (GO:0046677)	51	3	.21	+	14.04	1.00E00
negative regulation of insulin secretion (GO:0046676)	38	2	.16	+	12.56	1.00E00
negative regulation of retinal cell programmed cell death (GO:0046671)	2	1	.01	+	 > 100	1.00E00
cardiac vascular smooth muscle cell development (GO:0060948)	3	0	.01	-	 < 0.2	1.00E00
cardiac vascular smooth muscle cell differentiation (GO:0060947)	6	0	.03	-	 < 0.2	1.00E00
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	2	0	.01	-	 < 0.2	1.00E00
regulation of retinal cell programmed cell death (GO:0046668)	3	1	.01	+	79.55	1.00E00
retinal cell programmed cell death (GO:0046666)	2	0	.01	-	 < 0.2	1.00E00
male sex differentiation (GO:0046661)	159	3	.67	+	4.50	1.00E00
response to luteinizing hormone (GO:0034699)	4	0	.02	-	 < 0.2	1.00E00
response to gonadotropin (GO:0034698)	30	0	.13	-	 < 0.2	1.00E00
response to prostaglandin F (GO:0034696)	2	0	.01	-	 < 0.2	1.00E00
epicardium-derived cardiac fibroblast cell development (GO:0060939)	3	0	.01	-	 < 0.2	1.00E00
response to prostaglandin E (GO:0034695)	26	1	.11	+	9.18	1.00E00
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	3	0	.01	-	 < 0.2	1.00E00
response to prostaglandin (GO:0034694)	33	1	.14	+	7.23	1.00E00
cardiac fibroblast cell development (GO:0060936)	3	0	.01	-	 < 0.2	1.00E00
cardiac fibroblast cell differentiation (GO:0060935)	3	0	.01	-	 < 0.2	1.00E00
His-Purkinje system cell differentiation (GO:0060932)	2	0	.01	-	 < 0.2	1.00E00
sinoatrial node cell development (GO:0060931)	1	0	.00	-	 < 0.2	1.00E00
folic acid catabolic process (GO:0046657)	1	0	.00	-	 < 0.2	1.00E00
folic acid metabolic process (GO:0046655)	18	0	.08	-	 < 0.2	1.00E00
tetrahydrofolate biosynthetic process (GO:0046654)	7	0	.03	-	 < 0.2	1.00E00
tetrahydrofolate metabolic process (GO:0046653)	19	0	.08	-	 < 0.2	1.00E00
lymphocyte proliferation (GO:0046651)	81	2	.34	+	5.89	1.00E00
vocal learning (GO:0042297)	7	0	.03	-	 < 0.2	1.00E00
atrioventricular node cell fate commitment (GO:0060929)	1	0	.00	-	 < 0.2	1.00E00
atrioventricular node cell development (GO:0060928)	2	0	.01	-	 < 0.2	1.00E00
cardiac pacemaker cell fate commitment (GO:0060927)	1	0	.00	-	 < 0.2	1.00E00
cardiac pacemaker cell development (GO:0060926)	3	0	.01	-	 < 0.2	1.00E00
cardiac muscle cell fate commitment (GO:0060923)	6	0	.03	-	 < 0.2	1.00E00
atrioventricular node cell differentiation (GO:0060922)	2	0	.01	-	 < 0.2	1.00E00
sinoatrial node cell differentiation (GO:0060921)	2	0	.01	-	 < 0.2	1.00E00
cardiac pacemaker cell differentiation (GO:0060920)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of regulation of vascular smooth muscle cell membrane depolarization (GO:1904199)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of granulosa cell proliferation (GO:1904197)	1	0	.00	-	 < 0.2	1.00E00
regulation of granulosa cell proliferation (GO:1904195)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of gamma-delta T cell activation (GO:0046645)	5	1	.02	+	47.73	1.00E00
negative regulation of cholangiocyte apoptotic process (GO:1904193)	1	0	.00	-	 < 0.2	1.00E00
regulation of gamma-delta T cell activation (GO:0046643)	6	1	.03	+	39.78	1.00E00
regulation of cholangiocyte apoptotic process (GO:1904192)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of alpha-beta T cell proliferation (GO:0046642)	7	0	.03	-	 < 0.2	1.00E00
cellular response to interleukin-17 (GO:0097398)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of alpha-beta T cell proliferation (GO:0046641)	21	2	.09	+	22.73	1.00E00
regulation of alpha-beta T cell proliferation (GO:0046640)	27	2	.11	+	17.68	1.00E00
response to interleukin-17 (GO:0097396)	8	0	.03	-	 < 0.2	1.00E00
mesenchymal cell proliferation involved in lung development (GO:0060916)	3	0	.01	-	 < 0.2	1.00E00
mesenchymal cell differentiation involved in lung development (GO:0060915)	2	0	.01	-	 < 0.2	1.00E00
heart formation (GO:0060914)	13	0	.05	-	 < 0.2	1.00E00
chemotaxis to arachidonic acid (GO:0034670)	1	0	.00	-	 < 0.2	1.00E00
cardiac cell fate determination (GO:0060913)	4	0	.02	-	 < 0.2	1.00E00
cardiac cell fate specification (GO:0060912)	1	0	.00	-	 < 0.2	1.00E00
cardiac cell fate commitment (GO:0060911)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of alpha-beta T cell differentiation (GO:0046639)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of transformation of host cell by virus (GO:1904188)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of alpha-beta T cell differentiation (GO:0046638)	39	1	.16	+	6.12	1.00E00
regulation of transformation of host cell by virus (GO:1904187)	1	0	.00	-	 < 0.2	1.00E00
regulation of alpha-beta T cell differentiation (GO:0046637)	55	1	.23	+	4.34	1.00E00
negative regulation of alpha-beta T cell activation (GO:0046636)	30	0	.13	-	 < 0.2	1.00E00
positive regulation of alpha-beta T cell activation (GO:0046635)	53	2	.22	+	9.01	1.00E00
regulation of alpha-beta T cell activation (GO:0046634)	80	2	.34	+	5.97	1.00E00
alpha-beta T cell proliferation (GO:0046633)	3	0	.01	-	 < 0.2	1.00E00
regulation of pyruvate dehydrogenase activity (GO:1904182)	1	0	.00	-	 < 0.2	1.00E00
alpha-beta T cell differentiation (GO:0046632)	48	2	.20	+	9.94	1.00E00
positive regulation of membrane depolarization (GO:1904181)	12	0	.05	-	 < 0.2	1.00E00
alpha-beta T cell activation (GO:0046631)	56	3	.23	+	12.79	1.00E00
negative regulation of membrane depolarization (GO:1904180)	7	2	.03	+	68.19	1.00E00
purine nucleoside metabolic process (GO:0042278)	76	0	.32	-	 < 0.2	1.00E00
error-prone translesion synthesis (GO:0042276)	20	1	.08	+	11.93	1.00E00
cellular lipid biosynthetic process (GO:0097384)	6	0	.03	-	 < 0.2	1.00E00
error-free postreplication DNA repair (GO:0042275)	1	0	.00	-	 < 0.2	1.00E00
ribosomal small subunit biogenesis (GO:0042274)	74	0	.31	-	 < 0.2	1.00E00
ribosomal large subunit biogenesis (GO:0042273)	70	0	.29	-	 < 0.2	1.00E00
positive regulation of macrophage cytokine production (GO:0060907)	7	0	.03	-	 < 0.2	1.00E00
susceptibility to natural killer cell mediated cytotoxicity (GO:0042271)	4	0	.02	-	 < 0.2	1.00E00
ncRNA catabolic process (GO:0034661)	24	0	.10	-	 < 0.2	1.00E00
protection from natural killer cell mediated cytotoxicity (GO:0042270)	5	1	.02	+	47.73	1.00E00
ncRNA metabolic process (GO:0034660)	560	3	2.35	+	1.28	1.00E00
regulation of protein folding in endoplasmic reticulum (GO:0060904)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of meiosis I (GO:0060903)	4	0	.02	-	 < 0.2	1.00E00
regulation of hair cycle by canonical Wnt signaling pathway (GO:0060901)	1	1	.00	+	 > 100	1.00E00
embryonic camera-type eye formation (GO:0060900)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of adipose tissue development (GO:1904179)	5	0	.02	-	 < 0.2	1.00E00
gamma-delta T cell activation (GO:0046629)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of insulin receptor signaling pathway (GO:0046628)	13	2	.05	+	36.72	1.00E00
regulation of adipose tissue development (GO:1904177)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of bleb assembly (GO:1904172)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of organ growth (GO:0046621)	28	2	.12	+	17.05	1.00E00
regulation of bleb assembly (GO:1904170)	2	0	.01	-	 < 0.2	1.00E00
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	35	1	.15	+	6.82	1.00E00
interneuron axon guidance (GO:0097376)	1	0	.00	-	 < 0.2	1.00E00
regulation of cytolysis (GO:0042268)	17	0	.07	-	 < 0.2	1.00E00
natural killer cell mediated cytotoxicity (GO:0042267)	25	0	.10	-	 < 0.2	1.00E00
sensory neuron axon guidance (GO:0097374)	3	0	.01	-	 < 0.2	1.00E00
nucleobase-containing small molecule catabolic process (GO:0034656)	15	0	.06	-	 < 0.2	1.00E00
peptidyl-asparagine hydroxylation (GO:0042265)	1	0	.00	-	 < 0.2	1.00E00
nucleobase-containing compound catabolic process (GO:0034655)	358	2	1.50	+	1.33	1.00E00
peptidyl-aspartic acid hydroxylation (GO:0042264)	2	0	.01	-	 < 0.2	1.00E00
nucleobase-containing compound biosynthetic process (GO:0034654)	2946	22	12.34	+	1.78	1.00E00
DNA protection (GO:0042262)	5	0	.02	-	 < 0.2	1.00E00
retinoic acid catabolic process (GO:0034653)	4	0	.02	-	 < 0.2	1.00E00
cortisol biosynthetic process (GO:0034651)	3	0	.01	-	 < 0.2	1.00E00
intestinal cholesterol absorption (GO:0030299)	9	0	.04	-	 < 0.2	1.00E00
cortisol metabolic process (GO:0034650)	3	0	.01	-	 < 0.2	1.00E00
optic placode formation involved in camera-type eye formation (GO:0046619)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of thyroid hormone receptor activity (GO:1904168)	1	0	.00	-	 < 0.2	1.00E00
drug export (GO:0046618)	5	0	.02	-	 < 0.2	1.00E00
regulation of thyroid hormone receptor activity (GO:1904167)	1	0	.00	-	 < 0.2	1.00E00
sodium ion import (GO:0097369)	14	0	.06	-	 < 0.2	1.00E00
establishment of Sertoli cell barrier (GO:0097368)	4	0	.02	-	 < 0.2	1.00E00
mature ribosome assembly (GO:0042256)	7	0	.03	-	 < 0.2	1.00E00
ribosome assembly (GO:0042255)	66	0	.28	-	 < 0.2	1.00E00
ribosome biogenesis (GO:0042254)	333	1	1.40	-	.72	1.00E00
cellular macromolecule biosynthetic process (GO:0034645)	3672	25	15.39	+	1.62	1.00E00
granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0042253)	1	0	.00	-	 < 0.2	1.00E00
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	18	0	.08	-	 < 0.2	1.00E00
cellular nitrogen compound metabolic process (GO:0034641)	5164	34	21.64	+	1.57	1.00E00
establishment of mitochondrion localization by microtubule attachment (GO:0034640)	1	0	.00	-	 < 0.2	1.00E00
bone mineralization (GO:0030282)	39	0	.16	-	 < 0.2	1.00E00
axonemal central apparatus assembly (GO:1904158)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of centrosome cycle (GO:0046607)	12	0	.05	-	 < 0.2	1.00E00
DN3 thymocyte differentiation (GO:1904156)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of centrosome cycle (GO:0046606)	12	0	.05	-	 < 0.2	1.00E00
DN2 thymocyte differentiation (GO:1904155)	1	0	.00	-	 < 0.2	1.00E00
regulation of centrosome cycle (GO:0046605)	53	1	.22	+	4.50	1.00E00
positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of mitotic centrosome separation (GO:0046604)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of mitotic centrosome separation (GO:0046603)	1	0	.00	-	 < 0.2	1.00E00
regulation of retrograde protein transport, ER to cytosol (GO:1904152)	13	0	.05	-	 < 0.2	1.00E00
regulation of mitotic centrosome separation (GO:0046602)	11	1	.05	+	21.70	1.00E00
positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	1	0	.00	-	 < 0.2	1.00E00
UDP-glucosylation (GO:0097359)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of centriole replication (GO:0046601)	3	0	.01	-	 < 0.2	1.00E00
establishment of planar polarity of embryonic epithelium (GO:0042249)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of centriole replication (GO:0046600)	6	0	.03	-	 < 0.2	1.00E00
establishment of planar polarity of follicular epithelium (GO:0042247)	1	0	.00	-	 < 0.2	1.00E00
phosphatidylcholine catabolic process (GO:0034638)	5	0	.02	-	 < 0.2	1.00E00
prenylation (GO:0097354)	10	0	.04	-	 < 0.2	1.00E00
tissue regeneration (GO:0042246)	54	3	.23	+	13.26	1.00E00
cellular carbohydrate biosynthetic process (GO:0034637)	53	2	.22	+	9.01	1.00E00
RNA repair (GO:0042245)	2	0	.01	-	 < 0.2	1.00E00
autophagosome maturation (GO:0097352)	24	0	.10	-	 < 0.2	1.00E00
glutathione transport (GO:0034635)	2	0	.01	-	 < 0.2	1.00E00
neutrophil clearance (GO:0097350)	4	1	.02	+	59.66	1.00E00
retinol transport (GO:0034633)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of ossification (GO:0030279)	71	1	.30	+	3.36	1.00E00
regulation of ossification (GO:0030278)	182	4	.76	+	5.25	1.00E00
maintenance of gastrointestinal epithelium (GO:0030277)	15	0	.06	-	 < 0.2	1.00E00
regulation of microglial cell mediated cytotoxicity (GO:1904149)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of alkaline phosphatase activity (GO:0010694)	6	1	.03	+	39.78	1.00E00
negative regulation of alkaline phosphatase activity (GO:0010693)	3	0	.01	-	 < 0.2	1.00E00
regulation of alkaline phosphatase activity (GO:0010692)	9	1	.04	+	26.52	1.00E00
positive regulation of microglial cell migration (GO:1904141)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of microglial cell migration (GO:1904140)	1	0	.00	-	 < 0.2	1.00E00
cellular protein complex localization (GO:0034629)	27	0	.11	-	 < 0.2	1.00E00
mitochondrial outer membrane permeabilization (GO:0097345)	15	1	.06	+	15.91	1.00E00
'de novo' NAD biosynthetic process from aspartate (GO:0034628)	3	0	.01	-	 < 0.2	1.00E00
'de novo' NAD biosynthetic process (GO:0034627)	3	0	.01	-	 < 0.2	1.00E00
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	7	0	.03	-	 < 0.2	1.00E00
ripoptosome assembly (GO:0097343)	3	0	.01	-	 < 0.2	1.00E00
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	7	0	.03	-	 < 0.2	1.00E00
zymogen inhibition (GO:0097341)	14	0	.06	-	 < 0.2	1.00E00
RNA splicing (GO:0008380)	393	0	1.65	-	 < 0.2	1.00E00
inhibition of cysteine-type endopeptidase activity (GO:0097340)	14	0	.06	-	 < 0.2	1.00E00
cellular macromolecular complex assembly (GO:0034622)	818	5	3.43	+	1.46	1.00E00
interleukin-13 biosynthetic process (GO:0042231)	1	0	.00	-	 < 0.2	1.00E00
cellular response to unfolded protein (GO:0034620)	122	2	.51	+	3.91	1.00E00
nuclear fragmentation involved in apoptotic nuclear change (GO:0030264)	1	0	.00	-	 < 0.2	1.00E00
apoptotic chromosome condensation (GO:0030263)	5	0	.02	-	 < 0.2	1.00E00
apoptotic nuclear changes (GO:0030262)	24	1	.10	+	9.94	1.00E00
chromosome condensation (GO:0030261)	31	1	.13	+	7.70	1.00E00
regulation of microglial cell migration (GO:1904139)	3	0	.01	-	 < 0.2	1.00E00
response to clozapine (GO:0097338)	3	0	.01	-	 < 0.2	1.00E00
interleukin-8 biosynthetic process (GO:0042228)	1	0	.00	-	 < 0.2	1.00E00
interleukin-6 biosynthetic process (GO:0042226)	2	0	.01	-	 < 0.2	1.00E00
response to laminar fluid shear stress (GO:0034616)	15	1	.06	+	15.91	1.00E00
response to antipsychotic drug (GO:0097332)	2	0	.01	-	 < 0.2	1.00E00
interleukin-1 biosynthetic process (GO:0042222)	1	0	.00	-	 < 0.2	1.00E00
response to tumor necrosis factor (GO:0034612)	260	5	1.09	+	4.59	1.00E00
response to cocaine (GO:0042220)	54	1	.23	+	4.42	1.00E00
lipid glycosylation (GO:0030259)	10	0	.04	-	 < 0.2	1.00E00
growth hormone secretion (GO:0030252)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	47	1	.20	+	5.08	1.00E00
regulation of cellular carbohydrate metabolic process (GO:0010675)	134	5	.56	+	8.91	1.00E00
positive regulation of otic vesicle morphogenesis (GO:1904120)	1	0	.00	-	 < 0.2	1.00E00
amino acid import across plasma membrane (GO:0089718)	9	0	.04	-	 < 0.2	1.00E00
cellular modified amino acid catabolic process (GO:0042219)	26	0	.11	-	 < 0.2	1.00E00
axon ensheathment (GO:0008366)	97	3	.41	+	7.38	1.00E00
response to antineoplastic agent (GO:0097327)	5	0	.02	-	 < 0.2	1.00E00
melanocyte adhesion (GO:0097326)	1	0	.00	-	 < 0.2	1.00E00
melanocyte proliferation (GO:0097325)	2	0	.01	-	 < 0.2	1.00E00
melanocyte migration (GO:0097324)	2	0	.01	-	 < 0.2	1.00E00
cellular response to heat (GO:0034605)	46	1	.19	+	5.19	1.00E00
regulation of cell size (GO:0008361)	155	3	.65	+	4.62	1.00E00
terpene metabolic process (GO:0042214)	3	0	.01	-	 < 0.2	1.00E00
regulation of cell shape (GO:0008360)	144	1	.60	+	1.66	1.00E00
L-aspartate transmembrane transport (GO:0089712)	6	0	.03	-	 < 0.2	1.00E00
plasma membrane tubulation (GO:0097320)	13	0	.05	-	 < 0.2	1.00E00
L-glutamate transmembrane transport (GO:0089711)	14	0	.06	-	 < 0.2	1.00E00
autophagy of peroxisome (GO:0030242)	5	0	.02	-	 < 0.2	1.00E00
skeletal muscle myosin thick filament assembly (GO:0030241)	3	0	.01	-	 < 0.2	1.00E00
skeletal muscle thin filament assembly (GO:0030240)	6	0	.03	-	 < 0.2	1.00E00
epithelial structure maintenance (GO:0010669)	22	0	.09	-	 < 0.2	1.00E00
ectodermal cell differentiation (GO:0010668)	6	0	.03	-	 < 0.2	1.00E00
regulation of otic vesicle morphogenesis (GO:1904118)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	19	2	.08	+	25.12	1.00E00
cellular response to vasopressin (GO:1904117)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	10	0	.04	-	 < 0.2	1.00E00
response to vasopressin (GO:1904116)	3	0	.01	-	 < 0.2	1.00E00
regulation of cardiac muscle cell apoptotic process (GO:0010665)	29	2	.12	+	16.46	1.00E00
negative regulation of striated muscle cell apoptotic process (GO:0010664)	23	2	.10	+	20.75	1.00E00
positive regulation of striated muscle cell apoptotic process (GO:0010663)	10	0	.04	-	 < 0.2	1.00E00
regulation of striated muscle cell apoptotic process (GO:0010662)	32	2	.13	+	14.92	1.00E00
positive regulation of muscle cell apoptotic process (GO:0010661)	19	1	.08	+	12.56	1.00E00
maternal determination of anterior/posterior axis, embryo (GO:0008358)	2	0	.01	-	 < 0.2	1.00E00
regulation of muscle cell apoptotic process (GO:0010660)	53	3	.22	+	13.51	1.00E00
L-histidine transmembrane transport (GO:0089709)	3	0	.01	-	 < 0.2	1.00E00
asymmetric cell division (GO:0008356)	14	0	.06	-	 < 0.2	1.00E00
olfactory learning (GO:0008355)	2	0	.01	-	 < 0.2	1.00E00
germ cell migration (GO:0008354)	9	0	.04	-	 < 0.2	1.00E00
cap2 mRNA methylation (GO:0097310)	1	0	.00	-	 < 0.2	1.00E00
protein kinase D signaling (GO:0089700)	3	0	.01	-	 < 0.2	1.00E00
myofibril assembly (GO:0030239)	59	1	.25	+	4.05	1.00E00
male sex determination (GO:0030238)	14	1	.06	+	17.05	1.00E00
female sex determination (GO:0030237)	2	0	.01	-	 < 0.2	1.00E00
cardiac muscle cell apoptotic process (GO:0010659)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of cholesterol import (GO:1904109)	1	0	.00	-	 < 0.2	1.00E00
striated muscle cell apoptotic process (GO:0010658)	6	0	.03	-	 < 0.2	1.00E00
muscle cell apoptotic process (GO:0010657)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of muscle cell apoptotic process (GO:0010656)	33	2	.14	+	14.46	1.00E00
protein localization to microvillus (GO:1904106)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cell communication by chemical coupling (GO:0010652)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of antimicrobial humoral response (GO:0008348)	1	0	.00	-	 < 0.2	1.00E00
cap1 mRNA methylation (GO:0097309)	1	0	.00	-	 < 0.2	1.00E00
glial cell migration (GO:0008347)	40	0	.17	-	 < 0.2	1.00E00
positive regulation of protein O-linked glycosylation (GO:1904100)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cell communication by electrical coupling (GO:0010650)	2	0	.01	-	 < 0.2	1.00E00
cellular response to alcohol (GO:0097306)	58	2	.24	+	8.23	1.00E00
adult locomotory behavior (GO:0008344)	83	0	.35	-	 < 0.2	1.00E00
adult feeding behavior (GO:0008343)	10	0	.04	-	 < 0.2	1.00E00
determination of adult lifespan (GO:0008340)	13	2	.05	+	36.72	1.00E00
programmed necrotic cell death (GO:0097300)	27	0	.11	-	 < 0.2	1.00E00
ribonucleoprotein complex assembly (GO:0022618)	208	1	.87	+	1.15	1.00E00
extracellular matrix disassembly (GO:0022617)	79	3	.33	+	9.06	1.00E00
macrophage differentiation (GO:0030225)	21	0	.09	-	 < 0.2	1.00E00
DNA strand elongation (GO:0022616)	23	1	.10	+	10.38	1.00E00
monocyte differentiation (GO:0030224)	17	1	.07	+	14.04	1.00E00
protein to membrane docking (GO:0022615)	4	0	.02	-	 < 0.2	1.00E00
membrane to membrane docking (GO:0022614)	5	0	.02	-	 < 0.2	1.00E00
neutrophil differentiation (GO:0030223)	4	0	.02	-	 < 0.2	1.00E00
ribonucleoprotein complex biogenesis (GO:0022613)	468	2	1.96	+	1.02	1.00E00
eosinophil differentiation (GO:0030222)	3	0	.01	-	 < 0.2	1.00E00
basophil differentiation (GO:0030221)	2	0	.01	-	 < 0.2	1.00E00
platelet formation (GO:0030220)	19	1	.08	+	12.56	1.00E00
regulation of cell communication by electrical coupling (GO:0010649)	11	1	.05	+	21.70	1.00E00
regulation of cell communication by chemical coupling (GO:0010645)	2	0	.01	-	 < 0.2	1.00E00
cell communication by electrical coupling (GO:0010644)	17	0	.07	-	 < 0.2	1.00E00
cell communication by chemical coupling (GO:0010643)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	16	1	.07	+	14.92	1.00E00
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	5	1	.02	+	47.73	1.00E00
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	23	2	.10	+	20.75	1.00E00
positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061395)	1	0	.00	-	 < 0.2	1.00E00
histone mRNA metabolic process (GO:0008334)	24	1	.10	+	9.94	1.00E00
regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance (GO:0061394)	2	0	.01	-	 < 0.2	1.00E00
endosome to lysosome transport (GO:0008333)	49	0	.21	-	 < 0.2	1.00E00
megakaryocyte differentiation (GO:0030219)	21	0	.09	-	 < 0.2	1.00E00
erythrocyte differentiation (GO:0030218)	69	3	.29	+	10.38	1.00E00
T cell differentiation (GO:0030217)	130	3	.54	+	5.51	1.00E00
keratinocyte differentiation (GO:0030216)	268	4	1.12	+	3.56	1.00E00
hyaluronan catabolic process (GO:0030214)	16	0	.07	-	 < 0.2	1.00E00
oogenesis stage (GO:0022605)	6	0	.03	-	 < 0.2	1.00E00
regulation of cell morphogenesis (GO:0022604)	438	4	1.84	+	2.18	1.00E00
hyaluronan biosynthetic process (GO:0030213)	7	0	.03	-	 < 0.2	1.00E00
hyaluronan metabolic process (GO:0030212)	32	1	.13	+	7.46	1.00E00
regulation of anatomical structure morphogenesis (GO:0022603)	968	10	4.06	+	2.47	1.00E00
ovulation cycle process (GO:0022602)	79	3	.33	+	9.06	1.00E00
heparin biosynthetic process (GO:0030210)	8	0	.03	-	 < 0.2	1.00E00
menstrual cycle phase (GO:0022601)	2	0	.01	-	 < 0.2	1.00E00
digestive system process (GO:0022600)	66	0	.28	-	 < 0.2	1.00E00
negative regulation of organelle organization (GO:0010639)	328	7	1.37	+	5.09	1.00E00
negative regulation of mitochondrial fusion (GO:0010637)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of mitochondrial fusion (GO:0010636)	3	0	.01	-	 < 0.2	1.00E00
regulation of mitochondrial fusion (GO:0010635)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of epithelial cell migration (GO:0010633)	58	1	.24	+	4.11	1.00E00
epithelial cell migration (GO:0010631)	80	2	.34	+	5.97	1.00E00
regulation of extent of cell growth (GO:0061387)	95	2	.40	+	5.02	1.00E00
closure of optic fissure (GO:0061386)	2	0	.01	-	 < 0.2	1.00E00
heart trabecula morphogenesis (GO:0061384)	35	1	.15	+	6.82	1.00E00
trabecula morphogenesis (GO:0061383)	48	1	.20	+	4.97	1.00E00
cell migration in diencephalon (GO:0061381)	1	0	.00	-	 < 0.2	1.00E00
dermatan sulfate catabolic process (GO:0030209)	1	0	.00	-	 < 0.2	1.00E00
dermatan sulfate biosynthetic process (GO:0030208)	12	0	.05	-	 < 0.2	1.00E00
chondroitin sulfate catabolic process (GO:0030207)	14	0	.06	-	 < 0.2	1.00E00
chondroitin sulfate biosynthetic process (GO:0030206)	24	0	.10	-	 < 0.2	1.00E00
dermatan sulfate metabolic process (GO:0030205)	13	0	.05	-	 < 0.2	1.00E00
chondroitin sulfate metabolic process (GO:0030204)	40	0	.17	-	 < 0.2	1.00E00
glycosaminoglycan metabolic process (GO:0030203)	154	2	.65	+	3.10	1.00E00
heparin metabolic process (GO:0030202)	8	0	.03	-	 < 0.2	1.00E00
heparan sulfate proteoglycan metabolic process (GO:0030201)	27	0	.11	-	 < 0.2	1.00E00
heparan sulfate proteoglycan catabolic process (GO:0030200)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of Schwann cell proliferation (GO:0010626)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of Schwann cell proliferation (GO:0010625)	1	0	.00	-	 < 0.2	1.00E00
regulation of Schwann cell proliferation (GO:0010624)	7	0	.03	-	 < 0.2	1.00E00
programmed cell death involved in cell development (GO:0010623)	11	0	.05	-	 < 0.2	1.00E00
inferior colliculus development (GO:0061379)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription by transcription factor localization (GO:0010621)	3	0	.01	-	 < 0.2	1.00E00
corpora quadrigemina development (GO:0061378)	2	0	.01	-	 < 0.2	1.00E00
mammary gland lobule development (GO:0061377)	20	1	.08	+	11.93	1.00E00
mammillothalamic axonal tract development (GO:0061374)	1	0	.00	-	 < 0.2	1.00E00
mammillary axonal complex development (GO:0061373)	2	0	.01	-	 < 0.2	1.00E00
determination of heart left/right asymmetry (GO:0061371)	64	0	.27	-	 < 0.2	1.00E00
testosterone biosynthetic process (GO:0061370)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of cardiac muscle adaptation (GO:0010616)	6	1	.03	+	39.78	1.00E00
positive regulation of cardiac muscle adaptation (GO:0010615)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cardiac muscle hypertrophy (GO:0010613)	24	1	.10	+	9.94	1.00E00
regulation of cardiac muscle adaptation (GO:0010612)	9	1	.04	+	26.52	1.00E00
negative regulation of testicular blood vessel morphogenesis (GO:0061369)	1	0	.00	-	 < 0.2	1.00E00
tarsal gland development (GO:1903699)	1	0	.00	-	 < 0.2	1.00E00
behavioral response to formalin induced pain (GO:0061368)	3	0	.01	-	 < 0.2	1.00E00
regulation of mRNA stability involved in response to stress (GO:0010610)	1	0	.00	-	 < 0.2	1.00E00
associative learning (GO:0008306)	72	0	.30	-	 < 0.2	1.00E00
behavioral response to chemical pain (GO:0061366)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of microvillus assembly (GO:1903697)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of triglyceride lipase activity (GO:0061365)	11	0	.05	-	 < 0.2	1.00E00
apoptotic process involved in luteolysis (GO:0061364)	3	0	.01	-	 < 0.2	1.00E00
isoprenoid catabolic process (GO:0008300)	8	0	.03	-	 < 0.2	1.00E00
optic chiasma development (GO:0061360)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	4	0	.02	-	 < 0.2	1.00E00
mRNA localization resulting in posttranscriptional regulation of gene expression (GO:0010609)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	5	0	.02	-	 < 0.2	1.00E00
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of Wnt protein secretion (GO:0061358)	1	0	.00	-	 < 0.2	1.00E00
axonal transport of mitochondrion (GO:0019896)	9	0	.04	-	 < 0.2	1.00E00
regulation of wound healing, spreading of epidermal cells (GO:1903689)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of Wnt protein secretion (GO:0061357)	3	0	.01	-	 < 0.2	1.00E00
regulation of Wnt protein secretion (GO:0061356)	4	0	.02	-	 < 0.2	1.00E00
Wnt protein secretion (GO:0061355)	1	0	.00	-	 < 0.2	1.00E00
planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354)	1	0	.00	-	 < 0.2	1.00E00
neural precursor cell proliferation (GO:0061351)	70	0	.29	-	 < 0.2	1.00E00
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350)	1	0	.00	-	 < 0.2	1.00E00
planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	98	0	.41	-	 < 0.2	1.00E00
planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cap-independent translational initiation (GO:1903679)	3	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	10	0	.04	-	 < 0.2	1.00E00
planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation of exogenous antigen (GO:0019884)	182	1	.76	+	1.31	1.00E00
planar cell polarity pathway involved in heart morphogenesis (GO:0061346)	2	0	.01	-	 < 0.2	1.00E00
regulation of cap-independent translational initiation (GO:1903677)	3	0	.01	-	 < 0.2	1.00E00
antigen processing and presentation of endogenous antigen (GO:0019883)	14	1	.06	+	17.05	1.00E00
positive regulation of cap-dependent translational initiation (GO:1903676)	1	0	.00	-	 < 0.2	1.00E00
antigen processing and presentation (GO:0019882)	214	1	.90	+	1.12	1.00E00
cell adhesion involved in heart morphogenesis (GO:0061343)	4	0	.02	-	 < 0.2	1.00E00
regulation of cap-dependent translational initiation (GO:1903674)	1	0	.00	-	 < 0.2	1.00E00
mitotic cleavage furrow formation (GO:1903673)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of sprouting angiogenesis (GO:1903672)	19	0	.08	-	 < 0.2	1.00E00
non-canonical Wnt signaling pathway involved in heart development (GO:0061341)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of sprouting angiogenesis (GO:1903671)	14	0	.06	-	 < 0.2	1.00E00
regulation of sprouting angiogenesis (GO:1903670)	36	0	.15	-	 < 0.2	1.00E00
lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.01	-	 < 0.2	1.00E00
establishment or maintenance of monopolar cell polarity (GO:0061339)	19	0	.08	-	 < 0.2	1.00E00
behavioral response to nicotine (GO:0035095)	8	0	.03	-	 < 0.2	1.00E00
response to nicotine (GO:0035094)	48	3	.20	+	14.92	1.00E00
cardiac conduction (GO:0061337)	87	1	.36	+	2.74	1.00E00
spermatogenesis, exchange of chromosomal proteins (GO:0035093)	9	0	.04	-	 < 0.2	1.00E00
sperm chromatin condensation (GO:0035092)	13	0	.05	-	 < 0.2	1.00E00
maintenance of apical/basal cell polarity (GO:0035090)	12	0	.05	-	 < 0.2	1.00E00
renal tubule morphogenesis (GO:0061333)	67	1	.28	+	3.56	1.00E00
negative regulation of complement-dependent cytotoxicity (GO:1903660)	3	0	.01	-	 < 0.2	1.00E00
establishment of apical/basal cell polarity (GO:0035089)	16	0	.07	-	 < 0.2	1.00E00
establishment or maintenance of apical/basal cell polarity (GO:0035088)	41	0	.17	-	 < 0.2	1.00E00
siRNA loading onto RISC involved in RNA interference (GO:0035087)	4	0	.02	-	 < 0.2	1.00E00
regulation of complement-dependent cytotoxicity (GO:1903659)	3	0	.01	-	 < 0.2	1.00E00
renal tubule development (GO:0061326)	81	2	.34	+	5.89	1.00E00
axoneme assembly (GO:0035082)	58	0	.24	-	 < 0.2	1.00E00
cell proliferation involved in outflow tract morphogenesis (GO:0061325)	2	0	.01	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324)	1	0	.00	-	 < 0.2	1.00E00
cell proliferation involved in heart morphogenesis (GO:0061323)	2	0	.01	-	 < 0.2	1.00E00
uracil metabolic process (GO:0019860)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cytoplasmic transport (GO:1903651)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of cytoplasmic transport (GO:1903650)	2	0	.01	-	 < 0.2	1.00E00
thymine metabolic process (GO:0019859)	3	0	.01	-	 < 0.2	1.00E00
cytosine metabolic process (GO:0019858)	2	1	.01	+	 > 100	1.00E00
5-methylcytosine metabolic process (GO:0019857)	1	0	.00	-	 < 0.2	1.00E00
renal filtration cell differentiation (GO:0061318)	17	1	.07	+	14.04	1.00E00
regulation of cytoplasmic transport (GO:1903649)	21	2	.09	+	22.73	1.00E00
pyrimidine nucleobase biosynthetic process (GO:0019856)	6	0	.03	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317)	2	0	.01	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in heart development (GO:0061316)	3	0	.01	-	 < 0.2	1.00E00
L-ascorbic acid biosynthetic process (GO:0019853)	2	0	.01	-	 < 0.2	1.00E00
Notch signaling involved in heart development (GO:0061314)	9	2	.04	+	53.04	1.00E00
L-ascorbic acid metabolic process (GO:0019852)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of chaperone-mediated protein folding (GO:1903645)	1	0	.00	-	 < 0.2	1.00E00
regulation of chaperone-mediated protein folding (GO:1903644)	2	0	.01	-	 < 0.2	1.00E00
BMP signaling pathway involved in heart development (GO:0061312)	6	0	.03	-	 < 0.2	1.00E00
cell surface receptor signaling pathway involved in heart development (GO:0061311)	21	2	.09	+	22.73	1.00E00
negative regulation of gastrin-induced gastric acid secretion (GO:1903640)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of histone acetylation (GO:0035067)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of histone acetylation (GO:0035066)	29	1	.12	+	8.23	1.00E00
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	6	1	.03	+	39.78	1.00E00
regulation of histone acetylation (GO:0035065)	53	2	.22	+	9.01	1.00E00
cardiac neural crest cell development involved in heart development (GO:0061308)	9	2	.04	+	53.04	1.00E00
regulation of gastrin-induced gastric acid secretion (GO:1903639)	1	0	.00	-	 < 0.2	1.00E00
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	9	2	.04	+	53.04	1.00E00
nuclear speck organization (GO:0035063)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein import into mitochondrial outer membrane (GO:1903638)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein import into mitochondrial outer membrane (GO:1903636)	1	0	.00	-	 < 0.2	1.00E00
retinal blood vessel morphogenesis (GO:0061304)	4	0	.02	-	 < 0.2	1.00E00
cornea development in camera-type eye (GO:0061303)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of leucine-tRNA ligase activity (GO:1903634)	1	0	.00	-	 < 0.2	1.00E00
smooth muscle cell-matrix adhesion (GO:0061302)	2	0	.01	-	 < 0.2	1.00E00
regulation of leucine-tRNA ligase activity (GO:1903633)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of aminoacyl-tRNA ligase activity (GO:1903632)	1	0	.00	-	 < 0.2	1.00E00
cerebellum vasculature morphogenesis (GO:0061301)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of aminoacyl-tRNA ligase activity (GO:1903631)	1	0	.00	-	 < 0.2	1.00E00
cerebellum vasculature development (GO:0061300)	2	0	.01	-	 < 0.2	1.00E00
regulation of aminoacyl-tRNA ligase activity (GO:1903630)	2	0	.01	-	 < 0.2	1.00E00
embryonic heart tube anterior/posterior pattern specification (GO:0035054)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of dUTP diphosphatase activity (GO:1903629)	1	0	.00	-	 < 0.2	1.00E00
hemolysis by symbiont of host erythrocytes (GO:0019836)	2	0	.01	-	 < 0.2	1.00E00
cytolysis (GO:0019835)	30	0	.13	-	 < 0.2	1.00E00
regulation of dUTP diphosphatase activity (GO:1903627)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of DNA catabolic process (GO:1903626)	4	1	.02	+	59.66	1.00E00
embryonic heart tube development (GO:0035050)	73	0	.31	-	 < 0.2	1.00E00
negative regulation of DNA catabolic process (GO:1903625)	2	0	.01	-	 < 0.2	1.00E00
regulation of DNA catabolic process (GO:1903624)	10	2	.04	+	47.73	1.00E00
protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transdifferentiation (GO:1903620)	1	0	.00	-	 < 0.2	1.00E00
splicing factor protein import into nucleus (GO:0035048)	1	0	.00	-	 < 0.2	1.00E00
stem cell population maintenance (GO:0019827)	138	3	.58	+	5.19	1.00E00
regulation of transdifferentiation (GO:1903618)	1	0	.00	-	 < 0.2	1.00E00
fertilization, exchange of chromosomal proteins (GO:0035042)	1	0	.00	-	 < 0.2	1.00E00
sperm chromatin decondensation (GO:0035041)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein tyrosine phosphatase activity (GO:1903615)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein tyrosine phosphatase activity (GO:1903613)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of calcium-dependent ATPase activity (GO:1903611)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcium-dependent ATPase activity (GO:1903610)	1	0	.00	-	 < 0.2	1.00E00
male pronucleus assembly (GO:0035039)	2	0	.01	-	 < 0.2	1.00E00
female pronucleus assembly (GO:0035038)	2	0	.01	-	 < 0.2	1.00E00
sperm entry (GO:0035037)	1	0	.00	-	 < 0.2	1.00E00
sperm-egg recognition (GO:0035036)	50	0	.21	-	 < 0.2	1.00E00
negative regulation of inward rectifier potassium channel activity (GO:1903609)	1	1	.00	+	 > 100	1.00E00
protein localization to cytoplasmic stress granule (GO:1903608)	7	0	.03	-	 < 0.2	1.00E00
signal release (GO:0023061)	171	1	.72	+	1.40	1.00E00
leading edge cell differentiation (GO:0035026)	2	1	.01	+	 > 100	1.00E00
positive regulation of Rho protein signal transduction (GO:0035025)	27	1	.11	+	8.84	1.00E00
negative regulation of Rho protein signal transduction (GO:0035024)	20	0	.08	-	 < 0.2	1.00E00
regulation of Rho protein signal transduction (GO:0035023)	130	3	.54	+	5.51	1.00E00
quinolinate biosynthetic process (GO:0019805)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of Rac protein signal transduction (GO:0035022)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of Rac protein signal transduction (GO:0035021)	4	0	.02	-	 < 0.2	1.00E00
regulation of Rac protein signal transduction (GO:0035020)	15	0	.06	-	 < 0.2	1.00E00
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	6	0	.03	-	 < 0.2	1.00E00
adaptation of signaling pathway (GO:0023058)	16	0	.07	-	 < 0.2	1.00E00
neural plate regionalization (GO:0060897)	5	0	.02	-	 < 0.2	1.00E00
neural plate pattern specification (GO:0060896)	7	0	.03	-	 < 0.2	1.00E00
somatic stem cell population maintenance (GO:0035019)	66	1	.28	+	3.62	1.00E00
limb epidermis development (GO:0060887)	1	0	.00	-	 < 0.2	1.00E00
neuronal signal transduction (GO:0023041)	6	0	.03	-	 < 0.2	1.00E00
semicircular canal fusion (GO:0060879)	1	0	.00	-	 < 0.2	1.00E00
CD40 signaling pathway (GO:0023035)	2	0	.01	-	 < 0.2	1.00E00
semicircular canal formation (GO:0060876)	2	0	.01	-	 < 0.2	1.00E00
lateral semicircular canal development (GO:0060875)	1	0	.00	-	 < 0.2	1.00E00
anterior semicircular canal development (GO:0060873)	1	0	.00	-	 < 0.2	1.00E00
semicircular canal development (GO:0060872)	9	0	.04	-	 < 0.2	1.00E00
regulation of centriole replication (GO:0046599)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of viral entry into host cell (GO:0046598)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of viral entry into host cell (GO:0046597)	19	0	.08	-	 < 0.2	1.00E00
regulation of viral entry into host cell (GO:0046596)	31	0	.13	-	 < 0.2	1.00E00
termination of signal transduction (GO:0023021)	3	1	.01	+	79.55	1.00E00
negative regulation of calcium-dependent cell-cell adhesion (GO:0046588)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of calcium-dependent cell-cell adhesion (GO:0046587)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcium-dependent cell-cell adhesion (GO:0046586)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of Ras protein signal transduction (GO:0046580)	48	0	.20	-	 < 0.2	1.00E00
signal transduction involved in regulation of gene expression (GO:0023019)	20	0	.08	-	 < 0.2	1.00E00
signal transduction by trans-phosphorylation (GO:0023016)	3	0	.01	-	 < 0.2	1.00E00
establishment of glial blood-brain barrier (GO:0060857)	2	0	.01	-	 < 0.2	1.00E00
establishment of blood-brain barrier (GO:0060856)	9	0	.04	-	 < 0.2	1.00E00
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription involved in cell fate commitment (GO:0060850)	17	0	.07	-	 < 0.2	1.00E00
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of Ras protein signal transduction (GO:0046579)	51	2	.21	+	9.36	1.00E00
growth plate cartilage chondrocyte development (GO:0003431)	4	0	.02	-	 < 0.2	1.00E00
regulation of Ras protein signal transduction (GO:0046578)	215	5	.90	+	5.55	1.00E00
growth plate cartilage chondrocyte growth (GO:0003430)	2	0	.01	-	 < 0.2	1.00E00
regulation of transcription involved in lymphatic endothelial cell fate commitment (GO:0060849)	2	0	.01	-	 < 0.2	1.00E00
endothelial cell fate specification (GO:0060847)	3	0	.01	-	 < 0.2	1.00E00
blood vessel endothelial cell fate commitment (GO:0060846)	3	0	.01	-	 < 0.2	1.00E00
arterial endothelial cell fate commitment (GO:0060844)	2	0	.01	-	 < 0.2	1.00E00
venous endothelial cell differentiation (GO:0060843)	1	0	.00	-	 < 0.2	1.00E00
arterial endothelial cell differentiation (GO:0060842)	6	0	.03	-	 < 0.2	1.00E00
venous blood vessel development (GO:0060841)	16	0	.07	-	 < 0.2	1.00E00
artery development (GO:0060840)	76	3	.32	+	9.42	1.00E00
growth plate cartilage chondrocyte morphogenesis (GO:0003429)	1	0	.00	-	 < 0.2	1.00E00
growth plate cartilage morphogenesis (GO:0003422)	2	0	.01	-	 < 0.2	1.00E00
growth plate cartilage axis specification (GO:0003421)	1	0	.00	-	 < 0.2	1.00E00
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	2	0	.01	-	 < 0.2	1.00E00
endothelial cell fate commitment (GO:0060839)	7	0	.03	-	 < 0.2	1.00E00
lymphatic endothelial cell fate commitment (GO:0060838)	3	0	.01	-	 < 0.2	1.00E00
blood vessel endothelial cell differentiation (GO:0060837)	8	0	.03	-	 < 0.2	1.00E00
lymphatic endothelial cell differentiation (GO:0060836)	8	0	.03	-	 < 0.2	1.00E00
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	7	0	.03	-	 < 0.2	1.00E00
growth plate cartilage chondrocyte proliferation (GO:0003419)	2	0	.01	-	 < 0.2	1.00E00
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	3	0	.01	-	 < 0.2	1.00E00
growth plate cartilage chondrocyte differentiation (GO:0003418)	6	0	.03	-	 < 0.2	1.00E00
growth plate cartilage development (GO:0003417)	13	0	.05	-	 < 0.2	1.00E00
endochondral bone growth (GO:0003416)	20	0	.08	-	 < 0.2	1.00E00
chondrocyte hypertrophy (GO:0003415)	4	0	.02	-	 < 0.2	1.00E00
chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414)	1	0	.00	-	 < 0.2	1.00E00
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	11	0	.05	-	 < 0.2	1.00E00
photoreceptor cell fate commitment (GO:0046552)	1	0	.00	-	 < 0.2	1.00E00
hydroxyproline transport (GO:0034589)	1	0	.00	-	 < 0.2	1.00E00
halogenated hydrocarbon metabolic process (GO:0042197)	2	0	.01	-	 < 0.2	1.00E00
piRNA metabolic process (GO:0034587)	18	0	.08	-	 < 0.2	1.00E00
chlorinated hydrocarbon metabolic process (GO:0042196)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829)	1	0	.00	-	 < 0.2	1.00E00
regulation of canonical Wnt signaling pathway (GO:0060828)	244	6	1.02	+	5.87	1.00E00
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827)	1	0	.00	-	 < 0.2	1.00E00
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825)	1	0	.00	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060823)	1	0	.00	-	 < 0.2	1.00E00
inactivation of X chromosome by DNA methylation (GO:0060821)	1	0	.00	-	 < 0.2	1.00E00
optic cup structural organization (GO:0003409)	1	0	.00	-	 < 0.2	1.00E00
optic cup formation involved in camera-type eye development (GO:0003408)	3	0	.01	-	 < 0.2	1.00E00
neural retina development (GO:0003407)	55	0	.23	-	 < 0.2	1.00E00
retinal pigment epithelium development (GO:0003406)	6	0	.03	-	 < 0.2	1.00E00
optic vesicle morphogenesis (GO:0003404)	2	0	.01	-	 < 0.2	1.00E00
planar cell polarity pathway involved in axis elongation (GO:0003402)	4	0	.02	-	 < 0.2	1.00E00
retinal cone cell development (GO:0046549)	9	0	.04	-	 < 0.2	1.00E00
axis elongation (GO:0003401)	26	0	.11	-	 < 0.2	1.00E00
regulation of protein O-linked glycosylation (GO:1904098)	3	0	.01	-	 < 0.2	1.00E00
retinal rod cell development (GO:0046548)	10	0	.04	-	 < 0.2	1.00E00
regulation of COPII vesicle coating (GO:0003400)	1	0	.00	-	 < 0.2	1.00E00
development of primary male sexual characteristics (GO:0046546)	137	3	.57	+	5.23	1.00E00
development of primary female sexual characteristics (GO:0046545)	92	4	.39	+	10.38	1.00E00
development of secondary male sexual characteristics (GO:0046544)	1	0	.00	-	 < 0.2	1.00E00
development of secondary female sexual characteristics (GO:0046543)	7	0	.03	-	 < 0.2	1.00E00
saliva secretion (GO:0046541)	5	0	.02	-	 < 0.2	1.00E00
regulation of nucleus size (GO:0097298)	1	0	.00	-	 < 0.2	1.00E00
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296)	13	0	.05	-	 < 0.2	1.00E00
inactivation of X chromosome by genetic imprinting (GO:0060819)	2	0	.01	-	 < 0.2	1.00E00
renal phosphate ion absorption (GO:0097291)	1	0	.00	-	 < 0.2	1.00E00
inactivation of paternal X chromosome (GO:0060817)	1	0	.00	-	 < 0.2	1.00E00
ketone catabolic process (GO:0042182)	9	0	.04	-	 < 0.2	1.00E00
ketone biosynthetic process (GO:0042181)	31	0	.13	-	 < 0.2	1.00E00
random inactivation of X chromosome (GO:0060816)	1	0	.00	-	 < 0.2	1.00E00
cellular ketone metabolic process (GO:0042180)	72	1	.30	+	3.31	1.00E00
positive regulation of photoreceptor cell differentiation (GO:0046534)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of photoreceptor cell differentiation (GO:0046533)	6	0	.03	-	 < 0.2	1.00E00
regulation of photoreceptor cell differentiation (GO:0046532)	7	0	.03	-	 < 0.2	1.00E00
photoreceptor cell differentiation (GO:0046530)	55	0	.23	-	 < 0.2	1.00E00
xenobiotic catabolic process (GO:0042178)	10	0	.04	-	 < 0.2	1.00E00
iron ion import (GO:0097286)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of protein catabolic process (GO:0042177)	111	3	.47	+	6.45	1.00E00
hepatocyte apoptotic process (GO:0097284)	12	1	.05	+	19.89	1.00E00
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	2	0	.01	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification (GO:0060807)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806)	1	1	.00	+	 > 100	1.00E00
positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804)	1	0	.00	-	 < 0.2	1.00E00
BMP signaling pathway involved in mesodermal cell fate specification (GO:0060803)	1	0	.00	-	 < 0.2	1.00E00
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	4	1	.02	+	59.66	1.00E00
positive regulation of trophectodermal cell proliferation (GO:1904075)	1	0	.00	-	 < 0.2	1.00E00
regulation of trophectodermal cell proliferation (GO:1904073)	1	0	.00	-	 < 0.2	1.00E00
presynaptic active zone assembly (GO:1904071)	1	0	.00	-	 < 0.2	1.00E00
sphingoid catabolic process (GO:0046521)	1	0	.00	-	 < 0.2	1.00E00
complement-dependent cytotoxicity (GO:0097278)	1	0	.00	-	 < 0.2	1.00E00
sphingoid biosynthetic process (GO:0046520)	9	0	.04	-	 < 0.2	1.00E00
cellular urea homeostasis (GO:0097277)	1	0	.00	-	 < 0.2	1.00E00
heme metabolic process (GO:0042168)	31	0	.13	-	 < 0.2	1.00E00
cellular creatinine homeostasis (GO:0097276)	1	0	.00	-	 < 0.2	1.00E00
heme catabolic process (GO:0042167)	7	0	.03	-	 < 0.2	1.00E00
cellular ammonia homeostasis (GO:0097275)	1	0	.00	-	 < 0.2	1.00E00
urea homeostasis (GO:0097274)	2	0	.01	-	 < 0.2	1.00E00
creatinine homeostasis (GO:0097273)	1	0	.00	-	 < 0.2	1.00E00
ammonia homeostasis (GO:0097272)	2	0	.01	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex II assembly (GO:0034553)	5	0	.02	-	 < 0.2	1.00E00
respiratory chain complex II assembly (GO:0034552)	5	0	.02	-	 < 0.2	1.00E00
lipoprotein oxidation (GO:0042161)	1	0	.00	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex III assembly (GO:0034551)	9	0	.04	-	 < 0.2	1.00E00
lipoprotein modification (GO:0042160)	1	0	.00	-	 < 0.2	1.00E00
collagen fibril organization (GO:0030199)	42	0	.18	-	 < 0.2	1.00E00
extracellular matrix organization (GO:0030198)	309	7	1.29	+	5.41	1.00E00
negative regulation of blood coagulation (GO:0030195)	46	2	.19	+	10.38	1.00E00
positive regulation of blood coagulation (GO:0030194)	25	1	.10	+	9.55	1.00E00
sphingoid metabolic process (GO:0046519)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of cation transmembrane transport (GO:1904064)	120	2	.50	+	3.98	1.00E00
negative regulation of cation transmembrane transport (GO:1904063)	73	1	.31	+	3.27	1.00E00
ceramide catabolic process (GO:0046514)	14	0	.06	-	 < 0.2	1.00E00
ceramide biosynthetic process (GO:0046513)	42	0	.18	-	 < 0.2	1.00E00
regulation of cation transmembrane transport (GO:1904062)	285	3	1.19	+	2.51	1.00E00
sphingosine biosynthetic process (GO:0046512)	8	0	.03	-	 < 0.2	1.00E00
sphinganine biosynthetic process (GO:0046511)	2	0	.01	-	 < 0.2	1.00E00
omega-hydroxylase P450 pathway (GO:0097267)	9	0	.04	-	 < 0.2	1.00E00
lipoprotein catabolic process (GO:0042159)	9	1	.04	+	26.52	1.00E00
lipoprotein biosynthetic process (GO:0042158)	152	0	.64	-	 < 0.2	1.00E00
lipoprotein metabolic process (GO:0042157)	177	1	.74	+	1.35	1.00E00
self proteolysis (GO:0097264)	8	0	.03	-	 < 0.2	1.00E00
melatonin biosynthetic process (GO:0030187)	2	0	.01	-	 < 0.2	1.00E00
melatonin metabolic process (GO:0030186)	2	0	.01	-	 < 0.2	1.00E00
nitric oxide transport (GO:0030185)	3	0	.01	-	 < 0.2	1.00E00
B cell differentiation (GO:0030183)	97	3	.41	+	7.38	1.00E00
regulation of locomotor rhythm (GO:1904059)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of sensory perception of pain (GO:1904058)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of sensory perception of pain (GO:1904057)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cholangiocyte proliferation (GO:1904056)	1	0	.00	-	 < 0.2	1.00E00
regulation of cholangiocyte proliferation (GO:1904054)	1	0	.00	-	 < 0.2	1.00E00
glycerol ether biosynthetic process (GO:0046504)	4	0	.02	-	 < 0.2	1.00E00
glycerolipid catabolic process (GO:0046503)	45	0	.19	-	 < 0.2	1.00E00
isoprenoid biosynthetic process (GO:0008299)	26	0	.11	-	 < 0.2	1.00E00
intracellular mRNA localization (GO:0008298)	12	0	.05	-	 < 0.2	1.00E00
uroporphyrinogen III metabolic process (GO:0046502)	2	0	.01	-	 < 0.2	1.00E00
protoporphyrinogen IX metabolic process (GO:0046501)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of spontaneous neurotransmitter secretion (GO:1904050)	1	0	.00	-	 < 0.2	1.00E00
S-adenosylmethionine metabolic process (GO:0046500)	13	0	.05	-	 < 0.2	1.00E00
cellular response to glucose starvation (GO:0042149)	37	3	.16	+	19.35	1.00E00
spermidine biosynthetic process (GO:0008295)	3	0	.01	-	 < 0.2	1.00E00
strand invasion (GO:0042148)	7	0	.03	-	 < 0.2	1.00E00
retrograde transport, endosome to Golgi (GO:0042147)	82	0	.34	-	 < 0.2	1.00E00
renal tubular secretion (GO:0097254)	1	0	.00	-	 < 0.2	1.00E00
acetylcholine biosynthetic process (GO:0008292)	2	0	.01	-	 < 0.2	1.00E00
acetylcholine metabolic process (GO:0008291)	4	0	.02	-	 < 0.2	1.00E00
oligodendrocyte apoptotic process (GO:0097252)	2	1	.01	+	 > 100	1.00E00
vacuole fusion, non-autophagic (GO:0042144)	1	0	.00	-	 < 0.2	1.00E00
late meiotic recombination nodule assembly (GO:0042140)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of Wnt signaling pathway (GO:0030178)	199	6	.83	+	7.20	1.00E00
positive regulation of Wnt signaling pathway (GO:0030177)	157	2	.66	+	3.04	1.00E00
regulation of DNA-dependent DNA replication initiation (GO:0030174)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of spontaneous neurotransmitter secretion (GO:1904049)	2	0	.01	-	 < 0.2	1.00E00
regulation of spontaneous neurotransmitter secretion (GO:1904048)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of endothelial cell migration (GO:0010596)	41	0	.17	-	 < 0.2	1.00E00
negative regulation of vascular endothelial growth factor production (GO:1904046)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of endothelial cell migration (GO:0010595)	74	4	.31	+	12.90	1.00E00
cellular response to aldosterone (GO:1904045)	1	0	.00	-	 < 0.2	1.00E00
regulation of endothelial cell migration (GO:0010594)	123	5	.52	+	9.70	1.00E00
response to aldosterone (GO:1904044)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of lamellipodium assembly (GO:0010593)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of lamellipodium assembly (GO:0010592)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of cystathionine beta-synthase activity (GO:1904042)	1	0	.00	-	 < 0.2	1.00E00
regulation of lamellipodium assembly (GO:0010591)	31	0	.13	-	 < 0.2	1.00E00
regulation of cystathionine beta-synthase activity (GO:1904041)	1	0	.00	-	 < 0.2	1.00E00
meiotic DNA double-strand break formation (GO:0042138)	5	0	.02	-	 < 0.2	1.00E00
sequestering of neurotransmitter (GO:0042137)	2	0	.01	-	 < 0.2	1.00E00
neurotransmitter biosynthetic process (GO:0042136)	18	0	.08	-	 < 0.2	1.00E00
neurotransmitter catabolic process (GO:0042135)	11	0	.05	-	 < 0.2	1.00E00
amyloid-beta clearance (GO:0097242)	11	1	.05	+	21.70	1.00E00
neurotransmitter metabolic process (GO:0042133)	31	0	.13	-	 < 0.2	1.00E00
hematopoietic stem cell migration to bone marrow (GO:0097241)	2	0	.01	-	 < 0.2	1.00E00
chromosome attachment to the nuclear envelope (GO:0097240)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of T cell proliferation (GO:0042130)	59	3	.25	+	12.14	1.00E00
proteoglycan catabolic process (GO:0030167)	4	0	.02	-	 < 0.2	1.00E00
proteoglycan biosynthetic process (GO:0030166)	56	0	.23	-	 < 0.2	1.00E00
protein catabolic process (GO:0030163)	636	8	2.66	+	3.00	1.00E00
positive regulation of epithelial cell apoptotic process (GO:1904037)	27	1	.11	+	8.84	1.00E00
miRNA catabolic process (GO:0010587)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of epithelial cell apoptotic process (GO:1904036)	37	1	.16	+	6.45	1.00E00
miRNA metabolic process (GO:0010586)	18	0	.08	-	 < 0.2	1.00E00
glutamine secretion (GO:0010585)	1	0	.00	-	 < 0.2	1.00E00
regulation of epithelial cell apoptotic process (GO:1904035)	67	2	.28	+	7.12	1.00E00
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277)	131	1	.55	+	1.82	1.00E00
cellular response to methylglyoxal (GO:0097238)	1	1	.00	+	 > 100	1.00E00
cellular response to toxic substance (GO:0097237)	9	0	.04	-	 < 0.2	1.00E00
nitrate assimilation (GO:0042128)	1	0	.00	-	 < 0.2	1.00E00
nitrate metabolic process (GO:0042126)	4	0	.02	-	 < 0.2	1.00E00
sulfate transport (GO:0008272)	16	0	.07	-	 < 0.2	1.00E00
response to vitamin B6 (GO:0034516)	1	0	.00	-	 < 0.2	1.00E00
protein galactosylation (GO:0042125)	1	0	.00	-	 < 0.2	1.00E00
cell motility in response to calcium ion (GO:0097231)	1	0	.00	-	 < 0.2	1.00E00
pancreatic juice secretion (GO:0030157)	7	0	.03	-	 < 0.2	1.00E00
protein import into mitochondrial matrix (GO:0030150)	17	0	.07	-	 < 0.2	1.00E00
positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway (GO:0010579)	9	0	.04	-	 < 0.2	1.00E00
regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway (GO:0010578)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of collagen fibril organization (GO:1904028)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of collagen fibril organization (GO:1904027)	1	0	.00	-	 < 0.2	1.00E00
regulation of collagen fibril organization (GO:1904026)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of vascular endothelial growth factor production (GO:0010575)	27	0	.11	-	 < 0.2	1.00E00
positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025)	1	0	.00	-	 < 0.2	1.00E00
regulation of vascular endothelial growth factor production (GO:0010574)	33	0	.14	-	 < 0.2	1.00E00
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	1	0	.00	-	 < 0.2	1.00E00
vascular endothelial growth factor production (GO:0010573)	3	0	.01	-	 < 0.2	1.00E00
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of platelet activation (GO:0010572)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of G-protein coupled receptor internalization (GO:1904022)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of G-protein coupled receptor internalization (GO:1904021)	2	0	.01	-	 < 0.2	1.00E00
regulation of G-protein coupled receptor internalization (GO:1904020)	4	0	.02	-	 < 0.2	1.00E00
endothelial cell activation (GO:0042118)	11	0	.05	-	 < 0.2	1.00E00
monocyte activation (GO:0042117)	8	0	.03	-	 < 0.2	1.00E00
centromere complex assembly (GO:0034508)	36	0	.15	-	 < 0.2	1.00E00
macrophage activation (GO:0042116)	36	2	.15	+	13.26	1.00E00
mitochondrial mRNA polyadenylation (GO:0097222)	1	0	.00	-	 < 0.2	1.00E00
tooth mineralization (GO:0034505)	15	0	.06	-	 < 0.2	1.00E00
B cell activation (GO:0042113)	142	4	.59	+	6.72	1.00E00
protein localization to chromosome (GO:0034502)	57	2	.24	+	8.37	1.00E00
T cell activation (GO:0042110)	226	5	.95	+	5.28	1.00E00
protein localization to kinetochore (GO:0034501)	14	0	.06	-	 < 0.2	1.00E00
sphingolipid catabolic process (GO:0030149)	22	0	.09	-	 < 0.2	1.00E00
sphingolipid biosynthetic process (GO:0030148)	86	0	.36	-	 < 0.2	1.00E00
epithelial cell apoptotic process (GO:1904019)	27	1	.11	+	8.84	1.00E00
regulation of double-strand break repair via homologous recombination (GO:0010569)	28	1	.12	+	8.52	1.00E00
positive regulation of vasculature development (GO:1904018)	151	3	.63	+	4.74	1.00E00
cellular response to Thyroglobulin triiodothyronine (GO:1904017)	2	0	.01	-	 < 0.2	1.00E00
regulation of ketone biosynthetic process (GO:0010566)	13	0	.05	-	 < 0.2	1.00E00
response to Thyroglobulin triiodothyronine (GO:1904016)	4	0	.02	-	 < 0.2	1.00E00
regulation of cellular ketone metabolic process (GO:0010565)	172	3	.72	+	4.16	1.00E00
negative regulation of glycoprotein biosynthetic process (GO:0010561)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of glycoprotein biosynthetic process (GO:0010560)	19	0	.08	-	 < 0.2	1.00E00
response to Aroclor 1254 (GO:1904010)	1	0	.00	-	 < 0.2	1.00E00
lymphotoxin A biosynthetic process (GO:0042109)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cytokine biosynthetic process (GO:0042108)	61	1	.26	+	3.91	1.00E00
cytokine metabolic process (GO:0042107)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of lysosomal membrane permeability (GO:0097214)	1	0	.00	-	 < 0.2	1.00E00
regulation of lysosomal membrane permeability (GO:0097213)	2	0	.01	-	 < 0.2	1.00E00
lysosomal membrane organization (GO:0097212)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of activated T cell proliferation (GO:0042104)	27	1	.11	+	8.84	1.00E00
cellular response to gonadotropin-releasing hormone (GO:0097211)	7	0	.03	-	 < 0.2	1.00E00
response to gonadotropin-releasing hormone (GO:0097210)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of T cell proliferation (GO:0042102)	99	4	.41	+	9.64	1.00E00
B cell proliferation (GO:0042100)	39	2	.16	+	12.24	1.00E00
regulation of lung blood pressure (GO:0014916)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of smooth muscle cell migration (GO:0014912)	20	1	.08	+	11.93	1.00E00
regulation of glycoprotein biosynthetic process (GO:0010559)	45	1	.19	+	5.30	1.00E00
cellular response to monosodium glutamate (GO:1904009)	1	0	.00	-	 < 0.2	1.00E00
response to monosodium glutamate (GO:1904008)	2	0	.01	-	 < 0.2	1.00E00
tRNA threonylcarbamoyladenosine modification (GO:0002949)	3	0	.01	-	 < 0.2	1.00E00
tRNA C5-cytosine methylation (GO:0002946)	1	0	.00	-	 < 0.2	1.00E00
tRNA dihydrouridine synthesis (GO:0002943)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of eating behavior (GO:1904000)	3	0	.01	-	 < 0.2	1.00E00
tRNA N2-guanine methylation (GO:0002940)	1	0	.00	-	 < 0.2	1.00E00
renal filtration (GO:0097205)	12	0	.05	-	 < 0.2	1.00E00
activation of cysteine-type endopeptidase activity (GO:0097202)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	13	1	.05	+	18.36	1.00E00
smooth muscle cell migration (GO:0014909)	11	1	.05	+	21.70	1.00E00
myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	3	0	.01	-	 < 0.2	1.00E00
myoblast fusion involved in skeletal muscle regeneration (GO:0014905)	1	0	.00	-	 < 0.2	1.00E00
myotube cell development (GO:0014904)	28	0	.12	-	 < 0.2	1.00E00
myotube differentiation (GO:0014902)	55	0	.23	-	 < 0.2	1.00E00
muscle hyperplasia (GO:0014900)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of platelet activation (GO:0010544)	18	1	.08	+	13.26	1.00E00
regulation of platelet activation (GO:0010543)	32	3	.13	+	22.37	1.00E00
desmosome organization (GO:0002934)	10	1	.04	+	23.87	1.00E00
retina vasculature morphogenesis in camera-type eye (GO:0061299)	9	0	.04	-	 < 0.2	1.00E00
lipid hydroxylation (GO:0002933)	6	0	.03	-	 < 0.2	1.00E00
retina vasculature development in camera-type eye (GO:0061298)	16	1	.07	+	14.92	1.00E00
trabecular meshwork development (GO:0002930)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296)	1	0	.00	-	 < 0.2	1.00E00
regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295)	1	0	.00	-	 < 0.2	1.00E00
canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290)	2	0	.01	-	 < 0.2	1.00E00
regulation of Wnt signaling pathway (GO:0030111)	321	7	1.35	+	5.20	1.00E00
positive regulation of activation of Janus kinase activity (GO:0010536)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925)	4	0	.02	-	 < 0.2	1.00E00
regulation of activation of Janus kinase activity (GO:0010533)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	7	0	.03	-	 < 0.2	1.00E00
Wnt signaling pathway involved in kidney development (GO:0061289)	2	0	.01	-	 < 0.2	1.00E00
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	11	0	.05	-	 < 0.2	1.00E00
opsonization (GO:0008228)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of humoral immune response (GO:0002922)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of humoral immune response (GO:0002921)	15	0	.06	-	 < 0.2	1.00E00
regulation of humoral immune response (GO:0002920)	129	0	.54	-	 < 0.2	1.00E00
water homeostasis (GO:0030104)	68	1	.28	+	3.51	1.00E00
vasopressin secretion (GO:0030103)	2	0	.01	-	 < 0.2	1.00E00
natural killer cell activation (GO:0030101)	54	1	.23	+	4.42	1.00E00
negative regulation of transposition (GO:0010529)	19	0	.08	-	 < 0.2	1.00E00
regulation of transposition (GO:0010528)	19	0	.08	-	 < 0.2	1.00E00
positive regulation of calcium ion transport into cytosol (GO:0010524)	51	2	.21	+	9.36	1.00E00
negative regulation of calcium ion transport into cytosol (GO:0010523)	16	1	.07	+	14.92	1.00E00
regulation of calcium ion transport into cytosol (GO:0010522)	95	3	.40	+	7.54	1.00E00
positive regulation of lymphocyte anergy (GO:0002913)	3	0	.01	-	 < 0.2	1.00E00
bioluminescence (GO:0008218)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of lymphocyte anergy (GO:0002912)	1	0	.00	-	 < 0.2	1.00E00
regulation of blood pressure (GO:0008217)	176	3	.74	+	4.07	1.00E00
regulation of lymphocyte anergy (GO:0002911)	7	0	.03	-	 < 0.2	1.00E00
regulation of reciprocal meiotic recombination (GO:0010520)	3	0	.01	-	 < 0.2	1.00E00
spermidine metabolic process (GO:0008216)	8	0	.03	-	 < 0.2	1.00E00
spermine metabolic process (GO:0008215)	7	0	.03	-	 < 0.2	1.00E00
protein dealkylation (GO:0008214)	32	0	.13	-	 < 0.2	1.00E00
protein alkylation (GO:0008213)	132	1	.55	+	1.81	1.00E00
mineralocorticoid metabolic process (GO:0008212)	6	0	.03	-	 < 0.2	1.00E00
glucocorticoid metabolic process (GO:0008211)	15	0	.06	-	 < 0.2	1.00E00
estrogen metabolic process (GO:0008210)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of phospholipase activity (GO:0010519)	7	0	.03	-	 < 0.2	1.00E00
regulation of phospholipase activity (GO:0010517)	60	4	.25	+	15.91	1.00E00
negative regulation of mature B cell apoptotic process (GO:0002906)	4	0	.02	-	 < 0.2	1.00E00
regulation of mature B cell apoptotic process (GO:0002905)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of B cell apoptotic process (GO:0002904)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	0	.01	-	 < 0.2	1.00E00
androgen metabolic process (GO:0008209)	28	0	.12	-	 < 0.2	1.00E00
negative regulation of B cell apoptotic process (GO:0002903)	12	0	.05	-	 < 0.2	1.00E00
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	6	0	.03	-	 < 0.2	1.00E00
regulation of B cell apoptotic process (GO:0002902)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of autophagy of mitochondrion (GO:1903599)	18	0	.08	-	 < 0.2	1.00E00
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	13	0	.05	-	 < 0.2	1.00E00
C21-steroid hormone metabolic process (GO:0008207)	28	1	.12	+	8.52	1.00E00
positive regulation of gap junction assembly (GO:1903598)	3	1	.01	+	79.55	1.00E00
bile acid metabolic process (GO:0008206)	38	0	.16	-	 < 0.2	1.00E00
negative regulation of gap junction assembly (GO:1903597)	1	0	.00	-	 < 0.2	1.00E00
regulation of gap junction assembly (GO:1903596)	4	1	.02	+	59.66	1.00E00
positive regulation of histamine secretion by mast cell (GO:1903595)	3	0	.01	-	 < 0.2	1.00E00
ergosterol metabolic process (GO:0008204)	2	0	.01	-	 < 0.2	1.00E00
cholesterol metabolic process (GO:0008203)	111	1	.47	+	2.15	1.00E00
steroid metabolic process (GO:0008202)	250	2	1.05	+	1.91	1.00E00
regulation of histamine secretion by mast cell (GO:1903593)	3	0	.01	-	 < 0.2	1.00E00
polyamine homeostasis (GO:0010509)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of autophagy (GO:0010508)	103	2	.43	+	4.63	1.00E00
negative regulation of autophagy (GO:0010507)	67	4	.28	+	14.25	1.00E00
RNA secondary structure unwinding (GO:0010501)	46	0	.19	-	 < 0.2	1.00E00
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	3	0	.01	-	 < 0.2	1.00E00
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of histone deubiquitination (GO:1903586)	1	0	.00	-	 < 0.2	1.00E00
regulation of histone deubiquitination (GO:1903584)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of ATP metabolic process (GO:1903580)	32	1	.13	+	7.46	1.00E00
negative regulation of ATP metabolic process (GO:1903579)	21	0	.09	-	 < 0.2	1.00E00
regulation of ATP metabolic process (GO:1903578)	90	1	.38	+	2.65	1.00E00
cellular response to L-arginine (GO:1903577)	1	0	.00	-	 < 0.2	1.00E00
establishment or maintenance of bipolar cell polarity (GO:0061245)	41	0	.17	-	 < 0.2	1.00E00
response to L-arginine (GO:1903576)	3	0	.01	-	 < 0.2	1.00E00
cornified envelope assembly (GO:1903575)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	41	1	.17	+	5.82	1.00E00
positive regulation of protein kinase D signaling (GO:1903572)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein kinase D signaling (GO:1903570)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of protein localization to ciliary membrane (GO:1903568)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to ciliary membrane (GO:1903567)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of protein localization to cilium (GO:1903566)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of protein localization to cilium (GO:1903565)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein localization to cilium (GO:1903564)	4	0	.02	-	 < 0.2	1.00E00
pattern specification involved in mesonephros development (GO:0061227)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	68	2	.28	+	7.02	1.00E00
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	49	3	.21	+	14.61	1.00E00
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	116	5	.49	+	10.29	1.00E00
positive regulation of extracellular exosome assembly (GO:1903553)	4	0	.02	-	 < 0.2	1.00E00
regulation of extracellular exosome assembly (GO:1903551)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of mesonephros development (GO:0061218)	6	0	.03	-	 < 0.2	1.00E00
regulation of mesonephros development (GO:0061217)	26	0	.11	-	 < 0.2	1.00E00
one-carbon compound transport (GO:0019755)	11	0	.05	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in mesonephros development (GO:0061216)	1	0	.00	-	 < 0.2	1.00E00
regulation of growth hormone activity (GO:1903547)	2	0	.01	-	 < 0.2	1.00E00
protein localization to photoreceptor outer segment (GO:1903546)	7	0	.03	-	 < 0.2	1.00E00
carboxylic acid metabolic process (GO:0019752)	871	8	3.65	+	2.19	1.00E00
cellular response to butyrate (GO:1903545)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mesonephros development (GO:0061213)	22	0	.09	-	 < 0.2	1.00E00
polyol metabolic process (GO:0019751)	101	2	.42	+	4.73	1.00E00
response to butyrate (GO:1903544)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of exosomal secretion (GO:1903543)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of exosomal secretion (GO:1903542)	3	0	.01	-	 < 0.2	1.00E00
regulation of exosomal secretion (GO:1903541)	16	0	.07	-	 < 0.2	1.00E00
establishment of protein localization to postsynaptic membrane (GO:1903540)	10	0	.04	-	 < 0.2	1.00E00
secondary metabolic process (GO:0019748)	46	2	.19	+	10.38	1.00E00
cell proliferation involved in mesonephros development (GO:0061209)	3	0	.01	-	 < 0.2	1.00E00
regulation of isoprenoid metabolic process (GO:0019747)	3	0	.01	-	 < 0.2	1.00E00
protein localization to postsynaptic membrane (GO:1903539)	10	0	.04	-	 < 0.2	1.00E00
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	1	0	.00	-	 < 0.2	1.00E00
paramesonephric duct development (GO:0061205)	3	0	.01	-	 < 0.2	1.00E00
pentacyclic triterpenoid metabolic process (GO:0019742)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein targeting (GO:1903533)	132	4	.55	+	7.23	1.00E00
nitrogen utilization (GO:0019740)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of secretion by cell (GO:1903531)	181	3	.76	+	3.96	1.00E00
positive regulation of membrane tubulation (GO:1903527)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of membrane tubulation (GO:1903526)	2	0	.01	-	 < 0.2	1.00E00
regulation of membrane tubulation (GO:1903525)	5	0	.02	-	 < 0.2	1.00E00
antifungal humoral response (GO:0019732)	5	0	.02	-	 < 0.2	1.00E00
antibacterial humoral response (GO:0019731)	37	1	.16	+	6.45	1.00E00
positive regulation of blood circulation (GO:1903524)	68	4	.28	+	14.04	1.00E00
antimicrobial humoral response (GO:0019730)	97	1	.41	+	2.46	1.00E00
negative regulation of blood circulation (GO:1903523)	31	0	.13	-	 < 0.2	1.00E00
regulation of blood circulation (GO:1903522)	278	5	1.16	+	4.29	1.00E00
positive regulation of mammary gland involution (GO:1903521)	4	0	.02	-	 < 0.2	1.00E00
regulation of mammary gland involution (GO:1903519)	4	0	.02	-	 < 0.2	1.00E00
cellular homeostasis (GO:0019725)	820	9	3.44	+	2.62	1.00E00
positive regulation of single strand break repair (GO:1903518)	1	0	.00	-	 < 0.2	1.00E00
B cell mediated immunity (GO:0019724)	180	1	.75	+	1.33	1.00E00
negative regulation of single strand break repair (GO:1903517)	1	0	.00	-	 < 0.2	1.00E00
regulation of single strand break repair (GO:1903516)	2	0	.01	-	 < 0.2	1.00E00
calcium-mediated signaling (GO:0019722)	109	2	.46	+	4.38	1.00E00
calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515)	1	0	.00	-	 < 0.2	1.00E00
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	8	0	.03	-	 < 0.2	1.00E00
endoplasmic reticulum to cytosol transport (GO:1903513)	16	0	.07	-	 < 0.2	1.00E00
Mo-molybdopterin cofactor metabolic process (GO:0019720)	6	0	.03	-	 < 0.2	1.00E00
mucopolysaccharide metabolic process (GO:1903510)	109	1	.46	+	2.19	1.00E00
liposaccharide metabolic process (GO:1903509)	122	0	.51	-	 < 0.2	1.00E00
negative regulation of nucleic acid-templated transcription (GO:1903507)	1189	15	4.98	+	3.01	1.00E00
regulation of mitotic spindle checkpoint (GO:1903504)	13	1	.05	+	18.36	1.00E00
apical constriction (GO:0003383)	3	0	.01	-	 < 0.2	1.00E00
epithelial cell morphogenesis (GO:0003382)	31	3	.13	+	23.10	1.00E00
regulation of transcription involved in primary germ layer cell fate commitment (GO:0060796)	2	0	.01	-	 < 0.2	1.00E00
cell fate commitment involved in formation of primary germ layer (GO:0060795)	28	0	.12	-	 < 0.2	1.00E00
sphingosine-1-phosphate signaling pathway (GO:0003376)	12	0	.05	-	 < 0.2	1.00E00
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	9	0	.04	-	 < 0.2	1.00E00
dynamin family protein polymerization involved in membrane fission (GO:0003373)	9	0	.04	-	 < 0.2	1.00E00
cellular response to camptothecin (GO:0072757)	4	0	.02	-	 < 0.2	1.00E00
cellular response to benomyl (GO:0072755)	1	0	.00	-	 < 0.2	1.00E00
cellular response to rapamycin (GO:0072752)	1	0	.00	-	 < 0.2	1.00E00
cellular response to leptomycin B (GO:0072750)	2	0	.01	-	 < 0.2	1.00E00
hair follicle placode formation (GO:0060789)	6	0	.03	-	 < 0.2	1.00E00
ectodermal placode formation (GO:0060788)	14	0	.06	-	 < 0.2	1.00E00
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	1	0	.00	-	 < 0.2	1.00E00
regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	1	0	.00	-	 < 0.2	1.00E00
mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783)	1	0	.00	-	 < 0.2	1.00E00
regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782)	1	0	.00	-	 < 0.2	1.00E00
cell-matrix adhesion involved in ameboidal cell migration (GO:0003366)	2	0	.01	-	 < 0.2	1.00E00
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	2	0	.01	-	 < 0.2	1.00E00
lamellipodium assembly involved in ameboidal cell migration (GO:0003363)	1	0	.00	-	 < 0.2	1.00E00
brainstem development (GO:0003360)	7	0	.03	-	 < 0.2	1.00E00
planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	6	0	.03	-	 < 0.2	1.00E00
noradrenergic neuron fate commitment (GO:0003359)	1	0	.00	-	 < 0.2	1.00E00
noradrenergic neuron development (GO:0003358)	3	0	.01	-	 < 0.2	1.00E00
noradrenergic neuron differentiation (GO:0003357)	7	0	.03	-	 < 0.2	1.00E00
regulation of cilium beat frequency (GO:0003356)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of cilium movement (GO:0003353)	1	0	.00	-	 < 0.2	1.00E00
regulation of cilium movement (GO:0003352)	14	0	.06	-	 < 0.2	1.00E00
epithelial cilium movement (GO:0003351)	21	0	.09	-	 < 0.2	1.00E00
S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.00	-	 < 0.2	1.00E00
S-adenosylhomocysteine metabolic process (GO:0046498)	6	0	.03	-	 < 0.2	1.00E00
pulmonary myocardium development (GO:0003350)	3	0	.01	-	 < 0.2	1.00E00
nicotinate nucleotide metabolic process (GO:0046497)	1	0	.00	-	 < 0.2	1.00E00
nicotinamide nucleotide metabolic process (GO:0046496)	111	2	.47	+	4.30	1.00E00
response to anisomycin (GO:0072739)	1	0	.00	-	 < 0.2	1.00E00
nicotinamide riboside metabolic process (GO:0046495)	1	0	.00	-	 < 0.2	1.00E00
cellular response to diamide (GO:0072738)	2	0	.01	-	 < 0.2	1.00E00
lipid A metabolic process (GO:0046493)	1	0	.00	-	 < 0.2	1.00E00
response to diamide (GO:0072737)	2	0	.01	-	 < 0.2	1.00E00
L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.00	-	 < 0.2	1.00E00
cellular response to staurosporine (GO:0072734)	5	1	.02	+	47.73	1.00E00
isopentenyl diphosphate metabolic process (GO:0046490)	5	0	.02	-	 < 0.2	1.00E00
response to staurosporine (GO:0072733)	5	1	.02	+	47.73	1.00E00
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	3	1	.01	+	79.55	1.00E00
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	10	1	.04	+	23.87	1.00E00
epithelial cell proliferation involved in prostate gland development (GO:0060767)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of androgen receptor signaling pathway (GO:0060766)	12	0	.05	-	 < 0.2	1.00E00
regulation of androgen receptor signaling pathway (GO:0060765)	26	0	.11	-	 < 0.2	1.00E00
cell-cell signaling involved in mammary gland development (GO:0060764)	2	0	.01	-	 < 0.2	1.00E00
mammary duct terminal end bud growth (GO:0060763)	4	0	.02	-	 < 0.2	1.00E00
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of response to cytokine stimulus (GO:0060761)	56	3	.23	+	12.79	1.00E00
positive regulation of response to cytokine stimulus (GO:0060760)	45	2	.19	+	10.61	1.00E00
cardiac endothelial cell differentiation (GO:0003348)	6	1	.03	+	39.78	1.00E00
proepicardium cell migration involved in pericardium morphogenesis (GO:0003345)	1	0	.00	-	 < 0.2	1.00E00
pericardium morphogenesis (GO:0003344)	9	0	.04	-	 < 0.2	1.00E00
septum transversum development (GO:0003343)	2	0	.01	-	 < 0.2	1.00E00
proepicardium development (GO:0003342)	2	0	.01	-	 < 0.2	1.00E00
cilium movement (GO:0003341)	59	0	.25	-	 < 0.2	1.00E00
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	3	0	.01	-	 < 0.2	1.00E00
glyoxylate metabolic process (GO:0046487)	8	0	.03	-	 < 0.2	1.00E00
ether lipid metabolic process (GO:0046485)	7	0	.03	-	 < 0.2	1.00E00
heterocycle metabolic process (GO:0046483)	4715	29	19.76	+	1.47	1.00E00
cellular response to dithiothreitol (GO:0072721)	1	0	.00	-	 < 0.2	1.00E00
response to dithiothreitol (GO:0072720)	2	0	.01	-	 < 0.2	1.00E00
regulation of response to cytokine stimulus (GO:0060759)	173	5	.72	+	6.90	1.00E00
positive regulation of mast cell chemotaxis (GO:0060754)	6	0	.03	-	 < 0.2	1.00E00
regulation of mast cell chemotaxis (GO:0060753)	7	0	.03	-	 < 0.2	1.00E00
branch elongation involved in mammary gland duct branching (GO:0060751)	5	0	.02	-	 < 0.2	1.00E00
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	4	0	.02	-	 < 0.2	1.00E00
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	8	0	.03	-	 < 0.2	1.00E00
metanephros morphogenesis (GO:0003338)	28	1	.12	+	8.52	1.00E00
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	8	0	.03	-	 < 0.2	1.00E00
corneocyte desquamation (GO:0003336)	1	0	.00	-	 < 0.2	1.00E00
corneocyte development (GO:0003335)	2	0	.01	-	 < 0.2	1.00E00
keratinocyte development (GO:0003334)	12	0	.05	-	 < 0.2	1.00E00
amino acid transmembrane transport (GO:0003333)	69	0	.29	-	 < 0.2	1.00E00
glycosphingolipid catabolic process (GO:0046479)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of extracellular matrix constituent secretion (GO:0003331)	3	0	.01	-	 < 0.2	1.00E00
regulation of extracellular matrix constituent secretion (GO:0003330)	3	0	.01	-	 < 0.2	1.00E00
lactosylceramide metabolic process (GO:0046478)	1	0	.00	-	 < 0.2	1.00E00
glycosylceramide catabolic process (GO:0046477)	6	0	.03	-	 < 0.2	1.00E00
glycosylceramide biosynthetic process (GO:0046476)	6	0	.03	-	 < 0.2	1.00E00
cellular response to cisplatin (GO:0072719)	6	0	.03	-	 < 0.2	1.00E00
glycerophospholipid catabolic process (GO:0046475)	16	0	.07	-	 < 0.2	1.00E00
response to cisplatin (GO:0072718)	9	0	.04	-	 < 0.2	1.00E00
glycerophospholipid biosynthetic process (GO:0046474)	234	4	.98	+	4.08	1.00E00
phosphatidic acid metabolic process (GO:0046473)	42	0	.18	-	 < 0.2	1.00E00
response to actinomycin D (GO:0072716)	4	2	.02	+	 > 100	1.00E00
phosphatidylglycerol metabolic process (GO:0046471)	30	0	.13	-	 < 0.2	1.00E00
cellular response to selenite ion (GO:0072715)	1	0	.00	-	 < 0.2	1.00E00
phosphatidylcholine metabolic process (GO:0046470)	75	0	.31	-	 < 0.2	1.00E00
response to selenite ion (GO:0072714)	1	0	.00	-	 < 0.2	1.00E00
cellular response to hydroxyurea (GO:0072711)	8	0	.03	-	 < 0.2	1.00E00
response to hydroxyurea (GO:0072710)	9	0	.04	-	 < 0.2	1.00E00
mammary gland alveolus development (GO:0060749)	20	1	.08	+	11.93	1.00E00
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	3	1	.01	+	79.55	1.00E00
parental behavior (GO:0060746)	14	0	.06	-	 < 0.2	1.00E00
mammary gland branching involved in pregnancy (GO:0060745)	6	1	.03	+	39.78	1.00E00
mammary gland branching involved in thelarche (GO:0060744)	5	0	.02	-	 < 0.2	1.00E00
epithelial cell maturation involved in prostate gland development (GO:0060743)	3	0	.01	-	 < 0.2	1.00E00
epithelial cell differentiation involved in prostate gland development (GO:0060742)	12	1	.05	+	19.89	1.00E00
prostate gland stromal morphogenesis (GO:0060741)	3	0	.01	-	 < 0.2	1.00E00
prostate gland epithelium morphogenesis (GO:0060740)	22	1	.09	+	10.85	1.00E00
pancreatic PP cell fate commitment (GO:0003329)	2	0	.01	-	 < 0.2	1.00E00
type B pancreatic cell fate commitment (GO:0003327)	1	0	.00	-	 < 0.2	1.00E00
pancreatic A cell fate commitment (GO:0003326)	2	0	.01	-	 < 0.2	1.00E00
type B pancreatic cell development (GO:0003323)	13	1	.05	+	18.36	1.00E00
pancreatic A cell development (GO:0003322)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	7	0	.03	-	 < 0.2	1.00E00
platelet activating factor metabolic process (GO:0046469)	6	0	.03	-	 < 0.2	1.00E00
membrane lipid biosynthetic process (GO:0046467)	128	0	.54	-	 < 0.2	1.00E00
membrane lipid catabolic process (GO:0046466)	26	0	.11	-	 < 0.2	1.00E00
dolichyl diphosphate metabolic process (GO:0046465)	7	0	.03	-	 < 0.2	1.00E00
cellular response to sorbitol (GO:0072709)	2	0	.01	-	 < 0.2	1.00E00
acylglycerol catabolic process (GO:0046464)	31	0	.13	-	 < 0.2	1.00E00
response to sorbitol (GO:0072708)	4	0	.02	-	 < 0.2	1.00E00
acylglycerol biosynthetic process (GO:0046463)	19	0	.08	-	 < 0.2	1.00E00
cellular response to sodium dodecyl sulfate (GO:0072707)	1	0	.00	-	 < 0.2	1.00E00
response to sodium dodecyl sulfate (GO:0072706)	1	0	.00	-	 < 0.2	1.00E00
monoacylglycerol metabolic process (GO:0046462)	2	0	.01	-	 < 0.2	1.00E00
neutral lipid catabolic process (GO:0046461)	31	0	.13	-	 < 0.2	1.00E00
neutral lipid biosynthetic process (GO:0046460)	19	0	.08	-	 < 0.2	1.00E00
late endosome to Golgi transport (GO:0034499)	3	0	.01	-	 < 0.2	1.00E00
cellular response to methyl methanesulfonate (GO:0072703)	1	0	.00	-	 < 0.2	1.00E00
early endosome to Golgi transport (GO:0034498)	9	0	.04	-	 < 0.2	1.00E00
response to methyl methanesulfonate (GO:0072702)	1	0	.00	-	 < 0.2	1.00E00
protein localization to pre-autophagosomal structure (GO:0034497)	12	0	.05	-	 < 0.2	1.00E00
mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739)	1	0	.00	-	 < 0.2	1.00E00
epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738)	2	0	.01	-	 < 0.2	1.00E00
prostate gland morphogenetic growth (GO:0060737)	4	0	.02	-	 < 0.2	1.00E00
prostate gland growth (GO:0060736)	11	1	.05	+	21.70	1.00E00
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	0	.00	-	 < 0.2	1.00E00
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)	2	0	.01	-	 < 0.2	1.00E00
regulation of eIF2 alpha phosphorylation by amino acid starvation (GO:0060733)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of intestinal epithelial structure maintenance (GO:0060731)	1	0	.00	-	 < 0.2	1.00E00
regulation of intestinal epithelial structure maintenance (GO:0060730)	2	0	.01	-	 < 0.2	1.00E00
cell migration to the midline involved in heart development (GO:0003318)	1	0	.00	-	 < 0.2	1.00E00
pancreatic PP cell differentiation (GO:0003312)	2	0	.01	-	 < 0.2	1.00E00
pancreatic D cell differentiation (GO:0003311)	1	0	.00	-	 < 0.2	1.00E00
short-chain fatty acid metabolic process (GO:0046459)	14	0	.06	-	 < 0.2	1.00E00
pancreatic A cell differentiation (GO:0003310)	7	0	.03	-	 < 0.2	1.00E00
prostanoid biosynthetic process (GO:0046457)	18	0	.08	-	 < 0.2	1.00E00
icosanoid biosynthetic process (GO:0046456)	43	1	.18	+	5.55	1.00E00
dihydrofolate metabolic process (GO:0046452)	2	0	.01	-	 < 0.2	1.00E00
T cell proliferation (GO:0042098)	36	0	.15	-	 < 0.2	1.00E00
interferon-gamma biosynthetic process (GO:0042095)	2	0	.01	-	 < 0.2	1.00E00
intestinal epithelial structure maintenance (GO:0060729)	3	0	.01	-	 < 0.2	1.00E00
interleukin-2 biosynthetic process (GO:0042094)	3	0	.01	-	 < 0.2	1.00E00
T-helper cell differentiation (GO:0042093)	25	0	.10	-	 < 0.2	1.00E00
type 2 immune response (GO:0042092)	11	0	.05	-	 < 0.2	1.00E00
regulation of cell proliferation involved in embryonic placenta development (GO:0060723)	2	0	.01	-	 < 0.2	1.00E00
regulation of spongiotrophoblast cell proliferation (GO:0060721)	2	0	.01	-	 < 0.2	1.00E00
type B pancreatic cell differentiation (GO:0003309)	19	1	.08	+	12.56	1.00E00
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	4	0	.02	-	 < 0.2	1.00E00
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	6	0	.03	-	 < 0.2	1.00E00
Wnt signaling pathway involved in heart development (GO:0003306)	5	0	.02	-	 < 0.2	1.00E00
creatinine metabolic process (GO:0046449)	4	2	.02	+	 > 100	1.00E00
physiological cardiac muscle hypertrophy (GO:0003301)	9	0	.04	-	 < 0.2	1.00E00
cardiac muscle hypertrophy (GO:0003300)	29	0	.12	-	 < 0.2	1.00E00
tropane alkaloid metabolic process (GO:0046448)	1	0	.00	-	 < 0.2	1.00E00
FMN metabolic process (GO:0046444)	1	0	.00	-	 < 0.2	1.00E00
FAD metabolic process (GO:0046443)	1	0	.00	-	 < 0.2	1.00E00
histone H3-K36 trimethylation (GO:0097198)	1	0	.00	-	 < 0.2	1.00E00
cytokine biosynthetic process (GO:0042089)	17	0	.07	-	 < 0.2	1.00E00
L-lysine metabolic process (GO:0046440)	4	0	.02	-	 < 0.2	1.00E00
T-helper 1 type immune response (GO:0042088)	20	0	.08	-	 < 0.2	1.00E00
pilomotor reflex (GO:0097195)	3	0	.01	-	 < 0.2	1.00E00
execution phase of apoptosis (GO:0097194)	59	3	.25	+	12.14	1.00E00
U6 snRNA 3'-end processing (GO:0034477)	1	0	.00	-	 < 0.2	1.00E00
U5 snRNA 3'-end processing (GO:0034476)	3	0	.01	-	 < 0.2	1.00E00
U4 snRNA 3'-end processing (GO:0034475)	8	0	.03	-	 < 0.2	1.00E00
chorionic trophoblast cell differentiation (GO:0060718)	5	0	.02	-	 < 0.2	1.00E00
U2 snRNA 3'-end processing (GO:0034474)	1	0	.00	-	 < 0.2	1.00E00
chorion development (GO:0060717)	7	0	.03	-	 < 0.2	1.00E00
U1 snRNA 3'-end processing (GO:0034473)	3	0	.01	-	 < 0.2	1.00E00
labyrinthine layer blood vessel development (GO:0060716)	21	2	.09	+	22.73	1.00E00
snRNA 3'-end processing (GO:0034472)	13	0	.05	-	 < 0.2	1.00E00
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	3	0	.01	-	 < 0.2	1.00E00
ncRNA 5'-end processing (GO:0034471)	3	0	.01	-	 < 0.2	1.00E00
ncRNA processing (GO:0034470)	400	3	1.68	+	1.79	1.00E00
labyrinthine layer morphogenesis (GO:0060713)	21	0	.09	-	 < 0.2	1.00E00
spongiotrophoblast layer development (GO:0060712)	12	1	.05	+	19.89	1.00E00
labyrinthine layer development (GO:0060711)	48	2	.20	+	9.94	1.00E00
cardiac muscle hypertrophy in response to stress (GO:0014898)	14	0	.06	-	 < 0.2	1.00E00
chorio-allantoic fusion (GO:0060710)	7	0	.03	-	 < 0.2	1.00E00
striated muscle hypertrophy (GO:0014897)	30	0	.13	-	 < 0.2	1.00E00
muscle hypertrophy (GO:0014896)	32	0	.13	-	 < 0.2	1.00E00
smooth muscle hypertrophy (GO:0014895)	1	0	.00	-	 < 0.2	1.00E00
response to denervation involved in regulation of muscle adaptation (GO:0014894)	11	0	.05	-	 < 0.2	1.00E00
striated muscle atrophy (GO:0014891)	9	1	.04	+	26.52	1.00E00
L-cysteine metabolic process (GO:0046439)	7	0	.03	-	 < 0.2	1.00E00
D-amino acid biosynthetic process (GO:0046437)	1	0	.00	-	 < 0.2	1.00E00
D-alanine metabolic process (GO:0046436)	1	0	.00	-	 < 0.2	1.00E00
organophosphate catabolic process (GO:0046434)	114	0	.48	-	 < 0.2	1.00E00
dentinogenesis (GO:0097187)	3	0	.01	-	 < 0.2	1.00E00
amelogenesis (GO:0097186)	20	0	.08	-	 < 0.2	1.00E00
germ-line stem cell division (GO:0042078)	4	0	.02	-	 < 0.2	1.00E00
cellular response to azide (GO:0097185)	1	0	.00	-	 < 0.2	1.00E00
response to azide (GO:0097184)	1	0	.00	-	 < 0.2	1.00E00
cell migration involved in gastrulation (GO:0042074)	15	0	.06	-	 < 0.2	1.00E00
response to carbon monoxide (GO:0034465)	4	0	.02	-	 < 0.2	1.00E00
glycogen cell differentiation involved in embryonic placenta development (GO:0060709)	1	1	.00	+	 > 100	1.00E00
spongiotrophoblast differentiation (GO:0060708)	4	0	.02	-	 < 0.2	1.00E00
intraciliary transport (GO:0042073)	49	0	.21	-	 < 0.2	1.00E00
trophoblast giant cell differentiation (GO:0060707)	12	1	.05	+	19.89	1.00E00
90S preribosome assembly (GO:0034463)	1	0	.00	-	 < 0.2	1.00E00
cell differentiation involved in embryonic placenta development (GO:0060706)	27	2	.11	+	17.68	1.00E00
small-subunit processome assembly (GO:0034462)	1	0	.00	-	 < 0.2	1.00E00
muscle atrophy (GO:0014889)	11	1	.05	+	21.70	1.00E00
negative regulation of endoribonuclease activity (GO:0060702)	2	0	.01	-	 < 0.2	1.00E00
striated muscle adaptation (GO:0014888)	26	1	.11	+	9.18	1.00E00
negative regulation of ribonuclease activity (GO:0060701)	2	0	.01	-	 < 0.2	1.00E00
cardiac muscle adaptation (GO:0014887)	14	0	.06	-	 < 0.2	1.00E00
regulation of ribonuclease activity (GO:0060700)	6	0	.03	-	 < 0.2	1.00E00
transition between slow and fast fiber (GO:0014886)	2	0	.01	-	 < 0.2	1.00E00
transition between fast and slow fiber (GO:0014883)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of JAK-STAT cascade (GO:0046427)	74	2	.31	+	6.45	1.00E00
negative regulation of JAK-STAT cascade (GO:0046426)	52	1	.22	+	4.59	1.00E00
regulation of JAK-STAT cascade (GO:0046425)	152	3	.64	+	4.71	1.00E00
ruffle assembly (GO:0097178)	8	0	.03	-	 < 0.2	1.00E00
regulation of catecholamine metabolic process (GO:0042069)	19	0	.08	-	 < 0.2	1.00E00
epoxide metabolic process (GO:0097176)	4	0	.02	-	 < 0.2	1.00E00
microtubule anchoring at centrosome (GO:0034454)	7	0	.03	-	 < 0.2	1.00E00
microtubule anchoring (GO:0034453)	21	0	.09	-	 < 0.2	1.00E00
myeloid cell differentiation (GO:0030099)	195	6	.82	+	7.34	1.00E00
lymphocyte differentiation (GO:0030098)	221	6	.93	+	6.48	1.00E00
response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878)	4	1	.02	+	59.66	1.00E00
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	11	0	.05	-	 < 0.2	1.00E00
response to injury involved in regulation of muscle adaptation (GO:0014876)	1	0	.00	-	 < 0.2	1.00E00
response to stimulus involved in regulation of muscle adaptation (GO:0014874)	16	1	.07	+	14.92	1.00E00
protein repair (GO:0030091)	7	0	.03	-	 < 0.2	1.00E00
response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	2	0	.01	-	 < 0.2	1.00E00
response to muscle inactivity (GO:0014870)	12	1	.05	+	19.89	1.00E00
D-amino acid metabolic process (GO:0046416)	3	0	.01	-	 < 0.2	1.00E00
urate metabolic process (GO:0046415)	13	0	.05	-	 < 0.2	1.00E00
mesenchymal stem cell proliferation (GO:0097168)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	42	2	.18	+	11.36	1.00E00
circadian regulation of translation (GO:0097167)	4	0	.02	-	 < 0.2	1.00E00
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	83	3	.35	+	8.63	1.00E00
ammonium ion metabolic process (GO:0097164)	182	1	.76	+	1.31	1.00E00
very-low-density lipoprotein particle clearance (GO:0034447)	6	0	.03	-	 < 0.2	1.00E00
substrate adhesion-dependent cell spreading (GO:0034446)	38	3	.16	+	18.84	1.00E00
negative regulation of plasma lipoprotein oxidation (GO:0034445)	2	0	.01	-	 < 0.2	1.00E00
regulation of dopamine metabolic process (GO:0042053)	19	0	.08	-	 < 0.2	1.00E00
regulation of plasma lipoprotein oxidation (GO:0034444)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of lipoprotein oxidation (GO:0034443)	3	0	.01	-	 < 0.2	1.00E00
regulation of lipoprotein oxidation (GO:0034442)	4	0	.02	-	 < 0.2	1.00E00
plasma lipoprotein oxidation (GO:0034441)	1	0	.00	-	 < 0.2	1.00E00
lipid oxidation (GO:0034440)	78	1	.33	+	3.06	1.00E00
skeletal myofibril assembly (GO:0014866)	8	0	.03	-	 < 0.2	1.00E00
regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862)	2	0	.01	-	 < 0.2	1.00E00
regulation of skeletal muscle contraction via regulation of action potential (GO:0014861)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of central B cell tolerance induction (GO:0002897)	1	0	.00	-	 < 0.2	1.00E00
regulation of central B cell tolerance induction (GO:0002895)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of type II hypersensitivity (GO:0002894)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of type II hypersensitivity (GO:0002893)	1	0	.00	-	 < 0.2	1.00E00
regulation of type II hypersensitivity (GO:0002892)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of immunoglobulin mediated immune response (GO:0002891)	34	0	.14	-	 < 0.2	1.00E00
negative regulation of immunoglobulin mediated immune response (GO:0002890)	11	0	.05	-	 < 0.2	1.00E00
olfactory behavior (GO:0042048)	8	0	.03	-	 < 0.2	1.00E00
fasciculation of motor neuron axon (GO:0097156)	2	0	.01	-	 < 0.2	1.00E00
fasciculation of sensory neuron axon (GO:0097155)	3	0	.01	-	 < 0.2	1.00E00
GABAergic neuron differentiation (GO:0097154)	13	0	.05	-	 < 0.2	1.00E00
epithelial fluid transport (GO:0042045)	8	0	.03	-	 < 0.2	1.00E00
glycoprotein transport (GO:0034436)	3	0	.01	-	 < 0.2	1.00E00
mesenchymal cell apoptotic process (GO:0097152)	2	0	.01	-	 < 0.2	1.00E00
fluid transport (GO:0042044)	26	0	.11	-	 < 0.2	1.00E00
cholesterol esterification (GO:0034435)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of inhibitory postsynaptic potential (GO:0097151)	7	0	.03	-	 < 0.2	1.00E00
sterol esterification (GO:0034434)	3	0	.01	-	 < 0.2	1.00E00
neuronal stem cell population maintenance (GO:0097150)	22	2	.09	+	21.70	1.00E00
steroid esterification (GO:0034433)	3	0	.01	-	 < 0.2	1.00E00
metal incorporation into metallo-molybdopterin complex (GO:0042040)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of skeletal muscle cell proliferation (GO:0014859)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of skeletal muscle cell proliferation (GO:0014858)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle cell proliferation (GO:0014857)	11	0	.05	-	 < 0.2	1.00E00
skeletal muscle cell proliferation (GO:0014856)	1	0	.00	-	 < 0.2	1.00E00
insulin secretion (GO:0030073)	39	1	.16	+	6.12	1.00E00
striated muscle cell proliferation (GO:0014855)	15	0	.06	-	 < 0.2	1.00E00
peptide hormone secretion (GO:0030072)	59	1	.25	+	4.05	1.00E00
response to inactivity (GO:0014854)	15	1	.06	+	15.91	1.00E00
regulation of mitotic metaphase/anaphase transition (GO:0030071)	46	3	.19	+	15.56	1.00E00
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	1	0	.00	-	 < 0.2	1.00E00
insulin processing (GO:0030070)	4	0	.02	-	 < 0.2	1.00E00
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	1	0	.00	-	 < 0.2	1.00E00
response to muscle activity (GO:0014850)	20	1	.08	+	11.93	1.00E00
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	4	0	.02	-	 < 0.2	1.00E00
proteasomal protein catabolic process (GO:0010498)	322	5	1.35	+	3.71	1.00E00
regulation of immunoglobulin mediated immune response (GO:0002889)	49	0	.21	-	 < 0.2	1.00E00
positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	23	1	.10	+	10.38	1.00E00
negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	10	0	.04	-	 < 0.2	1.00E00
intercellular transport (GO:0010496)	1	0	.00	-	 < 0.2	1.00E00
regulation of myeloid leukocyte mediated immunity (GO:0002886)	44	2	.18	+	10.85	1.00E00
positive regulation of hypersensitivity (GO:0002885)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of hypersensitivity (GO:0002884)	3	0	.01	-	 < 0.2	1.00E00
regulation of hypersensitivity (GO:0002883)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002881)	1	0	.00	-	 < 0.2	1.00E00
regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cytokine biosynthetic process (GO:0042036)	28	1	.12	+	8.52	1.00E00
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	10	0	.04	-	 < 0.2	1.00E00
regulation of cytokine biosynthetic process (GO:0042035)	99	2	.41	+	4.82	1.00E00
chemokine biosynthetic process (GO:0042033)	1	0	.00	-	 < 0.2	1.00E00
post-translational protein acetylation (GO:0034421)	3	0	.01	-	 < 0.2	1.00E00
urinary tract smooth muscle contraction (GO:0014848)	7	0	.03	-	 < 0.2	1.00E00
esophagus smooth muscle contraction (GO:0014846)	2	0	.01	-	 < 0.2	1.00E00
growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle satellite cell proliferation (GO:0014842)	10	0	.04	-	 < 0.2	1.00E00
skeletal muscle satellite cell proliferation (GO:0014841)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878)	1	0	.00	-	 < 0.2	1.00E00
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875)	1	0	.00	-	 < 0.2	1.00E00
regulation of chronic inflammatory response to antigenic stimulus (GO:0002874)	3	0	.01	-	 < 0.2	1.00E00
regulation of epidermal cell division (GO:0010482)	3	0	.01	-	 < 0.2	1.00E00
epidermal cell division (GO:0010481)	1	0	.00	-	 < 0.2	1.00E00
urate biosynthetic process (GO:0034418)	2	0	.01	-	 < 0.2	1.00E00
protein refolding (GO:0042026)	21	0	.09	-	 < 0.2	1.00E00
tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	3	0	.01	-	 < 0.2	1.00E00
DNA endoreduplication (GO:0042023)	1	0	.00	-	 < 0.2	1.00E00
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	2	0	.01	-	 < 0.2	1.00E00
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	2	1	.01	+	 > 100	1.00E00
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	4	0	.02	-	 < 0.2	1.00E00
vesicle transport along actin filament (GO:0030050)	7	0	.03	-	 < 0.2	1.00E00
urinary bladder smooth muscle contraction (GO:0014832)	7	0	.03	-	 < 0.2	1.00E00
gastro-intestinal system smooth muscle contraction (GO:0014831)	6	0	.03	-	 < 0.2	1.00E00
response to sulfur dioxide (GO:0010477)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	6	0	.03	-	 < 0.2	1.00E00
regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	13	0	.05	-	 < 0.2	1.00E00
regulation of gastrulation (GO:0010470)	38	0	.16	-	 < 0.2	1.00E00
regulation of inflammatory response to antigenic stimulus (GO:0002861)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	7	0	.03	-	 < 0.2	1.00E00
receptor localization to synapse (GO:0097120)	23	0	.10	-	 < 0.2	1.00E00
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.01	-	 < 0.2	1.00E00
muscle filament sliding (GO:0030049)	38	0	.16	-	 < 0.2	1.00E00
actin filament-based movement (GO:0030048)	104	0	.44	-	 < 0.2	1.00E00
vascular smooth muscle contraction (GO:0014829)	14	0	.06	-	 < 0.2	1.00E00
actin modification (GO:0030047)	2	0	.01	-	 < 0.2	1.00E00
parallel actin filament bundle assembly (GO:0030046)	5	0	.02	-	 < 0.2	1.00E00
intestine smooth muscle contraction (GO:0014827)	4	0	.02	-	 < 0.2	1.00E00
vein smooth muscle contraction (GO:0014826)	4	0	.02	-	 < 0.2	1.00E00
actin filament fragmentation (GO:0030043)	4	0	.02	-	 < 0.2	1.00E00
actin filament depolymerization (GO:0030042)	9	0	.04	-	 < 0.2	1.00E00
artery smooth muscle contraction (GO:0014824)	8	0	.03	-	 < 0.2	1.00E00
actin filament polymerization (GO:0030041)	26	1	.11	+	9.18	1.00E00
response to activity (GO:0014823)	62	1	.26	+	3.85	1.00E00
detection of wounding (GO:0014822)	1	0	.00	-	 < 0.2	1.00E00
phasic smooth muscle contraction (GO:0014821)	18	0	.08	-	 < 0.2	1.00E00
tonic smooth muscle contraction (GO:0014820)	9	0	.04	-	 < 0.2	1.00E00
regulation of receptor activity (GO:0010469)	578	6	2.42	+	2.48	1.00E00
negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859)	2	0	.01	-	 < 0.2	1.00E00
gene expression (GO:0010467)	3754	24	15.73	+	1.53	1.00E00
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of peptidase activity (GO:0010466)	258	5	1.08	+	4.63	1.00E00
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)	2	0	.01	-	 < 0.2	1.00E00
regulation of mesenchymal cell proliferation (GO:0010464)	37	0	.16	-	 < 0.2	1.00E00
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	9	0	.04	-	 < 0.2	1.00E00
mesenchymal cell proliferation (GO:0010463)	17	0	.07	-	 < 0.2	1.00E00
postsynaptic density protein 95 clustering (GO:0097119)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of heart rate (GO:0010460)	23	0	.10	-	 < 0.2	1.00E00
positive regulation of peripheral T cell tolerance induction (GO:0002851)	1	0	.00	-	 < 0.2	1.00E00
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	4	1	.02	+	59.66	1.00E00
guanylate kinase-associated protein clustering (GO:0097117)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of DNA replication (GO:0008156)	36	1	.15	+	6.63	1.00E00
gephyrin clustering involved in postsynaptic density assembly (GO:0097116)	3	0	.01	-	 < 0.2	1.00E00
actin polymerization or depolymerization (GO:0008154)	44	1	.18	+	5.42	1.00E00
neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.00	-	 < 0.2	1.00E00
NMDA glutamate receptor clustering (GO:0097114)	5	0	.02	-	 < 0.2	1.00E00
regulation of embryonic development (GO:0045995)	121	2	.51	+	3.94	1.00E00
AMPA glutamate receptor clustering (GO:0097113)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of translational initiation by iron (GO:0045994)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of translational initiation by iron (GO:0045993)	1	0	.00	-	 < 0.2	1.00E00
gamma-aminobutyric acid receptor clustering (GO:0097112)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of embryonic development (GO:0045992)	26	1	.11	+	9.18	1.00E00
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	2	0	.01	-	 < 0.2	1.00E00
carbon catabolite activation of transcription (GO:0045991)	5	0	.02	-	 < 0.2	1.00E00
carbon catabolite regulation of transcription (GO:0045990)	6	0	.03	-	 < 0.2	1.00E00
translocation of peptides or proteins into host (GO:0042000)	1	0	.00	-	 < 0.2	1.00E00
contractile actin filament bundle assembly (GO:0030038)	13	1	.05	+	18.36	1.00E00
regulation of skeletal muscle contraction (GO:0014819)	13	0	.05	-	 < 0.2	1.00E00
actin filament reorganization involved in cell cycle (GO:0030037)	1	0	.00	-	 < 0.2	1.00E00
actin cytoskeleton organization (GO:0030036)	430	6	1.80	+	3.33	1.00E00
microspike assembly (GO:0030035)	5	0	.02	-	 < 0.2	1.00E00
skeletal muscle satellite cell differentiation (GO:0014816)	4	0	.02	-	 < 0.2	1.00E00
microvillus assembly (GO:0030033)	11	0	.05	-	 < 0.2	1.00E00
lamellipodium assembly (GO:0030032)	32	0	.13	-	 < 0.2	1.00E00
cell projection assembly (GO:0030031)	420	1	1.76	-	.57	1.00E00
skeletal muscle satellite cell commitment (GO:0014813)	1	0	.00	-	 < 0.2	1.00E00
cell projection organization (GO:0030030)	1066	12	4.47	+	2.69	1.00E00
muscle cell migration (GO:0014812)	22	1	.09	+	10.85	1.00E00
negative regulation of heart rate (GO:0010459)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014810)	1	0	.00	-	 < 0.2	1.00E00
exit from mitosis (GO:0010458)	13	0	.05	-	 < 0.2	1.00E00
regulation of peripheral T cell tolerance induction (GO:0002849)	1	0	.00	-	 < 0.2	1.00E00
centriole-centriole cohesion (GO:0010457)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of cell fate commitment (GO:0010455)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of cell fate commitment (GO:0010454)	12	0	.05	-	 < 0.2	1.00E00
regulation of cell fate commitment (GO:0010453)	30	1	.13	+	7.96	1.00E00
histone H3-K36 methylation (GO:0010452)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of striated muscle contraction (GO:0045989)	16	0	.07	-	 < 0.2	1.00E00
postsynaptic density assembly (GO:0097107)	5	0	.02	-	 < 0.2	1.00E00
regulation of T cell mediated immune response to tumor cell (GO:0002840)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of striated muscle contraction (GO:0045988)	9	0	.04	-	 < 0.2	1.00E00
postsynaptic density organization (GO:0097106)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of smooth muscle contraction (GO:0045987)	32	1	.13	+	7.46	1.00E00
presynaptic membrane assembly (GO:0097105)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of smooth muscle contraction (GO:0045986)	14	0	.06	-	 < 0.2	1.00E00
postsynaptic membrane assembly (GO:0097104)	10	1	.04	+	23.87	1.00E00
endothelial tip cell fate specification (GO:0097102)	2	0	.01	-	 < 0.2	1.00E00
blood vessel endothelial cell fate specification (GO:0097101)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of nucleotide metabolic process (GO:0045981)	144	4	.60	+	6.63	1.00E00
negative regulation of nucleotide metabolic process (GO:0045980)	72	1	.30	+	3.31	1.00E00
actin filament-based process (GO:0030029)	503	6	2.11	+	2.85	1.00E00
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	4	0	.02	-	 < 0.2	1.00E00
protein maturation by protein folding (GO:0022417)	9	0	.04	-	 < 0.2	1.00E00
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	7	0	.03	-	 < 0.2	1.00E00
cellular manganese ion homeostasis (GO:0030026)	1	0	.00	-	 < 0.2	1.00E00
regulation of somitogenesis (GO:0014807)	10	0	.04	-	 < 0.2	1.00E00
smooth muscle hyperplasia (GO:0014806)	2	0	.01	-	 < 0.2	1.00E00
smooth muscle adaptation (GO:0014805)	4	0	.02	-	 < 0.2	1.00E00
circadian sleep/wake cycle process (GO:0022410)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of immune response to tumor cell (GO:0002839)	9	0	.04	-	 < 0.2	1.00E00
response to acidic pH (GO:0010447)	22	1	.09	+	10.85	1.00E00
negative regulation of immune response to tumor cell (GO:0002838)	2	0	.01	-	 < 0.2	1.00E00
response to alkaline pH (GO:0010446)	3	0	.01	-	 < 0.2	1.00E00
regulation of immune response to tumor cell (GO:0002837)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of response to tumor cell (GO:0002836)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of response to tumor cell (GO:0002835)	2	0	.01	-	 < 0.2	1.00E00
regulation of response to tumor cell (GO:0002834)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of response to biotic stimulus (GO:0002833)	41	1	.17	+	5.82	1.00E00
negative regulation of response to biotic stimulus (GO:0002832)	42	0	.18	-	 < 0.2	1.00E00
fungiform papilla formation (GO:0061198)	3	0	.01	-	 < 0.2	1.00E00
regulation of response to biotic stimulus (GO:0002831)	130	2	.54	+	3.67	1.00E00
fungiform papilla morphogenesis (GO:0061197)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of type 2 immune response (GO:0002830)	15	0	.06	-	 < 0.2	1.00E00
fungiform papilla development (GO:0061196)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mitotic cell cycle, embryonic (GO:0045976)	2	0	.01	-	 < 0.2	1.00E00
taste bud development (GO:0061193)	1	0	.00	-	 < 0.2	1.00E00
regulation of translation, ncRNA-mediated (GO:0045974)	12	0	.05	-	 < 0.2	1.00E00
regulation of sclerotome development (GO:0061190)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell-cell adhesion (GO:0022408)	151	5	.63	+	7.90	1.00E00
membrane docking (GO:0022406)	165	1	.69	+	1.45	1.00E00
hair cycle process (GO:0022405)	76	4	.32	+	12.56	1.00E00
molting cycle process (GO:0022404)	76	4	.32	+	12.56	1.00E00
maintenance of cell polarity (GO:0030011)	18	0	.08	-	 < 0.2	1.00E00
establishment of cell polarity (GO:0030010)	101	1	.42	+	2.36	1.00E00
negative adaptation of signaling pathway (GO:0022401)	15	0	.06	-	 < 0.2	1.00E00
regulation of rhodopsin mediated signaling pathway (GO:0022400)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of type 2 immune response (GO:0002829)	14	0	.06	-	 < 0.2	1.00E00
regulation of type 2 immune response (GO:0002828)	30	0	.13	-	 < 0.2	1.00E00
positive regulation of T-helper 1 type immune response (GO:0002827)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of T-helper 1 type immune response (GO:0002826)	7	0	.03	-	 < 0.2	1.00E00
regulation of T-helper 1 type immune response (GO:0002825)	22	0	.09	-	 < 0.2	1.00E00
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	80	1	.34	+	2.98	1.00E00
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	39	0	.16	-	 < 0.2	1.00E00
positive regulation of sclerotome development (GO:0061189)	1	0	.00	-	 < 0.2	1.00E00
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	126	1	.53	+	1.89	1.00E00
negative regulation of chromatin silencing at rDNA (GO:0061188)	2	0	.01	-	 < 0.2	1.00E00
fatty acid omega-oxidation (GO:0010430)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of adaptive immune response (GO:0002821)	84	1	.35	+	2.84	1.00E00
regulation of chromatin silencing at rDNA (GO:0061187)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of adaptive immune response (GO:0002820)	42	0	.18	-	 < 0.2	1.00E00
negative regulation of dermatome development (GO:0061185)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dermatome development (GO:0061184)	3	0	.01	-	 < 0.2	1.00E00
regulation of dermatome development (GO:0061183)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of chondrocyte development (GO:0061182)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of dopamine metabolic process (GO:0045964)	6	0	.03	-	 < 0.2	1.00E00
regulation of chondrocyte development (GO:0061181)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of dopamine metabolic process (GO:0045963)	3	0	.01	-	 < 0.2	1.00E00
cellular potassium ion homeostasis (GO:0030007)	9	0	.04	-	 < 0.2	1.00E00
cellular monovalent inorganic cation homeostasis (GO:0030004)	111	2	.47	+	4.30	1.00E00
cellular cation homeostasis (GO:0030003)	577	4	2.42	+	1.65	1.00E00
cellular anion homeostasis (GO:0030002)	15	0	.06	-	 < 0.2	1.00E00
metal ion transport (GO:0030001)	629	3	2.64	+	1.14	1.00E00
regulation of adaptive immune response (GO:0002819)	137	1	.57	+	1.74	1.00E00
intracellular defense response (GO:0002818)	1	0	.00	-	 < 0.2	1.00E00
DNA methylation on cytosine within a CG sequence (GO:0010424)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	9	1	.04	+	26.52	1.00E00
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	54	1	.23	+	4.42	1.00E00
hydrogen peroxide-mediated programmed cell death (GO:0010421)	2	0	.01	-	 < 0.2	1.00E00
biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of complement activation, classical pathway (GO:0045959)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of complement activation, alternative pathway (GO:0045957)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	13	1	.05	+	18.36	1.00E00
negative regulation of hair follicle placode formation (GO:0061170)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of mitotic recombination (GO:0045950)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of antibacterial peptide production (GO:0002803)	3	0	.01	-	 < 0.2	1.00E00
regulation of hair follicle placode formation (GO:0061168)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of translational initiation (GO:0045948)	28	1	.12	+	8.52	1.00E00
negative regulation of translational initiation (GO:0045947)	22	1	.09	+	10.85	1.00E00
asymmetric protein localization (GO:0008105)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase III promoter (GO:0045945)	11	1	.05	+	21.70	1.00E00
endoplasmic reticulum polarization (GO:0061163)	1	0	.00	-	 < 0.2	1.00E00
establishment of monopolar cell polarity (GO:0061162)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase I promoter (GO:0045943)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of mitotic cytokinesis (GO:1903490)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of steroid metabolic process (GO:0045940)	24	0	.10	-	 < 0.2	1.00E00
box H/ACA snoRNA metabolic process (GO:0033979)	1	0	.00	-	 < 0.2	1.00E00
3'-UTR-mediated mRNA destabilization (GO:0061158)	12	0	.05	-	 < 0.2	1.00E00
positive regulation of lactation (GO:1903489)	1	1	.00	+	 > 100	1.00E00
mRNA destabilization (GO:0061157)	21	0	.09	-	 < 0.2	1.00E00
negative regulation of steroid metabolic process (GO:0045939)	25	1	.10	+	9.55	1.00E00
choline metabolic process (GO:0019695)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of lactation (GO:1903488)	1	0	.00	-	 < 0.2	1.00E00
pulmonary artery morphogenesis (GO:0061156)	7	1	.03	+	34.09	1.00E00
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	7	0	.03	-	 < 0.2	1.00E00
regulation of lactation (GO:1903487)	2	1	.01	+	 > 100	1.00E00
pulmonary artery endothelial tube morphogenesis (GO:0061155)	1	0	.00	-	 < 0.2	1.00E00
ribose phosphate metabolic process (GO:0019693)	396	4	1.66	+	2.41	1.00E00
endothelial tube morphogenesis (GO:0061154)	11	0	.05	-	 < 0.2	1.00E00
deoxyribose phosphate metabolic process (GO:0019692)	32	0	.13	-	 < 0.2	1.00E00
trachea gland development (GO:0061153)	2	0	.01	-	 < 0.2	1.00E00
trachea submucosa development (GO:0061152)	2	0	.01	-	 < 0.2	1.00E00
BMP signaling pathway involved in renal system segmentation (GO:0061151)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of muscle contraction (GO:0045933)	48	1	.20	+	4.97	1.00E00
renal system segmentation (GO:0061150)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of muscle contraction (GO:0045932)	23	0	.10	-	 < 0.2	1.00E00
box C/D snoRNA metabolic process (GO:0033967)	2	0	.01	-	 < 0.2	1.00E00
cytoplasmic mRNA processing body assembly (GO:0033962)	13	0	.05	-	 < 0.2	1.00E00
neural plate anterior/posterior regionalization (GO:0021999)	4	0	.02	-	 < 0.2	1.00E00
neural plate mediolateral regionalization (GO:0021998)	1	0	.00	-	 < 0.2	1.00E00
neural plate axis specification (GO:0021997)	2	0	.01	-	 < 0.2	1.00E00
initiation of neural tube closure (GO:0021993)	1	0	.00	-	 < 0.2	1.00E00
BMP signaling pathway involved in ureter morphogenesis (GO:0061149)	1	0	.00	-	 < 0.2	1.00E00
Peyer's patch morphogenesis (GO:0061146)	3	0	.01	-	 < 0.2	1.00E00
lung smooth muscle development (GO:0061145)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of growth (GO:0045926)	236	6	.99	+	6.07	1.00E00
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	19	1	.08	+	12.56	1.00E00
alveolar secondary septum development (GO:0061144)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of female receptivity (GO:0045925)	3	0	.01	-	 < 0.2	1.00E00
alveolar primary septum development (GO:0061143)	1	0	.00	-	 < 0.2	1.00E00
regulation of female receptivity (GO:0045924)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of fatty acid metabolic process (GO:0045923)	32	1	.13	+	7.46	1.00E00
lung ciliated cell differentiation (GO:0061141)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of fatty acid metabolic process (GO:0045922)	30	1	.13	+	7.96	1.00E00
lung secretory cell differentiation (GO:0061140)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of exocytosis (GO:0045921)	80	1	.34	+	2.98	1.00E00
negative regulation of exocytosis (GO:0045920)	30	0	.13	-	 < 0.2	1.00E00
olfactory lobe development (GO:0021988)	33	0	.14	-	 < 0.2	1.00E00
cerebral cortex development (GO:0021987)	117	2	.49	+	4.08	1.00E00
habenula development (GO:0021986)	3	0	.01	-	 < 0.2	1.00E00
neurohypophysis development (GO:0021985)	2	0	.01	-	 < 0.2	1.00E00
adenohypophysis development (GO:0021984)	14	0	.06	-	 < 0.2	1.00E00
pituitary gland development (GO:0021983)	43	1	.18	+	5.55	1.00E00
propionate metabolic process, methylcitrate cycle (GO:0019679)	1	0	.00	-	 < 0.2	1.00E00
NAD catabolic process (GO:0019677)	1	0	.00	-	 < 0.2	1.00E00
morphogenesis of a branching epithelium (GO:0061138)	158	3	.66	+	4.53	1.00E00
ammonia assimilation cycle (GO:0019676)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cytolysis (GO:0045919)	11	0	.05	-	 < 0.2	1.00E00
regulation of proteasomal protein catabolic process (GO:0061136)	169	5	.71	+	7.06	1.00E00
negative regulation of cytolysis (GO:0045918)	5	0	.02	-	 < 0.2	1.00E00
NAD metabolic process (GO:0019674)	69	1	.29	+	3.46	1.00E00
positive regulation of complement activation (GO:0045917)	3	0	.01	-	 < 0.2	1.00E00
GDP-mannose metabolic process (GO:0019673)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of complement activation (GO:0045916)	11	0	.05	-	 < 0.2	1.00E00
positive regulation of mitotic cell cycle DNA replication (GO:1903465)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of catecholamine metabolic process (GO:0045915)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of mitotic cell cycle DNA replication (GO:1903464)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of catecholamine metabolic process (GO:0045914)	3	0	.01	-	 < 0.2	1.00E00
regulation of mitotic cell cycle DNA replication (GO:1903463)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of carbohydrate metabolic process (GO:0045913)	70	4	.29	+	13.64	1.00E00
negative regulation of carbohydrate metabolic process (GO:0045912)	50	1	.21	+	4.77	1.00E00
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of DNA recombination (GO:0045911)	27	0	.11	-	 < 0.2	1.00E00
negative regulation of DNA recombination (GO:0045910)	23	0	.10	-	 < 0.2	1.00E00
hypothalamus cell differentiation (GO:0021979)	7	0	.03	-	 < 0.2	1.00E00
telencephalon regionalization (GO:0021978)	13	0	.05	-	 < 0.2	1.00E00
corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of vasoconstriction (GO:0045907)	33	3	.14	+	21.70	1.00E00
negative regulation of vasoconstriction (GO:0045906)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of translational termination (GO:0045905)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of translational fidelity (GO:0045903)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of G1 to G0 transition (GO:1903452)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of translational elongation (GO:0045901)	4	0	.02	-	 < 0.2	1.00E00
regulation of G1 to G0 transition (GO:1903450)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of translational elongation (GO:0045900)	4	0	.02	-	 < 0.2	1.00E00
corticospinal neuron axon guidance (GO:0021966)	2	0	.01	-	 < 0.2	1.00E00
spinal cord ventral commissure morphogenesis (GO:0021965)	3	0	.01	-	 < 0.2	1.00E00
anterior commissure morphogenesis (GO:0021960)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of heart growth (GO:0061117)	19	2	.08	+	25.12	1.00E00
lung proximal/distal axis specification (GO:0061115)	1	0	.00	-	 < 0.2	1.00E00
protein transport from ciliary membrane to plasma membrane (GO:1903445)	3	0	.01	-	 < 0.2	1.00E00
branching involved in pancreas morphogenesis (GO:0061114)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of brown fat cell differentiation (GO:1903444)	1	0	.00	-	 < 0.2	1.00E00
pancreas morphogenesis (GO:0061113)	4	0	.02	-	 < 0.2	1.00E00
response to lipoic acid (GO:1903442)	1	0	.00	-	 < 0.2	1.00E00
protein localization to ciliary membrane (GO:1903441)	7	0	.03	-	 < 0.2	1.00E00
corticospinal tract morphogenesis (GO:0021957)	6	0	.03	-	 < 0.2	1.00E00
central nervous system interneuron axonogenesis (GO:0021956)	1	0	.00	-	 < 0.2	1.00E00
central nervous system neuron axonogenesis (GO:0021955)	30	0	.13	-	 < 0.2	1.00E00
central nervous system neuron development (GO:0021954)	71	0	.30	-	 < 0.2	1.00E00
central nervous system neuron differentiation (GO:0021953)	171	0	.72	-	 < 0.2	1.00E00
central nervous system projection neuron axonogenesis (GO:0021952)	24	0	.10	-	 < 0.2	1.00E00
aerobic electron transport chain (GO:0019646)	1	0	.00	-	 < 0.2	1.00E00
seminal vesicle epithelium development (GO:0061108)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mitotic cytokinetic process (GO:1903438)	2	0	.01	-	 < 0.2	1.00E00
seminal vesicle development (GO:0061107)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of stomach neuroendocrine cell differentiation (GO:0061106)	1	0	.00	-	 < 0.2	1.00E00
regulation of mitotic cytokinetic process (GO:1903436)	2	0	.01	-	 < 0.2	1.00E00
regulation of stomach neuroendocrine cell differentiation (GO:0061105)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.00	-	 < 0.2	1.00E00
adrenal chromaffin cell differentiation (GO:0061104)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of constitutive secretory pathway (GO:1903434)	1	0	.00	-	 < 0.2	1.00E00
carotid body glomus cell differentiation (GO:0061103)	1	0	.00	-	 < 0.2	1.00E00
glucuronate catabolic process to xylulose 5-phosphate (GO:0019640)	5	0	.02	-	 < 0.2	1.00E00
regulation of constitutive secretory pathway (GO:1903433)	2	0	.01	-	 < 0.2	1.00E00
stomach neuroendocrine cell differentiation (GO:0061102)	1	0	.00	-	 < 0.2	1.00E00
regulation of TORC1 signaling (GO:1903432)	26	1	.11	+	9.18	1.00E00
neuroendocrine cell differentiation (GO:0061101)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of cell maturation (GO:1903431)	7	1	.03	+	34.09	1.00E00
lung neuroendocrine cell differentiation (GO:0061100)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell maturation (GO:1903430)	9	0	.04	-	 < 0.2	1.00E00
formation of radial glial scaffolds (GO:0021943)	4	0	.02	-	 < 0.2	1.00E00
radial glia guided migration of Purkinje cell (GO:0021942)	5	0	.02	-	 < 0.2	1.00E00
protein localization to microtubule cytoskeleton (GO:0072698)	31	0	.13	-	 < 0.2	1.00E00
negative regulation of cerebellar granule cell precursor proliferation (GO:0021941)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	8	0	.03	-	 < 0.2	1.00E00
protein localization to cell cortex (GO:0072697)	2	0	.01	-	 < 0.2	1.00E00
regulation of cell maturation (GO:1903429)	21	1	.09	+	11.36	1.00E00
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	53	2	.22	+	9.01	1.00E00
regulation of DNA recombination at telomere (GO:0072695)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	23	1	.10	+	10.38	1.00E00
regulation of reactive oxygen species biosynthetic process (GO:1903426)	76	3	.32	+	9.42	1.00E00
positive regulation of synaptic vesicle recycling (GO:1903423)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of synaptic vesicle recycling (GO:1903422)	3	0	.01	-	 < 0.2	1.00E00
regulation of synaptic vesicle recycling (GO:1903421)	11	0	.05	-	 < 0.2	1.00E00
protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.00	-	 < 0.2	1.00E00
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938)	4	0	.02	-	 < 0.2	1.00E00
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	6	0	.03	-	 < 0.2	1.00E00
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	11	0	.05	-	 < 0.2	1.00E00
cerebellar granule cell precursor tangential migration (GO:0021935)	1	0	.00	-	 < 0.2	1.00E00
hindbrain tangential cell migration (GO:0021934)	2	0	.01	-	 < 0.2	1.00E00
radial glia guided migration of cerebellar granule cell (GO:0021933)	1	0	.00	-	 < 0.2	1.00E00
hindbrain radial glia guided cell migration (GO:0021932)	10	0	.04	-	 < 0.2	1.00E00
urate catabolic process (GO:0019628)	1	0	.00	-	 < 0.2	1.00E00
cerebellar granule cell precursor proliferation (GO:0021930)	6	0	.03	-	 < 0.2	1.00E00
urea metabolic process (GO:0019627)	13	0	.05	-	 < 0.2	1.00E00
short-chain fatty acid catabolic process (GO:0019626)	5	0	.02	-	 < 0.2	1.00E00
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.00	-	 < 0.2	1.00E00
response to glycoside (GO:1903416)	6	0	.03	-	 < 0.2	1.00E00
T cell extravasation (GO:0072683)	1	0	.00	-	 < 0.2	1.00E00
iron cation export (GO:1903414)	1	0	.00	-	 < 0.2	1.00E00
cellular response to bile acid (GO:1903413)	3	0	.01	-	 < 0.2	1.00E00
response to bile acid (GO:1903412)	3	0	.01	-	 < 0.2	1.00E00
muscle hypertrophy in response to stress (GO:0003299)	14	0	.06	-	 < 0.2	1.00E00
physiological muscle hypertrophy (GO:0003298)	9	0	.04	-	 < 0.2	1.00E00
atrial ventricular junction remodeling (GO:0003294)	1	0	.00	-	 < 0.2	1.00E00
cardiac septum cell differentiation (GO:0003292)	2	0	.01	-	 < 0.2	1.00E00
atrial septum secundum morphogenesis (GO:0003290)	2	0	.01	-	 < 0.2	1.00E00
cell proliferation in external granule layer (GO:0021924)	6	0	.03	-	 < 0.2	1.00E00
thymocyte migration (GO:0072679)	2	0	.01	-	 < 0.2	1.00E00
T cell migration (GO:0072678)	21	0	.09	-	 < 0.2	1.00E00
eosinophil migration (GO:0072677)	10	0	.04	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification (GO:0021920)	1	0	.00	-	 < 0.2	1.00E00
reactive oxygen species biosynthetic process (GO:1903409)	25	1	.10	+	9.55	1.00E00
lymphocyte migration (GO:0072676)	56	0	.23	-	 < 0.2	1.00E00
osteoclast fusion (GO:0072675)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of sodium:potassium-exchanging ATPase activity (GO:1903408)	1	0	.00	-	 < 0.2	1.00E00
catechol-containing compound catabolic process (GO:0019614)	9	0	.04	-	 < 0.2	1.00E00
multinuclear osteoclast differentiation (GO:0072674)	6	0	.03	-	 < 0.2	1.00E00
lamellipodium morphogenesis (GO:0072673)	6	0	.03	-	 < 0.2	1.00E00
regulation of sodium:potassium-exchanging ATPase activity (GO:1903406)	1	0	.00	-	 < 0.2	1.00E00
neutrophil extravasation (GO:0072672)	7	1	.03	+	34.09	1.00E00
protein localization to nuclear body (GO:1903405)	1	0	.00	-	 < 0.2	1.00E00
mitochondria-associated ubiquitin-dependent protein catabolic process (GO:0072671)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of renal phosphate excretion (GO:1903403)	1	0	.00	-	 < 0.2	1.00E00
regulation of renal phosphate excretion (GO:1903402)	1	0	.00	-	 < 0.2	1.00E00
L-lysine transmembrane transport (GO:1903401)	4	0	.02	-	 < 0.2	1.00E00
L-arginine transmembrane transport (GO:1903400)	2	0	.01	-	 < 0.2	1.00E00
atrial septum primum morphogenesis (GO:0003289)	5	0	.02	-	 < 0.2	1.00E00
septum secundum development (GO:0003285)	3	0	.01	-	 < 0.2	1.00E00
BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919)	1	0	.00	-	 < 0.2	1.00E00
septum primum development (GO:0003284)	6	0	.03	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment (GO:0021918)	1	0	.00	-	 < 0.2	1.00E00
atrial septum development (GO:0003283)	20	1	.08	+	11.93	1.00E00
somatic motor neuron fate commitment (GO:0021917)	1	0	.00	-	 < 0.2	1.00E00
ventricular septum development (GO:0003281)	63	1	.26	+	3.79	1.00E00
neural tube development (GO:0021915)	158	2	.66	+	3.02	1.00E00
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	4	0	.02	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification (GO:0021913)	4	0	.02	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification (GO:0021912)	3	0	.01	-	 < 0.2	1.00E00
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	4	0	.02	-	 < 0.2	1.00E00
establishment of protein localization to vacuole (GO:0072666)	35	0	.15	-	 < 0.2	1.00E00
protein localization to vacuole (GO:0072665)	44	0	.18	-	 < 0.2	1.00E00
butyrate metabolic process (GO:0019605)	1	0	.00	-	 < 0.2	1.00E00
establishment of protein localization to peroxisome (GO:0072663)	17	0	.07	-	 < 0.2	1.00E00
protein localization to peroxisome (GO:0072662)	17	0	.07	-	 < 0.2	1.00E00
maintenance of protein location in plasma membrane (GO:0072660)	1	0	.00	-	 < 0.2	1.00E00
regulation of endoribonuclease activity (GO:0060699)	4	0	.02	-	 < 0.2	1.00E00
mechanosensory behavior (GO:0007638)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of phospholipid catabolic process (GO:0060697)	2	1	.01	+	 > 100	1.00E00
regulation of phospholipid catabolic process (GO:0060696)	6	1	.03	+	39.78	1.00E00
chemosensory behavior (GO:0007635)	17	0	.07	-	 < 0.2	1.00E00
negative regulation of cholesterol transporter activity (GO:0060695)	1	0	.00	-	 < 0.2	1.00E00
optokinetic behavior (GO:0007634)	1	0	.00	-	 < 0.2	1.00E00
regulation of cholesterol transporter activity (GO:0060694)	2	0	.01	-	 < 0.2	1.00E00
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	8	0	.03	-	 < 0.2	1.00E00
visual behavior (GO:0007632)	53	0	.22	-	 < 0.2	1.00E00
feeding behavior (GO:0007631)	95	0	.40	-	 < 0.2	1.00E00
epithelial cell maturation involved in salivary gland development (GO:0060691)	1	1	.00	+	 > 100	1.00E00
cardiac septum development (GO:0003279)	96	2	.40	+	4.97	1.00E00
epithelial cell differentiation involved in salivary gland development (GO:0060690)	1	1	.00	+	 > 100	1.00E00
apoptotic process involved in heart morphogenesis (GO:0003278)	3	0	.01	-	 < 0.2	1.00E00
endocardial cushion fusion (GO:0003274)	3	0	.01	-	 < 0.2	1.00E00
cell migration involved in endocardial cushion formation (GO:0003273)	4	0	.02	-	 < 0.2	1.00E00
endocardial cushion formation (GO:0003272)	17	1	.07	+	14.04	1.00E00
forebrain-midbrain boundary formation (GO:0021905)	1	0	.00	-	 < 0.2	1.00E00
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)	1	0	.00	-	 < 0.2	1.00E00
dorsal/ventral neural tube patterning (GO:0021904)	18	0	.08	-	 < 0.2	1.00E00
rostrocaudal neural tube patterning (GO:0021903)	11	0	.05	-	 < 0.2	1.00E00
protein localization to plasma membrane (GO:0072659)	158	2	.66	+	3.02	1.00E00
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	6	0	.03	-	 < 0.2	1.00E00
maintenance of protein location in membrane (GO:0072658)	1	0	.00	-	 < 0.2	1.00E00
protein localization to membrane (GO:0072657)	405	5	1.70	+	2.95	1.00E00
maintenance of protein location in mitochondrion (GO:0072656)	5	1	.02	+	47.73	1.00E00
establishment of protein localization to mitochondrion (GO:0072655)	69	2	.29	+	6.92	1.00E00
cell differentiation involved in salivary gland development (GO:0060689)	3	1	.01	+	79.55	1.00E00
regulation of morphogenesis of a branching structure (GO:0060688)	53	1	.22	+	4.50	1.00E00
adult walking behavior (GO:0007628)	30	0	.13	-	 < 0.2	1.00E00
regulation of branching involved in prostate gland morphogenesis (GO:0060687)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of prostatic bud formation (GO:0060686)	4	0	.02	-	 < 0.2	1.00E00
locomotory behavior (GO:0007626)	197	2	.83	+	2.42	1.00E00
regulation of prostatic bud formation (GO:0060685)	6	1	.03	+	39.78	1.00E00
grooming behavior (GO:0007625)	13	0	.05	-	 < 0.2	1.00E00
epithelial-mesenchymal cell signaling (GO:0060684)	7	0	.03	-	 < 0.2	1.00E00
ultradian rhythm (GO:0007624)	1	0	.00	-	 < 0.2	1.00E00
circadian rhythm (GO:0007623)	135	4	.57	+	7.07	1.00E00
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.00	-	 < 0.2	1.00E00
rhythmic behavior (GO:0007622)	23	1	.10	+	10.38	1.00E00
negative regulation of female receptivity (GO:0007621)	4	0	.02	-	 < 0.2	1.00E00
branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.00	-	 < 0.2	1.00E00
copulation (GO:0007620)	16	0	.07	-	 < 0.2	1.00E00
regulation of secondary heart field cardioblast proliferation (GO:0003266)	9	0	.04	-	 < 0.2	1.00E00
regulation of cardioblast proliferation (GO:0003264)	10	0	.04	-	 < 0.2	1.00E00
cardioblast migration (GO:0003260)	1	0	.00	-	 < 0.2	1.00E00
interferon-gamma secretion (GO:0072643)	7	0	.03	-	 < 0.2	1.00E00
courtship behavior (GO:0007619)	3	0	.01	-	 < 0.2	1.00E00
mating (GO:0007618)	35	0	.15	-	 < 0.2	1.00E00
dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678)	1	0	.00	-	 < 0.2	1.00E00
ureteric bud elongation (GO:0060677)	5	0	.02	-	 < 0.2	1.00E00
mating behavior (GO:0007617)	22	0	.09	-	 < 0.2	1.00E00
ureteric bud formation (GO:0060676)	4	0	.02	-	 < 0.2	1.00E00
long-term memory (GO:0007616)	34	1	.14	+	7.02	1.00E00
ureteric bud morphogenesis (GO:0060675)	52	1	.22	+	4.59	1.00E00
placenta blood vessel development (GO:0060674)	31	3	.13	+	23.10	1.00E00
short-term memory (GO:0007614)	9	0	.04	-	 < 0.2	1.00E00
memory (GO:0007613)	104	1	.44	+	2.29	1.00E00
epithelial cell morphogenesis involved in placental branching (GO:0060672)	3	0	.01	-	 < 0.2	1.00E00
learning (GO:0007612)	136	2	.57	+	3.51	1.00E00
epithelial cell differentiation involved in embryonic placenta development (GO:0060671)	3	0	.01	-	 < 0.2	1.00E00
learning or memory (GO:0007611)	232	6	.97	+	6.17	1.00E00
branching involved in labyrinthine layer morphogenesis (GO:0060670)	12	0	.05	-	 < 0.2	1.00E00
cardioblast anterior-lateral migration (GO:0003259)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003257)	4	0	.02	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)	7	0	.03	-	 < 0.2	1.00E00
regulation of membrane depolarization (GO:0003254)	42	2	.18	+	11.36	1.00E00
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.00	-	 < 0.2	1.00E00
UDP-glucuronate metabolic process (GO:0046398)	4	0	.02	-	 < 0.2	1.00E00
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	2	0	.01	-	 < 0.2	1.00E00
carboxylic acid catabolic process (GO:0046395)	239	0	1.00	-	 < 0.2	1.00E00
carboxylic acid biosynthetic process (GO:0046394)	279	4	1.17	+	3.42	1.00E00
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	4	0	.02	-	 < 0.2	1.00E00
ribose phosphate biosynthetic process (GO:0046390)	138	3	.58	+	5.19	1.00E00
embryonic placenta morphogenesis (GO:0060669)	26	0	.11	-	 < 0.2	1.00E00
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.00	-	 < 0.2	1.00E00
sensory perception of smell (GO:0007608)	458	0	1.92	-	 < 0.2	1.00E00
branch elongation involved in salivary gland morphogenesis (GO:0060667)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of neurofibrillary tangle assembly (GO:1902998)	1	0	.00	-	 < 0.2	1.00E00
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	5	0	.02	-	 < 0.2	1.00E00
sensory perception of chemical stimulus (GO:0007606)	534	0	2.24	-	 < 0.2	1.00E00
negative regulation of neurofibrillary tangle assembly (GO:1902997)	1	0	.00	-	 < 0.2	1.00E00
sensory perception of sound (GO:0007605)	146	1	.61	+	1.63	1.00E00
regulation of neurofibrillary tangle assembly (GO:1902996)	2	0	.01	-	 < 0.2	1.00E00
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	4	0	.02	-	 < 0.2	1.00E00
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of phospholipid efflux (GO:1902995)	2	0	.01	-	 < 0.2	1.00E00
phototransduction, visible light (GO:0007603)	19	0	.08	-	 < 0.2	1.00E00
regulation of phospholipid efflux (GO:1902994)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	11	0	.05	-	 < 0.2	1.00E00
salivary gland cavitation (GO:0060662)	5	0	.02	-	 < 0.2	1.00E00
phototransduction (GO:0007602)	43	0	.18	-	 < 0.2	1.00E00
negative regulation of amyloid precursor protein catabolic process (GO:1902992)	9	0	.04	-	 < 0.2	1.00E00
visual perception (GO:0007601)	207	1	.87	+	1.15	1.00E00
submandibular salivary gland formation (GO:0060661)	2	0	.01	-	 < 0.2	1.00E00
regulation of amyloid precursor protein catabolic process (GO:1902991)	20	0	.08	-	 < 0.2	1.00E00
sensory perception (GO:0007600)	947	5	3.97	+	1.26	1.00E00
mitotic telomere maintenance via semi-conservative replication (GO:1902990)	3	1	.01	+	79.55	1.00E00
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247)	1	0	.00	-	 < 0.2	1.00E00
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	2	0	.01	-	 < 0.2	1.00E00
growth involved in heart morphogenesis (GO:0003241)	4	0	.02	-	 < 0.2	1.00E00
deoxyribose phosphate catabolic process (GO:0046386)	21	0	.09	-	 < 0.2	1.00E00
deoxyribose phosphate biosynthetic process (GO:0046385)	11	0	.05	-	 < 0.2	1.00E00
CMP-N-acetylneuraminate metabolic process (GO:0046381)	1	0	.00	-	 < 0.2	1.00E00
N-acetylneuraminate biosynthetic process (GO:0046380)	1	0	.00	-	 < 0.2	1.00E00
nipple morphogenesis (GO:0060658)	1	0	.00	-	 < 0.2	1.00E00
neurofibrillary tangle assembly (GO:1902988)	1	0	.00	-	 < 0.2	1.00E00
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.00	-	 < 0.2	1.00E00
sinus venosus morphogenesis (GO:0003236)	1	0	.00	-	 < 0.2	1.00E00
sinus venosus development (GO:0003235)	1	0	.00	-	 < 0.2	1.00E00
cardiac ventricle development (GO:0003231)	118	4	.49	+	8.09	1.00E00
extracellular polysaccharide metabolic process (GO:0046379)	3	0	.01	-	 < 0.2	1.00E00
cardiac atrium development (GO:0003230)	35	1	.15	+	6.82	1.00E00
interleukin-21 secretion (GO:0072619)	1	0	.00	-	 < 0.2	1.00E00
L-arabinose metabolic process (GO:0046373)	2	0	.01	-	 < 0.2	1.00E00
interleukin-18 secretion (GO:0072616)	1	0	.00	-	 < 0.2	1.00E00
interleukin-17 secretion (GO:0072615)	1	0	.00	-	 < 0.2	1.00E00
fructose biosynthetic process (GO:0046370)	2	1	.01	+	 > 100	1.00E00
interleukin-12 secretion (GO:0072610)	2	0	.01	-	 < 0.2	1.00E00
mammary gland bud morphogenesis (GO:0060648)	3	0	.01	-	 < 0.2	1.00E00
mitotic DNA replication termination (GO:1902979)	1	0	.00	-	 < 0.2	1.00E00
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.00	-	 < 0.2	1.00E00
mammary gland epithelial cell differentiation (GO:0060644)	17	1	.07	+	14.04	1.00E00
mitotic DNA replication initiation (GO:1902975)	1	0	.00	-	 < 0.2	1.00E00
ventricular cardiac muscle tissue development (GO:0003229)	52	1	.22	+	4.59	1.00E00
atrial cardiac muscle tissue development (GO:0003228)	7	0	.03	-	 < 0.2	1.00E00
right ventricular compact myocardium morphogenesis (GO:0003226)	1	0	.00	-	 < 0.2	1.00E00
ventricular compact myocardium morphogenesis (GO:0003223)	8	0	.03	-	 < 0.2	1.00E00
ventricular trabecula myocardium morphogenesis (GO:0003222)	16	1	.07	+	14.92	1.00E00
right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	3	0	.01	-	 < 0.2	1.00E00
GDP-L-fucose metabolic process (GO:0046368)	4	0	.02	-	 < 0.2	1.00E00
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	2	0	.01	-	 < 0.2	1.00E00
monosaccharide catabolic process (GO:0046365)	59	1	.25	+	4.05	1.00E00
monosaccharide biosynthetic process (GO:0046364)	55	2	.23	+	8.68	1.00E00
interleukin-10 secretion (GO:0072608)	1	0	.00	-	 < 0.2	1.00E00
interleukin-8 secretion (GO:0072606)	4	0	.02	-	 < 0.2	1.00E00
2-oxobutyrate metabolic process (GO:0046361)	1	0	.00	-	 < 0.2	1.00E00
interleukin-6 secretion (GO:0072604)	2	0	.01	-	 < 0.2	1.00E00
2-oxobutyrate biosynthetic process (GO:0046360)	1	0	.00	-	 < 0.2	1.00E00
interleukin-4 secretion (GO:0072602)	5	0	.02	-	 < 0.2	1.00E00
telomere tethering at nuclear periphery (GO:0034398)	9	0	.04	-	 < 0.2	1.00E00
telomere localization (GO:0034397)	16	1	.07	+	14.92	1.00E00
establishment of protein localization to Golgi (GO:0072600)	9	0	.04	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	2	0	.01	-	 < 0.2	1.00E00
protein localization to cell surface (GO:0034394)	24	0	.10	-	 < 0.2	1.00E00
mesenchymal-epithelial cell signaling (GO:0060638)	8	0	.03	-	 < 0.2	1.00E00
mitotic DNA replication (GO:1902969)	7	1	.03	+	34.09	1.00E00
positive regulation of smooth muscle cell apoptotic process (GO:0034393)	9	1	.04	+	26.52	1.00E00
negative regulation of smooth muscle cell apoptotic process (GO:0034392)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of protein localization to early endosome (GO:1902966)	6	0	.03	-	 < 0.2	1.00E00
regulation of smooth muscle cell apoptotic process (GO:0034391)	16	1	.07	+	14.92	1.00E00
regulation of protein localization to early endosome (GO:1902965)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633)	5	0	.02	-	 < 0.2	1.00E00
regulation of microtubule-based movement (GO:0060632)	25	0	.10	-	 < 0.2	1.00E00
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963)	2	0	.01	-	 < 0.2	1.00E00
regulation of meiosis I (GO:0060631)	8	0	.03	-	 < 0.2	1.00E00
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	5	0	.02	-	 < 0.2	1.00E00
cardiac right ventricle formation (GO:0003219)	4	0	.02	-	 < 0.2	1.00E00
cardiac left ventricle formation (GO:0003218)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	1	0	.00	-	 < 0.2	1.00E00
cardiac right ventricle morphogenesis (GO:0003215)	19	1	.08	+	12.56	1.00E00
cardiac left ventricle morphogenesis (GO:0003214)	14	1	.06	+	17.05	1.00E00
cardiac right atrium morphogenesis (GO:0003213)	2	0	.01	-	 < 0.2	1.00E00
cardiac ventricle formation (GO:0003211)	10	0	.04	-	 < 0.2	1.00E00
cardiac atrium formation (GO:0003210)	1	0	.00	-	 < 0.2	1.00E00
acetyl-CoA catabolic process (GO:0046356)	2	0	.01	-	 < 0.2	1.00E00
disaccharide catabolic process (GO:0046352)	1	0	.00	-	 < 0.2	1.00E00
disaccharide biosynthetic process (GO:0046351)	5	0	.02	-	 < 0.2	1.00E00
lipid particle organization (GO:0034389)	19	0	.08	-	 < 0.2	1.00E00
regulation of homologous chromosome segregation (GO:0060629)	2	0	.01	-	 < 0.2	1.00E00
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	6	0	.03	-	 < 0.2	1.00E00
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	12	0	.05	-	 < 0.2	1.00E00
high-density lipoprotein particle clearance (GO:0034384)	9	0	.04	-	 < 0.2	1.00E00
low-density lipoprotein particle clearance (GO:0034383)	25	0	.10	-	 < 0.2	1.00E00
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	2	0	.01	-	 < 0.2	1.00E00
chylomicron remnant clearance (GO:0034382)	8	0	.03	-	 < 0.2	1.00E00
negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	2	0	.01	-	 < 0.2	1.00E00
plasma lipoprotein particle clearance (GO:0034381)	41	0	.17	-	 < 0.2	1.00E00
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	4	0	.02	-	 < 0.2	1.00E00
high-density lipoprotein particle assembly (GO:0034380)	13	0	.05	-	 < 0.2	1.00E00
positive regulation of early endosome to recycling endosome transport (GO:1902955)	1	0	.00	-	 < 0.2	1.00E00
regulation of chromosome condensation (GO:0060623)	4	1	.02	+	59.66	1.00E00
regulation of early endosome to recycling endosome transport (GO:1902954)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of dendritic spine maintenance (GO:1902952)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of cholesterol import (GO:0060621)	2	0	.01	-	 < 0.2	1.00E00
cardiac atrium morphogenesis (GO:0003209)	31	0	.13	-	 < 0.2	1.00E00
regulation of cholesterol import (GO:0060620)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of dendritic spine maintenance (GO:1902951)	2	0	.01	-	 < 0.2	1.00E00
regulation of dendritic spine maintenance (GO:1902950)	8	0	.03	-	 < 0.2	1.00E00
cardiac ventricle morphogenesis (GO:0003208)	72	3	.30	+	9.94	1.00E00
cardiac chamber formation (GO:0003207)	11	0	.05	-	 < 0.2	1.00E00
cardiac chamber morphogenesis (GO:0003206)	120	4	.50	+	7.96	1.00E00
cardiac chamber development (GO:0003205)	155	4	.65	+	6.16	1.00E00
endocardial cushion morphogenesis (GO:0003203)	28	2	.12	+	17.05	1.00E00
amino sugar biosynthetic process (GO:0046349)	11	0	.05	-	 < 0.2	1.00E00
amino sugar catabolic process (GO:0046348)	13	0	.05	-	 < 0.2	1.00E00
CDP-diacylglycerol metabolic process (GO:0046341)	14	0	.06	-	 < 0.2	1.00E00
diacylglycerol catabolic process (GO:0046340)	3	0	.01	-	 < 0.2	1.00E00
very-low-density lipoprotein particle assembly (GO:0034379)	11	0	.05	-	 < 0.2	1.00E00
chylomicron assembly (GO:0034378)	10	0	.04	-	 < 0.2	1.00E00
craniofacial suture morphogenesis (GO:0097094)	18	0	.08	-	 < 0.2	1.00E00
plasma lipoprotein particle assembly (GO:0034377)	26	0	.11	-	 < 0.2	1.00E00
high-density lipoprotein particle remodeling (GO:0034375)	17	0	.07	-	 < 0.2	1.00E00
low-density lipoprotein particle remodeling (GO:0034374)	13	0	.05	-	 < 0.2	1.00E00
synaptic vesicle clustering (GO:0097091)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of tau-protein kinase activity (GO:1902949)	4	0	.02	-	 < 0.2	1.00E00
nipple development (GO:0060618)	1	0	.00	-	 < 0.2	1.00E00
presynaptic membrane organization (GO:0097090)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of tau-protein kinase activity (GO:1902948)	1	0	.00	-	 < 0.2	1.00E00
intermediate-density lipoprotein particle remodeling (GO:0034373)	1	0	.00	-	 < 0.2	1.00E00
regulation of tau-protein kinase activity (GO:1902947)	6	0	.03	-	 < 0.2	1.00E00
very-low-density lipoprotein particle remodeling (GO:0034372)	7	0	.03	-	 < 0.2	1.00E00
mammary gland bud formation (GO:0060615)	2	0	.01	-	 < 0.2	1.00E00
chylomicron remodeling (GO:0034371)	9	0	.04	-	 < 0.2	1.00E00
protein localization to early endosome (GO:1902946)	2	0	.01	-	 < 0.2	1.00E00
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	13	0	.05	-	 < 0.2	1.00E00
fat pad development (GO:0060613)	6	0	.03	-	 < 0.2	1.00E00
adipose tissue development (GO:0060612)	31	1	.13	+	7.70	1.00E00
positive regulation of voltage-gated chloride channel activity (GO:1902943)	2	0	.01	-	 < 0.2	1.00E00
mammary gland fat development (GO:0060611)	1	0	.00	-	 < 0.2	1.00E00
regulation of voltage-gated chloride channel activity (GO:1902941)	2	0	.01	-	 < 0.2	1.00E00
diacylglycerol metabolic process (GO:0046339)	16	0	.07	-	 < 0.2	1.00E00
phosphatidylethanolamine catabolic process (GO:0046338)	2	0	.01	-	 < 0.2	1.00E00
phosphatidylethanolamine metabolic process (GO:0046337)	17	0	.07	-	 < 0.2	1.00E00
octopamine metabolic process (GO:0046333)	3	0	.01	-	 < 0.2	1.00E00
methyl-branched fatty acid metabolic process (GO:0097089)	2	0	.01	-	 < 0.2	1.00E00
lateral inhibition (GO:0046331)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of JNK cascade (GO:0046330)	122	1	.51	+	1.96	1.00E00
plasma lipoprotein particle remodeling (GO:0034369)	28	0	.12	-	 < 0.2	1.00E00
protein-lipid complex remodeling (GO:0034368)	28	0	.12	-	 < 0.2	1.00E00
vascular smooth muscle cell development (GO:0097084)	8	0	.03	-	 < 0.2	1.00E00
macromolecular complex remodeling (GO:0034367)	28	0	.12	-	 < 0.2	1.00E00
negative regulation of intracellular calcium activated chloride channel activity (GO:1902939)	1	0	.00	-	 < 0.2	1.00E00
regulation of intracellular calcium activated chloride channel activity (GO:1902938)	3	0	.01	-	 < 0.2	1.00E00
tube closure (GO:0060606)	91	2	.38	+	5.25	1.00E00
tube lumen cavitation (GO:0060605)	5	0	.02	-	 < 0.2	1.00E00
mammary gland duct morphogenesis (GO:0060603)	30	2	.13	+	15.91	1.00E00
branch elongation of an epithelium (GO:0060602)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of alcohol biosynthetic process (GO:1902932)	21	0	.09	-	 < 0.2	1.00E00
lateral sprouting from an epithelium (GO:0060601)	9	1	.04	+	26.52	1.00E00
dichotomous subdivision of an epithelial terminal unit (GO:0060600)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of alcohol biosynthetic process (GO:1902931)	9	0	.04	-	 < 0.2	1.00E00
regulation of alcohol biosynthetic process (GO:1902930)	64	1	.27	+	3.73	1.00E00
negative regulation of JNK cascade (GO:0046329)	33	1	.14	+	7.23	1.00E00
regulation of JNK cascade (GO:0046328)	167	4	.70	+	5.72	1.00E00
glycerol biosynthetic process from pyruvate (GO:0046327)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glucose import (GO:0046325)	13	2	.05	+	36.72	1.00E00
glucose import (GO:0046323)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of fatty acid oxidation (GO:0046322)	9	1	.04	+	26.52	1.00E00
positive regulation of fatty acid oxidation (GO:0046321)	14	1	.06	+	17.05	1.00E00
regulation of fatty acid oxidation (GO:0046320)	28	2	.12	+	17.05	1.00E00
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356)	15	0	.06	-	 < 0.2	1.00E00
ductus arteriosus closure (GO:0097070)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of glial cell apoptotic process (GO:0034351)	8	2	.03	+	59.66	1.00E00
regulation of glial cell apoptotic process (GO:0034350)	8	2	.03	+	59.66	1.00E00
negative regulation of glucosylceramide biosynthetic process (GO:0046318)	1	0	.00	-	 < 0.2	1.00E00
regulation of glucosylceramide biosynthetic process (GO:0046317)	1	0	.00	-	 < 0.2	1.00E00
phosphocreatine biosynthetic process (GO:0046314)	1	0	.00	-	 < 0.2	1.00E00
cellular response to thyroxine stimulus (GO:0097069)	2	0	.01	-	 < 0.2	1.00E00
response to thyroxine (GO:0097068)	5	0	.02	-	 < 0.2	1.00E00
cellular response to thyroid hormone stimulus (GO:0097067)	17	0	.07	-	 < 0.2	1.00E00
response to thyroid hormone (GO:0097066)	26	1	.11	+	9.18	1.00E00
positive regulation of type III interferon production (GO:0034346)	1	0	.00	-	 < 0.2	1.00E00
dendritic spine maintenance (GO:0097062)	8	0	.03	-	 < 0.2	1.00E00
dendritic spine organization (GO:0097061)	27	0	.11	-	 < 0.2	1.00E00
regulation of type III interferon production (GO:0034344)	3	0	.01	-	 < 0.2	1.00E00
response to type III interferon (GO:0034342)	2	0	.01	-	 < 0.2	1.00E00
response to interferon-gamma (GO:0034341)	149	2	.62	+	3.20	1.00E00
positive regulation of protein polyubiquitination (GO:1902916)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of protein polyubiquitination (GO:1902915)	5	0	.02	-	 < 0.2	1.00E00
response to type I interferon (GO:0034340)	70	2	.29	+	6.82	1.00E00
regulation of protein polyubiquitination (GO:1902914)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of neuroepithelial cell differentiation (GO:1902913)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of melanosome transport (GO:1902910)	1	1	.00	+	 > 100	1.00E00
negative regulation of peptide secretion (GO:0002792)	121	3	.51	+	5.92	1.00E00
peptide secretion (GO:0002790)	150	1	.63	+	1.59	1.00E00
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056)	4	0	.02	-	 < 0.2	1.00E00
agmatine biosynthetic process (GO:0097055)	2	0	.01	-	 < 0.2	1.00E00
RNA folding (GO:0034337)	1	0	.00	-	 < 0.2	1.00E00
L-kynurenine catabolic process (GO:0097053)	2	0	.01	-	 < 0.2	1.00E00
L-kynurenine metabolic process (GO:0097052)	5	0	.02	-	 < 0.2	1.00E00
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	3	0	.01	-	 < 0.2	1.00E00
retrograde axonal transport (GO:0008090)	9	0	.04	-	 < 0.2	1.00E00
adherens junction maintenance (GO:0034334)	3	0	.01	-	 < 0.2	1.00E00
adherens junction assembly (GO:0034333)	34	3	.14	+	21.06	1.00E00
regulation of melanosome transport (GO:1902908)	2	1	.01	+	 > 100	1.00E00
type B pancreatic cell apoptotic process (GO:0097050)	2	0	.01	-	 < 0.2	1.00E00
cell junction maintenance (GO:0034331)	14	0	.06	-	 < 0.2	1.00E00
positive regulation of supramolecular fiber organization (GO:1902905)	176	1	.74	+	1.36	1.00E00
negative regulation of supramolecular fiber organization (GO:1902904)	112	1	.47	+	2.13	1.00E00
regulation of supramolecular fiber organization (GO:1902903)	307	4	1.29	+	3.11	1.00E00
negative regulation of autophagosome assembly (GO:1902902)	12	0	.05	-	 < 0.2	1.00E00
negative regulation of antibacterial peptide production (GO:0002787)	1	0	.00	-	 < 0.2	1.00E00
regulation of antibacterial peptide production (GO:0002786)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of antimicrobial peptide production (GO:0002785)	1	0	.00	-	 < 0.2	1.00E00
regulation of antimicrobial peptide production (GO:0002784)	4	0	.02	-	 < 0.2	1.00E00
anterograde axonal transport (GO:0008089)	31	0	.13	-	 < 0.2	1.00E00
motor neuron apoptotic process (GO:0097049)	3	0	.01	-	 < 0.2	1.00E00
axo-dendritic transport (GO:0008088)	46	0	.19	-	 < 0.2	1.00E00
histone monoubiquitination (GO:0010390)	28	0	.12	-	 < 0.2	1.00E00
antibacterial peptide biosynthetic process (GO:0002780)	1	0	.00	-	 < 0.2	1.00E00
cell junction assembly (GO:0034329)	139	5	.58	+	8.58	1.00E00
phosphatidylserine exposure on blood platelet (GO:0097045)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of muscle adaptation (GO:0014745)	11	1	.05	+	21.70	1.00E00
positive regulation of muscle adaptation (GO:0014744)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of muscle hypertrophy (GO:0014742)	24	1	.10	+	9.94	1.00E00
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	194	4	.81	+	4.92	1.00E00
negative regulation of muscle hyperplasia (GO:0014740)	2	0	.01	-	 < 0.2	1.00E00
COP9 signalosome assembly (GO:0010387)	3	0	.01	-	 < 0.2	1.00E00
antibacterial peptide production (GO:0002778)	2	0	.01	-	 < 0.2	1.00E00
antimicrobial peptide biosynthetic process (GO:0002777)	1	0	.00	-	 < 0.2	1.00E00
antimicrobial peptide production (GO:0002775)	2	0	.01	-	 < 0.2	1.00E00
Fc receptor mediated inhibitory signaling pathway (GO:0002774)	3	0	.01	-	 < 0.2	1.00E00
cell wall polysaccharide metabolic process (GO:0010383)	1	0	.00	-	 < 0.2	1.00E00
mesodermal cell migration (GO:0008078)	4	0	.02	-	 < 0.2	1.00E00
protein linear polyubiquitination (GO:0097039)	3	0	.01	-	 < 0.2	1.00E00
heme export (GO:0097037)	1	0	.00	-	 < 0.2	1.00E00
regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.00	-	 < 0.2	1.00E00
regulation of membrane lipid distribution (GO:0097035)	40	1	.17	+	5.97	1.00E00
mitochondrial respiratory chain complex IV biogenesis (GO:0097034)	17	0	.07	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex III biogenesis (GO:0097033)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	5	0	.02	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex II biogenesis (GO:0097032)	5	0	.02	-	 < 0.2	1.00E00
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	16	0	.07	-	 < 0.2	1.00E00
mitochondrial respiratory chain complex I biogenesis (GO:0097031)	65	0	.27	-	 < 0.2	1.00E00
Arp2/3 complex-mediated actin nucleation (GO:0034314)	23	0	.10	-	 < 0.2	1.00E00
diol biosynthetic process (GO:0034312)	16	0	.07	-	 < 0.2	1.00E00
diol metabolic process (GO:0034311)	19	0	.08	-	 < 0.2	1.00E00
primary alcohol catabolic process (GO:0034310)	15	0	.06	-	 < 0.2	1.00E00
positive regulation of muscle hyperplasia (GO:0014739)	1	0	.00	-	 < 0.2	1.00E00
regulation of muscle hyperplasia (GO:0014738)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of muscle atrophy (GO:0014737)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of muscle atrophy (GO:0014736)	2	0	.01	-	 < 0.2	1.00E00
regulation of muscle atrophy (GO:0014735)	3	0	.01	-	 < 0.2	1.00E00
skeletal muscle hypertrophy (GO:0014734)	1	0	.00	-	 < 0.2	1.00E00
regulation of skeletal muscle adaptation (GO:0014733)	13	0	.05	-	 < 0.2	1.00E00
skeletal muscle atrophy (GO:0014732)	8	1	.03	+	29.83	1.00E00
natural killer cell inhibitory signaling pathway (GO:0002769)	2	0	.01	-	 < 0.2	1.00E00
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	6	0	.03	-	 < 0.2	1.00E00
immune response-inhibiting signal transduction (GO:0002765)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of myeloid leukocyte differentiation (GO:0002763)	52	2	.22	+	9.18	1.00E00
mature conventional dendritic cell differentiation (GO:0097029)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of myeloid leukocyte differentiation (GO:0002762)	49	1	.21	+	4.87	1.00E00
dendritic cell differentiation (GO:0097028)	32	1	.13	+	7.46	1.00E00
regulation of myeloid leukocyte differentiation (GO:0002761)	116	3	.49	+	6.17	1.00E00
positive regulation of antimicrobial humoral response (GO:0002760)	4	0	.02	-	 < 0.2	1.00E00
establishment of blood-nerve barrier (GO:0008065)	4	0	.02	-	 < 0.2	1.00E00
dendritic cell dendrite assembly (GO:0097026)	2	0	.01	-	 < 0.2	1.00E00
primary alcohol biosynthetic process (GO:0034309)	1	0	.00	-	 < 0.2	1.00E00
primary alcohol metabolic process (GO:0034308)	59	0	.25	-	 < 0.2	1.00E00
regulation of actin polymerization or depolymerization (GO:0008064)	166	3	.70	+	4.31	1.00E00
Toll signaling pathway (GO:0008063)	6	0	.03	-	 < 0.2	1.00E00
lymphocyte migration into lymph node (GO:0097022)	1	0	.00	-	 < 0.2	1.00E00
lymphocyte migration into lymphoid organs (GO:0097021)	3	0	.01	-	 < 0.2	1.00E00
regulation of the force of skeletal muscle contraction (GO:0014728)	2	0	.01	-	 < 0.2	1.00E00
regulation of twitch skeletal muscle contraction (GO:0014724)	4	0	.02	-	 < 0.2	1.00E00
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	5	0	.02	-	 < 0.2	1.00E00
twitch skeletal muscle contraction (GO:0014721)	3	0	.01	-	 < 0.2	1.00E00
regulation of antimicrobial humoral response (GO:0002759)	6	0	.03	-	 < 0.2	1.00E00
innate immune response-activating signal transduction (GO:0002758)	229	6	.96	+	6.25	1.00E00
immune response-activating signal transduction (GO:0002757)	508	9	2.13	+	4.23	1.00E00
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	33	0	.14	-	 < 0.2	1.00E00
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	33	0	.14	-	 < 0.2	1.00E00
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	35	0	.15	-	 < 0.2	1.00E00
cell surface pattern recognition receptor signaling pathway (GO:0002752)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045899)	10	0	.04	-	 < 0.2	1.00E00
negative regulation of anion channel activity (GO:0010360)	3	0	.01	-	 < 0.2	1.00E00
eye pigment granule organization (GO:0008057)	1	0	.00	-	 < 0.2	1.00E00
regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898)	13	0	.05	-	 < 0.2	1.00E00
renal protein absorption (GO:0097017)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of transcription during mitotic cell cycle (GO:0045897)	1	0	.00	-	 < 0.2	1.00E00
regulation of transcription during mitotic cell cycle (GO:0045896)	3	0	.01	-	 < 0.2	1.00E00
mitochondrial fusion (GO:0008053)	16	0	.07	-	 < 0.2	1.00E00
sensory organ boundary specification (GO:0008052)	1	0	.00	-	 < 0.2	1.00E00
response to granulocyte macrophage colony-stimulating factor (GO:0097012)	11	2	.05	+	43.39	1.00E00
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	11	2	.05	+	43.39	1.00E00
female courtship behavior (GO:0008050)	2	0	.01	-	 < 0.2	1.00E00
eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	2	0	.01	-	 < 0.2	1.00E00
skeletal muscle satellite cell activation (GO:0014719)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718)	2	0	.01	-	 < 0.2	1.00E00
regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717)	3	0	.01	-	 < 0.2	1.00E00
regulation of anion channel activity (GO:0010359)	9	0	.04	-	 < 0.2	1.00E00
male courtship behavior (GO:0008049)	1	0	.00	-	 < 0.2	1.00E00
energy homeostasis (GO:0097009)	16	0	.07	-	 < 0.2	1.00E00
positive regulation of cytokine secretion involved in immune response (GO:0002741)	7	2	.03	+	68.19	1.00E00
negative regulation of cytokine secretion involved in immune response (GO:0002740)	6	0	.03	-	 < 0.2	1.00E00
regulation of plasma lipoprotein particle levels (GO:0097006)	73	0	.31	-	 < 0.2	1.00E00
motor neuron axon guidance (GO:0008045)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of synaptic growth at neuromuscular junction (GO:0045887)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of smoothened signaling pathway (GO:0045880)	28	0	.12	-	 < 0.2	1.00E00
branchiomeric skeletal muscle development (GO:0014707)	3	0	.01	-	 < 0.2	1.00E00
striated muscle tissue development (GO:0014706)	279	7	1.17	+	5.99	1.00E00
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085032)	1	0	.00	-	 < 0.2	1.00E00
regulation of cytokine secretion involved in immune response (GO:0002739)	14	2	.06	+	34.09	1.00E00
negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737)	1	0	.00	-	 < 0.2	1.00E00
regulation of plasmacytoid dendritic cell cytokine production (GO:0002736)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of protein tyrosine kinase activity (GO:0061099)	27	2	.11	+	17.68	1.00E00
positive regulation of protein tyrosine kinase activity (GO:0061098)	44	2	.18	+	10.85	1.00E00
neuron recognition (GO:0008038)	32	0	.13	-	 < 0.2	1.00E00
positive regulation of dendritic cell cytokine production (GO:0002732)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein tyrosine kinase activity (GO:0061097)	75	4	.31	+	12.73	1.00E00
negative regulation of smoothened signaling pathway (GO:0045879)	27	0	.11	-	 < 0.2	1.00E00
cell recognition (GO:0008037)	194	1	.81	+	1.23	1.00E00
negative regulation of dendritic cell cytokine production (GO:0002731)	2	0	.01	-	 < 0.2	1.00E00
regulation of dendritic cell cytokine production (GO:0002730)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of sister chromatid cohesion (GO:0045876)	9	0	.04	-	 < 0.2	1.00E00
tRNA processing (GO:0008033)	121	1	.51	+	1.97	1.00E00
negative regulation of sister chromatid cohesion (GO:0045875)	5	0	.02	-	 < 0.2	1.00E00
positive regulation of phospholipid translocation (GO:0061092)	3	0	.01	-	 < 0.2	1.00E00
regulation of phospholipid translocation (GO:0061091)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of sequestering of zinc ion (GO:0061090)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of rhodopsin gene expression (GO:0045872)	2	0	.01	-	 < 0.2	1.00E00
extracellular matrix assembly (GO:0085029)	18	0	.08	-	 < 0.2	1.00E00
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	1	0	.00	-	 < 0.2	1.00E00
protein K6-linked ubiquitination (GO:0085020)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of natural killer cell cytokine production (GO:0002729)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of natural killer cell cytokine production (GO:0002728)	1	0	.00	-	 < 0.2	1.00E00
regulation of natural killer cell cytokine production (GO:0002727)	2	0	.01	-	 < 0.2	1.00E00
response to non-ionic osmotic stress (GO:0010335)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of T cell cytokine production (GO:0002726)	15	0	.06	-	 < 0.2	1.00E00
negative regulation of T cell cytokine production (GO:0002725)	9	0	.04	-	 < 0.2	1.00E00
regulation of T cell cytokine production (GO:0002724)	25	0	.10	-	 < 0.2	1.00E00
regulation of sequestering of zinc ion (GO:0061088)	10	0	.04	-	 < 0.2	1.00E00
positive regulation of histone H3-K27 methylation (GO:0061087)	6	0	.03	-	 < 0.2	1.00E00
regulation of B cell cytokine production (GO:0002721)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of cytokine production involved in immune response (GO:0002720)	36	2	.15	+	13.26	1.00E00
negative regulation of histone H3-K27 methylation (GO:0061086)	4	0	.02	-	 < 0.2	1.00E00
regulation of histone H3-K27 methylation (GO:0061085)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of protein refolding (GO:0061084)	4	0	.02	-	 < 0.2	1.00E00
regulation of protein refolding (GO:0061083)	4	0	.02	-	 < 0.2	1.00E00
myeloid leukocyte cytokine production (GO:0061082)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of proteolysis (GO:0045861)	349	6	1.46	+	4.10	1.00E00
maintenance of symbiont-containing vacuole by host (GO:0085018)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cytokine production involved in immune response (GO:0002719)	25	0	.10	-	 < 0.2	1.00E00
regulation of cytokine production involved in immune response (GO:0002718)	66	2	.28	+	7.23	1.00E00
positive regulation of natural killer cell mediated immunity (GO:0002717)	21	1	.09	+	11.36	1.00E00
negative regulation of natural killer cell mediated immunity (GO:0002716)	14	1	.06	+	17.05	1.00E00
membrane invagination (GO:0010324)	102	0	.43	-	 < 0.2	1.00E00
regulation of natural killer cell mediated immunity (GO:0002715)	37	1	.16	+	6.45	1.00E00
positive regulation of B cell mediated immunity (GO:0002714)	34	0	.14	-	 < 0.2	1.00E00
negative regulation of B cell mediated immunity (GO:0002713)	11	0	.05	-	 < 0.2	1.00E00
regulation of B cell mediated immunity (GO:0002712)	49	0	.21	-	 < 0.2	1.00E00
positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.00	-	 < 0.2	1.00E00
chaperone-mediated protein folding (GO:0061077)	66	0	.28	-	 < 0.2	1.00E00
positive regulation of T cell mediated immunity (GO:0002711)	34	1	.14	+	7.02	1.00E00
regulation of heart contraction (GO:0008016)	231	3	.97	+	3.10	1.00E00
negative regulation of T cell mediated immunity (GO:0002710)	19	0	.08	-	 < 0.2	1.00E00
negative regulation of neural retina development (GO:0061076)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of neural retina development (GO:0061075)	2	0	.01	-	 < 0.2	1.00E00
blood circulation (GO:0008015)	375	7	1.57	+	4.45	1.00E00
regulation of neural retina development (GO:0061074)	6	0	.03	-	 < 0.2	1.00E00
ciliary body morphogenesis (GO:0061073)	4	1	.02	+	59.66	1.00E00
iris morphogenesis (GO:0061072)	10	0	.04	-	 < 0.2	1.00E00
pH elevation (GO:0045852)	6	1	.03	+	39.78	1.00E00
pH reduction (GO:0045851)	46	0	.19	-	 < 0.2	1.00E00
regulation of T cell mediated immunity (GO:0002709)	57	1	.24	+	4.19	1.00E00
positive regulation of lymphocyte mediated immunity (GO:0002708)	79	1	.33	+	3.02	1.00E00
negative regulation of lymphocyte mediated immunity (GO:0002707)	40	1	.17	+	5.97	1.00E00
regulation of lymphocyte mediated immunity (GO:0002706)	126	1	.53	+	1.89	1.00E00
positive regulation of leukocyte mediated immunity (GO:0002705)	98	2	.41	+	4.87	1.00E00
negative regulation of leukocyte mediated immunity (GO:0002704)	50	1	.21	+	4.77	1.00E00
regulation of leukocyte mediated immunity (GO:0002703)	167	3	.70	+	4.29	1.00E00
positive regulation of production of molecular mediator of immune response (GO:0002702)	77	4	.32	+	12.40	1.00E00
regulation of hydrogen peroxide metabolic process (GO:0010310)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of production of molecular mediator of immune response (GO:0002701)	34	0	.14	-	 < 0.2	1.00E00
regulation of production of molecular mediator of immune response (GO:0002700)	118	4	.49	+	8.09	1.00E00
positive regulation of nitrogen utilization (GO:0045848)	1	0	.00	-	 < 0.2	1.00E00
protein localization to kinetochore involved in kinetochore assembly (GO:1903394)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of adherens junction organization (GO:1903393)	26	0	.11	-	 < 0.2	1.00E00
negative regulation of adherens junction organization (GO:1903392)	16	1	.07	+	14.92	1.00E00
negative regulation of striated muscle tissue development (GO:0045843)	45	2	.19	+	10.61	1.00E00
regulation of adherens junction organization (GO:1903391)	56	1	.23	+	4.26	1.00E00
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	21	2	.09	+	22.73	1.00E00
positive regulation of mitotic nuclear division (GO:0045840)	52	1	.22	+	4.59	1.00E00
ribonucleoside bisphosphate metabolic process (GO:0033875)	39	0	.16	-	 < 0.2	1.00E00
negative regulation of mitotic nuclear division (GO:0045839)	37	3	.16	+	19.35	1.00E00
positive regulation of membrane potential (GO:0045838)	13	2	.05	+	36.72	1.00E00
positive regulation of homophilic cell adhesion (GO:1903387)	1	0	.00	-	 < 0.2	1.00E00
sclerotome development (GO:0061056)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of membrane potential (GO:0045837)	10	0	.04	-	 < 0.2	1.00E00
myotome development (GO:0061055)	3	0	.01	-	 < 0.2	1.00E00
regulation of homophilic cell adhesion (GO:1903385)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of meiotic nuclear division (GO:0045836)	12	0	.05	-	 < 0.2	1.00E00
somite development (GO:0061053)	78	2	.33	+	6.12	1.00E00
negative regulation of meiotic nuclear division (GO:0045835)	13	0	.05	-	 < 0.2	1.00E00
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	6	2	.03	+	79.55	1.00E00
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of lipid metabolic process (GO:0045833)	84	2	.35	+	5.68	1.00E00
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382)	2	0	.01	-	 < 0.2	1.00E00
regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	13	2	.05	+	36.72	1.00E00
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of isotype switching (GO:0045830)	23	0	.10	-	 < 0.2	1.00E00
nucleoside bisphosphate catabolic process (GO:0033869)	1	0	.00	-	 < 0.2	1.00E00
nucleoside bisphosphate biosynthetic process (GO:0033866)	16	0	.07	-	 < 0.2	1.00E00
nucleoside bisphosphate metabolic process (GO:0033865)	39	0	.16	-	 < 0.2	1.00E00
positive regulation of NAD(P)H oxidase activity (GO:0033864)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of NAD(P)H oxidase activity (GO:0033861)	3	0	.01	-	 < 0.2	1.00E00
regulation of NAD(P)H oxidase activity (GO:0033860)	8	0	.03	-	 < 0.2	1.00E00
commitment of multipotent stem cells to neuronal lineage in forebrain (GO:0021898)	4	0	.02	-	 < 0.2	1.00E00
forebrain astrocyte development (GO:0021897)	2	0	.01	-	 < 0.2	1.00E00
forebrain astrocyte differentiation (GO:0021896)	2	0	.01	-	 < 0.2	1.00E00
cerebral cortex neuron differentiation (GO:0021895)	22	0	.09	-	 < 0.2	1.00E00
cerebral cortex GABAergic interneuron development (GO:0021894)	6	0	.03	-	 < 0.2	1.00E00
cerebral cortex GABAergic interneuron fate commitment (GO:0021893)	2	0	.01	-	 < 0.2	1.00E00
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	10	0	.04	-	 < 0.2	1.00E00
olfactory bulb interneuron development (GO:0021891)	7	0	.03	-	 < 0.2	1.00E00
cell growth involved in cardiac muscle cell development (GO:0061049)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of branching involved in lung morphogenesis (GO:0061048)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of branching involved in lung morphogenesis (GO:0061047)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of isotype switching (GO:0045829)	4	0	.02	-	 < 0.2	1.00E00
glucuronate metabolic process (GO:0019585)	21	0	.09	-	 < 0.2	1.00E00
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	2	1	.01	+	 > 100	1.00E00
regulation of branching involved in lung morphogenesis (GO:0061046)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of wound healing (GO:0061045)	65	3	.27	+	11.02	1.00E00
negative regulation of isoprenoid metabolic process (GO:0045827)	1	0	.00	-	 < 0.2	1.00E00
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	8	1	.03	+	29.83	1.00E00
facioacoustic ganglion development (GO:1903375)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of vascular wound healing (GO:0061044)	1	1	.00	+	 > 100	1.00E00
regulation of vascular wound healing (GO:0061043)	5	2	.02	+	95.46	1.00E00
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	3	0	.01	-	 < 0.2	1.00E00
vascular wound healing (GO:0061042)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of innate immune response (GO:0045824)	48	3	.20	+	14.92	1.00E00
positive regulation of heart contraction (GO:0045823)	35	1	.15	+	6.82	1.00E00
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of heart contraction (GO:0045822)	23	0	.10	-	 < 0.2	1.00E00
female gonad morphogenesis (GO:0061040)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of glycolytic process (GO:0045821)	18	0	.08	-	 < 0.2	1.00E00
negative regulation of glycolytic process (GO:0045820)	12	0	.05	-	 < 0.2	1.00E00
olfactory bulb interneuron differentiation (GO:0021889)	12	0	.05	-	 < 0.2	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	3	0	.01	-	 < 0.2	1.00E00
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	3	0	.01	-	 < 0.2	1.00E00
forebrain cell migration (GO:0021885)	61	3	.26	+	11.74	1.00E00
forebrain neuron development (GO:0021884)	31	0	.13	-	 < 0.2	1.00E00
regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment (GO:0021882)	3	0	.01	-	 < 0.2	1.00E00
Wnt-activated signaling pathway involved in forebrain neuron fate commitment (GO:0021881)	1	0	.00	-	 < 0.2	1.00E00
uterus morphogenesis (GO:0061038)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of cartilage development (GO:0061037)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of glycogen catabolic process (GO:0045819)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cartilage development (GO:0061036)	29	0	.12	-	 < 0.2	1.00E00
positive regulation of fear response (GO:1903367)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of glycogen catabolic process (GO:0045818)	1	0	.00	-	 < 0.2	1.00E00
regulation of cartilage development (GO:0061035)	62	0	.26	-	 < 0.2	1.00E00
regulation of fear response (GO:1903365)	8	0	.03	-	 < 0.2	1.00E00
olfactory bulb mitral cell layer development (GO:0061034)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cellular protein catabolic process (GO:1903364)	203	6	.85	+	7.05	1.00E00
positive regulation of gene expression, epigenetic (GO:0045815)	55	3	.23	+	13.02	1.00E00
secretion by lung epithelial cell involved in lung growth (GO:0061033)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of cellular protein catabolic process (GO:1903363)	69	1	.29	+	3.46	1.00E00
visceral serous pericardium development (GO:0061032)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of gene expression, epigenetic (GO:0045814)	83	1	.35	+	2.88	1.00E00
regulation of cellular protein catabolic process (GO:1903362)	287	7	1.20	+	5.82	1.00E00
endodermal digestive tract morphogenesis (GO:0061031)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of Wnt signaling pathway, calcium modulating pathway (GO:0045813)	1	0	.00	-	 < 0.2	1.00E00
protein localization to basolateral plasma membrane (GO:1903361)	7	1	.03	+	34.09	1.00E00
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	4	0	.02	-	 < 0.2	1.00E00
forebrain neuron differentiation (GO:0021879)	54	0	.23	-	 < 0.2	1.00E00
forebrain neuron fate commitment (GO:0021877)	11	0	.05	-	 < 0.2	1.00E00
Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874)	1	0	.00	-	 < 0.2	1.00E00
forebrain neuroblast division (GO:0021873)	8	0	.03	-	 < 0.2	1.00E00
forebrain generation of neurons (GO:0021872)	64	0	.27	-	 < 0.2	1.00E00
forebrain regionalization (GO:0021871)	24	0	.10	-	 < 0.2	1.00E00
eyelid development in camera-type eye (GO:0061029)	13	2	.05	+	36.72	1.00E00
Cajal-Retzius cell differentiation (GO:0021870)	1	0	.00	-	 < 0.2	1.00E00
establishment of endothelial barrier (GO:0061028)	28	0	.12	-	 < 0.2	1.00E00
arabinose metabolic process (GO:0019566)	2	0	.01	-	 < 0.2	1.00E00
regulation of Golgi organization (GO:1903358)	11	1	.05	+	21.70	1.00E00
umbilical cord development (GO:0061027)	2	0	.01	-	 < 0.2	1.00E00
cardiac muscle tissue regeneration (GO:0061026)	1	0	.00	-	 < 0.2	1.00E00
membrane fusion (GO:0061025)	174	0	.73	-	 < 0.2	1.00E00
positive regulation of endocytosis (GO:0045807)	122	4	.51	+	7.82	1.00E00
glycerol catabolic process (GO:0019563)	6	0	.03	-	 < 0.2	1.00E00
negative regulation of endocytosis (GO:0045806)	49	1	.21	+	4.87	1.00E00
L-ornithine transmembrane transport (GO:1903352)	4	0	.02	-	 < 0.2	1.00E00
cellular response to dopamine (GO:1903351)	14	1	.06	+	17.05	1.00E00
blood coagulation, extrinsic pathway (GO:0007598)	5	0	.02	-	 < 0.2	1.00E00
response to dopamine (GO:1903350)	14	1	.06	+	17.05	1.00E00
blood coagulation, intrinsic pathway (GO:0007597)	18	0	.08	-	 < 0.2	1.00E00
lactation (GO:0007595)	42	2	.18	+	11.36	1.00E00
forebrain ventricular zone progenitor cell division (GO:0021869)	6	0	.03	-	 < 0.2	1.00E00
forebrain radial glial cell differentiation (GO:0021861)	4	0	.02	-	 < 0.2	1.00E00
pyramidal neuron development (GO:0021860)	10	0	.04	-	 < 0.2	1.00E00
histidine catabolic process to glutamate and formate (GO:0019557)	4	0	.02	-	 < 0.2	1.00E00
histidine catabolic process to glutamate and formamide (GO:0019556)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of bicellular tight junction assembly (GO:1903348)	3	0	.01	-	 < 0.2	1.00E00
hepatoblast differentiation (GO:0061017)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of bicellular tight junction assembly (GO:1903347)	4	0	.02	-	 < 0.2	1.00E00
snRNA import into nucleus (GO:0061015)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mRNA catabolic process (GO:0061014)	38	0	.16	-	 < 0.2	1.00E00
regulation of mRNA catabolic process (GO:0061013)	175	4	.73	+	5.46	1.00E00
glutamate catabolic process to 2-oxoglutarate (GO:0019551)	2	0	.01	-	 < 0.2	1.00E00
glutamate catabolic process to aspartate (GO:0019550)	2	0	.01	-	 < 0.2	1.00E00
body fluid secretion (GO:0007589)	68	2	.28	+	7.02	1.00E00
hepatic duct development (GO:0061011)	1	0	.00	-	 < 0.2	1.00E00
excretion (GO:0007588)	46	0	.19	-	 < 0.2	1.00E00
gall bladder development (GO:0061010)	3	0	.01	-	 < 0.2	1.00E00
digestion (GO:0007586)	139	0	.58	-	 < 0.2	1.00E00
respiratory gaseous exchange (GO:0007585)	47	0	.20	-	 < 0.2	1.00E00
pyramidal neuron differentiation (GO:0021859)	11	0	.05	-	 < 0.2	1.00E00
GABAergic neuron differentiation in basal ganglia (GO:0021858)	1	0	.00	-	 < 0.2	1.00E00
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	3	0	.01	-	 < 0.2	1.00E00
hypothalamus cell migration (GO:0021855)	5	0	.02	-	 < 0.2	1.00E00
hypothalamus development (GO:0021854)	23	0	.10	-	 < 0.2	1.00E00
cerebral cortex GABAergic interneuron migration (GO:0021853)	5	0	.02	-	 < 0.2	1.00E00
pyramidal neuron migration (GO:0021852)	2	0	.01	-	 < 0.2	1.00E00
arginine catabolic process to ornithine (GO:0019547)	1	0	.00	-	 < 0.2	1.00E00
common bile duct development (GO:0061009)	5	0	.02	-	 < 0.2	1.00E00
arginine deiminase pathway (GO:0019546)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of vacuolar transport (GO:1903337)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of vacuolar transport (GO:1903336)	2	0	.01	-	 < 0.2	1.00E00
cell differentiation involved in kidney development (GO:0061005)	43	1	.18	+	5.55	1.00E00
regulation of vacuolar transport (GO:1903335)	5	0	.02	-	 < 0.2	1.00E00
pattern specification involved in kidney development (GO:0061004)	9	0	.04	-	 < 0.2	1.00E00
propionate biosynthetic process (GO:0019542)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of dendritic spine morphogenesis (GO:0061003)	17	0	.07	-	 < 0.2	1.00E00
propionate metabolic process (GO:0019541)	3	0	.01	-	 < 0.2	1.00E00
negative regulation of protein folding (GO:1903333)	5	0	.02	-	 < 0.2	1.00E00
negative regulation of dendritic spine morphogenesis (GO:0061002)	7	0	.03	-	 < 0.2	1.00E00
regulation of protein folding (GO:1903332)	7	0	.03	-	 < 0.2	1.00E00
regulation of dendritic spine morphogenesis (GO:0061001)	37	0	.16	-	 < 0.2	1.00E00
negative regulation of dendritic spine development (GO:0061000)	13	0	.05	-	 < 0.2	1.00E00
nucleolar fragmentation (GO:0007576)	1	0	.00	-	 < 0.2	1.00E00
age-dependent general metabolic decline (GO:0007571)	1	0	.00	-	 < 0.2	1.00E00
neuroblast division in subventricular zone (GO:0021849)	2	0	.01	-	 < 0.2	1.00E00
ventricular zone neuroblast division (GO:0021847)	3	0	.01	-	 < 0.2	1.00E00
cell proliferation in forebrain (GO:0021846)	27	0	.11	-	 < 0.2	1.00E00
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	8	1	.03	+	29.83	1.00E00
establishment of protein localization to endoplasmic reticulum (GO:0072599)	106	0	.44	-	 < 0.2	1.00E00
chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842)	2	1	.01	+	 > 100	1.00E00
directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840)	2	1	.01	+	 > 100	1.00E00
maintenance of protein localization in organelle (GO:0072595)	32	1	.13	+	7.46	1.00E00
reactive oxygen species metabolic process (GO:0072593)	103	4	.43	+	9.27	1.00E00
oxalate transport (GO:0019532)	12	0	.05	-	 < 0.2	1.00E00
oxygen metabolic process (GO:0072592)	3	0	.01	-	 < 0.2	1.00E00
taurine metabolic process (GO:0019530)	6	1	.03	+	39.78	1.00E00
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	203	4	.85	+	4.70	1.00E00
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	152	3	.64	+	4.71	1.00E00
regulation of protein modification by small protein conjugation or removal (GO:1903320)	293	4	1.23	+	3.26	1.00E00
parturition (GO:0007567)	19	0	.08	-	 < 0.2	1.00E00
embryo implantation (GO:0007566)	43	0	.18	-	 < 0.2	1.00E00
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	0	.01	-	 < 0.2	1.00E00
embryonic olfactory bulb interneuron precursor migration (GO:0021831)	1	0	.00	-	 < 0.2	1.00E00
interneuron migration from the subpallium to the cortex (GO:0021830)	8	1	.03	+	29.83	1.00E00
pentitol catabolic process (GO:0019527)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of protein maturation (GO:1903319)	24	1	.10	+	9.94	1.00E00
negative regulation of protein maturation (GO:1903318)	43	2	.18	+	11.10	1.00E00
regulation of protein maturation (GO:1903317)	172	3	.72	+	4.16	1.00E00
caveolin-mediated endocytosis (GO:0072584)	5	2	.02	+	95.46	1.00E00
clathrin-dependent endocytosis (GO:0072583)	47	0	.20	-	 < 0.2	1.00E00
D-gluconate metabolic process (GO:0019521)	2	0	.01	-	 < 0.2	1.00E00
regulation of nitrogen cycle metabolic process (GO:1903314)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of mRNA metabolic process (GO:1903313)	65	1	.27	+	3.67	1.00E00
aldonic acid metabolic process (GO:0019520)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of mRNA metabolic process (GO:1903312)	78	1	.33	+	3.06	1.00E00
regulation of mRNA metabolic process (GO:1903311)	279	5	1.17	+	4.28	1.00E00
endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199)	3	0	.01	-	 < 0.2	1.00E00
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	12	1	.05	+	19.89	1.00E00
tricuspid valve formation (GO:0003195)	2	0	.01	-	 < 0.2	1.00E00
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	3	0	.01	-	 < 0.2	1.00E00
pulmonary valve formation (GO:0003193)	2	0	.01	-	 < 0.2	1.00E00
mitral valve formation (GO:0003192)	3	0	.01	-	 < 0.2	1.00E00
postnatal olfactory bulb interneuron migration (GO:0021827)	2	0	.01	-	 < 0.2	1.00E00
substrate-independent telencephalic tangential migration (GO:0021826)	8	1	.03	+	29.83	1.00E00
substrate-dependent cerebral cortex tangential migration (GO:0021825)	5	0	.02	-	 < 0.2	1.00E00
atrioventricular valve formation (GO:0003190)	7	0	.03	-	 < 0.2	1.00E00
cerebral cortex tangential migration using cell-axon interactions (GO:0021824)	3	0	.01	-	 < 0.2	1.00E00
cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	2	0	.01	-	 < 0.2	1.00E00
glycine receptor clustering (GO:0072579)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822)	1	0	.00	-	 < 0.2	1.00E00
pentitol metabolic process (GO:0019519)	1	0	.00	-	 < 0.2	1.00E00
neurotransmitter-gated ion channel clustering (GO:0072578)	8	0	.03	-	 < 0.2	1.00E00
L-threonine catabolic process to glycine (GO:0019518)	2	0	.01	-	 < 0.2	1.00E00
endothelial cell apoptotic process (GO:0072577)	8	0	.03	-	 < 0.2	1.00E00
liver morphogenesis (GO:0072576)	5	0	.02	-	 < 0.2	1.00E00
lactate oxidation (GO:0019516)	2	0	.01	-	 < 0.2	1.00E00
response to phenylpropanoid (GO:0080184)	5	1	.02	+	47.73	1.00E00
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	4	0	.02	-	 < 0.2	1.00E00
positive regulation of regulated secretory pathway (GO:1903307)	47	1	.20	+	5.08	1.00E00
hepatocyte proliferation (GO:0072574)	4	0	.02	-	 < 0.2	1.00E00
negative regulation of regulated secretory pathway (GO:1903306)	22	0	.09	-	 < 0.2	1.00E00
histone H3-K4 trimethylation (GO:0080182)	15	0	.06	-	 < 0.2	1.00E00
tolerance induction to lipopolysaccharide (GO:0072573)	2	0	.01	-	 < 0.2	1.00E00
regulation of regulated secretory pathway (GO:1903305)	113	2	.47	+	4.22	1.00E00
peptidyl-proline hydroxylation (GO:0019511)	14	0	.06	-	 < 0.2	1.00E00
S-adenosylhomocysteine catabolic process (GO:0019510)	1	0	.00	-	 < 0.2	1.00E00
dosage compensation (GO:0007549)	12	0	.05	-	 < 0.2	1.00E00
sex differentiation (GO:0007548)	266	7	1.11	+	6.28	1.00E00
positive regulation of hexokinase activity (GO:1903301)	7	0	.03	-	 < 0.2	1.00E00
negative regulation of hexokinase activity (GO:1903300)	5	0	.02	-	 < 0.2	1.00E00
primary sex determination, germ-line (GO:0007542)	2	0	.01	-	 < 0.2	1.00E00
heart valve formation (GO:0003188)	13	0	.05	-	 < 0.2	1.00E00
tricuspid valve morphogenesis (GO:0003186)	5	0	.02	-	 < 0.2	1.00E00
sinoatrial valve morphogenesis (GO:0003185)	1	0	.00	-	 < 0.2	1.00E00
layer formation in cerebral cortex (GO:0021819)	14	0	.06	-	 < 0.2	1.00E00
pulmonary valve morphogenesis (GO:0003184)	12	1	.05	+	19.89	1.00E00
mitral valve morphogenesis (GO:0003183)	10	0	.04	-	 < 0.2	1.00E00
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817)	3	0	.01	-	 < 0.2	1.00E00
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	2	0	.01	-	 < 0.2	1.00E00
atrioventricular valve morphogenesis (GO:0003181)	21	1	.09	+	11.36	1.00E00
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	5	0	.02	-	 < 0.2	1.00E00
aortic valve morphogenesis (GO:0003180)	6	0	.03	-	 < 0.2	1.00E00
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	6	0	.03	-	 < 0.2	1.00E00
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.00	-	 < 0.2	1.00E00
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.01	-	 < 0.2	1.00E00
L-methionine salvage from methylthioadenosine (GO:0019509)	5	0	.02	-	 < 0.2	1.00E00
chemokine (C-X-C motif) ligand 2 production (GO:0072567)	3	0	.01	-	 < 0.2	1.00E00
lytic vacuole organization (GO:0080171)	55	0	.23	-	 < 0.2	1.00E00
type B pancreatic cell maturation (GO:0072560)	2	0	.01	-	 < 0.2	1.00E00
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	2	1	.01	+	 > 100	1.00E00
primary sex determination (GO:0007538)	3	0	.01	-	 < 0.2	1.00E00
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	1	0	.00	-	 < 0.2	1.00E00
mammary placode formation (GO:0060596)	3	0	.01	-	 < 0.2	1.00E00
fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595)	2	0	.01	-	 < 0.2	1.00E00
mammary gland specification (GO:0060594)	3	0	.01	-	 < 0.2	1.00E00
mammary gland formation (GO:0060592)	7	0	.03	-	 < 0.2	1.00E00
chondroblast differentiation (GO:0060591)	5	0	.02	-	 < 0.2	1.00E00
sex determination (GO:0007530)	23	1	.10	+	10.38	1.00E00
heart valve morphogenesis (GO:0003179)	35	2	.15	+	13.64	1.00E00
pulmonary valve development (GO:0003177)	12	1	.05	+	19.89	1.00E00
aortic valve development (GO:0003176)	6	0	.03	-	 < 0.2	1.00E00
tricuspid valve development (GO:0003175)	6	0	.03	-	 < 0.2	1.00E00
mitral valve development (GO:0003174)	11	0	.05	-	 < 0.2	1.00E00
sinoatrial valve development (GO:0003172)	1	0	.00	-	 < 0.2	1.00E00
atrioventricular valve development (GO:0003171)	24	1	.10	+	9.94	1.00E00
heart valve development (GO:0003170)	39	2	.16	+	12.24	1.00E00
cerebral cortex radial glia guided migration (GO:0021801)	24	0	.10	-	 < 0.2	1.00E00
cerebral cortex tangential migration (GO:0021800)	9	0	.04	-	 < 0.2	1.00E00
regulation of nitric oxide metabolic process (GO:0080164)	1	0	.00	-	 < 0.2	1.00E00
regulation of protein serine/threonine phosphatase activity (GO:0080163)	1	0	.00	-	 < 0.2	1.00E00
blood vessel lumenization (GO:0072554)	2	0	.01	-	 < 0.2	1.00E00
terminal button organization (GO:0072553)	4	0	.02	-	 < 0.2	1.00E00
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	1	0	.00	-	 < 0.2	1.00E00
neuromuscular junction development (GO:0007528)	37	0	.16	-	 < 0.2	1.00E00
negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	0	.00	-	 < 0.2	1.00E00
regulation of lipoprotein lipid oxidation (GO:0060587)	2	0	.01	-	 < 0.2	1.00E00
multicellular organismal iron ion homeostasis (GO:0060586)	9	0	.04	-	 < 0.2	1.00E00
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	3	0	.01	-	 < 0.2	1.00E00
somatic muscle development (GO:0007525)	4	0	.02	-	 < 0.2	1.00E00
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	3	0	.01	-	 < 0.2	1.00E00
visceral muscle development (GO:0007522)	1	0	.00	-	 < 0.2	1.00E00
cell fate determination involved in pattern specification (GO:0060582)	1	0	.00	-	 < 0.2	1.00E00
cell fate commitment involved in pattern specification (GO:0060581)	15	0	.06	-	 < 0.2	1.00E00
muscle cell fate determination (GO:0007521)	2	0	.01	-	 < 0.2	1.00E00
myoblast fusion (GO:0007520)	19	0	.08	-	 < 0.2	1.00E00
coronary vein morphogenesis (GO:0003169)	2	0	.01	-	 < 0.2	1.00E00
ventral spinal cord interneuron fate determination (GO:0060580)	1	0	.00	-	 < 0.2	1.00E00
Purkinje myocyte differentiation (GO:0003168)	1	0	.00	-	 < 0.2	1.00E00
atrioventricular bundle cell differentiation (GO:0003167)	1	0	.00	-	 < 0.2	1.00E00
bundle of His development (GO:0003166)	3	0	.01	-	 < 0.2	1.00E00
Purkinje myocyte development (GO:0003165)	2	0	.01	-	 < 0.2	1.00E00
His-Purkinje system development (GO:0003164)	4	0	.02	-	 < 0.2	1.00E00
sinoatrial node development (GO:0003163)	2	0	.01	-	 < 0.2	1.00E00
atrioventricular node development (GO:0003162)	3	0	.01	-	 < 0.2	1.00E00
cardiac conduction system development (GO:0003161)	11	1	.05	+	21.70	1.00E00
endocardium morphogenesis (GO:0003160)	6	0	.03	-	 < 0.2	1.00E00
regulation of fertilization (GO:0080154)	29	0	.12	-	 < 0.2	1.00E00
T-helper 17 cell lineage commitment (GO:0072540)	6	0	.03	-	 < 0.2	1.00E00
ventral spinal cord interneuron fate commitment (GO:0060579)	15	0	.06	-	 < 0.2	1.00E00
skeletal muscle tissue development (GO:0007519)	129	3	.54	+	5.55	1.00E00
myoblast fate determination (GO:0007518)	2	0	.01	-	 < 0.2	1.00E00
superior vena cava morphogenesis (GO:0060578)	1	0	.00	-	 < 0.2	1.00E00
muscle organ development (GO:0007517)	288	5	1.21	+	4.14	1.00E00
pulmonary vein morphogenesis (GO:0060577)	2	0	.01	-	 < 0.2	1.00E00
intestinal epithelial cell development (GO:0060576)	11	1	.05	+	21.70	1.00E00
intestinal epithelial cell differentiation (GO:0060575)	18	1	.08	+	13.26	1.00E00
intestinal epithelial cell maturation (GO:0060574)	4	1	.02	+	59.66	1.00E00
cell fate specification involved in pattern specification (GO:0060573)	11	0	.05	-	 < 0.2	1.00E00
morphogenesis of an epithelial bud (GO:0060572)	8	0	.03	-	 < 0.2	1.00E00
adult heart development (GO:0007512)	11	0	.05	-	 < 0.2	1.00E00
morphogenesis of an epithelial fold (GO:0060571)	20	2	.08	+	23.87	1.00E00
morphogenesis of an endothelium (GO:0003159)	11	0	.05	-	 < 0.2	1.00E00
endothelium development (GO:0003158)	87	3	.36	+	8.23	1.00E00
endocardium development (GO:0003157)	11	1	.05	+	21.70	1.00E00
regulation of animal organ formation (GO:0003156)	34	1	.14	+	7.02	1.00E00
outflow tract morphogenesis (GO:0003151)	68	2	.28	+	7.02	1.00E00
muscular septum morphogenesis (GO:0003150)	5	0	.02	-	 < 0.2	1.00E00
glycolate catabolic process (GO:0046296)	1	0	.00	-	 < 0.2	1.00E00
T-helper 17 cell differentiation (GO:0072539)	8	0	.03	-	 < 0.2	1.00E00
glycolate biosynthetic process (GO:0046295)	1	0	.00	-	 < 0.2	1.00E00
T-helper 17 type immune response (GO:0072538)	8	0	.03	-	 < 0.2	1.00E00
formaldehyde catabolic process (GO:0046294)	2	0	.01	-	 < 0.2	1.00E00
fibroblast activation (GO:0072537)	4	0	.02	-	 < 0.2	1.00E00
formaldehyde biosynthetic process (GO:0046293)	1	0	.00	-	 < 0.2	1.00E00
formaldehyde metabolic process (GO:0046292)	3	0	.01	-	 < 0.2	1.00E00
amino acid homeostasis (GO:0080144)	1	0	.00	-	 < 0.2	1.00E00
pyrimidine-containing compound transmembrane transport (GO:0072531)	16	0	.07	-	 < 0.2	1.00E00
purine-containing compound transmembrane transport (GO:0072530)	8	0	.03	-	 < 0.2	1.00E00
mesoderm migration involved in gastrulation (GO:0007509)	2	0	.01	-	 < 0.2	1.00E00
gonadal mesoderm development (GO:0007506)	8	0	.03	-	 < 0.2	1.00E00
positive regulation of DNA-templated transcription, termination (GO:0060566)	1	0	.00	-	 < 0.2	1.00E00
regulation of postsynaptic density protein 95 clustering (GO:1902897)	3	1	.01	+	79.55	1.00E00
terminal web assembly (GO:1902896)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895)	20	2	.08	+	23.87	1.00E00
negative regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902894)	11	0	.05	-	 < 0.2	1.00E00
neuroepithelial cell differentiation (GO:0060563)	46	2	.19	+	10.38	1.00E00
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893)	29	2	.12	+	16.46	1.00E00
epithelial tube morphogenesis (GO:0060562)	299	5	1.25	+	3.99	1.00E00
apoptotic process involved in morphogenesis (GO:0060561)	16	0	.07	-	 < 0.2	1.00E00
mesodermal cell fate specification (GO:0007501)	7	0	.03	-	 < 0.2	1.00E00
developmental growth involved in morphogenesis (GO:0060560)	112	0	.47	-	 < 0.2	1.00E00
mesodermal cell fate determination (GO:0007500)	3	0	.01	-	 < 0.2	1.00E00
membranous septum morphogenesis (GO:0003149)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of root hair elongation (GO:1902891)	1	0	.00	-	 < 0.2	1.00E00
outflow tract septum morphogenesis (GO:0003148)	25	0	.10	-	 < 0.2	1.00E00
regulation of root hair elongation (GO:1902890)	1	0	.00	-	 < 0.2	1.00E00
neural crest cell migration involved in heart formation (GO:0003147)	1	0	.00	-	 < 0.2	1.00E00
embryonic heart tube formation (GO:0003144)	1	0	.00	-	 < 0.2	1.00E00
embryonic heart tube morphogenesis (GO:0003143)	64	0	.27	-	 < 0.2	1.00E00
cardiogenic plate morphogenesis (GO:0003142)	1	0	.00	-	 < 0.2	1.00E00
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	6	0	.03	-	 < 0.2	1.00E00
pyrimidine-containing compound catabolic process (GO:0072529)	34	0	.14	-	 < 0.2	1.00E00
pyrimidine-containing compound biosynthetic process (GO:0072528)	43	0	.18	-	 < 0.2	1.00E00
pyrimidine-containing compound metabolic process (GO:0072527)	80	1	.34	+	2.98	1.00E00
pyridine-containing compound catabolic process (GO:0072526)	6	0	.03	-	 < 0.2	1.00E00
pyridine-containing compound biosynthetic process (GO:0072525)	35	0	.15	-	 < 0.2	1.00E00
pyridine-containing compound metabolic process (GO:0072524)	117	2	.49	+	4.08	1.00E00
purine-containing compound catabolic process (GO:0072523)	49	0	.21	-	 < 0.2	1.00E00
purine-containing compound biosynthetic process (GO:0072522)	141	2	.59	+	3.39	1.00E00
purine-containing compound metabolic process (GO:0072521)	421	3	1.76	+	1.70	1.00E00
seminiferous tubule development (GO:0072520)	11	1	.05	+	21.70	1.00E00
positive regulation of calcidiol 1-monooxygenase activity (GO:0060559)	3	0	.01	-	 < 0.2	1.00E00
protein localization to spindle microtubule (GO:1902889)	1	0	.00	-	 < 0.2	1.00E00
regulation of calcidiol 1-monooxygenase activity (GO:0060558)	7	0	.03	-	 < 0.2	1.00E00
positive regulation of vitamin D biosynthetic process (GO:0060557)	3	0	.01	-	 < 0.2	1.00E00
regulation of vitamin D biosynthetic process (GO:0060556)	9	1	.04	+	26.52	1.00E00
positive regulation of response to oxidative stress (GO:1902884)	22	1	.09	+	10.85	1.00E00
negative regulation of response to oxidative stress (GO:1902883)	45	1	.19	+	5.30	1.00E00
positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)	1	0	.00	-	 < 0.2	1.00E00
regulation of response to oxidative stress (GO:1902882)	82	2	.34	+	5.82	1.00E00
regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)	1	0	.00	-	 < 0.2	1.00E00
secondary heart field specification (GO:0003139)	9	0	.04	-	 < 0.2	1.00E00
primary heart field specification (GO:0003138)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of heart induction by canonical Wnt signaling pathway (GO:0003136)	1	0	.00	-	 < 0.2	1.00E00
endodermal-mesodermal cell signaling involved in heart induction (GO:0003134)	3	0	.01	-	 < 0.2	1.00E00
endodermal-mesodermal cell signaling (GO:0003133)	3	0	.01	-	 < 0.2	1.00E00
mesodermal-endodermal cell signaling (GO:0003131)	1	0	.00	-	 < 0.2	1.00E00
BMP signaling pathway involved in heart induction (GO:0003130)	3	0	.01	-	 < 0.2	1.00E00
proteasome core complex assembly (GO:0080129)	1	0	.00	-	 < 0.2	1.00E00
stilbene catabolic process (GO:0046272)	1	0	.00	-	 < 0.2	1.00E00
phenylpropanoid catabolic process (GO:0046271)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	4	0	.02	-	 < 0.2	1.00E00
trivalent inorganic cation transport (GO:0072512)	39	0	.16	-	 < 0.2	1.00E00
AMP transport (GO:0080121)	2	0	.01	-	 < 0.2	1.00E00
divalent inorganic cation transport (GO:0072511)	294	1	1.23	-	.81	1.00E00
CAAX-box protein maturation (GO:0080120)	3	0	.01	-	 < 0.2	1.00E00
regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of necrotic cell death (GO:0060547)	13	1	.05	+	18.36	1.00E00
negative regulation of necroptotic process (GO:0060546)	10	1	.04	+	23.87	1.00E00
positive regulation of necroptotic process (GO:0060545)	2	0	.01	-	 < 0.2	1.00E00
regulation of necroptotic process (GO:0060544)	20	1	.08	+	11.93	1.00E00
regulation of strand invasion (GO:0060542)	1	0	.00	-	 < 0.2	1.00E00
respiratory system development (GO:0060541)	196	5	.82	+	6.09	1.00E00
positive regulation of amacrine cell differentiation (GO:1902871)	2	0	.01	-	 < 0.2	1.00E00
heart induction (GO:0003129)	3	0	.01	-	 < 0.2	1.00E00
heart field specification (GO:0003128)	9	0	.04	-	 < 0.2	1.00E00
negative regulation of amacrine cell differentiation (GO:1902870)	1	0	.00	-	 < 0.2	1.00E00
detection of nodal flow (GO:0003127)	2	0	.01	-	 < 0.2	1.00E00
divalent inorganic cation homeostasis (GO:0072507)	425	4	1.78	+	2.25	1.00E00
trivalent inorganic anion homeostasis (GO:0072506)	12	0	.05	-	 < 0.2	1.00E00
divalent inorganic anion homeostasis (GO:0072505)	12	0	.05	-	 < 0.2	1.00E00
cellular divalent inorganic cation homeostasis (GO:0072503)	405	3	1.70	+	1.77	1.00E00
DNA demethylation (GO:0080111)	16	0	.07	-	 < 0.2	1.00E00
cellular trivalent inorganic anion homeostasis (GO:0072502)	9	0	.04	-	 < 0.2	1.00E00
cellular divalent inorganic anion homeostasis (GO:0072501)	9	0	.04	-	 < 0.2	1.00E00
diaphragm development (GO:0060539)	8	0	.03	-	 < 0.2	1.00E00
regulation of amacrine cell differentiation (GO:1902869)	3	0	.01	-	 < 0.2	1.00E00
skeletal muscle organ development (GO:0060538)	136	3	.57	+	5.26	1.00E00
positive regulation of retina development in camera-type eye (GO:1902868)	2	0	.01	-	 < 0.2	1.00E00
muscle tissue development (GO:0060537)	293	7	1.23	+	5.70	1.00E00
cartilage morphogenesis (GO:0060536)	12	1	.05	+	19.89	1.00E00
negative regulation of retina development in camera-type eye (GO:1902867)	1	0	.00	-	 < 0.2	1.00E00
regulation of retina development in camera-type eye (GO:1902866)	7	0	.03	-	 < 0.2	1.00E00
trachea cartilage morphogenesis (GO:0060535)	4	0	.02	-	 < 0.2	1.00E00
trachea cartilage development (GO:0060534)	8	0	.03	-	 < 0.2	1.00E00
bronchus cartilage development (GO:0060532)	2	0	.01	-	 < 0.2	1.00E00
propionyl-CoA biosynthetic process (GO:1902860)	1	0	.00	-	 < 0.2	1.00E00
detection of monosaccharide stimulus (GO:0034287)	3	0	.01	-	 < 0.2	1.00E00
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	2	0	.01	-	 < 0.2	1.00E00
response to disaccharide (GO:0034285)	7	0	.03	-	 < 0.2	1.00E00
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	4	0	.02	-	 < 0.2	1.00E00
response to monosaccharide (GO:0034284)	146	5	.61	+	8.17	1.00E00
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	6	0	.03	-	 < 0.2	1.00E00
propionyl-CoA metabolic process (GO:1902858)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of non-motile cilium assembly (GO:1902857)	8	0	.03	-	 < 0.2	1.00E00
prostate glandular acinus morphogenesis (GO:0060526)	6	0	.03	-	 < 0.2	1.00E00
prostate glandular acinus development (GO:0060525)	11	0	.05	-	 < 0.2	1.00E00
negative regulation of non-motile cilium assembly (GO:1902856)	2	0	.01	-	 < 0.2	1.00E00
regulation of non-motile cilium assembly (GO:1902855)	11	0	.05	-	 < 0.2	1.00E00
prostate epithelial cord elongation (GO:0060523)	3	0	.01	-	 < 0.2	1.00E00
activation of prostate induction by androgen receptor signaling pathway (GO:0060520)	1	1	.00	+	 > 100	1.00E00
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	93	1	.39	+	2.57	1.00E00
negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glomerular filtration by angiotensin (GO:0003106)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of glomerular filtration (GO:0003105)	6	0	.03	-	 < 0.2	1.00E00
positive regulation of glomerular filtration (GO:0003104)	4	0	.02	-	 < 0.2	1.00E00
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	5	0	.02	-	 < 0.2	1.00E00
terpene catabolic process (GO:0046247)	1	0	.00	-	 < 0.2	1.00E00
kynurenic acid biosynthetic process (GO:0034276)	1	0	.00	-	 < 0.2	1.00E00
kynurenic acid metabolic process (GO:0034275)	1	0	.00	-	 < 0.2	1.00E00
epithelial cell proliferation involved in prostatic bud elongation (GO:0060517)	1	0	.00	-	 < 0.2	1.00E00
regulation of neuronal signal transduction (GO:1902847)	1	0	.00	-	 < 0.2	1.00E00
primary prostatic bud elongation (GO:0060516)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.00	-	 < 0.2	1.00E00
prostatic bud formation (GO:0060513)	4	0	.02	-	 < 0.2	1.00E00
prostate gland morphogenesis (GO:0060512)	24	1	.10	+	9.94	1.00E00
Type II pneumocyte differentiation (GO:0060510)	5	0	.02	-	 < 0.2	1.00E00
Type I pneumocyte differentiation (GO:0060509)	5	0	.02	-	 < 0.2	1.00E00
regulation of nuclear migration along microtubule (GO:1902838)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of GTPase activity (GO:0034260)	46	0	.19	-	 < 0.2	1.00E00
bud dilation involved in lung branching (GO:0060503)	1	0	.00	-	 < 0.2	1.00E00
epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	6	0	.03	-	 < 0.2	1.00E00
coumarin catabolic process (GO:0046226)	2	0	.01	-	 < 0.2	1.00E00
aflatoxin catabolic process (GO:0046223)	1	0	.00	-	 < 0.2	1.00E00
aflatoxin metabolic process (GO:0046222)	2	0	.01	-	 < 0.2	1.00E00
regulation of urea metabolic process (GO:0034255)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of cellular amide metabolic process (GO:0034250)	132	5	.55	+	9.04	1.00E00
positive regulation of late endosome to lysosome transport (GO:1902824)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of late endosome to lysosome transport (GO:1902823)	2	0	.01	-	 < 0.2	1.00E00
regulation of late endosome to lysosome transport (GO:1902822)	4	0	.02	-	 < 0.2	1.00E00
indolalkylamine biosynthetic process (GO:0046219)	5	0	.02	-	 < 0.2	1.00E00
indolalkylamine catabolic process (GO:0046218)	10	0	.04	-	 < 0.2	1.00E00
nitric oxide catabolic process (GO:0046210)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of cellular amide metabolic process (GO:0034249)	159	2	.67	+	3.00	1.00E00
snoRNA splicing (GO:0034247)	2	0	.01	-	 < 0.2	1.00E00
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)	12	0	.05	-	 < 0.2	1.00E00
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	27	0	.11	-	 < 0.2	1.00E00
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of macrophage fusion (GO:0034241)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	2	0	.01	-	 < 0.2	1.00E00
nitric oxide metabolic process (GO:0046209)	17	1	.07	+	14.04	1.00E00
negative regulation of immune effector process (GO:0002698)	113	1	.47	+	2.11	1.00E00
spermine catabolic process (GO:0046208)	4	0	.02	-	 < 0.2	1.00E00
regulation of immune effector process (GO:0002697)	409	7	1.71	+	4.08	1.00E00
negative regulation of leukocyte activation (GO:0002695)	154	5	.65	+	7.75	1.00E00
nor-spermidine metabolic process (GO:0046204)	1	0	.00	-	 < 0.2	1.00E00
spermidine catabolic process (GO:0046203)	2	0	.01	-	 < 0.2	1.00E00
positive regulation of cellular extravasation (GO:0002693)	14	0	.06	-	 < 0.2	1.00E00
negative regulation of cellular extravasation (GO:0002692)	8	0	.03	-	 < 0.2	1.00E00
regulation of cellular extravasation (GO:0002691)	24	0	.10	-	 < 0.2	1.00E00
positive regulation of leukocyte chemotaxis (GO:0002690)	89	3	.37	+	8.04	1.00E00
regulation of macrophage fusion (GO:0034239)	3	0	.01	-	 < 0.2	1.00E00
regulation of skeletal muscle fiber differentiation (GO:1902809)	3	0	.01	-	 < 0.2	1.00E00
positive regulation of cell cycle G1/S phase transition (GO:1902808)	37	1	.16	+	6.45	1.00E00
islet amyloid polypeptide processing (GO:0034231)	1	0	.00	-	 < 0.2	1.00E00
positive regulation of synaptic vesicle transport (GO:1902805)	5	0	.02	-	 < 0.2	1.00E00
enkephalin processing (GO:0034230)	1	0	.00	-	 < 0.2	1.00E00
negative regulation of synaptic vesicle transport (GO:1902804)	8	0	.03	-	 < 0.2	1.00E00
regulation of synaptic vesicle transport (GO:1902803)	37	0	.16	-	 < 0.2	1.00E00
negative regulation of leukocyte chemotaxis (GO:0002689)	15	0	.06	-	 < 0.2	1.00E00
regulation of leukocyte chemotaxis (GO:0002688)	109	3	.46	+	6.57	1.00E00
positive regulation of leukocyte migration (GO:0002687)	123	4	.52	+	7.76	1.00E00
negative regulation of leukocyte migration (GO:0002686)	35	0	.15	-	 < 0.2	1.00E00
regulation of leukocyte migration (GO:0002685)	171	4	.72	+	5.58	1.00E00
somatic recombination of T cell receptor gene segments (GO:0002681)	5	0	.02	-	 < 0.2	1.00E00
tRNA thio-modification (GO:0034227)	5	0	.02	-	 < 0.2	1.00E00
lysine import (GO:0034226)	1	0	.00	-	 < 0.2	1.00E00
cellular response to zinc ion starvation (GO:0034224)	2	0	.01	-	 < 0.2	1.00E00
